<SEC-DOCUMENT>0001387131-17-001688.txt : 20170329
<SEC-HEADER>0001387131-17-001688.hdr.sgml : 20170329
<ACCEPTANCE-DATETIME>20170329103043
ACCESSION NUMBER:		0001387131-17-001688
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		79
CONFORMED PERIOD OF REPORT:	20161231
FILED AS OF DATE:		20170329
DATE AS OF CHANGE:		20170329

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NANOPHASE TECHNOLOGIES Corp
		CENTRAL INDEX KEY:			0000883107
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS PRIMARY METAL PRODUCTS [3390]
		IRS NUMBER:				363687863
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22333
		FILM NUMBER:		17721013

	BUSINESS ADDRESS:	
		STREET 1:		1319 MARQUETTE DRIVE
		CITY:			ROMEOVILLE
		STATE:			IL
		ZIP:			60446
		BUSINESS PHONE:		6303231200

	MAIL ADDRESS:	
		STREET 1:		1319 MARQUETTE DRIVE
		CITY:			ROMEOVILLE
		STATE:			IL
		ZIP:			60446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOPHASE TECHNOLOGIES CORPORATION
		DATE OF NAME CHANGE:	19970305
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>nanx-10k_123116.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>





<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 14pt">United
States</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 14pt">SECURITIES
AND EXCHANGE COMMISSION</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt">Washington, D.C.
20549</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 18pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 18pt">FORM
10-K</FONT></P>

<P STYLE="font: bold 18pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 12pt">&#9746;&nbsp;
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 12pt">OF
THE SECURITIES EXCHANGE ACT OF 1934</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">For the fiscal year
ended December 31, 2016</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">or</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>&#9744;&nbsp;
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) <FONT STYLE="font-family: Times New Roman Bold,serif; text-transform: uppercase">of
the Securities Exchange Act of 1934</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>FOR
THE TRANSITION PERIOD FROM _______ TO _______</B></FONT></P>

<P STYLE="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 10pt">Commission
File Number 000-22333</FONT></P>

<P STYLE="font: bold 18pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 24pt">NANOPHASE
TECHNOLOGIES CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">(Exact name of registrant
as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">(State or
        other jurisdiction</FONT></P>
        <P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">of incorporation
or organization)&nbsp;</FONT></P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>36-3687863</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer
        Identification No.)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>1319 Marquette
Drive, Romeoville, Illinois 60446</B><BR>
(Address of principal executive offices) (zip code)</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <B>(630) 771-6708</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Securities registered
pursuant to Section 12(b) of the Act: <B>None</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Securities registered
pursuant to Section 12(g) of the Act:</FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Common Stock, par value $.01 per share</B></FONT><BR>
<FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Indicate
by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744;&nbsp; No &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744;&nbsp; No &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Indicate
by check mark if the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes &#9746;&nbsp; No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&sect;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). &#9746;&nbsp; Yes &nbsp;&nbsp;&#9744;&nbsp; No</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not
be contained, to the best of registrant&rsquo;s knowledge, in definitive proxy or information statements incorporated by reference
in Part III of this Form 10-K or any amendment to this Form 10-K. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definition of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller
reporting company&rdquo; in Rule 12b-2 of the Exchange Act. (Check one):</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">Large accelerated filer &#9744;</FONT></TD>
    <TD STYLE="width: 55%; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">Accelerated filer &#9744;</FONT></TD>
    <TD STYLE="width: 20%; font-family: Times New Roman,serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">Non-accelerated filer &#9744;</FONT></TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">Smaller reporting company &#9746;</FONT></TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-family: CG Times,serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744;&nbsp; No &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
aggregate market value of the registrant&rsquo;s voting stock held by non-affiliates of the registrant based upon the last reported
sale price of the registrant&rsquo;s common stock on June 30, 2016 was $10,265,000 as of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
number of shares outstanding of the registrant&rsquo;s common stock, par value $.01, as of March 14, 2017 was 31,229,996.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>DOCUMENTS INCORPORATED
BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">None.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Table of Contents</U></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: top; width: 10%; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 80%; font-family: Times New Roman,serif; text-align: center"><A HREF="#nanx10k123116a001"><FONT STYLE="font-size: 10pt"><B>PART I</B></FONT></A></TD>
    <TD STYLE="vertical-align: bottom; width: 10%; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a002">Item 1.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a002">Business</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">3</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a003">General</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">3</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a004">Nanomaterials</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">4</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a005">Our Technologies</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">4</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a006">Marketing and Distribution Methods</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">5</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a007">Technology and Engineering</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">6</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a008">Manufacturing Operations</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a009">Intellectual Property and Proprietary Rights</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">7</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a010">Competition</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">7</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a011">Governmental Regulations, Including Climate Change</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">8</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a012">Employees</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">9</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a013">Backlog</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">9</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a014">Business Segment and Geographical Information</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">9</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a015">Key Customers</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">9</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a016">Forward-Looking Statements</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">10</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a017">Investor Information</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">10</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a018">Item 1A.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a018">Risk Factors</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">10</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a019">Item 1B.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a019">Unresolved Staff Comments</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">18</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a020">Item 2.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a020">Properties</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">18</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a021">Item 3.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a021">Legal Proceedings</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">19</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a022">Item 4.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a022">Mine Safety Disclosures</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">19</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center"><FONT STYLE="font-size: 10pt"><B><A HREF="#nanx10k123116a023">PART II</A></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a024">Item 5.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a024">Market for Registrant&rsquo;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">19</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a025">Item 6.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a025">Selected Financial Data</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">20</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a026">Item 7.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a026">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">20</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a027">Item 7A.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a027">Quantitative and Qualitative Disclosures About Market Risk</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a028">Item 8.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a028">Financial Statements and Supplementary Data</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a029">Item 9.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a029">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a030">Item 9A.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a030">Controls and Procedures</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a031">Item 9B.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a031">Other Information</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">25</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center"><FONT STYLE="font-size: 10pt"><B><A HREF="#nanx10k123116a032">PART III</A></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a033">Item 10.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a033">Directors, Executive Officers and Corporate Governance</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">25</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a034">Item 11.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a034">Executive Compensation</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">30</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a035">Item 12.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a035">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">36</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a036">Item 13.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a036">Certain Relationships and Related Transactions and Director Independence</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">37</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a037">Item 14.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a037">Principal Accountant Fees and Services</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">38</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center"><FONT STYLE="font-size: 10pt"><B><A HREF="#nanx10k123116a038">PART IV</A></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a039">Item 15.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a039">Exhibits and Financial Statement Schedules</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right">39</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a040">Item 16.</A></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><A HREF="#nanx10k123116a040">Form 10-K Summary</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif; text-align: right"><FONT STYLE="font-size: 10pt">39</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a001"></A>PART
I</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a002"></A>Item 1. Business</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><A NAME="nanx10k123116a003"></A>General </B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Nanophase
Technologies Corporation (&ldquo;Nanophase&rdquo; or the &ldquo;Company&rdquo;, including &ldquo;we&rdquo;, &ldquo;our&rdquo;
or &ldquo;us&rdquo;) is an advanced materials and applications developer and commercial manufacturer with an integrated family
of materials technologies. We produce engineered nano and sub-micron materials for use in a variety of diverse markets: personal
care including sunscreens, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives,
medical diagnostics, energy and a variety of surface finishing technologies (polishing) applications, including optics.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">While
our origin is based on the creation of nanoscale metal oxide products, we have expanded our offerings to include larger but still
sub-micron materials. We have developed techniques for managing attributes including particle size, shape, surface coatings, and
other valuable aspects of the material. Our focus is on customer need where we believe we have an advantage, as opposed to finding
uses for one particular technology. Additionally, as the format of delivery is important to customers, we have developed proprietary
capabilities for dispersing our materials into both aqueous (water-based) and solvent-based liquid media. These capabilities allow
us to better integrate with the customer&rsquo;s need and application. Finally, we have expanded our offerings beyond active ingredients
to include targeted full formulations of skin care products, marketed and sold by our wholly-owned subsidiary, Sol&eacute;sence
&trade; LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
target markets in which we believe practical solutions may be found using our products. We work closely with current and potential
customers in these target markets to identify their material and performance requirements. We market our materials to various
end-use applications manufacturers and our Sol&eacute;sence &trade; solutions to cosmetic and skin care brands. Recently developed
technologies have made certain new products possible and opened potential new markets. We expect growth in end-user (manufacturing
customers, including customers of our customers) adoption in 2017 and beyond. Our initiatives in targeted market areas are progressing
at differing rates of speed, but we have been broadly moving through testing and development cycles, and in a number of cases
believe we are approaching first revenue or next stage revenue with particular customers in the industries referenced above. During
2015 we were granted a patent on a new type of particle surface treatment (coating), which became the cornerstone of our new product
development in personal care, with first revenue recognized during 2016 and the creation of our Sol&eacute;sence &trade; LLC subsidiary
to manufacture and sell fully developed solutions to targeted customers in the skin care industry, in addition to the additives
we have traditionally sold in the personal care area. During 2015 and 2016 we developed and began to sell solutions in the energy
management (particularly solar control) industry. We believe that successful introduction of our materials with manufacturers
may lead to follow-on orders for other materials in their applications. Although our primary strategic focus has been the North
American market, we currently sell material to customers overseas and have been working to expand our reach within foreign markets.
The Company was incorporated in Illinois on November 25, 1989, and became a Delaware corporation during November 1997. Our common
stock trades on the OTCQB marketplace under the symbol NANX.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have created a leading commercial approach to the application of our integrated materials technologies designed to deliver an
optimal engineered solution for a target market or specific customer application. With respect to our products, we have complete
capability from application development and laboratory samples through pilot production and, finally, commercial production currently
at rates as high as hundreds of metric tons per year for individual products. We have development and application laboratories
and manufacturing capacity in two locations in the Chicago area. Our manufacturing is based on Lean Six Sigma discipline and is
certified to ISO 9001, American National Standard, Quality Management System Requirements; ISO 14001, American National Standard,
Environmental Management System Requirements; and is compliant with current Good Manufacturing Practices (&ldquo;cGMP&rdquo;)
for products under U.S. Food and Drug Administration (&ldquo;FDA&rdquo;) regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have undergone a strategic shift during recent years toward penetrating key markets via interactive applications development with
end-use customers in these markets. We also supply both nanoscale and larger materials, based on market requirement. We believe
this strategy leverages the applications development expertise we have cultivated over the last several years and best positions
us to build direct sales to end-use customers, in addition to translating these advantages through our market partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><A NAME="nanx10k123116a004"></A>Nanomaterials</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Nanomaterials
are generally comprised of particles (nanoparticles) that are less than 100 nanometers in diameter and these nanoparticles have
a wide range of unique properties owing to their very small size. A nanometer is one-billionth of a meter, or about 100,000 times
smaller in size than the width of a human hair.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Nanotechnology
involves manipulating the properties of materials, made up of basic elements or combinations thereof, at the 100-nanometer level
or below. At this scale, the relatively small number of constituent atoms, the large proportion of these atoms on surfaces, and
their confined dimensions lead materials to exhibit unique properties that can be used in many applications to benefit performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Nanomaterials
are an important and enabling part of the diverse field of nanotechnology and are the building blocks of our nanotechnology products.
The ultimate performance and value of Nanophase&rsquo;s products in a given application is a function of nanoparticle composition,
size, shape, structure, surface chemistry and coating and dispersion potential. Our technologies for engineering and manufacturing
nanomaterials, and our understanding of how to make nanomaterials exhibit desirable performance characteristics in various media,
result in commercial nanomaterials solutions that we believe offer superior performance in many applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Nanomaterials
have applications in diverse global markets where they are incorporated into a process, such as optics polishing, or a product,
such as an industrial coating to prevent degradation or aid in application, or significantly improve wear resistance, or promote/hamper
particular chemical reactions within respective systems. Multiple markets exist for our products since nanomaterials offer advantages
in many applications, such as improved properties and performance, longer wear or product life, lower overall product cost, or
in the development of new products or processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Most
of the raw materials we use are commercially available. In some cases, we rely on sole-source processors of materials that utilize
an array of worldwide sources for the raw materials that they process to our specifications. However, in certain cases we deal
with very limited supply of certain elements, such as those classified as &ldquo;Rare Earth&rdquo; elements- specifically cerium
oxide for use in surface finishing technologies (polishing) applications, as well as the very high purity zinc that we use in
personal care applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a005"></A>Our Technologies</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have created an integrated platform of commercial nanomaterial technologies that are patented, patent-pending or proprietary.
These technologies are designed to deliver a nanomaterial solution for a targeted market or a specific customer application. Our
platform provides flexibility and capability to engineer nanomaterials that meet a customer&rsquo;s performance requirements and
delivers our nanomaterial solutions in a readily usable format. Our technologies are scalable and robust, having produced several
hundred metric tons annually.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
nanomaterials platform includes two distinct manufacturing processes (PVS &ndash; Plasma Vapor Synthesis and NAS - NanoArc&reg;
Synthesis) to make nanomaterials or nanoparticles. These technologies allow us to control critical nanomaterial properties (composition,
size, shape, structure, surface chemistry) and engineer these attributes to meet specific application performance. Compared to
other well-developed known nanoparticle processes, our plasma-produced particles are produced as nonporous, dense, discrete single
crystals, which we believe possess a unique set of bulk and surface properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Perhaps
of greater importance, we have developed proprietary technology to disperse nanoparticles in both aqueous (water-based) and several
organic solvent systems. These dispersions are stable at high weight loading (typically 18-55% by weight). These aspects provide
distinct market advantages. Dispersed nanomaterials are desired by many customers for use in their processes or products because
of the ease of incorporation. As examples, dispersed nanomaterials are used in industrial coatings, plastic additives and optical
and semiconductor polishing. This integration flexibility allows us to serve more customers and serve them better, and is critical
to our role as a solutions provider, not simply that of a materials provider.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have also developed patented and proprietary technology to coat or surface treat nanoparticles to further engineer surface chemistry
by two main processes. In many applications, such as sunscreens, this technology is vital to ensure formulation compatibility
and, in some cases, optimal application performance. We deliver hundreds of metric tons of surface engineered nanoparticles to
our customers annually, including coated nanomaterials that are used by major global consumer products companies for sunscreens
and personal care products.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
markets continue to develop and grow, we believe that customers&rsquo; preferred delivery formats will often be dispersed and/or
coated nanomaterials. We believe we are well-positioned with our platform of integrated commercial nanomaterial technologies to
respond to this demand. We plan to maintain and advance our intellectual property and technologies to remain competitive in the
fields of nanomaterials development, applications development and commercialization.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have used our expertise in nanoscale materials to develop larger sub-micron particle&ndash;based products that are not considered
&ldquo;nano&rdquo; in various applications. Controlling aspects including particle size and shape, as well as surface chemistries,
allow us to provide superior materials to the marketplace in various formats, both at the nano level and above.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have steadily expanded our ability to commercially utilize and deliver our technologies. Through large-scale manufacturing of
nanomaterials utilized in the manufacture of consumer sunscreen and personal care products and architectural coatings, we have
developed production expertise that has allowed us to improve processes relating to those nanomaterials as well as processes relating
to other nanomaterials. This experience has translated into additional know-how, intellectual property and advances in the technologies
and manufacturing processes that reduce variable manufacturing costs and improve gross margins.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a006"></A>Marketing and Distribution Methods</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
focus our marketing strategy on differentiated solutions that create superior value for our customers. This customer-focused strategy
means we are not solely dependent upon the efforts of a distributor for future sales growth. We have found many cases where our
ability to effectively integrate nanomaterials into a customer&rsquo;s specific chemistry is critical to presenting an effective
solution. Given this reality, we launched a &ldquo;customer direct&rdquo; business model during 2009 for those markets that are
not conducive to an intermediary. In these markets, we interact with customers directly rather than through intermediaries, demonstrating
the benefits of our solutions in their products. Our deep market knowledge of certain markets and applications has allowed us
to understand customer needs and our products&rsquo; value proposition, and adapt our offerings accordingly. This knowledge, combined
with our applications development expertise, supports leveraging our development efforts by marketing and selling our solutions
to multiple customers within each market. We work closely with each customer to develop a material solution for that entity&rsquo;s
specific application(s), but we find that as we develop greater applications development expertise in a given area, specific applications
development often becomes a routine process within Nanophase. This is where we believe our future customers will perceive the
greatest value in working with us, and where we will be able to leverage our product development efforts into multiple revenue
generating customer solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
see this customer-focused marketing approach increasing our probability of success in many markets, allowing us to use an integrated
platform of material technologies and typically reducing the total time-to-market. The more our applications development scientists
and sales team work directly with customers to develop nanomaterial solutions, the more quickly and successfully we believe we
will be able to grow sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
addition to serving customers in diverse markets and geographic locations, we will continue to devote significant resources to
maintaining and growing our relationship with BASF Corporation (&ldquo;BASF&rdquo;), our largest customer in the personal care
market. This has been a successful relationship that we expect will contribute to our future growth. BASF, which describes itself
as the world&rsquo;s leading chemical company with revenue of approximately $100 billion, is a global leader in the personal care
market with recognized brands, significant revenues and sales reach. We have a long-term exclusive relationship with BASF, primarily
to provide zinc oxide-based products to be used in personal care with sunscreens and daily wear products being the dominant applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
addition to the personal care applications described above, our products are used in a variety of other applications, including
architectural coatings, polishing applications (including optical glass and CMP), plastics additives, medical diagnostics, textiles
and graphic arts, energy control applications, and others. Recent activities have expanded our presence in the personal care space,
with a new particle surface treatment process (coating) providing the basis for new product offerings. 2016 saw our first revenue
from products using our proprietary particle coating, which we look to expand under our new Sol&eacute;sence &trade; brand.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Because
our technology can be applied to a wide variety of applications, we focus our efforts on only a handful of applications to gain
a depth of knowledge and leverage our learning curve. If we find a unique application outside of our core markets that does not
require significant development resources then we may pursue it as &ldquo;opportunistic&rdquo; business. We believe this focused
approach will contribute to a higher success rate for related opportunities than we would experience by pursuing more opportunities
simultaneously.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a007"></A>Technology and Engineering</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
efforts in research and development, process engineering and advanced engineering groups are focused in three major areas: 1)
application development for our products; 2) creating or obtaining additional core material technologies and/or materials that
have the capability to serve multiple markets; and 3) continuing to improve our core technologies to improve manufacturing operations
and reduce costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Most
of our research and development is directly related to applications development. We endeavor to either meet specific customer
needs or to develop applications solutions to address unmet needs in a particular market where we believe our materials will offer
a distinct performance advantage. We believe that aggressively pursuing applications in targeted areas will help us compete as
a technical and commercial innovator using our materials expertise, and more importantly, become perceived as a solutions provider
by our customers and not simply as another materials supplier.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
total research and development expense, which includes all expenses relating to our technology and advanced engineering groups,
during the years ended December 31, 2016 and 2015, was $1.6 million and $1.3 million, respectively. This represents our share
of these expenses only and does not take into account amounts spent by any of our customers in support of new product development.
Our future success will depend in large part upon our ability to develop products which bring a high degree of value to our customers&rsquo;
products. Through the three-year period ended December 31, 2016, we had cumulative research and development expenses of approximately
$4 million and cumulative expenditures on equipment and leasehold improvements of approximately $0.7 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B><A NAME="nanx10k123116a008"></A>Manufacturing
Operations </B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have manufacturing capacity based in two locations in the Chicago area. At each of these facilities, we are able to develop and
supply nanomaterials in quantities ranging from grams to metric tons. Our facilities are certified to ISO 9001:2008 international
standards and are cGMP compliant for applicable bulk pharmaceutical manufacturing. We are also in the process of registering some
of the chemicals we ship to customers in Europe pursuant to the European Chemical Agency&rsquo;s regulations issued to date pertaining
to Registration Evaluation and Authorization of Chemicals (&ldquo;REACH&rdquo;). We have registered Zinc Oxide and Aluminum Oxide
under REACH and filed preliminary registrations for other materials. Our facilities are also certified to the international standard
for environmental management, ISO 14001:2004.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
operations employ a cellular, team-based manufacturing approach, where workers operate in work &ldquo;cells,&rdquo; under a lean
manufacturing environment to continuously advance and improve production capabilities. We have also developed a highly flexible
workforce that has been cross-trained to allow it to be employed broadly across our manufacturing processes. Our manufacturing
approach and targeted engineering actions have resulted in continuing process innovations and improvements that have reduced the
variable manufacturing cost significantly over the past several years.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are committed to a lean manufacturing approach, to the extent possible given a certain measure of irregular demand, where we are
able to reduce excess labor and manage the lowest practical inventory and supply levels in order to minimize working capital demands.
This approach complements two of our major operational goals - (1) to increase output without adding unnecessarily to existing
equipment and (2) to continually reduce production costs while consistently producing high quality products.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a009"></A>Intellectual Property and Proprietary
Rights</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
rely on a combination of patent, trademark, copyright, trade secret and other intellectual property laws, nondisclosure agreements
and other protective measures to protect our intellectual property. In addition to obtaining patent and trademarks based on our
inventions and products, we may also license certain third-party patents from time-to-time to expand our technology base.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
of the date of this filing, we own 11 U.S. patents and 1 pending U.S. patent application. We also own 34 foreign patents and patent
applications consisting of 26 issued or allowed foreign patents and 8 pending foreign patent applications. All of the pending
and owned foreign patents are counterparts to domestic filings covering our platform of nanotechnologies. Our oldest issued patents
began to expire during 2013. We do not believe that the expiration of these patents will have a material impact on our business
or financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a010"></A>Competition</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Within
each of our targeted markets and product applications, we face potential competition from advanced materials and chemical companies,
and suppliers of traditional materials. In many markets, the actual or potential competitors are larger and more diversified than
we are; however, we believe we focus in market segments and opportunities where our materials and related technologies are superior
to those of our competitors, often due to our ability to produce highly engineered products to meet specific performance requirements
and develop nanomaterial solutions for customers&rsquo; specific applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">With
respect to traditional suppliers, we may compete against lower priced traditional materials for certain customer applications.
In some product or process applications the benefits of using nanomaterials do not always justify a process change or outweigh
their frequently higher costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">With
respect to larger producers of nanomaterials, while many of these producers do not currently offer directly competitive products,
these companies may have greater financial and technical resources, larger research and development staffs, and greater manufacturing
and marketing capabilities, and could compete directly against us. In addition, the number of development-stage companies involved
in nanocrystalline materials continues to grow on a global basis, posing increasing competitive risks. Many of these companies
are associated with university or national laboratories and use chemical and physical methods to produce nanocrystalline materials.
We believe that most of these companies are engaged primarily in funded research and not commercial production; however, they
may represent competitive risks in the future. Some development-stage companies, especially in other countries, receive significant
government assistance or enjoy other benefits due to their location. We anticipate that foreign competition will play a greater
role in the nanomaterials arena in the future, something we are increasingly seeing today, albeit indirectly.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
addition to competition in the advanced materials and related markets, our Sol&eacute;sence &trade; LLC subsidiary faces competition
from a wide variety of offerings in the field of skin care. Sol&eacute;sence &trade; competes with existing solutions as well
as new solutions from a wide variety of sources, and must differentiate its value proposition in order to gain traction in this
marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
believe that our nanomaterial technologies and manufacturing platforms are strong. We believe we are well-positioned with our
platform of integrated commercial nanomaterial technologies and track record of technology improvement and evolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a011"></A>Governmental Regulations, Including
Climate Change</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
manufacture and use of certain of the products that contain our nanocrystalline materials are subject to governmental regulations.
As a result, we are required to adhere to the cGMP requirements of the FDA and similar regulations that include testing, control
and documentation requirements enforced by periodic inspections. We are also in the process of registering some of the chemicals
we ship to customers in Europe in compliance with the European Chemical Agency&rsquo;s regulations issued to date pertaining to
REACH (to date, we have registered Zinc Oxide and Aluminum Oxide under REACH and filed preliminary registrations for other materials).</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are committed to environmental health and safety (&ldquo;EH&amp;S&rdquo;). We believe we comply with all applicable exposure limit
standards issued by OSHA. Because nanotechnology remains an emerging and evolving science, there are no currently accepted standards,
measurements or personal protective equipment available that are specific to nanoparticle safety. Accordingly, we rely on general
chemical safety and process safety practices to identify safe personal protective equipment and appropriate handling protocols.
We believe that we have taken a leadership position on EH&amp;S in our operations and have internal and external review and monitoring
of our practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
addition, our facilities and operations are subject to the plant and laboratory safety requirements of various environmental and
occupational safety and health laws. We believe we are in compliance with all such laws and regulations, and to date, those regulations
have not materially restricted or impeded operations. Further, we believe our processes to be highly efficient, generating very
low levels of waste and emissions. For this reason, we do not view issues surrounding climate change and any currently foreseeable
related regulations as materially impacting our business and financial statements, beyond any inestimable impact on the macro-economic
environment.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have taken a responsible, proactive approach to EH&amp;S by implementing appropriate procedures and processes to have our facilities
certified to ISO 14001, American National Standard, Environmental Management System Requirements. We are also involved with leading
industry groups that are defining nanomaterial standards and protocols. These currently include the ASTM International Committee
on Nanotechnology, Nanoscale Materials Stewardship Program under the Toxic Substances Control Act, and the US TAG to ISO TC 229
Nanotechnology committee managed by the American National Standards Institute committee (ANSI). We also participate in FDA reviews
relative to cosmetic applications. We have a full-time, advanced degreed professional who spends a significant amount of time
managing governmental regulation compliance and EH&amp;S. We believe that our Company has an exemplary safety record.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a012"></A>Employees</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
December 31, 2016, we had a total of 46 full-time employees, 6 of whom hold advanced degrees. We have no collective bargaining
agreements and believe that we have a strong relationship with our employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><A NAME="nanx10k123116a013"></A>Backlog </B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
do not believe that a backlog as of any particular date is indicative of future results. Our sales are primarily pursuant to purchase
orders for delivery of our nanomaterials. We have some agreements that give customers the right to purchase a specific quantity
of nanomaterials during a specified time period. These agreements, however, do not obligate the customers to purchase any minimum
quantity of such nanomaterials. The quantities actually purchased by the customer, as well as the shipment schedules, are frequently
revised during the agreement term to reflect changes in the customer&rsquo;s needs. For these reasons we do not believe that such
agreements are meaningful for determining backlog amounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a014"></A>Business Segment and Geographical
Information</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt; font-weight: normal">Our
operations comprise a single business segment and all of our long-lived assets are located within the United States. See Note
13 to the accompanying Financial Statements for additional information.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a015"></A>Key Customers</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A
limited number of key customers account for a substantial portion of our commercial revenue. In particular, revenue from three
customers - our largest customer in personal care applications (BASF), our largest coatings customer, and our medical diagnostics
application customer - constituted approximately 69%, 5% and 4%, respectively, of our 2016 total revenue. Many of our customers
are significantly larger than we are and, therefore, may be able to exert a high degree of influence over us. While our agreements
with BASF are long-term agreements, they may be terminated by BASF under certain circumstances with reasonable notice and do not
provide any guarantees that BASF will buy our products. The loss of one of our largest customers or the failure to attract new
customers could have a material adverse effect on our business, results of operations and financial condition. Due to the high
concentration of sales to a limited number of customers, we have aggressively pursued new customers through our customer direct
business model. To the extent we are successful in adding a large number of customers through this model and maintaining or expanding
our existing partners, we believe we will be able to best manage the risks associated with customer concentration.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a016"></A>Forward-Looking Statements</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
want to provide investors with more meaningful and useful information. As a result, this Annual Report on Form 10-K (the &ldquo;Form
10-K&rdquo;) contains certain &ldquo;forward-looking statements&rdquo;, as defined in Section 21E of the Securities Exchange Act
of 1934, as amended (the &ldquo;Exchange Act&rdquo;). These statements reflect our current expectations of the future results
of our operations, performance and achievements. Forward-looking statements are covered under the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. We have tried, wherever possible, to identify these statements by using words
such as &ldquo;anticipates&rdquo;, &ldquo;believes&rdquo;, &ldquo;estimates&rdquo;, &ldquo;expects&rdquo;, &ldquo;plans&rdquo;,
&ldquo;intends&rdquo; and similar expressions. These statements reflect management&rsquo;s current beliefs and are based on information
now available to it. Accordingly, these statements are subject to certain risks, uncertainties and contingencies that could cause
our actual results, performance or achievements in 2017 and beyond to differ materially from those expressed in, or implied by,
such statements. These risks, uncertainties and factors include, without limitation: our ability to be consistently profitable
despite the losses we have incurred since our incorporation; a decision by a customer to cancel a purchase order or supply agreement
in light of our dependence on a limited number of key customers; the terms of our supply agreements with BASF which could
trigger a requirement to transfer technology and/or sell equipment to that customer; our potential inability to obtain working
capital when needed on acceptable terms or at all; our ability to obtain materials at costs we can pass through to our customers,
including Rare Earth elements, specifically cerium oxide, as well as high purity zinc; uncertain demand for, and acceptance of,
our nanocrystalline materials; our manufacturing capacity and product mix flexibility in light of customer demand; our limited
marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies;
our dependence on patents and protection of proprietary information; our ability to maintain an appropriate electronic trading
venue for our securities; the impact of any potential new governmental regulations that could be difficult to respond to or costly
to comply with; and the resolution of litigation or other legal proceedings in which we may become involved. In addition, our
forward-looking statements could be affected by general industry and market conditions and growth rates. Readers of this Form
10-K should not place undue reliance on any forward-looking statements. Except as required by federal securities laws, we undertake
no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B><A NAME="nanx10k123116a017"></A>Investor
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are subject to the informational requirements of the Exchange Act and, accordingly, file periodic reports, proxy statements and
other information with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;). Such reports, proxy statements and other
information may be obtained by visiting the Public Reference Room of the SEC at 100 F Street, N.E., Washington, DC 20549 or by
calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains an Internet site <B>(http://www.sec.gov)</B> that contains reports,
proxy and information statements and other information regarding issuers that file electronically.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Financial
and other information may also be accessed at our website. The address is <U>www.nanophase.com</U>. We make available, free of
charge, copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to
those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after
filing such material electronically with, or otherwise furnishing it to, the SEC, and intend to make all such reports and amendments
to reports available free of charge on our website. We have included our website address throughout this Form 10-K as textual
references only. The information contained on, or accessible through, our website is not incorporated into this Form 10-K.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt"><A NAME="nanx10k123116a018"></A>Item
</FONT><FONT STYLE="font-size: 10pt">1A. Risk Factors</FONT></P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">The
following factors, among others, could cause actual results to differ materially from those contained in forward-looking statements
made in this Annual Report on Form 10-K and presented elsewhere by management from time to time. Such factors may have a material
adverse effect on our business, financial condition, and results of operations, and you should carefully consider them before
deciding to invest in, or retain, shares of our common stock. Additional risks and uncertainties not presently known to us or
which are currently not believed to be material or which we have not predicted may also harm our business operations or affect
our actual results. Because of these and other factors, past performance should not be considered an indication of future performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><I>We have a history of losses that
may continue in the future. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">We
have incurred net losses in each year since our inception, with net losses of $1.3 million in 2016 and $1.2 million in 2015. As
of December 31, 2016, we had an accumulated deficit of approximately $95 million and may incur a loss on an annual basis during
2017. We believe that our business depends, among other things, on our ability to significantly increase revenue. If revenue fails
to grow at anticipated rates or if operating expenses increase without a commensurate increase in revenue, or if we fail to adjust
operating expense levels accordingly, then the imbalance between revenue and operating expenses will negatively impact our cash
balances and our ability to achieve profitability in future periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>We depend on a few major customers
for a high percentage of our sales, and the loss of orders from a significant customer could cause a decline in revenue and/or
increases in the level of losses incurred. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Sales
to our customers are executed pursuant to purchase orders and long-term supply contracts; however, customers can cease doing business
with us at any time with limited advance notice. It is possible that a significant portion of our future sales may remain concentrated
within a limited number of strategic customers. We may not be able to retain our strategic customers, such customers may cancel
or reschedule orders, or in the event of canceled orders, such orders may not be replaced by other sales or by sales that are
on as favorable terms. In addition, sales to any particular customer may fluctuate significantly from quarter to quarter, which
could affect our ability to achieve anticipated revenues on a quarterly basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Sales to our three
largest customers accounted for 69%, 5% and 4%, respectively, of our total revenue in 2016 and sales to these same customers accounted
for 63%, 4% and 7%, respectively, of our total revenue in 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">We
plan to expand both our marketing and business development efforts and our production efficiency in order to address the issues
of our dependence upon a limited amount of customers, enhancement of gross profit and operating cash flows, and the achievement
of profitability. Given the nature of our products, and the fact that markets for them are not yet fully developed, it is difficult
to accurately predict when additional large customers will materialize. Going forward, our margins, as a percentage of revenue,
will be dependent upon revenue mix, revenue volume, raw materials pricing, and our ability to effectively manage costs. The extent
of the growth in revenue volume and the related gross profit that this revenue generates will be the main drivers in generating
positive operating cash flows and, ultimately, net income.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Any downturn
in the product markets served by us would harm our business. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">A
majority of our products are incorporated into products such as personal care applications including sunscreens. Additional product
areas include architectural coatings, surface finishing technologies (polishing), medical diagnostics, solar control applications/energy
management, abrasion-resistant coatings and other products. These markets have from time to time experienced cyclical, depressed
business conditions, often in connection with, or in anticipation of, a decline in general economic conditions. These industry
downturns often result in reduced product demand and declining average selling prices. Our business would be harmed by a continuation
of any downturn and/or any future downturns in the markets that we serve.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><I>Our products often have long adoption
cycles, which could make it difficult to achieve market acceptance and makes it difficult to forecast revenues. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Due
to their often novel characteristics and potential unfamiliarity with them that exists in the marketplace, our nanomaterials may
require longer adoption cycles than existing materials technologies, to the point that adoption cycles typically require one to
five years. Our nanomaterials have to receive appropriate attention within any potential customer&rsquo;s organization, and then
they must be tested to prove a performance advantage over existing materials, typically on a systems-cost basis. Once we have
proven initial commercial viability, pilot scale production runs are typically required and completed by the customer, followed
by further testing. Once production-level commercial viability is established, then our nanomaterials can be introduced, often
to a downstream marketplace that needs to be familiarized with them. If we are unable to demonstrate to our potential customers
the performance advantages and economic value of our nanomaterials over existing and competing materials and technologies, we
will be unable to generate significant sales. Our long adoption cycle makes it difficult to predict when sales will occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>We frequently
depend on collaborative development relationships with our customers. If we are unable to initiate or sustain such collaborative
relationships or if the terms of these relationships limit the distribution of our products, then we may be unable to successfully
develop, manufacture or market our current and future nanomaterials or applications. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">We
have established, and will continue to pursue, strategic relationships with many of our customers and do not have a substantial
direct sales force or an established distribution network (other than distribution arrangements for research samples). Through
these relationships, we seek to develop new applications for our nanomaterials and share development and manufacturing resources.
We also seek to coordinate the development, manufacture and marketing of our nanomaterials products, particularly as a result
of our selling additives that must be integrated into complete formulations by the customer. Future success will depend, in part,
on our continued relationships with these customers and our ability to enter into similar strategic relationships with other customers.
Our customers may not continue in these collaborative development relationships, may not devote sufficient resources to the development
or sale of our materials or may enter into strategic development relationships with our competitors. These customers may also
require a share of control of these collaborative programs. While less prevalent than in the past, some of our agreements with
these customers limit our ability to license our technology to others and/or limit our ability to engage in certain product development
or marketing activities with others. These relationships generally can be terminated unilaterally by customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">If
we are unable to initiate or sustain such collaborative relationships or if the terms of these relationships materially limit
our access to distribution channels for our products, then we may be unable to successfully develop, manufacture or market our
current and future nanomaterials or applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>If commodity
metal prices increase at such a rate that we are unable to recover lost margins on a timely basis or that our products became
uncompetitive in their current marketplaces, our financial and liquidity position and results of operations would be substantially
harmed. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Many
of our significant raw materials come from commodity metal markets that may be subject to rapid price increases. While we generally
have been able to pass a significant portion of commodity &ldquo;price-related&rdquo; increases on to our customers, it is possible
that, given our limited customer base and the limited control we have over it, commodity metal prices could increase at such a
rate that could hinder our ability to recover lost margins from our customers. Such a potential challenge could be exacerbated
as our specifications often require particular grades/types of these materials, including certain materials that are classified
as &ldquo;Rare Earth&rdquo; elements and very high purity zinc, that are available in limited supply. It is also possible that
such drastic cost increases could render some of our materials uncompetitive in their current marketplaces when considered relative
to other materials on a cost benefit basis. If either of these potential results occurred, our financial and liquidity position
and results of operations would be substantially harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Protection
of our intellectual property is limited and uncertain. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Our
intellectual property is important to our business. We seek to protect our intellectual property through patent, trademark, copyright,
and trade secret protection and confidentiality or license agreements with our employees, customers, suppliers and others. Our
means of protecting our intellectual property rights in the United States or abroad may not be adequate and others, including
our competitors, may use our proprietary technology without our consent. We may not receive the necessary patent protection for
any applications pending with the U.S. Patent and Trademark Office (&ldquo;USPTO&rdquo;) and any of the patents that we currently
own or license may not be sufficient to keep competitors from using our materials or processes. In addition, patents that we currently
own or license may not be held valid if subsequently challenged by others and others may claim rights in the patents and other
proprietary technology that we own or license. Additionally, others may have already developed or may subsequently develop similar
products or technologies without violating any of our proprietary rights. If we fail to obtain or maintain patent protection or
preserve our trade secrets, we may be unable to effectively compete against others offering similar products and services. In
addition, if we fail to operate without infringing the proprietary rights of others or lose any license to technology that we
currently have or will acquire in the future, we may be unable to continue making the products that we currently make.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Moreover,
at times, attempts may be made to challenge the prior issuance of our patents. Furthermore, litigation may be necessary to enforce
our intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights
of others, or to defend against claims of infringement or invalidity. Such litigation could result in substantial costs and diversion
of resources and could harm our business, operating results and financial condition. Such litigation might occur with parties
that have substantially greater resources, and thus more capability to engage and continue litigation. In addition, if others
assert that our technology infringes their intellectual property rights, resolving the dispute could divert our management team
and financial resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Due
to the expanding length of time required in order to obtain a patent, and the inherent ongoing risks of the protections truly
provided by any patent, we made a decision during 2008 that we could no longer place a value on these intangible assets. In the
future, we may license certain of our intellectual property, such as trademarks, to third parties. While we would attempt to ensure
that any licensees maintain the quality and value of our brand, these licenses might diminish this quality and value.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>If a catastrophe
strikes either of our manufacturing facilities or if we were to lose our lease for either facility due to non-renewal or other
unforeseen events, we may be unable to manufacture our materials to meet customers&rsquo; demands. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Our
manufacturing facilities are located near Chicago - in Romeoville and Burr Ridge, Illinois. These facilities and some of our manufacturing
and testing equipment would be difficult to replace in a timely manner. Therefore, any material disruption at one of our facilities
due to a natural or man-made disaster or a loss of lease due to non-renewal or other unforeseen events could have a material adverse
effect on our ability to manufacture products to meet customers&rsquo; demands. While we maintain property insurance, this insurance
may not adequately compensate us for all losses that we may incur in the event of a material interruption in our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;<FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>If we are
unable to expand our production capabilities to meet unexpected demand, we may be unable to manage our growth and our business
would suffer. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Our
success will depend, in part, on our ability to manufacture nanomaterials in significant quantities, with consistent quality and
in an efficient and timely manner. We expect to be able to expand our current facilities or obtain additional facilities in the
future, and outsource production aspects as necessary, available and appropriate, in order to respond to unexpected demand for
existing materials or for new materials that we do not currently make in quantity. Such unplanned demand, if it resulted in rapid
expansion, could create a situation where growth could become difficult to manage, which could cause us to lose potential revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Our industry
is experiencing rapid changes in technology. If we are unable to keep pace with these changes, our business may not grow. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Rapid
changes have occurred, and are likely to continue to occur, in the development of advanced materials and processes. Our success
will depend, in large part, upon our ability to keep pace with advanced materials technologies, industry standards and market
trends and to develop and introduce new and improved products on a timely basis. We expect to commit substantial resources to
develop our technologies and product applications and, in the future, to expand our commercial manufacturing capacity as volume
grows. Our development efforts may be rendered obsolete by the research efforts and technological advances of others and other
advanced materials may prove more advantageous than those we produce.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>The markets
we serve are highly competitive, and if we are unable to compete effectively, then our business will not grow. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">The
advanced materials industry is new, rapidly evolving and intensely competitive, and we expect competition to intensify in the
future. The market for materials having the characteristics and potential uses of our nanomaterials is the subject of intensive
research and development efforts by both governmental entities and private enterprises around the world. We believe that the level
of competition will increase further as more product applications with significant commercial potential are developed. The nanomaterials
product applications that we are developing will compete directly with products incorporating both conventional and advanced materials
and technologies. While commercially available competitive products may not possess the same attributes as those we offer, other
companies may develop and introduce new or competitive products. Our competitors may succeed in developing or marketing materials,
technologies and better or less expensive products than the ones we offer. In addition, many of our potential competitors have
substantially greater financial and technical resources, and greater manufacturing and marketing capabilities than we do. If we
fail to provide nanomaterials at an acceptable price, or otherwise compete on a commodity basis with producers of conventional
materials, we will lose market share and revenue to our competitors.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>We may need
to raise additional capital in the future, which may not be available on acceptable terms or at all. If we are unable to obtain
adequate funds, we may be required to delay, scale-back or eliminate some of our manufacturing and marketing operations or we
may need to obtain funds through arrangements on less favorable terms or we may be required to sell key production equipment to
our largest customer. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">We
expect to expend resources on research, development and product testing, and in expanding current capacity or capability for new
business. In addition, we may incur significant costs in preparing, filing, prosecuting, maintaining and enforcing our patents
and other proprietary rights. We may need additional financing if we were to lose an existing customer or suffer a significant
decrease in revenue from one or more of our customers. If necessary, we may seek funding through public or private financing and
through contracts with governmental entities or other companies. Additional financing may not be available on acceptable terms
or at all. If we are unable to obtain adequate funds, we may be required to delay, scale-back or eliminate some of our manufacturing
and marketing operations or we may need to obtain funds through arrangements on less favorable terms. Such circumstances could
raise doubt as to our ability to continue as a going concern. If we obtain funding on unfavorable terms, we may be required to
relinquish rights to some of our intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">To raise additional
funds in the future, we would likely sell our equity or debt securities or enter into loan agreements. To the extent that we issue
debt securities or enter into loan agreements, we may become subject to financial, operational and other covenants that we must
observe. In the event that we were to breach any of these covenants, then the amounts due under such loans or debt securities
could become immediately payable by us, which could significantly harm us. To the extent that we sell additional shares of our
equity securities, our stockholders may face economic dilution and dilution of their percentage of ownership.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">We
currently have a supply agreement with BASF that contains provisions which could potentially result in a mandatory license of
technology and/or sale of production equipment to BASF, providing capacity sufficient to meet BASF&rsquo;s production needs. Under
our supply agreement with BASF, a &ldquo;triggering event&rdquo; also would occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 24.5pt; font: 10pt Times New Roman,serif; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; font: 10pt Times New Roman,serif; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman,serif; text-align: justify"><FONT STYLE="font-size: 10pt">if our
    earnings for a twelve month period ending with our most recently published quarterly financial statements are less than zero
    and our cash, cash equivalents and certain investments are less than $1 million, or </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 24.5pt; font: 10pt Times New Roman,serif; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; font: 10pt Times New Roman,serif; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman,serif; text-align: justify"><FONT STYLE="font-size: 10pt">upon
    the acceleration of any debt maturity having a principal amount of more than $10 million, or if we become insolvent as defined
    in the supply agreement. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">In
the event of a triggering event where we are required to sell to BASF production equipment providing capacity sufficient to meet
BASF&rsquo;s production needs, the equipment would be sold at either 115% of the equipment&rsquo;s net book value or at the greater
of 30% of the original book value of such equipment (including any associated upgrades to it) or 115% of the equipment&rsquo;s
net book value, depending on the particular equipment and contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">If
we were determined to have materially breached certain other provisions of our supply agreement with BASF, we similarly could
be subject to a &ldquo;triggering event&rdquo; that potentially could result in a mandatory license of technology and/or sale
of certain production equipment to the customer.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">If
a triggering event were to occur and BASF elected to proceed with the license and related sale mentioned above, we would lose
both significant revenue and the ability to generate significant revenue to replace that which was lost in the near term. Replacement
of necessary equipment that would be purchased and removed by the customer pursuant to this triggering event could take in excess
of 12 months. Any additional capital outlays required to rebuild capacity would probably be greater than the proceeds from the
purchase of the assets pursuant to our agreement with BASF. This potential shortfall might put us in a position where it would
be difficult to secure additional funding given what would then be an already tenuous cash position. Such an event would also
likely result in the loss of many of our key staff and line employees due to economic realities. We believe that our employees
are a critical component of our success and would be difficult to quickly replace and train. Upon the occurrence of such an event,
we might not be able to hire and retrain skilled employees given the stigma relating to such an event and its impact on us. We
might elect to effectively reduce our size and staffing to a point where we could remain a going concern in the near term.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><I>We depend on key personnel, and
their unplanned departure could harm our business. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Our
success will depend, in large part, upon our ability to attract and retain highly qualified research and development, management,
manufacturing, marketing and sales personnel on favorable terms. Due to the specialized nature of our business, we may have difficulty
locating, hiring and retaining qualified personnel on favorable terms. If we were to lose the services of any of our key executive
officers or other key personnel, or if we are unable to attract and retain other skilled and experienced personnel on acceptable
terms in the future, or if we are unable to implement a succession plan to prepare qualified individuals to assume key roles upon
any loss of our key personnel, then our business, results of operations and financial condition could be materially harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>We face potential
product liability risks which could result in significant costs that exceed our insurance coverage, damage our reputation and
harm our business. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">We
may be subject to product liability claims in the event that any of our products are alleged to be defective or cause harmful
effects to humans or physical environments. Because our nanomaterials are used in other companies&rsquo; products, to the extent
our customers become subject to suits relating to their products, these claims may also be asserted against us. As our Sol&eacute;sence
&trade; LLC subsidiary sells fully formulated skin care products to firms in that space, we are now supplying completed products
in addition to ingredients. We may incur significant costs including payment of significant damages, in defending or settling
product liability claims. Although we maintain insurance for product liability claims, our coverage may not prove sufficient.
Even if a suit is without merit and regardless of the outcome, claims can divert management time and attention, injure our reputation
and adversely affect demand for our nanomaterials.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>We may be
subject to periodic litigation and other regulatory proceedings or governmental investigations, which could result in the unexpected
expenditure of time and resources. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">From
time to time, we may be a defendant in lawsuits and regulatory proceedings or are the subject of governmental investigations relating
to our business. Due to the inherent uncertainties of litigation, regulatory proceedings and governmental investigations, we cannot
accurately predict the ultimate outcome of any such proceedings or investigations. An unfavorable outcome could have a material
adverse impact on our business, financial condition and results of operations. In addition, regardless of the outcome of any litigation,
regulatory proceedings or governmental investigations, such matters are expensive and will require that we devote substantial
resources and executive time to defend, thereby diverting management&rsquo;s attention and resources that are needed to successfully
run our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>The disclosure
requirements under the &ldquo;conflict minerals&rdquo; provisions of the Dodd-Frank Act could increase our costs and limit the
supply of certain metals used in our products and affect our reputation with customers and shareholders. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Under the Dodd-Frank
Wall Street Reform and Consumer Protection Act of 2010, as amended, or the Dodd-Frank Act, the SEC adopted disclosure requirements,
which became effective in 2014, for public companies using certain minerals and metals in their products. These minerals and metals
are generally referred to as &ldquo;conflict minerals&rdquo; regardless of their country of origin. Commercial sales of our products
containing these materials began during 2015. Under these rules, we are required to perform due diligence and disclose our efforts
to prevent the sourcing of such conflict minerals from the Democratic Republic of Congo or adjoining countries. As a result of
these regulations, we have incurred and expect to continue to incur costs to comply with the disclosure requirements, including
costs related to determining the source of any of the conflict minerals used in our products. These new requirements could also
adversely affect the sourcing, availability and pricing of such minerals, and the pool of suppliers who provide &ldquo;conflict
free&rdquo; metals may be limited. As a result, we or our suppliers may not be able to obtain materials necessary for production
of our products in sufficient quantities or at competitive prices. In addition, we may not be able to sufficiently verify the
origins of all metals used in our products and confirm that they are &ldquo;conflict free,&rdquo; which may adversely affect our
reputation.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>We are subject
to governmental regulations. The costs of compliance and liability for noncompliance with governmental regulations could have
a material adverse effect on our business, results of operations and financial condition. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Current
and future laws and regulations may require us to make substantial expenditures for preventive or remedial action. Our operations,
business or assets may be materially and adversely affected by governmental interpretation and enforcement of current or future
environmental, health and safety laws and regulations. In addition, our coating and dispersion operations may pose a risk of accidental
contamination or injury. The damages in the event of an accident or the costs to prevent or remediate a related event could exceed
both the amount of our liability insurance and our resources or otherwise have a material adverse effect on our business, results
of operations and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">In
addition, both of our facilities and all of our operations are subject to the plant and laboratory safety requirements of various
occupational safety and health laws. We believe we have complied in all material respects with governmental regulations applicable
to us. However, we may have to incur significant costs in defending or settling future claims of alleged violations of governmental
regulations and compliance with these regulations may materially restrict or impede our operations in the future. In addition,
our efforts to comply with or contest any regulatory actions may distract personnel or divert resources from other important initiatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">The
manufacture and use of certain products that contain our nanomaterials are subject to extensive governmental regulation, including
regulations promulgated by the FDA, the U.S. Environmental Protection Agency and OSHA. As a result, we are required to adhere
to the requirements of the regulations of governmental authorities in the United States and other countries, including regulations
issued to date pertaining to REACH. These regulations could increase our cost of doing business and may render some potential
markets prohibitively expensive. In addition, new rules or regulations could impose restrictions or prohibitions on certain materials
being marketed with or incorporated into certain applications, which could limit our ability to sell our nanomaterials in the
marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>A large investor
and his affiliates have significant influence on all matters requiring stockholder approval because they beneficially own a large
percentage of our common stock and they may vote their shares of common stock in ways with which other stockholders disagree.
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">As
of March 14, 2017, Bradford T. Whitmore, together with his affiliates, Grace Brothers, Ltd. and Grace Investments, Ltd., beneficially
owned approximately 43% of the outstanding shares of our common stock. The current ownership position of Mr. Whitmore and his
affiliates could delay, deter or prevent a change of control or adversely affect the price that investors might be willing to
pay in the future for shares of our common stock. The interests of Mr. Whitmore and his affiliates may differ from the interests
of our other stockholders and they may vote the common stock they beneficially own in ways with which our other stockholders disagree.
R. Janet Whitmore, one of our directors since 2003 and a stockholder, is the sister of Mr. Whitmore.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>We have never
paid dividends. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">We
currently intend to retain earnings, if any, to support our growth strategy. We do not anticipate paying dividends on our stock
in the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Additional
sales, or the availability for sale, of substantial amounts of our common stock could adversely affect the value of our common
stock. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">No
prediction can be made as to the effect, if any, that future sales of our common stock, or the availability of our common stock
for future sales, will have on the market price of our common stock. Sales of substantial amounts of our common stock in the public
market and the availability of shares for future sale could adversely affect the prevailing market price of our common stock.
This in turn could impair our future ability to raise capital through an offering of our equity securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>There may
be future sales or other dilution of our equity, which may adversely affect the market price of our common stock. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">To
the extent of our authorized but unissued shares pursuant to our certificate of incorporation, as amended, we are not restricted
from issuing additional shares of common stock, including any securities that are convertible into or exchangeable for, or that
represent the right to receive, common stock. The market price of our common stock could decline as a result of future sales of
our common stock or the perception that such sales could occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Provisions
in our certificate of incorporation, our by-laws, and Delaware law could make it more difficult for a third party to acquire us,
discourage a takeover, and adversely affect existing stockholders. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">Our
certificate of incorporation, our by-laws and the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;) contain provisions
that may have the effect of making more difficult, delaying or deterring attempts by others to obtain control of our Company,
even when these attempts may be in the best interests of stockholders. These include provisions on our maintaining a classified
Board of Directors and limiting the stockholders&rsquo; powers to remove directors or take action by written consent instead of
at a stockholders&rsquo; meeting. Our certificate of incorporation also authorizes our Board of Directors, without stockholder
approval, to issue one or more series of preferred stock, which could have voting and conversion rights that adversely affect
or dilute the voting power of the holders of common stock. The DGCL also imposes conditions on certain business combination transactions
with &ldquo;interested stockholders.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">These
provisions and others that could be adopted in the future could deter unsolicited takeovers or delay or prevent changes in our
control or management, including transactions in which stockholders might otherwise receive a premium for their shares over then
current market prices. These provisions may also limit the ability of stockholders to approve transactions that they may deem
to be in their best interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Failure to
protect the integrity and security of individually identifiable data of our customers, vendors and employees could expose us to
litigation and damage our reputation. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">We receive and maintain
certain personal, sensitive and confidential information about our customers, vendors and employees. The collection and use of
this information is regulated at the international, federal and state levels, and is subject to certain contractual restrictions
in third party contracts. Although we have implemented processes to collect and protect the integrity and security of this personal
information, there can be no assurance that this information will not be obtained by unauthorized persons, or collected or used
inappropriately. If our security and information systems or the systems of our employees or external business associates are compromised
or our employees or external business associates fail to comply with these laws and regulations and this information is obtained
by unauthorized persons, or collected or used inappropriately, it could negatively affect our reputation, as well as our operations
and financial results, and could result in litigation or regulatory action against us or the imposition of costs, fines or other
penalties. While we have not experienced losses related to this area, as privacy and information security laws and regulations
change, we may incur additional costs to remain in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><A NAME="nanx10k123116a019"></A>Item 1B. Unresolved Staff Comments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal">There
are currently no open comments from the SEC Staff.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><A NAME="nanx10k123116a020"></A>Item 2. Properties</FONT></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
operate two facilities in the Chicago suburbs - a 36,000 square-foot production, research and headquarters facility in Romeoville,
Illinois and a 20,000 square-foot production facility in Burr Ridge, Illinois. We also lease a 9,000 square-foot offsite warehouse
in the vicinity of the Romeoville facility.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
manufacturing operations in Burr Ridge are certified under ISO 9001:2008, and we believe that our manufacturing operations are
within the cGMP requirements of the FDA for products that require such compliance. Our facilities are also ISO 14001:2004 certified
which is the international standard for environmental management. The Burr Ridge facility has a quality control laboratory designed
for the dual purposes of validating operations to cGMP and ISO standards and production process control. This laboratory is equipped
to handle many routine analytical and in-process techniques that are currently required.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
Romeoville facility houses our headquarters, advanced engineering, manufacturing (including nanoparticle coating, nanoparticle
dispersion and pilot-scale manufacturing) and research and development with three applications development laboratories. All Romeoville
manufacturing processes are certified to ISO 9001:2008 and ISO 14001:2004, and we believe that the manufacturing of nanoparticle
coating used for sunscreens and personal care is in compliance with the cGMP requirements of the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
lease our Romeoville and Burr Ridge facilities. <FONT STYLE="font-family: Times New Roman, Times, Serif">During October 2016 we
entered into an amendment to our Industrial Lease Agreement for the facility in Romeoville, Illinois, which, among other things,
extended the term of such lease through December 31, 2024. We renewed the Burr Ridge facility lease as of September 2010, extending
the terms through September 2014 (we subsequently exercised our final tenant option to extend the term through September 2017).
On March 14, 2017, we entered into a new Building Lease for the Burr Ridge facility that will begin September 2017 and end during
September 2021, with our option to further extend this lease by three additional one-year periods. During 2016 we also renewed
the lease for our offsite warehouse through August 2019.</FONT>&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
believe that our leased facilities provide sufficient capacity to fulfill current known customer demand as well as allow for the
creation of substantial additional space to enable expansion of key production processes. We believe additional facilities could
be obtained in the area at competitive prices if necessary to support growth. We believe that our capital expenditures made in
2016, and projected for 2017, will support currently anticipated demand from existing customers. Our actual future capacity requirements
will depend on many factors, including new and potential customer acceptance of our current and potential nanomaterials and product
applications, both expected and currently unplanned growth from existing customers, continued progress in our research and development
activities and product testing programs and the magnitude of these activities and programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="nanx10k123116a021"></A>Item&nbsp;3. Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are not a party to any pending legal
proceedings or claims that we believe will result in a material adverse effect on our business, financial condition, or operating
results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="nanx10k123116a022"></A>Item&nbsp;4. Mine Safety Disclosures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="nanx10k123116a023"></A>PART II</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="nanx10k123116a024"></A>Item&nbsp;5. Market for Registrant&rsquo;s Common Equity,
Related Stockholder Matters and Issuer Purchases of Equity Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Market Information; Holders; Dividends </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
traded on the OTCQB marketplace, operated by OTC Markets Group, since voluntarily delisting from the NASDAQ Capital Market on March
20, 2012. Our symbol, &ldquo;NANX&rdquo;, did not change as a result of this venue transfer. The following table sets forth, for
the periods indicated, the range of high and low sale prices for our common stock on the OTCQB marketplace:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Fiscal year ended December&nbsp;31, 2016:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 38%; text-align: left; padding-left: 5.4pt">First Quarter</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">0.48</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">0.37</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Second Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.73</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.44</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Third Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.87</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.57</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Fourth Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.81</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Fiscal year ended December&nbsp;31, 2015:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">First Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.56</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Second Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.52</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.41</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Third Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.48</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.35</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Fourth Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.49</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.38</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 14, 2017,
the last reported sale price of our common stock was $0.70 per share, and there were 110 holders of record of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared
or paid any cash dividends on our common stock and do not currently anticipate paying any cash dividends or other distributions
on our common stock in the foreseeable future. We intend instead to retain any future earnings for reinvestment in our business.
Any future determination to pay cash dividends will be at the discretion of our Board of Directors and will be dependent upon our
financial condition, results of operations, capital requirements and such other factors deemed relevant by our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Securities Authorized for Issuance under Equity Compensation
Plan </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
gives information about our common stock that may be issued upon the exercise of options and rights under our 2010 Equity Compensation
Plan (the &ldquo;2010 Equity Plan&rdquo;) on December 31, 2016. The 2010 Equity Plan replaced the 2004 Equity Compensation Plan
(the &ldquo;2004 Plan&rdquo;), the 2005 Non-Employee Director Restricted Stock Plan (as amended, the &ldquo;2005 Plan&rdquo;),
and the Amended and Restated 2006 Stock Appreciation Rights Plan (the &ldquo;2006 Plan&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Plan Category</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(a)&nbsp;Number&nbsp;of&nbsp;securities to be issued upon exercise of outstanding options, warrants and rights</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(b)&nbsp;Weighted - average
    exercise price of outstanding options, warrants and rights</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(c)&nbsp;Number&nbsp;of&nbsp;securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Plans Approved by Shareholders</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">3,027,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">0.81</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">1,196,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Plans Not Approved by Shareholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">None</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">None</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="nanx10k123116a025"></A>Item&nbsp;6. Selected Financial Data</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not required for a smaller reporting company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="nanx10k123116a026"></A>Item&nbsp;7. Management&rsquo;s Discussion and Analysis of
Financial Condition and Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>The following discussion
and analysis should be read in conjunction with risks discussed in Part I, Item 1A, Risk Factors of this Form 10-K, and the financial
statements and related notes thereto appearing elsewhere in this Form&nbsp;10-K. When used in the following discussions, the words
&ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;intends&rdquo;
and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks, uncertainties
and contingencies that could cause actual results, performance or achievements to differ materially from those expressed in, or
implied by, such statements. See the &ldquo;Forward Looking Statements&rdquo; section in Part 1, Item 1, of this Form 10-K. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Overview</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nanophase is an advanced
materials and applications developer and commercial manufacturer with an integrated family of materials technologies. We produce
engineered nano and sub-micron materials for use in a variety of diverse markets: personal care including sunscreens, architectural
coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, solar control/energy,
and a variety of surface finishing technologies (polishing) applications, including optics. Finally, we have expanded our offerings
beyond active ingredients to include targeted full formulations of skin care products, marketed and sold by our wholly-owned subsidiary,
Sol&eacute;sence &trade; LLC. We target markets in which we believe practical solutions may be found using our products. We work
closely with current and potential customers in these target markets to identify their material and performance requirements and
market our materials to various end-use applications manufacturers. Recently developed technologies have made certain new products
possible and opened potential new markets. For example, we have applied our skills at producing precisely defined nanomaterials
to now create and sell larger, sub-micron material products. Our focus is on customer need where we believe we have an advantage,
as opposed to finding uses for one particular technology. We expect growth in end-user (manufacturing customers, including customers
of our customers) adoption in 2017 and beyond. Our initiatives in targeted market areas are progressing at differing rates of speed,
but we have been broadly moving through testing and development cycles, and in a number of cases believe we are approaching first
revenue or next stage revenue with particular customers in the industries referenced above. For example, during 2015 we were granted
a patent on a new type of particle surface treatment (coating), which became the cornerstone of our new product development in
personal care, with first revenue recognized during 2016 and the creation of our Sol&eacute;sence &trade; LLC subsidiary to manufacture
and sell fully developed solutions to targeted customers in the skin care industry, in addition to the additives we have traditionally
sold in the personal care area. During 2015 and 2016 we developed and began to sell solutions in the energy management (particularly
solar control) industry. We believe that successful introduction of our materials with manufacturers may
lead to follow-on orders for other materials in their applications. We expect that we will both work more deeply with current customers
and attract additional customers, which should help us achieve growth in these markets in 2017 and beyond.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 2; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Critical Accounting Estimates</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We review long-lived
assets for impairment whenever events or changes in circumstances indicate that the asset&rsquo;s carrying amount may not be recoverable.
We conduct long-lived asset impairment analyses in accordance with Financial Accounting Standards Board (&ldquo;FASB&rdquo;) Accounting
Standards Codification (&ldquo;ASC&rdquo;) Topic 360-10-15, <I>Impairment or Disposal of Long-Lived Assets</I>. ASC 360-10-15 requires
us to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows
of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. If the undiscounted
cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which
the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis or appraisals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain assumptions
are necessary to assess the impact of risks and uncertainties on the financial information, such as cash flow projections, availability
of capital if needed to support the ongoing operations of the business, and our expected compliance with contractual commitments.
Any changes in those plans or assumptions could have a material impact on our liquidity and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Results of Operations</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-style: normal">Years
Ended December&nbsp;31, 2016 and 2015</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Total revenue increased
to $10,783,000 in 2016, compared to $10,313,000 in 2015. A substantial majority of our revenue for each year is from our largest
customers, in particular sales to our largest customer in personal care and sunscreen applications. Product revenue, the primary
component of our total revenue, increased to $10,720,000 in 2016, compared to $10,272,000 in 2015. This increase was primarily
due to increased revenue from our largest customer (personal care). Revenue from our top three customers was approximately 69%,
5% and 4%, respectively, in 2016, compared to 63%, 4% and 7% for the same customers in 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other revenue increased
to $63,000 in 2016, compared to $41,000 in 2015. This increase primarily relates to customer-paid shipping charges, as that and
any customer-paid development projects are reflected in &ldquo;other revenue.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of revenue generally
include costs associated with commercial production and customer development arrangements. Cost of revenue increased to $7,543,000
in 2016, compared to $7,199,000 in 2015. The increase in cost of revenue was primarily driven by the increase in product revenue
volume, as our annual gross margin was similar (approximately 30%) for each period. We expect to continue new nanomaterial development,
primarily using our NanoArc&reg; synthesis and dispersion technologies, for targeted applications and new markets during 2017 and
beyond. At current revenue levels we have generated a positive gross margin, though margins have been impeded by not having enough
revenue to efficiently absorb manufacturing overhead that is required to work with current customers and expected future customers.
We believe that our current fixed manufacturing cost structure is sufficient to support significantly higher levels of production.
The extent to which margins grow, as a percentage of total revenue, will be dependent upon revenue mix, revenue volume, our ability
to continue to cut costs and pass commodity market-driven raw materials increases on to customers. We expect that, as product revenue
volume increases, our fixed manufacturing costs would be more efficiently absorbed, leading to increased margins. We expect to
continue to focus on reducing controllable variable product manufacturing costs, with potential variability related to the commodity
metals markets, but may or may not realize absolute dollar gross margin growth through 2017 and beyond, dependent upon the factors
discussed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development
expense, which includes all expenses relating to the technology and advanced engineering groups, primarily consists of costs associated
with the development or acquisition of new product applications and coating formulations and the cost of enhancing our manufacturing
processes. As an example, we have been, and continue to be, engaged in research to enhance our ability to disperse material in
a variety of organic and inorganic media for use as coatings and polishing materials, including polishing products. Much of this
work has led to several new products and additional potential new products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Having demonstrated
the capability to produce pilot quantities of mixed-metal oxides in a single crystal phase, we do not expect development of further
variations on these materials to present material technological challenges. Many of these materials exhibit performance characteristics
that can enable them to serve in various catalytic applications. We are now working on several related commercial opportunities
using the same materials. We expect that this technique should enable us to scale to large quantity commercial volumes. We also
have an ongoing advanced engineering effort that is focused on the development of new nanomaterials as well as the refinement of
existing nanomaterials, as dictated by our customer-driven marketing strategy. We are not certain when or if any significant revenue
will be generated from the production of the materials described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development
expense increased to $1,554,000 in 2016, compared to $1,273,000 in 2015. The primary reasons for this increase were salary, outside
testing, and materials charges associated with the development and launch of our Sol&eacute;sence &trade; line of personal care
products and related capabilities. We also had an increase in patent legal spending, in part related to additional surface treatment
applications and in part related to solar control applications. We expect similar spending in this area during 2017 as we continue
with these efforts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Selling, general and
administrative expense decreased to $2,954,000 in 2016, compared to $3,019,000 in 2015. The net decrease was primarily attributed
to a (primary Romeoville facility) lease extension at a lower rate, partially offset by increased legal fees, and decreased consulting
fees and marketing and selling expenses related to the completed launch of our 2015 initiatives in surface finishing applications,
and which are now again increasing as we launch Sol&eacute;sence &trade; personal-care type solutions. We expect 2017 expenses
in this area to be approximately 5% higher and driven largely by the selling function as we launch products in personal care, energy,
and other areas, depending on the status of certain initiatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We had no interest
income in either 2016 or 2015. Interest expense was $15,000 in 2016, compared to $14,000 in 2015, due to the impact of capital
leases on some of our equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Inflation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe inflation
has not had a material effect on our operations or financial position. However, supplier price increases and wage and benefit inflation,
both of which represent a significant component of our costs of operations, may have a material effect on our operations and financial
position in 2017 and beyond if we are unable to pass through any increases under present contracts or through to our markets in
general.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Liquidity and Capital Resources</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our cash, cash equivalents
and short-term investments amounted to $1,779,000 as of December&nbsp;31, 2016, compared to $1,275,000 on December&nbsp;31, 2015.
The net cash used in our operating activities for the year ended December 31, 2016 was $241,000 compared to $240,000 for the year
ended December 31, 2015. Net cash used in investing activities amounted to $165,000 for the year ended December 31, 2016, compared
to $288,000 for the year ended December 31, 2015. Capital expenditures amounted to approximately $204,000 (including a new capital
lease for $75,000) and $420,000 (including new capital leases for $132,000) for the years ended December 31, 2016 and 2015, respectively.
Net cash provided by financing activities was $910,000 in 2016, compared to $59,000 used by financing activities in 2015. On February
10, 2016, we sold 2.6 million shares of our common stock to our largest investor for $988,000 in proceeds. There were no placement
agent or similar fees associated with this transaction. We have used, and expect to continue to use, the proceeds for general corporate
purposes. Additionally, on March 4, 2016, we extended the Line of Credit Agreement with Libertyville Bank and Trust, a Wintrust
Community Bank, until March 2017. During February 2017, we further extended this agreement until March 2018. No borrowings were
outstanding on this line of credit as of December 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our supply agreements
with our largest customer, BASF, contain certain financial covenants which could potentially impact our liquidity. The most restrictive
financial covenants under these agreements require that we maintain a minimum of $1 million in cash, cash equivalents and certain
investments, and that we not have the acceleration of any debt maturity having a principal amount of more than $10 million, in
order to avoid triggering the customer&rsquo;s potential right to transfer certain technology and equipment to that customer at
a contractually defined price. We had approximately $1.8 million in cash on December 31, 2016, and no debt. This supply agreement
and its covenants are more fully described in Note 12, and our line of credit is more fully described in Note 3, to our Financial
Statements referred to in Part II, Item 8, of this Annual Report on Form 10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that cash
from operations and cash on hand, in addition to unused borrowing capacity, will be adequate to fund our operating plans through
2017. Our actual future capital requirements in 2017 and beyond will depend, however, on many factors, including customer acceptance
of our current and potential nanomaterials and product applications, continued progress in research and development activities
and product testing programs, the magnitude of these activities and programs, and the costs necessary to increase and expand our
manufacturing capabilities and to market and sell our materials and product applications. Other important issues that will drive
future capital requirements will be the development of new markets and new customers as well as the potential for significant unplanned
growth with existing customers. Depending on the success of certain projects, we expect that capital spending relating to currently
known capital needs for 2017 will be between $600,000 and $1,000,000, and further expect to enter into one or more financing leases
to finance these acquisitions. If those projects are delayed or ultimately prove unsuccessful, or if we fail to obtain financing
on acceptable terms to us, we would expect our capital expenditures may fall below the lower end of the range. Similarly, substantial
success in business development projects may cause the actual 2017 capital investment to exceed the top of this range.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Should events arise
that make it appropriate for us to seek additional financing, such additional financing may not be available on acceptable terms
or even at all, and any such additional financing could be dilutive to our shareholders. Such financing could be necessitated by
such things as the loss of existing customers; currently unknown capital requirements in light of the factors described above;
new regulatory requirements that are outside our control; the need to meet previously discussed cash requirements to avoid a triggering
event under our BASF agreement; or various other circumstances coming to pass that we currently do not anticipate. The failure
to have access to sufficient capital to fund our business plans may result in a curtailment or other change in those plans, and
under such circumstances, may raise doubt as to our ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December&nbsp;31,
2016, we had a net operating loss carryforward of approximately $82 million for income tax purposes. Because the Company may have
experienced &ldquo;ownership changes&rdquo; within the meaning of the U.S. Internal Revenue Code in connection with its various
prior equity offerings, future utilization of this carryforward may be subject to certain limitations as defined by the Internal
Revenue Code. If not utilized, the remaining carryforward will expire at various dates between January 1, 2018 and December 31,
2036. As a result of the annual limitation and uncertainty as to the amount of future taxable income that will be earned prior
to the expiration of the carryforward, we have concluded that it is likely that some portion of this carryforward will expire before
ultimately becoming available to reduce income tax liabilities. Changes in Illinois state tax law that began during 2011 will impact
net loss carryforward duration and utilization on the state tax level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not created,
and are not party to, any special-purpose or off-balance sheet entities for the purposes of raising capital, incurring debt or
operating our business. We do not have any off-balance sheet arrangements or relationships with entities that are not consolidated
into our financial statements that are reasonably likely to materially affect our liquidity or the availability of capital resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As more fully described
in Note 3 to our Financial Statements, referenced in Part II, Item 8 and set forth on page F-11 of this Form 10-K, during July
2014 we entered into a new bank-issued letter of credit and promissory note for up to $30,000 supporting our obligations under
our facility lease agreement. No borrowings have been incurred under this promissory note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="nanx10k123116a027"></A>Item&nbsp;7A. Quantitative and Qualitative Disclosures
About Market Risk</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not required for a smaller reporting company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="nanx10k123116a028"></A>Item&nbsp;8. Financial Statements and Supplementary Data</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The financial statements,
with the report of independent auditors, listed in Item 15 appear on pages F-1 through F-18 of this Form 10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><A NAME="nanx10k123116a029"></A>Item
9.&nbsp; Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: blue">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><A NAME="nanx10k123116a030"></A>Item
9A.&nbsp; Controls and Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><U>Evaluation of Disclosure
Controls and Procedures</U>. We are responsible for establishing and maintaining disclosure controls and procedures that are designed
to ensure that information required to be disclosed by us in the reports filed by us under the Exchange Act is: (a)&nbsp;recorded,
processed, summarized and reported within the time periods specified in the SEC&rsquo;s rules and forms; and (b)&nbsp;accumulated
and communicated to our management, including our principal executive and principal financial officers, to allow timely decisions
regarding required disclosures. It should be noted that in designing and evaluating our disclosure controls and procedures, we
recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of
achieving the desired control objectives, and that our management necessarily was required to apply its judgment regarding the
design of our disclosure controls and procedures. As of the end of the period covered by this report, we conducted an evaluation,
under the supervision (and with the participation) of our management, including our Chief Executive Officer and Chief Financial
Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15(e)
and 15d-15(e) of the Exchange Act. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded
that our disclosure controls and procedures were effective at reaching that level of reasonable assurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><U>Management&rsquo;s
Annual Report on Internal Control Over Financial Reporting</U>. Management is responsible for the preparation, integrity and fair
presentation of the financial statements and Notes to the financial statements. The financial statements were prepared in accordance
with the accounting principles generally accepted in the U.S. and include certain amounts based on management&rsquo;s judgment
and best estimates. Other financial information presented is consistent with the financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Management is also
responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and
15d-15(f) under the Securities Exchange Act of 1934. The Company&rsquo;s internal control over financial reporting is designed
under the supervision of the Company&rsquo;s principal executive and principal financial officers in order to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles. The Company&rsquo;s internal control over financial reporting includes
those policies and procedures that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets of the Company; </FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 6; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and </FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&rsquo;s assets that could have a material effect on the financial statements. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Because of its inherent
limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may deteriorate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Management assessed
the effectiveness of the Company&rsquo;s internal control over financial reporting as of December&nbsp;31, 2016. In making this
assessment, management used the criteria established in Internal Control&ndash;Integrated Framework (2013) issued by the Committee
of Sponsoring Organizations of the Treadway Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Based on our assessment
and those criteria, management believes that the Company maintained effective internal control over financial reporting as of December&nbsp;31,
2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">This annual report
does not include an attestation report of the Company&rsquo;s registered public accounting firm regarding internal control over
financial reporting. Management&rsquo;s report was not subject to attestation by the Company&rsquo;s registered public accounting
firm pursuant to the rules of the Securities and Exchange Commission that permit the Company to provide only management&rsquo;s
report in this annual report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><U>Changes in Internal
Control over Financial Reporting</U>. The Company&rsquo;s management, including Mr.&nbsp;Jankowski, the CEO, and Mr. Cesario, the
CFO, confirms that there was no change in the Company&rsquo;s internal control over financial reporting during the quarter ended
December&nbsp;31, 2016 that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal
control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><A NAME="nanx10k123116a031"></A>Item
9B.&nbsp; Other Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in;">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in; color: #00C000">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><A NAME="nanx10k123116a032"></A>PART III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="nanx10k123116a033"></A>Item&nbsp;10. Directors, Executive Officers and Corporate
Governance</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DIRECTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-weight: normal">Set forth
below is certain information regarding the directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Age</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Position with Company</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Served as<BR> Director<BR> Since</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Term<BR> Expires</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Class</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 30%; text-align: left">James A. Henderson</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">82</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 18%; text-align: center">Chairman of the Board of Directors</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">2001</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">I</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">James A. McClung, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">79</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">I</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">R. Janet Whitmore</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">62</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2003</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">I</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Jess A. Jankowski</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">51</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">President, Chief Executive Officer and Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2009</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">II</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Richard W. Siegel, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">79</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1989</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">II</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">W. Ed Tyler</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">64</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2011</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">II</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">George A. Vincent, III</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">72</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2007</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">III</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Mr. Henderson</B>
has served as a director of the Company since July 2001 and Chairman of the Board of Directors since August 2011. He retired as
Chairman and Chief Executive Officer of Cummins Engine Company (now Cummins Inc.) in December 1999, after joining the company in
1964. Mr. Henderson became President and Chief Operating Officer of Cummins in 1977, was promoted to President and Chief Executive
Officer in 1994 and served as Chairman and Chief Executive Officer from 1995 until his retirement in 1999. Mr. Henderson attended
Culver Military Academy, holds an A.B. in public and international affairs from Princeton University and an M.B.A. from Harvard
Business School. Mr. Henderson previously served as a director of AT&amp;T, Inc., International Paper, Rohm &amp; Haas, Hillenbrand,
Inc., Inland Steel, and Ryerson, Inc. He serves as Chairman Emeritus of the Board of the Culver Education Foundation and is a past
Chair of the Princeton University Board of Trustees. We believe that Mr. Henderson&rsquo;s extensive and diverse background in
corporate leadership in technology-based companies, operations experience, and business acumen makes him a valuable member of our
Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Mr.&nbsp;McClung</B>
<FONT STYLE="font-size: 10pt">has served as a director of the Company since February 2000, and is chair of the Audit and Finance
Committee. Currently he is Chair and CEO of Lismore International. He retired as a senior vice president and executive officer
for FMC Corporation (which has since split into 3 public corporations: FMC Corporation; TechnipFMC; JB Technologies), a leading
producer of a diversified portfolio of chemicals and machinery. He has over 30 years of global business development and operational
experience in over 75 countries. This includes managing and developing new technologies and operational processes, and strategic
partnerships, for diversified global businesses, including specialized chemicals, process machinery, and health care systems while
living in the United States, Europe and Africa. In addition to serving currently on the Boards for Nanophase, 4 D Healthware, and
the Nuseed advisory board, he previously served on other corporate boards: Amway Corporation; NCCI; Turtle Wax; Beaulieu Corporation;
and Hu-Friedy. He was a founding member of the US-Russia Business Council and is active in other international business organizations,
such as Japan American Society, Chicago Council on Global Affairs, Economic Club of Chicago and the Executive Club of Chicago.
He is an active Emeritus Trustee for the College of Wooster (Ohio). Mr. McClung earned a bachelor&rsquo;s degree from the College
of Wooster (Ohio), master&rsquo;s degree from the University of Kansas, and a doctorate from Michigan State University. We believe
that Mr. McClung&rsquo;s extensive global business development and worldwide management experience, including experience in the
specialty chemical industry, make him a valuable member of our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Ms. Whitmore</B>
joined the board in November 2003. She is a former director of Silverleaf Resorts, Inc., where she served as Chairman of the Compensation
Committee and as a member of the Audit Committee. She is also a former director of Epoch Biosciences, a supplier of proprietary
products used to accelerate genomic analysis. Ms. Whitmore is Founder of Benton Consulting, LLC, which specializes in business
development and processes. From 1976 through 1999, Ms. Whitmore held numerous engineering and finance positions at Mobil Corporation,
including Mobil&rsquo;s Chief Financial Analyst and Controller of Mobil&rsquo;s Global Petrochemicals Division. Ms. Whitmore holds a B.S. degree
in Chemical Engineering from Purdue University and an M.B.A. from Lewis University. We believe that Ms. Whitmore&rsquo;s combination
of global financial, engineering, and management expertise makes her a valuable member of our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Mr.&nbsp;Jankowski
</B>joined the board in February 2009. He has served as the Company&rsquo;s President and Chief Executive Officer since that time.
After joining the Company in 1995, Mr. Jankowski held offices including Vice President of Finance, Chief Financial Officer, Secretary,
Treasurer and Controller. From 1990-1995 he served as Controller for two building and public works contractors in the Chicago area,
during which time he had significant business development responsibilities. From 1986 to 1990, he worked for Kemper Financial Services
in their accounting control corporate compliance unit, serving as unit supervisor during his last two years. Mr. Jankowski holds
a B.S. from Northern Illinois University and an M.B.A. from Loyola University. He served on the TechAmerica Midwest Board from
2008 to 2012 and was an active member of the TechAmerica Midwest CFO Committee from 2006 through 2008. He was appointed to the
Advisory Board of the Nanobusiness Commercialization Association in 2009. Mr. Jankowski was also appointed to the Romeoville Economic
Development Commission and served from 2004 to 2010. He has also served on the advisory board of NITECH (Formerly WESTEC), an Illinois
Technology Enterprise Center focusing on the commercialization of advanced manufacturing technologies from 2003 to 2008. In 2009,
Mr. Jankowski was appointed to the board of directors of the Northern Illinois Technology Foundation, an economic development and
technology transfer entity that is part of Northern Illinois University. We believe that Mr. Jankowski&rsquo;s long-term and intimate
experience with Nanophase operations, along with his financial and management expertise, makes him a valuable member of our Board
of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Dr.&nbsp;Siegel</B>
is a co-founder of the Company and has served as a director of the Company since 1989. Dr. Siegel served as a consultant to the
Company from 1990 to 2002 with regard to the application and commercialization of nanomaterials. Dr. Siegel is an internationally
recognized scientist in the field of nanomaterials. During his tenure on the research staff at Argonne National Laboratory from
July 1974 to May 1995, he was the principal scientist engaged in research with the laboratory-scale synthesis process that was
the progenitor of the Company&rsquo;s physical-vapor-synthesis production system. Dr. Siegel has been the Robert W. Hunt Professor in
Materials Science and Engineering at Rensselaer Polytechnic Institute since June 1995, and served as Department Head from 1995
to 2000. Dr. Siegel was the founding Director of both the Rensselaer Nanotechnology Center (2001-2015) and the U.S. National Science
Foundation funded Nanoscale Science and Engineering Center for Directed Assembly of Nanostructures (2001-2013). During the period
from 1995 until 1998, he was also a visiting professor at the Max Planck Institute for Microstructure Physics in Germany on an
Alexander von Humboldt Research Prize received in 1994. During the period from 2003 until 2004 he was a visiting professor in Japan
on a RIKEN Eminent Scientist Award. He chaired the World Technology Evaluation Center worldwide study of nanostructure science
and technology for the U.S. government, has served on the Council of the Materials Research Society and as Chairman of the International
Committee on Nanostructured Materials. He also served on the Committee on Materials with Sub-Micron Sized Microstructures of the
National Materials Advisory Board and was the co-chairman of the Study Panel on Clusters and Cluster-Assembled Materials for the
U.S. Department of Energy. He served on the Nanotechnology Technical Advisory Group to the U.S. President&rsquo;s Council of Advisors
on Science and Technology during 2003-2009. Dr. Siegel holds an A.B. degree in physics from Williams College and an M.S. degree
and Ph.D. from the University of Illinois at Urbana-Champaign. We believe that Dr. Siegel&rsquo;s value to our Board of Directors,
as co-founder of the Company and inventor of our initial base technology, is self-explanatory.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Mr. Tyler</B> joined
Nanophase as a director in January 2011. Mr. Tyler is Chairman of the Board of First Industrial Realty Trust, where he has served
as a director since 2000. He has also served in recent leadership positions at Ideapoint Ventures, an early stage venture fund
that focuses on nanotechnologies, and Industrial Nanotech, Inc., an entity which develops and sells nanomaterial solutions. Previously,
Mr. Tyler served as President and CEO of Moore Corporation Limited, a provider of data capture, information design, marketing services,
digital communications and print solutions. Mr. Tyler also worked for 24 years with R. R. Donnelley &amp; Sons Company in Chicago,
beginning his career as an electronics engineer and ultimately serving as Executive Vice President, Sector President, and Chief
Technology Officer. He also was responsible for 77 Capital, an early stage venture capital subsidiary of Donnelley, where he was
directly responsible for investment decisions and worked closely with the portfolio companies while participating on many of their
boards. Mr. Tyler is a former Chairman of the American Red Cross (Mid-America Chapter) and Campaign Chairman of the United Way
of Lake County, and serves as a director for several small, private companies. He is a member of the Board of Directors of Lake
Forest Graduate School of Management, where he is also an adjunct faculty member. We believe that Mr. Tyler&rsquo;s extensive and
diverse background in corporate leadership in technology-based companies, operations experience, and business acumen makes him
a valuable member of our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Mr. Vincent</B>
has served as a director of the Company since November 2007. He is the retired Chairman and President of The HallStar Company,
where he served as CEO for twenty years. HallStar is a chemical manufacturer and innovator specializing in material science, marketing
its products worldwide, primarily into the polymer and personal care industries. Prior to HallStar, Mr. Vincent held positions
in purchasing, sales, commercial development and strategic planning with FMC Corporation (chemicals) and General Electric Company
(chemicals and plastics). Mr. Vincent has served as Chairman of the Illinois Manufacturers&rsquo; Association (IMA) and the Chemical
Industry Council of Illinois (CICI), as well as Director of the American Chemistry Council (ACC). Mr. Vincent serves on the Boards
of several closely-held companies in the chemicals and materials industry sector. Mr. Vincent holds a Bachelor of Arts degree in
Chemistry from Dartmouth College and an M.B.A. degree from Harvard Business School. We believe that Mr. Vincent&rsquo;s extensive
experience in the chemicals industry and management leadership makes him a valuable member of our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Meetings of the
Board and Committees</B>&nbsp;-- During the year ended December&nbsp;31, 2016, the Board of Directors held five meetings. No director
missed more than one board or committee meeting held during 2016 (for all committees on which a particular director served).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Committees of the
Board of Directors</B>&nbsp;-- The Board of Directors has established an Audit and Finance Committee, Compensation Committee and
Nominating and Corporate Governance Committee. Each operates in accordance with its charter (available on our website <U>www.nanophase.com</U>
under the &ldquo;Investor Relations&rdquo; section). The members of the Audit and Finance Committee are Mr.&nbsp;McClung (Chairman),
Mr.&nbsp;Vincent and Dr. Siegel. The members of the Compensation Committee are Mr.&nbsp;Tyler (Chairman), Mr. Henderson, and Mr.
Vincent. The members of the Nominating and Corporate Governance Committee are Mr. Henderson (Chairman), Mr. McClung, Dr. Siegel,
Mr. Vincent, Mr. Tyler and Ms. Whitmore.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit and Finance
Committee generally has responsibility for retaining the Company&rsquo;s independent public auditors, reviewing the plan and scope
of the accountants&rsquo; annual audit, reviewing the Company&rsquo;s internal control functions and financial management policies, reviewing
and approving all related party transactions, and reporting to the Board of Directors regarding all of the foregoing. The Audit
and Finance Committee held eight meetings during 2016. The Board of Directors has
determined that Mr. Vincent and Mr. McClung are the &ldquo;audit committee financial experts&rdquo; as described in applicable SEC
rules. Each member of the Audit and Finance Committee is independent, as defined in applicable SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
generally has responsibility for establishing executive officer and key employee compensation, reviewing and establishing the Company&rsquo;s
executive compensation, evaluating our Outside Director compensation, and reporting to the Board of Directors regarding the foregoing.
The Compensation Committee also has responsibility for administering the 2010 Equity Compensation Plan, as amended (the &ldquo;2010
Equity Plan&rdquo;), determining the number of options, if any, to be granted to the Company&rsquo;s employees and consultants pursuant
to the 2010 Equity Plan and reporting to the Board of Directors regarding the foregoing. Regarding most compensation matters, including
executive compensation, our management provides recommendations to the Compensation Committee; however, the Compensation Committee
does not delegate any of its functions to others in setting compensation. The Compensation Committee does not currently utilize
external consultants in executive or director compensation matters. The Compensation Committee held five meetings during 2016.
Each member of the Compensation Committee is independent, as defined in applicable SEC rules, is a &ldquo;non-employee director&rdquo;
as defined in Rule 16b-3 under the Exchange Act and is an &ldquo;Outside Director&rdquo; as defined by the regulations under Section
162(m) of the Internal Revenue Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and
Corporate Governance Committee generally has responsibility for evaluating and nominating candidates to serve on the Board of Directors,
and for establishing and reviewing our Corporate Governance Principles. Five of the six members of the Nominating and Corporate
Governance Committee are independent, as defined in applicable SEC rules. The Nominating and Corporate Governance Committee held
one meeting during 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
considers its role in risk oversight to focus primarily on evaluating risk at the entity and strategic levels, with management
primarily responsible for managing day-to-day risk factors and presenting summary materials for those positions to the Board of
Directors. Consistent with this philosophy, the Board of Directors has no formal policy as to whether the roles of Chief Executive
Officer and Chairman should be segregated or combined. The Board of Directors considers the circumstances of the Company and makes
a determination as to the appropriate leadership structure for the Company at that time. As of the time of this filing, the positions
of CEO and Chairman are held by two individuals &ndash; Mr. Henderson serves as Chairman and Mr. Jankowski serves as CEO. Mr. Henderson
brings extensive experience in corporate leadership from his own working experience and from the many Boards on which he serves
or has served in the past, and Mr. Jankowski is expected to benefit from that experience. The Board of Directors believes that
is the most appropriate structure for the Company at this time. Under our Corporate Governance Principles, in the event that the
Chairman of the Board is not an Outside Director, the Board will elect a lead independent director, who will have the responsibility
to schedule and prepare agendas for meetings of the Outside Directors, communicate with the CEO, disseminate information to the
rest of the Board and raise issues with management on behalf of the Outside Directors when appropriate. The Board evaluates its
leadership structure on an ongoing basis and may change it as circumstances warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
does not have a stated policy regarding diversity, although pursuant to our Corporate Governance Principles, diversity is one factor
that the Nominating and Corporate Governance Committee considers when recommending directors for stockholder approval. The Board
seeks experienced individuals for service who bring extensive experience in leadership, operations, finance, and engineering, particularly
in areas directly applicable to the Company or its intended future endeavors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>EXECUTIVE OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Set forth below is
certain information regarding the executive officers of the Company as of the date of this Form 10-K who are not identified above
as directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Age</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Position</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; text-align: justify; text-indent: 0in">Frank Cesario</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: center">47</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: left; text-indent: 0in">Chief Financial Officer</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; text-indent: 0in">Kevin Cureton</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">55</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">Vice President &ndash; Sales, Marketing and Business Development</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; text-indent: 0in">Nancy Baldwin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">65</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">Vice President - Human Resources and Investor Relations</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Mr. Cesario</B>
joined the Company in June 2009 as Chief Financial Officer. He brings more than 10 years of CFO and controller experience at manufacturing
entities. Prior to joining Nanophase, Mr. Cesario served in a similar capacity with ISCO International, Inc., a publicly traded
global supplier of telecommunications equipment, as well as Turf Ventures LLC, a privately held chemicals distributor. He began
his career with KPMG Peat Marwick and then served in progressively responsible finance positions within Material Sciences Corporation
and Outokumpu Copper, Inc. Mr. Cesario holds an M.B.A. (Finance) from DePaul University and a B.S. (Accountancy) from the University
of Illinois, as well as being a registered CPA in the state of Illinois.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Mr.
Cureton </B></FONT>joined the Company in November 2012 as Vice President of Sales, Marketing and Business Development. His chemical
industry experience has spanned more than twenty years with companies including twelve years at AMCOL, where one of his roles was
Managing Director of its nanomaterial-based Health &amp; Beauty Solutions division. Prior to that, he made significant contributions
at Air Products, Borden, and other entities. He holds an undergraduate degree in chemical engineering from Carnegie Mellon University
and an M.B.A. from the University of Chicago.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Ms. Baldwin </B>has
served as the Director of Human Resources and Information Technology since joining the Company in 2000. In September of 2008, she
was appointed as the Company&rsquo;s Vice President of Human Resources and Investor Relations. Prior to joining Nanophase, she
served as Vice President of iLink Global, and Chief Human Resources Officer at the Marketing Store, a global supplier to McDonald&rsquo;s
Corporation. Previous experience includes 14 years at Arthur Andersen, LLP &amp; Andersen Consulting, LLP in various positions.
Ms. Baldwin has a B.S. in Education from Western Illinois University and post graduate studies at Northern Illinois University.
In 2010, Ms. Baldwin was appointed to the Romeoville Economic Development Commission. She is currently an active member of the
Will County Three Rivers Manufacturing Human Resources Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
elects executive officers and such executive officers, subject to the terms of their employment agreements, serve at the discretion
of the Board of Directors. Messrs.&nbsp; Jankowski, Cesario, and Cureton, and Ms. Baldwin, each have employment agreements with
the Company. See Item 11 below. There are no family relationships among any of the directors or officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>SECTION 16(a) BENEFICIAL
OWNERSHIP REPORTING COMPLIANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 16 of the
Exchange Act requires the Company&rsquo;s officers (as defined under Section 16), directors and persons who beneficially own
greater than 10% of a registered class of our equity securities to file reports of ownership and changes in ownership with
the SEC. Based solely on a review of the forms we have received and on written representations from certain reporting persons
that no such forms were required for them, we believe that during 2016 all Section 16 filing requirements applicable to our
officers, directors and 10% beneficial owners were complied with by such persons except for the following forms, which were
filed late: a Form 4 filing reporting a purchase of 27 shares of stock by Mr. Henderson on February 27, 2015, a Form 4 filing
reporting the purchase of 15,523 shares of stock between February 29, 2016 and March 7, 2016 were reported March 10, 2016,
and a Form 4 filing reporting an option exercise and the acquisition of the underlying 44,500 shares of stock by Mr.
Henderson on September 22, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in;"><B>CODE OF ETHICS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: blue">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted a
Code of Business Conduct and Ethics (&ldquo;Code of Ethics&rdquo;) that applies to, among others, our principal executive officer,
principal financial officer and principal accounting officer or controller, or persons performing similar functions. The Code
of Ethics is posted on our Internet website www.nanophase.com under the &ldquo;Investor Relations&rdquo; section. In the event that
we make any amendment to, or grant any waiver from, a provision of the Code of Ethics that requires disclosure under applicable
SEC rules, we intend to disclose such amendment or waiver on our website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="nanx10k123116a034"></A>Item&nbsp;11. Executive Compensation</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><I>Compliance with Section 162(m)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Compensation Committee currently intends for all compensation paid to the executive officers to be tax deductible to the Company
pursuant to Section 162(m) of the Internal Revenue Code (&ldquo;Section 162(m)&rdquo;). Section 162(m) provides that compensation
paid to the executive officers in excess of $1,000,000 cannot be deducted by the Company for Federal income tax purposes unless,
in general, (1) such compensation is performance-based, established by a committee of Outside Directors and objective, and (2)
the plan or agreement providing for such performance-based compensation has been approved in advance by stockholders. The Compensation
Committee may determine to adopt a compensation program that does not satisfy the conditions of Section 162(m) if in its judgment,
after considering the additional costs of not satisfying Section 162(m), it deems such program to be appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>SUMMARY COMPENSATION TABLE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following
table sets forth a summary of the compensation for each of our named executive officers in U.S. dollars for the years ended December&nbsp;31,
2016 and 2015.</P>

<P STYLE="margin: 0pt 0">&nbsp;</P>


<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Name
    and Principal Position</B></FONT></TD>
    <TD NOWRAP STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Year</B></FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 8pt Times New Roman, Times, Serif"><B>Salary <BR> ($)</B></FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 8pt Times New Roman, Times, Serif"><B>Bonus <BR> ($)</B></FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 8pt Times New Roman, Times, Serif"><B>Option Awards <BR> ($)</B></FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 8pt Times New Roman, Times, Serif"><B>Non-Equity<BR>
 Incentive Plan <BR>
Compensation ($)</B></FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 8pt Times New Roman, Times, Serif"><B>All Other <BR>
Compensation ($)</B></FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font: 8pt Times New Roman, Times, Serif"><B>Total ($)</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-right: Black 1pt solid"><FONT STYLE="font-size: 8pt"><B>(1)</B></FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-right: Black 1pt solid"><FONT STYLE="font-size: 8pt"><B>(2)</B></FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-right: Black 1pt solid"><FONT STYLE="font-size: 8pt"><B>(3)</B></FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-right: Black 1pt solid"><FONT STYLE="font-size: 8pt"><B>(4)</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 39%"><FONT STYLE="font-size: 8pt"><B>Jess
    Jankowski</B></FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 4%"><FONT STYLE="font-size: 8pt">2016</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 2%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><FONT STYLE="font-size: 8pt">305,831</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 2%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 2%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 7%"><FONT STYLE="font-size: 8pt">23,247</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 2%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 9%"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 2%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 9%"><FONT STYLE="font-size: 8pt">22,960</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 2%"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 6%"><FONT STYLE="font-size: 8pt">352,038</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt"><B>Chief
    Executive Officer </B></FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">2015</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">316,371</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">28,928</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">21,910</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">367,209</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt"><B>Frank
    Cesario</B></FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">2016</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">169,834</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">10,613</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">1,224</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">181,671</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; background-color: White"><FONT STYLE="font-size: 8pt"><B>Chief
    Financial Officer </B></FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">2015</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">175,520</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">12,859</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">1,224</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">189,603</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt"><B>Kevin
    Cureton</B></FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">2016</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">186,411</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">14,656</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">23,666</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">224,733</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="vertical-align: top; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt"><B>Vice
    President Sales, Marketing, Business Development </B></FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">2015</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">188,850</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">17,857</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">24,094</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">230,801</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt"><B>Nancy
    Baldwin</B></FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">2016</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">166,686</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">10,613</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">9,348</FONT></TD>
    <TD NOWRAP STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-size: 8pt">186,647</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; background-color: White"><FONT STYLE="font-size: 8pt"><B>Vice
    President Human Resources and Investor Relations</B></FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">2015</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">172,626</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">12,859</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">8,884</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">194,369</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">Any amounts earned during 2016 and 2015 would have been paid in early 2017 and 2016, respectively.
Bonus compensation is driven by Company performance against its goals as ultimately determined by the Compensation Committee of
the Board of Directors. A set of Company-level objectives is created at the beginning of the year, focusing on total revenue, revenue
growth, particular sources of revenue growth, business development achievements, cash flows and related targets, as well as a small
discretionary component designed to capture items not specifically listed. Each measure has varying levels of achievement, which
is reflected in the aggregate bonus measurement. The resulting bonus calculation is then applied to each individual&rsquo;s bonus
potential as a percentage of salary. Because total revenue growth was approximately 4% during 2016 and 2015, performance targets
were not met and thus no bonus was awarded to any of the named executive officers for 2016 or 2015.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">The amounts in this column represent the aggregate fair value of awards granted in 2016 and 2015
fiscal years in accordance with FASB ASC Topic 718. See Note 10 of the notes to our financial statements contained elsewhere in
this Form 10-K for a discussion of all assumptions made by us in determining the FASB ASC Topic 718 values.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">None.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">The amounts in this column represent 401(k) match (none during 2016 and 2015), health and life
insurance. Health insurance benefits are the same for all employees. Life insurance is provided in the amount of one times the
annual base salary with a maximum of $150,000.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Employment Agreements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective as of August
12, 2009, we entered into an employment agreement with Jess Jankowski in connection with his services as President and Chief Executive
Officer. No term has been assigned to Mr. Jankowski&rsquo;s employment agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the terms
of his employment agreement, Mr. Jankowski will receive an annual base salary of not less than $275,000. In addition, Mr. Jankowski
will be eligible for discretionary bonuses for services to be performed as an executive officer of the Company based on performance
and achieving milestones approved by our Board of Directors (the &ldquo;Board&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Jankowski will
be eligible for such stock options and other equity compensation as the Board deems appropriate, subject to the provisions of the
2010 Equity Plan. Mr. Jankowski will also be entitled to the employee benefits made available by us generally to all of our other
executive officers, subject to the terms and conditions of our employee benefit plan in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event Mr. Jankowski&rsquo;s
employment is terminated other than for &ldquo;cause&rdquo; (as such term is defined in the employment agreement), Mr. Jankowski
will receive a sum equal to Mr. Jankowski&rsquo;s base salary in effect at the time of termination for 52 full weeks after the
effective date of termination, payable in proportionate amounts on our regular pay cycle for professional employees, provided that
Mr. Jankowski signs, without subsequent revocation, a separation agreement and release in a form acceptable to us. In addition,
all stock options granted to Mr. Jankowski prior to termination will become fully vested and exercisable in accordance with the
applicable option grant agreement and the 2010 Equity Plan. If he is terminated for cause, or if he resigns as an employee of the
Company, Mr. Jankowski will not be entitled to any severance or other benefits accruing after the term of the employment agreement
and such rights will be forfeited immediately upon the end of such term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If, within two years
after the occurrence of a change in control, as defined in his employment agreement, Mr. Jankowski&rsquo;s employment is terminated
other than for cause, his responsibilities or annual compensation are materially reduced without his prior consent, or we cease
to be publicly held (each, a &ldquo;Trigger&rdquo;), then, subject to Mr. Jankowski signing, without subsequently revoking, a separation
agreement and release in a form acceptable to us, Mr. Jankowski will receive a sum equal to his base salary for 104 full weeks
after the date the Trigger occurs. In addition, all stock options granted to Mr. Jankowski prior to the Trigger will become fully
vested and exercisable in accordance with the applicable option grant agreement and the 2010 Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Effective
as of June 24, 2009, we entered into an employment agreement with Mr. Frank Cesario providing for an annual base salary of not
less than $150,000. We also granted to Mr. Cesario options to purchase up to 20,000 shares of common stock at an exercise price
of $1.07 per share with options for one-third of such shares becoming exercisable on each of the first three anniversaries of the
date of grant. No term has been assigned to Mr. Cesario&rsquo;s employment agreement. As subsequently amended during 2012, if Mr.
Cesario is terminated other than for &ldquo;cause&rdquo; (as such term is defined in Mr. Cesario&rsquo;s employment agreement),
Mr. Cesario will receive severance benefits in an amount equal to Mr. Cesario&rsquo;s base salary for 26 weeks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Effective
as of November 28, 2012, we entered into an employment agreement with Mr. Kevin Cureton providing for an annual base salary of
not less than $190,000. No term has been assigned to Mr. Cureton&rsquo;s employment agreement. If Mr. Cureton is terminated other
than for &ldquo;cause&rdquo; (as such term is defined in Mr. Cureton&rsquo;s employment agreement), Mr. Cureton will receive severance
benefits in an amount equal to Mr. Cureton&rsquo;s base salary for 26 weeks. In addition, all stock options granted to Mr. Cureton
prior to termination will become fully vested and exercisable in connection with the applicable option grant agreement and the
2010 Equity Plan. A signing bonus of $25,000 was paid upon Mr. Cureton&rsquo;s acceptance of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Effective
as of September 25, 2008, we entered into an employment agreement with Ms. Nancy Baldwin providing for an annual base salary of
not less than $150,000. No term has been assigned to Ms. Baldwin&rsquo;s employment agreement. If Ms. Baldwin is terminated other
than for &ldquo;cause&rdquo; (as such term is defined in Ms. Baldwin&rsquo;s employment agreement), Ms. Baldwin will receive severance
benefits in an amount equal to Ms. Baldwin&rsquo;s base salary for 26 weeks. In addition, all stock options granted to Ms. Baldwin
prior to termination will become fully vested and exercisable in connection with the applicable option grant agreement and the
2010 Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 2; Value: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth information regarding each unexercised option held by each of our named executive officers as of December 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 9pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; padding-bottom: 1pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; font-variant: small-caps; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; font-weight: bold; font-variant: small-caps; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Option
    Awards</B></FONT></TD><TD COLSPAN="10" STYLE="padding-bottom: 1pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Stock
                          Awards</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; font-variant: small-caps; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">name</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>number
                                         of</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>securities</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>underlying</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>unexercised</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>options</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>(#)</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>Exercisable</B></FONT></P></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>Number
                                         of Securities Underlying Unexercised Options</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>(#)</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>Unexercisable</B></FONT></P></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>option</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>exercise</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>price</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>($)</B></FONT></P></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>option</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>expiration</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>date</B></FONT></P></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>number</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>of
                                         shares of stock</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>that
                                         have not</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>vested</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>(#)</B></FONT></P></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>market
                                         value</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>of
                                         shares of stock</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>that
                                         have not</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>vested</B></FONT></P> <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>($)</B></FONT></P></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">Jess Jankowski</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 13%; font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 10pt">18,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-size: 10pt">4.480</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">11/06/17</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">23,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3.140</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/12/18</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">30,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/04/19</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">27,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.700</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/03/20</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">85,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.260</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/02/21</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">98,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.300</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">08/07/22</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">90,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.415</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/14/23</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">60,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">30,000</FONT></TD><TD STYLE="text-align: left">
                                         (1)<FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.520</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/13/24</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">27,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">54,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt"></FONT>
                                         (2)</TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.440</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/18/25</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">69,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">
                                         (3)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.420</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/23/26</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">Frank Cesario</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">20,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.070</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">06/24/19</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">20,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.700</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/03/20</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">31,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.260</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/02/21</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">13,667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.300</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">08/07/22</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">13,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.415</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/14/23</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">26,667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">13,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">
                                         (1)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.520</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/13/24</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">12,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">24,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">
                                         (2)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.440</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/18/25</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">31,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">
                                         (3)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.420</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/23/26</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt"></FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">Kevin Cureton</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">52,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.300</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">11/28/22</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">48,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.415</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/14/23</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">25,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">
                                         (1)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.520</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/13/24</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">16,667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">33,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt"></FONT>
                                         (2)</TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.440</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/18/25</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">43,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">
                                         (3)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.420</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/23/26</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">Nancy Baldwin</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">9,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">4.480</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">11/06/17</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">15,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3.140</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/12/18</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">30,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/04/19</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">27,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.700</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/03/20</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">31,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.260</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">05/02/21</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">41,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.300</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">08/07/22</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">39,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.415</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/14/23</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">26,667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">13,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">
                                         (1)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.520</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/13/24</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">12,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">24,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">
                                         (2)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.440</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/18/25</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">31,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">
                                         (3)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.420</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">02/23/26</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 1.75pt; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 1.75pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>The grants expiring February 13, 2024 vested in three equal installments on February 13, 2015, 2016 and 2017.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>The grants expiring February 18, 2025 vest in three equal installments on February 18, 2016, 2017 and 2018.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>The grants expiring February 23, 2026 vest in three equal installments on February 23, 2017, 2018 and 2019.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POTENTIAL PAYMENT UPON TERMINATION OR
CHANGE IN CONTROL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Severance Benefits.
</I></B>Please see discussion of severance benefits under &ldquo;Employment Agreements&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Change in Control.
</I></B>Upon a change in control, the 2010 Equity Plan provides that: (1) vesting under all outstanding stock options will automatically
accelerate and each option will become fully exercisable; (2) the restrictions and conditions on all outstanding restricted shares
shall immediately lapse; and (3) the holders of performance shares will receive a payment in settlement of the performance shares,
in an amount determined by the Compensation Committee, based on the target payment for the performance period and the portion of
the performance period that precedes the change in control. If the Company is not the surviving entity, the successor is required
to assume all unexercised options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Payments. </I></B>The
following table quantifies the estimated payments that would be made in each covered circumstance to our named executive officers:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 9pt; font-weight: bold; font-variant: small-caps; text-align: left">Name</TD><TD STYLE="font-size: 9pt; font-weight: bold; font-variant: small-caps">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 9pt; font-weight: bold; font-variant: small-caps; text-align: center">Termination by Company Without Cause (1)</TD><TD STYLE="font-size: 9pt; font-weight: bold; font-variant: small-caps">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 9pt; font-weight: bold; font-variant: small-caps; text-align: center">Change in Control (2)</TD><TD STYLE="font-size: 9pt; font-weight: bold; font-variant: small-caps">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 9pt; font-weight: bold; font-variant: small-caps; text-align: center">Involuntary Termination in connection with or following a Change in Control (3)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">Jess Jankowski</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">341,820</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">41,820</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">661,820</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Frank Cesario</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">85,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,837</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">104,037</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Kevin Cureton</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">125,633</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">27,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">125,633</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Nancy Baldwin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">104,037</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,837</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">104,037</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>This amount represents the severance benefits that would be received under the executive officer&rsquo;s employment agreement
as described had the executive officer been terminated by the Company without cause on December 31, 2016, including the value of
any stock options that would have accelerated in connection with such termination. For this purpose, the closing price of our common
stock as of December 30, 2016, the last business day of 2016, was used. The amount represents the difference between the exercise
price of any unvested options and $0.72.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"></TD><TD>&nbsp;</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">This amount represents an estimate of the value that would have been received under the equity
compensation plans had a change in control occurred as of December 31, 2016 and the executive officers benefited from an acceleration
of vesting in the equity-based plan awards, as described above. For this purpose, the closing price of our common stock as of December
30, 2016, the last business day of 2016, was used. The amount represents the difference between the exercise price of any unvested
options and $0.72.</TD></TR>                            <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD>This amount represents an estimate of the payments and value (including acceleration of vesting of equity-based
                                                                awards) that would have been received by the executive officers had the executive officers been terminated by the Company
                                                                without cause on December 31, 2016 in connection with a change in control on this date. For this purpose, the closing price
                                                                of our common stock as of December 30, 2016, the last business day of 2016, was used. The amount represents the difference
                                                                between the exercise price of any unvested options and $0.72.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>


<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DIRECTOR COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon first being elected
to the Board of Directors, each director of the Company who is not an employee or consultant of the Company (an &ldquo;Outside
Director&rdquo;) is granted stock options to purchase shares of common stock at the closing price as of the date of issuance (the
fair market value). This initial option grant to an Outside Director typically vests over three years, though may accelerate upon
termination from the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2016, we paid quarterly
compensation to the Chairman of the Board of Directors, for an annual rate of $22,000. We paid quarterly compensation to the Chairman
of the Audit and Finance Committee and to the Chairman of the Compensation Committee totaling $18,000 to each. Each of our other
Outside Directors was paid quarterly compensation for an annual total of $16,000 per Outside Director for services performed in
their capacity as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to 2011, we granted
our Outside Directors stock appreciation rights (SARs) totaling 106,750 shares, under our Amended and Restated 2006 Stock Appreciation
Rights Plan and subsequently under the 2010 Equity Plan. No SARs were granted during 2016 or 2015. The SARs granted vested immediately
and were payable upon the directors&rsquo; termination from the position of director. During November 2016, we terminated this
program and cancelled all vested awards. At the same time, we issued the Outside Directors who had vested SARs cancelled an identical
number of options, fully vested on the date of grant, at strike prices identical to the comparable SARs values, which strike prices
were all in excess of the closing price of our common stock on this date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the first quarter
of 2016, we granted our Outside Directors stock options totaling 55,890 shares under the 2010 Equity Plan, as follows: the Chairman
of the Board of Directors received stock options to purchase 12,150 shares of our common stock, the Chairman of the Audit and Finance
Committee and the Chairman of the Compensation Committee each received stock options to purchase 9,720 shares of our common stock
and each of our other Outside Directors received stock options to purchase 8,100 shares of our common stock. Our Outside Directors
had the following shares of our common stock underlying stock options (both vested and unvested) outstanding as of December 31,
2016: Mr. Henderson: 50,150 shares; Mr. McClung: 84,270 shares; Mr. Vincent: 86,850 shares; Ms. Whitmore: 71,100 shares; Dr. Siegel:
71,100 shares; and Mr. Tyler: 64,520 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2015, we paid quarterly
compensation to the Chairman of the Board of Directors, for an annual rate of $22,000. We paid quarterly compensation to the Chairman
of the Audit and Finance Committee and to the Chairman of the Compensation Committee totaling $18,000 to each. Each of our other
Outside Directors was paid quarterly compensation for an annual total of $16,000 per Outside Director for services performed in
their capacity as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2005, we adopted,
and our stockholders approved, the 2005 Non-Employee Director Restricted Stock Plan (the &ldquo;Director Restricted Stock Plan&rdquo;)
which reserved 150,000 shares of our common stock to be issued to Outside Directors in the form of restricted shares. In 2005,
no awards were made under the Director Restricted Stock Plan. In 2005, we also adopted the Non-Employee Director Deferred Compensation
Plan (the &ldquo;Director Deferred Compensation Plan&rdquo;) which permits an Outside Director to defer the receipt of director
fees until separation from service or the Company undergoes a change in control. We amended the Director Restricted Stock Plan
in 2005 to permit an Outside Director to defer receipt of restricted stock granted under it. The deferred restricted shares are
accounted for under the Director Deferred Compensation Plan and issued upon separation from service or the Company&rsquo;s change
in control. Under the Director Deferred Compensation Plan, the deferred fees that would have been paid in cash are deemed invested
in 5 year U.S. Treasury Bonds during the deferral period. The accumulated hypothetical earnings are paid following the Outside
Director&rsquo;s separation from service or the Company&rsquo;s change in control. The deferred fees that would have been paid
as restricted shares are deemed invested in our common stock during the deferral period. The Director Deferred Compensation Plan
is an unfunded, nonqualified deferred compensation arrangement. In 2009, all Outside Directors elected to defer receipts of all
of the restricted shares they became entitled to under the Director Restricted Stock Plan, which was consolidated into the 2010
Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All Outside Directors
are reimbursed for their reasonable out-of-pocket expenses incurred in attending board and committee meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>2016 Outside Director Compensation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 15%; border-collapse: collapse; width: 85%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">Name</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center"><P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fees Earned or Paid in Cash</B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>($)</B></FONT></P>

</TD>
    <TD STYLE="font-size: 8pt; text-align: center"><P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Option Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>($) (1)</B></FONT></P>

</TD>
    <TD STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Stock Appreciation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>($)</B></FONT></P>

</TD>
    <TD STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">Total($)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; font-size: 8pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">James A. Henderson</FONT></TD><TD STYLE="width: 2%; font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 10%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">22,000</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 10%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">11,467</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 10%; font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">33,467</FONT></TD><TD STYLE="width: 1%; font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">James A. McClung</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">18,000</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">11,570</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">29,570</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">W. Ed Tyler</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">18,000</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">3,275</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">21,275</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">R. Janet Whitmore</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">16,000</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">10,102</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">26,102</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 8pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">George A. Vincent, III</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">16,000</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">11,024</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">27,024</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 8pt; text-align: center; padding-left: 1.75pt"><FONT STYLE="font-size: 10pt">Dr. Richard Siegel</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">16,000</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">10,102</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 8pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 8pt; text-align: right"><FONT STYLE="font-size: 10pt">26,102</FONT></TD><TD STYLE="font-size: 8pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.2in; text-align: right">(1)&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">The amounts in this column represent the aggregate fair value of awards granted in
fiscal 2016 in accordance with FASB ASC Topic 718. See Note 10 of the notes to our financial statements contained elsewhere in
this Form 10-K for a discussion of all assumptions made by us in determining the FASB ASC Topic 718 values.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 5; Value: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="nanx10k123116a035"></A>Item 12. Security Ownership of Certain Beneficial Owners
and Management and Related Stockholder Matters</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITY OWNERSHIP OF MANAGEMENT&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AND PRINCIPAL STOCKHOLDERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth, as of March
14, 2017 certain information with respect to the beneficial ownership of our common stock by (1) each person known by us to own
beneficially more than 5% of the outstanding shares of common stock, (2) each of our directors, (3) each of our named executive
officers and (4) all of our executive officers and directors as a group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-transform: none; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Name</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number of Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Beneficially Owned (1)</B></FONT></P>

</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Percent of Shares Beneficially Owned</B></FONT></TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 72%; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Bradford T. Whitmore</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 10pt">13,493,599</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="width: 2%; text-transform: none"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-transform: none; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-transform: none; text-align: right"><FONT STYLE="font-size: 10pt">43.2</FONT></TD><TD STYLE="width: 1%; text-transform: none; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Spurgeon Corporation</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;3,034,710</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">9.7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Grace Brothers, Ltd.</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;2,433,300</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">7.8</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">John H. Conley, Jr.</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,140,650</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">6.9</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">James A. Henderson</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;519,665</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Richard W. Siegel, Ph.D.</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">452,538</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">James A. McClung</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">121,843</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">W. Ed Tyler</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">54,440</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">R. Janet Whitmore</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,407,158</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">4.5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">George A. Vincent, III</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">78,450</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Jess A. Jankowski</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">577,801</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.8</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Kevin Cureton</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;222,833</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Nancy Baldwin</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">267,487</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Frank J. Cesario</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">255,950</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">All current executive officers and directors
    as a group (10 persons) <BR></FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3,958,165</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">12.0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated
below, the person&rsquo;s address is the same as the address for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*Denotes beneficial ownership of less than
one percent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">Beneficial ownership is determined in accordance with the rules of the SEC. Unless otherwise indicated
below, the persons in the above table have sole voting and investment power with respect to all shares of common stock shown as
beneficially owned by them.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">Includes 2,433,300 shares of common stock held by Grace Brothers, Ltd., 601,410 shares of common
stock held by Grace Investments, Ltd. and 10,407,435 shares held by Bradford T. Whitmore, as well as 51,454 shares held by his
daughter. Mr. Whitmore is a general partner of both Grace entities. In such capacities, Mr. Whitmore shares voting and investment
power with respect to the shares of common stock held by the Grace entities. This information is based on information reported
on a Form 5 filed on January 11, 2017 with the SEC. The address of the stockholder is 1603 Orrington Avenue, Suite 900, Evanston,
Illinois 60201.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">Includes 2,433,300 shares of common stock held by Grace Brothers, Ltd. and 601,410 shares of common
stock held by Grace Investments, Ltd. Spurgeon Corporation is a general partner of both Grace entities and shares voting and investment
power with respect to the shares of common stock held by such Grace entities. This information is based on information reported
on the Form 5 referenced above. The address of the stockholder is 1603 Orrington Avenue, Suite 900, Evanston, Illinois 60201.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 6; Value: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">This information is based on information reported on the Form 5 referenced above. The address of
the stockholder is 1603 Orrington Avenue, Suite 900, Evanston, Illinois 60201.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(5)</TD><TD STYLE="text-align: justify">This information is based on information reported on Schedule 13G/A filed with the SEC on January
5, 2017. The address of the stockholder is 8 Rene Carr Street, Elkton, Maryland 21921.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(6)</TD><TD STYLE="text-align: justify">Includes Mr. Henderson&rsquo;s 37,550 shares of common stock issuable upon exercise of options
exercisable currently or within 60 days of March 14, 2017.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(7)</TD><TD STYLE="text-align: justify">Includes Dr. Siegel&rsquo;s 62,700 shares of common stock issuable upon exercise of options exercisable
currently or within 60 days of March 14, 2017.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(8)</TD><TD STYLE="text-align: justify">Includes Mr. McClung&rsquo;s 74,190 shares of common stock issuable upon exercise of options exercisable
currently or within 60 days of March 14, 2017, as well as 30,071 shares held by his spouse.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(9)</TD><TD STYLE="text-align: justify">Includes Mr. Tyler&rsquo;s 54,440 shares of common stock issuable upon exercise of options exercisable
currently or within 60 days of March 14, 2017.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(10)</TD><TD STYLE="text-align: justify">Includes Ms. Whitmore&rsquo;s 62,700 shares of common stock issuable upon exercise of options exercisable
currently or within 60 days of March 14, 2017, as well as 238,493 shares held by her children.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(11)</TD><TD STYLE="text-align: justify">Includes Mr. Vincent&rsquo;s 78,450 shares of common stock issuable upon exercise of options exercisable
currently or within 60 days of March 14, 2017.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(12)</TD><TD STYLE="text-align: justify">Includes Mr. Jankowski&rsquo;s 538,000 shares of common stock issuable upon exercise of options
exercisable currently or within 60 days of March 14, 2017, as well as 1,000 shares held by his spouse.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(13)</TD><TD STYLE="text-align: justify">Includes Mr. Cureton&rsquo;s 222,833 shares of common stock issuable upon exercise of options exercisable
currently or within 60 days of March 14, 2017.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(14)</TD><TD STYLE="text-align: justify">Includes Ms. Baldwin&rsquo;s 266,500 shares of common stock issuable upon exercise of options exercisable
currently or within 60 days of March 14, 2017.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(15)</TD><TD STYLE="text-align: justify">Includes Mr. Cesario&rsquo;s 172,167 shares of common stock issuable upon exercise of options exercisable
currently or within 60 days of March 14, 2017.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(16)</TD><TD STYLE="text-align: justify">Includes all executive officers and directors as a group&rsquo;s 1,569,530 shares of common stock
issuable upon exercise of options exercisable currently or within 60 days of March 14, 2017.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="nanx10k123116a036"></A>Item 13. Certain Relationships and Related Transactions,
and Director Independence</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under our Audit and
Finance Committee&rsquo;s charter, the Audit and Finance Committee must review and approve all related person transactions in which
any executive officer, director, director nominee or more than 5% stockholder, or any of their immediate family members, has a
direct or indirect material interest. The Audit and Finance Committee may not approve a related person transaction unless it is
in, or not inconsistent with, our best interests and, where applicable, the terms of such transaction are at least as favorable
to us as could be obtained from an unrelated third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We did not engage
in any transactions in which a related person had or will have a direct or indirect material interest during 2016 or 2015, except
for the February 2016 sale of 2.6 million shares of our common stock to our largest shareholder, Bradford T. Whitmore, at a price
of $0.38 per share, for proceeds of $988,000, which was reviewed and approved in advance by our Audit and Finance Committee pursuant
to the parameters described above. No related party transactions are currently contemplated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Director Independence</B>.
The Board of Directors has determined that the following directors are &ldquo;independent&rdquo; as that term is defined in the
rules and regulations of the SEC and the NASDAQ Stock Market: Mr. McClung, Mr. Henderson, Dr. Siegel, Mr. Tyler and Mr. Vincent.
Though we are no longer listed on NASDAQ, our Board of Directors used the NASDAQ listing standards in making its independence
determinations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
has established an Audit and Finance Committee, Compensation Committee and Nominating and Corporate Governance Committee. The
members of the Audit and Finance Committee are Mr.&nbsp;McClung (Chairman), Mr. Vincent, and Dr. Siegel. The members of the Compensation
Committee are Mr.&nbsp;Tyler (Chairman), Mr. Henderson, and Mr. Vincent. The members of the Nominating and Corporate Governance
Committee are Mr. Henderson (Chairman), Mr. McClung, Dr. Siegel, Mr. Vincent, Mr. Tyler and Ms. Whitmore.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: black"><A NAME="nanx10k123116a037"></A>Item&nbsp;14. Principal Accountant Fees
and Services</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: black">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"><U>Audit Fees</U>.
The aggregate amount billed by our principal accountant, RSM US LLP (&ldquo;RSM&rdquo;), for audit services performed for the
fiscal years ended December&nbsp;31, 2016 and 2015 was approximately $142,000 and $158,000, respectively. Audit services include
the auditing of financial statements and quarterly reviews.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black"><U>Audit
Related Fees</U>. There were no audit related fees billed by RSM for the years ended December 31, 2016 and 2015, which may include
costs incurred for reviews of registration statements, assistance with Staff comment letters, and consultation on various accounting
matters in support of our financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black"><U>Tax
Fees</U>. There were no fees billed by our principal accountant for tax related services for the fiscal years ended December&nbsp;31,
2016 and 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black"><U>All
Other Fees</U>. Other than those fees described above, during the fiscal years ended December 31, 2016 and 2015, there were no
other fees billed for services performed by our principal accountant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">All of
the fees described above were approved by our Audit and Finance Committee. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black"><U>Audit
and Finance Committee Pre-Approval Policies and Procedures</U>. Our Audit and Finance Committee pre-approves the audit and non-audit
services performed by RSM, our principal accountants, in order to assure that the provision of such services does not impair RSM&rsquo;s
independence. Unless a type of service to be provided by RSM has received general pre-approval, it will require specific pre-approval
by the Audit and Finance Committee. In addition, any proposed services exceeding pre-approval cost levels or budgeted amounts
will require specific pre-approval by the Audit and Finance Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">The term
of any pre-approval is 12&nbsp;months from the date of pre-approval, unless the Audit and Finance Committee specifically provides
for a different period. The Audit and Finance Committee will periodically revise the list of pre-approved services, based on subsequent
determinations, and has delegated pre-approval authority to the Chairman of the Audit and Finance Committee. In the event the
Chairman exercises such delegated authority, he shall report such pre-approval decisions to the Audit and Finance Committee at
its next scheduled meeting. The Audit and Finance Committee does not delegate its responsibilities to pre-approve services performed
by the independent auditor to management. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: black">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: black">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="nanx10k123116a038"></A>PART IV</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="nanx10k123116a039"></A>Item&nbsp;15. Exhibits and Financial Statement Schedules</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The following documents are filed as
                                         part of this Form&nbsp;10-K:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">The following financial statements
                                         of the Company, with the report of independent registered public accounting firm, are
                                         filed as part of this Form&nbsp;10-K:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Report of
RSM US LLP, Independent Registered Public Accounting Firm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Balance Sheets as of December&nbsp;31,
2016 and 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Statements of Operations for the
Years Ended December&nbsp;31, 2016 and 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Statements of Stockholders&rsquo; Equity
for the Years Ended December&nbsp;31, 2016 and 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Statements of Cash Flows for the
Years Ended December&nbsp;31, 2016 and 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Notes to Financial Statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">A list of exhibits required to be
                                         filed as part of this Form 10-K is set forth in the Exhibit Index beginning on page E-1
                                         of this Form 10-K, which immediately precedes such exhibits, and is incorporated herein
                                         by reference.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="nanx10k123116a040"></A>Item&nbsp;16. Form 10-K Summary</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">None.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Value: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">NANOPHASE
TECHNOLOGIES CORPORATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">INDEX TO
FINANCIAL STATEMENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 97%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: right; border-bottom: Black 1pt solid">Page</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><A HREF="#nanx10k123116b001">Report of RSM US LLP, Independent Registered Public Accounting Firm</A></TD>
    <TD STYLE="text-align: right">F-2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><A HREF="#nanx10k123116b002">Balance Sheets as of December&nbsp;31, 2016 and 2015</A></TD>
    <TD STYLE="text-align: right">F-3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><A HREF="#nanx10k123116b003">Statements of Operations for the years ended December&nbsp;31, 2016 and 2015</A></TD>
    <TD STYLE="text-align: right">F-4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><A HREF="#nanx10k123116b004">Statements of Stockholders&rsquo; Equity for the years ended December 31, 2016 and 2015</A></TD>
    <TD STYLE="text-align: right">F-5</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><A HREF="#nanx10k123116b005">Statements of Cash Flows for the years ended December&nbsp;31, 2016 and 2015</A></TD>
    <TD STYLE="text-align: right">F-6</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><A HREF="#nanx10k123116b006">Notes to the Financial Statements</A></TD>
    <TD STYLE="text-align: right">F-7</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal"><U><A NAME="nanx10k123116b001"></A>Report
of Independent Registered Public Accounting Firm</U> </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Board of Directors and Stockholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nanophase Technologies Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying balance
sheets of Nanophase Technologies Corporation as of December 31, 2016 and 2015, and the related statements of operations, stockholders&rsquo;
equity, and cash flows for the years then ended. These financial statements are the responsibility of the Company&rsquo;s management.
Our responsibility is to express an opinion on these financial statements based on our audits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance
with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The
Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our
audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s
internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that
our audits provide a reasonable basis for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our opinion, the financial statements
referred to above present fairly, in all material respects, the financial position of Nanophase Technologies Corporation as of
December 31, 2016 and 2015, and the results of its operations and its cash flows for the years then ended, in conformity with
U.S. generally accepted accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ RSM US LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Schaumburg, Illinois</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 29, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">NANOPHASE
TECHNOLOGIES CORPORATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="nanx10k123116b002"></A>BALANCE
SHEETS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White">&nbsp;</TD><TD STYLE="font-weight: bold; background-color: White">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; background-color: White">(in thousands except share and per share data)</TD><TD STYLE="font-weight: bold; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White">&nbsp;</TD><TD STYLE="font-weight: bold; background-color: White">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; background-color: White">As of December&nbsp;31,</TD><TD STYLE="font-weight: bold; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; background-color: White">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; background-color: White">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid; background-color: White">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; background-color: White">ASSETS</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.65pt; background-color: White">Current assets:</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">1,779</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">1,275</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.25in">&nbsp;&nbsp;&nbsp;Trade accounts receivable, less allowance for
    doubtful accounts of $5 and $6 on December 31, 2016 and 2015, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">434</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">507</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Inventories, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">772</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">662</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1pt; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">442</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">247</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,427</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,691</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Equipment and leasehold improvements, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,861</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Other assets, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">20</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">22</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.65pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">4,842</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">4,574</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center; padding-left: 0.65pt">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center; padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.65pt">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Current portion of capital lease obligations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">107</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">94</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">669</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">508</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Accrued expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">521</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">276</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,297</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">878</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Long-term portion of capital lease obligations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">110</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">144</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Long-term deferred rent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">466</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">519</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Asset retirement obligations</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">178</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">172</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">754</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">835</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.65pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contingent
liabilities&nbsp;</B></P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.65pt">Stockholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.25in">&nbsp;&nbsp;&nbsp;Preferred stock, $.01 par value,
    24,088 shares authorized and no shares issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.25in">&nbsp;&nbsp;&nbsp;Common stock, $.01 par value,
    42,000,000 and 35,000,000 shares authorized; 31,229,996 and 28,585,496 shares issued and outstanding on December 31, 2016 and
    December 31, 2015, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">312</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">286</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">97,359</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,172</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(94,880</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(93,597</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.65pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,791</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,861</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.65pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">4,842</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">4,574</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I>(See
accompanying Notes to Financial Statements)</I></FONT><BR CLEAR="ALL"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">NANOPHASE
TECHNOLOGIES CORPORATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="nanx10k123116b003"></A>STATEMENTS
OF OPERATIONS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">(in thousands except share and per share data)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Years ended December&nbsp;31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Revenue:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left">Product revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">10,720</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">10,272</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">63</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">41</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Total revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,783</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,313</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating expense:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Cost of revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,543</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,199</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,240</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,114</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Research and development expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,554</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,273</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Selling, general and administrative expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,954</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,019</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,268</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,178</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;&nbsp;&nbsp;Other, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss before provision for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,283</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,192</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">(1,283</TD><TD STYLE="padding-bottom: 2pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">(1,192</TD><TD STYLE="padding-bottom: 2pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share-basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">(0.04</TD><TD STYLE="padding-bottom: 2pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">(0.04</TD><TD STYLE="padding-bottom: 2pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Weighted average number of basic and diluted common
    shares outstanding</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">30,911,869</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">28,574,902</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>(See accompanying Notes to Financial
Statements)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">NANOPHASE
TECHNOLOGIES CORPORATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="nanx10k123116b004"></A>STATEMENTS
OF STOCKHOLDERS&rsquo; EQUITY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>(in thousands except
share data)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
    Stock</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Additional Paid-in</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Accumulated</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Shares</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Amount</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Shares</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Amount</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Capital</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Deficit</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    on December 31, 2014</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,516,163</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">285</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,966</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(92,405</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,846</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Stock option exercises</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Stock-based compensation</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">181</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">181</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss for the year ended December 31, 2015</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,192</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,192</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    on December 31, 2015</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,585,496</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">286</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,172</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(93,597</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,861</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Sale of common stock</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,600,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">962</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">988</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Stock option exercises</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Stock-based compensation</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">207</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">207</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss for the year ended December 31, 2016</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,283</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,283</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    on December 31, 2016</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,229,996</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">312</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,359</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(94,880</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,79</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I>(See
accompanying Notes to Financial Statements)</I></FONT><BR CLEAR="ALL"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">NANOPHASE
TECHNOLOGIES CORPORATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="nanx10k123116b005"></A>STATEMENTS
OF CASH FLOWS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">(in thousands)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Years ended December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">Operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left">Net loss</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(1,283</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">(1,192</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to cash
    used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">735</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Impairment of fixed asset</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">207</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">182</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Changes in assets and liabilities related to operations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(119</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(110</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">288</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(194</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">241</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(240</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(241</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(240</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Acquisition of equipment and leasehold improvements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(128</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(280</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Payment of accounts payable incurred for
    the purchase of equipment and leasehold improvements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(37</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(165</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(288</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Principal payment on capital leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(96</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(85</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Proceeds from sale of common stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">988</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Proceeds from exercise of stock options</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">18</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">26</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Net cash provided by (used in) financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">910</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(59</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Increase/(Decrease) in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">504</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(587</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,275</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,862</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">1,779</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">1,275</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental cash flow information:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Interest paid</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">15</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">14</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental non-cash investing and financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in">Accounts payable incurred for the
    purchase of equipment and leasehold improvements</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">37</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Capital lease obligations incurred in the purchase of equipment</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">75</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">132</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(See accompanying Notes to Financial
Statements)</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0pt 0; text-align: center">NANOPHASE TECHNOLOGIES CORPORATION&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="nanx10k123116b006"></A>NOTES TO FINANCIAL
STATEMENTS</P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">(In thousands, except share
and per share data or as otherwise noted herein)</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman Bold,serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Description of Business</TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nanophase Technologies Corporation
(&ldquo;Nanophase&rdquo;, &ldquo;Company&rdquo;, &ldquo;we&rdquo;, &ldquo;our&rdquo;, or &ldquo;us&rdquo;) is an advanced materials
and applications developer and commercial manufacturer with an integrated family of nanomaterial and related technologies. We produce
engineered nano and larger, sub-micron, materials for use in a variety of diverse markets: personal care including sunscreens,
architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics,
energy, and a variety of surface finishing technologies (polishing) applications, including optics. We have recently expanded our
offerings beyond active ingredients to include targeted full formulations of skin care products, marketed and sold by our wholly-owned
subsidiary, Sol&eacute;sence &trade; LLC. We target markets in which we believe practical solutions may be found using our products.
We work closely with current and potential customers in these target markets to identify their material and performance requirements
and market our materials to various end-use applications manufacturers. Recently developed technologies have made certain new products
possible and opened potential new markets. We recently developed new material solutions in the light energy-management area (particularly
solar control) that have been taken to potential customers, and for which we are experiencing early-stage, accelerating revenue
growth. We also developed a new solution for surface treatments (coatings) which we used to launch new products in personal care,
including those of our subsidiary, Sol&eacute;sence &trade; LLC, in the fall of 2016. Although our primary strategic focus has
been the North American market, we currently sell material to customers overseas and have been working to expand our reach within
foreign markets. The Company was incorporated in Illinois on November 25, 1989, and became a Delaware corporation during November
1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While product sales comprise
the majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected
to drive the long-term growth of the business. For this reason, we classify such revenue as &ldquo;other revenue&rdquo; in our
Statements of Operations, as it does not represent revenue directly from our nanocrystalline materials.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman Bold,serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Summary of Significant Accounting Policies</TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Use of Estimates and
Risks and Uncertainties</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial
statements requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying
notes. Actual results could differ from those estimates. Certain assumptions are also necessary to assess the impact of risks and
uncertainties on the financial statements, such as cash flow projections, availability of capital if needed to support the ongoing
operations of the business, and our expected compliance with contractual commitments. These risks and uncertainties are further
discussed in Note 12. Any changes in these assumptions or business plans could have a material impact on the financial statements.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Cash and Cash Equivalents</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash and cash equivalents primarily
consist of demand deposits, but also include certain lower risk investments with a stated maturity upon acquisition of 90 days
or less (e.g., money market funds or a certificate of deposit with a maturity of 90 days or less at the time of purchase).</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"><B>Trade Accounts Receivable</B></P>

<P STYLE="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Trade accounts receivable are
carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts
on a monthly basis. We determine the allowance for doubtful accounts by identifying troubled accounts and by using historical experience
applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts
receivable previously written off are recorded when received. Our typical credit terms are thirty days from shipment and invoicing.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Inventories</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Inventories are stated at the
lower of cost, maintained on a first in, first out basis, or market. We have recorded allowances to reduce inventory relating to
excess quantities of certain materials. Write-downs of inventories establish a new cost basis, which is not increased for future
increases in market value of inventories or changes in estimated excess quantities.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Equipment and Leasehold
Improvements</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Equipment is stated at cost
and is being depreciated over its estimated useful life (3-20 years) using the straight-line method. Leasehold improvements are
stated at cost and are being amortized using the straight-line method over the shorter of the useful life of the asset or the term
of the lease (3-13 years). Depreciation expense for leased assets is included with depreciation expense for owned assets. From
time to time we have self-constructed assets. These assets are stated at cost plus the capitalization of labor and are depreciated
over an estimated useful life (7-10 years) using the straight-line method.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Long Lived Assets</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We review long-lived assets
for impairment whenever events or changes in circumstances indicate that the asset&rsquo;s carrying amount may not be recoverable.
We conduct long-lived asset impairment analyses in accordance with ASC 360-10-15, <I>Impairment or Disposal of Long-Lived Assets</I>.
ASC 360-10-15 requires us to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent
of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash
flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is
measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis
or appraisals.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"><B>Asset Retirement Obligations</B></P>

<P STYLE="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with our leased
facilities, we are required to remove certain leasehold improvements upon termination of our occupancy. We follow the provisions
of the FASB issued ASC 410-20, <I>Asset Retirement Obligations</I>, under which we recognize a liability for the fair value of
these asset retirement obligations. The fair value of that liability is measured based on an expected cash flow approach and accretion
expense is recognized each period to recognize increases to the fair value of the liability due to the passage of time. Increases
to the fair value of the liability, except for accretion, are added to the carrying value of the long-lived asset. Those increases
are then reported in amortization expense over the estimated useful life of the long-lived asset.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity in the asset retirement
obligation account for the years ended December 31, is as follows:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD COLSPAN="2" STYLE="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid">2016</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD><TD COLSPAN="2" STYLE="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid">2015</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; text-align: left; text-indent: -9pt; padding-left: 9pt">Balance, beginning</TD>
    <TD STYLE="width: 1%">&nbsp;</TD><TD STYLE="width: 1%">$</TD>
    <TD STYLE="width: 8%; text-align: right">172</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD><TD STYLE="width: 1%">$</TD>
    <TD STYLE="width: 8%; text-align: right">166</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.15in">Accretion of liability due to passage of time</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">6</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2px; padding-left: 0.15in">Amortization of asset due to passage of time</TD>
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 2px; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2px; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 2px; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2px; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">Balance, ending</TD>
    <TD>&nbsp;</TD><TD STYLE="border-bottom: Black 2pt double">$</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: right">178</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="border-bottom: Black 2pt double">$</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: right">172</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Value: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Financial Instruments</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We follow ASC Topic 820, <I>Fair
Value Measurements and Disclosures</I>, which defines fair value, establishes a framework for measuring fair value, and expands
disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into
three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure
of fair value, whereas Level 3 generally requires significant management judgment.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our financial instruments include
cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with the promissory note with no related
borrowings described in Note 3, and any borrowings on the working capital line of credit described in Note 3. The fair values of
all financial instruments were not materially different from their carrying values.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There were no financial assets
or liabilities adjusted to fair value on December 31, 2016 and 2015.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Product Revenue </FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Product revenue consists of
sales of product that are recognized when realized and earned. This occurs when persuasive evidence of an arrangement exists, title
transfers via shipment of products or when delivery has occurred, the price is fixed or determinable and collectability is reasonably
assured.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Other Revenue </FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other revenue may include revenue
from technology license fees and paid development projects. Technology license fees and paid development projects are recognized
when earned pursuant to the agreed upon contractual arrangement, when performance obligations are satisfied, the amount is fixed
or determinable, and collectability is reasonably assured.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Shipping and handling costs
are included in other revenue when products are shipped and invoiced to the customer. We include the related cost of shipping and
handling in cost of goods sold.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><B>Research and Development Expenses</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;Research and development
expenses are recognized as expense when incurred.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Income Taxes </FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We account for income taxes
using the liability method. As such, deferred income taxes reflect the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets
and liabilities are calculated using the enacted tax rates and laws that are expected to be in effect when the anticipated reversal
of these differences is scheduled to occur. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,
it is more likely than not that some portion or all of the deferred tax assets will not be realized.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When tax returns are filed,
it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are
subject to uncertainty about merits of the position taken or the amount of the position that would be ultimately sustained. The
benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence,
management believes it is more likely than not that the position will be sustained upon examination, including the resolution of
appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that
meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent
likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax
positions taken that exceeds the amount measured, as described above, is reflected as a liability for uncertain tax benefits in
the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities
upon examination.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Value: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not recorded a reserve
for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing
of such deductibility. We file tax returns in all appropriate jurisdictions, which includes a federal tax return and Illinois state
tax return. Open tax years for both jurisdictions are 2013 to 2015, which statutes expire in 2017 to 2019, respectively, under
most cases and subject to appropriate laws and regulations. When and if applicable, potential interest and penalty costs are accrued
as incurred, with expenses recognized in selling, general and administrative expenses in the statements of operations. As of December
31, 2016 and 2015, we had no liability for unrecognized tax benefits.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Earnings Per Share</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Options to purchase approximately
859,000 shares of common stock that were outstanding as of December 31, 2016 were not included in the computation of earnings per
share for the year ended December 31, 2016, as the impact of such shares would be both negligible and anti-dilutive. Options to
purchase approximately 210,000 shares of common stock that were outstanding as of December 31, 2015 were not included in the computation
of earnings per share for the year ended December 31, 2015, as the impact of such shares would be both negligible and anti-dilutive.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><B>New Accounting Pronouncements </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During May 2014, the FASB issued Accounting Standards
Update (&ldquo;ASU&rdquo;) No. 2014-09 (&ldquo;ASU 2014-09&rdquo;), <I>Revenue from Contracts with Customers</I>, and several related
updates including ASU No. 2016-08 and ASU No. 2016-10, which supersedes nearly all existing revenue recognition guidance under
U.S. generally accepted accounting principles. The new standard requires a company to recognize revenue when it transfers goods
or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services.
Additionally, the guidance requires certain disclosures designed to help users of financial statements better understand the nature,
amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for annual
reporting periods beginning after December 15, 2017, including interim periods within that reporting period, which is our first
quarter of 2018. The new standard allows application either retrospectively to each prior reporting period presented or retrospectively
as a cumulative-effect adjustment as of the date of adoption. We are evaluating the effect that ASU 2014-09 will have on our financial
statements and related disclosures, but do not expect it to have a material impact on our financial position, results of operations,
or cash flows.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During February 2016, the FASB issued ASU No. 2016-02
(&ldquo;ASU 2016-02&rdquo;), <I>Leases (Topic 842)</I>. This standard requires the recognition of assets and liabilities arising
from lease transactions on the balance sheet and the disclosure of key information about leasing arrangements. Accordingly, a lessee
will recognize a lease asset for its right to use the underlying asset and a lease liability for the corresponding lease obligation.
Both the asset and liability will initially be measured at the present value of the future minimum lease payments over the lease
term. Subsequent measurement, including the presentation of expenses and cash flows, will depend on the classification of the lease
as either a finance or an operating lease. Initial costs directly attributable to negotiating and arranging the lease will be included
in the asset. For leases with a term of 12 months or less, a lessee can make an accounting policy election by class of underlying
asset to not recognize an asset and corresponding liability. Lessees will also be required to provide additional qualitative and
quantitative disclosures regarding the amount, timing and uncertainty of cash flows arising from leases. These disclosures are
intended to supplement the amounts recorded in the financial statements and provide additional information about the nature of
an organization&rsquo;s leasing activities. The amendments in this standard are effective for fiscal years, and interim periods
within those fiscal years, beginning after December 15, 2018, with early adoption permitted. We are currently evaluating the impact
its adoption will have on the presentation of our financial statements and related disclosures.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Value: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in; text-align: right">During August 2014, the FASB issued ASU No. 2014-15,
<I>Disclosure of Uncertainties about an Entity&rsquo;s Ability to Continue as a Going Concern</I> (&ldquo;ASU 2014-15&rdquo;).
ASU 2014-15 will explicitly require management to assess an entity&rsquo;s ability to continue as a going concern, and to provide
related footnote disclosure in certain circumstances. The new standard is effective for all entities in the first annual period
ending after December 15, 2016, or January 1, 2017 for us. Earlier adoption was permitted. The adoption did not impact the presentation
of our financial statements, financial position, results of operations, cash flows and related disclosures.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">During March 2016, the FASB issued ASU No. 2016-09,
<I>Improvements to Employee Share-Based Payment Accounting</I>, which amends ASC Topic 718, <I>Compensation - Stock Compensation</I>.
The objective of this update is part of the FASB&rsquo;s Simplification Initiative as it applies to several aspects of the accounting
for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,
and classification on the statement of cash flows. The effective date of the update is for fiscal years beginning after December
15, 2016 and interim periods within that reporting period, or January 1, 2017 for us. Early adoption was permitted. The adoption
did not have a material impact on the presentation of our financial statements, financial position, results of operations, cash
flows and related disclosures.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Note and Line
of Credit</P>

<P STYLE="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">During
July 2014 we entered into a bank-issued letter of credit and related promissory note for up to $30 in borrowings to support our
obligations under our facility lease agreement. We then sold our certificates of deposit. No borrowings have been incurred under
this promissory note. Should any borrowings occur in the future, the interest rate would be the prime rate plus 1%, with the bank
having the right to &ldquo;set off&rdquo; or apply unpaid balances against our checking account if we fail to meet our obligations
under any borrowings under the note. It is our intention to renew this note annually, for as long as we need to pursuant to the
terms of our facility lease agreement. Because there were no amounts outstanding on the note at any time during 2016 or 2015, we
have recorded no related liability on our balance sheet. </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During March 2015, we entered
into a Business Loan Agreement (the &ldquo;Line of Credit Agreement&rdquo;) with Libertyville Bank and Trust Company, a Wintrust
Community Bank (&ldquo;Libertyville&rdquo;), our primary bank. This Line of Credit Agreement was subsequently amended on April
13, 2015. Under the Line of Credit Agreement, as amended, Libertyville will provide a maximum of $300, or 75% of our eligible accounts
receivable, whichever is less, of revolving credit, collateralized by a senior priority lien on our accounts receivable, inventory,
equipment, general intangibles and fixtures. Interest on any borrowings would be the prime rate at the time plus 1%. Availability
to draw on the line requires us to have at least $1 million in cash, including any amounts borrowed, at Libertyville on the date
of any advance. Advances may only occur at the beginning or end of a fiscal quarter and must be repaid in full within five days
of the advance. The Line of Credit Agreement was to expire on March 4, 2016, but during March 2016 was extended until March 4,
2017. During February 2017, this agreement was further extended to March 2018. No borrowing on this line was outstanding on December
31, 2016.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Value: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>


<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
consist of the following:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif;margin-left:5%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 54%; text-align: left">Raw materials</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">283</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">184</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Finished goods</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">510</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">530</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">793</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">714</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Allowance for excess quantities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(21</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(52</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2pt">&nbsp;</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">772</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">662</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equipment
and Leasehold Improvements</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment
and leasehold improvements consist of the following:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif;margin-left:5%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Machinery and equipment</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">14,587</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">14,562</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Office equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">790</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">778</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Office furniture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">110</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">110</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Leasehold improvements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,814</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,789</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Construction in progress</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">75</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,376</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation and amortization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(18,981</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(18,389</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2pt">&nbsp;</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">1,395</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">1,861</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $605 and $726, for the years ended December 31, 2016 and 2015, respectively.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(6)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease
Commitments &nbsp;</B></FONT></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease our operating facilities under operating leases. During October 2016 we entered into a Third Lease Amendment related to
our primary facility in Romeoville, Illinois, extending the term of the lease through December 31, 2024. The current monthly rent
on this lease amounts to $25.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
lease our Burr Ridge, Illinois, facility under an agreement extended during September 2010, which extended the term through September
2014 (we have since exercised our final tenant option to extend the term through September 2017). During March 2017, we entered
into a new Building Lease for this facility that will begin September 2017 and extend through September 2021, with our having
the option to further extend this lease by three additional one-year periods. The current monthly rent on this lease amounts to
$15. During 2016 we also renewed our lease for our offsite warehouse in Romeoville, Illinois, through August 2019. The current
monthly rent on this lease amounts to $5.&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a schedule of future minimum lease payments including real estate taxes as required under the above operating leases,
as well as the remaining lease payments under capital leases as referenced below:</FONT></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="margin-left: 1in; border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">Year ending December 31:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">Operating<BR>
 Leases</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">Capital<BR>
 Leases</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 54%; text-align: justify">2017</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">698</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">58</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">700</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">691</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">589</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">554</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1pt">Thereafter</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,289</TD><TD STYLE="padding-bottom: 1pt; text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2pt; padding-left: 0.125in">Total minimum payments required:</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">4,521</TD><TD STYLE="padding-bottom: 2pt; text-align: left; border-bottom: Black 2pt double">*</TD><TD STYLE="padding-bottom: 2pt; border-bottom: Black 2pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">170</TD><TD STYLE="padding-bottom: 2pt; text-align: left">*</TD></TR>
</TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
After paying $60 to retire a capital lease during January 2017, the remaining payments under capital leases include principal
of $147 and interest of $23. Also, includes future payments of the Burr Ridge Building Lease executed March 2017 as described
above.&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent
expense, including real estate taxes, under these leases amounted to $597 and $588, for the years ended December 31, 2016 and
2015, respectively.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
On December 31, 2016 equipment under capital leases had a cost of $362 with accumulated depreciation of $62, compared to $316
and $29, respectively, on December 31, 2015. Principal and interest payments are due monthly under the capital lease
obligations through October 2020. We entered into one new capital lease during 2016 for $75 and a 5-year duration (through
August 2021), and recognized an impairment charge, reducing the value of two other pieces of capital equipment by $54 in
aggregate. We entered into three new capital leases during 2015 for $132 and 3 to 5 year durations (through August
2020).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued
Expenses</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses consist of the following:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; text-align: left">Accrued payroll and related expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">167</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">108</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Customer net volume rebate payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">201</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">153</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">168</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2pt">&nbsp;</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">521</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">276</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income
Taxes</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net income tax provision, including both current and deferred, related to U.S. federal and state income taxes, is none.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of income tax expense to the amount computed by applying the Federal income tax rate to loss before provision for
income taxes as of December 31, 2016 and 2015 is as follows:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; text-align: left">Income tax credit at statutory rates</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(436</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(405</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Nondeductible expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">State income tax, net of federal benefits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(66</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(61</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">144</TD><TD STYLE="text-align: left"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Increase in valuation allowance</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">356</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">466</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2pt">&nbsp;</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Value: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of our deferred income taxes consist of
the following:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White">Deferred tax assets:</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; text-align: left; padding-left: 0.125in">Net operating loss carryforwards</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">31,935</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">31,590</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Inventory and other allowances</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Charitable contribution carryforwards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Excess (tax) book depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">805</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">709</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Excess (tax) book amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Share-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,328</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,396</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Other accrued costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">219</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">225</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Total deferred tax assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,377</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,021</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less: Valuation allowance</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(34,377</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(34,021</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2pt">Deferred income taxes</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 2pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
valuation allowance increased approximately $0.4 million and $0.5 million for the years ended December 31, 2016 and 2015, respectively
(with no expiring net operating loss carryforwards and credits for either period; a portion of the charitable contribution carryforward
expired during 2016) due principally to the change in the net operating loss carryforward and uncertainty as to whether future
taxable income will be generated prior to the expiration of the carryforward period. Under the Internal Revenue Code, certain
ownership changes, including the prior issuance of preferred stock and our public offering of common stock, may subject us to
annual limitations on the utilization of our net operating loss carryforward. As of December 31, 2016, the amounts subject to
limitations has not yet been determined.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have net operating loss carryforwards for tax purposes of approximately $82 million on December 31, 2016, which expire between
2018 and 2036.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2011, the state of Illinois suspended the use of net operating loss carryforwards for a four year period beginning 2011, extending
the term of all net loss carryforwards by a corresponding four years.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital
Stock</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2016 and 2015, we had 24,088 authorized but unissued shares of preferred stock. In addition, as of December 31,
2016, 1,196,000 authorized but unissued shares of common stock have been reserved for future issuance upon exercise of stock options.
During August 2016, our stockholders authorized an additional 7,000,000 shares of common stock, increasing our authorized shares
of common stock from 35,000,000 to 42,000,000 authorized shares. Our stockholders also authorized an additional 1,200,000 shares
of common stock that may be issued pursuant to our 2010 Equity Compensation Plan.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
Options and Stock Grants</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into stock option agreements with certain officers, employees and directors. The stock options generally expire ten
years from the date of grant.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal"><U>Employee
Stock Options</U></FONT></P>

<P STYLE="font: italic 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">We
follow </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB ASC Topic 718<FONT STYLE="letter-spacing: -0.1pt">,
<I>Share-Based Payments</I>, in which compensation expense is recognized only for share-based payments expected to vest. We recognized
compensation expense related to stock options of </FONT>$207 and $181 for the years ended December 31, 2016 and 2015, respectively.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">As
of December 31, 2016, there was approximately $183 of total unrecognized compensation cost related to nonvested share-based compensation
arrangements granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period
of 1.7 years.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">The
following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for options granted
for all years presented:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 9pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Years Ended December
    31,</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">2016</FONT></TD><TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">2015</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; text-align: left"><FONT STYLE="font-size: 10pt">Weighted-average risk-free interest
    rates:</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-size: 10pt">1.5</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-size: 10pt">1.7</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Dividend yield:</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Weighted-average expected life of the option:</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">7 years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">7 years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Weighted-average expected stock price volatility:</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">95</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">95</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 12pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Weighted-average fair value of the options
    granted:</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.36</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">0.36</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
use the Black&minus;Scholes option pricing model to determine the fair value of stock based compensation. The Black&minus;Scholes
model requires us to make several assumptions, including the estimated length of time employees will retain their vested stock
options before exercising them (&ldquo;expected term&rdquo;), the estimated volatility of our common stock price over the expected
term and estimated forfeitures. Expected price volatility of the fiscal 2016 and 2015 grants is based on the daily market rate
changes of our stock going back to January 1, 2008. The shares granted in fiscal 2016 and 2015 had a vesting period of three years
and a contractual life of 10 years. Forfeitures were estimated at 4% and 4% for the years ended December 31, 2016 and 2015, based
on our historical experience. The Black&minus;Scholes model also requires a risk free interest rate, which is based on the U.S.
Treasury yield curve in effect at the time of the grant, and the dividend yield on our common stock, which is assumed to be zero
since we do not pay dividends and have no current plans to do so in the future. Changes in these assumptions can materially affect
the estimate of fair value of stock based compensation and consequently, the related expense recognized on the statement of operations.
We recognize stock based compensation expense on a straight-line basis.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
following table summarizes the option activity for our employees and directors during the year ended December 31, 2016:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom">(rounded)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">Weighted Average Exercise Price per </TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">Weighted Average Remaining Contractual Term </TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">Aggregate Intrinsic </TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">Options</TD><TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">Share</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">(years)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">Value</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%">Outstanding on January 1, 2016</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">2,574,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">0.95</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">508,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.48</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(44,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Forfeited or expired</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(105,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.08</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Outstanding on December 31, 2016</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,933,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.81</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.3</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">616</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Exercisable on December 31, 2016</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,053,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.96</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.3</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">378</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Shares available for grant</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,196,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
aggregate intrinsic value in the table above is based on our closing stock price of $0.72 on the last business day for the year
ended December 31, 2016.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">During
the years ended December 31, 2016 and 2015, the total intrinsic value of our stock options exercised was $19 and $10, respectively.
Cash received for option exercises was $18 and $26 during the years ended December 31, 2016 and 2015, respectively. We had approximately
44,000 options exercised during the year ended December 31, 2016, compared to 69,000 in 2015. Based on our election of the &ldquo;with
and without&rdquo; approach, no realized tax benefits from stock options were recognized for the years ended December 31, 2016
and 2015.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">Stock
Appreciation Rights</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Prior
to 2011, we granted our Outside Directors stock appreciation rights (SARs) under our Amended and Restated 2006 Stock Appreciation
Rights Plan and subsequently under our 2010 Equity Plan. The change in fair value of the awards granted during prior years was
included in non-cash compensation expense for the years ended December 31, 2016 and 2015. The SARs granted vested immediately
and were payable upon the directors&rsquo; removal or resignation from the position of director. These awards were accounted for
as liability awards, included in accrued expenses as of December 31, 2015, and adjusted to fair value each reporting period. The
fair value of the liability on December 31, 2016 and 2015 was zero. During November 2016, all vested SARs were terminated. Those
Outside Directors whose vested SARs were cancelled received immediately vested options in the same quantity, and at the same strike
price, as their cancelled SARs. The options granted are included in the above chart. We have no remaining SARs outstanding.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Restricted
Stock</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
of both December 31, 2016 and 2015, we did not have any unvested non-director restricted stock or performance shares outstanding.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">(11)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;401(k)
Profit-Sharing Plan</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have a 401(k) profit-sharing plan covering substantially all employees who meet defined service requirements. We have made in
the past, and may make in the future, maximum contributions of 100% of the first 3% and 50% of the next 2% of the participant&rsquo;s
salary. We made changes to our benefits program and, as part of those changes, discontinued these Company contributions effective
January 2014, which resulted in no contributions made during 2016 or 2015. During 2017, we implemented a new Company contribution
program, in which 10% of the employee&rsquo;s contribution will be matched up to an 8% contribution (for a match of up to 0.8%
of a participant&rsquo;s salary).</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">(12)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Significant
Customers and Contingencies</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Revenue
from three customers constituted approximately 69%, 5% and 4%, respectively, of our 2016 revenue. Amounts included in accounts
receivable on December 31, 2016 relating to these three customers were approximately none, $39 and $180, respectively. Revenue
from these three customers constituted approximately 63%, 4% and 7%, respectively, of our 2015 revenue. Amounts included in accounts
receivable on December 31, 2015 relating to these three customers were approximately none, $35 and $240, respectively. The loss
of one of these significant customers or the failure to attract new customers could have a material adverse effect on our business,
results of operations and financial condition.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
currently have exclusive supply agreements with BASF Corporation (&ldquo;BASF&rdquo;), our largest customer, that have contingencies
outlined which could potentially result in the license of technology and/or the sale of production equipment from the Company
to the customer intended to provide capacity sufficient to meet the customer&rsquo;s production needs. This outcome may occur
if we fail to meet certain performance requirements, certain other obligations and/or certain financial condition covenants. The
financial condition covenants in one of our supply agreements with BASF &ldquo;trigger&rdquo; a technology transfer right (license
and equipment sale at BASF&rsquo;s option) in the event (a) that earnings for the twelve month period ending with our most recently
published quarterly financial statements are less than zero and our cash, cash equivalents and certain investments are less than
$1 million, or (b) of an acceleration of any debt maturity having a principal amount of more than $10 million. Our supply agreements
with BASF also &ldquo;trigger&rdquo; a technology transfer right in the event of our insolvency, as further defined within the
agreements. In the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer
at either 115% of the equipment&rsquo;s net book value or the greater of 30% of the original book value of such equipment, and
any associated upgrades to it, or 115% of the equipment&rsquo;s net book value, depending on the equipment and related products.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
believe that we have sufficient cash and credit availability, (See Liquidity and Capital Resources in Management&rsquo;s Discussion
and Analysis in Part II, Item 7 of this Form 10-K for a further discussion, as well as the description of our Line of Credit Agreement
described in Note 3<B>) </B>to operate our business during 2017. If a triggering event were to occur and BASF elected to proceed
with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products
sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to
replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer
pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity
would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar
consequences would occur if we were determined to have materially breached certain other provisions of the supply agreement with
BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities.
We believe that our employees are a critical component of our success and could be difficult to replace them quickly. Given the
occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event
and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including with respect
to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated investments.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Should
events arise that make it appropriate for us to seek additional financing, such additional financing may not be available on acceptable
terms or even at all, and any such financing could be dilutive to our stockholders. Such a financing could be necessitated by
such things as the loss of one or more significant customers or a significant decline in revenue from those customers, currently
unknown capital requirements, new regulatory requirements, the need to meet cash requirements under our BASF agreement to avoid
a triggering event, or other circumstances not currently anticipated by us. The failure to obtain sufficient capital may impair
or curtail our business plans and under such circumstances may raise doubt regarding our ability to continue as a going concern.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: none"><B>(13)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business
Segmentation and Geographical Distribution</B></FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Revenue
from international sources approximated $1,039 and $1,393 for the years ended December 31, 2016 and 2015, respectively. <FONT STYLE="letter-spacing: -0.1pt">As
part of our revenue from international sources, we recognized approximately $902 and $1,339 in product revenue from a number of
German companies, in the aggregate, for the years ended December 31, 2016 and 2015, respectively.</FONT></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; font-weight: normal; text-transform: none">Our
operations comprise a single business segment and all of our long-lived assets are located within the United States.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><FONT STYLE="font-size: 10pt; text-transform: none"><B>(14)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;Subsequent Events</B></FONT></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
discussed in Note 3, the Line of Credit Agreement with our primary bank (Libertyville) was to expire on March 4, 2017, but during
February 2017 this agreement was further extended to March 2018.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As discussed in Note
6, during March 2017 we entered into a new Building Lease for our Burr Ridge facility. The previous lease expires September 2017,
at which time this new lease will begin, and extend through September 2021. We have the option to further extend this lease by
up to three additional one year periods.&nbsp;</P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
discussed in Note 6, during January 2017 we paid $60 to retire  a capital lease related to equipment that we sold to a third
party for $100, its remaining book value. No gain or loss was recognized during 2017 associated with the transaction.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized, on the 29th day of March, 2017.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 42%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 56%"><B>NANOPHASE TECHNOLOGIES CORPORATION</B></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="width: 46%; border-bottom: Black 1pt solid">/s/ Jess A.
Jankowski</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Jess A. Jankowski</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>President and Chief
Executive Officer</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Frank J.
Cesario</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Frank J. Cesario</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in"><FONT STYLE="font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf
of the registrant and in the capacities indicated on the 29th day of March, 2017.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Signature&nbsp;</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">/s/
                                         Jess A. Jankowski&nbsp;</FONT></P></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;<FONT STYLE="letter-spacing: -0.1pt">President,
                    Chief Executive Officer (principal executive officer) and Director</FONT></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Jess A. Jankowski</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">/s/
                                         Frank J. Cesario&nbsp;</FONT></P></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Chief Financial Officer
        (principal financial and principal accounting officer)</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Frank J. Cesario</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">/s/
                                         James A. Henderson&nbsp;&nbsp;</FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Chairman of the Board
        of Directors</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">James
    A. Henderson</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">/s/
George A. Vincent, III&nbsp;</FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Director</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">George
    A. Vincent, III</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">/s/
                                         James A. McClung&nbsp;</FONT></P></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Director</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">James
    A. McClung</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">/s/
                                         Richard W. Siegel&nbsp;</FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Director</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Richard
    W. Siegel</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">/s/
                                         W. Ed Tyler &nbsp;&nbsp;&nbsp;</FONT></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Director&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">W. Ed
    Tyler</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">/s/
    R. Janet Whitmore&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-size: 10pt">R. Janet
    Whitmore</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="width: 19%">&nbsp;</TD>
    <TD STYLE="width: 30%; text-align: left"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
                                             <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 47%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 4.5pt"><FONT STYLE="font-size: 10pt"><B>EXHIBIT
INDEX&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                          <TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Number </B></FONT></TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Plan and
                                         Agreement of Merger dated as of November 25, 1997 by and between the Company and its
                                         Illinois predecessor, incorporated by reference to Exhibit 2 to the Company&rsquo;s Annual
                                         Report on Form 10-K for the year ended December 31, 1997 (the &ldquo;1997 10-K&rdquo;),
                                         SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">3(i).1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Certificate
                                         of Incorporation of the Company, incorporated by reference to Exhibit 3.1 to the 1997
                                         10-K, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">3(i).2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">First
                                         Amendment to the Certificate of Incorporation of the Company dated July 27, 2006, incorporated
                                         by reference to Exhibit 99.3 to the Company&rsquo;s Current Report on Form 8-K filed
                                         July 27, 2006, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">3(i).3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Second
                                         Amendment to the Certificate of Incorporation of the Company dated August 23, 2010, incorporated
                                         by reference to Exhibit A of the Company&rsquo;s Definitive Proxy Statement on Form DEF14A
                                         filed July 9, 2010, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">3(i).4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Third
                                         Amendment to the Certificate of Incorporation of the Company, incorporated by reference
                                         to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed August 29, 2016.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">3(ii).1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By-Laws
                                         of the Company, incorporated by reference to Exhibit 3.2 to the 1997 10-K, SEC File No.
                                         000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Specimen
                                         stock certificate representing common stock, incorporated by reference to Exhibit 4.1
                                         to the Company&rsquo;s Registration Statement on Form S-1/A filed November 4, 1997 (File
                                         No. 333-36937) (the &ldquo;Form S-1/A&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form
                                         of Warrants, incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Registration
                                         Statement on Form S-1 filed October 1, 1997 (File No. 333-36937) (the &ldquo;IPO S-1&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Certificate
                                         of Designation of Series A Junior Participating Preferred Stock, incorporated by reference
                                         to Exhibit 4.4 to the Company&rsquo;s Annual Report on Form 10-K for the year ended December
                                         31, 1998, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Stock
                                         Purchase Agreement dated March 23, 2004 between the Company and Altana Chemie AG, incorporated
                                         by reference to Exhibit 4.10 to the Company&rsquo;s Annual Report on Form 10-K for the
                                         year ended December 31, 2003 (the &ldquo;2003 10-K&rdquo;), SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Registration
                                         Rights Agreement dated March 23, 2004 between the Company and Altana Chemie AG, incorporated
                                         by reference to Exhibit 4.11 to the 2003 10-K, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Stock
                                         Purchase Agreement dated August 25, 2006 between the Company and Rohm and Haas Electronic
                                         Materials CMP Holdings, Inc., incorporated by reference to Exhibit 99.1 to the Company&rsquo;s
                                         Current Report on Form 8-K filed August 28, 2006, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Registration
                                         Rights Agreement dated August 25, 2006 between the Company and Rohm and Haas Electronic
                                         Materials CMP Holdings, Inc., incorporated by reference to Exhibit 99.2 to the Company&rsquo;s
                                         Current Report on Form 8-K filed August 28, 2006, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Common
                                         Stock Purchase Agreement, dated February 10, 2016, between the Company and Bradford T.
                                         Whitmore, incorporated by reference to Exhibit 4.1 of the Company&rsquo;s Current Report
                                         on Form 8-K filed February 10, 2016.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Industrial
                                         Building Lease dated September 15, 2004 between the Company and the Village of Burr Ridge,
                                         incorporated by reference to Exhibit 10.32 to the Company&rsquo;s Annual Report on Form
                                         10-K for the year ended December 31, 2004 (the &ldquo;2004 10-K&rdquo;), SEC File No.
                                         000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Industrial
                                         Building Lease Agreement between Centerpoint Properties Trust (formerly CP Financing
                                         Trust) and the Company, dated June 15, 2000, incorporated by reference to Exhibit 10.23
                                         to the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2000
                                         (the &ldquo;2000 10-K&rdquo;), SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Lease
                                         Amendment effective October 1, 2005 between the Company and Centerpoint Properties Trust,
                                         incorporated by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form
                                         8-K filed October 20, 2005, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Second
                                         Amendment to Industrial Lease Agreement, dated as of November 13, 2014 between the Company
                                         and MLRP 1319 Marquette LLC, successor-in-interest to Centerpoint Properties Trust, incorporated
                                         by reference to Exhibit 10.4 to the Company&rsquo;s Annual Report on Form 10-K for the
                                         year ended December 31, 2014.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.5</FONT></TD><TD><FONT STYLE="font-size: 10pt">Third Amendment to Industrial Lease
                                         Agreement, entered into on October 17, 2016 and effective October 1, 2016, by and between
                                         the Company and 1319 Marquette, LLC, incorporated by reference to Exhibit 10.1 to the
                                         Company&rsquo;s Current Report on Form 8-K filed October 19, 2016.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mutual
                                         Cooperation Agreement entered into on January 17, 2012, by and among the Company, C.I.
                                         Kasei Co., Ltd. and CIK NanoTek Corporation, incorporated by reference to Exhibit 10.1
                                         to the Company&rsquo;s Current Report on Form 8-K filed January 20, 2012, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Trademark
                                         Ownership Assignment Agreement, dated March 31, 2012, between the Company and CIK NanoTek
                                         Corporation, incorporated by reference to Exhibit 10.1 to the Company&rsquo;s Current
                                         Report on Form 8-K filed April 4, 2012, SEC File No 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Memorandum
                                         on the Payment of Royalty, dated March 31, 2012, between the Company and CIK NanoTek
                                         Corporation, incorporated by reference to Exhibit 10.2 to the Company&rsquo;s Current
                                         Report on Form 8-K filed April 4, 2012, SEC File No 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Supply
                                         Agreement between the Company and Schering-Plough HealthCare Products, Inc. dated as
                                         of March 15, 1997, incorporated by reference to Exhibit 10.17 to the Form S-1/A.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.10*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Zinc
                                         Oxide Supply Agreement dated as of September 16, 1999 between the Company and BASF Corporation,
                                         as assignee, incorporated by reference to Exhibit 10.22 to the Company&rsquo;s Annual
                                         Report on Form 10-K for the year ended December 31, 1999, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.11*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Amendment
                                         No. 1 to Zinc Oxide Supply Agreement dated as of January, 2001 between the Company and
                                         BASF Corporation, incorporated by reference to Exhibit 10.24 to the 2000 10-K, SEC File
                                         No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.12</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Amendment
                                         No. 2. to Zinc Oxide Supply Agreement dated as of March 17, 2003 between the Company
                                         and BASF Corporation, incorporated by reference to Exhibit 10.26 to the Company&rsquo;s
                                         Annual Report on Form 10-K for the year ended December 31, 2002 (the &ldquo;2002 10-K&rdquo;),
                                         SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.13*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Amendment
                                         No. 3 to Zinc Oxide Supply Agreement entered into on December 2, 2012, between the Company
                                         and BASF Corporation, incorporated by reference to Exhibit 10.1 of the Company&rsquo;s
                                         Current Report on Form 8-K filed December 6, 2012.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.14</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Z-COTE
                                         HP-2 Brand Supply Agreement dated May 15, 2006 between the Company and BASF Corporation,
                                         incorporated by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form
                                         8-K filed June 20, 2006, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.15*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Amended
                                         and Restated Cooperation Agreement dated August 25, 2006 between the Company and Rohm
                                         and Haas Electronic Materials CMP Inc., incorporated by reference to Exhibit 99.3 to
                                         the Company&rsquo;s Current Report on Form 8-K filed August 28, 2006, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.16</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Supply
                                         Agreement effective as of March 23, 2009, between the Company and Rohm and Haas Electronic
                                         Materials CMP Inc., incorporated by reference to Exhibit 10.56 to the Company&rsquo;s
                                         Annual Report on Form 10-K for the year ended December 31, 2008, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.17*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Distributor
                                         Agreement dated October 24, 2005 between Johnson Matthey Catalog Company, Inc., d/b/a
                                         ALFA AESAR and the Company, incorporated by reference to Exhibit 99.1 to the Company&rsquo;s
                                         Current Report on Form 8-K filed November 1, 2005, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.18*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Supply
                                         Agreement dated March 3, 2006 between Roche Diagnostics GmbH and the Company, incorporated
                                         by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K filed
                                         March 9, 2006, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.19*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">First
                                         Amendment to the Supply Agreement entered into on November 19, 2014 between the Company
                                         and Roche Diagostics GmbH, incorporated by reference to Exhibit 10.1 to the Company&rsquo;s
                                         Current Report on Form 8-K filed November 25, 2014.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.20*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Second
                                         Amendment to the Supply Agreement, entered into on November 21, 2016, between the Company
                                         and Roche Diagnostics GmbH, incorporated by reference to Exhibit 10.1 to the Company&rsquo;s
                                         Current Report on Form 8-K filed November 28, 2016.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.21</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Joint
                                         Development Agreement dated March 23, 2004 between the Company and Altana Chemie AG,
                                         incorporated by reference to Exhibit 10.29 to the 2003 10-K, SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.22*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Agreement
                                         dated July 7, 2008 between the Company and Altana Chemie GmbH, incorporated by reference
                                         to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K filed July 18, 2008,
                                         SEC File No. 000-22333.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.23*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Settlement
                                         and Termination Agreement, dated August 20, 2010, between the Company and Altana Chemie
                                         GmbH, i<FONT STYLE="font-family: Times New Roman, Times, Serif">ncorporated by reference
                                         to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K filed August 25, 2010,
                                         SEC File No. 000-22333</FONT>.</FONT></TD></TR>                                                                                                                                                                                                                                                                        <TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">10.24*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Supply Agreement,
                                         dated August 20, 2010, between the Company and Altana Chemie GmbH, i<FONT STYLE="font-family: Times New Roman, Times, Serif">ncorporated
                                         by reference to Exhibit 10.2 to the Company&rsquo;s Current Report on Form 8-K filed
                                         August 25, 2010, SEC File No. 000-22333</FONT>.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.25*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Supply
                                         Agreement, dated as of March 31, 2016, between the Company and Ester Solutions Company,
                                         incorporated by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form
                                         8-K filed April 6, 2016.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.26</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Business
                                         Loan Agreement, dated March 4, 2015, between the Company and Libertyville Bank and Trust
                                         Company (incorporated by reference to Exhibit 10.1 to the Company&rsquo;s Current Report
                                         on Form 8-K filed March 10, 2015).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.27</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Promissory
                                         Note, dated March 4, 2015, granted by the Company in favor of Libertyville Bank and Trust
                                         Company (incorporated by reference to Exhibit 10.2 to the Company&rsquo;s Current Report
                                         on Form 8-K filed March 10, 2015).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.28</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Commercial
                                         Security Agreement, dated March 4, 2015, between the Company and Libertyville Bank and
                                         Trust Company (incorporated by reference to Exhibit 10.3 to the Company&rsquo;s Current
                                         Report on Form 8-K filed March 10, 2015).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.29</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Change
                                         in Terms Agreement and Business Loan Agreement, dated April 13, 2015, between the Company
                                         and Libertyville Bank and Trust Company, incorporated by reference to Exhibit 10.1 to
                                         the Company&rsquo;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2015.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.30</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Business
                                         Loan Agreement, dated March 4, 2016, between the Company and Libertyville Bank and Trust
                                         Company, incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K
                                         filed  March 10, 2016.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.31</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Change
                                         in Terms Agreement, dated March 4, 2016, between the Company and Libertyville Bank and
                                         Trust Company, incorporated by reference to Exhibit 10.2 of the Current Report on Form
                                         8-K filed  March 10, 2016.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.32</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ex10-32.htm">Change in Terms Agreement, dated February 14, 2017, between the Company and Libertyville Bank and Trust Company</A>.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.33</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Employment
                                         Agreement effective as of September 25, 2008, between the Company and Nancy Baldwin,
                                         incorporated by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form
                                         8-K filed October 2, 2008, SEC File No. 000-22333. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.34</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Employment
                                         Agreement dated June 24, 2009 between the Company and Frank Cesario, incorporated by
                                         reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K filed June
                                         26, 2009, SEC File No. 000-22333. +</FONT></TD></TR>                                                                                             <TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">10.35</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Employment Agreement
                                         effective August 12, 2009 between the Company and Jess Jankowski, incorporated by reference
                                         to Exhibit 10.3 to the Company&rsquo;s Quarterly Report on Form 10-Q for the quarter
                                         ended June 30, 2009, SEC File No. 000-22333. +</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">10.36</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Employment Agreement
                                         dated November 28, 2012, between the Company and Kevin Cureton, incorporated by reference
                                         to Exhibit 10.36 to the Company&rsquo;s Annual Report on Form 10-K for the year ended
                                         December 31, 2012. +</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.37</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form
                                         of Indemnification Agreement between the Company and each of its directors and executive
                                         officers, incorporated by reference to Exhibit 10.2 to the Form S-1/A. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.38</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Nanophase
                                         Technologies Corporation 2004 Equity Compensation Plan (&ldquo;2004 Equity Plan&rdquo;),
                                         incorporated by reference to Exhibit 4 to the Company&rsquo;s Registration Statement
                                         on Form S-8 (File No. 333-119466). +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.39</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">First
                                         Amendment to 2004 Plan, incorporated by reference to Exhibit 99.1 to the Company&rsquo;s
                                         Current Report on Form 8-K filed July 27, 2006, SEC File No. 000-22333. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.40</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form
                                         of Stock Option Agreement under the 2004 Equity Plan, incorporated by reference to Exhibit
                                         4.13 to the 2004 10-K, SEC File No. 000-22333. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.41</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form
                                         of Restricted Share Grant Agreement under the 2004 Equity Plan, incorporated by reference
                                         to Exhibit 4.14 to the 2004 10-K, SEC File No. 000-22333. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.42</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form
                                         of Performance Share Grant Agreement under the 2004 Equity Plan, incorporated by reference
                                         to Exhibit 4.15 to the 2004 10-K, SEC File No. 000-22333. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.43</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Nanophase
                                         Technologies Corporation Non-Employee Director Deferred Compensation Plan, incorporated
                                         by reference to Exhibit 99.2 to the Company&rsquo;s Current Report on Form 8-K filed
                                         January 9, 2006, SEC File No. 000-22333. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.44</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2006
                                         Stock Appreciation Rights Plan (the &ldquo;2006 Plan&rdquo;), incorporated by reference
                                         to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K filed October 3, 2006,
                                         SEC File No. 000-22333. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.45</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Amended
                                         and Restated 2006 Stock Appreciation Rights Plan, adopted April 8, 2009, incorporated
                                         by reference to Exhibit 99.1 to the Company&rsquo;s Current Report on Form 8-K filed
                                         April 9, 2009, SEC File No. 000-22333. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.46</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form
                                         of Grant Agreement under the 2006 Plan, incorporated by reference to Exhibit 99.2 to
                                         the Company&rsquo;s Current Report on Form 8-K filed October 3, 2006, SEC File No. 000-22333.
                                         +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.47</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2008
                                         Long-Term Cash Incentive Plan, incorporated by reference to Exhibit 10.1 to the Company&rsquo;s
                                         Current Report on Form 8-K filed July 25, 2008, SEC File No. 000-22333. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.48</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Nanophase
                                         Technologies Corporation 2010 Equity Compensation Plan, as amended, incorporated by reference
                                         to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K filed August 29, 2016.
                                         +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.49</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form
                                         of Stock Option Award Agreement under the 2010 Equity Compensation Plan, incorporated
                                         by reference to Exhibit 10.47 to the Company&rsquo;s Annual Report on Form 10-K for the
                                         year ended December 31, 2013. +</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.50</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex10-50.htm">Building Lease, dated as of September 15, 2010, between the Company and the Village of Burr Ridge.</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.51</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex10-51.htm">Building Lease, dated as of March 13, 2017, between the Company and the Village of Burr Ridge.</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">23.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ex23-1.htm">Consent of RSM US LLP</A>.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">31.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ex31-1.htm">Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act.</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">31.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ex31-2.htm">Certification of the Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act.</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">32</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="ex32.htm">Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">101</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The following
                                         materials from the Company&rsquo;s Annual Report on Form 10-K for the year ended December
                                         31, 2016, formatted in XBRL (Extensible Business Reporting Language): (1) the Balance
                                         Sheets, (2) the Statements of Operations, (3) the Statements of Cash Flows, (4) the Statements
                                         of Stockholders&rsquo; Equity, and (5) the Notes to the Financial Statements.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD><FONT STYLE="font-size: 10pt">Confidentiality previously
granted for portions of this agreement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">+</FONT></TD><TD><FONT STYLE="font-size: 10pt">Indicates management contracts
or compensatory plans or arrangements.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.32
<SEQUENCE>2
<FILENAME>ex10-32.htm
<DESCRIPTION>CHANGE IN TERMS AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><A HREF="nanx-10k_123116.htm">Nanophase Technologies Corporation 10-K</A></P>

<P STYLE="font: 10pt/10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Exhibit 10-32</P>

<P STYLE="font: 10pt/10pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="ex10-32_img001.gif" ALT="" STYLE="height: 1056px; width: 816px"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%; border-bottom: Black 1pt solid">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/10pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="ex10-32_img002.gif" ALT="" STYLE="height: 1056px; width: 816px"></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%; border-bottom: Black 1pt solid">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/10pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="ex10-32_img003.gif" ALT="" STYLE="height: 1056px; width: 816px"></P>
<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%; border-bottom: Black 1pt solid">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.50
<SEQUENCE>3
<FILENAME>ex10-50.htm
<DESCRIPTION>BUILDING LEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%"></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><A HREF="nanx-10k_123116.htm">Nanophase Technologies Corporation - 10-K</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
10.50</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BUILDING
LEASE</U></B></FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATE OF LEASE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TERM OF LEASE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BASE RENT AMOUNT</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________, _______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$142,323.12 for first year</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/15/2010</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/15/2014</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOCATION OF PREMISES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">453 Commerce</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Deposit:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Burr Ridge, Illinois</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ 10,000.00</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF PREMISES: &nbsp;The property being leased hereunder is as depicted upon That diagram/site plan attached hereto as <B>Exhibit
    A</B>, together with those rights of ingress, egress, storage and loading set forth herein.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSEE</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSOR</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: &nbsp;Nanophase Technologies Corporation</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: &nbsp;Village of Burr Ridge</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">453 Commerce</FONT><FONT STYLE="font-size: 10pt"><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif">Burr Ridge, IL</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7660 S. County Line Rd.</FONT><FONT STYLE="font-size: 10pt"><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif">Burr Ridge, IL 60521</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
consideration of the mutual covenants and agreements herein stated, Lessor hereby leases to Lessee and Lessee hereby leases from
Lessor, the premises designated above (the &ldquo;Premises&rdquo;), together with the appurtenances thereto, for the above Term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rent</U>:
Lessee shall pay Lessor the base rent amount of $142,323.12, which consists of approximately $7.12/square foot for 20,000 square
feet, in twelve (12) equal installments in the amount of Eleven Thousand Eight Hundred and Sixty and 26/100 Dollars ($11,860.26)
as rent for the Premises, at Lessor&rsquo;s address as shown above, payable on or before the 15th of each calendar month. The
first monthly payment and the security deposit in the amount of $10,000 shall be due on or before September 15, 2010. Rent shall
continue to be due monthly for the term of this Lease to be calculated based upon the following: for each year after the first
year of this Lease, the base rental amount of $142,323.12 will increase annually by that percentage equal to the annual percentage
increase for the preceding twelve (12) months in the Consumer Price Index, (Chicago-All Items for all Urban Wage Earners and Clerical
Workers) (CPI-W) or an amount of 3% annually, whichever is greater.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Improvements</U>:
Lessee shall be responsible for any improvements to the Premises, including, for example, carpeting, lighting and fixtures, partitions
or ceiling enhancements, provided that any alteration or addition to the Premises by Lessee requires the prior written consent
of Lessor. Said consent will not be unreasonably withheld by Lessor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Condition
and Upkeep of Premises</U>: Lessee has examined and knows the condition of the Premises and has received the same in good order
and repair, and acknowledges that no representations as to the condition and repair thereof have been made by Lessor, or his agent,
prior to or at the execution of this Lease that are not herein expressed; Lessee will keep the Premises including all appurtenances,
in good repair, replacing all broken glass and all damaged plumbing fixtures with others of equal quality, and will keep the Premises,
including adjoining areas, in a clean and healthful condition according to the applicable municipal ordinances during the term
of this Lease at Lessee&rsquo;s expense. Lessor will remove all snow and ice from the roof when necessary, and will be responsible
for snow removal, as needed, from the sidewalk abutting the Premises and parking lot serving the Premises. Upon the termination
of this Lease, for any reason, Lessee will yield up the Premises to Lessor, in good condition and repair, loss by fire and ordinary
wear excepted. Lessor has responsibility for upkeep of all areas on the exterior of building, including, but not limited to the
roof, parking area, grass area, sidewalks and exterior walls. Lessee has responsibility for upkeep of all elements on the interior
of the space within the Premises, including, but not limited to, plumbing, electric, and H.V.A.C. equipment and facilities. Lessor
represents that the plumbing, electric, gas and H.V.A.C. equipment and facilities is in good working order at the commencement
of this lease. Lessor shall not be obliged to incur any other expense for repairing any improvements upon said demised premises
or connected therewith, and the Lessee at his own expense will keep all improvements in good repair (injury by fire, or other
causes beyond Lessee&rsquo;s control excepted) as well as in a good tenantable and wholesome condition, and will comply with all
local or general regulations, laws and ordinances applicable thereto. If Lessee does not make repairs as required hereunder promptly
and adequately. Lessor may, but need not make such repairs and pay the costs thereof, and such costs shall be so much additional
rent immediately due from and payable by Lessee to Lessor. Lessee is obligated to provide Lessor prompt notice of any necessary
repairs for which Lessor may be responsible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lessee&rsquo;s
Access to Premises</U>: Lessee shall have rights of reasonable ingress and egress to the Premises over the paved portions and
sidewalks on Lessor&rsquo;s property as well as ingress and egress rights over Lessor&rsquo;s property to access Lessee&rsquo;s
loading dock and shared use of Lessor&rsquo;s paved parking area. Lessee shall also be entitled to reasonable use of that area
needed to the south of the Premises to locate its outside storage tank(s). The storage tank(s) shall be located generally in that
area depicted for such use on <B><U>Exhibit A</U></B>. Lessee agrees to locate and install said tank(s) in a neat and orderly
fashion. Lessee shall petition the Village of Burr Ridge or other applicable governmental entity for any variations(s) or permit(s)
that may be needed to lawfully locate, construct and/or operate such tanks, Lessor acknowledges that said storage tanks are an
integral part of Lessee&rsquo;s use of the Premises. If such permit, variation or approval as is needed to permit the lawful construction
and use of such tanks is denied by the governmental entity with jurisdiction. Lessee shall have the option, within thirty (30)
days after such denial, to terminate this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lessee
Not to Misuse; Sublet: Assignment</U>: Lessee will not allow the Premises to be used for any purpose that will increase the rate
of insurance thereon for Lessor, and will not load floors with machinery or goods beyond the floor load rating prescribed by applicable
governmental ordinances, and will not allow the Premises to be occupied in whole, or in part, by any other person, and will not
sublet the same or any part thereof, nor assign this Lease without in each case the prior written consent of the Lessor first
had, and Lessee will not permit any transfer by operation of law, mortgage or other encumbrance of the interest in the Premises
acquired through this Lease. Lessee will not permit the Premises to be used for any unlawful purpose, or for any purpose that
will injure the reputation of the building or increase the fire hazard of the building, or disturb the neighborhood, provided
however, it is understood and acknowledged by Lessor that Lessee will conduct certain warehousing and manufacturing activities
on the Premises and such activities shall be permitted if in compliance with applicable federal, state and local law. Lessee will
not allow any signs, cards or placards to be posted, or placed thereon, nor permit any alteration of or addition to any part of
the Premises, except by written consent of Lessor which consent would not be unreasonably withheld; all alterations and additions
to the Premises shall remain for the benefit of Lessor unless otherwise provided in the consent aforesaid. Lessor represents that
the Premises are currently zoned for Lessee&rsquo;s manufacturing, warehousing and office uses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Mechanic&rsquo;s
Lien</U>: Lessee will not permit any mechanic&rsquo;s lien or liens to be placed upon the Premises or any building or improvement
thereon during the term hereof, and in case of the filing of such lien Lessee will promptly pay same. If a default in payment
shall continue for thirty (30) days after written notice to Lessee from Lessor to the Lessee, the Lessor shall have the right
and privilege at Lessor&rsquo;s option of paying the same or any portion of the lien amount without inquiry as to its validity,
and any amounts so paid, including expenses and interest, shall be so much additional indebtedness hereunder due from Lessee to
Lessor and shall be repaid to Lessor immediately on tender of bill the lien costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnify
for Accidents</U>: Lessee covenants and agrees that it will protect and save and keep the Lessor forever harmless and indemnified
against and from any penalty or damages or charges imposed for any violation of any laws or ordinances, whether occasioned by
the neglect of Lessee or those holding under Lessee, and that Lessee will at all times protect, indemnity and save and keep harmless
the Lessor against and from any and all loss, cost, damage or expense, arising out of or from any accident or other occurrences
on or about the Premises, causing injury to any person or property whomsoever or whatsoever and will protect, indemnify and save
and keep harmless the Lessor against and from any and all claims and against and from any and all loss, cost, damage or expense
arising out of any failure of Lessee in any respect to comply with and perform all the requirements and provisions hereof. Lessee
agrees to obtain from a responsible insurance company, or companies, at its expense, public liability insurance in an amount not
less than ONE MILLION ($1,000,000.00) DOLLARS with respect to any one accident and FIVE HUNDRED THOUSAND ($500,000.00) DOLLARS
property damage with respect to any one accident, and a certificate as to such insurance shall be deposited with Lessor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Liability
of Lessor</U>: None of the provisions of this Lease shall operate to waive any protections or immunities from suit or liability
that the Lessor is entitled to as a municipal entity under Illinois or Federal law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Water,
Gas and Electric Charges</U>: Lessee will pay, in addition to the rent above specified, all water rents, gas and electric light
and power bills taxed, levied or charged on the Premises, for and during the time for which this Lease is granted, and in case
said water rents and bills for gas, electric light and power shall not be paid when due, Lessor shall, upon three days notice
to Lessee have the right to pay the same, which amounts so paid are declared to be so much additional rent and payable with the
installment of rent next due thereafter. Such services shall be separately metered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lessor&rsquo;s
Access to Premises</U>: Lessor and its designees shall have the right, upon reasonable notice to Lessee, to enter upon the Premises
at all reasonable hours (and in emergencies at all times and without notice): (a) to inspect the same; (b) to make repairs, additions
or alterations to the Premises or the building in which the same are located or any property owned or controlled by Lessor; provided,
however, if Lessor intends to be reimbursed by Lessee for any such repairs, additions or alterations, it shall so notify Lessee
at least fourteen (14) days prior to taking any such action in order for Lessee to determine whether it is responsible for any
such repairs, additions or alterations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Option
Period</U>: Lessee has the right to extend the Lease term for three (3) consecutive 12 month periods. The annual rent escalation
for each of the one year option periods will continue to be determined in the manner utilized during the initial 36 month Lease
term. Responsibility for real estate taxes will continue to be determined in the manner utilized during the initial 36 month Lease
term. Lessee must provide written notice to Lessor of its intent to exercise this option to extend the lease for a 12 month period
at least six (6) months prior to the expiration of the term of the Lease. Notice must be provided in conformance with paragraph
25.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Abandonment
and Reletting</U>: If Lessee shall abandon or vacate the Premises, or if Lessee&rsquo;s right to occupy the Premises is terminated
by Lessor by reason of Lessee&rsquo;s breach of any of the covenants herein, the same may be re-let by Lessor for such rent and
upon such terms as Lessor may reasonably deem fit, subject to Illinois statute; and if a sufficient sum shall not thus be realized
monthly, after paying the out-of-pocket expenses of such re-letting and collecting to satisfy the rent hereby reserved. Lessee
agrees to satisfy and pay all deficiencies monthly during the remaining period of this Lease. Lessor shall exercise reasonable
efforts to obtain a new lessee to occupy the Premises following abandonment or vacation thereof by Lessee at a rate of rental
then prevailing in the Burr Ridge area and upon such other lease terms as are herein contained. Upon abandonment or vacation of
the Premises, Lessee&rsquo;s obligation is to restore the Premises to its original condition at the commencement of this Lease
and return the Premises to Lessor in good condition and repair, provided, however, Lessee shall not be required to remove any
improvements to the Premises approved by Lessor (unless such improvements are special or unique to Lessee&rsquo;s business, as
reasonably determined by Lessor, and are so conditioned by Lessor). Lessee shall be solely responsible for the complete removal
of any outside storage tank(s) and restoration of the affected location of the tank(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Hazards
and Hazardous Substances</U>: Lessor hereby represents that no hazardous materials exist on, within, or under the Premises as
of the commencement of Lessee&rsquo;s occupancy hereunder in violation of applicable environmental requirements under local, Illinois
or Federal law. Lessee shall not cause or permit any hazardous material to be brought upon, or kept or used in or about the premises
by Lessee, its agents, employees, contractors, or invitees, without the prior written consent of Lessor, (which consent Lessor
shall not unreasonably withhold) so long as Lessee demonstrates to Lessor&rsquo;s reasonable satisfaction that such hazardous
material is necessary or useful to Lessee&rsquo; s business and will be used, kept, and stored and disposed of in a manner that
complies with all laws, rules, statutes, and ordinances regulating any such hazardous material so brought upon or used or kept
in or about the Premises. Lessor consents to Lessee&rsquo;s use and storage of materials which are determined to be hazardous
in reasonable quantities on the Premises so long as such materials are necessary or appropriate in connection with Lessee&rsquo;s
manufacturing and warehousing uses on the Premises. If Lessee or Lessor breach their respective representations or obligations
stated above in this paragraph, or if the presence of hazardous material on or about the Premises caused or permitted by Lessee
or Lessor results in contamination of the Premises or Lessor&rsquo;s adjacent property, or if contamination of the Premises or
surrounding area by hazardous material otherwise occurs the responsible party (Lessee or Lessor) shall indemnify, defend, and
hold harmless the other from any and all claims, judgments, damages, penalties, fines, costs, liabilities, or losses (including,
without limitation, diminution in value of the Premises or Lessor&rsquo;s adjacent property, or the entire building, damages for
the loss or restriction on the use of rentable or usable space or of any amenity of the Premises or Lessor&rsquo;s adjacent property,
damages arising from any adverse impact on marketing of space in the building, and sum paid in settlement of claims, reasonable
attorneys&rsquo; fees, reasonable consultant fees and expert fees) that arise during or after the term of this Lease as a result
of that contamination. This indemnification includes, without limitation, reasonable costs incurred in connection with any investigation
of site conditions or any cleanup, remedial, removal, or restoration work required by any federal, state, or local governmental
agency or political subdivision because of hazardous material present in the soil or ground water on, under or about the Premises
or Lessor&rsquo;s adjacent property. Without limiting the above, if the presence of any hazardous material on or about the Premises
caused or permitted by either Lessor or Lessee results in any contamination of the Premises or surrounding area, or causes the
Premises or surrounding area to be in violation of any laws, rules, statutes, or ordinances, the responsible party (Lessee or
Lessor) shall promptly take all actions at its sole expense as are necessary to return the Premises and surrounding area to the
condition existing before the introduction of any such hazardous material: provided that, if Lessee is responsible, Lessor&rsquo;s approval of those actions shall first be obtained, which approval shall not be unreasonably withheld so long as those actions
would not potentially have any material adverse long-term or short-term effect on the Premises or surrounding area.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Lease, the term &ldquo;hazardous material&rdquo; means any hazardous or toxic substance, material or waste which
is or becomes regulated by any local governmental authority, the state of Illinois, or the United States government, including
any material which, when present, would require environmental remediation (&ldquo;clean-up&rdquo;) under any such local, Illinois
or Federal law. Lessee shall not allow, keep or use on the Premises any inflammable or explosive liquids or materials save such
as may be necessary for use in the business of the Lessee, and in such case, any such substances shall be delivered and stored
in amount, and used, in accordance with the rules for the applicable Board of Underwriters and statutes and ordinances now or
hereafter in force. Further, no unlawful activities of any kind shall be conducted by Lessee on the Premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this paragraph 13 shall be construed to impose any additional liability whatsoever upon either of the parties hereto as a result
of any acts or omissions of any third parties, specifically including any tenants leasing other space from Lessor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Default
by Lessee</U>: If Lessee shall vacate or abandon the Premises, or in case of the non-payment of the rent reserved hereby, or any
part thereof, or of the breach of any covenant in this Lease, Lessee&rsquo;s right to the possession of the Premises thereupon
shall terminate upon written notice to Lessee from Lessor and upon Lessee&rsquo;s failure to cure any such default within sixty
(60) days of receipt of such notice, and the mere retention of possession thereafter by Lessee shall constitute a forcible detainer
of the Premises; and if the Lessor so elects, but not otherwise, and upon written notice of such election to Lessee, this Agreement
shall thereupon terminate, and upon the termination of Lessee&rsquo;s right of possession, as aforesaid, whether this Agreement
be terminated or not. Lessee agrees to surrender possession of the Premises immediately, without the receipt of any demand for
rent, notice to quit or demand for possession of the Premises whatsoever, and hereby grants to Lessor full and free license to
enter into and upon the Premises or any part thereof, to take possession thereof after due process of law, and to expel and to
remove Lessee or any other person who may be occupying the Premises or any part thereof, and Lessor may repossess itself of the
Premises as of its former estate, but such entry of the Premises shall not constitute a trespass or foreible entry or detainer,
nor a waiver of any covenants, agreement or promise in this Agreement contained, to be performed by Lessee. The acceptance of
rent, whether in a single instance or repeatedly, after it falls due. or after knowledge of any breach hereof by Lessee, or the
giving or making of any notice or demand, whether according to any statutory provision or not, or any act or series of acts except
as an express written waiver, shall not be construed as a waiver of Lessor&rsquo;s rights hereunder, or as an election not to
proceed under the provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Real
Estate Taxes</U>: Lessor is responsible for the base real estate taxes during the Lease term. The base real estate taxes for the
2009 tax year are $____________. Following the base year of 2009, the Lessor is subsequently responsible for the base real estate
taxes plus an amount not to exceed 3% escalation of the base taxes. Lessor&rsquo;s obligation cannot increase more than 3% over
the base taxes plus escalation amount of the prior year in any subsequent year. Following the first year. Lessee will be responsible
for that portion of annual increases in real estate taxes for each subsequent year which exceeds the base year taxes plus a 3%
escalation of that base amount, as set forth herein. Lessee&rsquo;s share shall be based on the actual increase in taxes each
year, not on its prior year&rsquo;s payment or share. Lessee&rsquo;s payment, as required hereunder, shall be due upon issuance
of the final tax bill for the second installment of taxes each year, within thirty (30) days of receipt of notice from Lessor,
along with a copy of the tax bill and a reasonably itemized statement by the Village showing the calculation by which Lessee&rsquo;s
share of such tax bill was determined. Nothing in this paragraph shall limit Lessor or Lessee in the exercise of any rights afforded
by Illinois law to challenge any assessment amount arrived at by the Assessor/County Clerk provided that any such challenge shall
not delay or excuse the payment obligations of Lessor and Lessee set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Rent Deduction or Set Off</U>: Lessee&rsquo;s covenant to pay rent is and shall be independent of each and every other covenant
of this Lease. Lessee agrees that any claim by Lessee against Lessor shall not be deducted from rent nor set off against any claim
for rent in any action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Security
Deposit</U>: The security deposit required herein shall be available to Lessor for its use or reimbursement to satisfy any of
Lessee&rsquo;s obligations hereunder, if Lessee shall fail to meet or abide by such obligations. Lessor shall otherwise be allowed
to use such security deposit monies as permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rent
after Notice or Suit</U>: It is further agreed, by the parties hereto, that after the service of notice, or the commencement of
a suit or after final judgment for possession of the Premises. Lessor may receive and collect any rent due, and the payment of
said rent shall not waive or affect said notice, said suit, or said judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Costs</U>: Lessee will pay and discharge all reasonable costs, attorney&rsquo;s fees and expenses that shall be made and incurred
by Lessor in enforcing the covenants and agreements of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
Cumulative</U>: The rights and remedies of Lessor under this Lease are cumulative. The exercise or use of any one or more thereof
shall not bar Lessor from exercise or use of any other right or remedy provide herein or otherwise provided by law, nor shall
exercise nor use of any right or remedy by Lessor waive any other right or remedy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fire
and Casualty</U>: In the event the Premises are substantially damaged by fire or other casualty, Lessor shall, within sixty (60)
days, notify Lessee in writing as to whether said Premises will be rebuilt or repaired, and in the event Lessor fails to so notify
Lessee, Lessee may, at its option, terminate this Agreement by giving written notice to Lessor within ten (10) days after the
expiration of said sixty (60) days. If Lessor so notifies Lessee that the Premises will be rebuilt or repaired, then this Agreement
shall continue in effect upon the same terms and conditions; provided, however, if Lessor fails to rebuild or repair said Premises
within sixty (60) days following the expiration of the sixty (60) day period in which Lessor must notify Lessee of such action,
then Lessee may terminate this Agreement upon written notice to Lessor; and provided further, if Lessor so notifies Lessee that
the Premises will be rebuilt or repaired, Lessee may, at its option, terminate this Agreement by giving written notice to Lessor
within sixty (60) days after Lessor has so notified Lessee. If Lessor notifies Lessee that the Premises will not be rebuilt or
repaired, and same are, in fact, not rebuilt or repaired within 180 days after the occurrence of the fire or other casualty, then
this Agreement shall forthwith terminate. The fixed or basic rent herein reserved shall abate during the time that the Premises
is untenantable. In the event of insubstantial damage to the Premises by fire or other casualty, said Premises shall be promptly
restored or repaired by Lessor, and a just and proportionate part of the fixed or basic rent herein specified shall abate until
said Premises have been fully restored or repaired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Right
to Cure Defaults</U>: If either party shall fail to comply fully with any of its obligations under this Lease (including, without
limitation, its obligations to make repairs, maintain various policies of insurance, comply with all laws, ordinances and regulations
and pay all bills for utilities), then the non-defaulting party shall give notice to the defaulting party regarding the nature
and extent of such default and the defaulting party will have sixty (60) days to cure any such default, and if it fails to cure
such default, then the non-defaulting party shall have the right, at its option, to cure such breach at the other party&rsquo;s
expense. Each party agrees to reimburse the other (as additional rental or otherwise) for all costs and expenses incurred as a
result thereof together with interest thereon promptly upon demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>:
Wherever possible each provision of this Lease shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Lease shall be prohibited by or invalid under applicable law, such provisions shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions
of this Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Relationships
of Parties</U>: Nothing contained in this Agreement shall be construed to create the relationship of principal and agent, partnership,
joint venture or any other relationship between the parties hereto other than the relationship of Lessor and Lessee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>:
Every notice. approval, consent or other communication authorized or required by this Agreement shall not be effective unless
served in writing and sent by United Stales registered or certified mail, return receipt requested, directed, if to Lessee to
the Premises, and if to Lessor at the address listed on page 1 hereof or such other address as either party may designate by notice
from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver</U>:
One or more waivers of any covenant or condition by either party hereto shall not be construed as a wavier of a subsequent breach
of the same or any other covenant or condition, and the consent or approval by one party to or of any act by the other party requiring
the consenting party&rsquo;s consent or approval shall not be construed to waive or render unnecessary the consenting party&rsquo;s
consent or approval to or of any subsequent similar act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>: No oral statement or prior written matter shall have any force or effect all of which shall merge herein and be
superseded hereby. No waiver of any provision of this Agreement shall be effective unless in writing, signed by the waiving party.
The parties agree that they are not relying on any representations or agreements other than those contained in this Agreement.
This Agreement shall not be modified except by a writing subscribed by all parties, nor may this Agreement be canceled by either
party except with the written consent of the other, unless otherwise specifically provided herein. The invalidity or unenforceability
of any provisions of this Agreement shall not affect or impair any other provision, All captions herein are solely for convenience
and shall not be given any legal effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in this Agreement, the covenants, conditions and agreements contained in this Agreement shall bind and inure
to the benefit of Lessor and Lessee and their respective successors and permitted assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereby set their hands and seals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSOR:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSEE:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VILLAGE
        OF BURR RIDGE</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cook
        and DuPage Counties, Illinois</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NANOPHASE TECHNOLOGIES CORORATION </FONT><FONT STYLE="font-size: 10pt"><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif">DuPage County, Illinois</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex1051001.jpg" ALT="(Signature)"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><IMG SRC="ex1051003.jpg" ALT="(Signature)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mayor</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATTEST:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATTEST:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex1051002.jpg" ALT="(Signature)"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex1051004.jpg" ALT="(Signature)"></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clerk</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4-8-10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/2/10</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex1051005.jpg" ALT="(GRAPHIC)">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P></DIV>

    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.51
<SEQUENCE>4
<FILENAME>ex10-51.htm
<DESCRIPTION>BUILDING LEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%"></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><A HREF="nanx-10k_123116.htm">Nanophase Technologies Corporation - 10-K</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
10.51</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BUILDING
    LEASE</U></B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATE OF LEASE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TERM OF LEASE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BASE RENT AMOUNT</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARCH 13,&nbsp;&nbsp;2017</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ending</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$176,382.00 for first year</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/15/2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9/15/2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOCATION OF PREMISES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">451 Commerce<BR>
    Burr Ridge, Illinois</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Deposit: <BR>
    $ 10,000.00</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF PREMISES: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
    property being leased hereunder is as depicted upon That diagram/site plan attached hereto as <B>Exhibit A</B>, together with
    those rights of ingress, egress, storage and loading set forth herein.</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSEE</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSOR</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Nanophase Technologies Corporation</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Village of Burr Ridge</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:
        &nbsp;451 Commerce</FONT></P>
        <P STYLE="margin-top: 0; margin-bottom: 0; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;Burr
        Ridge, IL</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:
        7660 S. County Line Rd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;Burr
Ridge, IL 60521</FONT></P>
</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the mutual covenants
and agreements herein stated, Lessor hereby leases to Lessee and Lessee hereby leases from Lessor, the premises designated above
(the &ldquo;Premises&rdquo;), together with the appurtenances thereto, for the above Term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rent</U>:
&nbsp;&nbsp;&nbsp;Lessee shall pay Lessor the base rent amount of $176,382.00, which consists of $8.82/square foot for 20,000 square feet, in twelve
(12) equal installments in the amount of Fourteen Thousand Six Hundred Ninety-Eight and 50/100 Dollars ($14,698.50) as rent for
the Premises, at Lessor&rsquo;s address as shown above, payable on or before the 15th of each calendar month. The first monthly payment,
and the security deposit in the amount of $10,000 shall be due on or before September 15, 2017. Rent shall continue to be due monthly
for the term of this Lease to be calculated based upon the following: for each year after the first year of this Lease, the base
rental amount of $176,382.00 will increase annually by that percentage equal to the annual percentage increase for the preceding
twelve (12) months in the Consumer Price Index, (Chicago-All Items for all Urban Wage Earners and Clerical Workers) (CPI-W) or
an amount of 3% annually, whichever is greater.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Improvements</U>:
&nbsp;&nbsp;&nbsp;Lessee shall be responsible for any improvements to the Premises, including, for example, carpeting, lighting and fixtures, partitions
or ceiling enhancements, provided that any alteration or addition to the Premises by Lessee requires the prior written consent
of Lessor. Said consent will not be unreasonably withheld by Lessor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Condition
and Upkeep of Premises</U>: &nbsp;&nbsp;&nbsp;Lessee has examined and knows the condition of the Premises and has received the same in good
order and repair, and acknowledges that no representations as to the condition and repair thereof have been made by Lessor,
or his agent, prior to or at the execution of this Lease that are not herein expressed; Lessee will keep the Premises
including all appurtenances, in good repair, replacing all broken glass and all damaged plumbing fixtures with others of
equal quality, and will keep the Premises, including adjoining areas, in a clean and healthful condition according to the
applicable municipal ordinances during the term of this Lease at Lessee&rsquo;s expense. Lessor will remove all snow and ice from
the roof when necessary, and will be responsible for snow removal, as needed, from the sidewalk abutting the Premises and
parking lot serving the Premises. Upon the termination of this Lease, for any reason, Lessee will yield up the Premises to
Lessor, in good condition and repair, loss by fire and ordinary wear excepted. Lessor has responsibility for upkeep of all
areas on the exterior of building, including, but not limited to the roof, parking area, grass area, sidewalks and exterior
walls. Lessee has responsibility for upkeep of all elements on the interior of the space within the Premises, including, but
not limited to, plumbing, electric, and H.V.A.C. equipment and facilities. Lessor represents that the plumbing, electric, gas
and H.V.A.C. equipment and facilities is in good working order at the commencement of this lease. Lessor shall not be obliged
to incur any other expense for repairing any improvements upon said demised premises or connected therewith, and the Lessee
at his own expense will keep all improvements in good repair (injury by fire, or other causes beyond Lessee&rsquo;s control
excepted) as well as in a good tenantable and wholesome condition, and will comply with all local or general regulations,
laws and ordinances applicable thereto. If Lessee does not make repairs as required hereunder promptly and adequately, Lessor
may, but need not make such repairs and pay the costs thereof, and such costs shall be so much additional rent immediately
due from and payable by Lessee to Lessor. Lessee is obligated to provide Lessor prompt notice of any necessary repairs for
which Lessor may be responsible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lessee&rsquo;s
Access to Premises</U>: &nbsp;&nbsp;&nbsp;Lessee shall have rights of reasonable ingress and egress to the Premises over the paved
portions and sidewalks on Lessor&rsquo;s property as well as ingress and egress rights over Lessor&rsquo;s property to access Lessee&rsquo;s loading
dock and shared use of Lessor&rsquo;s paved parking area. Lessee shall also be entitled to reasonable use of that area needed to the
south of the Premises to locate its outside storage tank(s). The storage tank(s) shall be located generally in that area depicted
for such use on <B><U>Exhibit A</U></B>. Lessee agrees to locate and install said tank(s) in a neat and orderly fashion. Lessee
shall petition the Village of Burr Ridge or other applicable governmental entity for any variations(s) or permit(s) that may be
needed to lawfully locate, construct and/or operate such tanks, Lessor acknowledges that said storage tanks are an integral part
of Lessee&rsquo;s use of the Premises. If such permit, variation or approval as is needed to permit the lawful construction and use
of such tanks is denied by the governmental entity with jurisdiction, Lessee shall have the option, within thirty (30) days after
such denial, to terminate this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lessee
Not to Misuse; Sublet; Assignment</U>: &nbsp;&nbsp;&nbsp;Lessee will not allow the Premises to be used for any purpose that
will increase the rate of insurance thereon for Lessor, and will not load floors with machinery or goods beyond the floor
load rating prescribed by applicable governmental ordinances, and will not allow the Premises to be occupied in whole, or in
part, by any other person, and will not sublet the same or any part thereof, nor assign this Lease without in each case the
prior written consent of the Lessor first had, and Lessee will not permit any transfer by operation of law, mortgage or other
encumbrance of the interest in the Premises acquired through this Lease. Lessee will not permit the Premises to be used for
any unlawful purpose, or for any purpose that will injure the reputation of the building or increase the fire hazard of the
building, or disturb the neighborhood, provided however, it is understood and acknowledged by Lessor that Lessee will conduct
certain warehousing and manufacturing activities on the Premises and such activities shall be permitted if in compliance with
applicable federal, state and local law. Lessee will not allow any signs, cards or placards to be posted, or placed thereon,
nor permit any alteration of or addition to any part of the Premises, except by written consent of Lessor which consent would
not be unreasonably withheld; all alterations and additions to the Premises shall remain for the benefit of Lessor unless
otherwise provided in the consent aforesaid. Lessor represents that the Premises are currently zoned for Lessee&rsquo; s
manufacturing, warehousing and office uses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Mechanic&rsquo;s
Lien</U>: &nbsp;&nbsp;&nbsp;&nbsp;Lessee will not permit any mechanic&rsquo;s lien or liens to be placed upon the Premises or any building or improvement thereon
during the term hereof, and in case of the filing of such lien Lessee will promptly pay same. If a default in payment shall continue
for thirty (30) days after written notice to Lessee from Lessor to the Lessee, the Lessor shall have the right and privilege at
Lessor&rsquo;s option of paying the same or any portion of the lien amount without inquiry as to its validity, and any amounts so paid,
including expenses and interest, shall be so much additional indebtedness hereunder due from Lessee to Lessor and shall be repaid
to Lessor immediately on tender of bill the lien costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnify
for Accidents</U>: &nbsp;&nbsp;&nbsp;Lessee covenants and agrees that it will protect and save and keep the Lessor forever harmless and indemnified
against and from any penalty or damages or charges imposed for any violation of any laws or ordinances, whether occasioned by the
neglect of Lessee or those holding under Lessee, and that Lessee will at all times protect, indemnify and save and keep harmless
the Lessor against and from any and all loss, cost, damage or expense, arising out of or from any accident or other occurrences
on or about the Premises, causing injury to any person or property whomsoever or whatsoever and will protect, indemnify and save
and keep harmless the Lessor against and from any and all claims and against and from any and all loss, cost, damage or expense
arising out of any failure of Lessee in any respect to comply with and perform all the requirements and provisions hereof. Lessee
agrees to obtain from a responsible insurance company, or companies, at its expense, public liability insurance in an amount not
less than ONE MILLION ($1,000,000.00) DOLLARS with respect to any one accident and FIVE HUNDRED THOUSAND ($500,000.00) DOLLARS
property damage with respect to any one accident, and a certificate as to such insurance shall be deposited with Lessor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Liability
of Lessor</U>: &nbsp;&nbsp;&nbsp;None of the provisions of this Lease shall operate to waive any protections or immunities from suit or liability
that the Lessor is entitled to as a municipal entity under Illinois or Federal law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Water,
Gas and Electric Charges</U>: &nbsp;&nbsp;&nbsp;Lessee will pay, in addition to the rent above specified, all water rents,
gas and electric light, and power bills taxed, levied or charged on the Premises, for and during the time for which this
Lease is granted, and in case said water rents and bills for gas, electric light and power shall not be paid when due, Lessor
shall, upon three days notice to Lessee have the right to pay the same, which amounts so paid are declared to be so much
additional rent and payable with the installment of rent next due thereafter. Such services shall be separately metered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lessor&rsquo;s
Access to Premises</U>: &nbsp;&nbsp;&nbsp;Lessor and its designees shall have the right, upon reasonable notice to Lessee, to
enter upon the Premises at all reasonable hours (and in emergencies at all times and without notice): (a) to inspect the same;
(b) to make repairs, additions or alterations to the Premises or the building in which the same are located or any property owned
or controlled by Lessor; provided, however, if Lessor intends to be reimbursed by Lessee for any such repairs, additions or alterations,
it shall so notify Lessee at least fourteen (14) days prior. to taking any such action in order for Lessee to determine whether
it is responsible for any such repairs, additions or alterations. Lessor shall also have the right to utilize the unused portion
of the area designated on <B>Exhibit A</B> as the &ldquo;OUTSIDE STORAGE TANK AREA&rdquo;, (&ldquo;AREA&rdquo;) including ingress
and egress to and across such AREA, for its Public Works&rsquo; operations. Prior to such use of the AREA, Lessor agrees, at Lessor&rsquo;s
expense, to install a chain link security fence around that portion of the AREA currently used by Lessee for its storage tank(s).
Lessor agrees to construct the fence in compliance with applicable IEPA standards and requirements regarding the security of Lessee&rsquo;s
existing storage tank(s) in the AREA. In the event Lessor constructs said fence, Lessee shall be allowed continued access, as
may be needed, to maintain its HVAC equipment and storage tank(s) in the AREA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Option
Period</U>: &nbsp;&nbsp;&nbsp;&nbsp;Lessee has the right to extend the Lease term for three (3) consecutive 12 month periods. The annual rent escalation
for each of the one year option periods will continue to be determined in the manner utilized during the initial 48 month Lease
term. Responsibility for real estate taxes will continue to be determined in the manner utilized during the initial 36 month Lease
term. Lessee must provide written notice to Lessor of its intent to exercise this option to extend the lease for a 12 month period
at least six (6) months prior to the expiration of the term of the Lease. Notice must be provided in conformance with paragraph
25.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Abandonment and Reletting</U>: &nbsp;&nbsp;&nbsp;If Lessee shall abandon or
vacate the Premises, or if Lessee&rsquo; s right to occupy the Premises is terminated by Lessor by reason of Lessee&rsquo;s breach of any
of the covenants herein, the same may be re-let by Lessor for such rent and upon such terms as Lessor may reasonably deem
fit, subject to Illinois statute; and if a sufficient sum shall not thus be realized monthly, after paying the out-of-pocket
expenses of such re-letting and collecting to satisfy the rent hereby reserved, Lessee agrees to satisfy and pay all
deficiencies monthly during the remaining period of this Lease. Lessor shall exercise reasonable efforts to obtain a new
lessee to occupy the Premises following abandonment or vacation thereof by Lessee at a rate of rental then prevailing in the
Burr Ridge area and upon such other lease terms as are herein contained. Upon abandonment or vacation of the Premises,
Lessee&rsquo;s obligation is to restore the Premises to its original condition at the commencement of this Lease and return the
Premises to Lessor in good condition and repair, provided, however, Lessee shall not be required to remove any
improvements to the Premises approved by Lessor (unless such improvements are special or unique to Lessee&rsquo;s business, as
reasonably determined by Lessor, and are so conditioned by Lessor). Lessee shall be solely responsible for the complete
removal of any outside storage tank(s) and restoration of the affected location of the tank(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Hazards and Hazardous Substances</U>:&nbsp;&nbsp;&nbsp; Lessor hereby represents
that it has not brought or caused any hazardous materials to exist on, within, or under the Premises as of the commencement
of Lessee&rsquo;s occupancy hereunder in violation of applicable environmental requirements under local, Illinois or Federal law.
Lessee shall not cause or permit any hazardous material to be brought upon, or kept or used in or about the premises by
Lessee, its agents, employees, contractors, or invitees, without the prior written consent of Lessor, (which consent Lessor
shall not unreasonably withhold) so long as Lessee demonstrates to Lessor&rsquo;s reasonable satisfaction that such hazardous
material is necessary or useful to Lessee&rsquo; s business and will be used, kept, and stored and disposed of in a manner that
complies with all laws, rules, statutes, and ordinances regulating any such hazardous material so brought upon or used or
kept in or about the Premises. Lessor consents to Lessee&rsquo;s use and storage of materials which are determined to be hazardous
in reasonable quantities on the Premises so long as such materials are necessary or appropriate in connection with Lessee&rsquo;s
manufacturing and warehousing uses on the Premises. If Lessee or Lessor breach their respective representations or
obligations stated above in this paragraph, or if the presence of hazardous material on or about the Premises caused or
permitted by Lessee or Lessor results in contamination of the Premises or Lessor&rsquo;s adjacent property, or if contamination of
the Premises or surrounding area by hazardous material otherwise occurs the responsible party (Lessee or Lessor) shall
indemnify, defend, and hold harmless the other from any and all claims, judgments, damages, penalties, fines, costs,
liabilities, or losses (including, without limitation, diminution in value of the Premises or Lessor&rsquo;s adjacent property, or
the entire building, damages for the loss or restriction on the use of rentable or usable space or of any amenity of the
Premises or Lessor&rsquo;s adjacent property, damages arising from any adverse impact on marketing of space in the building, and
sum paid in settlement of claims, reasonable attorneys&rsquo; fees, reasonable consultant fees and expert fees) that arise during
or after the term of this Lease as a result of that contamination. This indemnification includes, without limitation,
reasonable costs incurred in connection with any investigation of site conditions or any cleanup, remedial, removal, or
restoration work required by any federal, state, or local governmental agency or political subdivision because of hazardous
material present in the soil or ground water on, under or about the Premises or Lessor&rsquo;s adjacent property. Without limiting
the above, if the presence of any hazardous material on or about the Premises caused or permitted by either Lessor or Lessee
results in any contamination of the Premises or surrounding area, or causes the Premises or surrounding area to be in
violation of any laws, rules, statutes, or ordinances, the responsible party (Lessee or Lessor) shall promptly take all
actions at its sole expense as are necessary to return the Premises and surrounding area to the condition existing before the
introduction of any such hazardous material; provided that, if Lessee is responsible, Lessor&rsquo;s approval of those
actions shall first be obtained, which approval shall not be unreasonably withheld so long as those actions would not
potentially have any material adverse long-term or short-term effect on the Premises or surrounding area.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this
Lease, the term &ldquo;hazardous material&rdquo; means any hazardous or toxic substance, material or waste which is or becomes
regulated by any local governmental authority, the state of Illinois, or the United States government, including any material
which, when present, would require environmental remediation (&ldquo;clean-up&rdquo;) under any such local, Illinois or Federal
law. Lessee shall not allow, keep or use on the Premises any inflammable or explosive liquids or materials save such as may
be necessary for use in the business of the Lessee, and in such case, any such substances shall be delivered and stored in
amount, and used, in accordance with the rules for the applicable Board of Underwriters and statutes and ordinances now or
hereafter in force. Further, no unlawful activities of any kind shall be conducted by Lessee on the Premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nothing in this
paragraph 13 shall be construed to impose any additional liability whatsoever upon either of the parties hereto as a
result of any acts or omissions of any third parties, specifically including any tenants leasing other space from Lessor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Default
by Lessee</U>: &nbsp;&nbsp;&nbsp;If Lessee shall vacate or abandon the Premises, or in case of the non-payment of the rent reserved hereby, or any
part thereof, or of the breach of any covenant in this Lease, Lessee&rsquo;s right to the possession of the Premises thereupon shall
terminate upon written notice to Lessee from Lessor and upon Lessee&rsquo;s failure to cure any such default within sixty (60) days of
receipt of such notice, and the mere retention of possession thereafter by Lessee shall constitute a forcible detainer of the Premises;
and if the Lessor so elects, but not otherwise, and upon written notice of such election to Lessee, this Agreement shall thereupon
terminate, and upon the termination of Lessee&rsquo;s right of possession, as aforesaid, whether this Agreement be terminated or not,
Lessee agrees to surrender possession of the Premises immediately, without the receipt of any demand for rent, notice to quit or
demand for possession of the Premises whatsoever, and hereby grants to Lessor full and free license to enter into and upon the
Premises or any part thereof, to take possession thereof after due process of law, and to expel and to remove Lessee or any other
person who may be occupying the Premises or any part thereof, and Lessor may repossess itself of the Premises as of its former
estate, but such entry of the Premises shall not constitute a trespass or forcible entry or detainer, nor a waiver of any covenants,
agreement or promise in this Agreement contained, to be performed by Lessee. The acceptance of rent, whether in a single instance
or repeatedly, after it falls due, or after knowledge of any breach hereof by Lessee, or the giving or making of any notice or
demand, whether according to any statutory provision or not, or any act or series of acts except as an express written waiver,
shall not be construed as a waiver of Lessor&rsquo;s rights hereunder, or as an election not to proceed under the provisions of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Real
Estate Taxes</U>: &nbsp;&nbsp;&nbsp;&nbsp;Lessor is responsible for the base real estate taxes during the Lease term. The base
real estate taxes for the 2015 tax year are $2,180.26. Following the base year of 2015, the Lessor is subsequently responsible
for the base real estate taxes plus an amount not to exceed 3% escalation of the base taxes. Lessor&rsquo;s obligation cannot
increase more than 3% over the base taxes plus escalation amount of the prior year in any subsequent year. Following the first
year, Lessee will be responsible for that portion of annual increases in real estate taxes for each subsequent year which exceeds
the base year taxes plus a 3% escalation of that base amount, as set forth herein. Lessee&rsquo;s share shall be based on the
actual increase in taxes each year, not on its prior year&rsquo;s payment or share. Lessee&rsquo;s payment, as required hereunder,
shall be due upon issuance of the final tax bill for the second installment of taxes each year, within thirty (30) days of receipt
of notice from Lessor, along with a copy of the tax bill and a reasonably itemized statement by the Village showing the calculation
by which Lessee&rsquo;s share of such tax bill was determined. Nothing in this paragraph shall limit Lessor or Lessee in the exercise
of any rights afforded by Illinois law to challenge any assessment amount arrived at by the Assessor/County Clerk provided that
any such challenge shall not delay or excuse the payment obligations of Lessor and Lessee set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Rent Deduction or Set Off</U>:&nbsp;&nbsp;&nbsp; Lessee&rsquo;s covenant to pay rent is and shall be independent of each and every other covenant of this
Lease. Lessee agrees that any claim by Lessee against Lessor shall not be deducted from rent nor set off against any claim for
rent in any action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Security
Deposit</U>: &nbsp;&nbsp;&nbsp;The security deposit required herein shall be available to Lessor for its use or reimbursement to satisfy any of Lessee&rsquo;s
obligations hereunder, if Lessee shall fail to meet or abide by such obligations. Lessor shall otherwise be allowed to use such
security deposit monies as permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rent
after Notice or Suit</U>: &nbsp;&nbsp;&nbsp;It is further agreed, by the parties hereto, that after the service of notice, or the commencement of
a suit or after final judgment for possession of the Premises, Lessor may receive and collect any rent due, and the payment of
said rent shall not waive or affect said notice, said suit, or said judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Costs</U>:&nbsp;&nbsp;&nbsp; Lessee will pay and discharge all reasonable costs, attorney&rsquo;s fees and expenses that shall be made and incurred
by Lessor in enforcing the covenants and agreements of this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
Cumulative</U>: &nbsp;&nbsp;&nbsp;&nbsp;The rights and remedies of Lessor under this Lease are cumulative. The exercise or use of any one or more thereof
shall not bar Lessor from exercise or use of any other right or remedy provide herein or otherwise provided by law, nor shall exercise
nor use of any right or remedy by Lessor waive any other right or remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fire and Casualty</U>: &nbsp;&nbsp;&nbsp;&nbsp;In the event the Premises are
substantially damaged by fire or other casualty, Lessor shall, within sixty (60) days, notify Lessee in writing as to whether
said Premises will be rebuilt or repaired, and in the event Lessor fails to so notify Lessee, Lessee may, at its option,
terminate this Agreement by giving written notice to Lessor within ten (10) days after the expiration of said sixty (60)
days. If Lessor so notifies Lessee that the Premises will be rebuilt or repaired, then this Agreement shall continue in
effect upon the same terms and conditions; provided, however, if Lessor fails to rebuild or repair said Premises within sixty
(60) days following the expiration of the sixty (60) day period in which Lessor must notify Lessee of such action, then
Lessee may terminate this Agreement upon written notice to Lessor; and provided further, if Lessor so notifies Lessee that
the Premises will be rebuilt or repaired, Lessee may, at its option, terminate this Agreement by giving written notice to
Lessor within sixty (60) days after Lessor has so notified Lessee. If Lessor notifies Lessee that the Premises will not be
rebuilt or repaired, and same are, in fact, not rebuilt or repaired within 180 days after the occurrence of the fire or other
casualty, then this Agreement shall forthwith terminate. The fixed or basic rent herein reserved shall abate during the time
that the Premises is untenantable. In the event of insubstantial damage to the Premises by fire or other casualty, said
Premises shall be promptly restored or repaired by Lessor, and a just and proportionate part of the fixed or basic rent
herein specified shall abate until said Premises have been fully restored or repaired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">22.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Right to Cure Defaults</U>: &nbsp;&nbsp;&nbsp;If either party shall fail to comply fully with any
of its obligations under this Lease (including, without limitation, its obligations to make repairs, maintain various
policies of insurance, comply with all laws, ordinances and regulations and pay all bills for utilities), then the
non-defaulting party shall give notice to the defaulting party regarding the nature and extent of such default and the
defaulting party will have sixty (60) days to cure any such default, and if it fails to cure such default, then the
non-defaulting party shall have the right, at its option, to cure such breach at the other party&rsquo;s expense. Each party agrees
to reimburse the other (as additional rental or otherwise) for all costs and expenses incurred as a result thereof together
with interest thereon promptly upon demand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">23. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>:
&nbsp;&nbsp;&nbsp;&nbsp;Wherever possible each provision of this Lease shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Lease shall be prohibited by or invalid under applicable law, such provisions shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions
of this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">24. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Relationships
of Parties</U>: &nbsp;&nbsp;&nbsp;Nothing contained in this Agreement shall be construed to create the relationship of principal and agent, partnership,
joint venture or any other relationship between the parties hereto other than the relationship of Lessor and Lessee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">25. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>:
&nbsp;&nbsp;&nbsp;Every notice, approval, consent or other communication authorized or required by this Agreement shall not be effective unless served
in writing and sent by United States registered or certified mail, return receipt requested, directed, if to Lessee to the Premises,
and if to Lessor at the address listed on page 1 hereof or such other address as either party may designate by notice from time
to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">26. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver</U>:
&nbsp;&nbsp;&nbsp;One or more waivers of any covenant or condition by either party hereto shall not be construed as a wavier of a subsequent breach
of the same or any other covenant or condition, and the consent or approval by one party to or of any act by the other party requiring
the consenting party&rsquo;s consent or approval shall not be construed to waive or render unnecessary the consenting party &rsquo;s consent
or approval to or of any subsequent similar act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">27. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>: &nbsp;&nbsp;&nbsp;No oral statement or prior written matter shall have any force or effect all of which shall merge herein and be
superseded hereby. No waiver of any provision of this Agreement shall be effective unless in writing, signed by the waiving party.
The parties agree that they are not relying on any representations or agreements other than those contained in this Agreement.
This Agreement shall not be modified except by a writing subscribed by all parties, nor may this Agreement be canceled by either
party except with the written consent of the other, unless otherwise specifically provided herein. The invalidity or unenforceability
of any provisions of this Agreement shall not affect or impair any other provision. All captions herein are solely for convenience
and shall not be given any legal effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as otherwise provided in this Agreement,
the covenants, conditions and agreements contained in this Agreement shall bind and inure to the benefit of Lessor and Lessee and
their respective successors and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the parties hereby set their hands and seals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSOR:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LESSEE:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VILLAGE OF BURR RIDGE</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NANOPHASE TECHNOLOGIES CORORATION</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cook and DuPage Counties,
    Illinois</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2">DuPage County, Illinois</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex1051006.jpg" ALT="(Signature)"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-left: 0.125in"><IMG SRC="ex1051008.jpg" ALT="(Signature)"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATTEST:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATTEST:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex1051007.jpg" ALT="(Signature)"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex1051009.jpg" ALT="(Signature)"></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clerk</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-14-17</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0.25in">2/27/17</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ex23-1.htm
<DESCRIPTION>CONSENT OF RSM US LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%"></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><A HREF="nanx-10k_123116.htm">Nanophase Technologies Corporation - 10-K</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 10pt">CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
consent to the incorporation by reference in Registration Statements (No. 333-53445, No. 333-74170, No. 333-119466, No. 333-150765,
and 333-187649) on Form S-8 and Registration Statements (No. 333-90326, No. 333-116224, No. 333-140461, and 333-163363) on Form
S-3, of Nanophase Technologies Corporation of our report dated March 29, 2017 relating to our audit of the financial statements,
which appears in this Annual Report on Form 10-K of Nanophase Technologies Corporation for the year ended December 31, 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">/s/ RSM US LLP&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Schaumburg, Illinois</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">March 29, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>ex31-1.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><A HREF="nanx-10k_123116.htm">Nanophase Technologies Corporation - 10-K</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit 31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Certification
of the Chief Executive Officer&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Pursuant
to&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Rules 13a-14(a)
and 15d-14(a) under the Exchange Act</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">I, Jess A. Jankowski, certify
that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have reviewed this annual report on Form 10-K of Nanophase Technologies Corporation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Evaluated
the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such
evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disclosed
in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons
performing the equivalent function):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Date: March 29, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; border-bottom: Black 1pt solid"></TD>
    <TD STYLE="width: 47%; border-bottom: Black 1pt solid; padding-left: 0.25in">/s/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;JESS
A. JANKOWSKI</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in">Jess A. Jankowski</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in">Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>ex31-2.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><A HREF="nanx-10k_123116.htm">Nanophase Technologies Corporation - 10-K</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit
31.2 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Certification
of the Chief Financial Officer&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Pursuant
to&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Rules 13a-14(a)
and 15d-14(a) under the Exchange Act&nbsp;</FONT></P>

<P STYLE="font: 9pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">I, Frank J. Cesario, certify
that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have reviewed this annual report on Form 10-K of Nanophase Technologies Corporation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Evaluated
the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such
evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disclosed
in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons
performing the equivalent function):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Date:
March 29, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; border-bottom: Black 1pt solid">/s/</TD>
    <TD STYLE="width: 47%; border-bottom: Black 1pt solid; padding-left: 0.25in">FRANK J. CESARIO</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in">Frank J. Cesario</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in">Chief Financial Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>8
<FILENAME>ex32.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND THE CHIEF FINANCIAL OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><A HREF="nanx-10k_123116.htm">Nanophase Technologies Corporation - 10-K<FONT STYLE="font-size: 10pt">&nbsp;</FONT></A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Exhibit
32</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 9pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Certification
Pursuant to 18 U.S.C. Section 1350&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">(as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)&nbsp;</FONT></P>

<P STYLE="font: 9pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
connection with this annual report of Nanophase Technologies Corporation (the &ldquo;Company&rdquo;) on Form 10-K for the year
ending December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), we,
Jess A. Jankowski, Chief Executive Officer of the Company and Frank J. Cesario, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to our knowledge:&nbsp;</FONT></P>

<P STYLE="font: 9pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and&nbsp;</FONT></P>

<P STYLE="font: 9pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
information contained in the Report fairly presents, in all material respects, the financial condition and result of operations
of the Company.&nbsp;</FONT></P>

<P STYLE="font: 9pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Date: March 29, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; border-bottom: Black 1pt solid"></TD>
    <TD STYLE="width: 37%; border-bottom: Black 1pt solid; padding-left: 0.25in">/s/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;JESS A. JANKOWSKI</TD>
    <TD STYLE="width: 10%; padding-left: 0.25in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jess A. Jankowski</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 0.25in">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; border-bottom: Black 1pt solid"></TD>
    <TD STYLE="width: 37%; border-bottom: Black 1pt solid; padding-left: 0.25in">/s/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FRANK J. CESARIO</TD>
    <TD STYLE="width: 10%; padding-left: 0.25in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 0.25in"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Frank J. Cesario</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>9
<FILENAME>nanx-20161231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: P:\EDGARizer\Clients\Nanophase Technologies\Xbrl\20161231\nanx_123116.xfr; Date: 2017%2D03%2D29T13:48:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:country="http://xbrl.sec.gov/country/2016-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2016-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:nanx="http://nanophase.com/20161231">
    <link:schemaRef xlink:href="nanx-20161231.xsd" xlink:type="simple" />
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20140731_0_2036993x2030533">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2094476">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2109069">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2199695">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_SupplyCommitmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">us-gaap:SupplyCommitmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_SupplyCommitmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">us-gaap:SupplyCommitmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20160630_0_2031208x2094476">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20160630_0_2031208x2109069">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20160630_0_2031208x2199695">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20141231_0">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_NonUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_SupplyCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">us-gaap:SupplyCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_NonUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_LetterOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_LineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_LineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_SupplyCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">us-gaap:SupplyCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_EquipmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_LeaseholdImprovementsMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_LeaseholdImprovementsMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_EquipmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1642130">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1641629">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1641298">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1633086">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1642925">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_OffsiteWarehouseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">nanx:OffsiteWarehouseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_RomeovilleIllinoisMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">nanx:RomeovilleIllinoisMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1510-K0007_STD_365_20111231_0">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-01-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-01-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-08-01to2016-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-08-01</xbrli:startDate>
        <xbrli:endDate>2016-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_EuropeanUnionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeanUnionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_EuropeanUnionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeanUnionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-01to2017-02-28_us-gaap_SubsequentEventMember_us-gaap_LineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-01</xbrli:startDate>
        <xbrli:endDate>2017-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-01to2017-03-31_us-gaap_SubsequentEventMember_custom_BurrRidgeFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">nanx:BurrRidgeFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD_per_shares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <us-gaap:ShortTermBorrowings contextRef="eol_PE4234----1610-Q0001_STD_0_20140731_0_2036993x2030533" unitRef="USD" decimals="-3">30000</us-gaap:ShortTermBorrowings>
    <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2094476" unitRef="USD" decimals="-3">240000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2109069" unitRef="USD" decimals="-3">35000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2199695" unitRef="USD" decimals="-3">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">434000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20160630_0_2031208x2094476" unitRef="USD" decimals="-3">180000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20160630_0_2031208x2109069" unitRef="USD" decimals="-3">39000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20160630_0_2031208x2199695" unitRef="USD" decimals="-3">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">507000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-12-31" unitRef="USD_per_shares" decimals="INF">.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2015-12-31" unitRef="USD_per_shares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">31229996</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2015-12-31" unitRef="shares" decimals="INF">28585496</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">31229996</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31" unitRef="shares" decimals="INF">28585496</us-gaap:CommonStockSharesIssued>
    <us-gaap:Assets contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">4842000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">4574000</us-gaap:Assets>
    <us-gaap:DeferredRentCreditNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">466000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:DeferredRentCreditNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">519000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">3427000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">2691000</us-gaap:AssetsCurrent>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">42000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-12-31" unitRef="shares" decimals="INF">35000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">5000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">6000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AssetRetirementObligationsNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">178000</us-gaap:AssetRetirementObligationsNoncurrent>
    <us-gaap:AssetRetirementObligationsNoncurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20141231_0" unitRef="USD" decimals="-3">166000</us-gaap:AssetRetirementObligationsNoncurrent>
    <us-gaap:AssetRetirementObligationsNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">172000</us-gaap:AssetRetirementObligationsNoncurrent>
    <us-gaap:CommonStockValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">312000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">286000</us-gaap:CommonStockValue>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">669000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">508000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">97359000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">96172000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CapitalLeaseObligationsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">107000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">94000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">110000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">144000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">521000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">276000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-12-31" unitRef="USD_per_shares" decimals="INF">.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2015-12-31" unitRef="USD_per_shares" decimals="INF">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">24088</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2015-12-31" unitRef="shares" decimals="INF">24088</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">510000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">530000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryGross contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">793000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">714000</us-gaap:InventoryGross>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">754000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">835000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2015-12-31" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:InventoryNet contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">772000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">662000</us-gaap:InventoryNet>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">4842000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">4574000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">1297000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">878000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">20000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">22000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:PreferredStockValue contextRef="AsOf2016-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2015-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InventoryRawMaterials contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">283000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">184000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">21000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">52000</us-gaap:InventoryValuationReserves>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">1395000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">1861000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">2791000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="eol_PE4234----1610-Q0001_STD_0_20141231_0" unitRef="USD" decimals="-3">3846000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">2861000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2014-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">286000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">312000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">285000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">96172000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">97359000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">95966000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-93597000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-94880000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-92405000</us-gaap:StockholdersEquity>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">183000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-12-31" unitRef="USD_per_shares" decimals="2">.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2015-12-31" unitRef="USD_per_shares" decimals="2">0.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">-94880000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">-93597000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">442000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">247000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2015-12-31" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">181000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">207000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2015-01-01to2015-12-31" unitRef="shares" decimals="INF">69000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2016-01-01to2016-12-31" unitRef="shares" decimals="INF">44000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2016-01-01to2016-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">44500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">69333</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:Revenues contextRef="From2015-01-01to2015-12-31_us-gaap_NonUsMember" unitRef="USD" decimals="-3">1393000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-01-01to2016-12-31_us-gaap_NonUsMember" unitRef="USD" decimals="-3">1039000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-01-01to2016-12-31_us-gaap_EuropeanUnionMember" unitRef="USD" decimals="-3">902000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-01-01to2015-12-31_us-gaap_EuropeanUnionMember" unitRef="USD" decimals="-3">1339000</us-gaap:Revenues>
    <dei:DocumentType contextRef="From2016-01-01to2016-12-31">10-K</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="From2016-01-01to2016-12-31">0000883107</dei:EntityCentralIndexKey>
    <dei:DocumentPeriodEndDate contextRef="From2016-01-01to2016-12-31">2016-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2016-01-01to2016-12-31">2016</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag contextRef="From2016-01-01to2016-12-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2016-01-01to2016-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2016-01-01to2016-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityFilerCategory contextRef="From2016-01-01to2016-12-31">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:TradingSymbol contextRef="From2016-01-01to2016-12-31">NANX</dei:TradingSymbol>
    <nanx:MajorCustomersNumberOfCustomers contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">3</nanx:MajorCustomersNumberOfCustomers>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-03-14" unitRef="shares" decimals="INF">31229996</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-1192000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">-1283000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-12-31_us-gaap_SupplyCommitmentMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-1283000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-1192000</us-gaap:NetIncomeLoss>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">1779000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE4234----1610-Q0001_STD_0_20141231_0" unitRef="USD" decimals="-3">1862000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">1275000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-240000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">-241000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-240000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">241000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-14000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">161000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-120000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">194000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-288000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">110000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">119000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">-73000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:ShareBasedCompensation contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">182000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">207000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">735000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">610000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="From2016-01-01to2016-12-31_us-gaap_LetterOfCreditMember">Prime rate</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="From2016-01-01to2016-12-31_us-gaap_LineOfCreditMember">Prime rate</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-12-31_us-gaap_LineOfCreditMember" unitRef="USD" decimals="-3">300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="From2016-01-01to2016-12-31_us-gaap_LetterOfCreditMember" unitRef="pure" decimals="INF">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="From2016-01-01to2016-12-31_us-gaap_LineOfCreditMember" unitRef="pure" decimals="INF">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <nanx:LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable contextRef="From2016-01-01to2016-12-31_us-gaap_LineOfCreditMember" unitRef="pure" decimals="INF">.75</nanx:LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable>
    <us-gaap:Cash contextRef="AsOf2016-12-31_us-gaap_LineOfCreditMember" unitRef="USD" decimals="-3">1000000</us-gaap:Cash>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2016-01-01to2016-12-31_us-gaap_LineOfCreditMember">2017-03-04</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2017-02-01to2017-02-28_us-gaap_SubsequentEventMember_us-gaap_LineOfCreditMember">2018-03-31</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">2933000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2015-12-31" unitRef="shares" decimals="INF">2574000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2015-01-01to2015-12-31" unitRef="pure" decimals="INF">.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2015-01-01to2015-12-31">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2016-01-01to2016-12-31">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="From2015-01-01to2015-12-31" unitRef="pure" decimals="INF">0.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">0.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2015-01-01to2015-12-31" unitRef="USD_per_shares" decimals="INF">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2016-01-01to2016-12-31" unitRef="USD_per_shares" decimals="INF">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2016-01-01to2016-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember" unitRef="pure" decimals="INF">0.69</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2016-01-01to2016-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember" unitRef="pure" decimals="INF">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2016-01-01to2016-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember" unitRef="pure" decimals="INF">.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember" unitRef="pure" decimals="INF">.63</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember" unitRef="pure" decimals="INF">.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember" unitRef="pure" decimals="INF">.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SignificantSupplyCommitmentDescription contextRef="From2016-01-01to2016-12-31_us-gaap_SupplyCommitmentMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0; text-align: justify"&gt;We currently have&#13;exclusive supply agreements with BASF Corporation (&amp;#8220;BASF&amp;#8221;), &lt;br /&gt;&#13;our largest customer, that have contingencies outlined&#13;which could potentially result in the license of technology &lt;br /&gt;&#13;and/or the sale of production equipment from the Company to the customer&#13;intended to provide capacity sufficient &lt;br /&gt;&#13;to meet the customer&amp;#8217;s production needs.&lt;/p&gt;</us-gaap:SignificantSupplyCommitmentDescription>
    <nanx:EquipmentSaleNetBookValueEquipmentAndUpgrades contextRef="AsOf2016-12-31_us-gaap_SupplyCommitmentMember" unitRef="pure" decimals="INF">1.15</nanx:EquipmentSaleNetBookValueEquipmentAndUpgrades>
    <nanx:EquipmentSaleNetBookValueEquipment contextRef="AsOf2016-12-31_us-gaap_SupplyCommitmentMember" unitRef="pure" decimals="INF">1.15</nanx:EquipmentSaleNetBookValueEquipment>
    <nanx:EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades contextRef="AsOf2016-12-31_us-gaap_SupplyCommitmentMember" unitRef="pure" decimals="INF">0.30</nanx:EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="AsOf2016-12-31_us-gaap_SupplyCommitmentMember_us-gaap_MaximumMember" unitRef="USD" decimals="-3">1000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <nanx:PrincipalAmountDebtAcceleratedMaturity contextRef="AsOf2016-12-31_us-gaap_SupplyCommitmentMember_us-gaap_MinimumMember" unitRef="USD" decimals="-3">10000000</nanx:PrincipalAmountDebtAcceleratedMaturity>
    <us-gaap:NumberOfOperatingSegments contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">1</us-gaap:NumberOfOperatingSegments>
    <dei:EntityRegistrantName contextRef="From2016-01-01to2016-12-31">NANOPHASE TECHNOLOGIES Corp</dei:EntityRegistrantName>
    <dei:EntityPublicFloat contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">10265000</dei:EntityPublicFloat>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2016-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2015-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">14000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">15000</us-gaap:InterestExpense>
    <us-gaap:OperatingIncomeLoss contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-1178000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">-1268000</us-gaap:OperatingIncomeLoss>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">3019000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">2954000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">1273000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">1554000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GrossProfit contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">3114000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">3240000</us-gaap:GrossProfit>
    <us-gaap:CostOfRevenue contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">7199000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">7543000</us-gaap:CostOfRevenue>
    <us-gaap:SalesRevenueNet contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">10313000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">10783000</us-gaap:SalesRevenueNet>
    <us-gaap:OtherSalesRevenueNet contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">41000</us-gaap:OtherSalesRevenueNet>
    <us-gaap:OtherSalesRevenueNet contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">63000</us-gaap:OtherSalesRevenueNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">10272000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">10720000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-1192000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">-1283000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2015-01-01to2015-12-31" unitRef="USD_per_shares" decimals="INF">-0.04</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-01-01to2016-12-31" unitRef="USD_per_shares" decimals="INF">-0.04</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2015-01-01to2015-12-31" unitRef="shares" decimals="INF">28574902</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-01-01to2016-12-31" unitRef="shares" decimals="INF">30911869</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding contextRef="AsOf2015-12-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2016-12-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2014-12-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2015-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">28585496</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2016-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">31229996</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2014-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">28516163</us-gaap:SharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">26000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">18000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2016-01-01to2016-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">18000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">25000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">181000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">207000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2016-01-01to2016-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">207000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">181000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2016-01-01to2016-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">2600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">988000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2016-01-01to2016-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">26000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2016-01-01to2016-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">962000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AssetImpairmentCharges contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">54000</us-gaap:AssetImpairmentCharges>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-288000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">-165000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">8000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">37000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">280000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">128000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-587000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">504000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">26000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">18000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">988000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">85000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">96000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:InterestPaid contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">14000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">15000</us-gaap:InterestPaid>
    <us-gaap:CapitalLeaseObligationsIncurred contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">132000</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalLeaseObligationsIncurred contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">75000</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">37000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-59000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">910000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2016-01-01to2016-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2016-01-01to2016-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2016-01-01to2016-12-31">Yes</dei:EntityCurrentReportingStatus>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2016-01-01to2016-12-31_us-gaap_EquipmentMember_us-gaap_MaximumMember">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2016-01-01to2016-12-31_us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_us-gaap_MinimumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2016-01-01to2016-12-31_us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_us-gaap_MaximumMember">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2016-01-01to2016-12-31_us-gaap_LeaseholdImprovementsMember_us-gaap_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2016-01-01to2016-12-31_us-gaap_LeaseholdImprovementsMember_us-gaap_MaximumMember">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2016-01-01to2016-12-31_us-gaap_EquipmentMember_us-gaap_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:OpenTaxYear contextRef="From2016-01-01to2016-12-31_us-gaap_MinimumMember">2013</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear contextRef="From2016-01-01to2016-12-31_us-gaap_MaximumMember">2015</us-gaap:OpenTaxYear>
    <nanx:OpenTaxYearExpirationPeriod contextRef="From2016-01-01to2016-12-31_us-gaap_MinimumMember">2017</nanx:OpenTaxYearExpirationPeriod>
    <nanx:OpenTaxYearExpirationPeriod contextRef="From2016-01-01to2016-12-31_us-gaap_MaximumMember">2019</nanx:OpenTaxYearExpirationPeriod>
    <us-gaap:AssetRetirementObligationAccretionExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">6000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">6000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">20376000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">20250000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1642130" unitRef="USD" decimals="-3">4789000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1641629" unitRef="USD" decimals="-3">110000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1641298" unitRef="USD" decimals="-3">778000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1633086" unitRef="USD" decimals="-3">11000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE4234----1510-K0007_STD_0_20151231_0_1634505x1642925" unitRef="USD" decimals="-3">14562000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-12-31_us-gaap_MachineryAndEquipmentMember" unitRef="USD" decimals="-3">14587000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-12-31_us-gaap_LeaseholdImprovementsMember" unitRef="USD" decimals="-3">4815000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-12-31_us-gaap_FurnitureAndFixturesMember" unitRef="USD" decimals="-3">110000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-12-31_us-gaap_OfficeEquipmentMember" unitRef="USD" decimals="-3">790000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-12-31_us-gaap_ConstructionInProgressMember" unitRef="USD" decimals="-3">75000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">18981000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">18389000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:Depreciation contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">726000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">605000</us-gaap:Depreciation>
    <nanx:OperatingLeaseNumberOfRenewals contextRef="From2016-01-01to2016-12-31_custom_RomeovilleIllinoisMember" unitRef="pure" decimals="INF">1</nanx:OperatingLeaseNumberOfRenewals>
    <nanx:OperatingLeaseNumberOfRenewals contextRef="From2017-03-01to2017-03-31_us-gaap_SubsequentEventMember_custom_BurrRidgeFacilityMember" unitRef="pure" decimals="INF">1</nanx:OperatingLeaseNumberOfRenewals>
    <us-gaap:OperatingLeasesRentExpenseMinimumRentals contextRef="From2016-01-01to2016-12-31_custom_OffsiteWarehouseMember" unitRef="USD" decimals="-3">5000</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
    <us-gaap:OperatingLeasesRentExpenseMinimumRentals contextRef="From2016-01-01to2016-12-31_custom_RomeovilleIllinoisMember" unitRef="USD" decimals="-3">25000</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
    <us-gaap:OperatingLeasesRentExpenseMinimumRentals contextRef="From2017-03-01to2017-03-31_us-gaap_SubsequentEventMember_custom_BurrRidgeFacilityMember" unitRef="USD" decimals="-3">15000</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
    <us-gaap:LeaseAndRentalExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">588000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">597000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:CapitalLeasedAssetsGross contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">362000</us-gaap:CapitalLeasedAssetsGross>
    <us-gaap:CapitalLeasedAssetsGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">316000</us-gaap:CapitalLeasedAssetsGross>
    <us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">62000</us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation>
    <us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">29000</us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation>
    <nanx:NumberOfCapitalLeases contextRef="From2015-01-01to2015-12-31" unitRef="pure" decimals="INF">3</nanx:NumberOfCapitalLeases>
    <nanx:NumberOfCapitalLeases contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">1</nanx:NumberOfCapitalLeases>
    <nanx:LesseeLeasingArrangementsCapitalLeasesTermOfContract contextRef="From2016-01-01to2016-12-31">P5Y</nanx:LesseeLeasingArrangementsCapitalLeasesTermOfContract>
    <nanx:LesseeLeasingArrangementsCapitalLeasesTermOfContract contextRef="From2015-01-01to2015-12-31_us-gaap_MinimumMember">P3Y</nanx:LesseeLeasingArrangementsCapitalLeasesTermOfContract>
    <nanx:LesseeLeasingArrangementsCapitalLeasesTermOfContract contextRef="From2015-01-01to2015-12-31_us-gaap_MaximumMember">P5Y</nanx:LesseeLeasingArrangementsCapitalLeasesTermOfContract>
    <us-gaap:PaymentsToAcquireEquipmentOnLease contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">132000</us-gaap:PaymentsToAcquireEquipmentOnLease>
    <us-gaap:PaymentsToAcquireEquipmentOnLease contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">75000</us-gaap:PaymentsToAcquireEquipmentOnLease>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">167000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">108000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">153000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">168000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">5000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">4000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <nanx:OperatingLossCarryforwardsExpirationYearStart contextRef="From2015-01-01to2015-12-31">2018</nanx:OperatingLossCarryforwardsExpirationYearStart>
    <nanx:OperatingLossCarryforwardsExpirationYearEnd contextRef="From2015-01-01to2015-12-31">2036</nanx:OperatingLossCarryforwardsExpirationYearEnd>
    <nanx:PeriodForSuspensionOfNetOperatingLossCarryforwards contextRef="eol_PE4234----1510-K0007_STD_365_20111231_0">P4Y</nanx:PeriodForSuspensionOfNetOperatingLossCarryforwards>
    <nanx:ExtensionOfTermOfNetLossCarryforwards contextRef="eol_PE4234----1510-K0007_STD_365_20111231_0">P4Y</nanx:ExtensionOfTermOfNetLossCarryforwards>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-405000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">-436000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">3000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">2000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-61000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">-66000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">-3000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">144000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">466000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">356000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">31935000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">31590000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">16000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">28000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">5000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">6000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">805000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">709000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">69000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">67000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">1328000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">1396000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">219000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">225000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">34377000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">34021000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">34377000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2015-12-31" unitRef="USD" decimals="-3">34021000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:CommonStockSharesSubscribedButUnissued contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">1196000</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">2053000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-01-01to2016-12-31">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">698000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">700000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">691000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">589000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">554000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">1289000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">58000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">45000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">34000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">18000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">15000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDue contextRef="AsOf2016-12-31" unitRef="USD" id="Foot-00-0" decimals="-3">170000</us-gaap:CapitalLeasesFutureMinimumPaymentsDue>
    <nanx:CashAndCashEquivalentsMaturityPeriodDescription contextRef="From2016-01-01to2016-12-31">90 days or less</nanx:CashAndCashEquivalentsMaturityPeriodDescription>
    <nanx:AccountsReceivablesCreditPeriod contextRef="From2016-01-01to2016-12-31">P30D</nanx:AccountsReceivablesCreditPeriod>
    <nanx:IncomeTaxRecognitionThresholdPercentage contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">0.50</nanx:IncomeTaxRecognitionThresholdPercentage>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2016-01-01to2016-12-31_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF">859000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2015-01-01to2015-12-31_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF">210000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <nanx:CapitalLeasesFutureMinimumPaymentsDuePrincipal contextRef="AsOf2017-01-31_us-gaap_SubsequentEventMember" unitRef="USD" decimals="-3">147000</nanx:CapitalLeasesFutureMinimumPaymentsDuePrincipal>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments contextRef="AsOf2017-01-31_us-gaap_SubsequentEventMember" unitRef="USD" decimals="-3">23000</us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments>
    <nanx:CustomerNetVolumeRebatePayable contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">201000</nanx:CustomerNetVolumeRebatePayable>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">82000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="From2016-08-01to2016-08-31" unitRef="shares" decimals="INF">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <nanx:AddtionalSharesAuthorizedDuringPeriod contextRef="From2016-08-01to2016-08-31" unitRef="shares" decimals="INF">7000000</nanx:AddtionalSharesAuthorizedDuringPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2015-01-01to2015-12-31" unitRef="pure" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2016-01-01to2016-12-31" unitRef="shares" decimals="INF">508000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2016-01-01to2016-12-31" unitRef="shares" decimals="INF">105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2016-12-31" unitRef="shares" decimals="INF">1196000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-12-31" unitRef="USD_per_shares" decimals="INF">.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-12-31" unitRef="USD_per_shares" decimals="INF">.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2016-01-01to2016-12-31" unitRef="USD_per_shares" decimals="INF">3.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2016-12-31" unitRef="USD_per_shares" decimals="INF">.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2016-01-01to2016-12-31">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2016-01-01to2016-12-31">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharePrice contextRef="AsOf2016-12-31" unitRef="USD_per_shares" decimals="INF">.72</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">19000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2016-01-01to2016-12-31">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <nanx:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1 contextRef="From2016-01-01to2016-12-31">P10Y</nanx:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1>
    <nanx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions contextRef="From2015-01-01to2015-12-31" unitRef="pure" decimals="INF">.04</nanx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions>
    <nanx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">.04</nanx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">616000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">378000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <nanx:DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">1.00</nanx:DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution>
    <nanx:DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">0.03</nanx:DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab>
    <nanx:DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">0.50</nanx:DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution>
    <nanx:DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab contextRef="From2016-01-01to2016-12-31" unitRef="pure" decimals="INF">0.02</nanx:DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab>
    <nanx:DefinedContributionPlanEmployerMatchingContributionAmount contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">0</nanx:DefinedContributionPlanEmployerMatchingContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch contextRef="From2017-01-01to2017-01-31_us-gaap_SubsequentEventMember" unitRef="pure" decimals="INF">0.08</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent contextRef="From2017-01-01to2017-01-31_us-gaap_SubsequentEventMember" unitRef="pure" decimals="INF">0.10</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent contextRef="From2017-01-01to2017-01-31_us-gaap_SubsequentEventMember" unitRef="pure" decimals="INF">0.008</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <dei:EntityListingParValuePerShare contextRef="From2016-01-01to2016-12-31" unitRef="USD_per_shares" decimals="INF">0.01</dei:EntityListingParValuePerShare>
    <us-gaap:NatureOfOperations contextRef="From2016-01-01to2016-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman Bold,serif; margin-top: 0; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.5in; text-align: left"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Description of Business&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Nanophase Technologies Corporation&#13;(&amp;#8220;Nanophase&amp;#8221;, &amp;#8220;Company&amp;#8221;, &amp;#8220;we&amp;#8221;, &amp;#8220;our&amp;#8221;, or &amp;#8220;us&amp;#8221;) is an advanced materials&#13;and applications developer and commercial manufacturer with an integrated family of nanomaterial and related technologies. We produce&#13;engineered nano and larger, sub-micron, materials for use in a variety of diverse markets: personal care including sunscreens,&#13;architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics,&#13;energy, and a variety of surface finishing technologies (polishing) applications, including optics. We have recently expanded our&#13;offerings beyond active ingredients to include targeted full formulations of skin care products, marketed and sold by our wholly-owned&#13;subsidiary, Sol&amp;#233;sence &amp;#8482; LLC. We target markets in which we believe practical solutions may be found using our products.&#13;We work closely with current and potential customers in these target markets to identify their material and performance requirements&#13;and market our materials to various end-use applications manufacturers. Recently developed technologies have made certain new products&#13;possible and opened potential new markets. We recently developed new material solutions in the light energy-management area (particularly&#13;solar control) that have been taken to potential customers, and for which we are experiencing early-stage, accelerating revenue&#13;growth. We also developed a new solution for surface treatments (coatings) which we used to launch new products in personal care,&#13;including those of our subsidiary, Sol&amp;#233;sence &amp;#8482; LLC, in the fall of 2016. Although our primary strategic focus has&#13;been the North American market, we currently sell material to customers overseas and have been working to expand our reach within&#13;foreign markets. The Company was incorporated in Illinois on November 25, 1989, and became a Delaware corporation during November&#13;1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;While product sales comprise&#13;the majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected&#13;to drive the long-term growth of the business. For this reason, we classify such revenue as &amp;#8220;other revenue&amp;#8221; in our&#13;Statements of Operations, as it does not represent revenue directly from our nanocrystalline materials.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2016-01-01to2016-12-31">&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman Bold,serif; margin-top: 0; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.5in; text-align: left"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Summary of Significant Accounting Policies&lt;/td&gt;&#13;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Use of Estimates and&#13;Risks and Uncertainties&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of financial&#13;statements requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying&#13;notes. Actual results could differ from those estimates. Certain assumptions are also necessary to assess the impact of risks and&#13;uncertainties on the financial statements, such as cash flow projections, availability of capital if needed to support the ongoing&#13;operations of the business, and our expected compliance with contractual commitments. These risks and uncertainties are further&#13;discussed in Note 12. Any changes in these assumptions or business plans could have a material impact on the financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Cash and cash equivalents primarily&#13;consist of demand deposits, but also include certain lower risk investments with a stated maturity upon acquisition of 90 days&#13;or less (e.g., money market funds or a certificate of deposit with a maturity of 90 days or less at the time of purchase).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Trade Accounts Receivable&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Trade accounts receivable are&#13;carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts&#13;on a monthly basis. We determine the allowance for doubtful accounts by identifying troubled accounts and by using historical experience&#13;applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts&#13;receivable previously written off are recorded when received. Our typical credit terms are thirty days from shipment and invoicing.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Inventories&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Inventories are stated at the&#13;lower of cost, maintained on a first in, first out basis, or market. We have recorded allowances to reduce inventory relating to&#13;excess quantities of certain materials. Write-downs of inventories establish a new cost basis, which is not increased for future&#13;increases in market value of inventories or changes in estimated excess quantities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Equipment and Leasehold&#13;Improvements&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Equipment is stated at cost&#13;and is being depreciated over its estimated useful life (3-20 years) using the straight-line method. Leasehold improvements are&#13;stated at cost and are being amortized using the straight-line method over the shorter of the useful life of the asset or the term&#13;of the lease (3-13 years). Depreciation expense for leased assets is included with depreciation expense for owned assets. From&#13;time to time we have self-constructed assets. These assets are stated at cost plus the capitalization of labor and are depreciated&#13;over an estimated useful life (7-10 years) using the straight-line method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Long Lived Assets&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We review long-lived assets&#13;for impairment whenever events or changes in circumstances indicate that the asset&amp;#8217;s carrying amount may not be recoverable.&#13;We conduct long-lived asset impairment analyses in accordance with ASC 360-10-15, &lt;i&gt;Impairment or Disposal of Long-Lived Assets&lt;/i&gt;.&#13;ASC 360-10-15 requires us to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent&#13;of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash&#13;flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is&#13;measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis&#13;or appraisals.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Asset Retirement Obligations&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In connection with our leased&#13;facilities, we are required to remove certain leasehold improvements upon termination of our occupancy. We follow the provisions&#13;of the FASB issued ASC 410-20, &lt;i&gt;Asset Retirement Obligations&lt;/i&gt;, under which we recognize a liability for the fair value of&#13;these asset retirement obligations. The fair value of that liability is measured based on an expected cash flow approach and accretion&#13;expense is recognized each period to recognize increases to the fair value of the liability due to the passage of time. Increases&#13;to the fair value of the liability, except for accretion, are added to the carrying value of the long-lived asset. Those increases&#13;are then reported in amortization expense over the estimated useful life of the long-lived asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Activity in the asset retirement&#13;obligation account for the years ended December 31, is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 48%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Balance, beginning&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;172&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;166&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.15in"&gt;Accretion of liability due to passage of time&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2px; padding-left: 0.15in"&gt;Amortization of asset due to passage of time&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2px; border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2px; border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;Balance, ending&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;178&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;172&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Financial Instruments&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We follow ASC Topic 820, &lt;i&gt;Fair&#13;Value Measurements and Disclosures&lt;/i&gt;, which defines fair value, establishes a framework for measuring fair value, and expands&#13;disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into&#13;three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure&#13;of fair value, whereas Level 3 generally requires significant management judgment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Our financial instruments include&#13;cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with the promissory note with no related&#13;borrowings described in Note 3, and any borrowings on the working capital line of credit described in Note 3. The fair values of&#13;all financial instruments were not materially different from their carrying values.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;There were no financial assets&#13;or liabilities adjusted to fair value on December 31, 2016 and 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Product Revenue &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Product revenue consists of&#13;sales of product that are recognized when realized and earned. This occurs when persuasive evidence of an arrangement exists, title&#13;transfers via shipment of products or when delivery has occurred, the price is fixed or determinable and collectability is reasonably&#13;assured.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Other Revenue &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Other revenue may include revenue&#13;from technology license fees and paid development projects. Technology license fees and paid development projects are recognized&#13;when earned pursuant to the agreed upon contractual arrangement, when performance obligations are satisfied, the amount is fixed&#13;or determinable, and collectability is reasonably assured.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Shipping and handling costs&#13;are included in other revenue when products are shipped and invoiced to the customer. We include the related cost of shipping and&#13;handling in cost of goods sold.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Research and Development Expenses&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;Research and development&#13;expenses are recognized as expense when incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Income Taxes &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We account for income taxes&#13;using the liability method. As such, deferred income taxes reflect the net tax effects of temporary differences between the carrying&#13;amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets&#13;and liabilities are calculated using the enacted tax rates and laws that are expected to be in effect when the anticipated reversal&#13;of these differences is scheduled to occur. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,&#13;it is more likely than not that some portion or all of the deferred tax assets will not be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;When tax returns are filed,&#13;it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are&#13;subject to uncertainty about merits of the position taken or the amount of the position that would be ultimately sustained. The&#13;benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence,&#13;management believes it is more likely than not that the position will be sustained upon examination, including the resolution of&#13;appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that&#13;meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent&#13;likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax&#13;positions taken that exceeds the amount measured, as described above, is reflected as a liability for uncertain tax benefits in&#13;the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities&#13;upon examination.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We have not recorded a reserve&#13;for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing&#13;of such deductibility. We file tax returns in all appropriate jurisdictions, which includes a federal tax return and Illinois state&#13;tax return. Open tax years for both jurisdictions are 2013 to 2015, which statutes expire in 2017 to 2019, respectively, under&#13;most cases and subject to appropriate laws and regulations. When and if applicable, potential interest and penalty costs are accrued&#13;as incurred, with expenses recognized in selling, general and administrative expenses in the statements of operations. As of December&#13;31, 2016 and 2015, we had no liability for unrecognized tax benefits.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Earnings Per Share&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Options to purchase approximately&#13;859,000 shares of common stock that were outstanding as of December 31, 2016 were not included in the computation of earnings per&#13;share for the year ended December 31, 2016, as the impact of such shares would be both negligible and anti-dilutive. Options to&#13;purchase approximately 210,000 shares of common stock that were outstanding as of December 31, 2015 were not included in the computation&#13;of earnings per share for the year ended December 31, 2015, as the impact of such shares would be both negligible and anti-dilutive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;New Accounting Pronouncements &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;During May 2014, the FASB issued Accounting Standards&#13;Update (&amp;#8220;ASU&amp;#8221;) No. 2014-09 (&amp;#8220;ASU 2014-09&amp;#8221;), &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;, and several related&#13;updates including ASU No. 2016-08 and ASU No. 2016-10, which supersedes nearly all existing revenue recognition guidance under&#13;U.S. generally accepted accounting principles. The new standard requires a company to recognize revenue when it transfers goods&#13;or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services.&#13;Additionally, the guidance requires certain disclosures designed to help users of financial statements better understand the nature,&#13;amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for annual&#13;reporting periods beginning after December 15, 2017, including interim periods within that reporting period, which is our first&#13;quarter of 2018. The new standard allows application either retrospectively to each prior reporting period presented or retrospectively&#13;as a cumulative-effect adjustment as of the date of adoption. We are evaluating the effect that ASU 2014-09 will have on our financial&#13;statements and related disclosures, but do not expect it to have a material impact on our financial position, results of operations,&#13;or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;During February 2016, the FASB issued ASU No. 2016-02&#13;(&amp;#8220;ASU 2016-02&amp;#8221;), &lt;i&gt;Leases (Topic 842)&lt;/i&gt;. This standard requires the recognition of assets and liabilities arising&#13;from lease transactions on the balance sheet and the disclosure of key information about leasing arrangements. Accordingly, a lessee&#13;will recognize a lease asset for its right to use the underlying asset and a lease liability for the corresponding lease obligation.&#13;Both the asset and liability will initially be measured at the present value of the future minimum lease payments over the lease&#13;term. Subsequent measurement, including the presentation of expenses and cash flows, will depend on the classification of the lease&#13;as either a finance or an operating lease. Initial costs directly attributable to negotiating and arranging the lease will be included&#13;in the asset. For leases with a term of 12 months or less, a lessee can make an accounting policy election by class of underlying&#13;asset to not recognize an asset and corresponding liability. Lessees will also be required to provide additional qualitative and&#13;quantitative disclosures regarding the amount, timing and uncertainty of cash flows arising from leases. These disclosures are&#13;intended to supplement the amounts recorded in the financial statements and provide additional information about the nature of&#13;an organization&amp;#8217;s leasing activities. The amendments in this standard are effective for fiscal years, and interim periods&#13;within those fiscal years, beginning after December 15, 2018, with early adoption permitted. We are currently evaluating the impact&#13;its adoption will have on the presentation of our financial statements and related disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;During August 2014, the FASB issued ASU No. 2014-15,&#13;&lt;i&gt;Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern&lt;/i&gt; (&amp;#8220;ASU 2014-15&amp;#8221;).&#13;ASU 2014-15 will explicitly require management to assess an entity&amp;#8217;s ability to continue as a going concern, and to provide&#13;related footnote disclosure in certain circumstances. The new standard is effective for all entities in the first annual period&#13;ending after December 15, 2016, or January 1, 2017 for us. Earlier adoption was permitted. The adoption did not impact the presentation&#13;of our financial statements, financial position, results of operations, cash flows and related disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;During March 2016, the FASB issued ASU No. 2016-09,&#13;&lt;i&gt;Improvements to Employee Share-Based Payment Accounting&lt;/i&gt;, which amends ASC Topic 718, &lt;i&gt;Compensation - Stock Compensation&lt;/i&gt;.&#13;The objective of this update is part of the FASB&amp;#8217;s Simplification Initiative as it applies to several aspects of the accounting&#13;for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,&#13;and classification on the statement of cash flows. The effective date of the update is for fiscal years beginning after December&#13;15, 2016 and interim periods within that reporting period, or January 1, 2017 for us. Early adoption was permitted. The adoption&#13;did not have a material impact on the presentation of our financial statements, financial position, results of operations, cash&#13;flows and related disclosures.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Use of Estimates and&#13;Risks and Uncertainties&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of financial&#13;statements requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying&#13;notes. Actual results could differ from those estimates. Certain assumptions are also necessary to assess the impact of risks and&#13;uncertainties on the financial statements, such as cash flow projections, availability of capital if needed to support the ongoing&#13;operations of the business, and our expected compliance with contractual commitments. These risks and uncertainties are further&#13;discussed in Note 12. Any changes in these assumptions or business plans could have a material impact on the financial statements.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Cash and cash equivalents primarily&#13;consist of demand deposits, but also include certain lower risk investments with a stated maturity upon acquisition of 90 days&#13;or less (e.g., money market funds or a certificate of deposit with a maturity of 90 days or less at the time of purchase).&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Trade Accounts Receivable&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Trade accounts receivable are&#13;carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts&#13;on a monthly basis. We determine the allowance for doubtful accounts by identifying troubled accounts and by using historical experience&#13;applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts&#13;receivable previously written off are recorded when received. Our typical credit terms are thirty days from shipment and invoicing.&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Inventories&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Inventories are stated at the&#13;lower of cost, maintained on a first in, first out basis, or market. We have recorded allowances to reduce inventory relating to&#13;excess quantities of certain materials. Write-downs of inventories establish a new cost basis, which is not increased for future&#13;increases in market value of inventories or changes in estimated excess quantities.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Equipment and Leasehold&#13;Improvements&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Equipment is stated at cost&#13;and is being depreciated over its estimated useful life (3-20 years) using the straight-line method. Leasehold improvements are&#13;stated at cost and are being amortized using the straight-line method over the shorter of the useful life of the asset or the term&#13;of the lease (3-13 years). Depreciation expense for leased assets is included with depreciation expense for owned assets. From&#13;time to time we have self-constructed assets. These assets are stated at cost plus the capitalization of labor and are depreciated&#13;over an estimated useful life (7-10 years) using the straight-line method.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Long Lived Assets&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We review long-lived assets&#13;for impairment whenever events or changes in circumstances indicate that the asset&amp;#8217;s carrying amount may not be recoverable.&#13;We conduct long-lived asset impairment analyses in accordance with ASC 360-10-15, &lt;i&gt;Impairment or Disposal of Long-Lived Assets&lt;/i&gt;.&#13;ASC 360-10-15 requires us to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent&#13;of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash&#13;flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is&#13;measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis&#13;or appraisals.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:AssetRetirementObligationsPolicy contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Asset Retirement Obligations&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In connection with our leased&#13;facilities, we are required to remove certain leasehold improvements upon termination of our occupancy. We follow the provisions&#13;of the FASB issued ASC 410-20, &lt;i&gt;Asset Retirement Obligations&lt;/i&gt;, under which we recognize a liability for the fair value of&#13;these asset retirement obligations. The fair value of that liability is measured based on an expected cash flow approach and accretion&#13;expense is recognized each period to recognize increases to the fair value of the liability due to the passage of time. Increases&#13;to the fair value of the liability, except for accretion, are added to the carrying value of the long-lived asset. Those increases&#13;are then reported in amortization expense over the estimated useful life of the long-lived asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Activity in the asset retirement&#13;obligation account for the years ended December 31, is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 48%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Balance, beginning&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;172&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;166&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.15in"&gt;Accretion of liability due to passage of time&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2px; padding-left: 0.15in"&gt;Amortization of asset due to passage of time&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2px; border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2px; border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;Balance, ending&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;178&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;172&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AssetRetirementObligationsPolicy>
    <us-gaap:ScheduleOfChangeInAssetRetirementObligationTableTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Activity in the asset retirement&#13;obligation account for the years ended December 31, is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 48%; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;Balance, beginning&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;172&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;166&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.15in"&gt;Accretion of liability due to passage of time&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;6&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2px; padding-left: 0.15in"&gt;Amortization of asset due to passage of time&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2px; border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2px; border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -9pt; padding-left: 9pt"&gt;Balance, ending&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;178&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;172&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfChangeInAssetRetirementObligationTableTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Financial Instruments&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We follow ASC Topic 820, &lt;i&gt;Fair&#13;Value Measurements and Disclosures&lt;/i&gt;, which defines fair value, establishes a framework for measuring fair value, and expands&#13;disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into&#13;three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure&#13;of fair value, whereas Level 3 generally requires significant management judgment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Our financial instruments include&#13;cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with the promissory note with no related&#13;borrowings described in Note 3, and any borrowings on the working capital line of credit described in Note 3. The fair values of&#13;all financial instruments were not materially different from their carrying values.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;There were no financial assets&#13;or liabilities adjusted to fair value on December 31, 2016 and 2015.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Product Revenue &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Product revenue consists of&#13;sales of product that are recognized when realized and earned. This occurs when persuasive evidence of an arrangement exists, title&#13;transfers via shipment of products or when delivery has occurred, the price is fixed or determinable and collectability is reasonably&#13;assured.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:RevenueRecognitionSoftware contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Other Revenue &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Other revenue may include revenue&#13;from technology license fees and paid development projects. Technology license fees and paid development projects are recognized&#13;when earned pursuant to the agreed upon contractual arrangement, when performance obligations are satisfied, the amount is fixed&#13;or determinable, and collectability is reasonably assured.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Shipping and handling costs&#13;are included in other revenue when products are shipped and invoiced to the customer. We include the related cost of shipping and&#13;handling in cost of goods sold.&lt;/p&gt;</us-gaap:RevenueRecognitionSoftware>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Research and Development Expenses&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;Research and development&#13;expenses are recognized as expense when incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Income Taxes &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We account for income taxes&#13;using the liability method. As such, deferred income taxes reflect the net tax effects of temporary differences between the carrying&#13;amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets&#13;and liabilities are calculated using the enacted tax rates and laws that are expected to be in effect when the anticipated reversal&#13;of these differences is scheduled to occur. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,&#13;it is more likely than not that some portion or all of the deferred tax assets will not be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;When tax returns are filed,&#13;it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are&#13;subject to uncertainty about merits of the position taken or the amount of the position that would be ultimately sustained. The&#13;benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence,&#13;management believes it is more likely than not that the position will be sustained upon examination, including the resolution of&#13;appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that&#13;meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent&#13;likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax&#13;positions taken that exceeds the amount measured, as described above, is reflected as a liability for uncertain tax benefits in&#13;the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities&#13;upon examination.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We have not recorded a reserve&#13;for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing&#13;of such deductibility. We file tax returns in all appropriate jurisdictions, which includes a federal tax return and Illinois state&#13;tax return. Open tax years for both jurisdictions are 2013 to 2015, which statutes expire in 2017 to 2019, respectively, under&#13;most cases and subject to appropriate laws and regulations. When and if applicable, potential interest and penalty costs are accrued&#13;as incurred, with expenses recognized in selling, general and administrative expenses in the statements of operations. As of December&#13;31, 2016 and 2015, we had no liability for unrecognized tax benefits.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&lt;font style="font-style: normal"&gt;Earnings Per Share&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Options to purchase approximately&#13;859,000 shares of common stock that were outstanding as of December 31, 2016 were not included in the computation of earnings per&#13;share for the year ended December 31, 2016, as the impact of such shares would be both negligible and anti-dilutive. Options to&#13;purchase approximately 210,000 shares of common stock that were outstanding as of December 31, 2015 were not included in the computation&#13;of earnings per share for the year ended December 31, 2015, as the impact of such shares would be both negligible and anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;New Accounting Pronouncements &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;During May 2014, the FASB issued Accounting Standards&#13;Update (&amp;#8220;ASU&amp;#8221;) No. 2014-09 (&amp;#8220;ASU 2014-09&amp;#8221;), &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;, and several related&#13;updates including ASU No. 2016-08 and ASU No. 2016-10, which supersedes nearly all existing revenue recognition guidance under&#13;U.S. generally accepted accounting principles. The new standard requires a company to recognize revenue when it transfers goods&#13;or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services.&#13;Additionally, the guidance requires certain disclosures designed to help users of financial statements better understand the nature,&#13;amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for annual&#13;reporting periods beginning after December 15, 2017, including interim periods within that reporting period, which is our first&#13;quarter of 2018. The new standard allows application either retrospectively to each prior reporting period presented or retrospectively&#13;as a cumulative-effect adjustment as of the date of adoption. We are evaluating the effect that ASU 2014-09 will have on our financial&#13;statements and related disclosures, but do not expect it to have a material impact on our financial position, results of operations,&#13;or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;During February 2016, the FASB issued ASU No. 2016-02&#13;(&amp;#8220;ASU 2016-02&amp;#8221;), &lt;i&gt;Leases (Topic 842)&lt;/i&gt;. This standard requires the recognition of assets and liabilities arising&#13;from lease transactions on the balance sheet and the disclosure of key information about leasing arrangements. Accordingly, a lessee&#13;will recognize a lease asset for its right to use the underlying asset and a lease liability for the corresponding lease obligation.&#13;Both the asset and liability will initially be measured at the present value of the future minimum lease payments over the lease&#13;term. Subsequent measurement, including the presentation of expenses and cash flows, will depend on the classification of the lease&#13;as either a finance or an operating lease. Initial costs directly attributable to negotiating and arranging the lease will be included&#13;in the asset. For leases with a term of 12 months or less, a lessee can make an accounting policy election by class of underlying&#13;asset to not recognize an asset and corresponding liability. Lessees will also be required to provide additional qualitative and&#13;quantitative disclosures regarding the amount, timing and uncertainty of cash flows arising from leases. These disclosures are&#13;intended to supplement the amounts recorded in the financial statements and provide additional information about the nature of&#13;an organization&amp;#8217;s leasing activities. The amendments in this standard are effective for fiscal years, and interim periods&#13;within those fiscal years, beginning after December 15, 2018, with early adoption permitted. We are currently evaluating the impact&#13;its adoption will have on the presentation of our financial statements and related disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;During August 2014, the FASB issued ASU No. 2014-15,&#13;&lt;i&gt;Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern&lt;/i&gt; (&amp;#8220;ASU 2014-15&amp;#8221;).&#13;ASU 2014-15 will explicitly require management to assess an entity&amp;#8217;s ability to continue as a going concern, and to provide&#13;related footnote disclosure in certain circumstances. The new standard is effective for all entities in the first annual period&#13;ending after December 15, 2016, or January 1, 2017 for us. Earlier adoption was permitted. The adoption did not impact the presentation&#13;of our financial statements, financial position, results of operations, cash flows and related disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"&gt;During March 2016, the FASB issued ASU No. 2016-09,&#13;&lt;i&gt;Improvements to Employee Share-Based Payment Accounting&lt;/i&gt;, which amends ASC Topic 718, &lt;i&gt;Compensation - Stock Compensation&lt;/i&gt;.&#13;The objective of this update is part of the FASB&amp;#8217;s Simplification Initiative as it applies to several aspects of the accounting&#13;for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,&#13;and classification on the statement of cash flows. The effective date of the update is for fiscal years beginning after December&#13;15, 2016 and interim periods within that reporting period, or January 1, 2017 for us. Early adoption was permitted. The adoption&#13;did not have a material impact on the presentation of our financial statements, financial position, results of operations, cash&#13;flows and related disclosures.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;(3)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Note and Line&#13;of Credit&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;During&#13;July 2014 we entered into a bank-issued letter of credit and related promissory note for up to $30 in borrowings to support our&#13;obligations under our facility lease agreement. We then sold our certificates of deposit. No borrowings have been incurred under&#13;this promissory note. Should any borrowings occur in the future, the interest rate would be the prime rate plus 1%, with the bank&#13;having the right to &amp;#8220;set off&amp;#8221; or apply unpaid balances against our checking account if we fail to meet our obligations&#13;under any borrowings under the note. It is our intention to renew this note annually, for as long as we need to pursuant to the&#13;terms of our facility lease agreement. Because there were no amounts outstanding on the note at any time during 2016 or 2015, we&#13;have recorded no related liability on our balance sheet. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During March 2015, we entered&#13;into a Business Loan Agreement (the &amp;#8220;Line of Credit Agreement&amp;#8221;) with Libertyville Bank and Trust Company, a Wintrust&#13;Community Bank (&amp;#8220;Libertyville&amp;#8221;), our primary bank. This Line of Credit Agreement was subsequently amended on April&#13;13, 2015. Under the Line of Credit Agreement, as amended, Libertyville will provide a maximum of $300, or 75% of our eligible accounts&#13;receivable, whichever is less, of revolving credit, collateralized by a senior priority lien on our accounts receivable, inventory,&#13;equipment, general intangibles and fixtures. Interest on any borrowings would be the prime rate at the time plus 1%. Availability&#13;to draw on the line requires us to have at least $1 million in cash, including any amounts borrowed, at Libertyville on the date&#13;of any advance. Advances may only occur at the beginning or end of a fiscal quarter and must be repaid in full within five days&#13;of the advance. The Line of Credit Agreement was to expire on March 4, 2016, but during March 2016 was extended until March 4,&#13;2017. During February 2017, this agreement was further extended to March 2018. No borrowing on this line was outstanding on December&#13;31, 2016.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(4)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Inventories&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventories&#13;consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif; margin-left: 5%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 54%; text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;283&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;184&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;510&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;530&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;793&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;714&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Allowance for excess quantities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(21&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;772&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;662&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventories&#13;consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif; margin-left: 5%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 54%; text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;283&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;184&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;510&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;530&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;793&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;714&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Allowance for excess quantities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(21&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;772&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;662&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(5)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Equipment&#13;and Leasehold Improvements&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Equipment&#13;and leasehold improvements consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif; margin-left: 5%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 64%; text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,587&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,562&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Office equipment&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;790&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;778&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Office furniture&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;110&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;110&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Construction in progress&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18,981&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18,389&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;1,395&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;1,861&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&#13;expense was $605 and $726, for the years ended December 31, 2016 and 2015, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Equipment&#13;and leasehold improvements consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif; margin-left: 5%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 64%; text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,587&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14,562&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Office equipment&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;790&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;778&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Office furniture&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;110&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;110&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Construction in progress&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18,981&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18,389&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;1,395&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;1,861&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">54000</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(7)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Accrued&#13;Expenses&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued&#13;expenses consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 44%; text-align: left"&gt;Accrued payroll and related expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;167&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Customer net volume rebate payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;201&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;153&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;168&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;521&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;276&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued&#13;expenses consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 44%; text-align: left"&gt;Accrued payroll and related expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;167&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Customer net volume rebate payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;201&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;153&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;168&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;521&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; text-align: right"&gt;276&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(9)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Capital&#13;Stock&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of December 31, 2016 and 2015, we had 24,088 authorized but unissued shares of preferred stock. In addition, as of December 31,&#13;2016, 1,196,000 authorized but unissued shares of common stock have been reserved for future issuance upon exercise of stock options.&#13;During August 2016, our stockholders authorized an additional 7,000,000 shares of common stock, increasing our authorized shares&#13;of common stock from 35,000,000 to 42,000,000 authorized shares. Our stockholders also authorized an additional 1,200,000 shares&#13;of common stock that may be issued pursuant to our 2010 Equity Compensation Plan.&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(10)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Stock&#13;Options and Stock Grants&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;have entered into stock option agreements with certain officers, employees and directors. The stock options generally expire ten&#13;years from the date of grant.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Employee&#13;Stock Options&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: italic 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.1pt"&gt;We&#13;follow &lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;FASB ASC Topic 718&lt;font style="letter-spacing: -0.1pt"&gt;,&#13;&lt;i&gt;Share-Based Payments&lt;/i&gt;, in which compensation expense is recognized only for share-based payments expected to vest. We recognized&#13;compensation expense related to stock options of &lt;/font&gt;$207 and $181 for the years ended December 31, 2016 and 2015, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt; letter-spacing: -0.1pt"&gt;As&#13;of December 31, 2016, there was approximately $183 of total unrecognized compensation cost related to nonvested share-based compensation&#13;arrangements granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period&#13;of 1.7 years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt; letter-spacing: -0.1pt"&gt;The&#13;following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for options granted&#13;for all years presented:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 9pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Years Ended December&#13;    31,&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;2016&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;2015&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 48%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average risk-free interest&#13;    rates:&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.5&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.7&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield:&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average expected life of the option:&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7 years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7 years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average expected stock price volatility:&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;95&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;95&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average fair value of the options&#13;    granted:&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.36&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.36&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-size: 10pt; letter-spacing: -0.1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;We&#13;use the Black&amp;#8722;Scholes option pricing model to determine the fair value of stock based compensation. The Black&amp;#8722;Scholes&#13;model requires us to make several assumptions, including the estimated length of time employees will retain their vested stock&#13;options before exercising them (&amp;#8220;expected term&amp;#8221;), the estimated volatility of our common stock price over the expected&#13;term and estimated forfeitures. Expected price volatility of the fiscal 2016 and 2015 grants is based on the daily market rate&#13;changes of our stock going back to January 1, 2008. The shares granted in fiscal 2016 and 2015 had a vesting period of three years&#13;and a contractual life of 10 years. Forfeitures were estimated at 4% and 4% for the years ended December 31, 2016 and 2015, based&#13;on our historical experience. The Black&amp;#8722;Scholes model also requires a risk free interest rate, which is based on the U.S.&#13;Treasury yield curve in effect at the time of the grant, and the dividend yield on our common stock, which is assumed to be zero&#13;since we do not pay dividends and have no current plans to do so in the future. Changes in these assumptions can materially affect&#13;the estimate of fair value of stock based compensation and consequently, the related expense recognized on the statement of operations.&#13;We recognize stock based compensation expense on a straight-line basis.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;The&#13;following table summarizes the option activity for our employees and directors during the year ended December 31, 2016:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; vertical-align: bottom"&gt;(rounded)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;Weighted Average Exercise Price per &lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;Weighted Average Remaining Contractual Term &lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;Aggregate Intrinsic &lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;(years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 40%"&gt;Outstanding on January 1, 2016&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;2,574,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;0.95&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;508,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(44,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(105,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3.08&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding on December 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,933,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.81&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.3&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;616&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable on December 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,053,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.96&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.3&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;378&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Shares available for grant&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,196,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;The&#13;aggregate intrinsic value in the table above is based on our closing stock price of $0.72 on the last business day for the year&#13;ended December 31, 2016.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;During&#13;the years ended December 31, 2016 and 2015, the total intrinsic value of our stock options exercised was $19 and $10, respectively.&#13;Cash received for option exercises was $18 and $26 during the years ended December 31, 2016 and 2015, respectively. We had approximately&#13;44,000 options exercised during the year ended December 31, 2016, compared to 69,000 in 2015. Based on our election of the &amp;#8220;with&#13;and without&amp;#8221; approach, no realized tax benefits from stock options were recognized for the years ended December 31, 2016&#13;and 2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-size: 10pt; letter-spacing: -0.1pt"&gt;Stock&#13;Appreciation Rights&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Prior&#13;to 2011, we granted our Outside Directors stock appreciation rights (SARs) under our Amended and Restated 2006 Stock Appreciation&#13;Rights Plan and subsequently under our 2010 Equity Plan. The change in fair value of the awards granted during prior years was&#13;included in non-cash compensation expense for the years ended December 31, 2016 and 2015. The SARs granted vested immediately&#13;and were payable upon the directors&amp;#8217; removal or resignation from the position of director. These awards were accounted for&#13;as liability awards, included in accrued expenses as of December 31, 2015, and adjusted to fair value each reporting period. The&#13;fair value of the liability on December 31, 2016 and 2015 was zero. During November 2016, all vested SARs were terminated. Those&#13;Outside Directors whose vested SARs were cancelled received immediately vested options in the same quantity, and at the same strike&#13;price, as their cancelled SARs. The options granted are included in the above chart. We have no remaining SARs outstanding.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Restricted&#13;Stock&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;As&#13;of both December 31, 2016 and 2015, we did not have any unvested non-director restricted stock or performance shares outstanding.&lt;/font&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt; letter-spacing: -0.1pt"&gt;The&#13;following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for options granted&#13;for all years presented:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 9pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Years Ended December&#13;    31,&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;2016&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font-size: 10pt"&gt;2015&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 48%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average risk-free interest&#13;    rates:&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.5&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.7&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield:&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average expected life of the option:&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7 years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7 years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average expected stock price volatility:&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;95&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;95&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average fair value of the options&#13;    granted:&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.36&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.36&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;The&#13;following table summarizes the option activity for our employees and directors during the year ended December 31, 2016:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; vertical-align: bottom"&gt;(rounded)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;Weighted Average Exercise Price per &lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;Weighted Average Remaining Contractual Term &lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;Aggregate Intrinsic &lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;(years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 40%"&gt;Outstanding on January 1, 2016&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;2,574,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;0.95&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;508,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(44,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(105,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3.08&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding on December 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,933,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.81&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.3&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;616&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable on December 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,053,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.96&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.3&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;378&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Shares available for grant&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,196,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;(11)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;401(k)&#13;Profit-Sharing Plan&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;We&#13;have a 401(k) profit-sharing plan covering substantially all employees who meet defined service requirements. We have made in&#13;the past, and may make in the future, maximum contributions of 100% of the first 3% and 50% of the next 2% of the participant&amp;#8217;s&#13;salary. We made changes to our benefits program and, as part of those changes, discontinued these Company contributions effective&#13;January 2014, which resulted in no contributions made during 2016 or 2015. During 2017, we implemented a new Company contribution&#13;program, in which 10% of the employee&amp;#8217;s contribution will be matched up to an 8% contribution (for a match of up to 0.8%&#13;of a participant&amp;#8217;s salary).&lt;/font&gt;&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;(12)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Significant&#13;Customers and Contingencies&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Revenue&#13;from three customers constituted approximately 69%, 5% and 4%, respectively, of our 2016 revenue. Amounts included in accounts&#13;receivable on December 31, 2016 relating to these three customers were approximately none, $39 and $180, respectively. Revenue&#13;from these three customers constituted approximately 63%, 4% and 7%, respectively, of our 2015 revenue. Amounts included in accounts&#13;receivable on December 31, 2015 relating to these three customers were approximately none, $35 and $240, respectively. The loss&#13;of one of these significant customers or the failure to attract new customers could have a material adverse effect on our business,&#13;results of operations and financial condition.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;We&#13;currently have exclusive supply agreements with BASF Corporation (&amp;#8220;BASF&amp;#8221;), our largest customer, that have contingencies&#13;outlined which could potentially result in the license of technology and/or the sale of production equipment from the Company&#13;to the customer intended to provide capacity sufficient to meet the customer&amp;#8217;s production needs. This outcome may occur&#13;if we fail to meet certain performance requirements, certain other obligations and/or certain financial condition covenants. The&#13;financial condition covenants in one of our supply agreements with BASF &amp;#8220;trigger&amp;#8221; a technology transfer right (license&#13;and equipment sale at BASF&amp;#8217;s option) in the event (a) that earnings for the twelve month period ending with our most recently&#13;published quarterly financial statements are less than zero and our cash, cash equivalents and certain investments are less than&#13;$1 million, or (b) of an acceleration of any debt maturity having a principal amount of more than $10 million. Our supply agreements&#13;with BASF also &amp;#8220;trigger&amp;#8221; a technology transfer right in the event of our insolvency, as further defined within the&#13;agreements. In the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer&#13;at either 115% of the equipment&amp;#8217;s net book value or the greater of 30% of the original book value of such equipment, and&#13;any associated upgrades to it, or 115% of the equipment&amp;#8217;s net book value, depending on the equipment and related products.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;We&#13;believe that we have sufficient cash and credit availability, (See Liquidity and Capital Resources in Management&amp;#8217;s Discussion&#13;and Analysis in Part II, Item 7 of this Form 10-K for a further discussion, as well as the description of our Line of Credit Agreement&#13;described in Note 3&lt;b&gt;) &lt;/b&gt;to operate our business during 2017. If a triggering event were to occur and BASF elected to proceed&#13;with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products&#13;sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to&#13;replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer&#13;pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity&#13;would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar&#13;consequences would occur if we were determined to have materially breached certain other provisions of the supply agreement with&#13;BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities.&#13;We believe that our employees are a critical component of our success and could be difficult to replace them quickly. Given the&#13;occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event&#13;and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including with respect&#13;to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated investments.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Should&#13;events arise that make it appropriate for us to seek additional financing, such additional financing may not be available on acceptable&#13;terms or even at all, and any such financing could be dilutive to our stockholders. Such a financing could be necessitated by&#13;such things as the loss of one or more significant customers or a significant decline in revenue from those customers, currently&#13;unknown capital requirements, new regulatory requirements, the need to meet cash requirements under our BASF agreement to avoid&#13;a triggering event, or other circumstances not currently anticipated by us. The failure to obtain sufficient capital may impair&#13;or curtail our business plans and under such circumstances may raise doubt regarding our ability to continue as a going concern.&lt;/font&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"&gt;&lt;font style="font-size: 10pt; text-transform: none"&gt;&lt;b&gt;(13)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Business&#13;Segmentation and Geographical Distribution&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Revenue&#13;from international sources approximated $1,039 and $1,393 for the years ended December 31, 2016 and 2015, respectively. &lt;font style="letter-spacing: -0.1pt"&gt;As&#13;part of our revenue from international sources, we recognized approximately $902 and $1,339 in product revenue from a number of&#13;German companies, in the aggregate, for the years ended December 31, 2016 and 2015, respectively.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt; font-weight: normal; text-transform: none"&gt;Our&#13;operations comprise a single business segment and all of our long-lived assets are located within the United States.&lt;/font&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2017-01-01to2017-01-31_us-gaap_SubsequentEventMember" unitRef="USD" decimals="-3">100000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <nanx:PaymentToRetireCapitalLease contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="-3">85000</nanx:PaymentToRetireCapitalLease>
    <nanx:PaymentToRetireCapitalLease contextRef="From2016-01-01to2016-12-31" unitRef="USD" decimals="-3">96000</nanx:PaymentToRetireCapitalLease>
    <nanx:PaymentToRetireCapitalLease contextRef="From2017-01-01to2017-01-31_us-gaap_SubsequentEventMember" unitRef="USD" decimals="-3">60000</nanx:PaymentToRetireCapitalLease>
    <us-gaap:LeasesOfLesseeDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(6)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Lease&#13;Commitments &amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;lease our operating facilities under operating leases. During October 2016 we entered into a Third Lease Amendment related to&#13;our primary facility in Romeoville, Illinois, extending the term of the lease through December 31, 2024. The current monthly rent&#13;on this lease amounts to $25.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;We&#13;lease our Burr Ridge, Illinois, facility under an agreement extended during September 2010, which extended the term through September&#13;2014 (we have since exercised our final tenant option to extend the term through September 2017). During March 2017, we entered&#13;into a new Building Lease for this facility that will begin September 2017 and extend through September 2021, with our having&#13;the option to further extend this lease by three additional one-year periods. The current monthly rent on this lease amounts to&#13;$15. During 2016 we also renewed our lease for our offsite warehouse in Romeoville, Illinois, through August 2019. The current&#13;monthly rent on this lease amounts to $5.&amp;#160;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following is a schedule of future minimum lease payments including real estate taxes as required under the above operating leases,&#13;as well as the remaining lease payments under capital leases as referenced below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="margin-left: 1in; border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;Year ending December 31:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;Operating&lt;br /&gt;&#13; Leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;Capital&lt;br /&gt;&#13; Leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 54%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;698&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;58&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;700&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;691&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;34&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;589&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;554&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;15&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,289&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Total minimum payments required:&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,521&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif"&gt;*&lt;/td&gt;&lt;td style="padding-bottom: 2pt; border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;170&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;*&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;br /&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;*&#13;After paying $60 to retire a capital lease during January 2017, the remaining payments under capital leases include principal&#13;of $147 and interest of $23. Also, includes future payments of the Burr Ridge Building Lease executed March 2017 as described&#13;above.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Rent&#13;expense, including real estate taxes, under these leases amounted to $597 and $588, for the years ended December 31, 2016 and&#13;2015, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&#13;On December 31, 2016 equipment under capital leases had a cost of $362 with accumulated depreciation of $62, compared to $316&#13;and $29, respectively, on December 31, 2015. Principal and interest payments are due monthly under the capital lease&#13;obligations through October 2020. We entered into one new capital lease during 2016 for $75 and a 5-year duration (through&#13;August 2021), and recognized an impairment charge, reducing the value of two other pieces of capital equipment by $54 in&#13;aggregate. We entered into three new capital leases during 2015 for $132 and 3 to 5 year durations (through August&#13;2020).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:LeasesOfLesseeDisclosureTextBlock>
    <nanx:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following is a schedule of future minimum lease payments including real estate taxes as required under the above operating leases,&#13;as well as the remaining lease payments under capital leases as referenced below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="margin-left: 1in; border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;Year ending December 31:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;Operating&lt;br /&gt;&#13; Leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;Capital&lt;br /&gt;&#13; Leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 54%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;698&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;58&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;700&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;691&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;34&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;589&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;554&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;15&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,289&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Total minimum payments required:&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,521&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif"&gt;*&lt;/td&gt;&lt;td style="padding-bottom: 2pt; border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;170&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;*&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;br /&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;*&#13;After paying $60 to retire a capital lease during January 2017, the remaining payments under capital leases include principal&#13;of $147 and interest of $23. Also, includes future payments of the Burr Ridge Building Lease executed March 2017 as described&#13;above.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</nanx:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2016-12-31" unitRef="USD" id="Foot-00-1" decimals="-3">4521000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(8)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income&#13;Taxes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Our&#13;net income tax provision, including both current and deferred, related to U.S. federal and state income taxes, is none.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;reconciliation of income tax expense to the amount computed by applying the Federal income tax rate to loss before provision for&#13;income taxes as of December 31, 2016 and 2015 is as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in"&gt;&#13;&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 44%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Income tax credit at statutory rates&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(436&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(405&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Nondeductible expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;State income tax, net of federal benefits&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(66&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(61&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;144&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;Increase in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;356&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;466&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred&#13;income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial&#13;reporting purposes and the amounts used for income tax purposes. Significant components of our deferred income taxes consist of&#13;the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in"&gt;&#13;&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 44%; text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Net operating loss carryforwards&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;31,935&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;31,590&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Inventory and other allowances&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;16&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;28&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Charitable contribution carryforwards&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Excess (tax) book depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;805&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;709&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Excess (tax) book amortization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;69&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;67&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Share-based compensation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;1,328&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;1,396&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Other accrued costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;219&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;225&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;34,377&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;34,021&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Less: Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(34,377&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(34,021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;Deferred income taxes&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;valuation allowance increased approximately $0.4 million and $0.5 million for the years ended December 31, 2016 and 2015, respectively&#13;(with no expiring net operating loss carryforwards and credits for either period; a portion of the charitable contribution carryforward&#13;expired during 2016) due principally to the change in the net operating loss carryforward and uncertainty as to whether future&#13;taxable income will be generated prior to the expiration of the carryforward period. Under the Internal Revenue Code, certain&#13;ownership changes, including the prior issuance of preferred stock and our public offering of common stock, may subject us to&#13;annual limitations on the utilization of our net operating loss carryforward. As of December 31, 2016, the amounts subject to&#13;limitations has not yet been determined.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;We&#13;have net operating loss carryforwards for tax purposes of approximately $82 million on December 31, 2016, which expire between&#13;2018 and 2036.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;2011, the state of Illinois suspended the use of net operating loss carryforwards for a four year period beginning 2011, extending&#13;the term of all net loss carryforwards by a corresponding four years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;reconciliation of income tax expense to the amount computed by applying the Federal income tax rate to loss before provision for&#13;income taxes as of December 31, 2016 and 2015 is as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in"&gt;&#13;&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 44%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Income tax credit at statutory rates&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(436&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(405&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Nondeductible expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;State income tax, net of federal benefits&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(66&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(61&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;144&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;Increase in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;356&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;466&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred&#13;income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial&#13;reporting purposes and the amounts used for income tax purposes. Significant components of our deferred income taxes consist of&#13;the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in"&gt;&#13;&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;2015&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 44%; text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Net operating loss carryforwards&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;31,935&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;31,590&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Inventory and other allowances&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;16&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;28&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Charitable contribution carryforwards&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Excess (tax) book depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;805&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;709&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Excess (tax) book amortization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;69&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;67&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Share-based compensation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;1,328&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;1,396&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Other accrued costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;219&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;225&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;34,377&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;34,021&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"&gt;Less: Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(34,377&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(34,021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;Deferred income taxes&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2016-01-01to2016-12-31">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"&gt;&lt;font style="font-size: 10pt; text-transform: none"&gt;&lt;b&gt;(14)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#13;&amp;#160;Subsequent Events&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;As&#13;discussed in Note 3, the Line of Credit Agreement with our primary bank (Libertyville) was to expire on March 4, 2017, but during&#13;February 2017 this agreement was further extended to March 2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As discussed in Note&#13;6, during March 2017 we entered into a new Building Lease for our Burr Ridge facility. The previous lease expires September 2017,&#13;at which time this new lease will begin, and extend through September 2021. We have the option to further extend this lease by&#13;up to three additional one year periods.&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;As&#13;discussed in Note 6, during January 2017 we paid $60 to retire  a capital lease related to equipment that we sold to a third&#13;party for $100, its remaining book value. No gain or loss was recognized during 2017 associated with the transaction.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">After paying $60 to retire a capital lease during January 2017, the remaining payments under capital leases include principal of $147 and interest of $23.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>nanx-20161231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: P:\EDGARizer\Clients\Nanophase Technologies\Xbrl\20161231\nanx_123116.xfr; Date: 2017%2D03%2D29T13:48:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSaWD2bP9w5dzCelBtm94HekqTy4rSM3awSkxuHbGcdcO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:nanx="http://nanophase.com/20161231" elementFormDefault="qualified" targetNamespace="http://nanophase.com/20161231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" id="DocumentandEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - STATEMENTS OF OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/StatementsOfStockholdersEquity" id="StatementsOfStockholdersEquity">
	  <link:definition>00000005 - Statement - STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" id="NotesToFinancialStatementsNatureOfOperations">
	  <link:definition>00000007 - Disclosure - Description of Business</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/NoteAndLineOfCredit" id="NoteAndLineOfCredit">
	  <link:definition>00000009 - Disclosure - Note and Line of Credit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" id="NotesToFinancialStatementsInventoryDisclosureTextBlock">
	  <link:definition>00000010 - Disclosure - Inventories</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovements" id="EquipmentAndLeaseholdImprovements">
	  <link:definition>00000011 - Disclosure - Equipment and Leasehold Improvements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/LeaseCommitments" id="LeaseCommitments">
	  <link:definition>00000012 - Disclosure - Lease Commitments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/AccruedExpenses" id="AccruedExpenses">
	  <link:definition>00000013 - Disclosure - Accrued Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000014 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/CapitalStock" id="CapitalStock">
	  <link:definition>00000015 - Disclosure - Capital Stock</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/StockOptionsAndStockGrants" id="StockOptionsAndStockGrants">
	  <link:definition>00000016 - Disclosure - Stock Options and Stock Grants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/KProfit-sharingPlan" id="KProfit-sharingPlan">
	  <link:definition>00000017 - Disclosure - 401(k) Profit-Sharing Plan</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" id="NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock">
	  <link:definition>00000018 - Disclosure - Significant Customers and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" id="NotesToFinancialStatementsSegmentReportingDisclosureTextBlock">
	  <link:definition>00000019 - Disclosure - Business Segmentation and Geographical Distribution</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000020 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000021 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000022 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" id="NotesToFinancialStatementsInventoryDisclosureTextBlockTables">
	  <link:definition>00000023 - Disclosure - Inventories (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables" id="EquipmentAndLeaseholdImprovementsTables">
	  <link:definition>00000024 - Disclosure - Equipment and Leasehold Improvements (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/LeaseCommitmentsTables" id="LeaseCommitmentsTables">
	  <link:definition>00000025 - Disclosure - Lease Commitments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
	  <link:definition>00000026 - Disclosure - Accrued Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000027 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsTables" id="StockOptionsAndStockGrantsTables">
	  <link:definition>00000028 - Disclosure - Stock Options and Stock Grants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails">
	  <link:definition>00000030 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/NoteAndLineOfCreditDetailNarratives" id="NoteAndLineOfCreditDetailNarratives">
	  <link:definition>00000031 - Disclosure - Note and Line of Credit (Detail Narratives)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/InventoriesDetails" id="InventoriesDetails">
	  <link:definition>00000032 - Disclosure - Inventories (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetailsNarrative" id="EquipmentAndLeaseholdImprovementsDetailsNarrative">
	  <link:definition>00000033 - Disclosure - Equipment and Leasehold Improvements (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetails" id="EquipmentAndLeaseholdImprovementsDetails">
	  <link:definition>00000034 - Disclosure - Equipment and Leasehold Improvements (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/LeaseCommitmentsDetailsNarrative" id="LeaseCommitmentsDetailsNarrative">
	  <link:definition>00000035 - Disclosure - Lease Commitments (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/LeaseCommitmentsDetails" id="LeaseCommitmentsDetails">
	  <link:definition>00000036 - Disclosure - Lease Commitments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
	  <link:definition>00000037 - Disclosure - Accrued Expenses (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000038 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
	  <link:definition>00000039 - Disclosure - Income Taxes (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
	  <link:definition>00000040 - Disclosure - Income Taxes (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/CapitalStockDetailsNarrative" id="CapitalStockDetailsNarrative">
	  <link:definition>00000041 - Disclosure - Capital Stock (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetailNarratives" id="StockOptionsAndStockGrantsDetailNarratives">
	  <link:definition>00000042 - Disclosure - Stock Options and Stock Grants (Detail Narratives)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetails" id="StockOptionsAndStockGrantsDetails">
	  <link:definition>00000043 - Disclosure - Stock Options and Stock Grants (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetails1" id="StockOptionsAndStockGrantsDetails1">
	  <link:definition>00000044 - Disclosure - Stock Options and Stock Grants (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/KProfit-sharingPlanDetailsNarrative" id="KProfit-sharingPlanDetailsNarrative">
	  <link:definition>00000045 - Disclosure - 401(k) Profit-Sharing Plan (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" id="SignificantCustomersAndContingenciesDetailNarratives">
	  <link:definition>00000046 - Disclosure - Significant Customers and Contingencies (Detail Narratives)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" id="DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation">
	  <link:definition>00000047 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000048 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="nanx-20161231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nanx-20161231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nanx-20161231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nanx-20161231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2016-01-31" schemaLocation="http://xbrl.sec.gov/currency/2016/currency-2016-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />
    <element id="nanx_MajorCustomersNumberOfCustomers" name="MajorCustomersNumberOfCustomers" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" name="LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades" name="EquipmentSaleNetBookValueEquipmentAndUpgrades" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_EquipmentSaleNetBookValueEquipment" name="EquipmentSaleNetBookValueEquipment" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" name="EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_PrincipalAmountDebtAcceleratedMaturity" name="PrincipalAmountDebtAcceleratedMaturity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_OpenTaxYearExpirationPeriod" name="OpenTaxYearExpirationPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_OperatingLeaseNumberOfRenewals" name="OperatingLeaseNumberOfRenewals" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_NumberOfCapitalLeases" name="NumberOfCapitalLeases" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract" name="LesseeLeasingArrangementsCapitalLeasesTermOfContract" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_OperatingLossCarryforwardsExpirationYearStart" name="OperatingLossCarryforwardsExpirationYearStart" nillable="true" xbrli:periodType="duration" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_OperatingLossCarryforwardsExpirationYearEnd" name="OperatingLossCarryforwardsExpirationYearEnd" nillable="true" xbrli:periodType="duration" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards" name="PeriodForSuspensionOfNetOperatingLossCarryforwards" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_ExtensionOfTermOfNetLossCarryforwards" name="ExtensionOfTermOfNetLossCarryforwards" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_CashAndCashEquivalentsMaturityPeriodDescription" name="CashAndCashEquivalentsMaturityPeriodDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_AccountsReceivablesCreditPeriod" name="AccountsReceivablesCreditPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_IncomeTaxRecognitionThresholdPercentage" name="IncomeTaxRecognitionThresholdPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal" name="CapitalLeasesFutureMinimumPaymentsDuePrincipal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_CustomerNetVolumeRebatePayable" name="CustomerNetVolumeRebatePayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_AddtionalSharesAuthorizedDuringPeriod" name="AddtionalSharesAuthorizedDuringPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" name="DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" name="DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" name="DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" name="DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_DefinedContributionPlanEmployerMatchingContributionAmount" name="DefinedContributionPlanEmployerMatchingContributionAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_PaymentToRetireCapitalLease" name="PaymentToRetireCapitalLease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" name="ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_CustomersThreeMember" name="CustomersThreeMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_CustomersTwoMember" name="CustomersTwoMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_CustomersOneMember" name="CustomersOneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_OffsiteWarehouseMember" name="OffsiteWarehouseMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_RomeovilleIllinoisMember" name="RomeovilleIllinoisMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_BurrRidgeFacilityMember" name="BurrRidgeFacilityMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_AccountingPoliciesTable" name="AccountingPoliciesTable" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" />
    <element id="nanx_AccountingPoliciesLineItems" name="AccountingPoliciesLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_StockOptionsAbstract" name="StockOptionsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_WeightedAverageExercisePriceAbstract" name="WeightedAverageExercisePriceAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_AggregateIntrinsicValueAbstract" name="AggregateIntrinsicValueAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>nanx-20161231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: P:\EDGARizer\Clients\Nanophase Technologies\Xbrl\20161231\nanx_123116.xfr; Date: 2017%2D03%2D29T13:48:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:href="nanx-20161231.xsd#DocumentandEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/BalanceSheets" xlink:href="nanx-20161231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/BalanceSheetsParenthetical" xlink:href="nanx-20161231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StatementsOfOperations" xlink:href="nanx-20161231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StatementsOfStockholdersEquity" xlink:href="nanx-20161231.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StatementsOfCashFlows" xlink:href="nanx-20161231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NoteAndLineOfCredit" xlink:href="nanx-20161231.xsd#NoteAndLineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovements" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitments" xlink:href="nanx-20161231.xsd#LeaseCommitments" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/AccruedExpenses" xlink:href="nanx-20161231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxes" xlink:href="nanx-20161231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/CapitalStock" xlink:href="nanx-20161231.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrants" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrants" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/KProfit-sharingPlan" xlink:href="nanx-20161231.xsd#KProfit-sharingPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SubsequentEvents" xlink:href="nanx-20161231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitmentsTables" xlink:href="nanx-20161231.xsd#LeaseCommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/AccruedExpensesTables" xlink:href="nanx-20161231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesTables" xlink:href="nanx-20161231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsTables" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NoteAndLineOfCreditDetailNarratives" xlink:href="nanx-20161231.xsd#NoteAndLineOfCreditDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/InventoriesDetails" xlink:href="nanx-20161231.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetails" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitmentsDetailsNarrative" xlink:href="nanx-20161231.xsd#LeaseCommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitmentsDetails" xlink:href="nanx-20161231.xsd#LeaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/AccruedExpensesDetails" xlink:href="nanx-20161231.xsd#AccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesDetailsNarrative" xlink:href="nanx-20161231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesDetails" xlink:href="nanx-20161231.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesDetails1" xlink:href="nanx-20161231.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/CapitalStockDetailsNarrative" xlink:href="nanx-20161231.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetailNarratives" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetails" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetails1" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/KProfit-sharingPlanDetailsNarrative" xlink:href="nanx-20161231.xsd#KProfit-sharingPlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:href="nanx-20161231.xsd#SignificantCustomersAndContingenciesDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:href="nanx-20161231.xsd#DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SubsequentEventsDetailsNarrative" xlink:href="nanx-20161231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/BalanceSheets" xlink:title="00000002 - Statement - BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapCapitalLeaseObligationsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapCapitalLeaseObligationsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaapCapitalLeaseObligationsNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapCapitalLeaseObligationsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaapDeferredRentCreditNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRentCreditNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="loc_us-gaapAssetRetirementObligationsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapAssetRetirementObligationsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapSalesRevenueNet" xlink:to="loc_us-gaapSalesRevenueGoodsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaapOtherSalesRevenueNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapSalesRevenueNet" xlink:to="loc_us-gaapOtherSalesRevenueNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - STATEMENTS OF STOCKHOLDERS' EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaapRepaymentsOfLongTermCapitalLeaseObligations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapRepaymentsOfLongTermCapitalLeaseObligations" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:title="00000007 - Disclosure - Description of Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NoteAndLineOfCredit" xlink:title="00000009 - Disclosure - Note and Line of Credit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:title="00000010 - Disclosure - Inventories" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovements" xlink:title="00000011 - Disclosure - Equipment and Leasehold Improvements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitments" xlink:title="00000012 - Disclosure - Lease Commitments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/AccruedExpenses" xlink:title="00000013 - Disclosure - Accrued Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxes" xlink:title="00000014 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/CapitalStock" xlink:title="00000015 - Disclosure - Capital Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrants" xlink:title="00000016 - Disclosure - Stock Options and Stock Grants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/KProfit-sharingPlan" xlink:title="00000017 - Disclosure - 401(k) Profit-Sharing Plan" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:title="00000018 - Disclosure - Significant Customers and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:title="00000019 - Disclosure - Business Segmentation and Geographical Distribution" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SubsequentEvents" xlink:title="00000020 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000022 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:title="00000023 - Disclosure - Inventories (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables" xlink:title="00000024 - Disclosure - Equipment and Leasehold Improvements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitmentsTables" xlink:title="00000025 - Disclosure - Lease Commitments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/AccruedExpensesTables" xlink:title="00000026 - Disclosure - Accrued Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesTables" xlink:title="00000027 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsTables" xlink:title="00000028 - Disclosure - Stock Options and Stock Grants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000030 - Disclosure - Summary of Significant Accounting Policies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NoteAndLineOfCreditDetailNarratives" xlink:title="00000031 - Disclosure - Note and Line of Credit (Detail Narratives)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/InventoriesDetails" xlink:title="00000032 - Disclosure - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryGross" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryGross" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000033 - Disclosure - Equipment and Leasehold Improvements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetails" xlink:title="00000034 - Disclosure - Equipment and Leasehold Improvements (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitmentsDetailsNarrative" xlink:title="00000035 - Disclosure - Lease Commitments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitmentsDetails" xlink:title="00000036 - Disclosure - Lease Commitments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueThereafter" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/AccruedExpensesDetails" xlink:title="00000037 - Disclosure - Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomerNetVolumeRebatePayable" xlink:label="loc_nanxCustomerNetVolumeRebatePayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_nanxCustomerNetVolumeRebatePayable" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000038 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesDetails" xlink:title="00000039 - Disclosure - Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesDetails1" xlink:title="00000040 - Disclosure - Income Taxes (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsCharitableContributionCarryforwards" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/CapitalStockDetailsNarrative" xlink:title="00000041 - Disclosure - Capital Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsDetailNarratives" xlink:title="00000042 - Disclosure - Stock Options and Stock Grants (Detail Narratives)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsDetails" xlink:title="00000043 - Disclosure - Stock Options and Stock Grants (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsDetails1" xlink:title="00000044 - Disclosure - Stock Options and Stock Grants (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/KProfit-sharingPlanDetailsNarrative" xlink:title="00000045 - Disclosure - 401(k) Profit-Sharing Plan (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:title="00000046 - Disclosure - Significant Customers and Contingencies (Detail Narratives)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:title="00000047 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000048 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>nanx-20161231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: P:\EDGARizer\Clients\Nanophase Technologies\Xbrl\20161231\nanx_123116.xfr; Date: 2017%2D03%2D29T13:48:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:href="nanx-20161231.xsd#DocumentandEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/BalanceSheets" xlink:href="nanx-20161231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/BalanceSheetsParenthetical" xlink:href="nanx-20161231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StatementsOfOperations" xlink:href="nanx-20161231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StatementsOfStockholdersEquity" xlink:href="nanx-20161231.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StatementsOfCashFlows" xlink:href="nanx-20161231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NoteAndLineOfCredit" xlink:href="nanx-20161231.xsd#NoteAndLineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovements" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitments" xlink:href="nanx-20161231.xsd#LeaseCommitments" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/AccruedExpenses" xlink:href="nanx-20161231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxes" xlink:href="nanx-20161231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/CapitalStock" xlink:href="nanx-20161231.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrants" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrants" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/KProfit-sharingPlan" xlink:href="nanx-20161231.xsd#KProfit-sharingPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SubsequentEvents" xlink:href="nanx-20161231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitmentsTables" xlink:href="nanx-20161231.xsd#LeaseCommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/AccruedExpensesTables" xlink:href="nanx-20161231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesTables" xlink:href="nanx-20161231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsTables" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NoteAndLineOfCreditDetailNarratives" xlink:href="nanx-20161231.xsd#NoteAndLineOfCreditDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/InventoriesDetails" xlink:href="nanx-20161231.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetails" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitmentsDetailsNarrative" xlink:href="nanx-20161231.xsd#LeaseCommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitmentsDetails" xlink:href="nanx-20161231.xsd#LeaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/AccruedExpensesDetails" xlink:href="nanx-20161231.xsd#AccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesDetailsNarrative" xlink:href="nanx-20161231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesDetails" xlink:href="nanx-20161231.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesDetails1" xlink:href="nanx-20161231.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/CapitalStockDetailsNarrative" xlink:href="nanx-20161231.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetailNarratives" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetails" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetails1" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/KProfit-sharingPlanDetailsNarrative" xlink:href="nanx-20161231.xsd#KProfit-sharingPlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:href="nanx-20161231.xsd#SignificantCustomersAndContingenciesDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:href="nanx-20161231.xsd#DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SubsequentEventsDetailsNarrative" xlink:href="nanx-20161231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/BalanceSheets" xlink:title="00000002 - Statement - BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - BALANCE SHEETS (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - STATEMENTS OF OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - STATEMENTS OF STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:title="00000007 - Disclosure - Description of Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/NoteAndLineOfCredit" xlink:title="00000009 - Disclosure - Note and Line of Credit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:title="00000010 - Disclosure - Inventories" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovements" xlink:title="00000011 - Disclosure - Equipment and Leasehold Improvements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitments" xlink:title="00000012 - Disclosure - Lease Commitments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/AccruedExpenses" xlink:title="00000013 - Disclosure - Accrued Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxes" xlink:title="00000014 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/CapitalStock" xlink:title="00000015 - Disclosure - Capital Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrants" xlink:title="00000016 - Disclosure - Stock Options and Stock Grants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/KProfit-sharingPlan" xlink:title="00000017 - Disclosure - 401(k) Profit-Sharing Plan" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:title="00000018 - Disclosure - Significant Customers and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:title="00000019 - Disclosure - Business Segmentation and Geographical Distribution" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/SubsequentEvents" xlink:title="00000020 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000022 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:title="00000023 - Disclosure - Inventories (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables" xlink:title="00000024 - Disclosure - Equipment and Leasehold Improvements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitmentsTables" xlink:title="00000025 - Disclosure - Lease Commitments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/AccruedExpensesTables" xlink:title="00000026 - Disclosure - Accrued Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesTables" xlink:title="00000027 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsTables" xlink:title="00000028 - Disclosure - Stock Options and Stock Grants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AccountingPoliciesLineItems" xlink:label="loc_nanxAccountingPoliciesLineItems" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AccountingPoliciesTable" xlink:label="loc_nanxAccountingPoliciesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_nanxAccountingPoliciesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nanxAccountingPoliciesTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapOtherCapitalizedPropertyPlantAndEquipmentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherCapitalizedPropertyPlantAndEquipmentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nanxAccountingPoliciesTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nanxAccountingPoliciesTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CashAndCashEquivalentsMaturityPeriodDescription" xlink:label="loc_nanxCashAndCashEquivalentsMaturityPeriodDescription_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_nanxCashAndCashEquivalentsMaturityPeriodDescription_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AccountsReceivablesCreditPeriod" xlink:label="loc_nanxAccountsReceivablesCreditPeriod_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_nanxAccountsReceivablesCreditPeriod_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_IncomeTaxRecognitionThresholdPercentage" xlink:label="loc_nanxIncomeTaxRecognitionThresholdPercentage_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_nanxIncomeTaxRecognitionThresholdPercentage_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaapOpenTaxYear_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_us-gaapOpenTaxYear_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OpenTaxYearExpirationPeriod" xlink:label="loc_nanxOpenTaxYearExpirationPeriod_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_nanxOpenTaxYearExpirationPeriod_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_120" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000030 - Disclosure - Summary of Significant Accounting Policies (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/NoteAndLineOfCreditDetailNarratives" xlink:title="00000031 - Disclosure - Note and Line of Credit (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaapLetterOfCreditMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLetterOfCreditMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaapLineOfCreditMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLineOfCreditMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermBorrowings_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaapDebtInstrumentDescriptionOfVariableRateBasis_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDescriptionOfVariableRateBasis_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:label="loc_nanxLineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxLineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_60" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/InventoriesDetails" xlink:title="00000032 - Disclosure - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000033 - Disclosure - Equipment and Leasehold Improvements (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetails" xlink:title="00000034 - Disclosure - Equipment and Leasehold Improvements (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaapConstructionInProgressMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapConstructionInProgressMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitmentsDetailsNarrative" xlink:title="00000035 - Disclosure - Lease Commitments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaapOperatingLeasedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaapLeaseArrangementTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapLeaseArrangementTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaapLeaseArrangementTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLeaseArrangementTypeAxis" xlink:to="loc_us-gaapLeaseArrangementTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaapLeaseArrangementTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLeaseArrangementTypeAxis" xlink:to="loc_us-gaapLeaseArrangementTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_RomeovilleIllinoisMember" xlink:label="loc_nanxRomeovilleIllinoisMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_nanxRomeovilleIllinoisMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OffsiteWarehouseMember" xlink:label="loc_nanxOffsiteWarehouseMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_nanxOffsiteWarehouseMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_BurrRidgeFacilityMember" xlink:label="loc_nanxBurrRidgeFacilityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_nanxBurrRidgeFacilityMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OperatingLeaseNumberOfRenewals" xlink:label="loc_nanxOperatingLeaseNumberOfRenewals_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxOperatingLeaseNumberOfRenewals_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:label="loc_us-gaapOperatingLeasesRentExpenseMinimumRentals_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseMinimumRentals_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasedAssetsGross" xlink:label="loc_us-gaapCapitalLeasedAssetsGross_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapCapitalLeasedAssetsGross_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xlink:label="loc_us-gaapCapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapCapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_NumberOfCapitalLeases" xlink:label="loc_nanxNumberOfCapitalLeases_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxNumberOfCapitalLeases_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract" xlink:label="loc_nanxLesseeLeasingArrangementsCapitalLeasesTermOfContract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxLesseeLeasingArrangementsCapitalLeasesTermOfContract_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireEquipmentOnLease" xlink:label="loc_us-gaapPaymentsToAcquireEquipmentOnLease_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireEquipmentOnLease_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal" xlink:label="loc_nanxCapitalLeasesFutureMinimumPaymentsDuePrincipal_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxCapitalLeasesFutureMinimumPaymentsDuePrincipal_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PaymentToRetireCapitalLease" xlink:label="loc_nanxPaymentToRetireCapitalLease_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxPaymentToRetireCapitalLease_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTransfersAndChanges_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTransfersAndChanges_120" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitmentsDetails" xlink:title="00000036 - Disclosure - Lease Commitments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/AccruedExpensesDetails" xlink:title="00000037 - Disclosure - Accrued Expenses (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000038 - Disclosure - Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesDetails" xlink:title="00000039 - Disclosure - Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesDetails1" xlink:title="00000040 - Disclosure - Income Taxes (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/CapitalStockDetailsNarrative" xlink:title="00000041 - Disclosure - Capital Stock (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsDetailNarratives" xlink:title="00000042 - Disclosure - Stock Options and Stock Grants (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember" xlink:label="loc_us-gaapStockAppreciationRightsSARSMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockAppreciationRightsSARSMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" xlink:label="loc_nanxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_nanxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrentAndNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrentAndNoncurrent_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" xlink:label="loc_nanxSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_nanxSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1_70" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsDetails" xlink:title="00000043 - Disclosure - Stock Options and Stock Grants (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsDetails1" xlink:title="00000044 - Disclosure - Stock Options and Stock Grants (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/KProfit-sharingPlanDetailsNarrative" xlink:title="00000045 - Disclosure - 401(k) Profit-Sharing Plan (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionAmount" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionAmount_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercentOfMatch_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercentOfMatch_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="loc_us-gaapDefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercent_30" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:title="00000046 - Disclosure - Significant Customers and Contingencies (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplyCommitmentAxis" xlink:label="loc_us-gaapSupplyCommitmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSupplyCommitmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember" xlink:label="loc_us-gaapSupplyCommitmentArrangementMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSupplyCommitmentAxis" xlink:to="loc_us-gaapSupplyCommitmentArrangementMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember" xlink:label="loc_us-gaapSupplyCommitmentArrangementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSupplyCommitmentAxis" xlink:to="loc_us-gaapSupplyCommitmentArrangementMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplyCommitmentMember" xlink:label="loc_us-gaapSupplyCommitmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSupplyCommitmentArrangementMember" xlink:to="loc_us-gaapSupplyCommitmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaapMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomersOneMember" xlink:label="loc_nanxCustomersOneMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersOneMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomersTwoMember" xlink:label="loc_nanxCustomersTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersTwoMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomersThreeMember" xlink:label="loc_nanxCustomersThreeMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersThreeMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_MajorCustomersNumberOfCustomers" xlink:label="loc_nanxMajorCustomersNumberOfCustomers_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxMajorCustomersNumberOfCustomers_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantSupplyCommitmentDescription" xlink:label="loc_us-gaapSignificantSupplyCommitmentDescription_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSignificantSupplyCommitmentDescription_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestments_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestments_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_180" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:label="loc_nanxPrincipalAmountDebtAcceleratedMaturity_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxPrincipalAmountDebtAcceleratedMaturity_180" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades" xlink:label="loc_nanxEquipmentSaleNetBookValueEquipmentAndUpgrades_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleNetBookValueEquipmentAndUpgrades_180" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:label="loc_nanxEquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_180" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_EquipmentSaleNetBookValueEquipment" xlink:label="loc_nanxEquipmentSaleNetBookValueEquipment_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleNetBookValueEquipment_180" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:title="00000047 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaapNonUsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_us-gaapNonUsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EuropeanUnionMember" xlink:label="loc_us-gaapEuropeanUnionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_us-gaapEuropeanUnionMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaapNumberOfOperatingSegments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNumberOfOperatingSegments_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000048 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaapLineOfCreditMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLineOfCreditMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PaymentToRetireCapitalLease" xlink:label="loc_nanxPaymentToRetireCapitalLease_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxPaymentToRetireCapitalLease_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment_30" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>nanx-20161231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: P:\EDGARizer\Clients\Nanophase Technologies\Xbrl\20161231\nanx_123116.xfr; Date: 2017%2D03%2D29T13:48:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LetterOfCreditMember" xlink:to="us-gaap_LetterOfCreditMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LetterOfCreditMember_lbl" xml:lang="en-US">Letter of Credit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomersThreeMember" xlink:label="nanx_CustomersThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersThreeMember" xlink:to="nanx_CustomersThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_CustomersThreeMember_lbl" xml:lang="en-US">Customers Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomersTwoMember" xlink:label="nanx_CustomersTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersTwoMember" xlink:to="nanx_CustomersTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_CustomersTwoMember_lbl" xml:lang="en-US">Customers Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomersOneMember" xlink:label="nanx_CustomersOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersOneMember" xlink:to="nanx_CustomersOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_CustomersOneMember_lbl" xml:lang="en-US">Customers One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplyCommitmentAxis" xlink:label="us-gaap_SupplyCommitmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplyCommitmentAxis" xlink:to="us-gaap_SupplyCommitmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplyCommitmentAxis_lbl" xml:lang="en-US">Supply Commitment [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplyCommitmentMember" xlink:label="us-gaap_SupplyCommitmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplyCommitmentMember" xlink:to="us-gaap_SupplyCommitmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplyCommitmentMember_lbl" xml:lang="en-US">BASF [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonUsMember" xlink:to="us-gaap_NonUsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonUsMember_lbl" xml:lang="en-US">Non-Domestic Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditMember" xlink:to="us-gaap_LineOfCreditMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditMember_lbl" xml:lang="en-US">Line of Credit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:label="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:to="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Self-Constructed Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Office Furniture [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US">Construction in Progress [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="us-gaap_LeaseArrangementTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseArrangementTypeAxis_lbl" xml:lang="en-US">Lease Arrangement, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OffsiteWarehouseMember" xlink:label="nanx_OffsiteWarehouseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OffsiteWarehouseMember" xlink:to="nanx_OffsiteWarehouseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_OffsiteWarehouseMember_lbl" xml:lang="en-US">Offsite Warehouse [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_RomeovilleIllinoisMember" xlink:label="nanx_RomeovilleIllinoisMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_RomeovilleIllinoisMember" xlink:to="nanx_RomeovilleIllinoisMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_RomeovilleIllinoisMember_lbl" xml:lang="en-US">Romeoville Illinois [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EuropeanUnionMember" xlink:label="us-gaap_EuropeanUnionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EuropeanUnionMember" xlink:to="us-gaap_EuropeanUnionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EuropeanUnionMember_lbl" xml:lang="en-US">Germany [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_BurrRidgeFacilityMember" xlink:label="nanx_BurrRidgeFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_BurrRidgeFacilityMember" xlink:to="nanx_BurrRidgeFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_BurrRidgeFacilityMember_lbl" xml:lang="en-US">Burr Ridge Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DocumentAndEntityInformationAbstract" xlink:label="nanx_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DocumentAndEntityInformationAbstract" xlink:to="nanx_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity a Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity a Voluntary Filer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity's Reporting Status Current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityListingParValuePerShare" xlink:label="dei_EntityListingParValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingParValuePerShare" xlink:to="dei_EntityListingParValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingParValuePerShare_lbl" xml:lang="en-US">Entity Common Stock, Par Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Trade accounts receivable, less allowance for doubtful accounts of $5 and $6 on December 31, 2016 and 2015, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Equipment and leasehold improvements, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="us-gaap_CapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsCurrent" xlink:to="us-gaap_CapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="us-gaap_CapitalLeaseObligationsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsNoncurrent" xlink:to="us-gaap_CapitalLeaseObligationsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsNoncurrent_lbl" xml:lang="en-US">Long-term portion of capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl" xml:lang="en-US">Long-term deferred rent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="us-gaap_AssetRetirementObligationsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationsNoncurrent" xlink:to="us-gaap_AssetRetirementObligationsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationsNoncurrent_lbl" xml:lang="en-US">Asset retirement obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Contingent liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.01 par value, 42,000,000 and 35,000,000 shares authorized; 31,229,996 and 28,585,496 shares issued and outstanding on December 31, 2016 and December 31, 2015, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Trade accounts receivable, less allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenue:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="us-gaap_SalesRevenueGoodsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="us-gaap_SalesRevenueGoodsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueGoodsNet_lbl" xml:lang="en-US">Product revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="us-gaap_OtherSalesRevenueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSalesRevenueNet" xlink:to="us-gaap_OtherSalesRevenueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSalesRevenueNet_lbl" xml:lang="en-US">Other revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US">Total revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expense:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provisions for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Net loss per share - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of basic and diluted common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, beginning (shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Sale of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Sale of common stock (shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Stock option exercises</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Stock option exercises (shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance, ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, ending (shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustment to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Impairment of fixed asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities related to operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Trade accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Acquisition of equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Payment of accounts payable incurred for the purchase of equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" xml:lang="en-US">Principal payment on capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Increase/(Decrease) in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental non-cash investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Accounts payable incurred for the purchase of equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:label="us-gaap_CapitalLeaseObligationsIncurred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsIncurred" xlink:to="us-gaap_CapitalLeaseObligationsIncurred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsIncurred_lbl" xml:lang="en-US">Capital lease obligations incurred in the purchase of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Note and Line of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Equipment and Leasehold Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Lease Commitments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Capital Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock Options and Stock Grants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US">Compensation and Retirement Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US">401(k) Profit-Sharing Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Significant Customers and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Business Segmentation and Geographical Distribution</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates and Risks and Uncertainties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Trade Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Equipment and Leasehold Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationsPolicy" xlink:label="us-gaap_AssetRetirementObligationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationsPolicy" xlink:to="us-gaap_AssetRetirementObligationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationsPolicy_lbl" xml:lang="en-US">Asset Retirement Obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Product Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionSoftware" xlink:label="us-gaap_RevenueRecognitionSoftware" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionSoftware" xlink:to="us-gaap_RevenueRecognitionSoftware_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionSoftware_lbl" xml:lang="en-US">Other Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock" xlink:label="us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock" xlink:to="us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock_lbl" xml:lang="en-US">Schedule of activity in asset retirement obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of components of equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:label="nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:to="nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of income tax expense by applying federal income tax rate to loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of significant components of deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions used to calculate Black-Scholes Ooption Pricing Model for stock options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of option activity</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AccountingPoliciesTable" xlink:label="nanx_AccountingPoliciesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_AccountingPoliciesTable" xlink:to="nanx_AccountingPoliciesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_AccountingPoliciesTable_lbl" xml:lang="en-US">Accounting Policies [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AccountingPoliciesLineItems" xlink:label="nanx_AccountingPoliciesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_AccountingPoliciesLineItems" xlink:to="nanx_AccountingPoliciesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_AccountingPoliciesLineItems_lbl" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CashAndCashEquivalentsMaturityPeriodDescription" xlink:label="nanx_CashAndCashEquivalentsMaturityPeriodDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CashAndCashEquivalentsMaturityPeriodDescription" xlink:to="nanx_CashAndCashEquivalentsMaturityPeriodDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_CashAndCashEquivalentsMaturityPeriodDescription_lbl" xml:lang="en-US">Cash and cash equivalents description</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AccountsReceivablesCreditPeriod" xlink:label="nanx_AccountsReceivablesCreditPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_AccountsReceivablesCreditPeriod" xlink:to="nanx_AccountsReceivablesCreditPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_AccountsReceivablesCreditPeriod_lbl" xml:lang="en-US">Credit period after shipment and invoicing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Equipment leasehold improvements and leased assets useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_IncomeTaxRecognitionThresholdPercentage" xlink:label="nanx_IncomeTaxRecognitionThresholdPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_IncomeTaxRecognitionThresholdPercentage" xlink:to="nanx_IncomeTaxRecognitionThresholdPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_IncomeTaxRecognitionThresholdPercentage_lbl" xml:lang="en-US">Threshold percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OpenTaxYear" xlink:to="us-gaap_OpenTaxYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OpenTaxYear_lbl" xml:lang="en-US">Open tax years for jurisdictions</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OpenTaxYearExpirationPeriod" xlink:label="nanx_OpenTaxYearExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OpenTaxYearExpirationPeriod" xlink:to="nanx_OpenTaxYearExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_OpenTaxYearExpirationPeriod_lbl" xml:lang="en-US">Income tax statutes expiration year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Anti-dilutive securities excluded from computation of earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationDisclosureAbstract" xlink:label="us-gaap_AssetRetirementObligationDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationDisclosureAbstract" xlink:to="us-gaap_AssetRetirementObligationDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationDisclosureAbstract_lbl" xml:lang="en-US">Asset Retirement Obligation Disclosure [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationsNoncurrent" xlink:to="us-gaap_AssetRetirementObligationsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AssetRetirementObligationsNoncurrent_2_lbl" xml:lang="en-US">Balance, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="us-gaap_AssetRetirementObligationAccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense_lbl" xml:lang="en-US">Accretion of liability due to passage of time</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:label="us-gaap_AssetRetirementObligationLiabilitiesIncurred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:to="us-gaap_AssetRetirementObligationLiabilitiesIncurred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationLiabilitiesIncurred_lbl" xml:lang="en-US">Amortization of asset due to passage of time</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationsNoncurrent" xlink:to="us-gaap_AssetRetirementObligationsNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AssetRetirementObligationsNoncurrent_3_lbl" xml:lang="en-US">Balance, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Letter of credit and related promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US">Basis spread variable interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" xml:lang="en-US">Variable interest rate basis</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:label="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:to="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_lbl" xml:lang="en-US">Borrowing capacity as percentage of accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Minimum amount of cash required on advances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Line of credit facility, expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US">Inventory gross, Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Allowance for excess inventory quantities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Net, Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OperatingLeaseNumberOfRenewals" xlink:label="nanx_OperatingLeaseNumberOfRenewals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OperatingLeaseNumberOfRenewals" xlink:to="nanx_OperatingLeaseNumberOfRenewals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_OperatingLeaseNumberOfRenewals_lbl" xml:lang="en-US">Operating lease number of renewals</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl" xml:lang="en-US">Monthly rent on lease amounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Rent Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasedAssetsGross" xlink:label="us-gaap_CapitalLeasedAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasedAssetsGross" xlink:to="us-gaap_CapitalLeasedAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasedAssetsGross_lbl" xml:lang="en-US">Cost of equipment under capital lease</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xlink:label="us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xlink:to="us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_NumberOfCapitalLeases" xlink:label="nanx_NumberOfCapitalLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_NumberOfCapitalLeases" xlink:to="nanx_NumberOfCapitalLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_NumberOfCapitalLeases_lbl" xml:lang="en-US">Number of capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract" xlink:label="nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract" xlink:to="nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract_lbl" xml:lang="en-US">Capital lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireEquipmentOnLease" xlink:label="us-gaap_PaymentsToAcquireEquipmentOnLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquipmentOnLease" xlink:to="us-gaap_PaymentsToAcquireEquipmentOnLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireEquipmentOnLease_lbl" xml:lang="en-US">Payments to acquire capital lease</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal" xlink:label="nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal" xlink:to="nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal_lbl" xml:lang="en-US">Capital leases, principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments_lbl" xml:lang="en-US">Capital leases, interest</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PaymentToRetireCapitalLease" xlink:label="nanx_PaymentToRetireCapitalLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_PaymentToRetireCapitalLease" xlink:to="nanx_PaymentToRetireCapitalLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_PaymentToRetireCapitalLease_lbl" xml:lang="en-US">Payment to retire capital lease</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:label="us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:to="us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_lbl" xml:lang="en-US">Change in value of capital equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesOperatingAbstract" xlink:label="us-gaap_LeasesOperatingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeasesOperatingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOperatingAbstract_lbl" xml:lang="en-US">Operating leases:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total minimum payments required</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:label="us-gaap_CapitalLeaseObligationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsAbstract" xlink:to="us-gaap_CapitalLeaseObligationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsAbstract_lbl" xml:lang="en-US">Capital leases:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total minimum payments required</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll and related expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomerNetVolumeRebatePayable" xlink:label="nanx_CustomerNetVolumeRebatePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomerNetVolumeRebatePayable" xlink:to="nanx_CustomerNetVolumeRebatePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_CustomerNetVolumeRebatePayable_lbl" xml:lang="en-US">Customer net volume rebate payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Increase in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OperatingLossCarryforwardsExpirationYearStart" xlink:label="nanx_OperatingLossCarryforwardsExpirationYearStart" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OperatingLossCarryforwardsExpirationYearStart" xlink:to="nanx_OperatingLossCarryforwardsExpirationYearStart_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_OperatingLossCarryforwardsExpirationYearStart_lbl" xml:lang="en-US">Capital loss carryforwards expiration period start</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OperatingLossCarryforwardsExpirationYearEnd" xlink:label="nanx_OperatingLossCarryforwardsExpirationYearEnd" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OperatingLossCarryforwardsExpirationYearEnd" xlink:to="nanx_OperatingLossCarryforwardsExpirationYearEnd_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_OperatingLossCarryforwardsExpirationYearEnd_lbl" xml:lang="en-US">Capital loss carryforwards expiration period end</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards" xlink:label="nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards" xlink:to="nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards_lbl" xml:lang="en-US">Period for suspension of net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_ExtensionOfTermOfNetLossCarryforwards" xlink:label="nanx_ExtensionOfTermOfNetLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ExtensionOfTermOfNetLossCarryforwards" xlink:to="nanx_ExtensionOfTermOfNetLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_ExtensionOfTermOfNetLossCarryforwards_lbl" xml:lang="en-US">Extension of the term of net loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax credit at statutory rates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Nondeductible expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State income tax, net of federal benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Increase in valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Inventory and other allowances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_lbl" xml:lang="en-US">Charitable contribution carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Excess (tax) book depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Excess (tax) book amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl" xml:lang="en-US">Other accrued costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="us-gaap_CommonStockSharesSubscribedButUnissued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesSubscribedButUnissued" xlink:to="us-gaap_CommonStockSharesSubscribedButUnissued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesSubscribedButUnissued_lbl" xml:lang="en-US">Authorized, unissued shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AddtionalSharesAuthorizedDuringPeriod" xlink:label="nanx_AddtionalSharesAuthorizedDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_AddtionalSharesAuthorizedDuringPeriod" xlink:to="nanx_AddtionalSharesAuthorizedDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_AddtionalSharesAuthorizedDuringPeriod_lbl" xml:lang="en-US">Addtional shares authorized during period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Addtional shares authorized 2010 Equity Compensation Plan during period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember" xlink:label="us-gaap_StockAppreciationRightsSARSMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAppreciationRightsSARSMember" xlink:to="us-gaap_StockAppreciationRightsSARSMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAppreciationRightsSARSMember_lbl" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Weighted-average period over which unrecognized compensation is expected to be recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" xlink:label="nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" xlink:to="nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions_lbl" xml:lang="en-US">Forfeiture rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Common stock issued pursuant to option exercises</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Total intrinsic value of stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:label="us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:to="us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_lbl" xml:lang="en-US">Fair value of the liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" xlink:label="nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" xlink:to="nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1_lbl" xml:lang="en-US">Contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Weighted-average risk-free interest rates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Weighted-average expected life of the option</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Weighted-average expected stock price volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average fair value of the options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_StockOptionsAbstract" xlink:label="nanx_StockOptionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_StockOptionsAbstract" xlink:to="nanx_StockOptionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_StockOptionsAbstract_lbl" xml:lang="en-US">Stock Options:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Stock options outstanding, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Shares, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xml:lang="en-US">Stock option exercises, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Shares, Forfeited or expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Stock options outstanding, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Shares, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Shares available for grant</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_WeightedAverageExercisePriceAbstract" xlink:label="nanx_WeightedAverageExercisePriceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_WeightedAverageExercisePriceAbstract" xlink:to="nanx_WeightedAverageExercisePriceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_WeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US">Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Forfeited or expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term Years, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AggregateIntrinsicValueAbstract" xlink:label="nanx_AggregateIntrinsicValueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_AggregateIntrinsicValueAbstract" xlink:to="nanx_AggregateIntrinsicValueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_AggregateIntrinsicValueAbstract_lbl" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution_lbl" xml:lang="en-US">Defined contribution plan employer matching contribution percent for three percent of employee contribution</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab_lbl" xml:lang="en-US">Defined contribution plan employer matching contribution percent for first compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution_lbl" xml:lang="en-US">Defined contribution plan employer matching contribution percent for two percent of employee contribution</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab_lbl" xml:lang="en-US">Defined contribution plan employer matching contribution percent for next compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionAmount" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionAmount" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" xml:lang="en-US">Contributions under profit sharing plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xml:lang="en-US">Employer's matching contribution</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xml:lang="en-US">Employee's contribution for matching</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xml:lang="en-US">Participant's salary for employer matching</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_MajorCustomersNumberOfCustomers" xlink:label="nanx_MajorCustomersNumberOfCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_MajorCustomersNumberOfCustomers" xlink:to="nanx_MajorCustomersNumberOfCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_MajorCustomersNumberOfCustomers_lbl" xml:lang="en-US">Number of major customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Revenue from top customers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_2_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantSupplyCommitmentDescription" xlink:label="us-gaap_SignificantSupplyCommitmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantSupplyCommitmentDescription" xlink:to="us-gaap_SignificantSupplyCommitmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantSupplyCommitmentDescription_lbl" xml:lang="en-US">Supply Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US">Cash, cash equivalents and investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:label="nanx_PrincipalAmountDebtAcceleratedMaturity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:to="nanx_PrincipalAmountDebtAcceleratedMaturity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_PrincipalAmountDebtAcceleratedMaturity_lbl" xml:lang="en-US">Accelerated debt maturity - principal amount debt</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades" xlink:label="nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades" xlink:to="nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades_lbl" xml:lang="en-US">Equipment sale - net book value equipment and upgrades</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:label="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:to="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_lbl" xml:lang="en-US">Equipment sale - original book value of equipment and upgrades</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_EquipmentSaleNetBookValueEquipment" xlink:label="nanx_EquipmentSaleNetBookValueEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleNetBookValueEquipment" xlink:to="nanx_EquipmentSaleNetBookValueEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_EquipmentSaleNetBookValueEquipment_lbl" xml:lang="en-US">Equipment sale - net book value equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue from international sources</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Number of operating segment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersOneMember" xlink:to="nanx_CustomersOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_CustomersOneMember_doc" xml:lang="en-US">Customer one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersThreeMember" xlink:to="nanx_CustomersThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_CustomersThreeMember_doc" xml:lang="en-US">Customers three.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersTwoMember" xlink:to="nanx_CustomersTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_CustomersTwoMember_doc" xml:lang="en-US">Customers two.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DocumentAndEntityInformationAbstract" xlink:to="nanx_DocumentAndEntityInformationAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_DocumentAndEntityInformationAbstract_doc" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:to="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_doc" xml:lang="en-US">Line of credit facility maximum borrowing capacity as percentage of accounts receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_MajorCustomersNumberOfCustomers" xlink:to="nanx_MajorCustomersNumberOfCustomers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_MajorCustomersNumberOfCustomers_doc" xml:lang="en-US">Represents number of significant customers.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades" xlink:to="nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades_doc" xml:lang="en-US">Percentage of equipment's net book value, including upgrades; to be sold to customer after a triggering event as stated in the supply agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:to="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_doc" xml:lang="en-US">Percentage of equipment's original value, including upgrades; to be sold to customer after a triggering event as stated in the supply agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleNetBookValueEquipment" xlink:to="nanx_EquipmentSaleNetBookValueEquipment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_EquipmentSaleNetBookValueEquipment_doc" xml:lang="en-US">Percentage of equipment's net book value to be sold to customer after a triggering event as stated in the supply agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:to="nanx_PrincipalAmountDebtAcceleratedMaturity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_PrincipalAmountDebtAcceleratedMaturity_doc" xml:lang="en-US">The total prinicipal amount of accelerated debt maturity, as defined in supply agreement financial convenants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_AccountingPoliciesTable" xlink:to="nanx_AccountingPoliciesTable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_AccountingPoliciesTable_doc" xml:lang="en-US">Accounting Policies [Table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_AccountingPoliciesLineItems" xlink:to="nanx_AccountingPoliciesLineItems_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_AccountingPoliciesLineItems_doc" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CashAndCashEquivalentsMaturityPeriodDescription" xlink:to="nanx_CashAndCashEquivalentsMaturityPeriodDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_CashAndCashEquivalentsMaturityPeriodDescription_doc" xml:lang="en-US">Cash And Cash Equivalents Maturity Period Description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_AccountsReceivablesCreditPeriod" xlink:to="nanx_AccountsReceivablesCreditPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_AccountsReceivablesCreditPeriod_doc" xml:lang="en-US">Description of period for which credit is generally granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_IncomeTaxRecognitionThresholdPercentage" xlink:to="nanx_IncomeTaxRecognitionThresholdPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_IncomeTaxRecognitionThresholdPercentage_doc" xml:lang="en-US">Income Tax Recognition Threshold Percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OpenTaxYearExpirationPeriod" xlink:to="nanx_OpenTaxYearExpirationPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_OpenTaxYearExpirationPeriod_doc" xml:lang="en-US">Open Tax Year Expiration Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:to="nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating and capital leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_BurrRidgeFacilityMember" xlink:to="nanx_BurrRidgeFacilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_BurrRidgeFacilityMember_doc" xml:lang="en-US">Burr Ridge Facility [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OffsiteWarehouseMember" xlink:to="nanx_OffsiteWarehouseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_OffsiteWarehouseMember_doc" xml:lang="en-US">Offsite Warehouse [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_RomeovilleIllinoisMember" xlink:to="nanx_RomeovilleIllinoisMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_RomeovilleIllinoisMember_doc" xml:lang="en-US">Romeoville Illinois [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OperatingLeaseNumberOfRenewals" xlink:to="nanx_OperatingLeaseNumberOfRenewals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_OperatingLeaseNumberOfRenewals_doc" xml:lang="en-US">Operating Lease Number Of Renewals</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_NumberOfCapitalLeases" xlink:to="nanx_NumberOfCapitalLeases_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_NumberOfCapitalLeases_doc" xml:lang="en-US">Number Of Capital Leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract" xlink:to="nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract_doc" xml:lang="en-US">Lessee leasing arrangements capital leases term of contract.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal" xlink:to="nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal_doc" xml:lang="en-US">The principal amount of minimum lease payments for capital leases.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OperatingLossCarryforwardsExpirationYearStart" xlink:to="nanx_OperatingLossCarryforwardsExpirationYearStart_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_OperatingLossCarryforwardsExpirationYearStart_doc" xml:lang="en-US">Operating Loss Carryforwards Expiration Year Start</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_OperatingLossCarryforwardsExpirationYearEnd" xlink:to="nanx_OperatingLossCarryforwardsExpirationYearEnd_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_OperatingLossCarryforwardsExpirationYearEnd_doc" xml:lang="en-US">Operating Loss Carryforwards Expiration Year End</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards" xlink:to="nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards_doc" xml:lang="en-US">Period For Suspension Of Net Operating Loss Carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ExtensionOfTermOfNetLossCarryforwards" xlink:to="nanx_ExtensionOfTermOfNetLossCarryforwards_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_ExtensionOfTermOfNetLossCarryforwards_doc" xml:lang="en-US">Extension Of Term Of Net Loss Carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution_doc" xml:lang="en-US">Defined Contribution Plan Employer Matching Contribution Percent For Three Percent Of Employee Contribution</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab_doc" xml:lang="en-US">Defined Contribution Plan Employer Matching Contribution Percent For First Compensation Slab</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution_doc" xml:lang="en-US">Defined Contribution Plan Employer Matching Contribution Percent For Two Percent Of Employee Contribution</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab_doc" xml:lang="en-US">Defined Contribution Plan Employer Matching Contribution Percent For Next Compensation Slab</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DefinedContributionPlanEmployerMatchingContributionAmount" xlink:to="nanx_DefinedContributionPlanEmployerMatchingContributionAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_DefinedContributionPlanEmployerMatchingContributionAmount_doc" xml:lang="en-US">Amount of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomerNetVolumeRebatePayable" xlink:to="nanx_CustomerNetVolumeRebatePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_CustomerNetVolumeRebatePayable_doc" xml:lang="en-US">Amount of expenses incurred but not yet paid for customer net volume rebates, due within one year or the normal operating cycle, if longer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_AddtionalSharesAuthorizedDuringPeriod" xlink:to="nanx_AddtionalSharesAuthorizedDuringPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_AddtionalSharesAuthorizedDuringPeriod_doc" xml:lang="en-US">Number of additional shares authorized for issuance by stockholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" xlink:to="nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1_doc" xml:lang="en-US">The contractual life for stock options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" xlink:to="nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions_doc" xml:lang="en-US">The estimated forfeitures percentage for options during a period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_PaymentToRetireCapitalLease" xlink:to="nanx_PaymentToRetireCapitalLease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_PaymentToRetireCapitalLease_doc" xml:lang="en-US">The cash outflow for retirement of the obligation for a capital lease.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_2_lbl" xml:lang="en-US">Revenue, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_2_lbl" xml:lang="en-US">Repayments of Long-term Capital Lease Obligations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_2_lbl" xml:lang="en-US">Inventory, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_2_lbl" xml:lang="en-US">Inventory Valuation Reserves</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:to="us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Transfers and Changes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Three Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Four Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Five Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>nanx-20161231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: P:\EDGARizer\Clients\Nanophase Technologies\Xbrl\20161231\nanx_123116.xfr; Date: 2017%2D03%2D29T13:48:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:href="nanx-20161231.xsd#DocumentandEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/BalanceSheets" xlink:href="nanx-20161231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/BalanceSheetsParenthetical" xlink:href="nanx-20161231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StatementsOfOperations" xlink:href="nanx-20161231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StatementsOfStockholdersEquity" xlink:href="nanx-20161231.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StatementsOfCashFlows" xlink:href="nanx-20161231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NoteAndLineOfCredit" xlink:href="nanx-20161231.xsd#NoteAndLineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovements" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitments" xlink:href="nanx-20161231.xsd#LeaseCommitments" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/AccruedExpenses" xlink:href="nanx-20161231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxes" xlink:href="nanx-20161231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/CapitalStock" xlink:href="nanx-20161231.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrants" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrants" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/KProfit-sharingPlan" xlink:href="nanx-20161231.xsd#KProfit-sharingPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SubsequentEvents" xlink:href="nanx-20161231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:href="nanx-20161231.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitmentsTables" xlink:href="nanx-20161231.xsd#LeaseCommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/AccruedExpensesTables" xlink:href="nanx-20161231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesTables" xlink:href="nanx-20161231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsTables" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="nanx-20161231.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NoteAndLineOfCreditDetailNarratives" xlink:href="nanx-20161231.xsd#NoteAndLineOfCreditDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/InventoriesDetails" xlink:href="nanx-20161231.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetails" xlink:href="nanx-20161231.xsd#EquipmentAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitmentsDetailsNarrative" xlink:href="nanx-20161231.xsd#LeaseCommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/LeaseCommitmentsDetails" xlink:href="nanx-20161231.xsd#LeaseCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/AccruedExpensesDetails" xlink:href="nanx-20161231.xsd#AccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesDetailsNarrative" xlink:href="nanx-20161231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesDetails" xlink:href="nanx-20161231.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/IncomeTaxesDetails1" xlink:href="nanx-20161231.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/CapitalStockDetailsNarrative" xlink:href="nanx-20161231.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetailNarratives" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetails" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/StockOptionsAndStockGrantsDetails1" xlink:href="nanx-20161231.xsd#StockOptionsAndStockGrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/KProfit-sharingPlanDetailsNarrative" xlink:href="nanx-20161231.xsd#KProfit-sharingPlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:href="nanx-20161231.xsd#SignificantCustomersAndContingenciesDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:href="nanx-20161231.xsd#DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SubsequentEventsDetailsNarrative" xlink:href="nanx-20161231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DocumentAndEntityInformationAbstract" xlink:label="loc_nanxDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityListingParValuePerShare" xlink:label="loc_deiEntityListingParValuePerShare" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityListingParValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/BalanceSheets" xlink:title="00000002 - Statement - BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaapCapitalLeaseObligationsNoncurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCapitalLeaseObligationsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaapDeferredRentCreditNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDeferredRentCreditNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="loc_us-gaapAssetRetirementObligationsNoncurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapAssetRetirementObligationsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapSalesRevenueGoodsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="loc_us-gaapOtherSalesRevenueNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapOtherSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - STATEMENTS OF STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaapRepaymentsOfLongTermCapitalLeaseObligations" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermCapitalLeaseObligations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:label="loc_us-gaapCapitalLeaseObligationsIncurred" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapCapitalLeaseObligationsIncurred" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:title="00000007 - Disclosure - Description of Business">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NoteAndLineOfCredit" xlink:title="00000009 - Disclosure - Note and Line of Credit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:title="00000010 - Disclosure - Inventories">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovements" xlink:title="00000011 - Disclosure - Equipment and Leasehold Improvements">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitments" xlink:title="00000012 - Disclosure - Lease Commitments">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/AccruedExpenses" xlink:title="00000013 - Disclosure - Accrued Expenses">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxes" xlink:title="00000014 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/CapitalStock" xlink:title="00000015 - Disclosure - Capital Stock">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrants" xlink:title="00000016 - Disclosure - Stock Options and Stock Grants">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/KProfit-sharingPlan" xlink:title="00000017 - Disclosure - 401(k) Profit-Sharing Plan">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaapPensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapPensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:title="00000018 - Disclosure - Significant Customers and Contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:title="00000019 - Disclosure - Business Segmentation and Geographical Distribution">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SubsequentEvents" xlink:title="00000020 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationsPolicy" xlink:label="loc_us-gaapAssetRetirementObligationsPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAssetRetirementObligationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionSoftware" xlink:label="loc_us-gaapRevenueRecognitionSoftware" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionSoftware" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000022 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock" xlink:label="loc_us-gaapScheduleOfChangeInAssetRetirementObligationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfChangeInAssetRetirementObligationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:title="00000023 - Disclosure - Inventories (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables" xlink:title="00000024 - Disclosure - Equipment and Leasehold Improvements (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitmentsTables" xlink:title="00000025 - Disclosure - Lease Commitments (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:label="loc_nanxScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_nanxScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/AccruedExpensesTables" xlink:title="00000026 - Disclosure - Accrued Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesTables" xlink:title="00000027 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsTables" xlink:title="00000028 - Disclosure - Stock Options and Stock Grants (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AccountingPoliciesTable" xlink:label="loc_nanxAccountingPoliciesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_nanxAccountingPoliciesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AccountingPoliciesLineItems" xlink:label="loc_nanxAccountingPoliciesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesTable" xlink:to="loc_nanxAccountingPoliciesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapOtherCapitalizedPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherCapitalizedPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CashAndCashEquivalentsMaturityPeriodDescription" xlink:label="loc_nanxCashAndCashEquivalentsMaturityPeriodDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_nanxCashAndCashEquivalentsMaturityPeriodDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AccountsReceivablesCreditPeriod" xlink:label="loc_nanxAccountsReceivablesCreditPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_nanxAccountsReceivablesCreditPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_IncomeTaxRecognitionThresholdPercentage" xlink:label="loc_nanxIncomeTaxRecognitionThresholdPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_nanxIncomeTaxRecognitionThresholdPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaapOpenTaxYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_us-gaapOpenTaxYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OpenTaxYearExpirationPeriod" xlink:label="loc_nanxOpenTaxYearExpirationPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_nanxOpenTaxYearExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAccountingPoliciesLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000030 - Disclosure - Summary of Significant Accounting Policies (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationDisclosureAbstract" xlink:label="loc_us-gaapAssetRetirementObligationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="loc_us-gaapAssetRetirementObligationsNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetRetirementObligationDisclosureAbstract" xlink:to="loc_us-gaapAssetRetirementObligationsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense" xlink:label="loc_us-gaapAssetRetirementObligationAccretionExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetRetirementObligationDisclosureAbstract" xlink:to="loc_us-gaapAssetRetirementObligationAccretionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:label="loc_us-gaapAssetRetirementObligationLiabilitiesIncurred" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetRetirementObligationDisclosureAbstract" xlink:to="loc_us-gaapAssetRetirementObligationLiabilitiesIncurred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="loc_us-gaapAssetRetirementObligationsNoncurrent_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetRetirementObligationDisclosureAbstract" xlink:to="loc_us-gaapAssetRetirementObligationsNoncurrent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NoteAndLineOfCreditDetailNarratives" xlink:title="00000031 - Disclosure - Note and Line of Credit (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaapLetterOfCreditMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLetterOfCreditMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaapLineOfCreditMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLineOfCreditMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaapDebtInstrumentDescriptionOfVariableRateBasis" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:label="loc_nanxLineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxLineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/InventoriesDetails" xlink:title="00000032 - Disclosure - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000033 - Disclosure - Equipment and Leasehold Improvements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetails" xlink:title="00000034 - Disclosure - Equipment and Leasehold Improvements (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaapConstructionInProgressMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapConstructionInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitmentsDetailsNarrative" xlink:title="00000035 - Disclosure - Lease Commitments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaapOperatingLeasedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapOperatingLeasedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaapLeaseArrangementTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapLeaseArrangementTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaapLeaseArrangementTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeAxis" xlink:to="loc_us-gaapLeaseArrangementTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_RomeovilleIllinoisMember" xlink:label="loc_nanxRomeovilleIllinoisMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_nanxRomeovilleIllinoisMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OffsiteWarehouseMember" xlink:label="loc_nanxOffsiteWarehouseMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_nanxOffsiteWarehouseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_BurrRidgeFacilityMember" xlink:label="loc_nanxBurrRidgeFacilityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_nanxBurrRidgeFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OperatingLeaseNumberOfRenewals" xlink:label="loc_nanxOperatingLeaseNumberOfRenewals" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxOperatingLeaseNumberOfRenewals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:label="loc_us-gaapOperatingLeasesRentExpenseMinimumRentals" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseMinimumRentals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasedAssetsGross" xlink:label="loc_us-gaapCapitalLeasedAssetsGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapCapitalLeasedAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xlink:label="loc_us-gaapCapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapCapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_NumberOfCapitalLeases" xlink:label="loc_nanxNumberOfCapitalLeases" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxNumberOfCapitalLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract" xlink:label="loc_nanxLesseeLeasingArrangementsCapitalLeasesTermOfContract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxLesseeLeasingArrangementsCapitalLeasesTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireEquipmentOnLease" xlink:label="loc_us-gaapPaymentsToAcquireEquipmentOnLease" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireEquipmentOnLease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal" xlink:label="loc_nanxCapitalLeasesFutureMinimumPaymentsDuePrincipal" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxCapitalLeasesFutureMinimumPaymentsDuePrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PaymentToRetireCapitalLease" xlink:label="loc_nanxPaymentToRetireCapitalLease" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_nanxPaymentToRetireCapitalLease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTransfersAndChanges" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTransfersAndChanges" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/LeaseCommitmentsDetails" xlink:title="00000036 - Disclosure - Lease Commitments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesOperatingAbstract" xlink:label="loc_us-gaapLeasesOperatingAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeasesOperatingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesOperatingAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesOperatingAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesOperatingAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesOperatingAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesOperatingAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesOperatingAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesOperatingAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:label="loc_us-gaapCapitalLeaseObligationsAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapCapitalLeaseObligationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeaseObligationsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeaseObligationsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeaseObligationsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeaseObligationsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeaseObligationsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueThereafter" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeaseObligationsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeaseObligationsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/AccruedExpensesDetails" xlink:title="00000037 - Disclosure - Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomerNetVolumeRebatePayable" xlink:label="loc_nanxCustomerNetVolumeRebatePayable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_nanxCustomerNetVolumeRebatePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000038 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OperatingLossCarryforwardsExpirationYearStart" xlink:label="loc_nanxOperatingLossCarryforwardsExpirationYearStart" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_nanxOperatingLossCarryforwardsExpirationYearStart" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_OperatingLossCarryforwardsExpirationYearEnd" xlink:label="loc_nanxOperatingLossCarryforwardsExpirationYearEnd" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_nanxOperatingLossCarryforwardsExpirationYearEnd" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards" xlink:label="loc_nanxPeriodForSuspensionOfNetOperatingLossCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_nanxPeriodForSuspensionOfNetOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_ExtensionOfTermOfNetLossCarryforwards" xlink:label="loc_nanxExtensionOfTermOfNetLossCarryforwards" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_nanxExtensionOfTermOfNetLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesDetails" xlink:title="00000039 - Disclosure - Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/IncomeTaxesDetails1" xlink:title="00000040 - Disclosure - Income Taxes (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsCharitableContributionCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/CapitalStockDetailsNarrative" xlink:title="00000041 - Disclosure - Capital Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaapCommonStockSharesSubscribedButUnissued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesSubscribedButUnissued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AddtionalSharesAuthorizedDuringPeriod" xlink:label="loc_nanxAddtionalSharesAuthorizedDuringPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_nanxAddtionalSharesAuthorizedDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsDetailNarratives" xlink:title="00000042 - Disclosure - Stock Options and Stock Grants (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember" xlink:label="loc_us-gaapStockAppreciationRightsSARSMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockAppreciationRightsSARSMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" xlink:label="loc_nanxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_nanxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrentAndNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" xlink:label="loc_nanxSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_nanxSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsDetails" xlink:title="00000043 - Disclosure - Stock Options and Stock Grants (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/StockOptionsAndStockGrantsDetails1" xlink:title="00000044 - Disclosure - Stock Options and Stock Grants (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_StockOptionsAbstract" xlink:label="loc_nanxStockOptionsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_nanxStockOptionsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxStockOptionsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxStockOptionsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxStockOptionsAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxStockOptionsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxStockOptionsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxStockOptionsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxStockOptionsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_WeightedAverageExercisePriceAbstract" xlink:label="loc_nanxWeightedAverageExercisePriceAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxStockOptionsAbstract" xlink:to="loc_nanxWeightedAverageExercisePriceAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_AggregateIntrinsicValueAbstract" xlink:label="loc_nanxAggregateIntrinsicValueAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxWeightedAverageExercisePriceAbstract" xlink:to="loc_nanxAggregateIntrinsicValueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/KProfit-sharingPlanDetailsNarrative" xlink:title="00000045 - Disclosure - 401(k) Profit-Sharing Plan (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_DefinedContributionPlanEmployerMatchingContributionAmount" xlink:label="loc_nanxDefinedContributionPlanEmployerMatchingContributionAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxDefinedContributionPlanEmployerMatchingContributionAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="loc_us-gaapDefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:title="00000046 - Disclosure - Significant Customers and Contingencies (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplyCommitmentAxis" xlink:label="loc_us-gaapSupplyCommitmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSupplyCommitmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember" xlink:label="loc_us-gaapSupplyCommitmentArrangementMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplyCommitmentAxis" xlink:to="loc_us-gaapSupplyCommitmentArrangementMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplyCommitmentMember" xlink:label="loc_us-gaapSupplyCommitmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplyCommitmentArrangementMember" xlink:to="loc_us-gaapSupplyCommitmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaapMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomersOneMember" xlink:label="loc_nanxCustomersOneMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomersTwoMember" xlink:label="loc_nanxCustomersTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_CustomersThreeMember" xlink:label="loc_nanxCustomersThreeMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_MajorCustomersNumberOfCustomers" xlink:label="loc_nanxMajorCustomersNumberOfCustomers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxMajorCustomersNumberOfCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantSupplyCommitmentDescription" xlink:label="loc_us-gaapSignificantSupplyCommitmentDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSignificantSupplyCommitmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:label="loc_nanxPrincipalAmountDebtAcceleratedMaturity" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxPrincipalAmountDebtAcceleratedMaturity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades" xlink:label="loc_nanxEquipmentSaleNetBookValueEquipmentAndUpgrades" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleNetBookValueEquipmentAndUpgrades" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:label="loc_nanxEquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_EquipmentSaleNetBookValueEquipment" xlink:label="loc_nanxEquipmentSaleNetBookValueEquipment" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleNetBookValueEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:title="00000047 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaapNonUsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_us-gaapNonUsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EuropeanUnionMember" xlink:label="loc_us-gaapEuropeanUnionMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_us-gaapEuropeanUnionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaapNumberOfOperatingSegments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNumberOfOperatingSegments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000048 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaapLineOfCreditMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLineOfCreditMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20161231.xsd#nanx_PaymentToRetireCapitalLease" xlink:label="loc_nanxPaymentToRetireCapitalLease" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxPaymentToRetireCapitalLease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex10-32_img001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-32_img001.gif
M1TE&.#=A, ,@!'<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M!MTP HXP"(/ "XV0#.4 !$WP"S(P!L,P":Q@"S,P"^C0"AGP"8Z0"*KP"X!
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MX"F>Y&F>Z$DX^%I#[,E#AV@B_@JP;; )-* +A) &_A (FM"?_& -5# -ET
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MUG:0"[PPUW5]UQ0=F%K@U[V9#XS  X1MV,:)V(8P#<*0"+;UV)E "7M0G:P
M"9?M!C.@"YS=!#P VB*P"*0=O[41#A"4VEVQVHO8B+"]C+1]!UGW";&@"NOP
M#3/PVPM !\(M!W_9RT\ "3V0!L^\":X W5YPH<&("]=-!]/P#VHP J70W:UP
M"^%]">&0"PYPW@'P"9L@"^V-"_#] O*=!Y0 !/<]!_E- */ "2XP"F'@"0+.
M"<+@#[E@!#X !@J^ PW^X!$^X;1@X<V0#AJ."6[0"+5P"!\>XKI  G*0#(C
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M:+OA9X#R*@_B(AX"<N ,,3_S*W[SLI#S.]_S-7[C.=Z20Z\+12_DND#D /$
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MT-PVZ* &98"N"C; !"A<X0LV# $:J\/G+QH1"$^P813QT$4:7C$)W:D2D^\
M!1P:T08@ ,)XJ^B$');7O!,L(GI]0$0O1$$(73RK$I+P!3)ZP04_U (79P "
M)=))A41,PQ***,0=I("+4$3B&?V0WQS>((,^H&(5<E!$(*8!C$LDPAMM.-<
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M@ UDT 0S2(% 8((16(1"R(=_,(=R$(?Z\\=__(?Y \B!?#.AFP3V<(\_J(=
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M_TY(!DTH@V^H!FPX1$58!4CPA3<0@F8(!C- @4D$A%NX!'5;AU;@Q$Q8@SQ
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M)YP!'3Q"+]B").S()\1!(OP5+'R!$;3"+V@"$;2!'KA!%BC_PC0 @BO(PAH
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M17 VK,_Z/^C#)N!"-!!")=# )41"$>1#)2P"*=#M#<Q;!)S!,ZC!'+ "3HC
MK/6 %-C"+> !(6@#/R1!#8A""G@(-N3"&YC"/_"!H8J!#&#"* A#(U!E*%C_
MP! $ @2DDI#X@2O40Q?@LR*(P2FL@1;<@R(<0"M\ S$9 :I^PR)4 SO4@B&T
M@![P@B>@ !&(@C>(,0-4 BJX@BM\ C;0PWVK<2>48B_$@7^_ 3V50!%4PR-\
M@RDX 2Z,0V=.)38L^+?&@3A4P@*@ 36DP1STPB=4@85'.(9K."\LPPMP@CB@
MP@+D@8C7 I*- !;\ XI'PKX8P2* PHMW@HS[08T; A9 P3,T TSQN(\#N1IT
M$ X4.2 <N4X3 P8U.3= I24@@3<, Y5_PBU$ I9K.9=[.1N401A0 IF;.9JK
M^29HM3^T@5?K@9Q# AJ@P2?X BK@N9Z'@8CW J"___4MQ((E!,&A.[ OTD*"
M!0(O2$(W2'H*[$% [H$CN *FJP(S( (=" (@P,&GA_JHXX(MV,.II[J2C@"K
M-S.M_SY%R#KP=_8]]*PQ $(EZ( G^#JP2\*P8Y<,I (I''NROX&+)P,*>($B
ML$"TWX(<5#L_""4KI, @\((UQ,*WA[NARD&YGWNZ_\,LL+N[PWLOR#N]XS,@
MX+L0\;N_ SPM, % Z$KQ;5$U=K0HM8C#RQ.*)J*\]>O%B$$E5*Y<?<+&[HP:
M?THZW2$$*XZR?VN&D"HAI5HG9::<X!J7Z\:A1=@2<2)%(XZX2@3H=%,CIM<G
M()/^:7LS1M4$,KR*O8 D#O_5@CR*$M52Q:N$D7_*=$4:0<O((E'W$'6J]<0/
MJA9RZ!@PA 7*LV:";DG2U,H2&WG U"QJA4,3(T#6$-E11HQ9G1*0N$7J90F)
MMV%I4GRZ%:E5I#VQUN4J,^H3FS)A*%DB]8[9F$EHK'SZQ0O6IC&V_+5Y$TO/
MC$>0T*#YY M5)UVL.H7!VBO9J2Y-;L6R% 2-FS=; &F+I(M6&".!>$GJEJ_3
M#C-K4NSQ]6J/(U?3B"52Q0P1'4& X 1ZUDN0&4Z#IL#%%GN,^40,'@#)8P1%
M CGFGW/&^4?""2FLT,(+,<Q0PPTY[-###T$,4<0120QQ&'#$(4?%$EELT<47
M88S_4<86[Z'D%V, J40'3R(I(I]*)"%%$7F2D2$54B(XXQDU^"CEGF1*Z$(1
M%J2PY18Y"-&&'REV8"6%1GBQ)I8W3/F'#QIBD4,&3$81II%%_IG%@B$"@4 3
M09SIQ0]7ZNG"A$*HB (0,4YYHXE[%#F@E6]VH(4)@0@R""&%&'(((HDHL@@C
MC3CR""212#())958<@DFF6BR"2>=>/()J&[ND*.HHY):JJFGHIJJJJNRVJJK
MK\(:JZRS$'EDK;;>BFNNNN[*:Z^^_@ILL,(.2VRQQAZ+;++*+LMLL\X^"VVT
MTDZCY)'56GLMMMEJNRVWW7K[+;CABCLNN>6:>RZZZ:J[_RZ[[;K[+KSQRCLO
MO?7:>R^^^>J[+[_]^OLOP $+/##!!1M\,,(9.>[8XX]!#EG"$U-<4>2344Y9
M91EKO#'''7O\,<@ABSPRR26;?#+**:N\,LLMN_PRS#'+/#/--=M\,\XYZ[PS
MSSW[_#/000L]--%%&WUTH((.2FBAAAZ*:***+LIHHXX^"HF04THZ*:656GHI
MIIE44#6GG7KZ*:A89T5**::<@DHJJJS"2JM??@4+$Q1VP<(L?1K99"TL3FE!
MC#8,Z(0)*NS":Y%#^&)CG6$"4P6'0Q!1!+$_O@D&FS%02(0;3&"AS)MCZLC,
M%454P62/7.S))8U1+.$C#3T,:?^$%M;$8*2-+S+Y!1=?#!DCE7='B0,%2X 3
MCCCCD.L#*U^2045?Z8*( XSK")DF$E6ZTP(37"2A!I].:OB#C!/4>^4,13@!
M'_D@A@Z$4,3#?-$?2 !(0 3ZA!P0-(87,,A!YS '.5:600UND(,;(IF*,-A!
M$8Z0A"RSD3$440D:\$@*^ZC$)G(!B'74C!05<,.2YL *?4BC!%]PA N*L(I6
MX*%]6_H!*U8PB%^(B0]E>H,.<H&''42B39F TRPH\(0ZM8$0TM"3*_#QA184
MX@I 4 0>8 $&++A#$1)P!:-VP01>G, 47*/%)FS0!UQ  @5!$ 4VCC&V1;RB
M$(7X!#/_V+$'->QC"IVH@R)XXPVWY0(%1:C&([YQ*G#D@@::J 0S$@&)G="!
M'(0@ !J$0I1/1.$0M0+<4Y Q DB$XQ00&(,C.+&+6]0""D 0AS=PD8@EX*()
MA!"%/S[AB%T(H0BP",'E(- ),VS!+H!0!2$&H8KBV6,895C$+T[7"$=8HQ%,
M*(7K^' %3W C$:CXA!"\@0\QV. 1B2#$+RX1AES<(Q9IB 4ER#"&-E@"#;B(
MAS;8D E$? $1N-B%+!YX/4V0@23;XP0=Z#"<4SQ"%::@1!\BX0E2.",57H .
M^O0 !C(LH1+3<,0M:+&'(@""%BVM!R5^P 0PJ& /L%C%&001_PCX>$(7W&@$
M'12!B3L$ AJQZ(\G&I$%7+S"'LOX!!].H(@YY$ 1EW!0.RY80K&.E:PD^J#)
MRII6M8ZU92@DQ \\H0@OZ..%L:C$.J1Q@R,=@ S/,(,81*&/:,P "9BH01!_
ML09"8$,>57 !*)*X1%+,H4Q@< $MV! #0O1"&)80Q#]$T8 L7(( >B#$-DYA
MAU;LXPLKN,44BA")-XQ"#V:HAR(2D A3W( 7?Z#%#4 AB&O0HZ8I.$,M6@&%
M(LQB&H$<1 8V80M(&!*1<5AD%OH2"%V$P1K_> ,2?%'&:S2"%:;H B_(00L[
M98D3@8@%#9"""0+$P:]C&,4CM-"&?_]TXPUU4$4"GG*-$22"EK8,1"MXD8A7
M*,$+X/"&+ IQA%\001&EV,<C+K$+)'C!F=#L!!R64$U=*"(3JLC$&[B9AD7P
MXG3)9$8Y6>&Z-2QAG9!XQ3N5D8\YF ##@OB%)_3)SS+$0A)@D,,D&K&'7\2#
M&FNP1".^P A9U$(7@\"#1,' -HMB5*.?6-0F^H )3^S"&;,PZ;Z"D%(W*&$1
MUE $3/?@!$&0XI/]D,0/L "&&^SA%*D(0R44,=1?4*,1<0AI&0+1C%STYQ*-
MX (N4*&/8C1B#2=PQ!M T-6OAG6MG?:T6,\:PD^/FM0@L\<F;J0(0-3 $X#H
MPCWJN@B\JB#_%+F00%_M,(:S& ,*A95!$'GA!D!X0QY 8 %DE6@-6E#V'VZX
M[)D$ 0MA/((0_V"%!++@"0'TX;2I76T74G"+(Q0!$VN(!1K4  Q'0. 2N_W%
M'T@A@UETD1ZD$$0*W$ *74!!"K/01B ;80!*V"(1U&4'NO?!!4N P1.%",,T
MO(N$7FP!"-= A"C,^XM_T((!FB $-SB!B?<RXA^>F&\VS&#?1QA!O\U80QK^
M^Q1IC, 3!1[#)73QXUEDH0L.AG 6)ESA?73B$K78<(<U 0%#@%C$)#8QBB^S
MXA8[XL5,8 5C9ESC&PLAQSON\8^#'(LA%UD.C$CRDIO\"2A+F<I6_\:REBUQ
MT8SZXA1>_@:8Q4QF,Y]T.NI;<YO?'%,YD^(F=L:SGOGL9T!/ QB>&'2A(Y$(
M1"M:$'!H]*,C/>E*7SK37OT'6$5=:M&/OF.A)OWI42^B4Z=ZU:U^=:QG7>M;
M/R/7N^XU)GZ]BF /N]C'CJRRF>UL6D!;VM2V-K:US6W4JG8?X!8WN<V-[F$X
MP@#MOL&[XSUO:=3[WOG>=[__W8N #[S@ASSX(A5.!D^XXN$1GWC%+Y[QC2?
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MX>)*H0LTCA;H[^-"[KT0H>1.+N7NR_\ ,.8&D.9LSA-4X<<4L.<>+,)X00L
M 10D4,.< .GDP@S_0@P:%&$#38P//)#%0% 1L*$1C.#JF"'K2O 5**/K4E 0
M=,$3^H 4^.D.Y- -RJX1S@#MWN 3,J$+V*[*Y  W#L$-3D$/7N 3Y*[+OBS,
MB-#,B, 58N$1F@ ) <\5!&_.FA#/R$ &S@ 50B$,%@$0&,_Q",T*TP +*^\2
M,@'SW*$8,F'SW@ '','S0$\-6;(E_P$-73(F2>W4= $9'&'5+D$1NH"N)"$7
MYK .^8KV\- 89D (,&$'I& 5?N$, ,$4Y"$*? "R$"%,EJT4FNW9:"#:#!&T
M#B +$B$ 3&OY6L$=K$ %7&$*I  3R$ 2IP\!+N$;5 #[,-$9N&\350$*_Y(@
M%,*O$1: $E*AX"P!&^C!NA+.$M2O$/H XLC "B:N"IP!$5A!&;Y %^9/$P"!
M&B#A_EJ)M.C+#L3 %U:NY5Y.%Q)@#7#A&DK $\#A%!9@##"!%WCA$G;."LR!
M&7:!$Y1 %N!@$4;!'R@A$'#A"Y+ F00J PR!";8@&YQA.P"A$70!$>;@'H:A
M#B0!%W+@$#*!$)1A$+1 %$90ZPS!"[QA']C !#[A$@BA%3PA#FA!'T9!#>CL
M#/" $0;!#71A'JA!#AK!$)R@'A$A#U;!'0:A#U[!#58 $0J!#N+@$WK!G5K!
MH\(@I/2N"Z* $T9A$_P@#LC #:9 $MRL$&CA#/^\H!)H01*PP?"PX UB  Q2
M 13 P! $81J& 1*J,/+RP!.:P=[@P!,L(0M4 1;VH;/6 $'X0 0B027'4":5
M5/1@<DF=E*SL@1)NH1@P01%V ! PP0G<01 JH19^LM8:P VRX0_D(+", 06T
MJ :\(!54H0\ X17D00MB !1.@!%J01LF2Q3^X0QT8/BRLA>*X1$^:Q8BX @X
MP07H !"V 17@H!7XX0E< !*4( D"P0W.+0V.01$8(!"8805^P0]H@=86(1O8
M8='P+1>2JPM.@1OP 18RP04V818\@1,DX1OB00^NZQ/<X!(2 0VTX1_Z@,.6
MH NT@1&401NLP!7^(1;_$$ 3' $:+D'D=& /Q"$0%D /NL$/\&"C</$-[H 7
M$( -=L$8MB 1S@$6?& ,%B$62"$01($+A* <K*$6(&$):F$,*($7W*$2P*,+
MI* 73$"@$H 2D#,;KB$0KDF)-$$.[N$8\D 29$$$#J$1!,$4&N$AB $;5FJ=
M%&P3D@ ;]H$/6B 3+@$07,$3T* ]?4$-:FH/YH 1$ $,="$=J*$.!D$2DH#M
M?F$0\N 5].$3T& 5WD &#L$5%#038 $<'Y02(G0@NP ((&$4*@$.T& -SN (
M-N%#0[0+%J%$;V<38B!%=8 ,0($5:+"ECH$3:A02QB 1FJ&FS. 2'B$+"L$7
M_^IAVMZ !PBA2#$!24/O20$WK9HT< EW@]:!$@I!& +!$62 7Z7 '0A!$&1!
M$O"*!V8A%RI@#[+!#W)('XRA!+@ $WZ@"T*A%=  $&)!'K"@!F:!!R8A%[B!
M%/!@%OYA#VC 3P4!4 7U'T"A 8Z@$&B@#12A&EY!#50A'9X !CQA"9S@$LX@
M%N(@#_H!$!P $Z;!!'@!5'D@%3;A&=0A%@AA!=P 5:& ,;EA'TZA$7Y $D"A
MX2J!%>1!#^!@'[+@$\+@$CQ!$[CA']!@&94 ";!A$IBA&Y" $_[!%PR@#2(A
M&:)U%'1@#<*A3OJ &IA@#E A-/\!&M9 #7#! /"@%O^*80H@ 1U.(0;$P!!.
M(18P@17@55[IU5[%P$;H*A!^X0O^-6#;( $VP0BNP& O014 06'%H&'S8!-V
M06(IUF(Q5F-)L&.E !O\X0U&-B=/E@Y4%@YH01!<EA$8@0QFMF8101*D0&=Y
M-M* UA;>8 >*M@W0 &F5%D(EM,RZH H206KA@ ZL%FNU]@RXUFN/ 6RUX(G6
M !1*X6R;2VTW,A+8%A+>EM$Z@6[M%F_UEF_]MG M&=10!(0N>9-5YG 3=W$;
M-Q >-W(GMW(O-W,WMW,_-W1'MW1/=Q14EW5=%W9EEW9M%W=U][-8X0&X !)Z
M( X @7B-%WF5EWF=%WJEEWK_K1=[M9=[O1=\Q9=\S1=]U9=]W1=^Y9=^[1=_
M]9=__1> !9B #1B!%9B!V>2!(Q@")KB"+]C_-)B#/1B$19B$31B%59B%XW5>
MZ[468O@7Z H3:K@( %9@=[B'K^&'@_@7-&&('783(A8[*_9BO9.).?85-N&)
MHWB*%:&*KSB+M[B+O[@.PGB,IVQG\\",T0"-U=@5V-B-+6%IFW9"Z=B.\?AJ
MLQ800-0-^E@2OI8&FD"0"=F0TW9MQX"1LSAN'[EN[_81\G9O1:!O-^UO.7FJ
M469PJ?JJ8\23%9=Q^;4((%=R*5<:+!=S-9=S=6B519=T6R%187EU6_=U8W=V
M:_=V_Z%-=ROA'[XA X3 Y-Q4F(\W>9>W>9\W>J>W>J\W>VEA>[OW>\-W?)-K
MFF&A$6K F@OA?>-W?NOW?O-W?_L7%I8 G >X@ \X@1>X@=%9@JG!"/"@G?7K
MG3OX@T-XA$OXA%-XA5M8GY6 GV6X$CR!%[[ "WHA!/) $T 1.9]A&Q!:B(EX
M$VCA!0YA$BI!B2=Z8]G)HC%:BALA)V_!$ZQ8'WP!B[7X94&:9D5:C!EA%]KN
MI'\VI8=V$FZ!C3\!%AST&Y@V\F2ZCJ>VIK'6?4 T#+R@:WGZ&"2A!HS@B<BV
MD#\!;1$9\B!!#(S:D;/ %2*9J2?YJ2L9JS$<9*PZPSE<1/^T>G%W@%^=P!\
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M"-^P#)[0"M^ "&%0"9R !YY _PVT0 ARP N 4%*^D _1P"8WH ANT *"X C
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M!A%U"K$@!I_@"JP@#9Q0"**@"55\"V=0"-/ "XB !9[P"%O@";0@#,'0"6/
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M"GN "JR0!97P#[EP 65@",80"70P"@OP!^50"0"0!J\0!&M "X8@!7.@H&P
MX!00!=LK I]@'Q30!(T "[?P":\@ DIP#L' #=]@4;@P"U@="M#0#8" GI_
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M<$0O*JH)>]##$9M !1->,8YNI $7W[C&/YJA"5*HPQ^C:$,E]AJ/7 Q"I_J
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M>/ $'+"#9< &/]B"*0"!G-Z"(_ "12@G 1[E<PMEN-7KC30/>Z $$Z@ #:B
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M&&-$W!QAP":N):10*1" T$@I/_K20@Q$%21/%0] TDP4 ;3BU!<I7.%"#JG
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MPPVFS0,9Z& %A#BE*!R @Y\6R08P& ,_.'&"#-0"(2%QAQ@:T 5C(&,*.?^
M14'B,0<7Z& .\#C()6X< QE@7@>I Y$O$J"#&B"_!FX+@U868H<&#($NG;C
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M"T !*@Q#$F3!3QS$++Q "X1!&CT;+,01W)B $'@"N_T#*L@ #IB ")@B"8
M&C2?0H"!#(A!S 6""Y#!/A0$./R""2R!(G2?0JS!#VQ"&/Z#-@1!#HR "+S
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M6%^,-. P WXFHBB"_BJ(: +__/'7PHC^^\<"@  D0A (& 4FW$$-:K@#$Z1
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MD'0LV/(D'%"A&))A#$[A[G)-Y*Y/4-H!$+X YP)%'$C!"X: "O8@'[K!#I+
M#V;@#J[_(1T X0C@H RFH ^&(1*<P ^DH ^$ 12"  6R@!8.X0MR0?ZL3\@"
MI1\:81**84[LH1!>H160X \"01GDX1V^@1-J81F X1M@@1/$X OZ8!2ZP1V*
MH1=VX1OR01^F(10B 1!080T (1;>@!:V@1< 817DX8_XP1+^8!4X 0@^X1Y
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M"I) #E0! K^+&S2!";B $)Y!#,)@$M0 $[[!#^:@#Y8 $"QO3I2!# X.&<C
M#V3!%\B &MPA#A2!$ZC #_(@%/(!"%Y@WQ1/#J)@&.2(DGZ!"0QA#9A &:R
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M%/XA&OA@$.CA&?" &NJ!""I!%.1 #/P@$N#A#_+ *O^A',C "G 2&&;!&?0
M#.)!%*Q %X[@$8@A#PPA%9Q $B(A"'I!&ZI@$VQ!$QCA"O( &]  %9R!#RJ!
M%** #NQ@% KP8E-,1^V4D;KA"$# "8  !,H@0@/A!L2@%J1@"9)!&C(@!NC
M%G"!![C@$8:!#W* $'+A"N3 %)( #K#!#C:@$XA!"BCA&Z9 $T0!";B@&O9
M![[ %?8!'SIA%>2O=\1!%:A !7"!$;# &RC!"8)@#H+A%91@#*+@#/I!%O#5
M#Q+!'H*@" 8A"G3_81J$H [:$Q&=8!*,H!"V00WTP X.(1T$00P0P0B:LGC\
MX D><A?N8!+@(!>&P0W*P G2@!L. 0B<F!;6@0N(P V^H!>R00S6@ R^X!DV
MP0^" 1/^( ZDH!6280K:P!.H]!2 H!G@8 U:00R6 1%>H!,J@5@#Q1FN0 Q4
MRA_JH @.P0P (1Z6@ EN01-,X!#J8 6\(1>2X!.PP BP01-\X!"T8142@1)*
M !88(00>P19\5!&\H"7^0!H$00 H00ZF@!CZ+WQ'#AT(H0N*;DZ>H6,/ 0^.
M(!9,X0DBX1],X04>X11&X!'^H1M>UA.@( DX 0V (!9DP0IR(5#4(1W*_V'C
MN"XSZ_9&[\%H;T$*',$;V, 0*L$,RN<1""$(VN 8!)$9[($2#@@7\J$2DB (
M&D$;&D$38 $-6N$4]F 2I. )]L -Z'5.^*$3S" 4?"$-U, 5$"$3VN"2-8$2
MDF$0YL 1HH *BN 72.T?]F$3S( *UP :XF :^B$,YL 3O( 7? $)-K=XF,$-
M#JX:]( 3_J$:TH 41 $*-@$6R$ 3L" -] $.X& 4YP02KF 3H $1TJ ;!B$-
MD$$1LH 4D* 5T@$1."$:_F 1,*$+$J$7JB 3* $+T&!ZO:$-OJ$>&@$3HN$,
MA* )N 'P?KG! O*WM(H:IH +WB ,NN *8@$9BO]@"7!2%G0@$:(A ([@UG)!
M!'ZAZ)X "SI-#$+@&1:A"SI!#E3@#7;!"4#!$60@#EJ!"W@@%/I@!3 !&N&A
M'2Q63\+A%^X@"(S #LQ &[JA$/Z@!+ !%;B % SA"6P!#J+ &^+@"XBA!,0@
M&: :%H1 %YAA"VH!&1QA$EJ@#:P!!*9@#5X!'XR $3B!!RZA3N=$"[+ &/YA
M#T) #&3 $EX!!WZ!&DHA&C0A#J*AGO%A"R)XJ04!"43A&40 $P:A#%+A#BAA
M'\3 "2PA!Z;A&+0 %6H!"D:!"OY $2Y\$6( "?"@&_X(&J!@# YP'9SA!,#@
M&"1A#?+!"3BA'13A!Y3_@1AP !<^80\>5@UJ81"40 %%80_BX 5B818B^QFH
MH!+.@!':X1V\0!4NX0OF@11&0!D64+#Q!!T4 05N@5-Z01B8  <L80Z&X""5
M !#^81;$.QG\  M4X0QL@ ]6 0F.8!/DP Z4@12>8!=J2Q0<(1NVCLLR$PV"
M@!)X816XH1$29@CL( RPP!,@(0_"P VB)@KBH!]>@0@L81DX@0O^@!O&8120
M( MXP1@F(0Y&X0T((1;68!/ H OD( Y.8=[D%A&NX SPH OV8!?X( _J &'[
M(!.HH0W&8!&T8 WPH RD84Z.00\,] 7* !3.8!J$@0_P(!3@0 O$X 4D 0*+
M_T<9V& 4_N$:W. 2_@$8Q@ +SF (*$$5G'02YZ$-9L :_@@8], +[* ('F$>
M0$$-WJ +^* ;O, 5XF$2;@$9B. 1V'H,WH /0N$2L" /MF /J*$3F $?%$$7
M[J$6N& -O+#+0XRPR7>1>E02X&$<IH$*^& 4EL ,?LT;8& 1HD$ AF!.LAP4
MYL0*W*#3^* &L@$5H( *$ $-CF (M$ >#$$%RF 1GG4;PL &5(&8+Y!WPD$5
MW" 5D& '^* :>N$3Q" )K,$4SH >3$$)(N$/!.$?8F$)A&$*".$?AK@2J  ;
MWN$)=&$;Z& 2K  .\"$4RH (%H$:C. ,!N$/6F'>BO\GON?[#:B $!XA&0HA
M!)8!'+@!&6B3'1IA#?J!"V@!'KQ $#0A"NKA'+X $"8A#R!<%_YA$+@ $49
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M2^90#K[E2.-@#G%#6&],#IC63- %#_&Z#O60#O*P#V"G;_\0#OH #/2P#OV
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M#V= !&\^&X40"+$@!VF "':0"2A"!WW)"6R !(L "4Y@!JT@%[H@!H<P"62
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M.,<_U)$/>(2#'69\1SO^48YYE,,A\& '=V1(DG+0XQSJH(<YV-&8>5#.'HX
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MD 0OO  'E8!'*M3@B>WP8Q-V^$9#VF$-3-2"$U5X RW8D =37$(-H&!'+NX
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MT,Z44>V5WA7GT4!HA5?XX!*6\1FG\1H'85!@!0HF85$HA=!5!F=HZ&IX!E-
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MF,,QQ!$*)C0"#'7X1F7&$@])%&&4U&C"".!@AA&(X W/F$VF_L&.5<!!"I0
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MV'3!$+06"C3".>C#%\C &&C"'BC"+70!",P!'?#!+6P#&; !KYD!(J!#*XS
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M%,,2^($AC(!NU<(Q5 ';I4,>L( H^ ,0< $TP((.B $:IL 7,,,OJ, >E(-
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M 88 &<Z #^+A("0A"03K%$8@%J;!"B!A8L"D';R+&ZY!&AH4$DP !Z8 #/.
M$\HA"J:@&; A$H;F'QHA"0SB%ZC %M"@!B9 %KA!"4+R"L#0P[0!3);!#O;
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MX!5B(0>:0 R*H!"^A!OJH)CKH0@"X1:$0.@(CPH\00X8UPS^X PT_!^*0 U
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M&@@!$(Z!&BZ!&\ZW%>1@$(QN%K2A%O[A&CQ!&:86%2A!#*I!%90!0\?A#80
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MGWS48M"!Z 4]N!$)3-A"Q^TH!2CJ<PU8Q(,5KBA$H9J!0#WCP[GDV(<TB,%
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ML:")^\ -,X,,^S%[Z8"KJ& *RV ->^ &UX"EXB /H: (LG ,ZE *E?\0";/
M#\2@"[\0":MP?[7@"+,"#],0"96 "_C "FL@"Z4P#?" "I4 !FK #<B@"(2
M"=W@#$90!J:P"_O@#ZU "9PP#/J@"I60"+)PH(00"+/":O]P#J @")8@"-(P
M#&9P!]:@J'OE#L/5":NP#[20"(K0"=VP#+N@"):P!JDP=H 6"9U ":=P#:Q@
M#^,0#:6P"TU@!H] ":'0#Z@@"8B0"-2P"'_@"\Y #:_P4+[P"L@C"K!P"5KP
M":N0"LCP#8*P"95P"LW@"I:P"(O "LM0"'W0"(FP#"-R#KV0!X2 #;S L9L@
M"]VP"&D0"<* H?\)N($[(LX0!ZY :^"U;;;_=0RZ, A[H FI0!4.:!G)(&$
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MRE )E2 )DJ ,J4 $E? )<0 -S, &>O (J  -C< (D1 'KZ *:: *KH +IO]
M!Y&0!U_ #*: !HW !X_0#7 P!JB "-"@"&W@"72 "Z$P!WV@"I.P"M,P!&>
MSZ0H#MQ !H 0"W&P"-J@!FR0#>GC7<%@"(K0!V30#8/@";FP!JT "(>@"X$
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M#X_@"/J0#]W0T.9@+IS@"T80#<[0!K-@#2R]"+G "VX0,83N"6RPS9'@")5
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M),&CA#M6Z<06:8+PX@Q;)"X%BGG^ 4>)0C ##\[0"V(2T0,A<.$)D/B'-7)
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M!7HP''\(A-^)!MHJAUZ !73P!CW(AD((N7D@A1I"B7H8A52 AFF8!6/H!GZ
M!75KBFG@AQ."!EA A6@8A_]FR"Q^D(9X0(>V>H5^T,]L8 9TB(9DL*9^L(55
M$(9@$(9L( 9ZZ 9?2(9T. S#@ =D> 5A@ =Q: =I> =PH -8F!!Q6(=Z\(=]
M: ?3_(=T. :\] =PX(=]J(=U" ?L+-%Y:(=Y&(9^6(=QF =]" =[Z(?((0=T
M(%=S2+QWR <C>962TH=JLYER0$M[. -;/8QQ\,[J4 =RH(> &0=Z8(?",0=U
M,$%P*$_N! ?S%(=P4(=Y. =R& ?V=)5P.(=V*+,2I0=Z,#.6%0=7"4YZ:(?6
M.8QP0 =U@$XN<4]Y:(9AX#XNH1!P.(=R0 F8S=JL)8=P>)5P($^8=4_]G+P7
M(T__P^C:KO7/8]"%3O@$3-B&R8M/B:&0%VNDGQ#:>8@'F:00KHV8IB#;P&.*
MIO!;+IE;NIT8_<PR(8P8L@5.BT&. CH.<\ IR)T8O[7<RMV8RVW0S0VBP^U<
M" U=T1W=B1D'92@%<(@&W0H'8E %6GB%["0%0'(&6Y4&=SN;<! RT3N&="4%
M"9&'7="%;, B:;B'?[B&9C@'=] &>Z 'O>R'D V&S6V'96A7?#"&:G ^;44'
M8DB&9]@&?HC*;  &\,2'<2"'YOV'7\V'>!@6?:@&UFD'O6V@*%A<<4@'XSL^
M8""I52"#4D@%,#BF<J@'? @5<%@'?1 '<+U?:TJ'?LB'_\E3!W:06*15!X@9
M3'1 !RZY!PD^7W% AZM%#.$<AW!U67'X3FW-3ZQE!XLZ(0_.SY.@A[EZGL2=
MNU#QG_\\B2V9$+IMX<A]AM#*W,@5W,?M&- UW,/-LKP !WDH4,)5XLM-XB$F
MK"AV7,S-7+\-!U>IW"0^XB-VW"^.F',8!FKH!F+PX2LV7.#25LC]7+[55L\-
MHC@&X[.Q8C:&8\*]8S9>XSWV7#W^8T!&8D >9$(NY$(F741.Y/ KT>]TV8BA
MDD8BLRYI'1.&X[RPF;SX6@I!!YOQSU=96;)MW+GE&$O6F"^N&')@AV/H8XK!
M!S2P BG A 8;936FF#QN8SJF9?\>QI@^[F(E)F+D"#PI_N4_WN63^,]"'EO]
M-&1F;N9BYF-GCF9IGN8[GF,>IF9J/HGR7-S-->1KQF9P!F<_EF9!#N=R#F=T
M9F5%7F=V]IC K>-<%F96IELA%EQZWN-TAN9IUF<]UB%OL 9 .MIL_N9T+FB#
M;F9^/FB%7FB&9NAQ;NAGYN,KAFB*9N:'=N9SQN:,KFB$;F>/_NB+>6>.EF2"
M=NC@'&DI7N9]1HE]2#MU!FF8CFF9GFF:KFF;OFF<SFF=;F=R"(9H (=G,(Z2
MSN=_.(-22.AJ!N8UQMRY984VL.52)F+#D6.-J>&,J>*)N80C>NF=[FJO_FJP
M#FNQ'FO_LBYK"&T'6<@%<_B%"OUEB=;ECGF%YNH8<[#5?QB&R3.'G\V+=C"'
M?,B&658'J(77-2B!W7"';% ;Q,B';L 'F/6':QB&84$)<$B&;!#%]- %:C %
M>JB':G@%>9@'6MB%I4B.0 @%H?6':? $9HB'6JB%1I*'7\ $XWV&B2"$>I '
M(HB"(*YGL_YMX YNX1YNXBYNXZ:8:C"#//"&2Y #1["$4""'>C"$3H@$8O!;
M3@ $3N@$ IH%-D %8H"%0D@$75 ':.@#0Z $3Z@$1%@?3@B&?= %7 @6?" %
M6BB$7&B'6<B$47"%:GB';D*%,/"&<< %49BK8P@$0]B#3' '_V&HA$BX+FGX
M@QF A6]8!%AH@UZ8X5/8!%@@!&; ,3. A8#YAV"@A%U 17Q8!DT A$]( H0#
M@T:@!D?8!$6@A&M(!420J5.HAT/0@T[X@TK !#G(AGTXA$4(!$VHATL  T\(
MKVB  R,PB:@^;BN_<BS/<BW?<B[7&&  @SBX!D 0 U1 @S_8ASW0!590!$NP
MQ[R0 C:8A3%UAR5JAD28@UG0A3*@!5*H AST E[@!2K8!B<P2#6@!$#P!E-@
M C)H!5, !2S A&F@A#78!SY8!&TX@SW !SN8A5?9L3'P!%@P@UK P6@X!?ZF
M RNP!C(X@U"@A#+8#1UR UW0!U20A/]5: ([ (:KC2!>\ 0Z\(-7V(1)\(=0
M>(%HT 1%,(9?^((SZ(07R"8D<(4T&(-5 ()&V(8_"(1A  18 (4L: -!6 %J
M6 1(T =6^ 1D0 0=X^HN?W=XCW=YGW=Z1V1ZX 19& =(>*QG\ )C: $P^ 0[
M( '=R@LMV(5_0 8W4 9M4 9RR(1-^ =T<)Q76(2]R ,)L8)G, )3J(=(D(,S
MX 9Y(!D]F(9;L(*\:(8A\/%KV#$AL 4]:"Z4* 9-H(9S$ ,T"(3D.H=>N(5*
M( )W, -#@(50^(42WX8V((9_@(?[@(-'R+)Z$ 1*T 0WP(4ZX(5_H(<GV(9!
M4(9_X 0S8 3_3G".1=@;!B<%-> $?Z"#;A@'HJ$%*4 $1V""99"$6!"'8< $
M8'B$2;CF>O][P ]\P1_\>G^'0-B%<M %?DR&(D &$D #03@$-< 'O="""KV&
M-J"&;%"&=MBKK&^$3T %XZJ:>0@'*\@&+2@%=Y@%6H"#2F"&4["%.-"#3XB"
MM.N%(L"'-N [<0@"->"%2LV+5$@#:YB')-"$B?J'?FB#^2Z"=Y #1L ':/B%
M_M&A,A!!4S $6R""OJ>044#V4K"#4R"$)AA)*$ &HRJ'1[L%44B#I4H#:J@Z
M4]""2.@',F".9@"%;X""1 @%(+@&@*"$:)XP0<$&P6%';N'"?PX?_T*,*'$B
MQ8H6+V+,J'$CQXX>/X(,*7(DR9(F3Z),J7(ERY8N7XI4URB/M$*R_E%;<DQ.
MHE6N7JE["*=+HDF.YGFS]4^4F$26^"@;%8?<O#SQPLWH%L44-4.O,KFJM6A:
MJTFV)%$:12;1/CK-',)"80WBKC+0YMV!%"U.JTZ'BM5R@FK4'ER> J5S*&Y7
MFUM[7L63L^A?0V=D2'&28PT8HTUI5BPCE*I<N5N2-J%Q!JU1($J^A&F*I8_0
M,W/5H*VSU*G2F7J_:)6K5ZO>J3QO&9*#J7PY\^;.GT./+GTZ]>K6KT\4%VJ1
MM&;=_N'S5.Z:($**BHD3BN31K6+_B+E'!__*TB)FX:*%(H?.%SIQE_*1<DP\
MI'CR"S'ME$*++\_\XX\LO)#"#CO*W/./.=.XL0]ER=7CS3WG>&,,.=@LT@HP
M_\A3"RKG@!*)+/8XE-P_S!#B2V+:;+.A0]%<8DLT^4 322)V6%&/,4']$P\W
MH%388"C=P'/.,NZ<,\P\X<#SCH7<E!+//_WP\X\Z_JBC3C?+;-@0=FNRV::;
M;\(9IYQSTOF2C Z!<V=$:EHQRD,RZ@G1G8%61*ABW\!Q2CEI7F1HFFK&&"-#
M$C&SARR3H-*.I((Z&BEE@GK*Z:1UDEJJJ:>BFJJJJ\*)7'*NPNJ0(]P\"JNM
MM^)JZS_@L/*)AK7_YAJLL+'^L\XU: ([K+*YLMJLL\]"&ZVTT[ZY+'*2CHJ1
MJQQ=BZUUD%(;KKCCDENNN>>N9"VS&6V[T;;=1M<NNO/26Z^]]^);I[JX:B0O
MN_Q*YV^^ Q-<L,$'(]SHOKK^FVW##,<+;\(34URQQ1>ONC#$"CNL+< 1=XRQ
MR".37++))Z.<LLHKL]RRRR_#'+/,,]-<L\TWXYRSSCOSW+///P,=M-!#Q\F0
M..)T2K322S/=]+CB@%/..> X7;755Z-*+-'BC(...N-@';;88V-WM-GI*4U.
M.%*'0[;;;\/]4CCC@%,WVFD?G73<>\.DL=]_#[LGX(,3/CC+XIBS3CWT_^C-
MM^./=U2XY( +/KGEE]_*,CGBT*./II"#'OI'F!NNKHZBPJNFZGJN_N>>$X4\
M*+CN@KKIRZ^.T[CHN^\>Z.RPZQYYO[\#+V,[][Q*ST/HG).<./PDYE [6NYZ
MCSD.W9.//@Z-8X\_W]NS:'+TN*,.//*T#<Z'SK_CCC_N^S/]/M_GHXXYWON3
M3V+F^*,/.N240Q_R2 \R0H&-Z*6,'. (A\1XY\ 'CB,;O\!%+I#QCW (8Q>Z
MD$4MG$$.:@1"$\I 6S;:, AJC$,>J>"%+EP!BG^\ Q;U.$8N5+'!8&1C%ZK8
M!2\*(0U5] *&F"@#&7QA#GK((A#F*,>#V/&I?__$@@]UF$0U_@&*,?#A#H;0
M4'+,$0LX% $/H%#'(QR1&$/0 1__,$8?QO 6=22B#_L AR_6L ]QZ$(+7R#"
M(/RQCSX4 0A)>(,%DP,+-8 B%F7PQC]8,8=D..0<@I!"%?P@!2O\HA%22((3
MEH"*8X"A"$[H@ABT,0PMW.$5Y_"%&C*1#E$0P0]>@$,P5@8.<^0I> _<)=S0
M(8@;[. &6)@&.&0!!2?<( 6JN,8?9@""(\SB']W00@M(T 5F%",(5V""$Y"P
MBV4X 12OR((4FO"$/@!B#%XH 1* < LM, (>B"@!$ZH @D#PPP@FZ 4\\)"&
M,#FD%S/P0AE.0 =P&&+_ E)0@R7R\9!F3 $)91!!%O!1AB!H* DON,8_6M&#
M""CB'_Q@@PM^\8]!C* 9I,C!$BJA! /40AI4* $>WF")$R5'$"XH1"4*\ 9U
M!*(%+_S'.+P!"3/HH V>6 47GH")5@0B&MBX@AEN@0@H .(:"1  (^(QAP
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M80IG9&,(3PA#'"#ACD^U5Q>"N (<C'"*^D9*'+<@ 8/Z4809\,$-OM*&$)#
MAB"801O.($$0@% *$)A!#/*@!ANFX 0Z<+2!'-XUK^NECC.,X1_B@,05;*&+
M(ZS!#7&(QC^>@0@_<*$0W!B"+A03CF8<@0I,X($8W&$,*,2"%"(P0QK$@(H
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M&/A!KHG)*+BA0UQ/1,2#&M"!\OP#)62!-Q(5G')/>MS2/]Q#).A9F0K*-+S
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M#4P #Q0!")J ">3@&Q(A##@A#8[ "PQ!& C(%]C@%C#A#NR@#B#!&R2!":S
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M5F$/M  -L& /4 $1$$$1BD +HD$KS&$6Y$ /0O<,_UQ!'V@C'SKA",# #89
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M#SR!#BHA%0+X&\"@-7+!$N" #F*A2E!!$\: $!J!6/! M8<W%?*@$13!"IJ
M$(Z!-O"A$X* %%P!PH%:%)0!$=96#Q;A#EXA'@:!"33!!IB $=A@$5*&J\8!
M-?E &0HA"Q@A$H@ %>Y!#RQ!%')@%]@!$Y! '=9A"RYA'OI #+ A")1 #[#@
M"! A$9[ "C0!#F#!%(8 &@A('$1A"ZY@$/Y@"S3A'MJ #$BA"KI3#T;X'%P!
M"%C!%H! $!1A#=!@"(I@%0Z!#?^ (!/V@3;H01":8!=N80R,H1_B !8"(0Q(
MP1/VH B:X!7"=A3>(!/6X!!8H14: 1#>0 SDH ^N.!-LH9N?P6*^.(SC0!5<
M 0]802OB(1#<(!5LH1$Z00_R #K48!/(P _6@ U:@>3^21WHX J*3PNX !_X
MX0W: !>@8!5FHQB^H ?JH![@P0Q08 0.(1)F( IZ81IBH KZH UL=162  K^
MH!Z*8$3_01"J !I^B)?X80Q:@ I*P 9ZP1IV=!%*H!9H80K.(!X<X08P@17*
M@ R8@0OF@!JJ8!EL@ =HX0F2X0_*X!>6(! 4(0?  !BTYQPV@0]F(0.>(! V
M5=+WP0K_PAD1_2@7AF F=V /@,$)IX 13.$%..$2I$ &-0(6F. 91D$&=($6
MLF CSZ ?HN )VF#8"=,6\" 4LF 3[@$(Q  9FH$7GF ,0*$+PL >F, ,-'H-
MWF 02J :ON$.S%1 :D$&?B$19$ 4_($,<,&EI2$29'I:LH$*LH$3G" :'H$*
MG($2<. 7Y  ,Q@$,L" :I  +D.$%$$$3H, 7MF 2T.$3L* >R  (N $4$&$&
M[  :R. -]L$+1N ,HF 2;F$+0H$2GJ 0Q-V/CN$+[D(+$*$9Q*#MR.!AV^ ?
M5F$+B@$)>"$<BF 0 OL?!EL2- (>^F %UD *F, ?UD 7X$$/_^;@$5Z &/X!
MA(T !HQ<"&2!#B*!-OSA$=* "/(@CR7O$_Z@& "AM35A"\J "RK!$$: %JRA
M#Y*!&;!@% SA#QH!"R#!%XH $_!A#=J $<A &T"!"] @@6(&(,@)_$?PGSP^
MDH2UF52,(+E_W@:%TG:H3QM&U$R!B76.8#E<4C:MRB,G#A8\<@[=TN2H5*1>
MS?JD05,GS)E&L<[L"87HCB$ZN$"IP5+MWT-SJ<0 2D5GS!A0!?$9TM)+%]5M
M9T:%&:+ISQI!:A)1DR,%C)(UL@#Y&J;-WL-_XT0)68.MU91#JII(>O6FU:PG
MS]!A^F(N79$WONILHA<&0J]'$SYE8__BI5.?C$B2/1QH+TD(5G)\.!*GB4PN
M()24Q4%ECN"Y7US ((KBBL^?14"*,--U1(2K=D;_M2ODA5(@.<;JH3GE:0\G
M283X,/'5\:$O/HDHF9GCIM*E-&_VQ%G5*=,J,'RRO05&R%6M0Z1XC>GU]EPH
M/GG8:,K5)L^K0'=X4HD;>KSQ2FL%):C@@@PVZ."#$$8HX8045OB/.HVX4,((
M,P@B3C!#^%+,"V&H0Q =/:SRSSI:D"&'$(S,<<<HT] @Q1EQ'(B*&)QLD<D2
MW1"T2!'4%"300 FN(X84O$1B!1JC7(&-/$-,XHD4J/RSR!?W2!-%(N(T<L0H
M=2!RQ!5^K&'_CQ1(D %")Y9448I##[WR!1HH6&&'&>ZX(48^5B2231;?&/50
M+%:PLDT(<YAB!!!3/()/$T;$L0AP;T$CQS6]O#"+-4/84@@8[4@B! ]$#%,0
M.+;(P<L5A(!C!!:IG)'&%&R(XL4A_Y#Q1X+RK+%&(S/DDTT=QACZSR@RR*+*
M#:DDT\0NRG AC2-<8$I0-E<\ PD>^\A"!#*"F' +'F'\LT<9]C@113$YC"&&
M$<H<P8<\@S11#QE8"))$('00D0P8<N#3Q1:J2+)**RB4 LT65H3ACK+'.-%&
M*"!\(BTJTKQ!B!]?N!/($<%P@0@Z50QBXD/<S( (/?# T\D,D1RR_\D^;_P2
M3QAOX'+%+,5P84@;)LBR2!S8:,))<-4<PHL>6@CS%CB<%*'*&3>$(D@=BH0!
M2B$CU,*,'LE@XX<N:?#!"QN$T%($)OSTH309E]QB\C2\<%/=6P3)\\8BPAPR
M"3*;_8--)K-HPX@E@;@Q22:67#,U-F2<,8D69WAR2!M@?+++(Y HP\DKTE"B
MAR%G:*+')[E,<@@KAKSA2B9T2/+'& T=5<H9DB1R1B>;-%/0/9?4L4HN>:02
MC2:K?%*%'F/$00H:>7P"!QN<M+'&(V#LTLL=UHA#T#C:W.''(74$<0HR;?BA
MQAG+**.&,>W@4D<[YD!B1!)I././+U[0AO\O1N"*<;1"#(X#!C?*8 SQ#:0<
MB$C#,C!A!:@(XA.@ (,KNE$)98S#-:_* A8F$8U?\.$,>4##,T11!"U@(QS!
M(0<WY("&A U#'Y=@1B\BD8I [($-DK@&.(*CC$TP@QJ(R,,CIM$,2LR!#8N8
MQB]:08U(*"(8;_''*%+QC5I(@QN+L 4Z@L./7NQ!$ZD(!BX<D0U0 $(;QAC%
M)6CAC^!8Z(YXS*,>]U@A=;3A!9@ A3'0@8Y(I. *63@!%_9!$$2XP!3_L$<3
MW+ )&>#A%G^(A2E&$(I[W&,>[1@%'_8Q"1OHP'__D(04BB0.3RHK0?;(0QK6
MT8\RI"$74RA$,H;_@(E?=,$6_^A$$,X1C2Z,@15,X!,:<-"'/8! %>4(PA,,
M<0=>=*((WC#40XHYA4K4 0>MF,<;\I /(7CB&4J Y$!ZL81-<*(%= #$%#Q1
MAC:$(Q8R0(%Z[/B,*J2"%T!HAC=.X E7P"\-@_B#$I"QJE6,X1M=",D27-$*
M(SRB"G\8A1/00 XR^ %89"!#(U!P#&CD@:$#B<4-=.&-$> !#5#(A3*>((U(
M/$%;_^#6,SB!!GO40@O5J 0)5#&'=.TA#6N* CZTX <B3 $:D^#")+" A7R
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M#_D@#_H@#^3 #^YP:^&0#O?G#^,@#KNVA0+1#O'0$?3@#A2(#N7 #^.@#OR
M@0)A#OQW>5'8:>RP#@<(#^0 #_,@#I_F&NU@B4FI@^% A49A#CHX1. P1/_P
MA7 1,UBP F(@#[17$%LH#K,P!PW!(.1@#@\Q#IDV9F\X@!]$B7G8AX$)(9MH
M)(<9B@N2F(N)B7B9@8I)B8Y))Y.91^,P#WW9B8@IF HRB9IY: Z!F(QI1X])
M#NO0_PWQL!G6=0[[%Y&)^9F4:20.,9>TJ9EO 9FT)XFZ29FX&9F^^9O+)@[S
M8 ]+2!#FH _J<"3\L Z9IG_E4'OR$ _C$ _P  [R8)0AZ0_[H _M@ [Q8&O_
M@'\"H93&5@[Q@ ZZ.9'G4(.A&8,$<98",0Y::%U&\88PY),*8HFXB2 PM!GB
M4 Z0.&:R( ?2T""Y  )<0#B&@I\3,I>P29J=R9N=^18^R3?T.:&5B9<3NIF+
MJ8FRR8*!0 C)T'RJ:5W#  KKD)N1R)OT^8QVQ)B=J)N2*)JWAI]\.*-'V)\;
M.I%S:!09"8>].1#@ * R*J/B(&IU=H(WR&MR.*0P6*36)?]U[P=_]&!K4'JE
MN\FB,WH.ZP /0'D.5(BE8CJF#\$.[H .=9:'6MJB5VH.\D"%_I .EJ@.]Y .
M_4F;%1J7H:EOC<FA#F$.NH:'L0F<A%JH>&2A&/JA$$HA%HJH- JC,?JA6?JB
MN#FCDKFGMSD0^* -$\.4#R$.^, ,V:A-M0FE=7:CEJJB1NJ@=N2I9/JJF0JK
M+JI-=7B8E6BELOJH6+H@[U!'5VH4^M /ZU6C_S /PG /N#H0IJD-I] 6O78,
MVU -]Q"8^# -Q*"%_B *OL *QV!LGOD0]U -Y2>9F(@D\N ,UTH0]@ -T8 ,
MR,"1^V /T3 -]W"IBAH<Z7 *EF#_"(M "L,@J'O*1U'ZH/\P#*J #<N@"L#0
M#*S0GRVJH7K:H0]"#8"0?)I(L!>J(,.@"]! #<V(A]O@"J6P87E8AVQ8APK2
MA.50AGH)#C\(@ #8A.< 0R'XG%'H@N<@>:-P"N_ A?2PLHMJJ$([M(U9KK(J
MHVOZFK.JJTBKHDR;JDD[H[6'JK!9HW/YM )!#]$@IUN*G*HJB3XIG-&@#L2P
M#R1ZM+L:#M 0"U&KK+OY$/$0"L?PJ=O "^\0'/>0"L<@F/K0#2E:HC%4HK=9
ML--PMYMHFT@B"$7P"?O #H3P!+= (9Y !\) H\(A"W#0"O)'$/. "5@0!?\B
M#]R@!VG _P2.0)S!0 E!$ @NV IP8 1-L G]H)J;J0V8 '?]E[,9Z++J4&MY
MB ZFP BU  ]'^@V'  FQ, K/  NZ\ RC4 D%6K,3"3/%AI:AN0]GD -%( 5.
M  C?67_S4(;Q8)'IP _I  _]=P_K(&OQ4(+VD'T6: [V< _L,(7WH ^826;P
MT&GI( _]QP[<< :DD I-@ VJT EX>)#ZX _NT!'E8 _Y\ [ML [S\ _\4*\/
M$0[PX [[4+["  SM<)4+? R@5@\2G _H0 I&P SI, S+D \R" S%@)1&\0[Y
M  S$D _#( Q+20_ @ S[<(+]H&C'8 ^\T 2"X I:L G.4 _L4/\*8: (W*"2
M]P ,[.!\V6 -UR ,\5 .^F -OD -^7 -Q7 ."YL-W@ *MJ ,S  +ID#! <8-
M_! /VD +I& *QX -<" 'S! ,H. +UE#!&4NTA&RHO?FU1TL0T_JU_T ,RX52
M*_@.L0 /TU *PXJTU5>YRD(.[! -U8'(#X$-BU /C5 );2L0IYJG_W ,@K -
M+,J4A$ &FNRTSN 'S4"["=(+0< ,F$JNUB4.T_ 'PJ '@; RMLF9]_H@?,,)
M6@":$T*?PK &\T80@7 %E?L0PX )!:H@KV 'Q/#,"9(.;< '&#S('.H'&S #
MR9 ,2Z !C? /^U ,PY .XV!]P+"!P'#_K.9P"$G@"\2@#V[U#Z @!"W0"<-J
M%)FE!H#P!41 #91 !)<P!WY #<: "$H0 HTPE'&0!Y>@!FF@&?HV$*R0";;@
M#-\@"J"P#:S%@L7PQVJ6=:=@"&K "?AP#3QA!(H@"J40"F"0!J_0;M'0#Z!
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MQP +TG -=D $L# '># ,GC $M< -@@ &0;#_&/J !G> "66 !]* R\IB"I0
M"XE0!G5@!G00;=>E"F_0!%J0"[. 0G\ !)RP"M13!5$0";+0"J[@!UY0"+^P
M";$@"%K !',@4PT_!G?@"NE <O@P!U9P"95 !)00#8&@<WX@"-,@!E  !J\0
M!%[P":X@!EB0!I,P"H+#"#8@";:P!Z3@!DD@!V80"JVP!46P"WE]"D1 "WV@
M J.@"YF "D'@"*_0!=\@"&6 EO0 4W/P!Y,0[6-@!UB #6W0">\@!F"P;X.@
M!/!1!&"0!'G #&7 !Y6@!&W@"",0"-B@!)1M!JO "V3P!5^@#;E@!6K@#6,D
M#H6 !93P!U\ "'D@_PG/H EE  9$@ FO( 5XT E$0 B&T 5HH A$0 :8P :\
M  MQL ED !23L ACC@Q:( 22  9N\ JJL EAD+F$\ B^H F54 A:$ >$\ =T
M8 @(]09)\ F3H#!\H :$< =]L I[\ FS@ A_0,PY[N#J;ZC@, S?4 K3\+?0
M$ K4H [&$ TRV SY( VF  K3@ P P4V9O7_#;#&+1PZ?,E'*BLT;PZ46.G+B
M_K&SANE4N&A(7*#)]^\?O5Z;:I4#EJ4?G3'W1/Z3EXM2+GK^;F6;=TJ9+!ES
MB*5"DTG;LRM3N#G[-(:2O&:4&*'Y-4]8FS!UNJ3*-$C?)$IB%I5#IR@,(?\T
MR/Z1(Y>L41XQONJIDD,GD:1KT_2 B1.)W; V<,[T8_.IGJLZ:>@@Z_>T$K1N
M,Y2]1 >&3IXZVTBU$/5K4SA5E+JU&9.'T-F*ULP,<K,-U)5M3 :Q._O/5!A-
M8B8",L.D##1F:=(T^96.31!&ILS(&E9&$K9)C?I@TN<JB!H145Z&@^4%WZ4K
MR##](3.%4"P@?^3XT;;M3)@NB?(-^H8K2)PE/(C%-M8FFJ 58+24 >4-%2(Q
MQ8\SF&BEGA*,&,.7.BHA A)EBO!"#U9DF4$%0, 1*1DI[M!""FK@N&&,$@RA
MYZ4R1!CA%4%*P*&3?/:H0P@C4L%""5=\"<(-2NC_R*:1(RII! M17C)&C#D$
M 2(3><@1"2URP%'''46BP(29.LC )Y$K M'G'F7DH 0>?=H(8@XBR(CF)2BC
MA-(42D;YA+@WM+!E')'2(>63.Y889!(U"B'$#$H:J0.33."01)!-?.FDC5,8
M"6(2/#19Y9 V>$G##4_&,$0>./_!9XXE/J'$"#=X<:,/9@@I Y<\QJ &&B#T
M" 4/('+YQ0A.$AGC#QO6>(014D1H0@\K"(GDBU?T":>B;8)XXXX=$$$$$V5*
M:,.6+DR)9 T._TG'#2>FP:0+:B#IXP\3;%$E#D[\P.4E>QA9(QI2EKCDC2]D
M\8(7>]) X\5$L%'"$E7$_RA%%TVT$"(64L[ AJ)_Q%$%#V88L:,90@@Y!8](
ME#&#C5K2J"49.1JYI8Q>8,$B*D$*B44/7CC1@PTQ:(%'I&74R(,;7O90Y9)!
M^$C"DU,H<8.-4'K! Q9KSN"%&D3V@$,(.C11I)<^*+EF$CEJD:2085Z) P\R
M6!GW);??ACMNN>>FNVZ[[\8[;[W;N60)+?QHQ)] HG@DCUAD68,I(KQ!HPM&
MZI CDR9HD2:/0QJA!)U?I""CB3GT,2('3MHY:QY+RC@C"$%Z<0('2'HVIQ0T
M/FD"%F*LJ.>0.0@2R1$KP&CBEE-&B$2?)MH(I05$M%$B"D6F088(/[;Q99$X
M7O_@9A<3-+F#"U8>X0*2.Z3H!0@_JI%ACT]>> :7%CXA@X!08J.E!378(*(0
M+&2X!)<Q0 G$#MSPAQ+T0Q)-Z(040 $'/EC#"T58!!0.\0Q$I,X1T(#"8T0"
M#QP8@1<F8,0IKF *,/@A'(_C! U,,(=37 Q*_:C$&4J0BU1LH3660$=LHE$)
M,:@ #Z#PPAMV(8A9X"$$M5"$,N*!@C0HPQ0S $0VN+ '04R!$4QX@BRL4(1L
MC*$*UZD%"H;!"!ELHQ-BZ 83S' +*NQA%EL8!#\H\0<!U&$8<ZC%&,H@C3N<
M(!BQ248=GL&('<SB$RJ8A2NTH(].G" /(>A",%! "&#_(&(&FK"!%W;1A1DP
M 1?7\(,4C!&;5SS!'=*P@R+D((9Z, (/[GC)';Z0AS,L00QYZ,0P5AD%(>#B
M#F1X1R]>T(MW=",Q1HB&,?CP"I&$HQ Y@$,8<!"%4K1C'. 0!Y3$D0U&-($0
M^/#''/ 0C$ <(1'F^,<UQ$ )=0BC#GKP12;L8 VPE.--I)$-)7QAB3SXPA-,
M4$7/_M$/15AB$%'0 Q_6D(U0L"$3?0C#,V"Q3D5$PANZ\ 0VVI"$N\2"'IPX
M@ROV4 AJ-((0[BB'/452CSET813<T$,0$ $&0*0C%W!(!!@4,8YM_*$6P+ #
M$+IABR;@PAI&Z((:B!"%7Z#"_P9_J,0:,!$)+<0C2B-! PK*( <I$$$4W)C!
M)&SQ!7"!85SIV(,3C,&+*,0"#(,( PUD@8PYC* .]8B-/C(AB7+X(@NQN$4@
M2E$$3RS##FT(!!4V00L<?*(5>-@%'M; AR'< A>'P*M(Q-$*-F@#$4!0AB 8
M(8N5R4(+>LA%&F*1C#+TP1-VN(0JB( +<PC"$[0( RVTH8D7="R;_RB&&:H
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M@V#@ V5@AT*( Q?4!TWP!'5P SN@!!2PAESH W\P!13@@S)P@W\8A2'PA21
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MAGK@$'ZH!GDXAGJ@!B/@@]M%"W!8AWW@D''@![A3!T]X T$H ULX"W4PAW9
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M"(=Q*(<P/M.S(/A\C_-F@H=TL(A^=WB+R/BK<O&#%PGW6G=W-O=3)OB21PN
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M^)<G9I &6FC""6[8 R2&88M)3.(3IC@@I'*HPQWR4")>*0@Z G$'7&C0(:-
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MR 8?_# '(>BA$$(PPRSN<(4NQ$$:"7&')D*@AUJ 80QRP$(@.K6_+,@!#&5
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M&B!!%L !O2Q$/X !$5C!$9P"%;R '5C!R8#$+>" 'R36+P1""W0!*"1*,[Q
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M&-1#(9X"(@ ""FB#+*QB*T8**YS!)EP!'"S#$PB"+4A",SR!%91"('B#))P
M&-R#&Y! -5Q""'Q"&=P!)BC!&:C"$FA#+(R +U1C$SB!/HB!'D!"%M!"*MS
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M@Q%'R/^$$J"PAB>0 AYQ( ,>Z'#M@9S""Y2H0PD\L0@GN.$+HDC$$Z0A%J:
M&9)"%*+@#J)@!E1!$ES "+QA(.*!#KK@#J: 0O1 $U+@$FP!"-I #0P!&,:@
M"\@ !MB -_)!"YS %51 ""9A!$IA%JR@$1X!"DI!$R0@$^(@"%AA$G#@%5*!
M! ;A#&:@&4[K'@JA%O9@!ZQA%)Q $4A!"3['#\R %G"@#9IA!_3 &Y(E'+JA
M!,Q@&0@A!VYA#00 %?8!$ *A"(S@&^#@!6BA'*XO#N5P#NFP#NW0^LRA#6+
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MO. /_. /HL'0>"$$UL +0, 2H@ >M^ 0U*$:H  $JJYH4N$)Y$ ,4L 74H$
M%($WWJ$-AO\@#9*@&L  "53B$6HA"ZJ "MH@&((@#,@A#;2 -_JA#&ZA'FZ@
M#/2!"BKA&-* "J[ "-SA#(! '7R!"FQA%AY #V A!+C!%D[@%$KB&JB@"_(@
M!@2!%-0 &\IA#FH %WK!"K+ "U8!&T) ._XE#WC@%0:A"8@A%E3@%%AA!J2@
M"?+ &7RA!/J $HX@.5^S2(WT2)$T23D-'@HA"LK@#9C!'L( "_C@#DHA$C)!
M'FJ!$N1A$FZA'> ##(RQ:%3/#NZ $42!%@[!$C+!%?SC"?B ']YH''*!#\[
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MS?[A&PSA&3[A$SH!#4I!B[5!$0#"5:9(S'1M@G0(TKM_Y/ZU$]5*VR-$F?B
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M#>H0"ZN@#JZ@!XYP")%@,;-0E0V1#YSP"[,@"++P#83@",,@'M$@"860"H*
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M!9M5'NIP"WI #7Y H'_ EW& "E@0)YNP1)QP"V,2"DT@#6: !FO !\&D6V+
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MIO +_T(@!(?@#]HP"=Z<CX<P"*E0#M5P"(>@!\F0#W60!L-8'K>PS^< "WV
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M:,1#&*8XA2RLD8ZLV",0G]A&+Q#!"TRX8AC,<,3K#L*.;B1"$WR0A3V>40A
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M88>3A*,;@D@$,LSAC4NH 0O-2089FJ""2_S#&&#00B38$0T_W($.G @'--+
MA$L$5B)H0,5!.A&(8_!!#)FX135F<08^G,$3AV!#,=+!"#?,818__<<HL#"-
M@__LP0CH*,0;W, (9XS!!K6819W5@(W5V*(-Q@#%%?10"R*( 0QN"$8_]'"(
M0]#A2%EAAC2D\8Y;Z.(?MPB")>C0"7LP@PV+",,7IID)0F#"#-ZH!QN\T8LX
M] ,9S#@&8WDAA7LD92AIT,1!0N&$/F1B#<SXQ2>6 8=:6.(-F3)), "Q#SH
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M EHXB';0!#)HAE<HA5+0 VE8AT(@A3A88VUH@WRX@T_ !4-X!4DPA"7-"%4
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M&^R!-.R"'\1!'3R"/<""&31"'?R!,.@!&NR!)@!#' 2!&-3#1$@")YA#)[R
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M A^\P2:L02T 0A_(PC?$@2YD@B20X+ \0RV4@B%0@C"4 B74 AWH0<#18<7
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M@A/L0A  PB*$@3:TBQ(Y#1D0 2%\0B2$)3#TP2^( C5OI N=PR:@ BL4P1A
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MEC\"$<49R0##)_S!!5P0XA#0P 8<H.$&,9 #%FCP!S/0<(I!;((8HY#$,D2
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M9#("'ZR!&J;A&AK'+07/[-1+NEJQ[2YMW+JQ++OQ!TVQ(L'!'6:K"]D,$>2
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MNM(GQ*$<\A2RVC?HTD 68.[DU&_FDBT=*@$-&D<>F"%'W<O_'TRA']KA#:H
M&YXAC- !&DRA&!HP&@0X(YXA%?*D',XA&Y1A<UTC'8@!>9CA484A'PYX%MR
M&#[A&Q:D':X!%$0A&QK''03!$%!D&;K@$814([SA$R)!0<IA%B8!$_#!'$0A
M$PBA&H!AI=1A%F9!&AHA#&XAK?YA&A[A$#P!%5S!$I3A'Z)!$09!%WS6%S"A
M%[+!$_JE&B*I&C@A$S;A&;!!"JP@$^[ "'(!&BJA#H[,'>(4#^S $JI!SZ8A
M#Q!A%_3 #M0 $:1A'61!#((@#4YA&SA!$\1@#$X!==U!%<;@#QRA&+YA#9Q
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MWH +2/@GSN$66*$=V. *N. -AN$3>H ,W*$7D. *T$ =AH$.S&#_$M@!$(3
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M&0[ND _W.0[C"9WFP)__*0[@\!/@P Z65P[(0 B=$%$(\WP.^J 0:E>E0 ;
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M#\\0"BI:#Z" ??B "M_@#=]P#Q$2#>K "JEP"LB MBXA#ZO0"KV0#/U "&6
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M#=804>%P#<Q@#.:@P<I0/2X1#L3@#4\Y#OU@#61?#.GPZ]XP#?Z@LCK[#-H
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MA75(!D.0A%^PAV?PA51(7*3A,$J@!%+8A6'(ANFZBF2(A'71!G4P!3BY0W;
M!GQ(!47P!$\HAFB !GI@AVP AN)9!%FPAWA@!5J(A7_2#G! !EX@!%9(AW.H
MAF)(L<.@AV1@AF^ J'CP!F&(AF!(!VG0A2=.L:LPY'18!VQ(A6U0AWB@!E:
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MR TN_"1D3RS!F*/,+[7L@HLRW>""RR^\K+*,+>XD5 \OZ_S#C29K]!'+5]L
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MD,(RN($KD((1U,,TD($WF$9G@(8X5/^!*? "(.#")""#(:!!0NB"'21$-NS
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M7CRBYXYE(*-V^<AA._31/W#,[R/_Y>!'9@+H#GM$)!P%W(<^#N@K2+U#"=A
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M?L<\(@+#&(*#T>!0,6=[#>O)]CJYN"UU<B/(:%TGFMS#AM2MX=WFQ,80'OQ
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M;] B.=9P##NH$0IB$ (7 +;U8NG"BE*<^1BT:*NQ;:M2=:OT'\J81)D3Z^]
M^,*PZ@8)H^-7;4C9XQ:S8 8B>"&[?[C#&_GL]3/W4 BOD?OAX@]).WQQ"<*.
MAN<_/(<[[N&BMBD<S.X=",8>_$$=UN$8XH&$7.X!(;"YY W/XJFP>F[F/ *N
M'/ ?I*$6W(:X_^I!%7XAM0)'%%P!&O8#'ZPAZBZ0TLQA&;:A!7\('&RA$MK!
M&/;!'C2A<_3L'U*!$F*NW&+.:6ZA/^@A%KB!'B[A'JI!$(:!/]9A$@S#S!YK
M&"KDYVAL'1KA#DPAM(I!#"A!/RH#&0"A#29!#<  &/J!$<B #BJA'N(A#O8
M$-!@&,RA$5*!#WPO$WYA8*AP&:3 9]#A$SQA'0"A#  !$XQ@%XYA%2HA"/R
M%Z9!$\@@'01!#D)!%=3@%/RA"NB $!8A$?(A")5%$J)AF2A)_3K/&"C!%-JJ
M\\P'Y5;/,=1!&I+!73YN]AP#'?:!?WCH'8JA'L:A'RC!%<;A'(8A&?_RH3+
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M&")!#!+C+=@@$0[S'A9A#N; $(8A9!!A#CK!(QT#&&A!$B#!%%[!%)R!$-Q
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M@4/B'3HA"5X!&,* $MA@!GKA%N @%%S!#]01!1(O)'YA#$:!%,A@$:[A"]
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MH04R\_1Q"RR ?..)6RO54\DGT*RQR3S>!#$-'6] T@DCR)C6BBS,,$$+/'K
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M8 5&L 5A8 9_X'__  ]7$#JQH 9T( 2.L M7  *P  E^@ 9_P N)80EY< A
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M5@ *=F /X!#_-YY7'F:0"..0"'U0#8E "LPP!_MP%?/ "MO0"EL@#%[@#>1
M"J3V!G86!F>0"*WP#JM0"Y7 "D23#,"0#*AP"-8L!;KP#\F@!XT0!ZI@!F/0
M#7B@!4UA$-F@">Q0"J3@"$8@ L= "&_5!WXP"GP0"\!YS)FMV9O-V9WMV<)<
M"%R0#]1 !YUI,<70"IA0!BVP#(K0!OJP#6[ #%>A"YZ %79 #M>@!Z]@"7;0
M!VRP!>R\$K60!\* #7D@@Y+P"\N@3DZ !,,@#TP !=2@#H7P"J<0!_;0#&Y
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MAKG !5OP![E0F?*0!BM !8I&Y[%?B03Q#%A0!H[ !-^0!5IP"('PYT; !'M
M"N;P"J00#Z>P#,5 ![+D#H=X" EN#Z>0UH6@5KH@CE5X"?YG$,.0"_0@_PLI
MT0V'H WBD L4%0^ 4#/[ !"ULOTC6-#@080)%2YDV-#A0X@1)4ZD6-'B18P9
M-6[DV-'C1Y A18ZTF U/I&S:_IVC5NI9'TW6*ED3Q8H=/EW(_I'[YT[2*VV
M_N%3%8P=*C28G(4KN,W7.F"^ZHU;!>T>+%O8LCW;]0Y<,EO5\AV;!6\=-7CJ
MGLF+M\I4-V+RHJ4K)ZS?.&')Q!$TQXW=/W6IMA&SM@[>OG;MN(ER5X[<8W#Q
M_/E;=XS>.G/(U/U[UV\8/(+SXOU#)V_O.'?#_(W[9P[?,'GHQ$'F5V^8/7#D
M\F7RM/,QN7'Z]L&+-^_((G^;MYVQ):\<:73AT/_E-IONG[AW_-31"U=NGKQV
M_\*U T?:WN;?Y,"U(V<NGG5VY\29:Q>.''GUZ,R1Y-_?_W\  Q1P0 (+-/!
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M&Y" .2@/5%@!:;B27R !.%@$$FB!LE."8T*%$3 %.P3#)DD%'O]  $FXD%U
M QR( DO(A3QP FB@@QQP!5C@ R4(!GN0@198!G!0 DY0DGT@ @^  V"8! N(
M1$,( 5>PKVVH!UL8!![H UOPATDH W#BA1B A53 @3- !F@H B+8!D:8 E:8
M!41 @6I0%V28@D* AVG@A4^@!7^HA1WX@V:(ADQH!&8@AV8 A$_ !6@(!#3
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M(/^H W_8!2]HA49P@A)V U=P@C38A;"=XDNP F!8A2>(AF1 O4D(@3/  CO
MAX)@ CE !VY( C7  ARPA#P@ F,(!$8 A270A%-P DT )X)@@SM@!4,@ 5RH
M!#]XABA9AC58!&K0 T8P!D88 EK(@RH8 RS8A:$-4E(0!4U8A5-  C"H!"U0
MA$C @C=HA$3HA3N@ V'0!C$P@S5H!%BHA4<P@RP0A%/ WW!U!STX!&$H!3,H
M@S60 DS0!>\T!"S  CR@ V$5#V?@@R0H2$R0AU2 V^D"A#18!+I3!#,@*BW*
M9@+99E/H D]8 C?@ AJ9!TXL#T8P@D7@A%I8AU#@ B#_0($8".M%F(%+@ 15
MR 9_T 9E^ 4X4 %F$NA.^)Q_@(<YX()JU0=40(9F.($4D(,8,(-R^ 84V";2
MD (@ *=DP 5WP 0K^*=<X )I<(0M0!."4(43L((^6 %&V(R33FES]84F( .F
MX(8A( 1AX )2$ ,D2(%:L-<D< 5$6 !"8(00\%<H& 7SH1%Q6.JF3E@56(5T
MZ 0=2(7Q5HE_F(02\ 5$: *"$(4<8(9R2(?7(6ME*()O6 8O,X8BR(5BX $Q
MH(0J,(1% (._^ (@P 0L4+DP((,@*(-9X ,D^%MH((%;X(=,. -\$ (TK(),
M0 \2%8-VP(096(95D %%N(0F_^"'3=B#+R"!>/L';9"#6(@"/[@&. B"0E #
MT$:!2IB$0#"'6]@#VUZ"0N@&0 "#%9 $J>(&)Z"$9JB$0J@#+J!U*VB&,?@$
M@, G8HR^(8"\99&D:X2M75A0S9EQ:L\67V%"H,FS"%8(19U:!#KW[U^U*W,2
M;2F4B\\^:G!@C7S79HJE+$SVC:37*,^E-UY*4=-21]*4,<K6B.D41(LL/[3B
MY?KBI@\20-GX,!'4A(TR1EWD>%&S3=Q(=VKD#*H22<^6.5K8Z")$QPL079<V
MH8HTQTF06=)."2/WCURP-4,0L3%CRMJ;,&VB^,GR9->E))WJ_1.7[<T>6G38
M$$'CK/^7+'LC\\7A4F;,I&7QT*10)#BS*2=-S%3IU<@('CN>1*G!<@B-J5=E
M4.USLZ(2/T!'>$WJ@HS9FV^<X( 9HD?>R'^Q1"B:]619-A.,DM5!\R86NNY[
M&*%S)H;/'2N\+G&)1(N0/$I)S,S!C3G=&:?&'W0(PPD?U\R6#QU\P#+((L)4
M\D<WKT@BR2"FJ#/2,IBP0LTEV'#31B&S]-&)-H$@=8DWA.3"SSRXN)&&(LW(
M0H88GR13#"-G;#,2/ZZHXDX]F(0QG"_77-()++1(TDDM^'17CC>-M*'*,/_L
MDXLL^X"#C">35$*--;7T,UAW:[+9IIMOPAFGG'/26:>==X[_],L.I\QB1SMS
M#+"$2/,HP0DX_V@""#_BE///*%AT8TH*DZ1C2!7MA!,..=\4 4H\D/#@S#_)
M3-%)H[-YDL(FTJ"10RV5W%"$$U.8D TK,W##CC[T,"(#)=X@08(PN5#12C-L
M,,&.(B2HTDTRQ,#QQ!AB)$&%-?_<XT0E_]##1A+;/*(");)@\4(SH)008@D"
M['(HET*,XLH&@;0B@RN2D* (*J.P,M@J(/!"UB L4/,/)S"0$LP40)"RR0M]
MQ*,)";= 4H4?_$ SR3%M1@/%+Z4X44HR/(2QS!%K@&)'&I7(D0PA;\3S#QE&
M1)*&+:-H$4@:4YB2R02/B"-8/D"L_V"8*_9 (0LY6=#!CIJ:!&!*("$L<PH-
MBPCB!#%/^"'%%-)TYXT?U(S2Q1-"].*-$6+8@0(=:%QR3B!@N/L.%8$DTH0=
M6;32SDC@+(*%$5WT0LH43R#A"3]A2+*/$&'8HT4AV Q1@A!LU-.-%%JHD08V
MJO P1RI>--'$*O[D,0,05/S2Z$B.#($"&/Z$PL@[SH01RDCHZ%)$&G60H4]W
MNQC1 A6JP$,.+$^$\) [BE0Q!!RT^&*&-N,,\X@42#2RI2EC/!'$*.04,TD2
M=9S2H6#S5,*&%F%(\XPF1M3A"3:NP%&$)-NP HLQI-0A#;\@!BG.P JR_&-&
M=HB#)2B1#/]C%((4H8A#$_)0B6M0(PZ,J,9@B*$*4C"C$VP8!#:H@0<V ",F
MKZC$(!Z!#7+P Q%(6$5WR*&/6B""$)$(Q2#F, E:O$,:9G"#+Z"!CFO0HAK5
MF,,00'$.:D3B&JEPQ3KRX8MZ].(-D#!"&.;1G7PX A?!<,4\]B$(99C#&:K
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MW. &.PC %T:"#2[80C"8< ('82$%4/PC$"C8P0K&D(UPJ$((2EB"]<0Q"R*
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MGCGL@SML'N<!FCKH0SLH$SP,0SR(7CFX@R_]G^JA0S'X@SFT8*2-@SWPPS@
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M7($EI  )'$(E:((^5$$+0 $*=(,WB$$U#((;@$(0A( 20$([/(()+,$2#$+
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MQ'^LD0&08I30)A8EBNG"D7$0B60:(5[9)(1L4MF#&C?&"&<0+(HA8Q5>_[C
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MBN"+,52!&730PC?44 9ZX($+K-##(#@Q!%&P@@J&>(05!''S7?C!#<+(@Q%
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M'$#1R$!Q"(,#'*Y!$L)@$GIA9L"!#4U-&9>1&9NC'1C!!LA "I3")=!!$VQ
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M%!7RH!EZF8FO.*+KMY-9.96I.(HG>CDPVJ)!694[&J3OER-@00A"YQ^&H0Y
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M@L$.1& 0;J$8T($2!F'!!4$5@(Q=FT$4Z"$;;.$83$%S/F$8V($3Y* ,AO_
M$_C!>FB!CV^!#@*!__[!$G2@#RJA!+@@#1)!'5)A$H#!%_K@OH2.($;A!7X!
M&+IN#Z8!'E1!#N3B'[R!#\A@#GS!)<KA&PHA&1JA$AC!&/93%-: "?K &,[A
M%NP@#:K3%/J #O! #\3 #Q0A'L) #<Z #Y3A'P9!=QT!$'AA!D3@%)IA#?"
M#$K!'\  #NA "O;@Q_?D$^XA$-:@&2 A$^@@$XA!%6[!'O0 #SXA#T;!&/)
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M">8+#)<_J^I$R=;FRS-,="Z1:#-E"3V%X/XTN6?G2C QG- %$0/&"CUC5?K
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ML [S4(-I)@[1< UXZ _], ^;D0[U< _T0 VUL WST X\QPZ(V _30 BJ< W
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M"=/ ""9@!FMP!MD@"XS0#7SP#*>P!FY@!XB0A$U !T[@",5P'MK0":#@"'C
M"Y/P"_E0!480!D.P"_R2$/F !GJ "IU "L:0!FH0"^&U&>  "WS0"H: ",-P
M!D:P"V%P"*)0":^ "YD "F5@"8!0!8K;"9?0"4DP"[A0![7@"(E0"(= "+5P
M"+RP"HS ":KP"+* "XW0"X7P"O( D9R+!H\@"6%@"[& "*BP"XV@"X[0"*Y0
M"X' !J0 #Y= "'')"J0@!H_0"K%0"I"0"]]@"(\ "9)@"MEP"(5P=N3 #Z7
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MJ$ -3:H0S+"Z_? *O&A,H# K"1$/O' )JT ) 7P+F! *_QO("X+@"<RA$/?
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M:&,8>0B&%;:1PW_\@1.S&0<L'@&/>1""$+ (PBTB(81\3,(6X0 %&%3!"7T
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MA6XH*T;0!'R@!CM8,/ @AUE @4MX Q-0!45X!$C( CT2D'#PA#)X!#[P!&=
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M$#0!&8YF'N  #6A"'(#!#81 $]QA'N) #8) "HQ!'L; #K) "I"A'\9@!*(
M%, !%8H@#[#A&4PA"LX #IYA),"A"D+@##2!#Y!!%M2@#$;@#TH!#:! #.[@
M%9"A!.H@&$1G#G; #HSA#,;@$-( &WB#'CZA"M; #9KA&T: #+2!#ZJ@$7;!
M_PKJ(13\8 VTH!$ZX06^8"$H A2"@ S2@ SPX1>& !*ZAA\.00OTH Q 0! L
M80U(P1(,01T$(00N 1>"8 ]N@0K,(!#(8!JV(0H281!FP!AZ@0@@066(81'P
MX!3@P!.T00L@81&J8!4(XAY^<A4(P0VN(0Y&0!7BXQ_000Z\P!]NP0F$P16B
MH!D0 0NR 1.(H,K^ 1G\P!> @0@B(136P!0TRA1:@0R@01"R@0BX(1FT@!'<
MX0RD 1B"@!0:P0^,01*8P1?"8!ND(0]P@1KPH!J\@0VF81,& 1RLX0^FP1=L
M(3ZDX!2.)A<281@((0YBH0]201D88R#@81#@H!^^(?\77J$.H$$4\L 9;&$4
M@@$3^( 42"$;S $7!J$5&.$?XB$,6N$.A@ (JL ("H$.FN$?]  0@$4:!H%G
M<,\5$&&-%"$,/D$6\D$E!*$30L45VB . J$<CB$2O('Q$D$/U@ ,M&$<(.$1
M8*$3[F -\( 35H$33D$5RN -)J$-5F$>!D*J#@$=_X$5]J /.J$/%B$3-"$8
MAJ$65 $19D$=2 $0+.$.T, 2XH 37,$0!&(DIH$.3.$;!"$:R $5W@ 5!N(<
M2B$1J@$;%,$8I($2?J$2]@ 1]D!$V> .*@$:KF$.S@ 65($5[$\?"H$-%J$.
MHB 9-F$4UD$6-"$:>J$2S@#_%(Z&'(#A%[ A%89 &X!!$QY!&,"@1[* &]K!
M"2;A%[;/'_A@#GK!$3;A&0:"C%;A'?C!%KI.'JJA$9B!#-9@&IP'$A)A7;YA
M$#;A$=;!%L3 %,:@$*YA%6X!&!X#$E@A%_# %^JA#_9@7ZSJ$7"J#G:A&W;!
M%JQ!,,_!%SB!&$)A$ZBA'PHA$FS!&T0!#?B@&]I!C)A"')8!$WQ!':8A#:H
M$#Q!$*K!&1XA%K9A%V(!$L( &ZX!$TBA$"@!% 1!&_"A%BXA%P2A&:RA#W;A
MA?PP7,45AGYA!72!&\B $_JA##@A&S1!$)#A".1@C?[!&<: &B0A % !&B*!
M%N; _Q.0@>&$ 1&.(0U" 1[X@!":H0Y8(1^Z(!!&8AZZ[&B&80[<@!@@00[J
M 0]&81C$ !8280ZDP1?&0!@F@8M:H1&2@1 0(1XLQ!7P0!M<(1?B93:.(!+F
M@1#^ !< @17B00_@0!H8H1/>X1/. !_8P!6^)1Q& 06: 18J@1C8P14"H5C^
MP1["0 RD 1NV(1KJ@!3JX0TD*A>@P&1+ 1ZV(19>00@LRR5RX1#H(1L:01#*
MP Q.@1*L !\0 17>013 H!C\@!;,(1@00>+DH!U,00R(I@DD81\D 1>&819Z
MX1-"X!9:H17XP1G8@!,@AAPB2Q5FH!9R 0[6@"#R 0XJ)?\=D, 9,.$/JD%9
M_B$,?I,6*.$?N.$04N$/O* 1V& +4N(EE.$-B.$?*J'N7&%?7$$6?@$,FH$0
MON$+_N$<*F$2TJ$4'N$-<& 7**$.\D$1J"$.-$&:_  1K"$3QA(10F$.,@%+
MM8#JM$$SJ@ 2"$(8(L$0M$ *>J$3D" .;&$UY $/PH JYL$4PF!/CN 5H@$,
MG" $^. 7"*$8RH$7-J$7RD ?FD$*5($.YB"$+.$4SH 6UJ$. ($<VL@EG($1
MM,$=(@$1:B$.H&$?V@ 0'&$7\&&';N$0HD$94I .&B$8L$%]%.%[-,$3^J 5
MO&$-XH 2-.$7"#,09F$3$L$5W #_$EXA$KXA.Y &$<Z &^:!'7[8%4"!$#1H
M$?ID%T9!$&Y!&RIA$7AAL6:A$20A$ SA'8YFI?K %T!!#V[!&P[!#>14*D,!
M$[8!&QP!&68T$=#'%<B@#TQA$EH!%WX!&BP!$6CA#%3A*XHA$]  %]B@"4K!
M$&!A'70!#8#A'<" #([A2H?A%[RA&8Q $G1!"R@!H7P!'N" $U2!"K!-%_1!
M'#PA#3P!#3Z!7MN!%,H $^K.$_PF&CK!%/* #71!#AKA.%Y7&2[!%OJ A;3@
M&G[A$!SA#*)E)%KA&V#A#%!A'R;A$.AU'SXA$YCA$?;@$<( %:2!?LX!%50!
M&%C!4?-!_Q=T02G!0 P"@1I&H10PJ9."P15>X1S0813.[1HX@0SX0!*(P1YH
MH16<"AJ$@=E( 1.L>9=&@1>D@18&00[\@!0H:5Q5>J4_PA6VP!C,014<X1F$
M )."X0N6X0L4@9+ @3\;(0MH(1 4 1Y$H1/0X KL(!C0H!U>80RTH0F$@1NJ
M8 S:8 H<07PDM@T(@AELP D8P0^<X!C"0" 8P1# X!;, 1^B*PRJX!0DH0_N
MDQ-(8A@6 0W, !56HQR$("4B 0YNH03_(1;V !06X1?^81.8 !UP81>RQ1:@
MX!A\@1=DXQ4\8=;*@1LV(0S>0!F$80Y6P1_2@QSRK1CH8'C_8?\?N($+9.'+
MM/4?WH$7+.$/F$ 5/L$/]J$1L,%VY6 8F*"*_&$2J*$3PM<4XN 8A,$,B&T3
M$"$5=,L0<N 27,$7T $9^" 1@,#MCF$?,($$-L$V.\%TR^!QU.$)I $3S, T
M7"(,#H$<<H$0_D&2;4$.&,$4KFT[7X(9\F ;QN$30JL0ZJ$<%B$6=,$-^-@:
MA, ?]*$-VH :[H 3?$$(=N$2ZJ 8*D$;.N$,X $?[H 04B$,_F$;)H$9)*$1
MT"$95H$:!($1Y"$<G( 4"*(3UB ?"N$/5,$;LF$3RL"TXX$,P& =KJ$68"$.
M@*$89F 5,&$2A*$-RL 0+$$8(A@3B('_#.Q #6; %&PA",:@"5IABH+ ")1
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MSA$.=^R2'?F Y3J>$0P&^<-[]/!'.<IQ)7"\ Q[F\$<_XO$.=$AI2?? TCN
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M&FRA#\GU#]%P"XOT$NC0#SC4#NN &ML0;.Q #:"@"V$0#?^@#;7 #>GP#LD
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M"8/ "@['4=EP!G1@"XFP"*/ "WE("$) "LU0";RP"&!0#(E@":_@!G2 "63
M#.A6G;D@"V< "K00";-@"<NP5_^P"(E "WH "KL@")L@!;& #7Z@"(] !ZQ
M!IH "IF@"JX0!T-F4W&P*WVP"<' #'#I!Y, "E:@!XZ !V/ "HL0"[= !I]@
M"6Q0"H&@!I; "=, 2S'!F*V@"I( !AI4"*[@B)!8#Y+0"*KP!G7_$ F=< O.
M  N%8 AW( B>L =HL O$@ MLL F2, FLL J#$ JH< =NH NED)1:H@V<D A]
M( F@L :?D N4P FTL B@\#G=B8QA*J;^@Q.XH&,+1 Z P OFD ;>4 [TA0JH
M("?$4(3R$P[9P = 4($Q,0_W@"95@@\(%0[]<#Z^50\&)P[Q\ ^=47L0)2>[
M41OJH _.8 WE$ ^'( 9GIC[T  \,\@XZ- _O4 B\$ UND NZ  7G5D#-8 O4
M,!+&$ K8H$#KX [-T N@5 [;  MZ" UO\ G74 G<X E:X W\L _YXPSX\ E:
MP J,B0JKH&]A%@R2X C) (DCT0^%D FG_[ BV; (TZ4.OK $@M -CW >BK )
MMG .@U #:/ .HF (AE *5@4-\7H-VV %=] ,S, -X, *F[ )JU <M4 )JN )
M4:E=ZW +=/ )T] .CF #K5!C_V -.. ([7 '8H &E: /_S *C# (M!%!ZO +
MFC )HZ .;5 %B/ (S?H'C[ *J/ .)],(8G *_O )C? )K> .8@ "N$ +ST /
MN. *GQ +[2 ,GL )G; *_U (9X .TM (CD!%_P ,=?"001E*<: *WX $EA!0
M5!(,28 ,:Y 'KJ +'6L<Z) (:Y *<0 'V6"5T+ (:= *FX %V@!4X< ';8 *
M!;L*<$ (OS 'M?]0"V!P"9* !X6 "4WP"TJJ"[8P":C "V#P"9)0"\7@"Z[0
M"GC0!]:@"VO %UKF"YFP"LC0"HQ@"[> "<2P*,.FF>HC#61@!VA0!I_@"7@
M"+[ "(YP"ZT@#:IP!KA@?)^P!FVP"'F0"7XZB[,P";Y0"(-0#='0"6=P#(O9
M#72 "NS "%>0+E@@"PTS#<_P"(: !M(RA[F ",T0#I]@"Q'D#KA@"7CP!(L
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MD >OP >8, YZL FWL 7,T NQ$&;YP 3^4 U^@ SJP 1DD M%< ;3( 9S8 R
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M"+10.:0 !HU@":>@#HH>"61 ".S0#7N@W!+E"YKP#?/@"GKP#;X@"YHZ$M(
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MPQ-,2#BEC3IR8D<856XIAQ9.;AE$(T[6V.>08?X1)(YC>+0%"R+#882/;J
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MI(=M2(9(  -WF =G<(9L> =0\(-"P =_"(=X<(9D6 9R4(=FJ(AD0!>&N <
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M!V'(AV%(+B9P K5>B%*@@F<H!3B8!EO8AG P5%; !K7NT'XPA>\-!ZW;!60
MA4!5AER8!FS0AU0@AF=P!%X8!6  AVH8A5PX!7= AC"(&)'=A5YX!2#Y@R#(
M!5^HAVG !++*=-C"!4YP!WD@!4&@A5*@!S H F@8A1R=A5B A?]E!05+\ 1$
M2 :Y0(1\<01&V 3VLH4XD"LEM(9'" 5L4(1#8(1N"(=H0(0PH(-@B ,'5@4E
M88-NF =*B(,QH %9< 5!N 8[6 ,WZ -F6(=+& 0T: )#*+E_J)-&4(UBR(<P
MD (C4 5[X(4B>().B =6(((LT )H8(<B$($AV )&L ,3$"PK$ $HR H02(-Z
MX+4QJ&YV@(0HF ,1R -Y&(4YF(,<V(5&J 'YTX5JN 0I$(,ZL 9B*((I4 (D
M: 8.2X8L8 (W@(-HV 8V  ,G*()C@ 4>T (\L )$&(4E<.\_"(,FH 5D< ([
M$ -=\"XE! 0A< > X,;&E*M,]6YU0E;_A%252;GP#&I%1],@4+/0-"+D*QZY
M?^2(08(D:4^P?__"D1'D#YD@6*D\\9)CIU6G2OF<32+ES) B0FVX@3,IS-*E
M3FK0X-I6SN2P3&\(/5JC#!@8$83\13K#K9^N6*T&19N6AXX@/(QX#7HCR)8R
M2GPHK9J6Z%<J3J@$U9IGDE@@:_,XX0G$:T^<2X,V^6F%J=&J5YPLY1$$JI.>
M2J(@_3F#)LT@187^68NSK>._97:*D5,U:1H=0I8*J3/Y[]L>;";W#2IC:=*8
M:$BD_?,R[8ZK?[@(83*SIU(82XC,!.VHCY&P06R&-4.43;:^5F,$]:E3258S
M2M/&F8+C35*N_WV"/+UJ].W?JT"N(&WG-DG44H^R39I32Q^ D*(''J6D4D@U
M_K1R2RF7:$+)+.^85$XRI0@S#2G&!!/++X <(DD>;\ 22!IKF+*,)8S H@HG
MO!#R"FGB-"-)*>5 HP@HD.1"SW\_ AFDD$,26:211R*9I)) Y@.)(ZXH<L\R
M6>AAAAOPP(+(&53T<<PF:8 !1C3*/,$%)9UHP0<@_/ B'A^I*//"%H8T@@<8
M=CSC'S%NG!')&*J0604H)H6SB@B&H.+$))VD$0P@1 "BQB?P^*>-&8(8DD<U
MP8R@B39)!+/'(+K( 4<N2=C2"12!U#&(/X*L80D1C0BCQS@FL5/''/_>G#E/
M&DW, H8EOD 23R%CY**%,IYX@8TR<.CBQA#U((+&,))<(PD?WMS2921>:-.&
M%LEXPLH_W@3QH2?MI,.%,N*0$V]'HS#ARB!R.)-)&/B\H8LPF=@2!B"C[.'.
M/TY@LP@B_B3"PBZ -+*-$9%@PT8<L-B1#C!J8'*.;*EBTXH-JSBB1SO0Y$*)
M%\_<LPHM04""3B]% #/'+.6\\8D[:&"""ARI'--'+_I8TL8BD(1C31K8/(%+
M.I^\88\KHDSCAR+<:.+-,[>XLD<JX?Q"A#=D^#-/*Y"T8U(R<R 33A_>"+-+
M*(@D@4TL881C3RNA-*.$+F/P\HHE<[S"!!G_M(#"CT?R_D.($/% @X<IMRQR
M3B^9&",%)TC@40D?CB2C#2]I5"*-,K6X$<8VYOPSSBICW((+'26=! 8F[>Q#
MR"]ML-$+&G @Y @[QPP"BS[?#&)$*_>05DPFB5C#"B=Y/&+P/_U\0@8GN,@"
M3#5S@-#'-;@T8@TRD)""4#W4X-%)+I?0U6(;;OP"C2F =()+)+E40\L9<2!#
M-L' 1#/*H8I#8",8J%!%(^8@B#T0 QF@>,4A5,$,0  B%-IHAB (X8@V@$(:
MJ "%*SR!CE"XX1JD44@H[.&)6JS#%F+ @C?\\X]G(&(4[XA'-"HA"6!T Q#(
MR,(R_O$%; R"$/90_P0E=-$'7 SC%*0 !!/"X1]W:*(8D\ #,:BAE?_P(@24
M^ 81[N",9'2B&_3 11"\T0EL&0(3L+"$;5#AB%$ 0A?&N(0<0/&.=;!#'#^2
MQR=H80]Z+(,.G8!$(JZ1#TZXHAZL8((8MN&?<CQ#%,6P!BV,(8Q:4.(-B) %
M&^1 "EU *1.C^$4@;!$)2?!B$[00Y#_$,8Q;7 (;L@B$,B Q"DHM*9C"'"8Q
MBQE,5R1ADYJH13:&@(YG9"$:>G!&.6YA"%KH01OEJ,,C<G&(>F2C#HBPA2F>
M 09< *,64B#%%I9ACD8<@A:_J(=_.$&(<HRC%IE AR(V8<6.U",+Q_!&'O^(
M,0XI]$)7J0A#&;KA'UT  1SV,(0@B$$&=;QC#=T0PFA(,0=<?.$5;>@$.'!!
M!F#HXQ=[V,(?@A&'6_V#'U,(!CFN 01GE($4Y+#&)QZA"WDD0@J>P,0_ME$'
M:ZRC%7MH@@B&08M1H ,-NRA"+?YA#SS4(A)K( <NAG"*2^3)&5(HPB>D(0YP
M#$$02V'<*+#0BD3<XA^BJ(0UKN#0<=0C#(0@11'Z\8\D,*,.N_C'-?RFB$9(
M8PRF,,<DNC"*3/S#')>P!>M,T@U$1&$)+!#%2$UR#D<<X1BM^\8,F/&/?!RA
M&'0PV"-TZHE(U&(-TY ')J:A#D>0 1/<N-X;5#'_@D'9H@_ F,00T% %,J1B
M$-S8ABX 08< KN()O]#$/\!Q"DZDC1S)B,,^_J&)::Q""V%80Q64$0I"Q/07
MILC&$7AQAT,8@A&"V$<S"#%#9\@F7O\(!!>>,8H[E((3AFA'+!A1#2E,@PV9
ML,8;,*$+2YR7$)!X!"L\L8=KW&H>A9B$*3S!AR+6T@U:2 4DBD>&/80B#'!P
MQ2<408]Z&,T=_@"#$T01%*%\ A"4L$0@]D (?9B$'ZYX@R4& 8AF\.(3E-A#
M*U21ASALXA/>H(4ACJ'%-CQ"$ZX@A20V$8<]"*(2F-AQ*P(1"WO0 E+I\ \P
M/.%0:SP"$)XX!"8<L0E?_\PA$EDFQ23"7(9&.*(/@D!$(E:!B$<\ @W4* 4B
M:,&(/!A#-L+P0A,N<09H6#4/>,"'#9WQ!CA,H@V)0,5,+%$)8E1!&/_0@C6V
ML8<V1.$0TIC$'P:A"6B\H@[__,<]+ $,0\2A'\_X@RA,TI%32$$5^FC#'M11
M#$!D@QVQ4 ,T;G$'4E!"%:(@A#;^$0I/;*,4>_"#$LRPC6=T ALP-8DXMK$)
M;5C1.(8 A"J*X8Y=T (=RXA5=SMBCFHP8QC.  4QAK$*6%2BC&)@A"U(@8UM
M),(5UN!$&L(@BF0$(A>[#L<U(F&(2SCC&*>81MJ,:?*3HSSE1/J%#[J0A2?H
M(O\;5K#J$ES!!GO\8QJ8"$^DW\"&1 AB'N-(Q1R2\(AG^&$*8@@#%W*1A7S\
M QJ2J,(+4$&:2W#")*CHA&0K8>Q_[(,+ZV#&&*!>!4@P(0F&T,,@JN&?5F#A
M'[?]81_"P8Y!,.,(SA '+3X:TC9XG11]P(8ETM *(C!!&'V *3^6X'9C$$$:
M=^#%/Y21B4T4(AN3<$(E*@$.9\AA%9(@@BPH,0)MX"(7YUC#+:10''>0816*
M(,,_9#&$7C@"WOV8!BW6T =V_&,(NA!'..#5D5@TX6RZ^$<I*I$-+WR#'<Q(
MQ!L440L45",>6;!&&S(!CVF\0!6$0(0S\O"-<1RB"[W_>$,\\ &PROXC"%B0
MQBA:\(I.[.$=UYA%'(30#'UXPR_\02O$@R]P03#H@3_\PR>00CC4V2],@C-@
MA36D@R!, B%T0CQ8 QL4 Q'4 C[T@1CT@A^ 0C\P01ZD A_0 C6X0FPEPCI4
M0AI(@Q[\@^6@C=K<@3:X Q.P!A\,@R-PP3>DPB+\@SP4 BE, Q7@ AKH0C'4
MQ2RL@3=X Q> PCFDPSCH5S/8P1<0 2(P@RQ$0CN\@B04@QP00RF\ 1/( 33H
M0R<4@1KX0C100A$ P2;80T>4PRL@'AC40:1YA!N\ !+802^P0RK4@1B< 27D
M B;( CND@Y]\PS$@@B4(0T=T_X0[N$(JI (E:,*1]8<X $,AZ$'YU(,LL((^
MI,(IM$(=R$$;Y,(Z4,,HW,,X= .$. (R^ ,M( (E>,,PR (:;,(K5 ,K*,,\
MP (;E$)T%*$IJ!H]E((A6,(K; ,H6(,^;)T@:(,_S,(C:$0I7(,L- (F5 ,Z
M9,,E; (VG,,Z@((GZ$(H4(A)Z(,B0((M6 ,]A,,Z9 (L6&)'K,,OZ,$>]($L
MK$,O$ (O! ,ZO *%V,(^D ,WC *@T$,TC (NF (X#,,L?)TZ< ,]),,VG(,]
MF (^6"+8L0(R@(,Q0 ,YO(,SR ,YX,,LQ,,]V((T7,,^S$,TN ,Y',,V$ ,K
MH (T./]")ZR#.WQ#3OZ'.,##/< #+<W#/=@#/YA#.?"#/)P#,[3!*,2&O)0#
M/8P#/%PA.'BE/!1#,-2#/LQ#/*"#.<B#/-##.A #/J3E.G $XZB#/>2#/9@#
M.=!#=JE<7_KE7RY)ZPF#!!U#,V3!/^@#%"0"&%!#.G#"(W "&13C'21"*CS"
M/'1(/\2"&.2"'M3",'"#+KP"%(A6+I0",$B!(526+R!"-,S#(AQ".3#1U^6#
M$E3#-]2!7R7!*/#!' 3#+,2"//C'*S1!-30#$WSF'I@#/%A"/\S!(J3"&91!
M+'C!*F@"$=*")LB"'00"-$"!'Q!#&\ 4/6 !'AR#X-Q#&9C_@3$<PB*P0AP4
M@ANP 2XX@2L1 2SP01TD0Q^  "_<0B;D0R6,@AL$P3;40AT(@R"X0>U9P2P@
M@M=A@Q[D0B.@ 3N,PQ=T S] PYIU1"_\P2^X N69PB+8PY?IPA\$0AP$ BQD
M 20P@@E @R@8@23(@0#$0B1\PC6P@3>8 R*H03%XP1OL01><PHW]@QQT 1T$
M@0O80C3<P1W\@264PAQ@@1SH035P0A:X014<PCUH@L%(0B^$ R<DPB[HPCTT
M"3? @R+HPC=T01Z8P2"< _+5@1. P3;D 1_D07%EPQO\02+@ C'P0A$801?8
M C(P0@V^@BJ4G#,\@1;XP1OD@RB8_\$?E $<3(,H1$+K>,(=^ (2>$,J/ $4
M($$IM,,F" $5" (Z\ (=J%I'M ,P0$--IL,ZZ$,X\(,_G,,QE ,[ (,S$(/'
MN$,R( -7[@--WJ$@X:HQ7 ,Q ,,GD@'A%$-L^&HQ'(,^O(,]<$3>!,,GA4$H
M4(J\X.H[P(,_#,,]G /CC,,Z'$,^J,,X\ ,]B ,[\ ,L&$(H#,,[@(,ZQ /K
MM(-=VD,YX.H^Z(,ZX&J[I@,XT(,^3,,B8 *0R<N\EASNY(.%S@,[A$,Z^,,]
M@ -2XH,[I ,\=&59LHXYZ,,^9%<[Z$,\!)*X\L,["-T_' ,F#$(Q+$Z\F ,_
MY,,QX$,\B/]#.F"K.,QK.)"#A?X#.LS#.Z1-.:3#.Z!#9+$#X]C=OH(#.83#
MNY*#T,(+.GA,.:2-.: #O(!#RUIH\9T$T1;?.\1"'@7"*]##OLI+W!H;X_Q'
M1X0#-M"!(G":W/Z(?O6MWQ8)W_XM8!)NX1KN/Q@#'IS! ]V#6/':$Y!"*.#!
M')R!) 0#(1@!')P!,,Q")<##/AR"'>3!'DB2&) !&3Q#,R"!7Y7"'> !'J1D
M1\3#)8Q!';A!,K!#(BC"U[U#$P3!W'278$7#)_#!&Z3"2,8#+YR!'#P"/=S#
M)8 #.OP"/ 0#<S!!)U0#(VC#+9#"/YC"+P #)]S!(WS")\3#+-#_$CD  ^_0
MP6A0@AX8PB,$0S[P@C+P@B[X@R-<PA[\ 3\8 R,@11R4PC;HP2J0ASW4 B8$
M0C.(@R^TPC\P@R4PB!K@*B1< BW4@SGP0ANX@RTD@@)V1#300C8T0S+\ S&8
M CG<6RN]@S9T0SK8@B=T6#^,@S:H BO0 C)8@RETL#\T9"[H US0@ABDPJU<
MXBPD@D-& SD40R+HPCZ PS[P@B<8@SC0PPX_@X4V0VP(0TX> \_B0SF@PS'$
MPS@00SV, S"D0CW68#>DB#&TPS$H@S0, S&HPS%0 S+@0SN40UC8 SBD0Z2%
M@SOT0W1D QE0PSVD@SC JSO(PSSD;'?%_Y0PQ,/JC$,_E."MJ(,_Y(/')((C
MQ,/B" EI"-,^]NU)9,(E6 \I#RXY( ,C[H,@T2TKWRPMY]=)0(,M'(,@P8LH
MYY<M_XCTP<(P$.TL V[=)@DKT[+@RH8[8 ,R&'&\".TIW[)^T2V0D$;<RFW$
M3O/B"*TI,\XQ9[.QR4,_X$,^I ,I:[,U\RW=RL,R[(/'K/,^:BTWU_,U'Z7Q
M >XZ'VX_^[,Q62T_[(,]N ,XE /S@$/!FH,_X(,]S$/&YD,]^"PZI$,XA$,Y
M^P-'+'0^^$-4Z@,6GL,^X ,_%'-'T -#RP/Q>67<WF,]J,,\5&V\DL,\[(,[
M/"WCG(,^N(./V/]=UJ(#.J@!(M2"'?S".<!#.:@#.I##.:B#.*"#.P 2/) #
M_)G$//C#.@@2/:0#/Z1S.*1E.Z!#*Q0!+_2!&E3U/;0#/)P#.,0K.Y1L/"SR
MT:H#.6PE.0B#)H0".5#TT][#'YB".'A#,V07.8##.8S#81-V9:5U4(##K8!E
M80>%.*@#.(0#.)B#.82#.8AM.0A#%2@N&/"#W.[K2<!4.WA,A3RM;-R8U>KS
M/,<M+56M#>W:2?2M\?VM-GL$3G#:*/LR;^<7/+0L/H^S?^SSC!!MW8XD<L?+
M,?A#--LRW:+#2)?T-O^RX*ZS.)QE7F;M/JIS=QL?(U/V.\A#=."V,;?_LSH/
M;G57M]]*<SAP92W#"_$1=W?CMK$1WS(CMVS<,SATK-9J;65G,WW7]X]L<FK+
MQC@$@SW0TMS^!SSH@SSC<\8"DSCLPS*XPSW( ^L$>-W"RR#7PX+W=HC_\XB3
M.)$ LPUA<S$M\S%_72VG>) P\X:'@RST01]X@@(BLY&<N)#L49WAEY(,=^MH
M0RZH<SHI3EKJ,S4K<XO?\I"01CE4@RK$PBK[-I/W-CO#^'#3MXGG]\WZLKR<
M0X:?=X"/9#B;N8 '^3S_"#A00R3LEB_/0S'T1^O@@X\HMW[9@S- ,8H'+C5C
MLS*C-SRLPUJI.3C@L3_ @S5 PC<0>HZ_^(#S_WFD-[F5,WB3DX8U_(*30WHT
MG,)N3SHV]_(_%((GW&I'#(,IR$,W1(+BY'=]VW(R/((V*.,_/*(I1'..7T,L
MT-,LF\0[3$,T&/$J4 (K< /NUM*";S>MDP(OW$,UR/JQSVTW[WB)4_N(N_9U
M?_,W7_NV7_O<;GLM\_-Z<_M"'T.X<CN+0SJXRTM=AO*8X[.Z^ULZQ^TYG$,W
MM[:[GWN^FP37?CJ\N_B56_>9;[.96[IY>SN9P^-@_X,[A+(H"[R78Z:!^_EM
ML_@_Q,,CQ($*F00R^,(Z3(,E !,YU,,KW /%5]<(.@(PE3@SJ,+>JODY*(,B
M//-K9<.M_T@XO(.^%O^\WSXU3+%#S]+2.?C#5"X#J^-5/_@(.:C#.O2#5(LR
M.W@,/]RJ%4*"&M2Q7E27, @#\'EY/!1#/8 #,J3"+.+#,EAX.<A8%_.C,*#Q
M/Y3#/O2#&+!!)9H$*.P!-]B"&<P"-AB,3I8"-V"UE]\#,[#","B],6B#+>P"
M)7>#+31#/^@#+6A#,4!#*;!"/UAQ,I"3/EA#(92$);X#-:R",Y1K<\%"-=##
M+_1.-AA#/N :+,S6.V##7%2#-$CG-%3#,_"#-CBQ-(!#/*S")12"-<1&M1N_
M\>=[U@IM.JR5BR>_FO^1D7JY9P&[NIN$-. #/D"S<J_WGZMWI0<3N@,(*X#_
M0LG)AC\TIC4T0WH??/>S.#&L@G#R><7#^X;K-S9@@CRH0@+%P7:\.XL#1#%
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M$/1@&9)!$TCA%%P!';CA#1@A#V(A&C;A$["A#79!#VJA'9H!%] L#"[!#/8
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MPK0 $V A$)HA%\*@$9A@$D2A"\[A'MH %ES!.!2U,\ J"L( &"+"&/C@/NV
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M 1WLH1NZ(1$"J@]V(1^: 1FP 1G&85;P(1IF@1N@P2R&84(-(AVV@1F*X1S
M81BP@1F P9&BX1CJH1A @1=D\!"RH1SZH1BD01N X1VDP1CP05O4@1B 01W$
M01WJ 1W@P1CNP52&UJS/FHG( 1.48!5*X1%.(1N0@!S@@1%DX0R8X1^*(1SM
MX$8781*H@1.XP1UR@1JPH0XRH174(!\N@0B@81)& 7+N@5(/0FU_ 0M& 1Q2
MTQN40!OLJA?VP!_ZH!.N(0_\P!3"8!2V80A^X;I*H1 P*A>(8!60@!9@(0E2
MX=_$H0V@X!1\P01"X1?0(!O_($&'_N!C*Z$7G( 6E $.;D$?R  KCB ;_L$)
M1/A&=6$3SF$6!@$7W. 6J.$0)D$;MB 1. $*ZB 6C( 94@$'G/0(4 $0)HL(
M/($6#J09T  NYL 7\(<=MF ;_N$,N.$?",$5&!L0"J$%#B$9,@$:W, ,R T0
M\,P71 $'H@$=T( ,!H'TZ&$4G,$D_L$6%@ /]J$+=D 5R@$6]@ ?2.H93.!&
M,V(-\#L9YJ 5H*$,V$"FHB$:6D .$B4B[$ +&,$+0&$5HD 0*$$0XB$C2J$$
MM($='"$-], .<&$46F 6/B$/Z*"Q;V$*]F ,K. 2>"$-\, .1,$6UN ,X$""
M[@ ._^3@#O0E(_+ !,#,TL2!$JY@/,CCFZ&@= U!#DPA#4KA'Z1A#T:!%2 A
M%)Y!&E1C&VC!%O !4,CA&GJ!P<"A'8PASQN"D>IA&BS]&HYA':(A'4+:%I"!
M.\FA';HA&O!''IYA%! ;$,J@%_ A&-+!(.:!&+9A'<!A'/;!&*+A'FQ-&.CA
M'K8A'N:A&NQ!'/@!&8QA'L9A&(C!'-#!'=BA'?R!UMM(4L#!'HZ!'<HA'A0Z
M(\#A'H A'MA!'^2!'<"!V_6!7P<!,#-"'+(A$U@!<@I"',*A6,#!'021UV.1
M'/0=6LI!'\RAQM(A'" B'-9A'90E'KJE'>:!',9A'FQ='/_&(>%]4]\QGB'@
M 1/$( SF8!K"X6<6NF#PIU9)/C(,0N#SO23RO5A>,N !WN7_H1X>P1)@&!L@
M)]\76AQ<_N=K-=\3OB1J%;YJM5+AA1SH01DHX1 Z(102)1Q4WC5Z/BO^#=\S
MOJS1FNN[GDVR00[B0 _6(!JZ80;$(1W(@!9F80WV( RJ0!LB@0TFH0Q.(1@J
MP1OL81'N  W8P!:V00\D 0S$P!CVX!=<I:E!HA#P.0A@01P\01&*, _"@!&4
MP0WB 17*(,;P8!@2 0S.@ =HX106H1I^@14(-P_B01 2] M>(93((17>H \P
M(0F^ 1@:(0SV($]= 9:M[[(TT!W_YJ$1YD$<_$!/\H 9= &7?<'2F&$1D*$7
M]J81@H$=. $\I$ 2@$$0"@$.8<$;W !\9^$<?.'(+>T:,.$?Y.$7D"$CT&$,
MIA$7IG$63$$8"J$/(F$22*$?:H$?LJ$-K $@G"DZI"@?LD?N_C5;9$<0OV%S
M<OTC1_$?,4VOT$'2@P\<-%G\9.FS9RC:1'+_=-'ZYR]7MW_0#E&"]J^<*D'L
M*%)<18@0J7C_:+DA9%+GOES[_MU+-(@3NWZMY US=$C6.WF_,NT")6P8H4RS
M_KV[U4C7NW_9).D*E4XG.5:Z5F&#I[03F']X\_Y#5ZK</V?,]$&[1PZ=-FCS
MS(5;+(Y<_SAPX<@UUCDQG#B]>E%*KDCQ,DIQH"=7;'P2Y;9%@ 8U,A9Y(MZ*
MKT&_7OQ/MKAPK_."1MF:'+C=F2FCS.NV,E[9>=&%0O0*'&5QP'H5TXQY(NG,
MP3WC=BN9^'78PU\7KTY.VR=$M>B)S[T>,V7W[,6/=X_RW#54N43I@U\]^/N3
MV,7&SS2Q*,-/;>^%1Q]U /;GX(,01BCAA!16:.&%$XTS32-QD/)//I>(<PXH
MQ9@SBB:_Y!)/.;4<<LHY]% #C%B>=&C./]ULHHLPXY2R#6Y.L%*:,\UD PLP
MY%S#C5BQ''F.,N: (THNV7!##SVLC%*(,,M(TXXP^)!SC#+%5/^R"!IE)#-9
M;<Z,,DPW2;GS2C8HF;/,,>C@-0PQZOQCSC7FB&/-/.1P8\\P]I"#3S#AV!/-
M.>$,4\R!>.433#?#B*-/,<,LX\\X^!Q335+_Q'/,C?,,XULZX^@$CC0YS5,.
M.5=.E ^D*[Z#VSQ _;,?7NVT]D\ZESGCR36ED3-..NS\TXX]M:DSSSC3_G-.
MJSJ]0^AMN 4HGX)Y\=/L?.!B".ZY_^%%#R=@9.-:?^<^B.Y_Z39(WKOQ#5<<
M./LTHPTP-^)+7'BP!5BNO?(6G.QXX%44SCW#].F6..W 8PZY^F9,+X#<:?QM
MQR!W_$\X[9Q3SF^BA5Q.L.. HYMF(8?_;,XYZ+0#<V?AC-.RR\J>$VC,0#LV
M3V+<-99SE(V%)MIQY;RS#STI<X?AU%17;?75$1Y<VX5:]Q=*4O5>)O#4PT&#
MABN)R))GO0(KZ#9Q\;U[L,)C\W=<O@FR%R_!\O6-US[Y\+QQ;6+K^RW>0=]<
M<.*$AP;RP(DW7%PZHBPY=N1 GX-/9$#[I],X_,"#;<?@V!,/YU+_ \YO (I#
M3SOYY(-.S.&4<_+$Z:AC#C^Z4G2./_>,3M_(]_AS,>8BBWSXX>3$LPYW\B1#
M&/+U"(-\Y[%%+?4RT+ S"S7Y5*..-*#,JCS"_R #S32H1",XW:HOLTVO"G?M
MFCC;:#/]?.2E_TP/,,#(1BZ( ;>!8>V "$R@ CU7G.LY4&.= <["&.<?O:"C
M&DB:(.0>R,$&*DUL45/:QY 7&@9B;X)TDXSV.LC"B2D-9.50AW.0AXYQ:! O
MZH#'O(+FK7_@XQ/J@9<078,.5E CB-69ARRPX;*L=689J1#&+5R1$ >MPQO5
M\$M%UG&*9N!C%<W(2SQ*P8P\&0PE^N!$)0AH(?M5*!VD@ 7'@O$+8RP(?L]0
M1MP@E#H,66,7_MB%-W 1!V)H0VT.HDM>I'695.BB$&MH13KNB))RS*(6T%A'
MP- A#W;@1AQ#<QDXTK$BO)1#'ZG@A3 \\QEXB.LQ].!'/-JQM'$\@_\3H9C%
M)E!QC5^UHQC5F.0"ATG,8DX(8RW$'LAV PYTG.-Z?AI'.="!NG:TQ6T=:X?-
MDMG!?\ C,KLA1SYT6+3=S(,8'20-.N#ACF] ;GDHU L]DK&/84CC8BD+3@')
M\[8>GL^;G'A'/_/R#%+\:I^'$P4K_((P=.2"$PXRW.'H40Q[N*P<P!@&.Y:1
M!'G\8QTMHT<_^I&G< 2CES6CY3AF-PYC!,(5B0'&-MKR46EXXQ"O,(<\C"$,
MD([C&,U8!M0HPP] L"$4FA@#+Z"Q#\7HPQG:B,8[F,$'2@##.2.SQAPJH0U"
M".(;R?#'.K"!#8AQ QKNF&%%S*$,,-RA%Y?_24<TFB$-=Z!#'\DP!CWNX:]B
MG..CS]#&,N !#V-0@QK7J(8UD+$R9'B#&KJR!V"T4<\PZ"$>G/%'*?IACRH]
M@U"4,0<RL-$-9ZR#&,U81U+*L8]TS&,:S'A&.^AA#&9\XQDYH8P]J($-:MB#
M'M# AC>*(8Y[8(,9TR#&.(8Q#6M0@A#X\$8R#%$$;#A#&>HX1C>>X0QXJ*,;
ME_R&/.+AC5'DXHBON$4B^% ):KB#'.M 1FXI,XY4T,$1L3"4,5*!"EADPQ[;
MF,4HOG$,9X3B%<JH1S]0@0M+;,(8K#2',4:ABUYL(QFRX$4LO@:@<JQB#ZKH
M11@.\8E(!(,>VBA$_R1@\5YCNOC%Q83-.8+!#X+5CX'#PTPW\A$UO:0#&L5P
M8D7:\0UW/",5?\6+-'S!S_><8A/]J%M$!VJWNN5#$7^%#2:6@5"\/&,3$<W:
M/^1QBFB 0@C5Z1:\QB.Z?P!C#:^0!1G4,YYVW(@W],!-SM#A%W2H0VQ[Z=,_
MQM$.=MBP-NQX9NH2/>8QW&/0B1Z'., !CWY,$AN)V$<XY@&,1T^D'OOXS7LH
M(8;-!DP=Q=@</?@0A=H4@T__F(?+XC&[<XB.,H8)!""F40Y15"(2HY@&$.Y!
M#5'0(Q6_<,4G6,$.;PQ"$H3(I3*(_ IV< ,0GY $,$YQ"T*H0AC"X$2V\?_@
M"VJX0A!-X9XG*E&)5]!E./MH@Q9R$8<OD&$2@4 &,'(1B$U\XA2\ ,(<NL%0
M<X3""&UH1B72T(A)M (9LQ %-BX![5A BS+N@,0C*&'5=(2B$908A"ZVX0H^
M%"+%DJA$)K!A#U0X(A**L$4S!G&(2>BA$G&8A#:408E,-&(7QSC%(0;!!T<P
MXPUYB+)FAD&+4GA"#(-8Q'1*@XQ,Q $0>-@%-RX!BULL5Q'=X$0;)-$'4UA#
M#'%@!!:2 :!S\&(/V.:%+?JPB#[0X1BOR,,GXA &9VP"#8((PB36\0A,-&((
ML[A%&ZSQB$4D A&A0 8?#'&).<RB&XM8A"'.H(S_7N@"$FL@1"M.X8Y8+*(>
MR5*=+<[ "51 (A1=U\4:-C$+0CP"$+M01B < 0E&W$(1C.#%(R0!8==$(Q*8
M*(0F'D&(,$0B*]C0RSB\T8E1A (-D9!%&PI1"I!O8@ZX:!:,QT]^JPTG'<X
MA#7PP@\D@JX=QWF'(MT2#G2DXQUF% L__/*.)P1"BT.V#*I"#\JP#;&&#.N
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M")$ !I^P"X1P#237#?X "X]P!U60!FJ0!J: "Z.@FVP0"]#&,=F@":$ "IO
M!V50"WQK#IS@"%W8"KLP#9_P#9= !X%@"-2  X1;"<L)!0:8!*L (,\P![U0
M$[30!Z7P#[3J"[W@"O0P#T7 "6'@+J_ ":^Y;F50#[0P!W10!NH0#J[@!M.P
M"/W0#I<0"X34"(TP!9 0"[J0"%GG#:W0"&#0#1YC2;2P.<GY"&' "6] !\^0
M#+L !I[Y"+I@#;;0"VA0"^? #*K &GGA"U I#XJP!H*@"YVF"M&G&\C "ZG
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MLT '53 *>F .]M (G& ,2^ &V5 'C" )F)V(09 &LH $8= -SLT)AS#_"E'
MW)OP#$&0".7@"G, "I 0"*C0!F9Q"560"[X !(6 #Y @",RP!YT0"7L0"K2
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M:64(7,PIQQYU9OI2'T=&6>6+?_PY8Y54^-!F&T>B^200>O9I@Q6G^-%D#6$
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M!D\8!5<PA&M(&'3HA4#H!V6H@U/@!TKXA7UE!4/P!4'(@V_@SF&PA$]PA$=
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M4X*#6^@$+:F%4>B91A $7;A7QLB&#S$&0$"%>/\(!$T A4U@ DKPA#,(!5\
M T#PA#B0!4#@ T*@!#+8YCB@A4D(@EW@!%32!565!"8 A398 U@HA$'P!D.(
M Z5@#$Z8 V98A4>PA5)X IIQO&G @EQ8AC[ A&=X@UZ@A2^ !%.X UPHA2!
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MVI1-_PDS8.$DZONSR=P?.<WX:%(72E4T/D!ZR9%R+R(Y8WZLP<N"J)F=1*_
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M5#@"$H_XAKH*4CM-7 (5\^C&-\YA#FJX0A&M6 8Y^*$+6,R#';5X!C1TD8A
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MV$.+]O>/?E#B%-0P 1WVH09LU*(5D'A#&?)1!68H@A;K>,,O* &"0NS""X$
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M 1#:F$\Q\I&.CRUW$]%X1/\G1)$)7%@C$X>PQB(B(8R9ML,2G2A%(MIPBTK
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M=.:E&_9 &&"!"&#A'A*!\&B.=D)A$V9*&YP *CYASM*M$Q*!$JII*_)!#/(
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M#C=XY!")3@WME(D(5XB0 RMEH8K6/\)4X<C!&?\S#PE&<..60M48@0,95A
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M:$(+9*!&,A#Q!S_@X1JO8,$2;'&,-AA!#,2:!A[,X(A*FHH;CZ (.A(Q!C9
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M_N")<Q1C'X^P1#G808I'*"(.ZE &%IQ1!E"H8Q1#L 8<6($\8O3!$9!H!3W
M80M<T*(,^3!&&&+!#4QT0A'4@(=9!L$(880#$)EP1BQ@$=]_H.,5BK!&( BQ
MC&L PA2Q4(4M5$$(0[@B&K/LARI6(3QSW*,8C-!$,E"!B5#TPA.+V .QPX ,
M8'#BP,J@QRU\>NA$[,$3HJ&E+6$ABGS_L$(5-QFFP0^.<(1+@PME4 @K1!$-
M)IC!.7R8 T_10(DD-*$>]S #!$K C5QX 1ML*();MM$*8MB#"GS0Q2]F$>&0
M#*,(<1A%$7Z0AU=PP0Y"44@<3*"K;BS!#IR !#3TD88N@*(;=4#!*22A BE8
MPA0HN($>BN$%(!AB$*F B4;_H0U=J*(+(/688&PA EPHI![^4$9<S3 '8/@"
M!VQH@A^X(0DMZ $-]1"Y)>IPBW,X(0EBP$'1>?"'F^P$%%\@@QB ,(HSI  .
MR##+P H'C5>48AEI&,,_</$"99 B#')H02W<80([."(5@OAY)4:1@RY\0@2>
MR 8(O)"*3(S@_PQ$D((T6O&#,= "3*9B!A(,T0E)E&(>4,[$%((ABT.< A'?
MR ,9II$&1O"$'GH PC_8H0M#D$(8?9#%.9!QAF5X@Q..0$$83M$'3 ##&HW@
M!!&0H PQ*.(9<8@$-[@0"FKP",)@"VQ0#&10!]6@#B'!#ILP!([0!%' #[E@
M!D;0($K0/)G@8V6@"ON@!D! "WW "/>C"HL0",' "X6@")M #4D@#?? 0&C@
M#3S1#Y! ")B !V@0"((0#M%0!LWP"(1 #)7 !V84!K\P"7'P"YG0'*Y0")W@
M"B$2$L"P!Z#@"6! #?^0#9T0"N?0$=6 "]E #8DP#?+P"I;0"&3@"/^]L B8
M$ QF 46\4 MK4#N.H NI@ O5$ [80 K+@ UOP OOL(/<4 NTL F!X#(5\0Z_
M8 G#8 ZJ<(>!4 S?L FA\PII( W8P AM@ W(@ G3  JR0 J3X F%T :#L E[
M$PI[8 MM@ KC, U$8 VZT NU, E[,Q+AD ^.H BVX >3, V$\ _5< :9L :E
M\ ^B$ >.IA!:< G#V R:T#'AH N(8(/_\ Q:( UR@!*G4&IWP K2  G]@ :2
M$ F) !.QH NT, ?L@ ^&L NPP N^( B8< QF80AH  S_( F?L VG &X=<0ZO
M( G4X J\X [(, FCD NTN NZL#JVP!$C00__JQ (V_ /R_ +K\ (F8 ,/:9K
MK5 (;M )D[ 'PM /Y<,(N$ -EL \AY (O1 &A=!OFH(&W] +I: /HM T">>3
M/PF4I6(-28 )%,$/1+ $>=!T=2 /]. %TL +*G *ZF '41 $:& (0  *?L!S
MKT $8! +^C #*#!X8) 0,D=SI& &;O &6# %9N P_] .;M "^T@-4^ $DW (
MJ8 />& "?J $18 -ZS (1] (0T );) "VU0-?= $2S &_6!VY( IT1 %FQ!2
M@C$+)5 +F,(.X[ '*Y +J  %KD *-L ]2A *A[ "1Y &W\ &/+ '67 L3$ '
M_6 $;] +2F ((M(._X.0!?MP#5%P",YP!;_080JA!B 0#>[P"%40:GO@!O\0
M"UR #;1P!FEP HU0#T\0#>(P#6" "#-P"*1 !9Q #F_P">5@!F'0#T>@!>50
M"B_P"JJP!<-0,J=B#4SP"J1D#-PW"'$  L;@!Y#P#^. #FIP"S"4"0XR$N70
M"4GP#^9P9GPP"ZYH#ML0!\3 "VU0" W&7B[C#7, "8?0!:B !ML1"(QP#U(@
M#%^ $NN@!:S0!P8J(NM@"&,0"X+0!_, #"20 O00#D]P)ZO 2HWP@GBP!\HX
M"-R@"\HP"5V@#+R@#9Q@!:?P!1A9"4 0"083$JFC"J@P!HC "W$0#*3P!__-
M8 F+, R\D >ST N#( J98 BF\ F>0 JJ\ V#L =W$A+U0**^P >.  V1@ ;*
MD)S(L(:S$ C68 ^P( F!T >*P'JTP \BH@^7< FPL&N]P FIX V_$ W@\ VT
ML S?, >J0 ^7T FIX B_T =[P W$L ]-H1#ST IY  BD4 FG@ J$$ S&L B4
M$ OO8U5\\ ;[@ ^"H RN@ B>D'V70 >M0 F&$ J^0PUGD OD\ Q1( J:L"1P
M( T/(@[%, =]0 M?T ;,@)G;L >"  AMT M[P :7NA. ( :0  >>8 N'< N$
M, FK  B=\ _4X 7U\ MT( E-L +,@ 6S$ QG\ K_8R (WF )GV )='"=90 /
M_= (N% +9S ).IB((V$-;: )GQ 'J0 ,M- +>_8/X "EKB (N+ /R- 'N( +
MKG *A/ &<* )U, =#'$,D- (^2@)WT )B[ ,H< )M; (EC (>= (E= )P( /
MOF -C(,&?\""NQ!%;0 +0R,8=LH-H."HRG )UA*4;>NV0&D-1S (?F,*JI ,
M<Z &ZK0&8+ .UB "?] $ O )XW &;Z *6H #3& *98 %P]@(/A '^; $EM ,
MV2 ,HC$2,Q<'M/ 'J! +)U #<!"7<UF7_\ -5T )\3 E\W '2- +>C $WF .
M;> 'I< "48 ))+ &A,@/_\<@"3* C"&E$,U0!9@Y%0K!##A0"?\@#6+P"GY@
M \+ #U4 ":0P \1@"E/ #*?@!F/0!9%P!R# "X:0"?* !8#P#VQ !JN@!!T3
M$O/@!D&@;'80!OF@!+1 M@JQ"3_@".>0#4BP K+0!].9"T*0"F0 !("0 I/0
M#T/ 4X6 !;CP!4R0"%N@"__0!ID0#F40!_+0!46@#MA GZTP!1&&#O)@JZ3"
M#;TY$:PP Z, "U10#&]0"/]@#<^@!L_H"Y3@0@UQ"BE0E"H%![U !H<P#J0@
M!_@ !P^$!V% "H50#^S0"6M #)$@!+:@!]A #ZW7G=0P!X,0#M60!]=P!HIP
M,/^700ER  R>0 ?Z$ E[$ 6&$ ]6( GS( B[, UHH WJ( =R( MU  G 0 B-
M$ =QX R*X B?0 ;9< ?68@M>T NNX2V2L F$8 >>4 R0$ EC4 3/$ FZ,&Z6
M\ AZ0 G%< J.<(6J< J= +"!8*\C80^=$ G2\ MM@ AZ\ O^( XA 1&W$ NM
M  WR$ JNX V\\#Z(4 IR$Q+EP JZP RV@ F6L G6( VG$ SBX RB  S.( BA
MP Z]\ O4< F5 (_:8%-VHQ#IX I-, >5T O#8 VYH _L0(F?0 C<$ [Z( NY
M !^D< W8D F9$ G>H RUL W?8 B40'# $,[D$ R/4&+_FE )N."E(\$/F! &
MG- (NR -L? /[E +WK -AB!(G#"1(P$,A5 )GT -Y= HGW 7RF QQ+ (Y^ .
MD? )DX (]= *=7,+W_"DZ3 +M(,+_ "5Z! /LR -Q5 (FU (U7 .#W,.WB (
MC0 +[P /SR -_!,2^A *JU *S\ /[Y *S@ -W# ,VH )BU *PH,PVW +F<!K
M_& -VO ._=$/UM *NH +I= -W(#5P5 -O8 +F  'A' /Q! *<3$G#Y/7^# ,
M]8 .^7 -(?*VEXW9P;0/?G "OB *(R $R& )AZ 0KN $]= '(P $8W $0( /
MF< $P1 &'Z %VQ )). *RX +_S30!_@ !6U@"C(=#.,PA4X0!KL0!+90#U_0
M '\PNF^@ L3052-0!Z>0"KW0#': !>/@#T* !-/0!W]P##?P KR0 FR =I4P
M"VMP MV0"Y#0&@]3L%]@"6_Q"["PRR&Q#G4P!7& ! ZP"Z0  F@P"$]@#;>@
M!/QP"E"0"HO !H.0 X*@"#S0!FZ0">]0!/5=!G+P#58@!3S#$.4@"TK@6R40
M"_4  KJ N;M2!B\ !FB0 U*@#72P ID@!5Q "D  !6B0 F@P#%!P)XA@!9JP
M!$/0"3B0"/] !IH@#G*0 Z5@GD90!'] #(D  I?:#8;@0J52"E:@"FA !XE@
M"B*@"?^6D .HP Q@0 9%P I^( C_P N,T,,6+0E%< 9Z8 =@( R\\ 5LP 9V
M< QT8 >[4 9]\ N.$ SHL,Z1P AJX MK  WLX B'< ]R, BP@ =LL :J@ YP
MT)L/(PZAP 1KH 658 UF %9$X U/P 6"H G%L UZH W_( N>C@K'  YP'0O&
M@ [9( NUT SI\ K\L Z0H D8*2+L, V[\ MM9 R.0 EX$ 31\ S+4 [@D R)
MX G/T [K\ VRX O#$ _,P NG0 RV$A+G4 W.0 _Q<)VEH"LB4@[%D S.D WZ
MT ["D S680VQ, U[YA#W$ WW( _9, O00 _S$ R^\0[]\ [_Z; ,_F .QQ ,
M]$ ,S1 -[X ,F\H_MQI@MX ,ZQ .;"$WYU /SP ,7'$.^C /X6 .]9 .YQ ,
MSQ :[! /YV ._= ,^4 .[< /4\(.R( .Z9 -U>!K#Q,._M -Q* /[A //#\.
M\: .Y4 ,U, -K2$BY* .6-T4\% ,P] .X5 .Y4 .Y6 P_P /\< 9XJ .YQ .
M[( .ZM .Y' .[Z"ZXC .ZA .+C\.X, .[T /2>,0XY .\0 3XL U9"L8YX .
M8T_<.,\UX# .\) .9&]VXV#SZ> 6Y8 8XS 7Y<!8C6\.<['+:UP(AL@*X! .
M[: .YI#?#1$.GC\.Q"T.X !'F8W[_[E/*B8;!59@!$HP"NK@")G %:[ !<H0
M!8-P#/RP"TC@#810!NS ##/@!_BP#W'@!6E0!&4P"_; !53P!5^ !+#0;4;P
M":<@![, #K>P V 0E^>0"4]0#\,H!EH@!W-P!Z>P"9K #^&P"T0 $*U^35H'
MAHTV/X#6$?HSQLND>7'&'/M'SB*Y?\;"_/J7#XRE<!4M_MM&1@D00_K()5*C
MAM"[56W,<0/3C1,1/'2BW6M4),VI=HQ&_;,$R%TA,LU$_INWJ$B93NG>,9H6
M\N(_9)_@_&&$31TS/& :*3+6B\T>0[W668KW[UF8.)T\L?JD[-^NH:GV:#.'
MBXPFI<\ZJ?_[E\S1O7^)%2]>O(V/H3Y^.K7#-0D0IF;C2.EII2X4-7+1F+$;
MJ9C5(TV!D/U+YPL1K%GOC'5JQ2K;M6?\_NDCM(@5MV6LXHV[1NV<LU[ONC7B
MI._?*6X71ZI#90G7/62A$C-S1H70J,SVK*ELQPQ:.'$5X;$#]P\</7KCQ)43
M)XW2+'HB+8H[1P]>.W"X.:022P2Y9YSV_C%GGG3&L0B=_Q(K!QYUK)(NG 3-
M8<<<QA(C9YQRZ!/'''/2,T>=<?2[*)P41SPG17+ L0K!?] 3!YSV;DQ/GF7X
M22\Q=KPA)9B**DH/(_=^K+%(<9!,D#%PE!0II!JIE"ZQ<#"R*$O_),G1L4/&
MD PSL2;!'+-#,<&\4K'2%DO30S-5O,I-..,LDIUK9K$%FG?07)--.P,5=%!"
M"S7T4$0#19*86F[1YI]RI'DF2V1FB>85?Q*;!Q9@KC&EG'&FF26=?]A9Y993
M@/GGG%Y^X44778C1\A]X0'&F'FLR78>4;CP<"9QM9F'G'WJJX48;;9C)9YAB
MSOD'G6Z,X;&<8HQAQYECR&DG&VN:@>>?8I9I1T5BD=EGU6*RU2^Q>)P11K%Q
MMEGM'WF&>2\8=,S9!AI25W6FG\2&>8<<8<Y59QX.2T.'&F':"R>=<K2<$QYY
M%C,G170T1:<==,"!ATIV;F0G''7&58<P_R_-I$]!=:2T<YQUADTG8T'%;!--
M0M_,V=<_Z?QGG#OJP=GG.N$D)Q]GXI%X3L7>X0864(Y)4<TSPRSM9D4!95.Z
M+MWLLNLBPZZ(QL7"04>=!$=:\RJV;?Z3:XEY?KM(KFN>$VZ\\]8;;J_W[GMO
MP /7N\83X2G'0L%[3G1QQAMW_/&EO/;5:CO?Q)K<JO'6VDS+JR93;J;=KGMK
MGW6.W,C/Q1Y]<CEO9KIRT\&^6VW3X]3YRL2M3GQWP4D'W3UJONUY:< 1#'QL
M=M#A\AQ]SN'ZX'::1%*=8XI9!W3%M\Y[1 =YW[UHU;T7?_S!;2?__+_S3O]\
M]-?/'7+XXY<_?O_3Q9&>_93)Q%]\^\F\'V[[!7!U[VO=]_SW/]'M3W/:*Q_L
M"O6Z EX.@NJ+H *!1)H8H:,<#.198LZQC[;\C&B>&V&<[F$+=S"F&MZH1X+4
M 0U9 ,(2A6@&8<"7*',4PSFZ4V":>OA# W(.B+UC( 6Q-T0D+G!^2V1B$RLW
M#GJ4#!U11.#YQ*$.?T0LB7MKDL< %T#[<6T>^3!'XO+AC^Z-+QW#0(>7$#@.
M=]SCAZT#!S#\ 0XE5@0<\:!'/*@1CUJ)PEAE1!0YY#$-=61#'_=S4SC\T0YC
M=&-JG2.=,6BV.=NEKT/6P,2\Y,$,?: #&M_ZFUL2<8E$C*(8+"(&,?+_DXYC
M%*P<]9#:/][A#F"<(QW!N$=[TE&,?8QC'/$XQC'F4:]AK'$4^/B@,,AH#5DL
M@TK?F$,;=+&+333"&/.(1XE01(Y^4*,9:*0',:ZQ#WQTXQO54,<Y_&&,;+ Q
M&)=X13Z&L\=Y<*F'[MOB$&'7SSP>KX@ [:<3#7I0)T:#$X50Q"4X@0JW98V#
MXT@%'[AQI)UATG.6B\8JAB:H9P B'Z>[(2(P,:R/EC ;EE!5Z4BQ"XEJ3Z+B
MX(0O,H8U=L0C/? (A3;P 0E\F(($G4"%(&B6GR*A(QZ(2PPZ^#$N;R !&'=X
MA56 U*=_",,0U4##%Z)APQKQ@S#B: <]$(:1_W.HH10840<_V@..<[C#'1.*
MQ[CB$8SVF$,8SAC85=AAC&I\:QE56$(V$N,/7PRC&UQ(Q3_6X8QBP @CRS##
M&WH!"3MXHAW*:,0C8#$/4/0!$8C(A208H0UTZ"(2C_ %*1Y1"'_,PQ>&P 0T
M_%$+.A2"&JU8A"4X88U=]*,4BJB$(:@A"EX8(R3G ,1!TD$/;OS"&;"@A3W:
M\0U@5&,1?6!#)([QC3B$P161V$,9XL"-:BBB#6YHA#9>\09)_ (6^.@'*KCA
MK,LA5+_[Y6]__?M?  ?83MV@A":^8 1*X*)&Z4#I%--Q#J7.0T'SR-$\WK'!
MJZ2##5/0Q+C^T8YBW/\#'<)L1SW<84AG9"HQ^Z@&8L3!#W\4(QWIZ%%ZXA&-
M93C+'#PJ!CO808DYV"-,[5A&,HQ1#G4$8QO;\$>6@N&-0NAA&T4*1[">01AV
M2&,6U2!'%>*0CGRDHQW \(8HA&:.9*Q"&QNR!UGK@9%CS&(/Q2@'-5!Q#6?Y
MHQ2QT(,K.I(*;A#C'N5H1BI8D9]\?,,6U7">12+%C&E(@QSZL(4WO+&,?\2#
M&]9 0R_P&YI9:.,>K"!$)WRA#F/,(1+R*(8]'J$$8:R#&N! QRH4 8J,24,5
MG4@$/O0CC4A48A?PT 80CH&'4%A%',Q01"=$<8Y=/*$7=!!!(R"A#'"8BA#_
MBFA&.7KQ"*!BI!Y*Z,,\JE&(1? B'N_X!1]J 8U-.*(0HEC$'V!A#E!TH@^#
MT(U%V &),>#!$?7@A0R X,E2;&,7*Y $, RAASB\PEF):00;A%88:%@##*UP
MQ2%.$0DK)"(-45#$) 8QC#0\@A-:&,0MW,",4[PA$6U @RTT40=1*$,/ORB$
M4!2Q#%40 A--, 0O>(&,D*Q#$(!@1SI" 0E>?.,3C#B&/"C!BEA<(A:-D(,I
M,,$&7?B"$Z/0!6=.<09(Y((/B< &(6*!"D<H8Q2+X M)!7QWO.==[WOG^T&1
M] Y>]"(Q]+ %)#C1#W#H0A*>\ 8O=@$)5,""$M-@_P<V7'$+7S3:(M&( BK*
MD"ERX.(,FP!$-IRA"CFHXAF4P,,F@"&.;K1A#Y*X!ST"T0DP;$(7;7B$/-0!
M"3>X01GL2,4@^G '7/2C#$[P!I1>,8E-N.$;W?B#'\Y@B7T@8PQ&B((85D..
M<#C##%)  B30(8LT.$$+UX!#)D(1B6!  P] &,&706&%*73!%_48!#B4D09]
M4(=)T 5-J =;,((O8 )N@ =-@((M@(+DZ(,N,((_4 1N\ (GJ )90 <PL((J
M6 -B*))B$(. ,X)AL(4;* ,D^(-[  0S0(,LH 4.28PHV $W\ 4V>(,V&()3
MT 84& 10H(-7< ,<  1>6/\#>W %.3@$(XB%<[B#/Y@$()B%(ED'1W"#30 #
M7Z"&*#B&.4BVBH@&(A@#-Q@!4. %+T %.E@!-,@#,>@'48"#2LB#,0B&.W@!
M2:"(?Q@&)4 #89 #-C $*N"$:FB"*M &5R@!2E"#+: #-1B"8E #0$ %/CB7
MQ#B%/X@$7  "3F"&+<B#?@$&1^"&5QB!7]@%+BB$0% $W4B,)@ #I$J,11 #
M<Z@'07B$3; "8$B$,@B.0U@&(["%>P@"5P"&,J@%0&""49"$,1 $39 $=["%
M0SB&=Y &43"$;9B&5\"$(>B#6\ %I'.L2B"$<CB&-C""-#"$,] $8*B',W@%
M;D#_!5S0 S,(A4TPA'X0KE/ A#D !%U  VH ACB(A&W@!6;H!T> A$]8!#T4
MF[Y[2(B,2(F<2 %#$GG0A:$@!VR0 CW(@S0XAB=0 D9P!"!H!4UX CT8@YK+
M RPXA#U((;:J!#OHASY8!7$XAC_ !4%(@4A(!">0@U1X RFH!3+8A&#X SOX
M!3O0@WV0 T^HA2MH@V^8 E& !:=$A#UXA>5+!3)H@FPX!#  *P]R!%FHAC#0
MA%6H DG@!C6 A4S(@W<P!"G M \CA4/H!B:8 6,( E\ AT3H!3TX@R9 A7^H
MA3Q AE+( U6@@T%H!U_8 VZ(@GYHA"U8!5A8A%C0A&W(_P-)( 8XH(1 ^(-G
M&(8UJ 59 ()_H 8DV -%Z(-ZR 8X\,Q"D(9+*(8BD89$T 9LF -8\ 4M^ =E
MN -92()C8"Y8F+A_J() ^(=IP 1JB 8@0 1T< 5FJ 8]X 97<()VB(4U^(8K
M\(5@X 0WV(=/H 1D2(5J*))E&(5JV =:H 0N]$(P' =)Z(/K 0(T8 :@&@0C
M4 =OB(-4D(1)N =HL(1<$ --2)A_$(<@R(9E4(-3L(?P(@5"D(9_@ 0U^ =1
M$ )(4H)9R(1.V 5K09))D 6,$ 1+" 8XT(,B&09 V 9IH()LJ 8V8 1<( 8'
M28PT. -24@=X8(0ZP")'6 1#^/^">/ %.K"'E2H&+<"&?[B#7. '/V@%25 #
M4< %3*"%2;B$=_"%-O '>>B%6F@$4& $3(B%*A"OY J)<N $/@"%8F"&1'@#
M2S@$-.@&4Q #6 @$1% %1* J2ZB$>7 &1_@%6=B#16B%.&@&>5 $7(B&2P@%
M>.B%-CB$4#B'=AB9VJ%(3NU43_U44)6<=5"%6/@P55 #;T@%+."&)\ $<Q@%
M.2@R0S 71'"%2Z@#0=@%F/R'8)@"-<@%,*@#=^ %26@+(]B$2!@$=Y &.Q #
M7@ #1M@%)&"$2TB#)CB&,$ 1,+ %<"@"2HB#/="%0-@X,YB$?W %))@&0FB$
M#@$':BC_A$, @D-X!4U(!G4@ DL@ T;XAUE@@VA(C''(!DFX.2JPA2SP-7,(
M!T>P@B)@AG^0A4>8AV"@@S/PA&3 BC505T'@@TYX!#Q(A6^@@UW  C,8!"9X
M!",8A%7AA$J8!"/X!W>X@S=XA#UXJ37P!U(PB#!X%SA##3J0@E5XA0PEADS0
MA2QPED) !0]+3EOXAU$8@]$B 4- !T_XAF(XK^Q$!QS<!1&H43F@@WZX!D_H
M@R)HA1]9AD% @TO0!$'HAB[\PI P!TUHA/RH@DF8ADO8AT'0 G:8!B:HA$O@
M UA0!4=(A36(!!A9T#XPAF7P T1 !4-P!5G@!%6!!#C@UR3(_X@9@(5N& 5"
ML()9^)%!P 6,&(1%V <_V(,B 09"N(9MX )M<(=IX 0P((*&U 4Y8 9= H1:
M" 4[P(5?> 1FD(0H> =80 1[$(QB\ .'S8-8>(<T4(5<P -7D 1", 5>BQ0Z
M\ 5<0(-=6(132(-)\ 0M0(-;V 5IJ@AD>(3<VP0]J,E>0 - : ,\*(5'<(-%
M((,@J(5*2(1T< 9*V 1)Z$=:R(1LF(=?& 5CV(1+T(=A0(1.Z =RV 9NB,50
MO6 ,SF -!K"1&-52;8==Z /=%-$CN(1P\(58)8:?TX<270=H$(0\\*@:.849
MH(-,B(,MH(5$0 1\& <MD(0AG0=CN/\#.FB&6Q@%5,B"32B%1#B$?MB#CIF$
M60"').B$N+ '>G@&96@"<RV$)^ &1T #N$J'D6 '/N %>^"$1Z#49&"')+@%
M0.@#=I %./C7?]B'.! $?E"%+6"%*1@E7- '1\"$1= #8" %28"'>ZA/2X $
M>)B%.0"'C8P#;0B"*<B'9C@#5I@#4K"'4  %2&B#9S"&0U %60@"?! %):"#
M2  $?  &0="'1*"&8^#!(LF%.6 &4%!&:S!781 *(I %8AB$44!.+SB%?U@#
M)."&9S@"1AB'0_@$;@B#:4@$)% '6I@#:$""6  &FF6&6P"%:/"#1O@16ZB#
M5&@&-[ $;G#_@F&(X9 (AU9P E+ !B](+$:@ADG0@GFP!BU(I5]$A3L0!3<
M0XP0AS: A&(8@TL@!C-XA%*XA'>!!#/XAU H I* @GG<A6G(@RE.#%_( U.X
MAC^@A7:P@S@HDF.(A!2+@TL@A#RXA4? @F&HPCRP@UV0!"_8A?/[!$-(!7@X
M!4<X!VZ0A7@HAEW AT4PAG]PA&DPAT(P!7L@!4M0A&X8!E_XABNRA4H !%^X
MAE- !E^0!$R A%^P!6UH,H#%!VO@A$:0A0/6!U2@!5A!!F:(!5*8!5^0AF[8
MAG)(!VH8!5LHA1G%!G= AVQ AG7@!F6PAW@(!%X@#&%HXPVN;,N^_VS,9IR1
M2$):J!%08(,G X)O*.%Q& 4Q, 85C@9W^(1&L 15X(9,:-I_L ?:TB!VJ#=1
M$(-(R 4J<(1(6(1U" =+.(-M6(1%V(8_*.D]<(-ZT -V& <@' <BD(16> -0
M4(5/, 4X0(1_: 4O& 988 )C6(5!F!ITZ(--N 4O -!#R 9U:();H(8U" 0\
MT (B^8=[8(0PB(4D.()ZP .9,P)D*(1;, 8S*(1<N 1Z6 =%4$5.Q(-'Z(@H
M:(5U$((YF(=GT(1^2(0Y6(0[\(5U((,D6 ,F0 5B $0_R()OT(8N6 ,^* 3;
M2P,Y< )N*!)F> ,RF(,@2&=)^ >BS89=$/\"-D@#5)C!?[ #*LR%(2#!$[B$
M?Q $(! $2<@&7# "='B^>/ $+Y #)I@&<+@$)%@"/U *C!"&-2B!--"#1G"&
M/, '-/@&*AF'6_B"*F@%>" '35@$%(V':D"$;T@'2SB"7UUM;+"J?_ %)HB&
M36Z"-T"&8* %57F%3G"+3/#Q.D@&:VB$25"$ML"(=N"$/D #7)@92""%(I&'
M4JB'=A@%0-"'0&@#1HB&(\$(?,"$,$"$63@'<5@'QM6I=<B'<)@'=W@/?2B'
M?B ,?/@6=V@+?JB&XBR'>^@3<7B'8B"&=X"'=1B'>2"&?M '?[ 'A(D<<_ '
M86C%<(B'>] '?:#_!W;@AWN !W9_[J9R;'8H!W. AW-XCXYA!WBH!U#FAO;P
MT2?);((O>(.W[)&0AUH@3,<"@R,P@E.8AS%X!7+XADVH.E\ !GC0A5+X!B)X
M@DJHF-TH<,5(AD'P!U'0!#"P 54X!5\@E6' A#WP+MA#A(36AW>0A7,XX6L
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M_RVNC!Y+[;_]$@PPD"".0P^F0+;[K7':"31//*M]*TX[[*0S6'*]C<-//<,
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M$SK\48^9Q,,=^> '6\YACU+_W&$8,PJ'// ACY6DHQ[Z: <]^-&5>?BC'>G
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MY,$0G$!$*K+A"VQ@HM>8P,4K8N$]RW9DA.0YAAT"T(49S("XN[F&" "P"79
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M@CVY R>H AS 02EL B.P95\0 Q2@PC<002#P0BO(0BH<@C3\ QB403G$ AA
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M*N"#/X!"*63#+^2"0,/"*TQ#,G"#]! WJ1P&,PS!"M3".(0#.,1#6+A&)<S
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MCSVZ$$()+_948D0V4?P2BR:\9%)(/<N@,0MUO*SQC#R46#(*$]B4PY0\_W
M4@\?@_3C32Z!A&$G)IHX4@DQRVRBR"V78 /),][<8<B:MO!22"V6U@.))L((
MI(XOBN@F"CNR<#(,0?,HLH8LE4A2RBUM(-)**8H(0LTKOX@BR"_V8-*&*;L0
M8@LJ- [RR;BB/))(?M3UZ^^_  <L\, $%VSPP0@G_$\Q>/B1BCWM-(,$._A4
MTPTA)1A#""[F!*+&(XYL$PXC>L@4#S>PS"%$/H=\PPXC8QA"2CKB#+(40<!
MTLTQ?4QB#29XE+)'*>N$,0H[8?SBCC*X_"'%,J[,0DD?XM2BQ3),-3/$/_<\
M<4PMZ_PSC2.T%-)/0=M,@E(D;)QSRB-K3$')&/^'0!<'+E @\P\ED$S2!!I]
M8-&M+/_PXH= !)TSRR1,O" ))F \UH@CDTSS3QR#7/3/*$!< D1!D8@"CD#B
M6,*+.43 \L\W8F334C-Q&*-Y,9, 4\17YTSAS"#1_ /-(LW"<PP8)SAQQ!2W
M4#?/)G^ H<4>]]!QS#^+] ($&.6\DPEO!%WCA E>+"&"+,$\0<\X9^"CR!9@
MS!&%OIS4\T\[[022!N+_E),+$W'\<<<O5PC&/[S C#003A>-> Q!XH&*00#A
M$,WXPC_8\8MX*"(*DH #'/)AB&S, 1)@P40JR$$+*<2B#*!X!2S&T9<A,$,<
ME(B$*7*3B5?\HQ)H>$;_:WQ1A4S80A+; $(^8*@*13AB%8M@A#2HPXPP).(2
MC+@&->  "U2\H125 ,0T./$)5*2A%O_HA"+8\X]\5"(.F*@#'F!1"&M$(A?\
M"H<HXJ"*6!CB&Y"8 R JT8=7>.,7]9!')  1BD>,PA>3>(0A"#$+4@@"$&=0
M!+_.,8HX7((2CZB&-%01"E_P#1&90,4N4(&.8$2B$K_@Q"FJX0I-M*(3F2#%
M)3SAC&)\XS'_"$<R$.$(610"&Z_(!"X"L8A0*&(3MV@$*6A!!U5XHA7/^(05
M B&)3PC#&VL !0OGUPA&% (+B !%(@BQ!TN\PUF^T$,@")&(7C1"'\$8Q#':
M_T &SU0B%*K(1SJ(LJ5<S,$/]?C%+W(A"&=@XQ&RB 4CM$&=?:BB$++HQ#>L
M@89FF(H@[SB$+/2Q"$[XXQF@H(8K J$*0HAB&[Y(I21X<0I8),,7QG"&)4Y1
M"T)@XA*FV(<W$H$+2ES"'P(IAS5&\0U7<$,=H: ,0<21#4A@HA*^*(4LN!&-
M;\#"$(QH12R248]1F (<U1A%+7Z!"F P(Q>UP(4WOD&*7?RB&^=0F%SG2M>Z
MVE5AY#C'-71!B3 T(QM=X,<ER) (3(P@&H! "23L(*ZS+:(13"G'+[#PBS8@
M(1^3T,8X6L&&3I""'^08Q*8($@Q2'*,>:W".("S!C/\],&,>;7B%.OI0"#KH
M(16#: (K9V&(.*S.#4LD"#2X (]L3.%K\_B'-B(QBD!40QVH(,4G8O$/1Y"!
M&4&XAC?^8(@\:*(=W4##*[A0BGFP 1" P$,A5D$)77S"$>@P!!/P1XPLY&(;
M:AC#)C(!5$3\@A&GH(<8$*&Y7$CA$DGXQSLP,8O1_0,<@[B%.9@@B7>TH@G)
M^,0GGE$'5FC.&&C81QXR(0]O<"$:DZC&/Z[1A_(R8IQ[,(8I"/$-IAAC"JK8
MQAK X X]"' 3N>B#'9)A#3E\A2#["$,>BL&*," C&$>@1SN* (QH% $2Q6C$
M+Z81!ERP(Q&CD$44Y$20?N#_X1*PJ\,OE!"3)& C$,S*1!C<P11E9&(9DKA#
M,[I #GKL0AZ( $,OZO '?&QB-*4AB#\FT3(Z2$(444@%*?H0&X* HPMO2 4<
M=B$-3N3"$E]AH^)(<8I Q"(;J- '(=8!#EXH@QNC&,4@-.$,Y8GB%K28Q3J:
M405.K((5\8C&*'DQ#7WD8CJP2$5<_Z&.9N1B%:1X!3*F,0QK)(,=! D'*-H0
M"5R@PA_(H$4L4N'28G1#'N. 1BB2$0IIX ,;AZ1&/HR!BER\PA@7)0<^2O$-
M4S#C'OKH1C'\P0T5=F,8S7"&.="QC4Z:(AAW6@4WMO&-592B'_P Q2W.-I!Y
M;(,;_])(!CZ*T8Q['*,;_3#&-+0QC7SL0QO=>,8RXED%96@C&N;0!RN*X>!R
M2(,;V#C%,^Z1#59@XQKY]L<LL*$-8-0C&>I(1S+H\0Q17.,;R1@&,-IACGPL
M8Q25*,4D^@"/=3CC&MEX!SR<X0QD/(/,!'&',[(A#7KP(QG\$$>9\E>->I1C
M&< H!S_V,8]Z;(,:UZ './:1#6A$ Q\NCP<^X!$/8]S#'=7@AC/6(0YX5",9
MT@@&.@0R#GODP^3H]L<]PE&F/@<C&\YPASZ.@0YSI ,:@K@$RM5A#G^$;1SZ
M0(8PUA&.= 3#&/TX!SR"$0UBD/&NT(^^]*<OL&2\8:IC\/^&,X2@#3W0 5DO
M0(8B8B&.0IBADIQ AATHP91T$((-H_E"/AAAC7&4H@^HD(,G?@$'9C"EM,40
M#H%P!ZQP"'C@#&B #?&@":_ #LW$!W?0"F)0!,C0"J*P"&WP#]A !RI&$,4@
M!&S !$J0#Z00#\H5"-L0!V[0"8= "Y2 $H&@!].@!&T@!GA0"7@P"$XQ"?E@
M"6;@!R:P"=>0!DU !HR #[4 !(SP!&* /_TP!'4 !F; !H+@"_#P#X- #;D0
M!'Z0 XZ@.;[@![L0! KF":7@8.#P"+Q0#I<P!4OP DZ 9Y)P#78 1GNW#&T
M#L\0!&*@!:KP,KTS#IPP!E9 !O[_D UFH 1)(&%,P0Z8< 1,@ B3H ^U\P^$
M0 J&=@1 0 8,52;B$ UZ  =B  OBT ]^P [GD ?U0 ZL8 F(@ C&, ZDH =H
M$ GZ< US $8"<0ZUT 1LT >1@ V: %26L WJ  AA\ :WD%P$@2AT\ C4$ R9
M0 [MH SG$ R,@ :ID G$4%:0X&$$P0^A8 AA0 OHP Z^L >?X P$D6V8T!BI
MT [IX T-1QO^, P3- S[H _^$ _WT [$8 [ZQ@_*T J^P B:H&), 0_#X _S
M0 [:X ?=L _T0 Z+UP_)]P_R,'KW< \LE#@ %P_TH'SF, _PP'H/Q@J<X W#
MP _@( [Q_^ ._! /Z' .:C$_ZS /(DD.Y7 /ZR"0X? .^^"2,B$.ZO .[\ .
MXF .[Z ./"D/[P .X) .-/-@,:D.>A<.]("5[6 /Z9 _SL ,ZE"4XR"5X7"6
M9?*2X@ .92D.:SD.X2 .^9 )<G .<?D/X@"7K2<.X0 .YJ"7?@D.K-=ZY# .
M;<F7;AF7X5"6@AF7K=<.K[ &>X &W\ 74OF2Y-"7:-EZ V&6 ^&8A.F6Y"":
MHIF9<$DZ4JEWI#F:>F>:*)F9@MF:GNB6JRD3HRF8K-E0L2 *\$"8>Y>9KWF6
M?(&7H$E]QGF<R*DP]' *C%8([> /E-(,:* )J* '^( *U@ .R_^0"_Z@#'H
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MP+EJ'UYHD2410>"@Q1UFKL*'$U4$(48<:3")9!-C_$EEGW9>N>:?;*CY)YE
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MALEJA"H@!#9@!7)X@QE0A%=H@S$(@D\8AU-0@C<P SE@ S4H!']H!'\( S+
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M& 8X&(5_R(..<X=)\(79V[@B^(=ML )@B(-WJ 8TJ (G( 9^J(0N0 )O> /
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M SK 0S$@HL,$2#=X0R]LG[/= _*HD"@4PC,<PBOLG#FL0S-0@S&@ S&H@2)
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M)^SHY! Z0MG$FG]:^>4?7<J(A M"PGC#E%T>&><5*HIA9)U_9.'CC%_LT=7
M9O\TT:>>-K*)9Y!?SH &H2^F48.4?^XQQ!E+[/@''#[JZ*:,3/((0I8&_Y%G
MB&V,$(,.-.;0QIA$Z$ACE<8HE08%;OX)!0U4OLA##S8\F40+-MI((Y ZZ/@G
MFSZT:280,:I(A;&#REGBVG^\J,69-&8QR$!>X/BG$R_^B6<,3<CY!@ICGF&F
M$"? >,<-0DBF]!Y:?-&$BU1PR.2430CQ98QD_F%E&45R^:<0,'KQHY4_XZBG
M#V;:*>0/,_9)[A]>)N&'G2@.&:6.7"QI@YHYNLU#%V8FL247)9BI1))8C*!%
MGF?RH30:.=I !9)6%&G$%T#PX$:0:2Z)!) W-H&DC$+_8)D#$T[<:"621J0)
MA1)GDIFC#4CR:,.73W)A1S1H!+$F&4Q"&4:73 HQI)!<VG"$%E**"8>516;Q
MY1%"V%ACE$0L240337;AQ!! S*CL$DT4@0B\K8@2B(B&/:01C\:$0QJ/Z 0M
MW/ (:R0B&-5@Q"<P,8G#%$(>0 K%&P:Q""P(@AFN@,8CKD$E8NC!$IS0Q"S>
M@8A/B&(3O-G$(-X!B4K<0@^^@(89SE&E93BA&ZI0!3J.(8E:[*(1GSA$-;KQ
M!UC,(A+MH$<@'+$(-$2B)L9@AQX&%@A.$",1G_A$)Y;!#33((QZ1:(4I^J"(
M771B$6WX!3\\@8NJ.,87<I#$_R,.D0IE**(-?G@#-FCQC'%$XQ*2^,0EGC&+
M363";:*0Q"R<00E: ",7M.B&+AJAB4(L@QFB8,<U8J$,64AB%[= !!H\00S1
M@",:D<C$)N8 R5,$HQBT8,8T'/&),"@B'V$RYC&1F4QE&I,98RC%MIK0CS-0
MXQ^>$ $K\F")711!&\$( S?8@88Q[,()C%A&'4"A#D\XPAE#>$<OQ "+'( A
M%VM(!#"D 8H\,(%N3CL)/$P!"U00(0JJ8$(S_.&*832"$>I8!BT,T0=@Y.,(
MAI!%J_RABVTT@PKQ"$<MPM '!5(*$FN8ABN,H!-$V*,2<R"&&[+!CS< 81:T
MR$,]_O\P"6]0@A&ER,0S,0&)?Q#"#IQ  C-T$0=D\.(0["!%"8H1AEH PQ6A
MF)HWVL&.2?V#&GW !S'(,(U[Z&$7E @$,$HQA608813_R,<;4*&+(,""%$*H
M@R&@X YF5 $6E###*PXA@F4\HA#WL$8D1 $(6H!B"IU@1S'>0:E\B($2QB #
M'X A!FV\(Q*G:$4=1 $,0Z2"$&5@1B:"8 M5?",97?#$J X"#C.\ 12<P,(S
MK!&&;OCS'[% 0C,&<81_J*,-4CC%'FY@#$(0PAIS@(,[R)"%8T2C&UN%!A9>
M 8DHW(8,O7!#+ZYQATEP0@K8N(48+C$%/\2B"(F0VA#TD0;_,8##'U(HPT@-
M- PXR.$3.D#$/1Q!ASZT0AVL. ,:VK"-=^""$8T80S5NL09-;((8RAC$T0[2
M#EN<X0R62 89XS"'79QM&Z>(A3<BH8=*M($6QKA$()BQ"TN$P1/]X,8O@"$/
M7$P"D+K@!BV\@0[1(",6U3C&*[BQCU#00AK64 4F?I&-;%##'^)8!B]$,8U
MH $(<O &,QR1"%Z@0AJS: 09O+")=SBC$(30J#%J00A/B"(?S.!%KDP2#U9
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M$;A@$I* "*[$'<J #"SA#IPA%+@@/L( 'E1!#1B!TX?!#&00#HCE%<Q!&;9
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M:..@#GI7#[@ "Z:0"OEPFHSV#CJ8FN< #^EPHWXI%.70?R%YE  B#O4 #=;
M#7IADOXP#_3HBM$0#.8PCWF"#9S@"J"P>,Y8#G+VBN:@#<X CZJX"I,$EI&(
MF6[H#['@-9U9F"_)'^/0#86@@[+YAL+9G$)8#O$0#RF8>.\ #^I@#O<0??-P
M#O@P"F8S",?0#L=0#//@B41(#OY0#/Z0@N.0#\10<LAP"]I@#;: #_$@#,-
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MQ5 (C_ (LL )9_ *P$ *R7 ,E3 )GN;_#I00!II@#>< "HO0![N@J-7X#7>
M"*; "KHQ"N>0"%S@#KC0")EP"NAP#9I@")9 #?W0"HUP!J=P#K& !H1P+]7P
M")&@";S3B/:P")+0"H;@#.R "Y"@"Y00"HGP"[V0!Y2P#']P#^:P";[ #)^P
M"DR !;O ")H ")!0#9)I@KG !I^P!KW@#(NP"8J@!J60"W]P"[_@"KR@"9F0
M"8'P#6&@!:I "F_]!H@@"<!*"VAP"(K\>8_R#(/0"1/1"Y7@!HX@"81P"G6B
M"FP Q8\2#X2 !Z[@"H%@"ZZ "=[ "XU0"ZT0!Y7@"9HP"J@0"_* "I_P"V&
M"+C@"+3P#3?"_PQMQVZ9L BEH =AH RJ, J#L >6( C.@ F+T N8P EMT >^
MX J*H R>0 >Z( =LT R_4 G6L MR< JX4 2)L @,?>ROL 9^8 B0X"C+H0Q:
M0"7CJ^7<+>AL4 NQ, FB\ F(8 U,T ;/X :Z@ F3  EW8 3*T)=PD0]]\ O&
M@ IM( J),&11_ _(0 FWL =JT V(\ BA@ :(X F=8 NF@$O<K Z2,.YN@$>
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M!^"@"$X $)32",IGQ J?7FDR#2J2C(\.38<H+>.SIIVA/__^D?OG3XT=.MB
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M!6*H'&W(AR';AU.(A54 !6%XAF-(AV0XLVJ(A5U A7[@)XZH!FOHAVPPAG(
MAV%@!E-(!GI8!U,0AG$0AGP !V  AC$RAV/PAF^@!FD AGQ0AW+8!W[@!U3
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M C?L01FP0C\PH3$@02I@PQ4<RR90V1K(0C5,PB \@R3L@2FX@1/(0S*, 3
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MWE]*_?G_7W9BJUOT"!@XJ160@ $<F_<4*#0$!LY[#Q0@.N2A+@D&)VJ0&Z
M SBD=W1C34L+$:DBR#2"R8UQLM"&QVPDC$5<(T*">]S@@G8/; @#;WEKV^&
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MDJ(LC=L8U#_FL8SN,? ?_B#&) 3Q(&,@(S_J&(8P] $.=]2#,^ @AC&"[ Z
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ML$$-*@$99/\0#(#@&6IA"VPA#I! (Q A'EK!$SKA"E2!$AAA&[[!#'*A#IJ
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MY@ -L( 9:N$09/^!%>S #>C 69#G'PA!%OXA'^) %?C@GFIA#V1C&ACA&JB
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M$VP!>W:A"(! 7O(%$+B8&N: %/  =MU9-E[A$Z1A!+[!'69 %LIA%W(A%/1
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M6]2DX73*NIKK !B \^5W *(.]-!>;"=J:T5WP20.]'!_D68.8;-L_^( #.I
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M"8&0"O>@#ZL "9#P"\8P#\P0"8# "NXP"WR@"--@"]4@"I8@"9R@#;-0#<!
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M_\\01I2@":RP)GIA#;E@")!@",Q "IS@"Y' "9X !K*0"WT@"9GP",T0"I/
M"(S@"<SP"RX\":@@E!]Q93DR";)0"V<P"-@@JN00#8P@!X\P"+F@#8;0!Y.
M"-^@#61Z"7&@"Y/""(: KJ:@"4RQ"+C0"9N@"XKP"X;@"\QP"9R "&. "F@
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M"4\%8Z@P!IC "+_P#(>0#^QP"Y/P"VZPLZGP"F^P4Z.@#'S@!KC0!)-0I;I
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MD UCP.$;K6E'/1@1"UT$X1!^F.TSKN")?AR!#>PP11S\80@V=,(+L7A'',K
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MAD%8!GH0A%1HF^D8AUB0A7]P!@?<A948A%A@1T< !33T!DQ8A%F ASE:ME=
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M6CG^W'] !5$XAUH !7!0!8_P7<QXA'OXASLPE8^0!UV8;#UNAU$0@T1(A#1
MA7; @F38X56)K%&H@W@!7728AD3  R6(A%KHVJ^]6CW^AU*H@RJ(CH\XRX]H
MAV>X!6LH!VWP!5@@;'U8!5@P!86[!E" _P5H> 9;L(:&  96& 5M8 <8ZX53
M@ 9^$(0A8(6_59!A (53Z(5BF(=J*(518(9A@(9C& =/VX<\Z;E7B(59\(=Y
M: 940(5H,(4Z:(-8^(5G< =K.(55< 9^@ 9:H(5<<$X&2@=>0 -6( 93^+A,
M= 59J 9N2&=N@(55R 9WH(9:J(58F(::_MEB$ 5;F(5H4.%#ML@$<0=;((5?
MZ 5W* 9<@(18:(98"(-8 (54N(=HR(5;L(I\> 5:< 5:J(9'(P55H(49HPY3
MT(5<>,UVH 9/T 5?B(9\Z(,S2)R/, 8ER(-J@#!9X 1[D 5*H(95N(9QT 99
MB)1U< 9.B 5:>/\%W/F(:8 #.L %53@&:P"%B/R&;3@F7%D%1@:&7@B%6-"&
M>> %2B %5Y@&8@B%6L"$2=@%9B %7,"%9" &01@,7#V&7.B&9O %72"$7G#M
MCW"'7 B$2XB%2B,$0;@$;"@&6' $3R $4.B&1! $1_@%8< '7RB$0I"%:X@&
M52 $5^@%5-B#/*B%63 &;K@$3_BB:,"&76 <6, 4MN9W?G\'-Q"#A-(,?4 $
M3BALRG2#)B>2=CC4.=X&!/V(< B&8<"&=IB'8HB&<@B&75!/9TCVNQZ&EP2)
M!)W/E?P(?[B&=GH'9."%1@"B=Y &XQB'K Z&RU"0>A!K*6T&;8A2=C#_17X(
M!FYPXV2[!EUX&+_FA%-P!T,"A?#FI74PA61"$'K0!4Z(!LW8AUK A8K, TH@
MAEJ@!K\&DGH(!V!@!EG@A;V(^&>HQ'S@AG=0AU-8AE10AF=  C=XAD6P T@H
M!&U 57%@A1=@HR!X@T* !(:,!6@8AU>0@SAP!E0%AC]@!7AXAUW@A7E( BM0
M VT:!UXH@SI0!G;@!DB0@TK %&7 @T9P!'/(!S*P@T=H\NDHA"IH!E. @SO(
M@UXH57/0;RCP!W(<A3& @WCQ!C?(@U3PD3UXCB!HA7_8AC=0@TU8^DR!AS_@
M!"+ A3'5AD' @S38!6H8!":@A60P!*=" W_P_P0]2(1)H(9SV ,WB(,WZ(1
MZ(-O0 8,V80^, 5;L -+V(1'  AA;83XFO>/',)__WPMPK7F4BE-;1I9"G6K
MU3YO@ZZ1^R?.6"),B]Z,@D5)4"=<OXBP"82HUJE-@BH1 O7)#L5/RLPIG)>(
MSRALD "U>00*%Z5*A:Y] Q0RT*A.>1[I:5-,H3A@CBCILJ3(%B,VO>HI#+>M
MU2I"?4*Y:N.IT"]!>V#E^I6,UZ51FAQ]ZV-)E:%6TLY02B3)WL%_Y1@-8G8H
M4K)&;4)1^E3LTZ%WB86AV&-,$*=?49B=:H-($;]EC0)%DD,KEY]9O?;L4_AO
M&I%!HL;(2N6IGS5*W/_ *8RFQQ:Z?^ITZ<'%"= V.G&L#5)T*Q"T5)TB66+$
MRU"G5VP #>,IKMHE4[YP/>.%J5HXCZ;H[.)V*E>F0,H$4=H5N-LFBHQBR"ZI
M*!(++7LHH@H:A@2RR"S(<,/,(I.P0DHIG!B2S"IT>-)*+M%\$\DUMIEX(HHI
MJK@BBRVZ^"*,,<JH4#QXY#&.+=K<0P<;> !"SSBXL#%&+]?@<@P[KC3SSS>Y
M+/*+.;S4(0<O_R0#1AY,]!$/-(CHT4<D]F#3!AF#2)/8/\[T(08>G+#SBQR,
M//-*-8^$888OP>QRC"UIL*D,.I>(L0<9I-@&3R+:G$/*)<U4<L8;:P@CS"3_
M;FC!QS[.[ '&'MS(@P86CY2C$#FSA"&(&*?<,\@7GQRCD#RF8*.+$600<4E'
M'87##!AD^.&-*6NT 8<@PV0"1"=J!/*/*G8@,D<MZ3RBR2-XU)/.&GC$L88O
M6ISAS"6BG&+$)VQ\HDXA531"!AWM*#2.);>4<\L4W>PS!S:<Z (-%V0\TP@*
MF+01Q#*DDN,,%)Z@8X07LD0AB3^04+/*'9" 2>H_Q931T3_CW%..%$%(XL0T
MV(!QB1MH8$/)'H&L(0LU<RPBAQ+^;++(+6#$HDYBJC2QC24H7%+'')HE% XD
M1[CK3!V.7*+&,814(<@L;PS2QA./K&$&,ZZHX8HA_QQAE0P<_LSR23[KN+%)
M(#*HX0LCJBS#";=A" &*%WRX,H<D^T212"E>2$*,'+^0DH8BDG01!R1C0*-,
M(\/P\D8R/"'$,2B7I")''Y[L(8LMC9!"2R;* ++),&4Y\U8@3602QB'4=---
M*'Q(TLH;AZ"AR#;0T"3&'**P8@@L[G9\BB3)5"-+(GBD,4HA1-BQBCZ7:/(*
M+I9(<@88T-QBABW$G9.*&+7L(TLCB5B"B3OHZ%J-*KT8LL8OC_#2SS#8_&+(
M-[4 0HLKD@$/4G1"%G$ A3!408AH(&(0'W*';<XQB5JT Q*"," HT)&+.F"#
M%ZXPSS_\P05,U ,7K8C%%O]0,8L_<.$2_T %$WX1"TT0@A9LX ?AR*(08[QA
M%NU@@QZ:$2Y5-&(?"3%.*L[QCW?T(0^;@(0CKK$'3K3#$&A8@R+0<8]8= (/
M8' $(A#A"S"@@C@>248E1+&*;YS#&X+ QJC0L8M,(.,?P, /-<ZABS@XXA/(
M*40C5*$(;M1#@8R 0PT_@89#Z"(>2Q0&)!31#%G @A"M"$<P-!$'3"@#'.[P
M1#=F),I1DK*4IA1E/-:@!FR$(1K2T($8&$$%67@#")J01!ZLH85<7 ,$ELB'
M( +A"%<P8P^7B(,=I$&',3PB"G;PAQSTD @A#*$79\@$*,"P+(648Q=\$(4@
MDN#_CS(8816^((,O@M"?;RCC#,G81!Y0X8<VK*(*M>#$$#IA&WZX 1;LH(,=
M>)$$0:QB"K&8F2TLH0EKM"$-RGB$&K;Q!T!X(QP=,4<3.I&-;9FB#&2 1G+^
MD0].M,(0=F#%)H1 G(ZPXP^&V(8DO!$&0@RC%VO8Q1W,$(Q)F($=A!B$/Q)1
M!5/,@!:@\,,K5.$%6TA#$-&8@R/R@8A").(3]T %'9RA"#, 8Q9<,(A'<N$&
M9^C!!*'8Q1GTH8E!Q",.G$A')]:0#FY$H108 P<2A/&/*D1B'(- 0S(H48I<
M;"$2J5A20HX1!\O9Y@N@^(<6,$$,6:""$7<@A2%<\0]>_S"B$'OX!S6$$(PJ
M)"(4>V@$8CKBLVM8 A'_P$8<^G&0CI3#$U-@QS]@4816]"(%A9C$*_XQ#$(<
M@QI?6$4_X' )4B3A$[^01V+ $8DJ8((22KC&,/ 0RC64P1>7. 8Z+,&$2(#!
M#+ 0 1DH,0<Z!(,)TR#''W;Q#SVTXA)=.,0@HG (5$0B'/XHA#]$,0E\V"8A
M[5@%)6YQ!S<X8A'8K<0MM"',,X1B5/\ !S,ZH8A/""$.:;"$.L01X##H A9A
M" ,><$&.=$!"$G@8Q#%&NHJ0_L,6A&"*(0@AASO$(GIPH-XBYC *7%3"$7K(
M!#M, 0=2C.H<L;B#*/YADP^9 O]C[ "%'C 1ASIXXA.Q2$<\ID$*2;""%H)(
M!"3Z<8Y>6$(7F1!&.GRAB'J0 A*&$(,RXO./<RQ"&?\@A2 N00=FA",4;V"&
M+A(Q#H_\(QU,2(0UT%")45P!%K9@PQTDD0Y22($7MH@$+V!AB'#((PP$5L@Z
M]H *=+#!#>O(Q2 6 8M%=R0:9XA%/,:ACS/,P1._V 4Q]E"+?VS"#6201#Z$
MP8M-D,$-E\ $+4JQ!S^/;1&@,,4SQJ$,0V10,:1H S:&X8U<=.(4U8@$(CAA
MB5.@XQ9AB,0@]>$+0C!B#)SX1BQP$0E(=,,8VIB&(PZ1"EZ@ A.;<(8M)K$(
M2)BB'?O_2 0U3BGQB5.\XBQJ*PG2P DK4<$8X4C#' 2A"''\(PRPZ$,A.!&%
M2"0B$<\ A" $H05;U$(3M7""07K!A64,P1C_ (09-E$&1)#B#(:@!S=AP0A1
M)"()^PA#E42A!V?PQQ/6T 8=DJ$*5/Q#QXBXPS_000A*V"8>= !%.RPA!EJ
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MPSBH0S1< RAL C)PC/,U0T$>PS[T SS00^3&@RDL C)(*#G$0S)@PS;OPSD
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M,.A#1Q #&OJ#-PQ#C.W9,@S#4XL#,LS"/#@#8O@#,?^P0S#(UCM$@YK-%L>
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M88A8)&(3K^!%(R[A_XA _((/;""U++PC#FE08A&LV,4G9$$)(Y!B@O'8!24
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M"83A'QXA%JR!#JJ!%=) $VI!&$ZB'#XA"$RV!?0 #>J #7A!"9 A&ZJM"]Q
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M$>" %O[!&9B@$SSA$_@A#8J@$]Q !-Q&)X)A"DKV%(! &5(!$':#'@ A"^C
M"/; '?1 .AXA%\!A#Q2A$9Y%(9)AYWXZ#]"K#>[A#?J 'DS!#?(!#N" $=C
M$TQA$EA!)UX!>:^!#"S!#6R!'-9!#7 !#5Z!DFG&$[)G#THA(O_A,?]!&RC!
M&7(@$V:A%E[!';@@S,+6&L*@&^!A_QINP0@:(:3*(1.BP&2O@!1L019TH1:H
M(!KB@ Q(H0[68!:2P!5200Y^814D 18N;AZ0X0\. 2=9H0R$@1#\0('4H!$P
M@0]TX10,816207//H1",(!=X81*< 1[6H!@$X1/Z81Z(X!& 9#LBB!5&0!G4
M87V"(!9"9QJX@0YJPQ)D(0T,@1[T !&B 0]L1!E6810RP:G4@Q4B01ZR@0]
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MJN4A&$X!&ZS!%7B!$@*A&WHA$52!%ZA!% "A&B!ZZ9D^@IY!#>J $V;!!.Q
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M#IW !Y#0!:ST#,8P!=?'"+5@"W"0#=1@ KI0#7S0#)(P!*U0!D'@"6(P">Q
M"6,H"[JP#D: !&=0"W'F8P"(B(FHB(O(B(WHB.H6$[B@!O] "%7P#_SP!K\@
M!F: ")E@!++ ;?\@#8H #-XP!UCP"9' "/GP#]IP!*. "-(2 FWP"7,0:PC1
M#9=@A:=@"(8P"/>V,*8@!.[P#'(0!N( "J@8"7AP#&9@"Z&@"8G0!770#9E
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M#;/D#+JP"T=T(&<2#S$!#"QW#@GS#&YD#+U #_%@"ZY!5_#0#*"@E.M #.=
M2>E0# NC#M(0#NR "J\0,/H@3L_P#=U@:^]0#.T##=W 4/^ #]/0#/@ 1_X
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M*YPP!BX1$[WP!WK_< 9[X NTP@^)0&*WJL.M&@^+L OZ&1/K  C9_%OVD F
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M#-X@"M&".EVC#V0 #.OPJ!+-/>K@/@&N#NXP#X $#^MP#[H+#O2 6L-@"2N
M" @'#YE !3GW6\10!M+0#H7P"?U@"(&@#]O@![X0#J*P!T#@"IM2UXF0!&TP
MCI,E#W%PW'C0!J#@#<<@#O7@#<H0<)G$#HM="\#@#ZFP#.! #-)@#-WP"M]
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MA#S0!$! AF] !$S A$GXAGGX!FRH!UV8!$[8!%? !U8X!$>8A#" AN#ZAVO
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M" 9.L -M4(5!"(=$< )EZ(,[$(5/H()\"(0T((92:(+":P-E*,L+(X40X(5
MZ,)WN(10B 41"(5K: (_T <[J 3D\0C!V0<WT +_4@"$:*"&-W &3+H%1D@%
M7V"":T"&+?C#SM,#"UJ%+&"&7Q@#=P!%6\@$66#-86 ',?@.-MP#+-"&.B "
M6> #"S,'3% ";0@2RVL"^P&'=[@'=U"%5A@'@YG/NY &)MC(0_@$=S"&3X $
M7A.&NPB'4R"%Q^@'7[@&SQB'4K $INC76 "$91"$S=D%2FB&4X"$6_ $;J"J
M<$@&2G@$2DB%?;@/2@@#D_.%:0 '[K '<4@&3]C846@&3,B%:L*Z9= %4*"J
M7["".@@,:L@%0@ &?_ $3I@%9I@'=? &4^ &0NB$[9BL2D@"-;"$6T &9'"%
M1("$Y/B&4X!7<&@&30 #_WI;!E"0!$<PA$^PAD3 !D.1!$H0A.)HAG^ AE70
M!UG0!(6[!VP@!$D8A&=X#,( AD0PR5U@!WD@A5*@"7C8!4G83&, !VD(A&#@
MGY@CB"'- T^ !%\ AE 0A$GXS5/8!$]PA$H@RFSX!TA(!2;BAU3X!FY8!$;
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M=0"'>-B'@O6'9W"&>& '8MB'_W!P17LH!W>X!__)0D!X!GDPAWL(!G9HAV$
MAGU8!S-;AW=@:VD8!G7@AV$@!3,0A&Q8AW (!WC@!W[8AW[0!W>(AWZ5AVN@
MAFW0!W#@AVBH!GW(AW4 AGE@AVK(AF'(AWVXA^ZE!WD@AWE(AFA0!W(XAV"0
M!F#PC L2AWE8AWO@T'98M* 0!WK@!W6XAWD0AW,XAG90!WL8YNPL#'ZX!F&(
MAF( AW8HAF1X!W%0!V18ABOVZ0K"ARF;)G0HAW&(A\-F('& OG+(!U^HAC#I
M4,.VZ'"8AW0(!W,8;'FH(*RQ!WXPASN;)G:0BG% !_H>Q'  !W2(BNX,!W5
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MB&;XP@R#\,8OW%")-G0B27P(Q"5@@0TK#*(>!<%7ZLIJUK.B-:V**4@W?F'
M5 BC&YH0@QN4T8Y(N"$.<=C'.#S1!S!$XA[ (,8Z#)&&)A2!6M>!1B76X:LV
ML.$9P4 "$?(!"CV<@1+'&,89F- +>S1B#VB A#A2T88V].$9GSA"(%(&#TZ\
M 0V+0$8IN&"$E/YC'/^KX (=:!&C2*1!'_]8!!^"<9!WV&$26YH$&S9!!(/$
MX@Z8.0D1<C"'-=R"'JY8A#GF(0M.Q*$$J=B(.]*@B4D8P13\: ,>^L"'*\E
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MHQ4P_TC$/YR!!"T 01/^& $3UD$'+:QBFGYP02PVD01U% ($MB $!.:@BRT
M80FUZ-8R2H"$%RA!%UY@PS+\H 5A9"($6I !$P@"#1:@X!SER $#H*$.+. @
M""W81"&*T(M_1((*PYA''VX@A2AD@A@C*(4Z9L"';'!! -?( R/<X8809*$5
M^S $%*"@AF"< @6FZ.50B5I4HY)((LL01"9PD0]P@"(0[8#9.6SQB$0 XT#0
MD(0BA"$08/!B&.08!S,^X0EDM",6WS@'-4RQ#FTDHA2XB$8V9A$.8^3"'?M
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MX(@H=!$2CGO(XQSTP%$TB"'5@K #=EMR-4'@<0QY>'LHY^B'/TY]DW8$PZE
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MM,&-VJ 5V($8-F$2_X9@#61Q(8Q!$!#!$*J!'1;P$0[!'G1J$#1!&#"A"_8
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M( YFU&$7@L ,HN /S $;QB +_]X@C,F!%IQ #O @#0Y:J'B!#J9A$^0=%9P
M%-[ %B!A#PPA#GSH'OAA$KR #)S O3LA86%ASZ52$?R@$AJA#8[2.O@Z%\(!
M&0YA$,C@# @!#%AA%X9@';XA!SY!$C(!%HCA"6X#:+FA#BPA$ZHA-9@A$/*!
M'J!9$=I@$;A!#Z@!' !A#VIA$M8A&[Q@#1P!#'Q!'KQA$:2 $'R!"2QA3F>!
M&JQ@X2#[&Q+AS27Z#TI=$ 3"374KZ4R$#H(!'O0D"5X!';YA$JKA&0;A"6I!
M'1:A#:#!%F#!%N9@$?A!%##A&=2 $FQA#>J@%BB!9G"!%5!A$D!AN^R!%-0
M#+"!#/^D(!:.01%DX7L- 1@R(0SL)PPRX7:WH1$N02S3(1?F !!L 1>\P17V
M0'\Y <-=01A>(0PFH0TB>!1*@17T !#8P1SX 1[DXAQH80]V@1+<@,I3X1Y,
MP1%<@1),@1@8P1"TCAR" 2 ZT3$EZ XF-+.RK4+5QDTE3M>>6:-W+M&F2Y6
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M/[7!.?]ZZ(O?X*Z4L_C%/PYX8'[_ !B !A> @$> !GB ")B "KB "HA[#/B
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M=W +HJ#_%=,@"\_ %<TP!*3S#XZP!P'I#9Y@1]) !(* I;\@"THK5MV@"[X
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MWP -AG )BX#_"G)6'4ZP!HI@![9P#)PP"(* "<(P#&VP!J/ "N@""-8 #Y?
M"(:P!\RP"R\P"(*9%>F !U4 "WP !()@":; #KZ ")+0"-]0U/_0#)G !6@0
M#[A !_D "V>@&Z(@#$E ".+I"(Z "'ND%?-]"WB@"]B0"8/ "'2P#?WP"990
M!U8P44 Q#[K*#-) "'X0#*5P"(XP";$@"F]0N-0<!X(@#44 !MO@"H\0"8W
M"M?0!XP@"3E@"W?T"4#@F;'@!=F "&UP"',P#?O@,Y: !\E0!I*&"YE0"GN@
M!F'@!W0P!W50"LQ0!YW0UL/ "&: "'8@!]_P!6QP#W20!IF0",:3_Q7QX IZ
M8 B4XPM&D GE<G?D$ @_$P384 M-, EB8 :;H 5HD ^>, F44 >C@ I:T B,
ML C'$ =@( @X4 K\( F($ AKL NW\ :K4$OHS =5D AQ$ G74 9Q  E>X JP
ML >48 V7L >54 :*\ I>  BZT B@D B'< W839U $0N=@ E,,.1E, FDP F=
M0 AK, GHUPZU< BF@ =Y( M]\ G+8"'@, J4LPJ$X WR< EU8/+ \PFF8"'H
M8 IIX :N0 BX8 J7\ NE\ ATH N D FX\ JGX N6$ :+P ::4 Q+0@R_< F/
M@ >.  A^H C"5 NJT :RD EH( TFE0I_T/\(BL (E) *DP (KW (E# *?1 &
MEW (B# *@9 )V+ *L: ,;>T/U+(,;5 )@O $I8 -8* )')$:]X )C" -O( '
MM) '@] -LQ 'H' $NI ,4S )JL +V" %*3L&;= /F% (DX % J((UT $MAP)
MTA &VOD/=QP'NU &@R ,GE %?[ *S'#TCL &A? +;] +W+ *VT (J? /OX +
M $$J$[-1932%>:-H3Z5DG+3,"O>/G+U8MRII221ICZE1FRR!H<7-$2U[__[9
M:R3(&2%&N!#1<?1F$Z1'M7A!6N0H%:Y=GL1\:E2&$"9-PGRIT02H3R- EX1!
MF^3-Y%2J5:U>Q9K_5>M6KEV]?@4;]BJG2/],]=EW+Y,BD^3(5<LRZ]\<2.C2
M!6D3S^V_9&)4C<*AR]<99:N.%'*5!5;$?\?<],J6A XU4KT8 >FE"H@S-T($
MR:$23.(_<5XBX1MCJ!><-Y>27,IFIA:U-%T$^3$2#(DU?8\TO<HRRNUP<O\&
M\1&VYE$Z5'J('3&S*(B7>U.I04J%11"@3KXTQ9IGB4BS3=]648DD:$JB<J-#
MN>(51$PO.8#ZY1%T*LJQ5'"F34U'C#D(\2.*:<A)0PM5[FBBDC!$V4833JH0
M@A5*OA%F"CX4J2.+3M"X1AXU0)&HN$^*P,>D59)P) MX_E&$B%U"XPL?_RM"
M^<<3-V!9 [PP?@F'D$86N>$3.5K@,9-_F)G!&":H@7&-0PK19S1V4*&$$"WB
M.$4*33+!9Z]_%K'$D1P4@<22<5(Q Y]:BDCE#CX:0<(-5,B(B ]:_B#F'S&\
M*06(/20IP0]+</D'FT:FLF<-/=CI9A!2GNCDEBPR::45>_:A8PQ!I- C%C'>
MH><74)KA0Y<Q4FG')'!HF002.]9H!)%EHHFC$5@L:6,8D]J))1-E]G!D'5($
MD8:Q4A[I!AI/IDFGE3=<B:,34A[Y1AR3A$$#DU%(^D>;7U:!9)9E/&F%GG^*
MD06,,PJA@PYNM"6'F$(4420.0A9YHQIY+-E7%?]R8)'7)'/>)$251RAYYA)0
M_'$%%U#PZ(,70R;!1!!4_@%''F$@D:0XB: )HQ)'K# EGT(:Z2.4B,@9!I-7
M_A'&#4GT^(\:.E2!0IA_B$"$)VND8*L3,(RAI!1>RHA8D6N( .8;-CIQQ)^I
M>B$"C%;80.2=6%:PHYYNL(CE%$1N^00-GX'99I-0Q*F$DUX J:87,2#9I15.
MW!B%'U3@@$@B8&[AQ),@)#%$DGB*X662/8I!YY17JOM'GT9R06<72Q(Y))-:
M)'&E$$MHT2644@:9Y!=O9#GCDD3ZP"212,JQI0Q#='FD$T5Z22<88<4"/GCA
MAR>^>*Y:*0N;0_!IIQ7_)4TJAY 6 GE%#2ZN^></6DK\YQY);'GEB'K@$820
M0*XPQ! S5AG')&\NL=J-/::I9),XI'C%ECK6"0*(3CZ)0S5$)HXN=.,?B;@$
M+^* !D($X1+/:(,[A.$'/G3B#&=8!A?:DXTPG&((S)C*</Y!"4VDXPR<^(<S
MVE"-%/#!$&UXPCZL PAY>",*5)"$(C31IUXHH1:MH 8F0F"(3^1A$^P8S2PF
M@8@[A $5G2C%/_# "%JHX1_#H,-_3/(./ 3"&(KP0S'^@04_* (1BTA$&'C!
M#$840@](@ 4@0A&,$$C"%X^P0QO1\8]-6(-[F8@"/TP""#N0(@DF4481"D&%
M_WC\ Q_^^. _?J&'7G1"%."(Q"[.48D]$*(+:6.#*/9PB79\8P;.(,(TRL$,
M3##!"U$LCCX@H8E/,$$3^."$'OR0BW*XI1Z3T$,FH,"(37 "'*L81#IXD81?
MW.$-FFA#*T+1B'&8XPR_*(/5T-"-6$B!#Y: 0R,VX8E_H"(.C%H#&M;AC$'T
MH@N-@(09."$+7M3#'XU@ R#J$(A3^&$;P7"$-]S1"3&$H4\F<<<DYN *-;"A
M#8>XAC/0$(=<<$(1^?@5*0;Q#9OUPQ>7J 9C0($(9D"#$+$HAB/F4(@^6*(6
MGS %O:*Q!T'X0A?9> <L+G$*3MB"&*3P1#2. 8M$Z/]!#[RHA">*H2UQ0*,3
ME_!$& 0AB3ET(Q^9N$0D"-$/631B&R89QRK40 A96 (0S0#$*8 1"%YHXPUA
MZ 4E#D&*2$C"'M2 Q3,"T0AU_>,<J2 "OKB0BV"\HIG+,0D[?H$)=BCC#+H(
M@S?&80TTS,(+O8A'$@;Q"UQ@ PB5^,<CPK"*)G1C%7>XQ"\((0TI] ,>;+!"
M*5[V#V\8P0VWR(,EJ'$).FAB%-C(PR].P8A0\"(,UC#&)90AB5HX P^.L 4:
M? $+1,"B%X' !24"P0U%!&$63#7%'!X1B"@L0A*2T,<U"B$(39SB&84@!>7X
M40E)B (1:*"KS!3QBT(,8A?_KOA&/1;AAU;DXQ1A"(0N&K&+0BR"'<V8!"!V
M<8A(T (0J^#%&Y1A/ YWV,,?+AXE&$';-N0#'I>0Q%3HX8<VW$(7JLB!(,:!
MA>WM)1^3B,4JH&",=3!BKE?0A2[@@(KVK8L1URB'$2;!!RI8 Q5%Z(4MC# ,
M/I@!&:F01)A,(@XD2 40D:@%'G1Q##W<HAEA",8QU  &9"2"$<+8 C/000DV
M/*-"_W!'.D1HB3(8PPV8^$<V!K&,'/ !&H%@0I5,P@U"B(80,""#*=P@B'L\
M(@C-> 0LO+$$6:Q"#JTXQU2:\ A\:((-EED%@C1ABR#4 QMF *%)XE&'7)@D
M#&#@_X<:R "-1:CB3HM8@Q&*88@MF+,-T;#"+=SQ"TK(0@[,Z <3Y+*73(R
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MP )8J 8PP 91Z(-2\(1,6(>I$(<J\*-+N 1I\#M6^ 1KB)1C: ==( -0^ 1
MX =*R(13X(-:* <XD I7X ;NJ04U4(5&^(5_V 9#> =#R(-1: -!Z*M_:(9
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M!4"H!&S8HW\8AVH0A6 X!6V !V30!GT(1V!0AF%HAVAPR5/H!6B8A6_8!F\
M!GK9AU? AG>H!EB@A54@!G^8AFNH0F:@!5@PAG:HAYU !6(0&7+0AU7 !$C(
M!6W@AE?8AWA(A6I8AUZ(!%< A1PTB7/(ADM0!%3@AWC0!F)(!VAXSGRP,%J(
M!G.@!U8X*1D:AEZX!L;@!U)8!$S@!6FH!U_H-3&:"GX(!4EHA6.8!V; AW#8
M!V\HE:3< ED0!F/P!UN(QV9@AG*@!EO_  53T 9D@ 9[>(5TV(= N(5.Y!Y[
M6 59X 9U*(9=I =J6(9C$(5;L(9668;*, 9TR =N* 5?V 9X, 9GL(=A, 50
M, 9Q" =IF 51T 9Y$!EP2(9Q285LJ(9E. =YN(9[<(=7*(15"(90@YYE$ 54
MT(9XF(=L4(9@,(=C@(9@*(9\& =^B(8J(8=]F 9HB(=R  9CB(AT> 8*E8AZ
MX(;DG <RE-1)I=2P^ 9#.(9C (5R\(8QH)QQZ(9-G8IXD 1C$(9-B$>W (=O
M&(5O8$-U8 8HJ8<&XX;B$)E[< 55>(5KT =M\ 5;" 6J:P9I( =IZ(5O>)GB
M$ =2")-G:(9P_]"'4(@%8_B'?M &)"H';' O@V&%4X@&D[ %&3($5N">=3"%
M4N &,9('*"'15^@&<Z *=X"&=S"):.B&<!B'9(@%[ $'8?"&>&@';Q"%2!V-
MRBD$3&@&8<@'8%B'MZ!6?4"%5^ &>C68:'"'B!"'9D &<G"64Z"'=JB&=X '
M5E"&;:B&=' ';&@D;E@%:@@U>3 %5! %0=J+O)P%:L@ZDUB&4J#8?_"'>FB?
M<KB'>GB'=Y"'8%B'<#@&&7('T:A6JPF'?*@'<#B':F"'=MB'=S"'=3@&>!43
M>X %:-C:DPB%_1,';7D'9:B&>V"'== '<$B'DKB'93 )9)B%U&N'B_\EAW0(
M!W+8!FG(AW30EFRXURTRAGU HN((!W90!W$HA\8EC=%4!W9@#')HE7\HA_9X
M$7#H!D* !+3CGG&8!W08AY2K3G20AZRS57-HAW-0A_;!5Q$*AW)@C*E AW(P
MA\S%75LMAW: UZH(!W1 !T34"N*@S'3H)7  AW$(!W!0!W@=AW-@7J84DZH(
MQW#<"I$I$<5-AR(CC7E(UNJM"I$9!U=(!$CH@Z#<LJX AU,8!&>@%Q&R"NT=
M7^.17["XWZ[07O$-(?JEWTH%X  &'N(@X (VX.%X!TL K>[9A$!HB_WE7XDX
M6^PMV I^X C67^,EC<D,H0ZFBO_5WF;HA^W_K5\+WEX(YN MH^#^S=\/3N$+
MKL[_#9X5UN /]M_JE6$.KLX0NEY;E6$"MEX>GN"KV&$+CF$3OF$;%I,CUF$<
MKHI5*H1J"+4:5F(E!F$89N$<)F$8EM\#]F(B+N(L+F#NN=\RW@L@OF QCF$@
M)H=\F(5>, :O7>,O-H?-5%T-]F(?7F+CS>,^[F,U/F,_%F0_%N!"-F2LP.$_
M+EBWT!8B-(EBN 5!.F$VUN-%/N!)'F0_GN"SY>),WF-/)F32V&10IF(DON1.
MSF-.EF!2%F147N(A)HU,5F5R$ =6MN5;SN3Y]60KQF4([N5>!F0TY@I0YN52
M9N7^S8HQ+AYE[N1#_W;F9X9F1+;<>!@'0BZ.=*"'6E9E5<;D/AZ'=@"'MJWF
M7Y;E35:'<R#G=!Z.=7"'3:YE6QX'>X@'>#B&?TB'91B&:@ '+QZ&?NA; ^YD
M*D6&>PB'=U[B$N[B&Q89?,@'7S8)>3@&<#A;<+@&=?#@![YH<=C1WW5E=?;H
M/![?70[F8^[HCP;IDL9@,,[ED0[D7TYF81X>9L;D:*;IFC;DXN"&39!1)AX.
M?4B]6^@%3]3E*\8*?Z &=>B&5IB^%^YF_'7AJO"%_VCAD$YI(@X>D%G?+;;J
MJV@'5Z %8>"%?U &/9@DBW[J?W #-W@1_BUHK ""0&@/,<'76/Z'WZWFJ?]0
M7K BS<F$UT<8,;]JCZF0AU:@ [-NAR/P!L>TU=:E"G.(B'%0!T0$ACJ AW)
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ME 0:+BO5"(6I%RH/JS&;PI'[5^X2F&1O[ "+XRR2FGG___Z%&_-K&!D]Q_3
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M0AUX/1$E?)&.4U3"'/SP13/X\8I<Q"*TVZ#%+O(1#D-H(1*K<,?_/X)!"5.
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M1"(;?Y %UL3QC"*,B1-,G 4A3*&%5L#"$M[8B'O@\X]C,&$,U>"#'+PQ"4$
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MP!-4P0[ P!-&(=IG 1)T81; 'R6<@<P7(1]2@0U(2@);X7<RH0VT(1MPX1(
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MN<U%],CRBRMX9(()(ZFT(R@H8!3R"QR#J$*)*:S4> D8>@DJ#2Z4\*'++X?
MT@LAN$ARABN.? (*('3@@H@FTN!83R!TY!))&ZDX(@<O_/QG$$F:;\YYYYZ3
M9% WCV#SB!)GW-').!>UO$0V9EPARQR"H$/(&Z^0D0F._[QCR1^X++W.&V+\
MPH4CLF@B3#Z-T,)($YS<408D;RRRC!:00')'-[9D04D<3!!SR!S^X1A(';7(
M448V9%"QBVX&S?-$+=28D0I;MN!2AS2>H/=+&8SP8@9N=$,,SL %"D@A#R$P
M A-'F(,ODK *;]RA%Y+P@E"L_V *3=C!'IVXQ#+6 (A*A"$:D6#",GZR"3S4
MXQ5RF,6;N"&.&W'C#]#0QA."48DC]((/6,C&(E)!CD,LHD[_H$40].$-.A#C
M#[0P1A 0P8U,]&,:9J %&#X1C$8, AAO($(V&&$$8G "%L*X!!+VT88>\@(,
MP/C$(>!QACE,HQ.GP)Q!\H&(532C#&1H11^2 0PA,(,747!%+O*@"VF0@1:O
M:,(P?!&$5QA"$=&@0QBN$0="Y((-I3A&'DSA"SQT(Q!SR,<H'G&-,0#"&YFX
MT3_4<8= N ,3;)B%$Q2Q#G-4A!9GN(<U(.&*) Q#&&W@!2]>T(QH* $4GZC%
M.E[AA_]N'&(3R.C$,%I1!U!881G'R$0BHB$$;NS#"ZU8A!AJ(0MJ\,H@II@#
M*>CQBR:(PA-] (8X<$0-)D3A#DW PS0:80E_&(,2J[C%'*IQ#43P@AJ6&$0U
MJK&&160"$I^0PAP2@0E:'$(/H4@$'0I!"4I(XQSW?(DB3L&/4A@"$V"@1#W,
M45)1@"$6\+A&(.( "%AL@A;HD,4BL+&*6,A"#FTXA2.>,8Q5U,(7=*CB+CQ1
M#5]LPA:!^,0LPA"+?$ B#-98A"WHH1%VP((4S1A$'WIQ"#J0 A67,P@XD&%,
M31P!&X&XA3Y,L0EG#,(2Y^#$&4H!B5E (@Z"&(0ZX%$-8L3_(A2+"$$W7.$)
M>)CM$++ !B4^X8Y$: $8&=F*'[11CF=H0Q*F,(<LPJ"+1A2B'ZY8*"6PL8Q1
MY$(35OC&)2SQBSVD A]@T$4GC+"(1M3A,J] !S;<((V+P.,6D+B$'K2C"E(0
MQ"#:((0V4'&(9^0C%[5HA!\>4;Y, ,,@XG &+4R!B4F@(0Z)"(0MSI&,-FQ"
M%;)P1B3VH(I.# (;X2A(-CKA"W9,0PZ*H,0FM (@EWQNP0QNL(,U8A!KT $5
M;4@2-,! -H.8 Q&*8 <3WA /7R2"&F=P!#T$\05BU$D?E>C%.89!!G^@8A:E
MV((EZE$'4<B"#]^01"OX08=&H,,7_U60!15FT0LWH.(4;P#&-I30#4FP D#_
MR,<D(#&.;_AA$IOX!4DK,@\[^&<0BIA$&% !BRGD0A!$X(<[)+$(7&3B'_&P
M1"1^<8=WE",+R4"'$&!ACC9\E1N!R$,21"$*1H0#%':@Q1)*0>=CA.$O@<@!
M-WXBB5OLIA6<D$8?KK&;UZ0C%)YHPPB"(0E P&,:?*@&)72!C4EHHT[MB(0;
M+**/6U !K)W@0S\.L0Q#H$$53;B#(YIP!H9BXA^G:)TS #$(*LS 'YJ00SJ@
ML8=C5((0X-C%$=)@B5FOK"+FF 8C_H""/"QB%*\)0S9:08ET^.()<G"$$ B*
M T6<(0F2B/^$,L+QBDN<PQ1Q,$03^D (*[3"%89 QS?2D UO*"(<CYC!'4C1
M7X.D0PG5^$<WE,")((QBW/^HA20L,@])? $HE:!#*Y9P.2LH@@R@+@8;M#&O
M8%QB';* @RJZ( [R2&(;4M '.:1 B%4<0@U^((4ZZM0*+%#C'[.0 BIT@0AY
MU"D<U!B$*=P1##Y00@V"&$<Z/(&*0FB"'L,@+3  \9YYN$$2I%!$'0QA"3+<
MHAN(^((?HC &3V"B?3^Q1R*4\8]K;*(2@GC%.7X2#4GPPAWV8"4;'"$(4J!C
M%Y2812'6( <@Q $5N(C'.%*A!S>(H0RYH 4O_ &*1XPB/J6P!#?_S-&+/5@#
M$]!X#3KH9)!X0*(.>[A#')XQ"STP@0PGM C7\>"&.AS!&K=0ACBR\0AM6&*(
MI&B#+S@!BD+LX1.6",<X]@&-,N3A#2UHABM4@8YF'*(-N&#&(+#@B4FT 1GG
MH+(XK*$&R0 .]8 -?/(/NX &NR )L9 .LB +W5 )W< ,>! ';- %WZ (E5 +
MC] ,_S (NK (3: 'C, (CA (H= .S+ 'R641\* *,F((KE$+N3!=_T -BZ ,
MI] (R# /IZ *AP!X=* 'O^ .Y)4,NY -Q0 )38 %BQ )MH .ST 'F:8*TA )
M<*()@6 ,-Y(-F] +\Z ,:Y (B^ ([F!'_P^&AFFHAB)A$--P"*<P"8) 9X3P
M>.25"6X@#W]@"/^@#*J@#'NP!K[@"(:07":!"<P *VY@#(- ![6@!80P#H10
M"'D ">RP"*C0#H- "/_ "E^@:Z#@#9C@#:A !_% #E_ #)(P#3]Q#(Q0"_^0
M#7EP")[0@3^1#F.P#_]@")N !I.0"M#@"<+0"79P#N\@"(X0"W,F#X(0";N@
M">;0#EQ %TZ >)T 5'W "XV0!*&@#)N0>(C@"B/P#;N##6"@":Q .IQ5$9N@
M"Q;Q"Y"P#7]4)UO!!I! "D4 #%UV#L;P:=9P"7^P":H3()4@!^2 #MF "5>@
M#^'@"6"@#X7@"/]8X W7X >(X V7, O$8 BJ\ ^OD 6QT :64 JYD 7XH EL
ML Z. 0R14 GT8 VD4 I^0 EGN$204 II, >80 CR( YRT RW( CGX M2\ O[
MD K74 M%D _-T K?$ G,T ZI4 CP8 U[( A\8 KYH O5P N?, ^E0 2S, N-
M  ^LT S#UPV90P])8 KD( ICT M%L O_47*,( ["( LJUP[\\ B$H M4X __
M@ 2+T :C4 [0D ;:P B20 R=4 VND :BD 3,4$V_  Q.D _FX 2"8 NA8 IL
M, F<91&AH :M@ ^%  ?8H N,< ]U,BB2@P_9, :!P B:H VAX'6J@ ;_[Q ,
MF\ *]: *F< ,TQ &9$0)8P *F  $OZ /F+ 'N[!PO: *H1 H%6$/@. *R4 +
MBC +OA *8%41Z: PA@(-F- &K9!JV1 (EI (C]$*;$ 'I\ +\K /E3 )L; (
M>; +NX +^9 *F3![8' *DG )U,!PW. (S1 .Z4 -E_,/X5 -8' (I9 )AV +
ML9 +F_ 'MJ!<H4!'G> %=,4(S, )D@ ,@R 'W- &B, ,GC +B: )G$ &R6 *
M?<E$@3 #T' +C_ -B$ )O' +V: (8K *BF (P4 ,/)DYPI 'O_ -A] +@N +
MPF (I"4(#$@*O^ ,E( +N_ &L0 (4N +@H +_ZCP")<V"*W0"U<F"X$0"Y[0
M";9 "'@ :BVH"ZV@"K4P#.$P"JL GO\@#;/8"HVP#? 0"KT@"WJ@6HKP#? @
M*,XP"M(P#M!P!UB@"KE0"&EG":] "I( "MFH"I$@"T97$&_7"+'@")G "I 0
M"(&YAJ\*J[%Z$1&F":<P3?\@#ZK0+N3E"$$P#'Y "_\0"H5P#7A@!L<@"6H0
MF ;!#X-0!LI "GI0"EFP";DP!7(@#]&@!5H@#.A@"*/ #I,P1+;0!-FP!)\0
M"V&@#:O0!_;P#Q ""'EP0AK6"6+@#7V !;. "9?V$_,@!)?P"D. "["@!9^@
M"GH0#8;@!^H@#Y30"O_;D :0@ MPL VQH GGT Y'@ SOR@K_D G6P E=P EL
M  *B8 J=D'B#  IY4 >O@ C?P M9$ F2X ;'\!.Z, :J  A@D W/L ?90$3?
MT 6X\ 8ED(^W@ [2< ;/, Y\L 3>@#G:X =QX 9L( QU\ ::P 6B, [9@ 1C
M8 _@X 9>P @3E Z9X K,]I%LH :#@ ==X ]M, <IF07=$ IWX*%B( A9( CQ
MX JF\!/#@ 5\D E68 ;0H 9YD E<\ SHR0_I$ =WT :=8 _2D 9QT =ZL S^
MU@ZKD CPH QA0 USD 9T  ;!D N-, ^L4 6AD I.X J6P AO  0X81'@( O_
M6! '0@ )R( $<TEE^V )9H %>] ,51 %88 %QL *4!"83U )V, $?H '20 -
MDV (]-!2KA 'Z  (=X &9- /[F '_F .<. *LV (CX '3E<GZK +8\ &8[!S
MHD ([E,0SS &3L $:= (UU -E5 '46 (\6 +C_ .QW )ID /QH (=@ 'GN /
MYX +G! ,JS (K# .R6 )>3 USI *T_ 4%7$.K' &3' 'N^ .V. -3Y=@^E +
M:_ '<( &&<D+=3 &>J *ID )3* '8>";L! /Z: +B;L'<: +HR#"V( )IE *
M=%!9:& &LF8,JN ,X7 -AQ -$Q$/B: &9! 'KB -_[$ >H!@A@8Q#EPQ!XR@
M!Z) "6 @!BD*#FU@ G(@"=)@#+(P#;*@"_D@"7+0QMD@!VF@H<8P"HR0!W-P
M#<;@"_B #XGP!G30#.X@"S!4)^.@#8V@!YX #,; "Y6@"-F #[4 &-#0"P]Y
M"-2@")=P"6^ "[J@#+N7#/_ ";U@#T_,!ZK@#\.@"Y70"8&0#W7"#J!0"JF@
M#?$@#M_0PG4R#[[0I;I0#P=Y#>[P#*Y ,TI:$/C0#?4@#NI@"Y<@#?MP"I0
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MQA /X< .]'#D:DD,SN ,QX .3"T,U3 ,\= .]A -PE /__< #_, #DR]#-=
M#/NP#N]PY>RP#O2@#FI^#OUP#?U0#N? #^C0#L]@",7P'^^ #-NPY>;P#L:
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MB.,-.Z:!:+_H*K+GE9L0["TP &'4"B\7:[3QQA</PW%''GO,KJ!FGJAB$4G
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M(K A"6^8 @UUTD8FAL$&4B"C%+%00QZBM(XM14^%*V1A"UWX0K7] QI&N(1
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M,'5XA44XA4/0@V:0!W;0#';0ONMKB&QH@B"8AG& !DC0!G* !^I3AV%X!$U
ML>J+AT53B'+@!WN0AW=0AW?PAWM@,7&8P&C !$4XM7\8AD]H!6< @T) OW8(
M_X=W< =W6 ?M@BQLJ )M\(=MT --T(=Q< =_X(=S4(5.  9XD,%Y,(=:,(((
M3+][8 =Q@ =[T(<C* 6?6(8S< 5\D(8P&(3?VP=_.$#U\@=_P(UT  ]T2 =Z
MX <JU(=[R$-X (=YP+][: <0<X=]X(=R\(0JN3'\:S&1*(=UV =]J#] =(?U
M2PAQ4))\<(=[H,)X0(<B](=UX+%WD(=K.(16B 9DX(8SZ -6D 9]4 =Y,,)W
MZ$- 7(5*H :?&(?[,T , P9,Y(?NN@=DN 5:R)".ZPAW"(36:P9I6 9CB =O
M*(=5 (/:$XAMP -80 98"(-+BH=M@(8HFX=LR(9ER/^'9(B&=,@'5( %8AB'
M;Y"*;\"'?\"&87"'7/@%:CB'=@B&;U"&@3 '2\.%? "'5V"&4?B&?JD&7I"%
M.(@%G^ '0B #9-"';6B$7$"'8,@-:#@&>,B&6G %:N@N;GB%?<@'7-"%:1 '
M>VB%6]B%8$B'.7 ";& '4U"%9J2'54@$4)@Y6! #7E %8)R'6%"%6; 36KB%
M;UB'5S"+>&@Y,)"%7@B&9WB&?WB':_BUU\N&7]"%9P '?8@%9I2'<9@E7: %
M?0B&*, !6:"&>U0%5_"%99"%5L %:# %7K@%L"P(9U %7<"%8;@&2_@%5<"&
M?Z"'7I"%14 !)%D(7*"#5G#_AU (@T.X)'Q0A#6@ V_0AS18 3:(@A2(@UQH
M!F= !#[XAE70A48(@UD@A3@HA9Z3AT(@ SH !7>8A%3H@UY(GG_H!T<@@T&(
M!GSX@QH0A)V !T) @4EP!!, @S@@A<S@!4)  U,0!UBPA6 (A#3PA>21!U?X
M!$*(!'4PAB2XA$JXA7VP!%W@AE#(AU!(A%JPA%C@!U'@A$A0!&E(!!$0!&3(
MA6!P!4!(!$X(AF*0!,'1!7_0!D< !%V0AEN[ADKH!GWXAFNH!T40G$C8!F)H
MA41@A#; !FJ !$!0A%!P!U9 @TMP!X$(ACV(@D)8@RZ8!$+H!7>HAUS A$C
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ME38$5VB#2.B&.Z"#:!B#7, Q^ "&4PC_!4^H@W[X CJ0AT. !$%8A'R@AC>
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M2!Y18 (OK@5ER 8WX(9YB(-$Z(1O$(=AD 526 ,MV 0W2(.V?(79^(=Q8(9
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M2,0D<'&+:0R&'-,HPSO^ 0]7D"$4E*A$+A:1#5@H A=H$(0B[( +;4CA%K8
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#!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex10-32_img002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-32_img002.gif
M1TE&.#=A, ,@!'<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M!T'TPQQON$$(]6:4:VSA"LE AQEF((,J8*,?V("!';Z[$$9$H!(("04#FJ!
MA.AC!2%HM1D(H C_2F &--@$/.K A3B<H!'\8 4)7D"%+UC"%?P(8S] (8),
M7&,,6+@%FSXA@B<4;QW/&-HO L>(&H@A%:H8A1EXX(5\M$,/*O!!) 8!"#]H
M8Q["$,,(]D"(2Q#"$L# !R* T(0B/((6:HB"$Z9@AV+@P@@CJ$,8SE '-&!#
M&8=8@162L(166&,/6#Z(.NBP@E4H>WW E$<03I +MHE#&O?_Z(<UJ% "2 BC
M&*D  @+H+#@M1'L,.N!#B/O1A0^,P 5M@(<C$C"'= 2B 7LP*$)4U ]W[ $$
M?E@%*%;QBE\D>U66QK0OBG #+;R@#KYPA:A)K1!*+  3SNJ'+@Z !4F,XA6@
MX$8_Q#$%%MRB%;>0! Q:L(M^4.(!1H "'DJ! R= P@.!Z,<\5'&)(LR !TS0
MQ(97-0\WW& 6_6#%#<( CW4T @18J)\PP$"$)C@!%.O8Q A8@(,=L( *@7#&
M.-#QA168X E;D,(4WOH+,8# !%O 0A7(( MZ($((:9@#'1!Q!B+<@0H%]X01
M3+ $.(0A#)JX!L1O,(0U0($-IMC#_QRR+%2.>WQBEB55^D=U#Q2 @!<N*Y O
MR! #&&@A"BC  0WH/ Y9Q  )YQ -)P #RW 014 #@M &$M +E5 #?? ,F0 !
M:&!FV%!OB[ )RR .8< "*= "CQ<#C" .(I1UR9 //K %@# %): )KM #HY9V
M97=V::<+-$ "3, $'N "?1 .[  &.K #)$ "-R &LX /_9 )$P )B] %;. "
MFE ).  )WS /^F .UL )&.8"GH ^J[(-4[ #?5 )>, "64 +ZW +)/ $V=,-
MB2 &4E #CY .BH "2N '<* #2I!3@I-597 +N* +L= ._" ,;W %EQ *K: +
MU7 /\U (A_]D"6U !5GP!8F0!=&G!$( "LP #=*@#.( 6"+ !J4 !UK0!D#
M!^0'#^;W<6VS?J)B#R'@ :40?]K4##[  V$ "9 0"5QP '2F#F7P 2B5"R 0
M KE0,D40 +_ "BS0!H-@!6R0#X% =./ #H.P #P0 "QP"N)PAWL@")A@"8:0
M#>P +UGG#.*@!E90"YX0 E80""90!F27$&:'=@:A"P/ !:E@"[" ";; @W@@
M GRP"#TP ^=WA!0 "KB  B(@!:^@"#A@"?A@"(! ?O% !3PP">Z ?IM0 A]
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M!2I !ZX "2W0!K&@!RF@!-K "2IP!L[ "UG  R*@ BJ  CT@!Z>@"2U !NT
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M D.PP--0!()T IU@4,-0!"QP DGPC^60"C>P C>P!XFN"UP  SOP!&W=#[T
M!3O@ 69P3]IP!"+0 R" !THB#62P R8@ GW@#41D C!P H[02JOR#H>W B
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MX6EX!D1%AF>8AAQ&!DFEU&'XA1\NU4\5XB'VU&I05VS8UFUPA5-@XE/8A5:
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M X<YD-</< B#'!K$T#F*80I1F"(4ZFC,-UIQPNKI8Q[7"U\YT &,^(VC&+T
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MPC?80R0H:V:P@B4@5IWQ@BH0X11LPC%T0@\P0S!L0CPP@QL@@R9X@354 C8
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MR(8KYM$G?WJ#%)*0CT3"00A*F,$^_&C'+K"A#M^0 QFJX,8\S+$()V#CE-]
M@QYD480RM,+_%?KHQSUVD0N&-84?P"@%*)J CG=<(Q2YX,HCOI .<3@C%<Y
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M%/I!%BK!'=P %BJA"!;N#JIA"7RF%IX@IH @&83!BHJ $/2!$03A#Q2A%E1
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M!<* #L0@!FF #I9P"8QP!\P@!YP0#8-@"X_0!Z?P!9U #7W@!]8U")@@"=G
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M#)L "600!,Z "FJP#K< !-@ !Z<P#6QP+.%0#(; "Y'@ \3@!F/@(JG!AL;
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M_4 ,JC *\! ,DE ((R!CQ; %RN (U3 .VC $&8(2G4 *5[$*N6#_"F70#[S
M!=*2#42 #I2@=J8P!YO0"6%6=]=P">77"6X0#X+ .B@1#W"P"-TP O\F#D&@
M"P+4"T<0"*4 !K'@"G.P#.;0"($@#%J@"YV !U<A![$ "(TP#\-@!QG""Z*
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M AK@ \TO]L )6@0"&+;XQ-,5X0E<T"$>E+"$N-DZC3((A588 UQPA3Z@A&
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M!U%(!%(8!4^@AEFH!%O0A#1(A6C(#Z4X!U;0@VWH!EK8A49 !5Q8A5=P TH
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M@TZ( VOX!FO(!%0X!$7X@S-0@T\XA$IPA5OHQ%@@PTFPA6  A6LX!2N3@R5
MA.D$+G/PWTEXA#WH/&$H!WQH!ES@!$_0!5; !4N@AG.(SU$ A00#AC_8!4_X
MA$T0!*94&J0P!U.X U^(G6H0A%HP!$+8!,^-AE' !#5@!'O8AE'P!64 A5YH
M!4NP!$EP!9V0GW* AUD8!4A0@V,HA4:0AVSH@UJHA3A8AUF8A8X"AUU(@WTH
MA\Y;A4H8*A>Q!3\ AWK@!#PHA"L@,#N0A7E@!&H(@S'XA$"X V<0!;.XADW(
MA:5:!$NX!B5PT43P@V/_V 506(-+@ _[@ 5+2$]8$(4T: 9ED 10H 55F(1,
M6(5;,%-#H(5O4(0X-85]<(9^Q5-F((19. 5>R =H0$1].(9*N(5"((5]8 5+
M@ =AR 1K0 IR0 5(4(1!H(-:$(9C8(=HV(1?"(9#8 0,DZF'"56X,8EE2(18
M^(9(\(-Q$(5/Z(=M8 (DZX=XX )(T(8DZ(5^L 1 T 930 4/Z0=I"(-'D =K
M4 )4D(8YN)T=X0<CZ(1BZ -5T <[*(13$ )$" 4?"(/2\ 4NL 9UD 15( =2
M( 58, %+*(5-V$HF:(57\ *SH(YX4(-22(=<Z 59B (^V 0EX(1>Z 1J4(8T
M_V"#51@".L"$'^@?4O#*1[B&\OF1-H"$<Z@$3JB%+H@#4S@#-K"%2S '6.B$
M9GB"6Q '14"#4KB"+P"%-ZB#5O #7NA>EN6#,8"%0  #0-@')9CF>0B"81@"
M62@'7"B$DO.#7;!(0V@$/Y $0Y@#.>@$/X@%*J #.9@"1H@%-1 &&QF$(G"B
M28 #:H@$A36)L<T&[S $--@";:@$PP2%00B&5W $/#@"4W &(>B'<5"%ND,"
M2?"&-1 U,^"$46B$<S@Q;^8$4T $3+ 1>[@"T@B$(NR$0&@#(I@&54@%2P@$
M5JB#1I@%1S"%TIB'&TT#%)B&8, $@7(#YJ*$1"B$L/_@AT]H FP0!2#(A5
MA'9X!A)< VN8!D%PAG;( TK A#FH!E @ T78A;P;-S\ A&9HASN :)6629/
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MADV(AVE  V!XAB8@@5D0DG*8A21XA#50@D_HAC3@@T@8A&3  T( AD:X@T$
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MPS!,PC.HP^90PR@@ DZ:@S2(@B)8 C>(0ROX@4F< J+U R\X 2@\ RQX037
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MT29\@6J( AIP@CI,0Q, 0C$$ 1ZX@SQ@0A\H@CT 52+< C 80APH0CU8QS@
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M+Q#",,!#(#@"*"2")XB#)*!!,(Q"_QJXPCN PB"LPBW,PAS<02,L BEP0A\
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MR*'US,$V>?&]Q"$>*X<34N$>:N$8Q@&U]/^A]=R!NMB!%S)A-3\,3]1K&(C
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M'=R %?K!#_A .VY!!N3@&7"@"J#@#/)A'$PA"+ @")(A'.P K5B!$V*A"\B
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M=8 @8JYL/'W9*K$->K &@O &:9!-7=XCR[ +[X!PS\0,L2 +H5@/SC,-.V[
MT1 +I_ ,WW /VH *VR"?1DT-IT +M$ /YM ,VY!I86M>T6 ,Z" * ]8-]0 /
MV7 *S@ /\% ,VT +S+ ,AC (O& -__#@"HF "PJ^"]>0#VB9(]Z0"K.0#OEP
M#;F@"LQ0+J<0#?+ VNLA"_ P#':F#17[(NEP"' @"[7@!Z^0?LJ""N Z##4F
M/LJ0"[40#-U M;'0@M/@#<&0"Z* "P0]#>^P#:4@#\+0"KI0!OA@#:1PVAE8
M[Y: !+N #[DP"K(@"\N@#[$P"ZQP#1E<=<$ "SDH"_90"4=0",REK#_0#<Y
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M4K@$2Y#_!$E(AW> !4F8A$E\!V%0!S\ !2=PFW-( ILH3T"HAGZ8A4N(A!4
MA#E0 VM@A5E@%BW@!32H#CY !D68!%, A=R0!408!$Z(PS&X+W*H!5T8"C;0
MA4M8A5#ABUK@@W:(!4$PF%F !5,(A')PA2O(M$S(!5XP@D,8!17(!%8(@VO
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M@[ SA&[H!3E !W)H!$78AC?@!$"0!'<$@C2P6V50 EY[B'LH S;@A$PXA5"
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M&(<SDC6-;>"A$+S QG(,\HYNX*(5H:C1-&(A"UUT(PQ1"$4HN@&.8Y!"%KN
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M!55P!5E0W'9OZYCA#QHA#Y8 %@@A,X!A"NB!&PPA&88@&BYA"#0A#XS@%7S
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M'A0!#P8A%LJ!&OH@$;I!4+T@#P@!K_MA& 0A$3#!'I+!#=0@"E8 "UY!&.C
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M-(43F$ %^D ?;D$.T&$.R" 1(D(?Q( %S$ 2L* *M  0]($9Q* *NB 7F"E
M,&$)@$ /Y($78, 'PD -U,$0U. 4+L$7^  6YD &#.$/W# 4Y*";'084>F,/
M2"$9LH $>,$[=2$,KH$<0"$3FH$>'($-QJ .B@$4>N 1/L$+X( 1J.$-Z* ,
MC* 8O'4<Z" 2P@$4#B$4VD ,W@ -[J$08$ -G($C^*$1?" 5'B$2Y($/ML /
MPJ@?G"$.>L%:Q$'_'^IA&>3@&KXA&P8A'>; $DPA"6+!%H9@#:#A#R+A%,3@
M#JZ!#<( $<  $9*A#D;A%YA@$W@A"+*A&/I@$RBO'^I!#,2@&QSA"]!!%_A
M.B+"%ZQ@%*B!"*(!&(YV$KR NF5A'!QA$AJ#%(; &*C!$8;A%; @%+SS&ZA
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M489BG@,>J'A$*Z9E#E!$PAAP0$0KM- )4(A"'_VX!!ZR\88] ",7U.C''\:
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MI7 )[@ +@T .T8 &>H -Y\ ,H2!)V4$,FF *S& )8$ (SF!H_?\ #5@@"H[
M#>6P#IC0"-6 !];0#Z,0!FL6&-ZP"[^S#>5@#*! @OW@48\0"K: #_V0#ZM
M"*+@#<%@"_TP% ^G#[4P"[9@#OR "V=4#,10#MV "_*@.R8&#BCT+\@P#^KP
M"\9@,!Q2#OCP#,CP(.S@#OO #&?D#?!0#_L@#]A@"I]P"$@W#]/0#NMP#^+
M#^I0#_ @#^! #LL@#>X0#N:@0OP #^3@E-! #]Y1?.RP#E?Y#O,@#_S #^O
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M< _%L F4$ FKX V]  6%X J0X B-$ WXP V_H*D%G=#%;=S'3;ZW, >N4 Q
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M!_- #'Z0"'-@"M50!'DP12Q5*;2 !T,@!UX0"/5@#1&Q!D\8F=R5"IIP".2
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MGV8,1^!9QYQOW"&'3&F\N$0>5$9P_T47.=0198YXRD@$'GA8:1&.?(#Y(Y1
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M!5P"!G[(06LH C7H!EJ !5A A7D AE%8A5W0AD&I!710AU)@!5+(!M!BA4\
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M6:"#4=B$55"&/EB$33""7D@T@>"$3# %/K"%5I #5M $_T90ATGP@DH@!#<
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M!FU0A4V@@T_PVE) 4U*H!%;HA:(P"W! AEOXA$9(A%RHA5&H!VQ@A$'@ VF
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M!23BD9M1<,(8=;N#'Y)RDW,8@@G]P <3D)$$'__V8PW6R$T:BC(V0&"B*):
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M9Y5'_)AE'Y7"R4^E,,4<D\PRS3P3S3357)/--MTTTYUC:@DEF6_$<:66/[*
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M_$$,AQ#$$>[C$33801[]B$0BDG$)9> G/]/80B1 L0<B7&,:8I#$*3#!"DO
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MX10^H]AB81$601^R4!BRH982 152HARFH1$N81'B !)F01#8(1I&@1AZ@1$
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M%OC@&CS!#M#!UTZN'_*A#^2@(#_!_KH!C[*%$(P@$!K!#_( %US!"3 A%^(
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MD@ I-"8;3$P4G,#=,B%3[B 5.N$-9D$.\F!WR&$-_[P $>!@$E+!#CJ!$,Z
M&AR!$?IA&!2A&U:!G\0 "4*A$JP!'H1 M^A@&ACA$&"A"')!%<9 &\)A#LXO
M/Y8!#W*A'$2A".ZA%TI!$]! '::!":PA$/! %<S #5Z!#5JA'QSA"_+!"_1
M$]I@S=+A#M@ $<C !)[A#CHH/X)AVSZ1&I3T'_OA&VRA"_K@#/A 'IC!"%*!
M$V#!^"3!&JCA#OJ@#=( 2#C!(Z"!"((!Y2PA#O)@"+AA]-P@1?(C&<Z #>B@
M#?[@5_U@#X3 #]8A%#S!3]*@-L,!$9( ""1A4RK!"_+A&NJ@(\B!$9A "&KA
M'3XA% @S/XH!#JK #=3!&/\:83VGB1U(H0Z @!"Z(1S8(1.XP!(V01JH@0[F
M8!-N(1DLI!^ YQ F81:H81>:P5<V 1Y0(0^>X1@8(1%RMQ2":IK.81<*81_0
MH1 &X15&TB,T00\N@15>RQ/P !6DH1GXX17<((YRMARDH1K081S(@1CT9II:
M01)PX1KB(3_>(1BLP7/,P1C$81SD]F;LP1J0P0#M@9?)H1WT=A[4@1W6 1W,
M86'%01SX 1_:P1O6P1Y\01]6QH[M01GP@1_,(1WV(1W>(1SX01S6P1O( 1EX
M@15BL1O  1_4P1W, 1Q:21_F01S"@1SL@1[X(1S.@1S*X1L@&AS4(1[6@9W[
MH1S_S$&4*AH<^*$<XAGERH$=Y&9CQ4&Y<C9,P.1Q\6B:@M3$6II,6.6EO<2F
M7?JFW^2E;7I,>EI-=!I;:#JFSX2E)Q>IDUJI450.MDT;Y$$-CF (G #19D$/
M/*<=[" *CN :3D$/K"$<5($*MH /ZL$>H"8,AN$>TD <P $-R, YIBD8VF 2
M4+(?J&$3G@$?8"$B_;! *\D2XJ@4,N$0BJ$?/,$6<I0;\$$<<B$3$F$3J.$:
MEL$<0$%#5&$=YD$1W, 6OH$:C#$<+*A0>8$/SF$99D$<DL$8KD$;S($<9J$=
M]L$2_F 7N*$::(%]C@&!?2$57L$7O$$7WH$>7J&)M($>_W [3.3!&;A!5N&A
M&-@8/]*A&H2A+VYN&7[AP\R!&#8E'V(!&,3A&]KACLYA%>  NOO!%[#!K@IE
MJ+WA&% A&%#:(\8A0>.6)\IAFL+AH-DY'-@9O_.C' [Z2_[;I\<!'/P[I_,C
M',;A&W:'H[]!FA;V&Q0\9Q><OW,:_186I1-\P %<FF0:$( !OP%L'':G'6Y(
M3%S:Q'S:&4)A)&.:PF4:J(.TPA-\IFNZJ&\<ICDL%CXA%5.$IH?Z<85ZR'WZ
MIV/<2UJ:PH]ZIHL:PV%:QV$\J)><I:L<IX<ZR;%<I@&,R8T<RKG\RCF\QL5\
MS+U<J<\<S:^R'.A&'-Q!8\'A'?]2:V7&81[$,=',X1S*(<"E:1SB/"7Z(9[9
MH;\A_!3:8!96NK_Y 1P@?- 7EA]XPJ<KFB<X^J#G&[_U', 5O<0QG:)+_(@@
MFJ,]W=.G:1DN 1GP2,\QO;^/"!PZG%5VA[[G6\(![+]37,FM7,@)/*8=?)KV
MX0Y*[,M5?,LY6JAQNLJ+_,B#_,EOW,:5?,IK6L>S?-EOW2-VH9-RO!_481AP
M%N6<G,KO*AZJ^]B7?,MAG,KSF\.'?<>Y7*<3O!S<(1[NP1QTG<QW/-W)'-_S
M7=_WG=^GW=[['> #7N '7N#3W. /7N6$_<K5/<NC738.X1 \B\FQO,ASW.*;
M?*>1G=G_V1W01SG*=UK:B5K%%1['O;S+D7S+SR$>+MS<R3W%NYS="5[F9Y[F
M W[4.5S/R[WF=W[?C1W@,9[G@U[H"_[6A][HC[[?$5[IE[Y-VAWIWQW1D5[J
MIRG"IW[B7U[H8S[?B][BK=[KOU[KC7S@P_[KAY[LRQ[MTU[MUW[JF=[MLQ+M
M?9[M:?[LCQ[KD?[?\9WK*W[N^][O_Q[P U_P!Y_PZ?[M#Q_A9?[NTQWQK\G?
MV:39X=[,CWSR]U[OUR3RFS[S-[_R']_RD[[NYU[NB3[O"Y_T2]_,SSWIV1[U
M59_?5WSM&U_VSUSQ/__J9Q_S*S_W=7_E/'_TS>3G=__VTX3Q_\.>ZRD?VQ=?
MW]>]Y,&^^.^]WK&EV[T^],6\^JU_]#>_]?6>];G_R9>?H\\!9LO<QGW:^LW?
M]W%?_7N?X)4__=>_3-[?J"L<<M\_O]$$W3$<W=V$]_&_\^\?(/H)[!>N8,&!
M"!,J'&CP(,&&#1DZ5&A08,2'$"L>O,@QG$2+'D%Z]/AN'3B,",>M<T?.';^/
M(F.*A ARIL=R[\CQJR=/)L:#X/"YZU?.&[QS",.-,^>N7$B"29].G-B/G;*3
M#R6&?"K0&[-Q%E%F3+J0*E>']*;1*P?3W+!T; W*T_<M842O\.XERU=3:T68
M82F>_;NPL.'#B!,K7LRXL>/'/[?2'/]IF.I/R)@S.Y:,^2]7S94MEPU<V>_6
MOHPO;D9I][-6J)U'<NY+[ED]IQ['67-ES1DM:"^C"D8\&&$Y?-#$V668D-DI
M>H7?<2OVRQF\TV294TQ<\5VT;>J*5=/NMY\W5;OXA:-&ZUY";\:(L8U*F#1L
M@?H^X</:[]NZ<P>5<PY8Y) C$#*#I*-<..<X-0X_XT0TCCCBC/,-../H](TX
MZ@GDCCM@L<...^QX! X_W'!2##OFS&-.0?R\,XTFVX#ET3F[;.--.?K$L]]?
MU!RBRBE^L++,/..,4X\R^9 CFT?LQ*/,/.6P8X\TZ9@##CGTM(////O< PXX
M\BQC#U+U@:;_YIILMJDF39$M] Z EPDDCS>1>3991G#JV=&3DLU&F)_,G5//
M?7SZ%!$ZU\2TT4;9'696/_$,1=]!] P#CC"GS&?9/,% 5Y$ZP;S3CBV Q:F-
M,JSPLERD>2K$C!J'P -5.;Y@HP\H!J*6$#R-V$%)&GKLDM WLK"R3D+:/",0
M.>D,%<X[\P#C1S<V]G-.'F4HL@HEBS33CSS(,(-G/_4$TPPYY\CS33GBS#,/
M/LH\@T\ZR*#SCGG,V-L/..HT0XT]WK1RB#7>*&,,,^MP=0XZP?C2#RV/E/),
M.^R\\XPKW*1##R:K]*+(-//U0PXRKORRSC?H5,,-.M^\@PPMQM1#_P\]W^"S
M3SWV'.-,/HRZ0@P[L"V32!G5U)*(+=;8\XT\SJ BC(&CHN&%,.QP(XHR^B3#
MC3'N3$.(*?+84\TIR)S4$#S7M.(,/OQ,0TLT[B%T#QRJZ!(-T=%4,DL\_4##
M2BSH().+)]WT$\T4DX12C#RVT!-./,',D]4YP7C"2C'Q"*.-++%PXPDV\I C
M#"ZX(.-.-*=XH@T]W@"#BB21< --+.BU,T\TLB#B1"PETR-((<L@4PLKNA2#
M9TC7>)'(*'0D(HHMZ/@B2RJD)",.9><\P\LGN"C#3"VKY!*---KPTDLOGI 2
M"C'2\')+*<50[9J;^.>O/_X1Y4(*2L!( _\U/'&,;7QB&)"P7$6&D08E!$$(
MKA+.=EY5F,&(ACSW:0VL/C..;:BB-:K)X'UD88>^..1^]YL@0M1P#,$<)!MT
M"$<O)(%!@1"C$\- 23(" 0]@7$)2%3&$+?8AKGZ@@QAU$0@]I#$0:@0#4!ZY
MAS/2T1](2"$7+_*(/BB!AV6LX6N^2*(RCM&K@4P##G(HAC7\, :!0(,:Y_@&
M(@ ACW),HQCT ,<@)&$Y:'#"$_A8QREJ<0@R%",N)F-"(IB1CFB0H13QN 4D
M#(&-XZA"$H*P!3%BX0YP/,,:Q[@%)SJQ"E T A;$T(<M+&$)7=!#&:+XPR$^
M(0Q(U&$2VA@%)/S_< US#.0;Q8!%(& !#4^,@5:*D 8R!($'-XAB&'Y0Q"L:
M08WYC$,8AL!#((:QCUM$@A*]@$8MW0 );* "%>\ QBV<P0M-;,(6H&#$(S#!
M1(O\0@Q,8,4HE."&-8 "':R0PR,"(0RU>00?FE"")9!Q#5 8HQ5KD(0A3E$-
M,5#B%Z/(!"4@P0Q$EB,7:=#$([;1#D%H@A&>2$@^@N '/^R!&<%P!![XD I^
M8.(*F,#%)0!A"3_DXQA/ $0CU% -/M""'++H1=T\T@U%?"(2?G!%)S+1"#X0
M0A"/P$4Q#*&(27Q"&IEXQ!\BX0I40&(3:< #[A;!B3^0 AN., 0@?H *_T3*
M(Q";N,8?_( +133"&-E*QAT.T0LT8"(4G<C%*C11B49@PAAJHQ0H)&J*8EPC
M%:"X1"!4(0A!I"(2DL"%*$0QB4=\8A.+6$96]L?:UKKV,151QB-2$9AED$(O
MZ0@&*M 1"4_LZR"A4 ,B2J$)1U"1')PC2#V0\0P#J2,>X5!'-]#1#WKL:Q[I
M&)$RS&&Z:>")'\_H1CL\Y0YB4(,OZ1!&/"R4#VK\0AW], <QD(&/<43#%%3L
MQS1@08I]B4-^^NC'.J9!"D7XHAY\Z$-+7O$*:,@&/]0 AGO000UMX(**YFC&
M,_SP@[#,0Q7?& <J;.6+8JP#%8XU1C^&@0A+H/_B%W_X1#&D80DY<.(=XTC&
M)/*@AV$XHPI-&$8LPF"$4:#)(] 8P@XX\0HH-($-U# /)-I@AD"0PP\LB,,T
MH'*.1I0 $-OP01V<@(=X?&,58R##'^SG$4F<HA2>\(8@WE"'48"C%&R8@QVP
M08Y5S,$+EE!@2%*1!SJ$01;W$,,)<A$67TBA"]60@Q/HL(<MH^(+8AA$.Q""
MC"]$,!59&$<VRM '.R#C%9S(QR'ZT ='"$,//W@&+@@Q"C3DHAM\ $4BN@ ,
M1)*C");85S_VT(M4H($4G*!G*?J0"UA8XA2.D >*1$&*.!AB$V)81"TR<8I6
MR"$0V=P%+NYPBT\DPA/_B*##+#B!!C\0HA66>Q8BO) )2T2C%G;8A"+6$(ML
M*((3D7 #+B3QB55@HAOS><<LTG"(5W!#%I%@Q"'P (MD;\,3L?@W.;01B%)4
MPA+'X 4>,&&(.>CB)1YIQQKL$(U;4.(8B, #+[SPA4H (A"BTB(F''&)1I0B
M%9X8!".ZL0I"R"(0GBC&&>30"2],8EFY^4,B:C&'3SP##X/8!*,1D@\R_*(9
M/I!%&O* B4S<P1>/&,(^3,$$26#B#*LHAAB,08U(B,(/BX@')%#ARQ=6@A5N
M<$,O%B&*8@2B$-& Q"40L09.C (0R0"#):"Q!E$LPA'3R(4C;B&(3K0"%'[8
M_P0AK+$--M@B6_RX12UT(8E0S$,;G7#%;_MA#$W48AN2N$8^_' ).=AAKY%
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M#N#@"9P "G>@#<!0!JH@#H- "H=P!IQ0"7:P"J9 !\OP#(;0/I @#)Z0"8&
M"-'@2P)Q#J2@!H2P"<= "HD0#--@"*1@#;HP?FIP205W< DG"X30":80"Z;
M<(:@!Y% "*BR#LVP"87 #KN0":PP"[9@#ZD0!H9@"730"](R+HRP!M+0/N%
M"]]&!6X "W+0!]1U$/(P";B@"W8@!Z;P"GC "OW@#'*0"[<085<0!@F%!_(7
M#N[P"I)0"G: "/DP"(D0"*201 *1#FI@((E0"D1 !(P0"7U #(_P0Y4  X\
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M"+! ",IP#Y6PMHT@"F57"WX "Z9@"=7T+->@"(2@!IL "Y$0"*-4")O7#L$
M<XX #)8P![F 'OE "G# ") @<&A278- ![_0"J0 #M7@!W\P!NZ:"9=PF-6%
M"-I0#X+P_P.#$ J.4 C-4'RM\ >EX QM@ :%@+"'4A#[H EKD MEL DFB0ES
MD ;G(A#WX ;U, ZGVP=[\ EG)0YI\$.JT 624+&Q$ U+P VNX :G( ^&4 :!
ML* 5,0IR< MS$ :%P F_0 ^UH KP,&L(B0F;( C4  :L4 Z44*V%P U-.0N*
M  B3X"VJ, BS< MB8 N(% ZS, K8\ F@< RBH'YUX1'$4).AD+&D^P>B %HM
M^0LHUP_S@ V@< B/, FPL F]T F!4&Z[T Z'\P[)P%5^8 JFD J@^Z T7,.Q
MT0_XT 0TM MX\ N>T O<H 6E, FHD N:P [ED 3(D!6Q@ :(H/\+G# (IY &
M%JH.F>"*BV!$2. 145 +VB*N:  +?S %O> 'HP4%H] )D; )G= %-5$.KJ &
M^' /0$!-D& *SG (KMH)?6 M_= .<" )WT(%OF +AY )GS (3@ )H3 'K1!+
MBM,&A9 +HP#'G+ &?? ,3Z$.G> 'J> #T3"+XH -;2 )O1 -_: +/A 6_" +
M9!#"6# (<[ /HC (J#!GQM )>0 .[E &)30,@( -N'"?]@"B_5"?\F &N. .
MJC *J> (WUD1N. $Y9 *C(##42"W@; +V, %A9 ,F5 ,*+$-C] YF: MM: )
MB* "JD +;B +*+>*WFK!0[ -NK (@C#_"H9 >T$0#Y8@@53 ?0=Q#7!@#>#Y
M!;]@"ET NO00"9T0#TD 7ZN0!I[@ WS5!8M -?W0:1\4#'U "OM !(6@"WJ@
MN;0P"GM0"XA  J=0";)@#V<@D'KP"<'@!LEP"S^0#(CT#D1P!J/P"6Y ".U0
M"#1;"Y2P#:)@!P?<"\A ":, "VS@![>P",@@#9NPK(R@>FD "(#@!M=0"Y&@
M#NU0";10"FOP"KT@"H@ ![  7\_""X'0"6SP!Z 0",I@#Z;P"8+ "*)0")00
M"I8@"OK[#/-!#MA@"(F ![V #>];")/ #:H0J*_0.HG@!VB0"*V "]BP#L-
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M"[2)"MXP#+G@#?+@"N$U"I40"ZR@")M0#$?V#<C "I.0"LTP#*@P%]K@#+^
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M:(0Y*(5\8(-.X(8N" 1F2 ,?T*D> (9,<@4ST 5<X 5F: -#V(=( (-M> -
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MH:U -.A?.)8'1^0#/1"%5/]8:JGS6TM8A"&HAEAHA'Y@!2? D"9XABW@!%7
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M@Q#T@3O, 0TP03Q<0A%LF2B80C!\@S34PB@40S:( BP@PSH@0B;0PI?, B*
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M*RCR)/@!*SA"_R]XPQ^0L2'\ BEPF/&!@RO(02>( B;, BCXP2I PA? 0B_
M@C1$ RA, BC,PT),J,QZ-3R)P@LHP2,P@1BD24_1@A2(0L XC1O40">T@1@L
MPQW\ #V40@_0@C$\ 2T00Q88 RUL@2PPP1R8@S&D S-< B0L01X$ R4X@CD
M0A.P @H,0SCL@1ST A0< S!LP2BD0AGD 1V<@C:9ER"L0!N80!#D@SB,@!>(
M A6(@B#40<E-@2Y8PA)\@RWDP",<PA.4 BZ$ 1O( 2V(01&(PACX 2IPP39T
M PK40C6XP3(P R;\ 17, 3SD02?@0P-# A9D$1,L B&< $!0BU6"U_^Q,& N
M10NW,%P_<K@:%3+AB%L2>OV,*()T1ET[+(7Z,6R(2L03(L:&<%GA2ITI2WU.
M !/EA5@_.4SV@:O5"!".3,FP&-/GI5"O+;+:(6E$"4NO0CP.F1HCIDNOD.,8
M]M.ZE6N_,5_<S1-RJ)^O-*.Z4F.BCU8L<]G<0*KDKM^>7+B*%)OGIM4N1OV\
M5?L#I9,?,<'*9>VG*9I6?G7$7,,$J]4::<0TW7)3K-\N-Y.* -I4AYF=+_-"
M9ITUQ!JC0<R<)?I$CBLP-H%BR1D%ZPVO;X[X-./$RY.318HRY=JUB%E#KKXD
MQ4HEZMTZ19QD@<%4BI"N7Z->*2L74JLP3++_2GWJAL]0IDF'L'$3U<@+)69<
MPR%K9*C5*4.3_EBD&73^V"201R1!8XX_"CE%G%<N(:637"P)9)M.$AEEDES@
MX8J<7!+1!11+OHGFCV:<VTH?4"11II]G O$#%DNP>66.?>[!!IE]2 &FGET^
M"0665QZI1)_4^CE'D3_T64<92QBA)8Q4 BG"DVP"J:<?3!PQ98U9]O'#$5K\
M, 4:5D[IIYHP^IDFCWUX 66;24[QA@Y4^@EE$GI,B60?9T)A)[6&VLE#CTTV
M\2.:;3BY!995VD'D$W9^J208>6S9Y)57<-&GF<RH.002:=K1I9102B'&%5SP
M&31)9PJ!!91/3E&D_Q5Q<LFEF%Y&@:218,;A"IU9-D%$E&*V0>253S:AQ9E)
M3!%%%5E<<8>83Z!!LJMMN>W6VV_!#5?<<<DME]M<0L"D'T.D *9;9$;08QQO
M"*F&#AA0 <0)9_1@LYHJFB&F"FS484(=;K8(1HD[WJD&F$J<N*2+,XYA!!)R
M &F"%1)4Z:8)1TB!HIUUJ%AD/DNVZ&.9:?(1J1]S_#A"GENV@,4;+8:00XI2
M"F$BE%J0H$60-_I1)84?ZGBBEU44U(&2.Z!PPPA+3N%"&V!ZJ.64/%HY! LW
MF- C'2724&:.-3B!@154GF@E$!RB424'75P!)!,:[G#5GB8\2$0$/8I)PO^7
M?HZ81!(K+('$!40&;:B;*"RX@Q]# A!!&5IF$$(,'(IY18UE^E$CBF;BH0(+
M36@(XY@>G*$'C3]V$8&,5)Z 1)4HFBA"!5@.$>.+$RBI1Q)8M/7V!SM0"Z2-
M52BQXYFN@HE"'EJ$88>6+VS9 X]-5F %&B*:&.0,7831@Y,OUK#EC$]F$00<
M5_MY(Y%>_* EDCUF:>248.YXIAD]6K$*-F#""6P QNMN80AU. $.6G*9,-(0
MBF108A&7,,0RQK,5<:C"%+7XA#&T$0D\T0\>I4@%-7HQB4_ XAG 4,0R4J25
M?,"B&K@(Q3O>H0M64&,2D[!&*%98"6&\PU7HN 7_+VR!"G2(0Q>I0$4MC &,
M5"A"$=P01U?>(8Q*7&(0B@#&-5B1#WGTIQJ@J(0B1H&*6 SC':ZHA34X@0E
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M\19QT0CUC92R@MKXP1QR\!:UXAV6P1FZ@1!;T13/@?URL1G#H1S> 1S$H1[
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MS2G_L2J=4BNXP?N 0?AJH1"& 6 IL &ILF,5T<' X1FL(0+'11LF(:7"<N+
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M: $8"$$,!N$47K"$!O^!#L!@%5CA$0!!C'=A%=R@$_B $=K!,:)!$:QA%,1
M%)*!%XP!$^0 #YI@$GCA$1RA%1IA#M9&$>[@#,P %%PA"2+!$="@&$ !"0H!
MPJOA$ 3Y$49A&_:@#0#A#P2E(=X!%_1@% A!$7XA$@#!$N* %DP!"?3@$NC
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M,N4.?.$4-"$78.$'\. 22O_!+(=-%"B!%E2A#QYA$\8@$%S!$6:!&5[!_>-
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MD<D?3K"QBQ?NU&/**=*<X<HF;/22!B6>_&'*-:&\<D@BT,BE3B9JX$-I+9=
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M2C?""4!)"X;@"70@"*H0"-8P#4=@#O'@!)-@"VH0"]90!J/0"6^0#/W "!X
ME. 2#KJ0!+"0(]50"9J "ZUP!\0P"86046L@!O.0"[<@#(_0#>ZF!4Z@0_,
M"]\H%YT "^1@87N#!L)@"B3 "&B@!L20"ZP0#M+P!9( "750#*7@;&/@"=R
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M#W20!3_@!=4P"T=P!7!@!,B@!K?0#[H !$4@!YDP"A32#]EP!NH0!D. #[F
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MV4"NV<PP!DE>V*M-\P$B#9* #->0"]+:#LP@J?VP#M, #0=ME_/0[;@B#_=
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M" 4T-Q$-5HRA%)[P@C8L80AA+,(1JP#$*& !AEU4PPIK< 0\XO(-6E3"%9&
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M]L@$*'K!ET)48AB<,(0OO,")6-3!%=HH0B-608NF(&0;O:#%&=PPBB($XAJ
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M D5H!S<PA%_@@V* !1(X!%"HD\78AUN8A2(X@U(( U#(ASA(!%C(A': !3R
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M2( $$8T*#"$$4G"%11A.5C@&>] &4Y $.> $2^@#4V@%54#_AU@PIE58A4G
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M!VB0!W"0'W=0AF:(AW, A^'^!G-X!W"0!U^P!WE8!W(0!W!@!V]X!E& A$)
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M70TG15SA!R\:S2,/5>?0$X\^2AH$CS 4?3,-,,G&18X?)'SR#E7Y:-.-/N[
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M/0:89G;X(BB'HXPYF(&+4D##U.VR^&C*D8]9VDUA\SB%?TF^]+>DPRO< [Q
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M0CI( B1PPAZ@0C2( "/,0B$$ BGX02FT@A3@ 2B,032P\SFP B'H2%QX0@A
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M&<GA'22W!;?Q'9C!$>Z!#RE8/OF!',@!B]&1'=[X'2CX'<C!';*Q'-[A''P
M$S!U',QA.[/1%1TB/D$1CQVK',X!ILI!&S A'2(X52WX&]R!&+Z4'<J@%QSI
ML2(8'["T@^F!&51Q'*71&\AA'>B!_PR]84GU87G3H1GR87W) 1V:@1[402"!
MH5DWMA.9 1GLP1RJ00XXH1WZZ2'V(1,( 1UPH1-081>F@7G1@1F( 1_DDV!Q
M%YNSF4K< 1A< 1N0P9JU]7 ']&M%3$+#(1VZ@1@!,1EP 1/^(!9*!V)32=OV
M@6<E=7+=5U=[U4G@M!RZP1/V#7$5M1_4@0YTV7V[P1*82W#UTY#]8!OL@1&<
M84R>9!R081*(D"!\00^T81]"P4<8UB_NV$G,\^!,NEY@MQ^L81.H[QS@V"_&
M08R%5UC#P15U]!WRN#D#-6=1=8[%81K?(1U"X1&TX12P(1:*P!=( 1@<0AD6
MCAK+(1Y$&/]C?B$:Y$$=5@$6)F$1TL$>%ID:\(%CX<&JG2$=W $9KN$:?F$>
MS$$:@N$5C( 8!-5+BR$:NH$<;($0 @:[YL$8H@$8&"T?KB$6HH$>D@$0;($9
MU%@?[,$8+H$2D,$;?L$3L*$>H&$4M*$;[($HXL'J_.(:+ $R?P%?0\$3D($8
M/L$14F$;GL$59H$9VL$50H$;X.$PVT$2Q, 4^%<52D$8O&$?6@&A;HS9O*$7
MVJ 4<*06=J$:\ $>:*$69&$:PIG<]J$6="%FI $7GL$<H@$9ZF$;2$$5=B$]
M%]#75 %)CE 55*$7ML$=GH$50J%/,-47#"$5< $5UB%O);@4GH'_&UZA%U;!
M%=8!'4(A%6;!&%@A#ESA&4*!.J_A"W&AOT(!'?2 %3CY(9YA%43A%F)A27'A
M$RQ!%8"A%7SA';8A&#QA$D9A$EXA%3CA%.AA&$#A#TQA&)1!%T3!%%8!&PX!
M#&@!P\-! $4A%1(C&V9A.>A!<OVB&>9R&E@!#Q#A^I A&U8AF,SK';59R[<<
M,7-A#IP2#V[AE,RABLNQ']ZX(<*4&,F4/YK!$)JA8_'AU8"*;QYK''ZA"="@
M$";A"$CA&N4S6/GO&;I!'NQS'O*A'OAA&KKA#RLY'YX!+DI!$Z:!$TV55$M-
MLL?!$[O!%QQI'JBA&[P %3!U'H!A&""G_QQ\81B(X1M" 0WTP1OPP1W:P1B&
MX1[@0AZ 01CL81[481OC\!R.P014H1^@P1-BG!J7X10&P0RPH1^8@<72[1N*
MH19<X?OH 15TH1M$=ANLX M:(0S6(!1VH6/TX11*(1;RP1T<H0V"(5L=0A\F
MX1AF(0Q"00$?ZQR0(11 P1XV\A4B%QEBX19FP1D\ 1&H 1RN@1,^017D01I:
M5Q4:X1-2P1O<@15ZIQNHFR!H ;>2H1:"6^)!81G8@1LJ(15B@=Y$X1-@(1X
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ME (2CB@#'%*1"U[DXZ5^F$4H&/$(4W3"$,U(JE'6T0I.E.(2O2B',BZAADH
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M#KE@"L=@"6Q#!WV(%N& #8E@"*_ !J2P#8S@!Y)@"=%@#9;P!Y:PE)4@"7_
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MB, &=# &F*$6X_ (4' (C( +N<$)Y' )0?^ !ET@!+O)!(< ,&D!#3X0"NK
M!G5 9T;2#GA AN) "52 !'B@#Y6P!O>0"WR0C*S0#)P0!6O@")/ 2?<P"<'
M#JU0"/H@"4S@!*$0G492#'4 !H2@"-$@"JSQ#(+ #E)'!J? #]'@!YEP8+^P
M"3>H"JX0#K'P"(\P"LK@#,<@#X(0?,G #NN6"=;P#<&0##[*#<N@#80 "]@@
M#/$@#<^ #,,0#MQ !=<P#F 3#NAP9]A@#,R #/CP#<K #*[+"J7@"NZP'N1P
M#*DPGM"@#-2 #;K0#./ #\U0"MD)#O1Y"MW@#NXP#>G@#LKP#-VP#.X@#\T
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M&S@*\F!^\W!^YW9-\R]OQ+P3P_1=[2]_])^4#OL XR=_Y5E>#OB0#N9P#<N
MY%$NZD#^+#O>#^[ #/N0\_2>Y,E0\+M-XV8OV&4..]ZP#;L@#T;!#LD0"RC-
MX]2P"IY.YK"#Y50![=&^]QL/Z1O/]S!"#Z: "$:A[D)N)+*0#<&P!BZ;]UH/
MZ8F/$2HL^)OM]%]=._MK#NN WX=J"]CC3'[@!K& WO5 #D"\#O-0HZJPG7Z
M#?+@649B#+RP#_Q0#_BP#D1!%?$P$_I@"Z9P#^(@%=\@#OK@W1Z?_(J.]"/_
MGS+\TPU)[KR]*_-P#^I-[_W_( _3$/I)6 [$P-I5T0[J@/W]( Y#M^]._NQ9
M7A6]H G;4"2PK/K<D%'IKQ'?D K&(!NKP(QJ<0[J$(4 T4]@.(($!1[L)^K:
MP' (#Q;L5T]/.H?]KM$2Y[!AQ8$.MW$CU\]@L6/G,JUYR)'C1I4B(;9$2*L1
M/9<L6QJLV9 =/G?]R.7"!(T0+WCDR@ETI^]=.7#BZKG[9A"<-WWSS)&S2M!I
M/7[AS,VKM^[;O%/1WO&;MXY?OW'KZGD#5Y#@5V^B/,7S]NWKMW+K[LE;*_?=
M/67XP)'3EP[?-X'DX(ECMP[J-V6?!&7;Y\U<ME;XV-%3=@]<-36Q[-UC5Y,=
MO&7*_^RE\P7OG+E\OM#5,Z>.'#AYAEV"4P<MWFYZR_8IC4>,FK1XSY#-&R=O
MFK%TC N6D]?M6J= \^R58Y</'#ATOYJE-B@O$J960RX-0^:M'+Y?P)Z) S<-
MV#1Q^W[]HB<<?O9!QAAT^&G'&F.FB2<NN?HI1QUFIFFFGGF4F888?<81J9]W
MC G%%E_>06<;78I1)Q0O O'EJ'ZV4:.37YBQA11:X,''%E!6B82.3RPIHQ-5
MG-&GH8:8<8499U3AI95F&!/)F"_X&&86-7)I)9D+3Y%E&W2LLPDF,<<DLTPS
MST0S381LV@@G?K;I"2%R@+%'(SO[.:>6;8SA8YD['WHI)?\(:[%$'3LW<L:1
M:3KJL-%BC "F0WS8&"4EG*2Y!,Q&V60)IP==$NB;)>:XQIP.1XD%'S]4:1/"
M<HPTZ)LNK@A&("\R6:L<%[OY9!^!=&5(KG$X[">,27(:2-<'UUF$IG" [4</
M/>01Z=6'QFFHG'&.,M)%3 K!!]1>-I&'C3&LS198@M2UMEIHGT57+F5%FF<I
M6,.IA1-PUB2'F'78@B8V#OWM9QUY4A.IGF-"T<8;>^B@@QL^,N%EEWHHPZ85
M;.")IQ52@%G'H'9FP0455*PYA19\TMD%%5V0.<>:7CSQI!MUL(DF05E0H6:=
M?5R1Q98O.W0G&E1D(:244F(AAYK_6-2!9Y=1>D$&X7#<$<842$CQ)9A9.'$E
MI'Z>>04S6[2Q9QI/'('#C4X\:<>55'SI1I1 7H$&FS?2,&028@XJ1YE7+MD$
M$<M6Z6:830I11)=I>OGEGE10$7L<8FYI9))HE.GECT)8H082.=) HY%$^)"E
MG57P4*,1/PWRIA<PUJ C$&XXF4\0?*CQ8_9?N.WGT3T:Z0*),\Z091W9[4AC
M&WK>^,$15!@1HXU/O*%FD$C2L$2:5\QX)!)#]$'VFUHRT82.CR3!@Y!JT.N'
M&C7F4&.6:3#!(Q(^<BEDB4B>.<HX6M&'0+#"#XF@Q!IJ80TTL&$1;' ") RQ
M!T 8@A*Q_WC'06@AB%8T0A.3&(0BZB009*"!#LYX11[^L A ;&,2>-C$(29Q
M#U"IR88WQ&$.=4BF<82$')&@"$)^$8F%].,>0>1'<90Q$'L4@Q*ED,<H[!&/
M;E"C0?T01S.ZT0T:&N0=SZ &,\PQ#GL\HQO'.(8YDA&-9XRH'^CHDC[R@8J
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MX@N.4,0N@O$(_S^\ @^&N 4A0O$O@@BC$M=(A1M0D8Y/9.(3B<C%R!3AC%L
M@A;&H(0@YG$07! B%[ HQ3)4(0AJ="@=@< $/GCQAWS(PA&F> 0:,/$(-6P2
M)SL$=* %#6A^5&(,<B"$.*B1AGYXHQ#:4$05.F&-2'PA#-( A0XV48Q'S$$,
M@Y"L$\#P!D/,PQ 0TP(KG'$&:;B!"Z:P S;( 5I!2 $3'2I'*)IP"TQHHAZ=
M,,,B%,(.,-@!$4.@Q3XN@8E#^"$5BB@&(KS0"S<, AYP4,,K[$J++;RT(>H8
M0Q400;%[7&(1DNC#/IBAB7S,P1*8&$,\"C$&1,1A%<E8@Q^:S8I "/\B$'BH
M54/,(8HQ@.(5?1#&*TRP"%,U9!YZR$0W]+"&9.!!%,MXA"N:L8E4[*LA_ B"
M)L" "':PX1*BD(,MN)&&5&AC#Z@HQ1FHH0T])&,CWX"$&JJ!C2$4@P^B0$4C
MUC%43H@B$<J@A36,U ]Y=($8>>Y&*Q(!#"\,X1B,:(0Z\1 -35!A&M@P@BBZ
M,6Y[M,$/K@B%/0B!!V(4Y!N%($0\^."#85 O'VFH!3,4<0A1F !T/\A#E!^!
M#2 S Q*7>$4;2A$,30SB(/QP1C6$00<]L&(+DWA&$721BDVT.A-"9<4U/M$'
M6J1B!-:0!A=^L8E>H&,/KS (-1;A"6^X@A+_VK#$(:01B5DH@Q."* 42',$*
M-B2B$(O ACNPU9!<U($>W/A!+) !"%A(V3MNH 4=P*4(0NC"%*FXA _0T(<Y
ML((3>@#$'W[QCH^3 A/!L(<B6B$)0:QCP+)8A!TR 0<O0+4?YC@%46@&=_"$
M3R@$0$"%ANL'?( %.:@R./"#(DL%3F@&:J@$4OB#-)B$3L &<5"'>+"%1S &
M>[@$0O"%4#&&/W %<V %49B'5H %;.@1,_ "8M@&,)"$/_B;AJB'3-B$!6P&
M_GDC16 $ LH'1  $>*B&/B@#*JB#-,B"0?@7@3B%04B'>=@$1^"%0S"B,FB&
M+$@"/C"#,'B=AO@$_UX0!C-0A7*@A#*(AB>P SH8 T!HAB9 AGX8 R6P!$2@
M EZ0 TGH!WVP!$OXA$I)!B]HAV#Y/UAXA$9X U8@!D]@A+.*+'30A3_ @T*P
M!CG(!+CC!%X0A&JPCK')A6=@!4I8E%:(!$1PA&L8!UH(!6E0A4,8AG/@A$ @
M'X&P,U:XA6KP!EK8!%!J"'D0A#_X)E4 !V$HA%%(A$-@A4KX W2HH4&CQFJT
M1IBPA2^H!E>(A%"XABM80#[0!6'8@VT(!#C !E%H!V= 1U48!&0PA#?(D3;X
M!3]H F8 @F, AB_@A5*P F/X 4V(AS3 !)1+AF#0 C[H$'((!!](AV@X@_^5
M@X1NJ(1,"*1)V <BN(526 1[:(9K@(5$V(9"8(1Z\(0DX!54P(4?, 54P )O
MZP=X$ -"4 =3((1BJ(9@*(0@2 5IT 1Y, 5K^ 04D 9RBH=!8 ,XHP9?  8Y
MH )04(4Y^(2#2 <^D(1Y2 <VT 1;X ):>!6#:(1;4(=(,(5QP(0O2(81H*XZ
MH /XX0<F^(-=* )NZ(-#J+"&( 0YF 9&F 8_V(&]NX)!6(O2TH2R[ <BP 4T
M$(56@ 0/] -400(Q* 1I3(\L8(9(@(5Q> 8O5(,^^0(I: ,MB ).B 0RZ(=N
M: $@J ,HP()T4 0P< ))((=*4 1O$!=0"(=BZX?_7? !91 #2; $/9@#4= "
M=% '*#"#2Z"#05B$,-B&W2RJ--B'<N $/#B(<= &.- #&LR%+(BF,T@%4<B%
M?M"%2D (=0@$/?@",9"%7M@"\@F"8@ &1[B$2&BSADB&3@"E9I $6@ %3' J
M6@"';,B$6V "/X"%.>B;54A$4,D%.^@'8M"$7[ '2Y@$.8@4<'B$7> #5>B'
M5K $3Y@%5@"$,#"%5_B#;8@&62@$+P!0@1 H3B"&;^@%63B$0* '5I@]2&"$
M7K"$3EB4_PO 9I@'79@%4RB$80"3<'"&.8@$15"#/%@$6F"%5; ':! %5D $
M-:B$1:@E8: %7L@$(O6#_T<@K6^@ADFHAI@BA0'=A%M8@U'@A#4@C##P EJ
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M7* #2X@'@1@':["$7<B&1= %_TYPA&UH!#]PAE5@#TFXA$TJK4"=A%+HA%
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M <4H^H&/."QA!<KP RWZP0HP_ (5@5@%$EYQC3O\@A_.*(0@ZF &=&CB&>5
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MBEA$* XA"5? (A?GH 4:?K&*2;3""[6 AR'Z( H_'.$3N/"5-"B1!K/)A!_
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M#E2A$=P $3@!"60AY\RA&=" %(;!#A9!$^1 '73!$)*!_OHA%W#A'OHH$':
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M $GH@0O*FQAB012T0QYL 1:JH3H](1V0@154H1C6X10JAA:\8W_M 10"P14
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M$.J+).<1G&N'DI2IXX;:GSF&BA!"_[8(4*=(J%XY><2-7+]OH>(L(L0(FZ)
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MH?J12]4,??\K!9%-8/TP PLLHT"CS"60( *+.O#,4LL:2;@CS2BJ1,A,)(D
M\TT_ZX3R2S^NC/+-,J)<4XLOK*SP!SQ:W/$(&+R8\QMV0(!!BBI\I#&).-*@
MD<8:<S@#S!IKI#$+.6Z8$8DLC7S1!A>\&,@,$5B<\HL90) !B#@&QO-&":Z
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M( P!(D03=- ''"YQN$1THPP^>,8EKH -.MD)1^%(AA."T8\X0 (:NK"&+NP
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M(/TP"DAP#7-0"_6Q"O&@"H1K!W1 J\!1"$WP!6D0"?) "&6 !V+P#+]@!V%
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M"?*@"%&S#* 0F@-4"SN]#8_ "+$P#F9#"X:0!>F0#I*P"-)0"?8 "NS##];
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M;U@$)C*(79 V0PB#9, %+A"%3 D')T@&18B#:!B%, @$,G@$9/\)"FHP S
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M:(9,P =AD(*<NH);4(,X< ,T& -<$ (P$X16P =LQ(=;( 0G\ /84(5!"$)
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M4U+&'"YQ"E^G$,Z1G4?;;F))HJWA$6E$$CGV(<"3= Y*^=#53> !#^^M@QX
MN@D^]L&-.=!#%]W Q!B888M3@(,?Z$#'=XGQ_PR \@8<\O#1.N0Q#V)T@QKJ
M@$PZIB&++["B'/%PQ9S=L0QD9"-T?57%%28!"DU4(A?=P!$\3J&+9G X'6G
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MPQLP0B-D C L@DB(P2V\0AQ0 S3P 2DTPAR(@AY<@C8P01IT0AR8PL5-0B3
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M=B>L0B/(#R/8@B?P@3,X0B%$R3>\@A;@6#.( 4!Q0R!,;BB, BA(0QC@@36
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M:J2N$R XI[R=R9/J#!I28*B]@Y7&EA!!B/]&O*+%Z5X_,[;XA/%6,1D?6_V
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M5%+,0$$(%H$1T" 1C(L=],%QZ($/A*$?O$$>R/$>KL@=ZZ%6RO_A'<0A&H1
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M,(4F3,$'4XPB#VPHPR':80M&^"(=G_#$4P:2CD"\00]]& 4\JB$*9BS='IU
M0R<8$8UWT$*LC?"!$_S C!W69A:.R$<_EI&(+T1C%WN@0AYB48]*;(<39/ !
M(:;A?78XHP]$^$(Q\'$+9\@6&Z(P$,I@"*) #)U@!G80"OG@!\*P$GD0!Y-
M#[V@"=30"T3@!/^!@ _VL A$  5QP"57Y 1/T :1@ I6! V(0 F&H$/Y4 @&
M00S>  OT!0K X G<( [3T O-0 ^U( S/@ F), GMH ZHX SC< ^OX NTL G&
M$ J'  F_X%@VL0RKD F<L S/( OK@ Z]T%.W( K:$ O6X S*8 W=X%C]$ _<
MH J<@ OZP _=D JS0 S@(%+D$ RZP O#\ [IH VX  SBP _[X K<H [KX OT
MP _Q0 _LP S,P [*L NQ@ SLP [24 W"T Q<HBA6UHF>^(G[PPZ(@ *?< ](
MX /?L QFL _=H 2+H L/= YS@ 6<T@=>< _)( K7$ B%X$OQ$&;(< C_0X .
MM9 *% -"<H!V0K"(JH!65X +O! '=S<0Q, 'HB *FD *>T )N' %C> *AM /
MQ1 )\) ,6M +>B (J% &ZD$;WF &0U +9" )Q#!<B[0,;\ 'I% $44 ,00 =
M;O!-J& $L;!(\W 4G_ &@I .>5 &LC %T)8)AZ -0_ %CH 'S- ,@M SZ>0.
MG. $?5 $MF );[ &=< (5J0)6*!/PD &8< '=+ /A3 '_1!HT2 *20 (1  $
MK* (K2 O0R ,N@ %A$,;TH '4[ %:B .MM!+Q1(.!SD%(W )WE *1; %2M *
MJA((_= +8R /Q+ '/_ (96 -U[0.9> %M' )_\1@#6HP!7;0#/,0"+S0#^RS
M#I/ "KXT#Y"0-^-P"*5P#MP0!TH "G_6#^"0#930!XZ@#O'038Y #^%0#K$
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M8 _$< _@4 XO)5*3:0X,&@[@X WU, [ZL SY< Z=P@[FL ^^  _K, [B  ]
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M#=#@#NOPI75H#O7 #^$P#O_PT W+,$GKX WA2P_Q(%=A&K"*(@[S( Y%&BX
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M<Y%P=.((978C?OU@#F^@!G>\FZ7@#@P;#:! "D\Q#:*P"G'@?]F "=LPJ,#
M"=RRO-*P;?/ "N*P#:(P":E #](@!\9 #KJ "><R#M;P!ZLP#>4 #(@ "D)=
M#L3 #>\@L21B"_L #)\G"NY@#*YP"J30#^\ #,"@#I9@!X!P3/Q@"&%@!F!"
M&[9@#.C ")F0"9C@LCA!"_'"#8R@#^$@"/%0"6#@!=  "DAT XNP#:X@#;,0
M!HW0"8%P#NO@!YU0"'2@"/<AU__LS-827N$6?N$8[M+:4 O]L&3OH R9\ R6
MT-Z4L _(( K1, OBUPET)PF>L GLI@J:X ='T A>,0]\, 2:X ;)P F@L Y
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MD,,F_ !'X,Y1P.N%PQOH4$8ZUL8.0KH/'.^X(_G&(8YTZ...Y> :.<3ACGG
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M,0"%<& '/U .$/B$91@"*Q#_A&KP@3(8@D[@!VYX ST( ED(ASBX B>X@SZ
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M@S @"*DBAWJPAVW(!#O@0%B8!FE(!3?( C'0!4XX!$\XA#  A#3 @V. B&#
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MAI+M!VB @EPH!BX !3^ A&,P@D+X!G2L!2[0!VM8 58(W!&8!8LRAB8@!$#
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M(5Q-/[3#)<Q"+ASE)_^XP2<<EDD@PB6X%AYD@RZ @2$XER=@ Q\@8#^L0R9
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M6$,N'KD26_"!#)U8ACF @0I;UF,2/V%(-8[!,Y$,PQ-R408L@/&.7S!"#I5
MQT*:L8I.D*(=U]J#$(3 AEFPH@]$( (9,'&-1@D"&^+XQC6PT0UFO*-GPU!&
M.<RA#4L80A;XV-M(GB$,'JXD&I80!"W(BO\]J>V5KTMK9E\!&UAUS>,+7- ;
M,+90A$B,(!7F  4K%"*29?Q@#T4 @B^$P00@R.$(>UA'-+0P$D!P(1ABXT,3
M3F(57.C !-M 1Q%2( AH5,$)SC@&(D 0"4/  "RE6$$.L-&/=M2!!T?X 1,F
M80PQJ(<:6W!#/%@5RM/U0Q2/D-(VV(")2]#!$(<HQ3*LX(9"-,(:$!$)./Q
MAU6$ 0_XL(4;4EN5A2!/%7AQA"G(,@TB>$(79S!$+PC11I7L PR=T)<Y '$,
MD7R##+> Q2CLZ LU6&L;BUC(+]I #S<DX0U>R ,8B#$(*H A#Y6PHTKN<8M=
M$- 4B(#&%,2 !SK_C $=@C!,/SRQB%BD 095L((43-$/?7SB%0OY!BZ$,(4E
M;,-$S23&&,P0"3!TP1"H "@T%B'31QRA#64HQCS"4 H>4J,3VL&>*=APDGM,
M@A7CH,4KFMD.+[C"$!K4%1\ :HHK".$(7."#,A9R#E&48:[FP(,K$B$E9;"A
M%0O)!RN ,1<3^:(39 ''*?[0CD<(0SFX, 0A=.$-?L@B%G@1AA^T,P]>6"-1
MQE.',-!A2F8,0@EIX(9Y^_$-9)#"%R(9AS1V 0T5C2T8[?@&/YA1#%LZQQ;"
M"$:RFZ&B<F#V%)M@A",^\0SSE@,=J;A$(%IQLY% HQF<5,DWI$$*5##Q_QO0
M& 4DRAL.?-B#9^6@QS3F48YY2".O)!J'.#2'CW1 Y!WTF$=#W-&.=323'<BP
M1SRL0XYV'+P?^-A'JT7RCF7,HYGA\ 59[G&,822J->UP9*'LT4QP_$(:IER'
M/D+)SW=,URH=_ZOQWFJTH_VU>'OEN7QY_DB:ZW4J.!?LT:46=*0OW:\$9,09
M- B.4E !"7)0!S^&4(90+3@06@C")\BJ"R!@@0W$,T88\.(+'UB"9X9PPU&M
M@HPX?$$=Y]C$$JK1#".08B'B:,,:7@$& 4D##G1HZCTH 04J3"$)E5@&(-P#
M#E/LX3FIT*GQ"L'VA>!#%(CX0Q*0P(5'R ,/=?_(@Q :P2"5I ,6D2B$WJI1
M"5L2O5"@V 9>5%'>?MRC%]!X!BP'\0A9' 8?M2B&OLX1"CLN!!?:H,4QK'.-
M4[AQ^C^2Q3DJ3(A!7.(/]7A',;"1C!.KA!V^, P_[*$.=UQ#&]781C;, 8^\
MF@,:\>B&*]P?#2^RHQU';68Y %#H1.(9\&\;DL&M4&(D\.'@W,$5H@$OQ 8
MQ68>+D^^ K!$FJQ+(A  :4X"-7 #54(D],IX3L<#37 #OTALJ((#1; J3L=X
M/! #;0Y[,-!T7E D8C '79 %4T("?= &/[ '@7 (RV(&A6YOC$[G<([V1M %
M7_ ($[#FG#"E:@X*G[#_Z*RP">4+"ZNPYYAN:FB."HN.]KZP#+O0#-$0"\$!
M66*N'\"!'TQD'+JA&:2K!\$!'$+PV(:M'!XDU[XA)<:A,Z0P$'NP,\KA#QEB
M'+Z!$ '1!A7Q#AW$(50P'/:$$5_0$DLD$-^0'_YP'.Z0$Z?K$)N,![=0!DOD
M!@_Q&_;D!C6P!,?A!%FQ$ -1!:.0%5D0"-.H!GNP%(UP#(F.%TTG [\H!5O0
M"]-H%(M1!(_1YI1&7Y1N:L:0 W,Q 9NLZ9CFKZ3Q&8NP",FP1+:1&'>.%HMG
M!@.0"Z-F"Z7PYF[N#)6F&-F1"I5.&Y'0&,^1#)WF(80Q'-B!'7!P$7>Q',#A
M_P\!417!@1UDYQP<Y!4!L2#/X1P,,FS^#1_,H055HAS$01_(JA\>0G;X@2+3
M\".C$"314 N[, QUSFF 3AO5D1N#[N?D$1U940!W+AUA4@!_#A[1<1RUD")M
MS@.-A@:Y42=QC@.ED2%^$!>S,!:[\0-S\"AM\!O8X4&$T =[<$]^D!,Y$!,!
M\ARL\A#?X2#%YB$>1"P=XAW,(6QJ$ #YX1VZ\AO,DAS@$!S,TAS( 2+?X2[O
M\@YEYRZCDA^X$@#%Y [Q\BR/#1S$1B[%!'?NLB/EB!V\H1[<P3#/P1OT01_F
MX1VD$@#!@1S,X17=TASVY#/)X1T,<QSHTC E<#/G8?\>R.$A*+,>YB$R4X(?
MQ*$>;),U_7(VS8$?R&$>;C-W>O <0#,<:'/F^$$?[D']OL$<U"$=[N$>Z.$<
MYL$Y[T$>9HY$OD$<X.$>]&$1W6$[[P$>W $(Q>$YG],;QL$=S#,=Y($?O $/
MN\0;\.$<PN$=Y,$\U:$>\&$[TT$==O,^PU-/2 0<ZN$YX:$>Z/,;TJ$:9.$7
M\BT<O$$8<"$4QFH>D"$>5 0=EJ$=MH$;Y (<F.$:?H$6&(,74,$7,"L=4B(?
MC@$;/$$55*$6G"$=@@$6&*$7VD$JP\$=DD$0$J$7XN$;T,$3:J$4=H$8S$L>
M13*PE'1) 6LGATXII71*J;3_2JWT2K$T2[7T2H]R2Y6R2^7(*4G12U%13,&T
M'] A&<QI*GV2'[!&%Z5!+DQ$'=Q*)?@!&;#A'GKP'G;!%F+A%-("'QQT(>AA
M&(H&'K9!%]Q#%\<!':I!(<1F':Q!%G#AJ."!&V+!%CQA??#!%6P!%6*!+^*!
M&U#A4XU!'+K!&M3!1*#!&C)G&SZU%9)!'9HA'ARD';(!&9P!5&W!%J"!DW+M
M%SH!#5)!'\:A&/Q #^8@$KBA LN!;%#!CNJA&K#A9M2A&F(!%ZK!K<3A%&KA
M'H+1'D0!#="@%]8A'CH!#+X #5X!0<IA&11A#OA #]R %*9!&WAH&7BA&68!
M#?1 _P\BP16 B1VX(13<:AHXH8B000Q 8 M@ 1]XX0E80 0\8 J<00YXX 1(
M0 FVX3#DH1"D  3B@![8P110  = P H^H=7Z 1$\  1 P ,<@1Q,@01.0 1R
MH B>X1)ZHRHR80B<H1]VH0M$X 1T( K*H Y6X 1"0 MD 1J4  1T8 5DCR%\
M@0]N0 =VH _0B!CXH A^H U8 7=NH0B:@ S"0!N,81-.@6<^(1(X80S>X!KZ
MP1L$80\NH0ZH@ T4 QMZ(0Q( 2]0@1 NX0ZZ  C> !9: 0_D8!,$R3 R+A3(
MP C"8 P8X1YLH0C>0 _"@!(@MTF=U.="MPS+ 6S6,G=4\?^+#/-T21,E9 <T
M-7(O^9%JHD$8R&H<Q"0OC><=DB$5?@$OY($:FJ$67&'8<% 8^(L;[&@=KH$7
M<($7A $>CJ$4<*$6@,$;=,$3/*$57&085$_AQ*$:>*$4DH&95$(<K$&B1F(8
MF,%$RL$8UB$;X"X<BB$9YFH<F(%Z0^$4Z&$<VJ&4G(,4OF -CB\?1.$9=D07
MKD$/P* /X. 2\J$>_J ,\  :W/$5GD$=8D$>ILIXDJ$3YHO-U($0S.D67($9
M%B$,YD --*0;,@$,Z( - F$9; $,Y@ ,\ !)&D(.2" $C  +8N 4VF0AAF&@
MAB$1VH$>TD!JB: 9BI$<[@ '0H#_"H*V$T"XAS(!T'S!"RQAHK0 C3"B%]P!
M&>I !SQ ! "!':(!"7"@AXN -1;"%Y@ '2+A"M:G'XR@T40B&7Z@!G2@!HA
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M,8DEB.(-@<A#):CQB%K$8Q-@(!Y,3!%F7^"""*Z@A1Q:@0YLO*$5I?#6].C
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MF=:0#<K #N: #^3@-14%#^J #MTP#,)@#.B@#_5P#G]9#_/P#9"A#_P =/-
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MH]F "4TS7.#@"6E#0H)0"_0@".90#K* !FV0"*D0#_ P":S2#[=P"#\1#)S
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M#N20&85-#@0L2RN;5NC0V/)@#O40#XP-Q9!A#XR=#ID-#X>MFE$,.NCPVOJ
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MO$E!!QA@$(OVV($!F5#=(-*0CXEX8Q=O/&).J)&'$=AB06O0P2GZ_S$/->
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M2;"$2P ,.["#,EB;3OB"?E %(O"5L\DJ1E0$7E $=.B'2H@"4P@'5_@!_R?
MA5.0 E$(!43@!78(A1\8 U+A TLH!D)8Q$W0@WD AB, !'X(!B6@@VD(!BO
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M (8THI)S_+W@<X=)" 2-"(96NH5PRPYQ4 5.@ >'.(=9D ,1T04]4!UC\ +
MZ4%/8)Q$$ 1;. 1E**T[6(9?* 3)$0S*$84<$87E.P35B4QPV(9'T A!<@5D
MJ 1\> AH (0&W(E=<(+_<7@'4-@#/C@Q;9B#:  3<YB&'Z"Y:J"#5NB&3]"&
M>G"'=_"&4KB$9T"'1L #:MA$A\"%/OB#0JB%?GB&.G "61@QP<B3+P@%:3"%
M/<B%44B$6E &;8@$46"M:)B'3Q "2* %3; %>0"$+: $4M@$4LB&!<N'44B#
M7L &1Y #(S*&1("A? "$3. &1^@#4O $1[@$;# $/D@'>HB$(P"%$=M#/0V'
M<9@'>_@W/0W4ZA"&35C$4U@"=!B$4E""7,B&-%"&+AB6?O@$.=@$/N@$>G2%
M=W $)V"$(1"#8QBT3V,"1;"%(%"@/:@%9_ !:H"%.>B'=X %$L@([( '*RB#
M_S\P@FCH!U%X!$Q@!EA8@D@(!5?H 4W(@RA@ W/P!$"P!CAHAD8XA6[0A)SI
M!U+P WE(AC0@A&,P!C#0A&F@AA6  S:P@S_0AT50!5,0&448QR_P@TK[CG04
M!70 @FYHOVI8@V"8!U)(@Q\@ U18$DZ( X[+@R'( QB8@GSXAE<HA>\A!BZ(
MA79XA3T(!&*P!3F0!(?\@4M@ S>(!GA(!%OPA#/XA2/P$X^4/^%$PY$<$318
MABE(28=X!TIHA$@ KG#X!GK8!SX  X?PA8IMAS1(!;X$!$A8@WA @U68*UGP
MAEP8A&&(!#*0A$IH2B&0MG'H@E!UB#HP!6PH@TG(A/\ST(:L<H=%( ) & (M
MF 8T" 1VN =/J(-+4(6RK(9(,(6400-:6 9IN(=]D )$:(9E\*E.& 0J (I&
M:"](\(']@ =Q* 8^B 9RL 0I^(*&. 4TV#R0S 48"(1^F 8G: -FL(=/L(7O
MX88BR 9P,(1L"(4XX 1?H(9'D(17\(-KT A7  ,O^HYZF --$(4^, -;$(5.
M0(0T& 6!$"U! (Q@4(-=\+_ Z 9("%M B(=Z. 0?2(7%L22T8TIQ*(1%$ B"
M^ 1!F .S6054.-"'6 <0,[=OV(8O< 1(F -!:(A?< )1* =QF(0U^(-(& -6
MD 5'4"%@Z(-!L 4[F(17, 7_:_J.;\@&.@ $3G "2;@%)WB$3Y@$;+B:;["%
M+ B$42@#35 '[CO 26"%G6F"2D"$9) %(1"18M""1S@Q6F ")YB#/B $55B"
M37@,3N"#[R2#,K #0N &4!""/= $-B %J,NP2<"$63"'=6"$'\ %E76(=KB$
M.9 #,9 $8E &14@#0. #25B&8!B)<>@&2OB$;+ $;BB';>@#1N@%-/ !)R"#
M19 &8R"$.AB#1Z"%*F&&1@B>>]@$1:@'8V"$S$N$8]"'7E@$> @';J"$5K@N
M0=7#<0".[[ED02T&0W@&A["%,FB'3! &6W ";) #2/4320"$45@$3] /;Y '
M2O""_T88@DL0U7"0A2V( S](@D<@AS*HVDP8A$1( X<PAB6@S^L(AU(0@C.@
M@RH@A6\ A5N0!$=0A#5(A%*(!2%HAWW8!W5 #D"HATU8LG1 AT0 Y7[P7\-Q
MA$;H@UV@H&E(!B*H#GZ@A%F@!_JEA*GLAW>%R:R:5W1@@GWX!2%(!#G AE 0
MD'$H@S@0D(%U"&1P@[!@!20(AG&H!!KM!WM  EMH!T7XA$4(@U00A4&XAD#
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M/R"&=4 '_W<(!CLX&UL8@V'Y#G?( SIHC57(@FLH T3HAU_H QEP@V0>@D[
M#GZ(!$[XA6F8!'79A%90!"NP!%V8@UR(A1%0N7V(!WP@!3<0AWQ8 A4@!G28
M@U+@##B@3U/HA5.X 4'0!3Y AF38 F;P!6AH!W=(!%!@!V<P@R(0F'X @UP.
M!W; !W'X',-YA7;8 A5B!"GX@6N  T+0TDA(!-6Q!#)8H3L@6W)@ R*0AE)
M@U"PAE<8@V&0!DA(AD;0@51P!3D0G3Q8JVT(!D'4A7)X!BWX '8N FD\"66
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M.L&E__KA&LB #/+ "Z[!%_B@">C@$4I!%_  #M)@%5A!$+:!MJ9A$, 7#,
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MB,6'F$*'+KA!$S]00BOH, 5-R,$0RT#&'231"4W8@8%/T(,F$@$*=Z !%:U
M1")B$:!N5 ((K!L&&H[1#WCT00R)B$0>[C":)=E%'C\8A2WRL ]^O&(-;LA#
M-^2@I2G(@RG74 /K/I4-01CC8M\0!"P*F0M93,,>7I #'<@@![ATP?\'ET@$
M(LR1"13@@1")T)\T[M &-8AB'M5I"C_RT(N24(,,9V $(YKP!7C4 Q*5P,41
M%,6<452"(8=:!"1.Q:![2((3F1B#,4C!BMSIP@J)T)8CP=&+,MPA#-6 1Q<R
M81)K!((5<NC&=0IQ!2.000@X<$8R\?&(T" A%-UP@_^@IJE$L (]T7A$+0A!
MR*:@8A&Y((0H"F$'571A)_KX B_DE0U+E (.93""%-#$I&WP 1K+<,<W1D$%
M??A"I5-"Q&C.@8=1<$,2"NW'-F3A"3:0QAN.  9I1/&'=/2#%GIH12$6@8R8
MQ&,68EA#,;::C'9P PV*L,=RHA$(-E1/%S__X ,ZBM&'37A"$23K!SA880KJ
M],-K34D&+(1!CENXP1*=D*I)^/&U;<DB%9G*ABF\ 0],*&(:L?C#1F\QCG60
MHQZ>: 0R]I&*13!#@]+P@RKLX0H[Z.(6IHB'.,BA#S\L8B?">(0B? &,02SB
M&&>8U"W6, QAZ,(7YO"&.<K1E&GHH0^MT,4JRA )QS1E'(.9AC3X8(I\ ((/
MUPA&);X0#5_(81#7X$492 &-(_@/&G#X S[Z,8U$R*(N4JJ$%ZR!CF/P00W<
M&,0RRJ$+(#@"'93@@R=0L89,#..(_=#'*#9!#V7HX0B<L,4@,.&*4S@"$L\H
MQS+L0(@&R2\/B[@%_R-N@0T]\*$7K-@%*4!Q6K/((A'8S$0AM)$+3WQV%;J*
MA!=F00I4M.,@XS@%(()ADGQ(,S$;#*&4ITSE*E^G&'\@1JW0T0=:'(0?M-/'
M'TIA!E7 8A:;F$0OTF *3N1B&&^0!",Z$8UI9$&>?SV((2 Q&B9*(A*N:@HK
M\D -/.0C$8V(V1:1: 8]R,$(8J0#%^20!DE 0XV2" ,.!M$/>DBA#W)PPRC6
MD8M=]*$7SEA%&ACACC\ LA^")*0AQ^ &/(R!D<ELBBY6<"\L?"(<L%@%,>9P
M"34D8QF>-$DP^*#E3_F!#*IXPQGB\0= ]",=A5!#'^(!!S2X@0R".(@0Y/_
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MB3<\@0=)$$)@PYS4,@CQB6U @A&(V$0UNI2-0^2U'*?@!<RP'.6P#9I ")<
M"/XC#)"0"'(0<>SP#KPP!X8P9_* #YH0)K9B"<'P#?D@"L50%]Y3"K:P-]8@
M"=5P"^]A#J]0"O0 "HE@"), ":C@&)I""W92@(3@"O*@#8A@"8V0-!^"#ZO
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M)L#@"NGP"\-P#N' #+8@#WPS"H\ "*A0#R+X#;N0"Y-"#ZYP#.Q@#Y[P"]2
M"7QP!YJ0#6S%!WK@!\FP1?"0"XLP"=4P#^H "FE !Q$7#P5Q$-_ #+]0$O%
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M" $H[%#%&M;1#VUPX0R21 85S" (0DRA# SQQ1#(4+UZ/(()O^A'/9+0#%
M0@5"2$0M\+$*(W1"%F>HPSQP08)$0$(33?@#/>CP"&Y@(@Q.,I4J4$ '?9D#
M%F1H12O>P 9[T.$(BPB$&= @CT%LHA:6@ 0Z9%&'1T "$M8@CSF<<0HT* $7
MR7#'$8!A%$I@HQ_#2,019N<.:J#B"S[@1C)2)QYW".,:;UC#+N[!"4Y :!MT
M8(4C[- -80S#'K_P C+.(8A/B*-8H?!#/GX1AB/$XAA?P$8OQL:(53 L&IF
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MG5P ATBH!G-PAP*9!>61.G8X)(8[!US@!*!% FUDDTQP!DPP@UF(+R_0Q'X
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M!D9PA%5X!41HAUB @T  A4IHA85#I'.0A7SFD"XP1G&1!$@(@U?(#W> !$H
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M5Y!Z(K_8&AE%(B<$,9[-P-ZU_<G(I[X ^SE]&?:NV6S^!@?58 W6_J_8>&T
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M[B ;C  4**(0#N$6E" 0FL$8B&'X^H$9JJ :XL$9WH 0'.L7W$ *3J'QV.
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M*U\7K2RN[ !A#Z2A'Y2!"E;!%2B!55<##O%!$L1@#?YC';A@%BBB$TC!&>)
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MSF *L  ,$B,D\[ -_Y^@!FH #,V "7Q0">@@#[F0!H.0#.V@"Y>@!YBP"FN
M"<C9"W20"-M #]E "7!P!Z,@;2V##)T0!GR@"O'@"IT0"9K@"KQYB8/3#;EP
M&.R@#9X 2OT "^.4"8F ",<0#7\I$L5@"BPG$MTP!%B@!9+@#K6@",XW?[=C
M=\-@"M!P>N: "$P !5K !76P#R&8;W97(DX@"L%(;UDT.J=WHM@H).<0";G
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M#4,#>7%Y@(XG$KUP!W,P#+@GBB.1#UIA#MT #^BRG;Y0&// #M2 #N#P"\?
MJ(>J#?]Q#O= #MN0#>-@#U'P!0PF).I #M(0"\L #;$@%.L #+00#19#H=\@
M#<(F$I(@!*90#:_I#K%@"+K L>C2#(;0"/'P#<PP#>. #ZV@#_FP"7XP#(5A
M#9K "??@"[3 #N0P#<SP"D@0"_R@#8[ "=MR#X60"5T !DZJ#Y'P Y0 "_.
M#)^ -<5@"T.Z#57@!/ @"Y>@":<@,=60"), #^F@"(F "<<A".+0"Y1 ")6
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M=9@-G? +_$ ,;@ '@P +]" ,_Z( #KE0!&,@#"A1#E)]1OV #?"0"U.@!4!
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MQ8 (CB )C\#,G: *I) ,[S#/2ZT/_Z2 M X6)9\@#;( VENW;H-C#92P#_*
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M>GC_AW(P!V^H/**IAWQP!\USAW*H/;PA!W2 !SIDQW.0!WV8$'YX!\4+AW&
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M@QY #]/< QA< 3?T@S"L@47+)^ V"SK,02W8PTZ"!!G$ C00PGY%+].Z\[=
M R!HPVS80S!/;#T0PB[ CST  SVHB3D6QCIX(CA0@XS:I#,@P[/P0S>H<T-1
M0S3X@MG.QCU8 S*DY.\)@SCT@S=T0S( @SS(1CM$0ROP02P00S:X A%DPC(
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M'/:!&9K!'M8!'8SA%TAA$5J!&UIA&>;A&8!A&4+W'F+Q9.D&$= @_QJHP1[
MH1ZHH1BF81[>(1^,P1C@P1Z$P1C201]Z00]B81V6(1F,X75GG-'7GNUY&](?
M_<QA7-+AOM+K/GS9P1G*(OC @1.*U^V/'3K4(6'^VJ$E RJ9W6?6@1>J!KK5
M$FD$_1N>Z6'&(174@!D^[,/*FG9UY<LX%QR8_!WT8!N*U1K*81-*H6B\P7>_
M@<D1MS#>@0]"86R=UG?'@=XG=$Y:_QR^H>7+P1SHUAW"MJLYMA_XH1V:(3/?
M81V \X=\X1%& 9G[V1ZNT1(&MEZ7OQKBH!K206[/03DQ0AZD 4_2@14(!!W@
M_,C3@1B>@1GMH1M2^!R681KX@!-8TB9Z^?\96%(<B $9K'H=F $@;(4QUZ]<
MN'[RIN'B\ZM?OF#V^J$B9(U7H5C&Q@T3!2W5)$Z>YGF:5(A;K$^->JECQHE3
MF3C4QO7[ANL'($NPH(DZ-8_:K&GE^O7[Q0D6I%384N%ZA2F?4'R1YJB"L^?0
M(5SM3B%2] ?5.J'GL T*]*K5OFZS6)D250U3FD"/ZA1Z!<D3J4Z"1F5+-DI1
M+VWNA+I#5">0GT_,L!GB],I6MU6)#-4")0C1IVV*FB#:):F3(5/M#(8;3;JT
MZ=.H4ZM>S;JUZ]5"8\N>W>\T[=NN;^O>S7NV[=[ @PL?3KRX<>/GF GSA8\3
MG6+=YA6<)@S9-W+_T(05N]=OW#)@T7SU<Q=,6+I^[+H5JP9&7NU^[Z+5LO:.
MG31LP,B-=G>L5BM?]\3A!"O.@-//,[J4,@PXSWC"337GY4,+*I65PTPMI0@S
MSCVNQ(*--_V<4XPKPKS3CS"L_!')-;61U@\XQ:!2#33G\'(>->J\(\PVJ(3F
M#"NG3-./+Z!L<XPO]8#!A#$'C?,*$'Z0,@T]H0CI2S;X"&5,+N- 4XDOY"0#
M#2J6@/),)]V44L4@R80!QC[VJ%*)*<5\\XL@A7Q2BXD'G?.',-U4TLLLI>BC
MSC:>C&(-,U[<D<PMA9RBC"'CL-/*-,-8,DLNM>#2"BGY>,.*():D D\[_Y9T
MP@@L]ECC@QONM7@0*H=L\L8@P? 233^VB (,'Z  PLP[J)3"3VWJ<(*)(</X
M@@T\UTRB2!FRV#.('Y984@\RC(ARRS/@K"*()%0@0DYMZ\#2R":PZ,,-'K!T
MLDLZEJPBB0\$C=8.(J)D$H<OUFP2RBS$X ((-Y,$\LDF]4S22"%ZV&+*&\P4
M HLUD.B1"RAYR,)+)_' DH<Q07VCRQC5&),)+:($,@TFAS!SD$26M!))&:.
MTHHIFSC5SSJCO/(+'X]8T\LKNA"RR"Y_&"+S>+W(<8HVF=SBRBRD0.*&(FH
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MX. .7\$/\\ /!\$.^J /WQ .YG .,G$.]3 /HTL.\B /WI"\0L$.]?^ #_K
M#N/P#)-@",UP$"+'#]ZP#N;@#N3 #NSP#N:0O"PJ#L![#N7P#>S 2<(K#D%Q
M$.;P"GVP#>P0%.6 ON-P#N? #OQ@$./ #^;P#D%!K-UQ#FY)&N.0O)42<GU*
MO.4 #J(A%.*KC5'FP9,:PB(\PB1L.>N@"G+ "O20#;+0#_  ">20#WX ";K
M"M>P#?30#]< #<N0"ZUP!G+ ?J_@" /$#[3@!\@0"_F"3\Z@"_E1CL\C<N]
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MA#HHAVFX 4?PA"X0 UV0/E=X SY@A"&8MD@8$UVP@U;H 4&HA">  W0H@[@
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M8(92> ;7P :J, 0G"P9:4 1U$(=0$(1)>(QA4(1 < 96"(17:)ZY*8=\2(5
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M@WOHAY'*!V"0 YO\@FM FS.@A(CP"$\X U%H!EV@@E3@ T" Q$/(!2RPG2B
MP"\8!WF @FW(@U% !2<0!$7P@LY4@U_@C'28!%HX!2KHAV=8 5WP9VJP@G/<
MASK(!&O@ U[ !CQ8AGD(!$L8AUR@A(L  V<(A%M @SR@E'X@AS@0@V$@AF/
M-$LP@LK) S4%A'" !I9T!4>(A7P  T&8.5> A2XXA7,XA$_HAU5P@F%H@ER0
M!4"P!G7H R*-!$VXABN0 WEP$U1P U# 'T1 @D$HP6M !BEP!W90@U0 !A^P
M!$0@@TOXA!W@($/Y UGH!U!8 O]TN -,D 0QH(:$_08S& -4N*U^N 1=F 8^
MD -)^ );Z+-N2 -,( 0\@(8<?(=DN(-FL(4V  4?,(7U[(=\N"Q#< 2!] A]
M6(-+6 5.@,-.& 1-P )N2(5&X(=G& 1&,(27F5U3\ -1F 8B6 =^D(-TZ(<S
MN 50R(1"Q 5B" -#Z >D  =:( 7PD8AG*(1*F 5T" =[B 50$(5B.(=]2 5L
MR(=8J 9VN 95((=R4 ;=985F>(=\>!A=( 9^0 8QLX=KX(XI 09>R(9KJ(=O
M: =CH =BV 56N 9U ([TU8-2 (9F\ 9E. 5/L(5HL%%?.)UG. E?\ 9\0(9H
M, 9\< ?_7S@&:T &Q23K>)@'<+ '># '92B&8=@'<K@'9K (?#"&2DT'<VB&
M8K"'>'"&8O %<2B'<@@'<,@':PB&=JCJ?$B&8< '/@J'<R &84B'>RB&8U &
M=P!T>[&'7U '*?^&OS3S-4^'84E)>?B%:OB%$O_F95B&>W"'9B"&8(@'?=@#
M30AM7Y@&9<"';Q"'>\ '>3B';X"'93@'0!^'=O!-?="'TO"&=9@'>I '>/!U
M=I"'>2 '?%@'<I '>: '<R@':N>CX/ &;\"A,K]G>-"'=S@':0D'?J@'>-CV
M<C@'?+B'>F"';T!WO2H';%('?7 '<E@'=@ '<S@'=O &?;!V_UA9]W7P!G=X
MAW'X!H$'ARN?!W88!W0/!QQ"=HL0Z(WG>&(\AC'0!G* A3A0A$B@!GYX@T=#
M%N!.A&-Q!49(!V-@A&0H!4G8A3X(A#0@C3ZK!#M @R' !%_  T[H!UKH!%2@
MA#7P@SNXA7@XA'&H!['&A$>XA"BH!'O8A$0( T+0I/#)A6(HAG6$AB&(!G]N
MZD=DQTF0 V<(!D-0!G,@A5XHAVNPDGI0A&68@S1XA%((975(@_KTB&UHA%W
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M.^7D:88TS T^:L$-C#JH+Q[1QV5>$QF\G*-Q;'''9=CRCGH$-1SSL$]:S'%
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M^ (UB*$&3X!#%Y-8A""(00@_/.(5[B %&C[1B59T*3C4T(0C_L");I2""T=
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M N$U QKD@2E,21SL "2< AZ,0BV>PQF8P1IH@AG$ 1BD02$0PAQTW!M @B5
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MNY?VZZ>!'6PLAUK8Q98SL<.,WEJW#],C84<G?TQE:ZZC.S &!SG L6HMYS7
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M';#A%_J # Z!#F1A']9@F %!&1BY$0C!%.)A1S^!#41!&A:!%$S!%"*.'8)
M&*+A# PA%!J!^I)J&/K %2(C%@:A$O1@%/2A#^# AQ-!$.8@#00A#2SA&"A!
M#3!A$:#A?)A!#&1A%1:A.R3A$A !#0[!&=[ #&S!%-9@% *AEH,A$D!!$.C
M&02A"1H!#^P $QHA#7QA%1C!%!*!%9:!#88 %-@ %J;A#29!>[3OAE>!"4Z!
M%LB #4Z!$/Y %,*@M48"'F89$[R %(KA"TCA#_ @'A9A#"XA%A8!%EBZ'M:
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M1B$.XA4<;B$+)L$:KJ 33D$)/D$5NJ 0L*$31($2-F$4_Y0 ';!!$(QA$HY
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MC4HUC$__I7#]^M5S-.B>I5']ADG*-6=1,UZR3-TAUG'<-3ND(,X*E V4JW6
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M.O&)2=S!"--(A">$H0<WA&(-W !'&<# C&=PXQF2H (QCC&*:%Q"#?PXQQT
MEX59O*$3T+"%,XSQB%ST8Q-=B 8@/G&.CO\0 P2@.,807B$+2]PC'V4P!35N
ML8V'] ,=A8@%/^3 !%3$X1K7X,4\Y#"+<_0"#J$@XSCL< 1/>.&'N>!!'P#'
MD67HP1Y]L$,]L(&"8:!!$K@@ R'FX 9<%*(4\@!%*,XA"2DDPA&F@ <P.H&)
M0?P!'I0H"S8"\8=5."(6Z, $++9Q"$%\HA?J8$8C!F$)/OQB9+$H!C94@8YY
M> (5S?A#(*[1BD)(0A#:6$='P(&+/XR"$:L@126248]L;",9N4C%'QKAN7Z
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M@"?:70"B'NY8@Q]RL0AL) ,/@/!#'B8AB%Q4HPNFZ 0?KB$),TQC$;I@!21
M(8E!G+@?@VC",')QAU4,0@[*Z\<Z+,&&4VP:'-'X!"V,< U1K/4,ETA61[81
MAT@<XA&$( 8B1*&^3+ "#8BX11&*<0D\G! ,I2B%('HA!D0XPTR+0$-$.<*/
M-LP"%YE@AA-C$<QD0 */Y@@%&AJQ!D3<HPP<E$4LR$&,5*#C'C$2120PT1X?
MY>(1XS4F&Z[!BE2P @Z V 8G?M&/:N#A$IIPQ/\]I*$'0N !#\@@!2S P8Y
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M!:O ./<P!)F@"EAB#>)0")B@#9( "\"P!EX0"[$0!*; "Z,@.W^0" *)#JA
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MT(TMG&(>88A"(ESQ#O)P_V,0?!"!*!0!A'NX(@VB0$,TW#&)2X"C)NM 0B_
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M PG!H(8:3IN8> Q"%S5!(B[0H(UQ[&(*W)!#+, !##GP5 ^>&(<V!N&+7JR
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M(0@7;&(18LB&)2XQ#D\005E<Z04;5@&()OQB$'DPQ0\H(0T\1((4<G#&*Y8
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M)5P",\ %*]S"(-A!.W3#*)0")"3"*[C!(?24/)"#'QS"&V3#.)!")0A"_QU
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M*SI,S-&L@20<@XO10R^X 1J@ 28$PRKX 3U,0R@DPRK0 23X028$0VFX RP
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M*$'T04(N(,,7? )!.8,NM $OA,+_''3#)4!N*8R"+, !+;3"$M!"-S@)*.R
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MMQ5T.JP@V/^!' K#/'PH(F;++;Z!6+]!+-#5CVRH'PY#;LY#*]1U+M@A%KP
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M!6R@#(K0 G"P")F "PMH!'80 FA0=>7@""? !EB  L(3"2% "+E@"L @#V"
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M TWP"\^R I:7!:=P"MTP#]L !7'P%.4P!R P!4KP I(0#I$P!O+@#9:0 W"
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M"RA0 K>0#UEP!:'@"GE  IY0#DEB"2E0"F(F!&0P#^10!CB@"(*@!;P0!U-
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MAR+"G\F<A ]H 30 ABK AG)(!Q2  V\HAT%P@F- 6G:8!2:X!7W(!25XH1R
MA'MPLGM(DE) !5&8!XLB EEPJ8%QA"J@!7G8!!2XAG!X!16  R>P$Y/E@D)
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MUUVX+R$)A3.8O$'( TRX!D= ;$HP@Q_ A$%@@YZ6 S 0A47P 4G8!52(AE"
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MF9;IMYDIFJ9IO$RIFK9IC[*IF\8IC<*IG/_6Z8K2J9WF*8GBJ9[V*8?R:;G
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MP0(<D,$9!) P/ (RA .A<(-#C0(;3 -8[(,<P  )W,$^J ,DL$$=# $8_()
MO,,>!($20,$)D (>P( 0=($.'$(_T,(1E(TFM -T) -0#($N@((0D,(XT((/
M1$,_P )V3 $:K)X11(*L88,0* $3Q $Q]$,[L$$2, $7O (_^,$8],(7_VR!
M$2S!'M#"/NA!%W#!&%2461R#&?2 %?C -?1#,<#!$XP %&#".6##" B!&10!
M&U##&Q[!$B#!GMP#']R #NA 'Z2#-[A!%#3!$@!!)Q!%,UCEOXK#'1B!"H@
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MPSW@@R[L@CFHMAJ,^#D$@2,(1RB4 BY$@1H(A"QP02V@ @MHPB!4 2[T0RO
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M!UR"R?67_]^;<<Y9YYUY[KFZC&\N6>BAB2[::*'[(28-%$1 H0<0MBADFW3
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M#"AA%3QA&WY!&1*%%L_!'*KFB;+'7YDQ%I.TF'A5\:0(0.;A&:KA%AC!#?3
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M"7R@$&H2$5" G8>A"V+A>(CN=$U9&T5S?M&VZSS7Z&26CNDV[DZH2?OA*DJ
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M4<,44+&.<GS#&YHXP"?"\0<LW*-SY3A'.=P8CGGP VGLJ,<\-L*[R/4D%P'
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M&WS!$6L(/G '<T &FS /(]$*=2"JDSB)UO\P![I P!ZQ#V= ?B71$]/P!D)
M!#Z@#=%+PREQ"-70#WZP"G0D$A8,F!C,P4FLQ$NL:Q';#XK@!3U@ F_P"?*
M#OLK0=)P"MW@#ISP!,A@#?6J#,VP#=RPK/5@#;A00K2@!*30#\8@"\[ /_JP
M%\( #1_9#.60#*T #>%0#\<0"ZS9$>+@!U@ "W]0!YR 0MR "I_H#L!@"Z6:
M#+% "^K0#_40#;)P#.1P#M1 &?:0QM6P#L4  VF@#H: 6-,@"Z[@?LW@"K&P
M#?%@Q'^)Q$QLR[>,RP44IE_0!Z"Y#8XP"(, #<_@!4K !J4P"E4@"7D "=Z
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M#-DP"I'  \W7$_7@!S_@"JP !)3P#$&0!MB@!8)P"B-P"OTP"D[ "Y?0!*!
M!U]0#&#0!\A0!X$@#FAP J  S>E !83 #CZ0"($ !ZVPS+7P!FK0#WA@!@4.
MYW$NYQR\"7[@?IX !E]@!]=@#610!S\ "[U0!X\\!,HP"9NP#GX !]. "$3@
M!&K #+]P![+ #4N@!&2@"Q9(!4%P XYP"DX@#:7P!N;7#N^<!V'@"M(+#W*@
M B.0!\@ #JS0!&3P!:SH!/-L"E2@!$W ">!@#7"@T-40#VI0"=\@"Z E!GQ
M#W)0!_&0!BF"!D>P!+/_H YXX <WR =SKNW;SNT26PUU)D'0L N?. [M@ W
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MAFPX!7W8AV$P!UU A&(0"/>S#V! !6_X!4]0AWZP!D40!5[(AY99!F' !WI
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M>-&%:JB&4Z@%7:"[7=@&_U30!6UH!GLX!EZX26UHA5(0!5) !6U0EU 8E4_
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M7[ %8!B(=D"%CMN&>J"%>/ %89#>PF&&I/1=DS[IGK#2E3A>ENY2XSU>W8K
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FP@U#7-7#$5-<L<478YRQQAMSW+'''X,<LL@CDURRR2>CS&E  #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex10-32_img003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-32_img003.gif
M1TE&.#=A, ,@!'<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MWB"7#B*-)3  #:R@!2UN\0Q]#&( (; $*_*>"E9HKPD-N(,N\K[W9/QC%!F
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M 4/@5@@A#"E0 JZ0$-<@?6XP@2J ?=HW! S0!GJX$/*@"1/ !:&($-O0 RT
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M1F"=_Z * 9 #,= $7X4#&P8/_^ )/J $M/4/I*!=E1 )C* /I. """!H%=
M%G  B. /NW@&,/  $+ "-G 'PO!3%M$/D' #"?  #S  2$ -!V$/^50 *(
M#Y $KR .[5 ))A #N= .XO )4#<)U* '/3 #@! .[F +4= #9Z ,LY %*^ "
M6. '6- #7( +[/^P#%.04"I0!D3@ S_@"21D%/I@"T.  @NE#MM0!SWP "$
M!'20!2>@!7(4"S$0 $' "9UP! 2  $$0#_3 #,ZP#.90#^H /-D !S3@ C10
M"/4 FEHBFJ:X8ZBX!!&P!&1 !G]0".;0B@2@ VO !VYP!WB 6O\ !1 P!4&0
M!$>0!%+ "__P#G<@ !:  $;@!XQ .AM#"!KV#/X@!!6P!_<X#$MP W(@ PE0
M!,@ "SR  '+6>MGY.(.P 3S0" QQ#0;  [X / CQ"2+0 J0 ..L9 NWY#]N
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MK>,T&EH +- %?E '=! $)O  2OL/IB ".6 +]I *&WD$CJ<*"< "8^ ,C_
M.1 (SK*Y/? +"*$*FO\@!C:  4P0#-"@!#[@!BJE$..P#=1P#.> #NM0"VTX
M!:Z 1Q61#G^0 UG@"N6 #X_  R'@"-#PM3LP"^C0#J9  S]P"NZ@""&  H\@
M#_D@"2YP Y80#;MP R3P"65YECJ "<,@"]<5!$4%#IN@ UEP"\YP!0?0!=/P
M#[@V BGPG?]P#6H0 @_P!:7P4]_P<B% "2J5#EN@ $"@7N0P#9QP":5 "#/@
MC>00#4-P9!4P 'Q #/J0#J)L#$%P 67PH.SK).X+OS-8)*;9 %> "(@0"+U@
M#ZTX .EK"Z) "ZV0# CB!!,P":F@"J1 "K?PH GQ#J)P"<I: ]H +ZD@ S;_
M-@F&  4'  %]4$38$  @X OT4 <)< / O *CT,(%^RV%8 $B8 HG.*VKD$J#
MH ,V0%L_C+%!+'UH8 [@D _70 ()-8\5H 7/8 _]T _IP _C0 ^:$ $[4 JC
MP 0#8 -BZR[]< 4;( 1]^0_F@ N_P _NX'\N$ CID _@\ HX, "$0 ]!/0 \
M< 1U8 4W  $AX-2J (&04*Y!\ !1  MX1 HO@ %[$)0KE08*P 30@ Q;< *2
MX+<) 0M:D ;*D!"+T )4  L=2!'!8 <K$ >.)PZ+, (]  G5X 8M$ 45^P_-
MP 0_8 KTT LO@ "30 _U('PP< KV, O!I+3E$ HP_Z #FK .L= %*P %DV0/
ME> #1L *P5 '!E %UDD/@L #)/"=\5 )(K "3O *HOP/\T &/7 "E# _Z_#.
M7L -YF -U4!"X[ +XT4&Z. /O> )F( )FR *H. &9U"-S$"O6U"A'=0D#7VL
MI9FL&M )J;F:_;@03M !];40Z9 +D* +"2$,(" "L'"),X,'OS8!'O !&Q
M&( $?00,/@ "<K8,.V  ,- "+- *USD!K) 0Z( )&T #GZD0V0 "*R &"T$'
M&! $?735&;L-TM<'"4$/\4BR$X &PXJ/^I@%H:@+)=D$"CTT8\  7Z"-"#$*
M,CH*XN!_-< ("=$-%$D(XO]P#%^@ !G  1\  "50!0K0!NX$@95 %ZD0!05@
M!+1E#U8@ #@@",<0#<L@"-AI!,7 #&M0 W'@"\*@"JK "LW@#\^P!#WP!DV$
M#7$@ $R #6TT$?T@!CE@!(=0#-2 !SN7"]J "2P@ IIP#,M <2 08MC@! 80
M!+ 0"UJP DS "N+0#4)@ E;P"L"0!SRP [W #LB !RV@ IK0#;. !#H0!\,
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MGSI<4U90D:)C!*9M_\3I&F)"!!,:#Z;(<E?N&1T6)J; >$!B43IG02(($'
MP0D552;AX]?)Q@,834*T*-/MGS<_ Q+<P+$ 1"6!_XP>+9=.$XX$(F"L:(&G
MF-%R58]>Q9I5ZU:N7;U^!1M6[%BR9<V>W5HNGSMQZ,JAA1M7[ERZ=>V6?2MM
M"85+_ZJ^#3<H  \TF S/\53O7Y,&9B 9Q@2G$;A1*U:8V25HR80;Q*B^_6>(
MQP1.]NSI4S<*Q@8BZKYUP2'+J/^_-0@"F$CVS]F+#(X]]:$Q@44IK>BPW;C
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ML0-7P(,.?_C$%$BABRC$HA9XT!P8X$&(*9!!#&CP@@V^. 1E# (+U,"%&8+
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M JQ",( !+AS!%*!#+I0 */@!()1#(CQ!*60!+[0#%G#='91 "P0!-DQ""*3
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M C:D@S7  C/8ECFP C"X2#GD@S7H BW0@C)0 S3@@S=0PSY< R_8PBZ(@LE
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M@S*80W88##-,A3:$@SH,PSU4!U @PV+%PS(@@W/X!#O8@S<<PQ_G0A9@@A^
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MX(<XWL$'2>B#&W%XQ#[(<0L_$,$-SGB7F!B93WW.Y81&VR?MQ"2-$)SA'/K
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M0./8UH[3-=8AC7G4O&O*X$0OO$&18I1B%\401[2'V E6,"@=MHC%1^)Q"D@
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M"G!A!R2A#^2@'R2A%)IP<,Y $4H@!MI "*SJ=M3A$48 "FC@!EA!%6*@.%6
M&O3A%5Y!#0H #*Y!&EJA%*: "N+A&KZ@"NR !"+A+?^%-X1!(AR@014N)1B^
MX1OR@1B,81FF(1_$01_2ZQWV01N@ 1_0 1Z681EX80B>X!8FHAZ*(1O(X1Z&
M(1O,01NR(1OB01WJP1N. 1S2P11,H0G181V\81V2H1E401B@@8%NAQSZ(1F2
M81X82![BH1BV 1_*H1W2(1F& 1S$KASLX1F(@<^N(1B&X:Y$V/. ES))M1%*
MP)X.800R(1GP( >JX!:*H0KZ@!_4P!&* 088(1G>@ :L0!O(X1!4H 1084$
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MQJ)-R2BR\UI[MDL[M;^1'*I!$V[!&!JA#_J@%]*!(N8!% !!&F)!#_#@#_!
M$@#!%I!AUOAA%?+@#I2)')AA$=@ #1BA&TXA#][@#/8 %HAZ'VZ!#_Q@$I9!
M'JA!#(#@#$YA'X@!$KS@#9HA"7D!?BYA&RZ$MGG/MIT-M>N:OP6<M)%/M&5[
MP&W.O\>VO^"@%DZ!,9G@"49!QG!A"K; %W+!"J@@!'P #?\4H0\.P=#& 1K<
M( B(P @4X1T @0F.( G*(!<"80WL@ MV8!$D<*W-8 C.P HZ 1K$8 @,P0K*
M0!@<H0NN8 O^X!OB80R>P ^NH!' &,%U3L%7#<"_6LJQ/,CD><I7*,O!C,I)
M]1KFP!&B(1>V@ V(H AD81]8H0^B0 AH81NP 1**0 A281I2A!8OQ!Q(X1/0
M@ H"H1KJX O. !,ZX1B&H1D. 0KB@!L&0QTNP06*)!-T(1CR8 LX@0X<+ ZX
MX!0V00IR(16$P!!: 0G& )V]O+;!7)&L?-7+Y,M=/=;S8AQN 0U^P1U@X0J:
M '%H@1;<0!/X  U4X>@4P0IL@1W_^H$,FN 5PD0>? $)HD 07"$(HN -\@ 2
M+FH=(@%=]&P;DD$5S,  CD ,V& 7ML$1L" .E* /1F$*BH ;&B$+* $7@( 7
MO.'('U/6O['5];W?_1UIVL$4S  ;W,$4P& 2)-$2(D$)X( -CH 3[.$:^( -
M;"@=,O$3F&0PMF$0B&!QCP + F$/@N 4U*$:KL /MH$=1D$.R@ ,N* &]  6
MZ* -7.$H&X$.S( 1C( ))C<+'B$7M& 4DN$*O  ._]T&^?WHE7[IR40<>@$,
MJ.$<%N$.4J$1N" ,YL )MJ (4J /AH$5PL==U@$.N. 38$8<O($7J@%"A0 2
MB(!EZ'P0_Z)AQ07A'-CA%<2 #M2@&G^J#;2 $(! #$@!#IS $3KH$-+1%E(!
MR&,A">@ G9G>CY-+U2._\BT_]80!#5QA'W)A#>0 ")2@$:@!%F2I"Q3!'D9A
M#7J!/=XA#Y@@%O:%'+IA#@SS"<B % BA"9" ".J &N+!$YK@%J#,'H*A&[XA
M%>0 "M# #!#!&C"A">P "/+ &60A#:P@#<) R?M "]@ "';AIR^?Y9(^_,F_
M_.D"&?) $.:!&:3O$FP!N<2!'K !%R[*&W A&/9%&Y;_&!CD'*JA$P!BDR-G
MY^+)>M0IE3I\NG+-^U<NXKAR^*@5"B2+F+QCEB =XN:.7ZI#I_^.L:-GC=$A
M6/ @_GL),Z;,F31KVKR),Z?.G3Q[^OP)-*A0GO?(E9LX-*G2I4R;.GT*-:K4
MJ52K6KVZ\YZC-\#&R?-WSQTZF.+HC14GC]V_=K#\6-H'L=P_<OC\A1,'D=X^
M?.W^C:,G5JY,<>KVN1LW]]R]<^1>L@LG;VPY<>'.T9LH&*OFS9P[>_YW#]TX
M=)D_FSZ-.K7JU:Q;LRYWC-"RF1$SEY;73-:WN!%EEHX+\[=PWZ5[QS3N.KGR
MY4Q#C_[-/+KTZ=2K6Z\>+IZ_VMR[=T<G+YQD[^3)$R^/OOSU]>Q9.R?=/K[\
M^?3KSS^*.;WWX/K3G^_?GWT"TH;>@#7_^2,:? 8NR&"##NH$('?\1:C?<11>
M*!>&&F[(88<>?@B@<A?*-$Z))IX(8FTOX<>:/48A]F",.'5W6HHVWHACCNI9
MJ..(*]K(8X]"#DEDD1N*2&&0Y9W(9)-.GKABB:SETQAT,E[YHXJF&<EEET+^
MYR6-68*H9)CFE6EFFF8B>:1-^#T)IY,0F3AEE5C>J62-:N[)IW]HAGD<;1:Z
M%"BA>!Z**&<F6OD9E88F&J.8G_5)::7(C0DDI -*^"=Z):(#*J@FBAKGIZ&B
M0TZJJJYZ*JJMGDJ..+**PTZMMK:#:ZZZ[LIKKO3( VRPPH9#++'G'(MLLOCL
M<T^SS?H#K3_\_TP[+5C.\F-/MMIN6T^WW?+3;;;@U&,64JLYRJA34N[HII:<
MN9O:A:/"&-2E$Z:+J:8/N@///-EL<\TUVS"#S##(,(,P,\,DD\PPWR"C3<3:
M,)Q,,,9 X\W"P1033,<=5QQ,,L480S+)WG@<C#?0',,RRR>KW/(Q&,-\C#$H
MTRRS,<=,T\TS/O^L##?*+$-TT41W@W0WR_S,M,]!<R.T,])4 PPPUF"C2M:J
M-%--U]9\_34UV#33C#752"/UU-BP0HLPU@!3#=AF@QVWW,*X;4TS=Y.B"C54
M7\U**J_4P@HV8K/"BMMZW\TXXZ0@#CDMJ4R>"BG"L&TYXZI SGGGD/_7,CDM
MK&A->NFDDX)ZZEH'7DLMM*#N>>2B<YXZV[J\<DLMM[S"^RV^__Z++\+[XDKQ
MQ?OR2_+)WZ)+\Z#?XHHO@T.S#ZCX<H:N5>2P,XXXU^M+';U"T3O:7*B*$ZNM
MM;;CCCSNO/^^L/++4]@^]M]O_SW1[@]M/=O:HX\ "G" !,R' 0W8CP0F<!W]
M>L<\'@C!"$KP@>^HH 4M.(]X9&.#V>@7!#7(P1!F@QC;((8)KX&,;ZAPA0]C
MA@E-N T6?F,8$M.&-XQ1C&^D0A"%& 0E-N$)3*@!#GS0@R<R@<0YD($,<XA$
M)B11B2A.0@UD<,,?SO ',O#A#V[@@Q>]" ?_-^1A#V00PQG.B$4^A&&-;K@#
M&L_@!CU@8@YJ7&,8R+ '/6C1#7"8@Q_G0$0OA@$.>PBC&>70AD2R00YG$$,7
M\]"'2/8A#VZHI!C%@,E,9C(/9( #(=W0!C#XP0]@6(,63JF%."2R#6BH QU>
M^<HZC(&1<=Q#&/* !SN8@0YM.$,>OM@'-JR2#7D(@Q?;^(9(WN$->!@#&\0
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MU&>)PQ,+W"8*KG!ZR)=\G^AYXC8*P:>)OM=<GY>)HVC_4[YV9&'V";:P"KD
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MS/B2(8+RRS1!#I10#8WQ#_S@!L/@"G*P&X7\#^H@"'P0"J6Q#6KP#6*0!^'
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M"+<0"I20"8"0#:1P!I2 "+JP#XD !YL@!;(PU)O  OOU FC@!GW #,G !XM
M"&' VSC-"C9P!L P!Y3 "'YP"LLP!]^ !G! "G=P";DP":U "'( #D! !>:
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MQ8]N?/D$E1?^T6>-3\Z88A1 >JA&DTCPZ<8-1X0A0HY=_@0&D%AJ2:2:,Z
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MD -YR(87X*HD> ,X,()?,(4\J $N$ -68 ,Y^ ==H -&: 0M> 1T* 01Z :
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M15"!)E $$K"#?V %$B %B\"%$H!@*7 C('@#??J!VKQFM+N()N"#G#@"-2B
M)R"#(T@%;^B$1T@".C#;:IB'*IB#([ ";+B"-K@%*,"$00@!83@',.""YKAC
M@2YMM[@&HBWH8U"!-/@'<L@$*E@%'" /1D"#75"!1BB'>]B'./"#?U $)G %
M.C#+/K"$=Z"#.MB"$\"#+* "8EB"4O@')""#9& "4_\H!S(0@C0P@D_8A"I8
M!U5 @F) @3QHAT/8 620@D(8!R> A*.. 3H !F@@!C(H@"C  2<X!!2(@1#
M 6[P"W0(AET0!C48 AZX!G>8 Q<PA'THAV.@!GUXAS(0@4<  B% (1)P!G2P
MAW,0A1I8!'[(@B30AS(P@F@P!2J@%+\&-Y!! A&]AC70 2W0A![ @GOH QQ0
M!"@8@WY@@I*!@QM8@5+(!R<(QD:HAE- @5[H!R"8@G_8Z=TT;=-VUWL+Z""E
MW1E(@FVH!1D8 V:X@3XXAC#  U%PZ5<0@UC  RU@ACZP 5>P SFHAS]0A'D
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MG"/:TIXVM?'ACVM?>Q_:UG8]].%M;^<CW/D 1S_*76YSH#O=Z4['.]K]CGG
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M.ZA#.+ #.>Q,$$KB).+'7_S#,T@!#;3!%T2!+ !<.T@!%(#,4V"'9JB&'M#
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M !:4014X S!DP1&$P!UT0Q?\01#40;(H1!\( <@\@A%H0Q\,P3\\PA>\ AV
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M( .\, (-8 ,GC  J2(,.#$$K[( ?E(U^[D8YL(,YV$/_#P+HF);F/RR#"HP
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MQ  8;((4% $\5$,"0$$D=8$WK $::%8?!($FK8(*Y, J_,,^M($/ $0D/%6
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M@ ,1,((=XPA$"G P@QEHXAE>*$0RN/"#'9" "XJPA0M"$((G;",UUC"""VK
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M/E608C/75"Y6'RMU7GFS&.R@#90AU5;C%YI@"AY!%V;!%5:A$1;!$ R!#.2
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M8(4N:H$*6-#B%K5(;BI>(8I?M (5LM"%*UIQ"UB$8A6C:(4K1C$*6"Q$%+W
M!2YD$8I2F+<4H+"%>FW!BUS@PA6O.$7_*7)ABU.H-Q>S<$4L< $*7/#B$YQ
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MZ2!PTJ +\- .T_ *_\Y0(/E@0]/1#S'@!LK " ,0"<&@!(+@:N@ #\*0#?_
M#**0@O& !4%0"QOR&O-P XB0#,=P#[O ".Z0#M4P"[.@#]O(":5@#N'0#<AP
M"JU0#_^P#HAP"_O0#XA #?_0#9)@"O30"T= BXCQ#\5P!:M@#M& "5  #)$
M WG0"$]P J' "Z;8#$V !-CP#^"@!S'P".+P#HM !D-@##;#'?6P"5&P!=EP
M#T0@ &E@#/_ ALR@! 6@!_G0!GKP#6VP T)@#/QP"6AP!$Q0"__P"D]P WNP
M#]8@!VTP!8% #LD  E;@!)>@#M,@!3%P!,. #'U !#+0"/]P"U=  YYP-O\@
MPC$+A1O*\D.*>)=XF9=Z2326@ 2I<%+WT MH@ B_( EOD FF< UJ0 ER  ;=
MT ]0\ MX4 DIB#-\P 6Q> RX\ ['P =FD G$, MT  EL( S<\ 9N, :N, QP
MX 6$@ N+4 V_8 9K8 6[P YD<V;>=P+/\ _\X C.< U+  16@ 7=P R*P S>
M0 =^H 8B1P58@ IL>"_X@ .<X'7V< =[H ^0X 1C8 6O  QLT)B-, U'\ =-
M  *Q@ ^)4 9<  ?8( 2,< QA  10T NV  2]28'_@ LE((-.A .OH 4BT >3
M8 ,RX J>T OKP =-0 1@\ RO  5X8 ;"\ TV@ 7_6[ -78(;H. #30 %=D +
M<J #9!"+;!@,0A %,* ,=$ &S> $9Q #A> -*@ "?Q  ?= -0] %?A %O) *
M() &2% "AP4#:J &)[ ,I^ &;I #L; (*L '?G *\' '=9 &-+ ,$I(9>_FE
M8!JF8BHJBG #8V (E@ -=W "H] -FQ &=- $J@ "9] (/5 (_2 %.Y $HT /
MND,'0F /B&,/F= %<F  A, '/M &=] -PQ &9  "?- -55 $QI (4\ ):T %
MJE )<6 .%"$>_[ ,-  -3B@;\( #=: +4M (R1 )I+ (14 )6$ &US &L+(P
M]W(/)% 'C) (W\ $6! /_UK0!,Y@!HW*!WQ@!$@ ##J !Z:  H.@#5(P"[ @
M"KJ0 H:@#9V !R70!Y:@!?LI&[+@ N @'=J  ]A "2K0"M0  X3@#W=@"RTB
M#>OP;),@!+9@!84P#$7@"/  (%IS#TS@!O5P"R' "92P!LR@+/WQ#&> "VA
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MRJ &MZ &+[ +9F"[;Z (], Q]^(//N"4_O$"71 /DOL/W3,''7 +E, %PG
MEO -.D 'SP #A2 &>" +.E )F! "D, $;. (QDH<C@$.;L $G9 )*@ &^G *
M5- -Q2 #N1 .?G (RV %:H )_T3P"IV@!;R@!Z10#"40"^+@'\T\#H:P G\P
M!E] #9H@!-'P/['A#'4@#?Q0!Q=@"(6P )O !TY #20@!_H@ U" #4YP!&KP
M!++P"BDP!D$@ \, #2HP#_T  K(0!&F@"T# "9^ "980!6+P#I70!G!P!M<0
M&\NRPA(]T13M?I]0!_L)#GQP!H'I!+( "&-0#6" "-MP!(<P#T!@#(_@!O,P
MMF-B"9$0"5I0"/?P"GN@")2@#+.@"8[ !K]P"VG0"7)@",; !H. #J/@!ZS0
M"G:08[RP#I2 "+_D2L"@!VX@!FHP#.\P!K+P#X+0"^E@"A\'"9P0"-1@#HO@
M"^$DE__9>8#CX Z>( GP$ B'4 Z-( BLX >E0 B1\ QU\ KFD F-4 ^X< GU
M\0QD, JD( F.H :<< O)Z80FQ0['@ EYX F+D SD\ J)  _$, G3T ZG@ WN
M( H-M@KMX V%@!+PD Z/L,;^<6;F4 AZ0 E-I JBL ^Z@0[QT K1P [.T FU
M  V!X BY\ G:( BPP ^,@ KWP V$L DHN @/X F=\ OND ^V$!:]H _=L C;
MU0W)T&BRD'G#L J<0 KE QX/6-'N_=[PO5;?\ P1T@[W\ W7L!7%8 W)0 S]
M( W(( _!\ [G4'CTH WW8!OPH SO,"GO4 WP\#_74 W$$#3_V? ,Q( /_J -
M\X .X% ,_O /^@ ,VO /PZ &I8!^B!$;8!@-LJ$.\""H4B$/#O$/]F ,R<@.
MYN")#CL.66<SFA,O[# 5Y& /*6@B]5(@=[4/_/@/2T(1CE-,_K LZO KR=3,
MLI%+;$B!E3$.68$]FL*?P^%*ZD2%M3$>U!0;6B,<DX(S=OD/A5  M)"\TU%+
MS*%6\9WG>K[GO/-#BM'F)YR\@JZ;O$$[IC$;X"& /U0\R53G6"X;_5 -R/ S
MO?&$46AUO (TLV$9LB$=Y&!G=9X8B-/,SP& NQ$;U(0SC![H6A,<\C<IN"$T
MWK'JLNZ(D3@;VEP<R;LQTR$IOFX;_QPS?\_1'];@"4WDY1HS?[Z^[,O.Y\[^
M[-!^*OE'A9HC.^7S&D+SZ5CA*+03'H C&Q6"#MMAPEI3=0[DIQF30) QB+_Q
M9N-H&(\Q'=+BY8;A2IF3&K 1ZY^SZ(A1&#UT+U34'8Y2Z8[R&/_C*(=Q?_<"
M'@,8[--A9X H[H;!\-S1)3CSZ1:_[%SR&KUN0\/AZV5NAHJC#E-.3<Q^\B<?
M[2J_\BR/'N<0&/X@&/TAL.%!1>X0#>; 0/[^2I A&_GPT+G#,:W4Z=J0#JX>
M\?X13KJC#LZP"CKXB!.?&JXD[E+G'719\\HB[O\C#^9P#O P#.? ,9/!B&9H
M(+VA]0VT3/_*DNK_ TG<GCL@=4K$(0_JQ.U9H595V$/M%%>2PO&<TDHA+RG!
M#E*!GBKHX ]B<L(HO_@MW_B.__C(D0MLH =JT := *#_X!NYTP]H, O/W-["
M(0MD4!L#*(#B(B9PC^C=\0_]X DT$  TH NV#H7"L2&ST1N(3AOBX JTX Z
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M^,,O_O&3O_SF/S_ZTZ_^];.__>Y_/_SC+__YT[_^]K\__O.O__WSO__^_S\
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3E@\\P1>\P1\\PB>\PK]B0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex1051001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1051001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 5P"T P$1  (1 0,1 ?_$ '<  0 " P$!
M       $!0$" P8( 0$                     $  !! $# 04&! ,( P
M   !  (#!!$Q$@4A05%A$Q1Q(C)"4@:1H6(C@;$S\-&"DD-C<R05)181 0
M                  #_V@ , P$  A$#$0 _ /JE 0$! 0$! 0$'*U;KU873
M3R-CC;J7''7N]J" .7NR1NFAH/%=@)WSN$+G-'4EK"'.TTW806<;P]C7C1P!
M&=>J#* @(-9)&1L<][@UK07.<X@  :DDH*47>2Y?(XXFG0.0>1>W,D@_V(W=
M,?K>/8"@TL</QU058((W2VYYV$V9'&2;$9\Q[W2.R[1N.[J@OT! 0$! 0$!
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M'EYKB8OZEV!N-<R-_O0:,Y_A7N#6787..@#P@F>?#Y?F;V[-=^1M_%!N@("
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)$! 0$! 0?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex1051003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1051003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ .P"T P$1  (1 0,1 ?_$ '(  0 " P$!
M       $!0$#!@(( 0$                     $  !! $!!08$!00#
M   !  (#! 41(3$2$P9!46&!(C)QD4(S4F)R(Q3!@E,U<Q46$0$
M            _]H # ,!  (1 Q$ /P#ZI0$! 0$! 0$! 0$! 0$$&7+UF3&N
MP.GLC3BAA]9;KVN.YOF@W,;8D!XR(A^%OJ/F2@WM;H--_B@R@(" @(" @("
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I_-_E0=-%]F/V^T>SV;NSP[D&Q 0$! 0$! 0$! 0$! 0$! 0$! 0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex1051002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1051002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ ) #( P$1  (1 0,1 ?_$ '0  0 " P$! 0
M       $!0$" P8'" $!                     !   @$# @0#!04) 0
M     0(# !$$$@4A,1,&05$B@9$R0A1A<:%28K'!\7*"LD-D%181 0
M              #_V@ , P$  A$#$0 _ /T_N.XQ8&/UY59DUHA""YO(P4'W
MF@D@WH#,%%R;"@XY.=C8RLT[A%47-SQ/W#F:"-B;S'EL##CS=$_Y70H/8&XT
M%@#<7H% H% H% H% H% ) H-))XH_C8+?@"Q O[Z"%D[A()UB@BZC !I"QL%
M!-A<?F/E03UY7M8GG09H% H% H%!7[XCOMDXB%Y/3I%[?.*"1D9<6-&KRWN;
M#2H+$D\. '&@CLNY9+LK,,6#Y=!#2GV\A0=L?;\.!]:I>8BQE8DN1SYDF@XX
M^];=+N3[=#*))XP2X7B%(YK?EJ'B*"PN.5!K)(D:,[L%51=B? 4'+%S<?*0O
M"^I0VDFQ''VT'>] H(#Y63+FOBPLL81%9V87:[WMI X>'C0:8^XM'FG;LMP<
MH1F9752$:,-IO]X\J"7D2902^,J2/XJS:1[P#0<3)NP!/2AM_.U_[:"'GYV[
MXRQ6Z!DR'$4*@,?4>-S]EAQH)1QMPE#=3,,8/+I(H_%M5!$W'(VS9<-]PGO+
M(I$:N]WD>20Z40']3<*#EVW+!/'(%)EF25AF9!%@\X-R%\PO(4%_=?/^- H%
MQ0*!<4#4/.@QJ6U[BU!YONS.G<0;1MWJW/,D0@#E''&P=W<CD.%!:#%FQHC(
MBKDY9XEY&TDF_&Q^44&BOW!)8=+&A7S9W=O<  ??05?<6Q]PYZXL4.8&QRY.
M;$&./J2PTJ&0,Q%^=!K@;1O^W[A.\&/@]!PHQV#R QJ!ZE":>-VXEKW/C03-
MTV'<LZ#7]>4RXRLD$8!6 .AOZU%V8'QH(N9M?=V><3JRX6*()!+((^I(&(%O
MA8+>WA>@M(-FR$@=),Z1Y9+F2=0$8D\B+>7A09@V_=H@$.X"5/SR1 R#[ 00
M*"PAC,<84L7/YFYT$/,6+#ZNX G6L80KP]>DW4??QL*"@;*R<_?=L;)B?&<=
M4_3IP(0QVU2,.?$@::#UJ  6 H,F]N'.@\\)ILOO!L8"^+M>,'U_[&0Q%OZ8
MU_&@N2<E6(T*R<E*M8@>%[T'SWN3?-RSN](=A@C!7!5'1 .J3-/Z>K+>P584
MU,/U6H+[8]E[HV7!AVO'?"RL&!B$R93*LQC)U7=55E9[GSH,KVIO6;NOUV\;
MJ7AB)^EP<53$B>3%CQ)]E!%QNW=X?N28PR3;?LB1=.0=4O+DRDWU"]]"CS\:
M"=B=M;\L\$N1NHOA:H\;1'J+QG@IEU$7>WE0=LWM_?\ *>QWV2* KI=884C>
M_F&NW[*"//L/=D&XXLNW[N)<.,6R8,P:M?@+:%%!8F#NEP5Z^%'?DZQR,1[&
M:U!(Q]LRA(DN5FO/(G)5411W^U1>@JNUNWMTP,N?-W3)2?)E01(L2E5"!BUR
M3\US0>EH% H% H% H% H*#-G6;N(+/*J8.U1#(F5@PU22W"$F]B%"\J#?:,;
M<,K<Y-VS-,<!0QX&. P81,VK7)<_&WEX4%Y0<<M<EHK8[(LA/$R D6M^DB@B
M;)M/T&/()).MDSR-+//8@LQX"]R>0X4%@5!%C^Z@X)@8B9,F2L2C(E 668 !
MF"\@2!Q%!( M0*!0*!0*!0*!0*!0*!0*!0*!0*"@W7_SO_:A^MM];9=.K5T[
=7].JWIOSM>@OU^$4"@4"@4"@4"@4"@4"@4"@_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex1051004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1051004.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ +P#( P$1  (1 0,1 ?_$ (\  0 !!0$!
M       & 0($!0<#" $!  ,! 0                $" P0%$  ! P,# @,$
M" ,) 0     ! @,$ !$%(1(&,0=!41-Q(E(488&1H3)RHB.Q0A7!LC-#4R0T
M)187$0$!  (!! $$ P$          1$" R$Q01($47$3%+$B,E+_V@ , P$
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<6I'36XMI625:!0*!0*!0*!0*!0*!0*!0*#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ex1051005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1051005.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@#:0*\ P$1  (1 0,1 ?_$ )P  0 " P$! 0
M       %!@,$!P(!" $!                     !   00! P(#! 8$"04,
M!P4) 0 " P0%$1(&(3%!$P=1(C(487&!0B,5D:%2"+'!T6*",T,D%G*2TE,7
M\**RPG.#DZ/#-$0E8[/3=#4F-N%49(2D15;Q53<8M$8G$0$
M        _]H # ,!  (1 Q$ /P#]4H" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M.+LYB3&LK2!T>:.",N]A!F$)F\P#N6]"W3N@N[1H-$'U 0"@>" @(" @:H"
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MKW,U+G'0==NIU\$&]2O4[T#;%29D\+NSXR"-?8?84&= 0$! 0$! 0$! 0$!
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MY7!Q2.N5;N2A 9DY*3MT7G>T$AFNH\=$&8VYKN=<*]F>K7QNK+M62N&PV"\
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M [S&^>1SOL!"#]!M[(/J @(" @(" @(" @% 0$! 0$! 0$! 0$! 0$! 0$!
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M@M,V&$$'.W6OAI1GVL:0'SGV;=!]*"=K\6CM8FO2Y,YG()HI1.Z:U%'M$O\
M,C T#6ZD#QT[H+     - .@ 0$! 0$'E[ YA;TZ]$'/<)>XEQCFTG%:0M?F5
MUK;-UQKOF;(^4N=&]\[?=C:T:@-V@(+-R'#LRCHQ9N[,. 67J#F1NBL GHU[
MW>^S0_LE!FP>5H2V;F(KUY*S\1Y4+HGM ;L>TF-S-"[W2!X]4$P@(" @(/A<
M-=$%:YCZB\0XC6,N:R#(9=-8ZC/?G>>X#8V]>OT]$' >:_O%<MY'8=B>'U):
M-:<[8I8P9+T@/3H "(_L_2@V>$?NRYO(3LR'+[7RE>5QD?3B>9;3R>OORNU#
M2?'Q0=_XIP[C_%Z#J.&IQU8'.W.V@%[N@'OO^)WVH)O:WV(#8V-!#6AH/4@#
M3J4'W0(" @(" @T8<E#;L".E)'89$]S+3HY&DQ/:/A<WJ==?!!M1>?J[S---
MQV;=?A\-=?%!D0$''_WGLK=QO *EBC9=6M'(QMC>QVUQ:Z&5KQ](+"=4'#IK
M$;;%KB>6R+Y(LJ</9;EI6><(WQUAY<$C!L!9ML: ^&FJ#NWI+Z2Y[B&=DO79
M:!JLHBA%\DUXDG(D\P3SEV@W:=.B#JEV&K/7=!:8V2&71KF/['KT_6@X!P;&
MP6.30&OY3PSF^7L,D:2=L<%0EP:?YQ=]J#]"MU(ZH/J @(" @(" @(" @("
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M8!LW*@["-S3TDC)Z>:[JWQ072[B\?DXH6W8&SLCE98C#O!\9W,=T]AZH-[1
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M=_?31QZH)K.8V7B_K-Q_(8;'2_EW(*KL;EHJL?X#'0G6&5P&C&;&_I0=:C:
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M(W&P6<A,Q[G, :?=UW >QG1!V4=@@(" @(" @(" @(" @(" @(" @(" @("
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M2-06N&H*#Y6R%&TY[:UB.9T9TD$;VO+3[';2=$&P@(" @(" @(" @(" @("
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M]O+AZM!/TZE!%<6] N=<PMNS'++LN/@G/F.DLZR7)-W4Z,)TC'UG[$'=>&\
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M[-%'Z2\@$@W"6%D;&]M7OE8&_K0;'IQZ?U, 7Y[YFS-D\S3J?F#)G#RVOCB
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M%DGU;)&N)^P(+#P"_+?X5@;DA]^?'UW/^EWEMU/VH+ @(" @U]/Q/M_B0;"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.6>J'J;Q/@^2HEV-^>
MY UKY:T4?X38X[!VRR/?\.K]OL)0<NYM^\CR+.U78SCM3\LCL,,<TV[S9SKT
M+8RT:-]FNFJ",]/OW=N5<@C;;RQ=A<8_:YHE;NG>#XM8>W3Q<@_2'#O3?B'$
MJS(L1CV1S-:&ON/ ?._Z72'K^A!9CHT:H(CF4>6DXGEX\0YS,HZI,*3F?&)2
MP[=O\[7L@_/OH]P/U/ES-OYVWD\!0?#_ 'NPX$22O<>C6B;<"[Q+P@_0&,XT
MVE?9<-VU8>RJVJ]D\I>)"TD^9(-=KGZ'37:$$Q)%'*PQR,#V.^)C@"#]8*#Z
MQC&-#&-#6-&C6@: #Z @^H" @(/FUNNN@U]OB@^H" @(" @(-#.YFGA<58R5
MQVD-=NNT=7/>3HR-@\7O<0UH]I0:7%,;DJ>.?:R\IDR^0>;-X;G.CB<X>[#$
M"2 R)NC!IWTU[E!2N6YG)5?4.*WCIL@^IC!4CRE2!LDM6069-L@>&@M8Z&(M
MDU\=4$-S>UGJ?-<\*%S)AC*V/GJRQV@RI4L6)7Q&2:-QZP^XW> /X4'NS4R\
MW(N1Q39;(T:%*VPG-B_I!3/R\,^SY9W5S7O<6_0"@P<IJUL%S*;+XJQEF4\8
MZ*WEF02SV*LLMJ0EX>'.<V/R8OQ-O;L$'9,8)&XZN);'S<@C;OM;0SS3I\>U
MO0;N^@0:>=Y)C,/%&;+W/GG);5IP-,L\SA]V.-O4_6>GM*"#&'Y/R;1_("<5
MB=^YF$K2:RRL\/F[#3V/C''T]I*"V5:=6K7CKUH60P1#2.)C0UK1] "#,@("
M @(" @(" @(" @YS^\)O'I-F7M!/EFN]S0-=P%AGNGV ^U!&?NS%C_38R,:&
M,?D+3FM'8 EN@'U=D'64%:]2J8N< Y#6/:3'61^B,G^)!%^B64CR7I;QR=FF
MK*K:[M"3[T!,9_X*"\H" @(/&S\371![0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 00..YSQS(9!F/KS3"Y(7!D4M6S#KM!)]Z2-C?NGQ03Q( U)T [E!
MI8C,XO,4FWL7:CN5'.<QLT1W-W,.UP^PA!ASO)<)@H&6,O<CHP/<&,EE)#2X
M^'0(.<^H_K?B,=QN6QQ'*XV_E6D:PRR^\V/LYS8^GF.'[.J#\UV+V<YMR(3Y
MG*-%J;1LEZV7".)C>N@# =K1K\("#N'#,+Z.<4O5LC4Y+,_(QC;9+XM[7@?$
MW8Z%Q8W7V'5!<<IZPT,5C;.;$D&:P]::."5]$21V(C.?<W,E&QVGB0[[$&CC
M?WD^!VJ=NU8\ZKY$S(J]=S=\\S7]Y QO1H;X]4&WR3UKX6'_ )10SC(+UJ(.
MK92./YFM%*YPVME_XWL""VX7G'&,J^"E5R]2SD7M!?#"_7<YHU?L!T)'=!FH
M<PXM>AFGIY2O/%7G%2>1D@(9.XZ-C)/WB?!!EL<KXY5L2UK.5J0SPG26.2:-
MCFD]=' D:(/=?E'')WAD.6IRO=T:UD\9))]@#D$CY\/G"$R-\YS2]L6HW%H(
M!<&]] 2.J#ZZ2-IT<X-/L) 0?//ATU\QNA^D>"#S);K1>7YLS(_.<&0[G!N]
MYZAK=3U/T!!E0?"X @:C4]A[4'U U" @(" @(*A8(Y)S".L&E^&XU()K#NFR
M;)%OX3![178XO/\ /(_906YP.B#G.3Q'*76<LVOQ+&6(,C,UT\SK\D;[+6=&
M/E:&'1P  TU086XGE LVK3^#8V2W>A%>]*<@#YL6@;L<'1G5NC0@T9^(6YYI
M+$OIM1,[W!SS^8M_$<"""X!H!TT'=!L_E7*3!EF.X/BH8LOJ_)LFR.YLY/Q&
M8",^""5QG(N09"K6PW'L?7JBLP1WLF'.FH5@WW1%6(#38>![/=;XE!9\/QZK
M0/S$DDES)/:&S9"?0S.'?:-  QO\UH 02R @(" @(" @(" @(" @(*+ZY _[
M)N2:?_=@?T2L00'[LG_],(S[;UG^%J#K*"(Y@POXIF8QU+Z-D ?\RY!1_P!W
M&>27TIQ3'M#1 ^>(%NNA D)U[#VH.GH" @(" @(" @(" @("#%:B?-5FACD,
M4DC',9*.[2X$!P^KN@J.*P@_Q+98R[-OQ;J;SNED>) Z![9&N:YY'ONT=V\$
M&O2DNP9[:VQ=$3\G) RQ8L%]5T;0'&#RW%SMWQ!F@';XO!!M4//9CL5)\[9D
MDER\K9'/F<XEH?,SRCUZL 8/=*#-A:<N4J1Y:QD;,60-D^8QDKFQ,$,Q;\MY
M((;HYHT.HW>.J#5QUJY)R-]:>];CH179Q7G<]ACL2@ _*=!JUL8#B!I[WMZ=
M0NJ @(" @(" @(" @((#EF2Y72&.;Q_&1Y V+3([[Y'[1! 2-S]NK2>FO;M[
M"@GT'QS6O:6N +7#0@]004&GB\/BL/3^4Q=2*G5#G/\ (@8&-W..KCH/:@Y9
MZG^H&?M<ACX5P\UC;? ^SDLE.6OCKQ,&KR-=S06-ZNZ$_0@X)0P?"+MU\^;Y
M':VOLZS6&4GO9)!ITE\QW5N_Z4'Z%QG$."<'R.(R.,-R09A[:N+JL8V5KA,P
M/<'O<-VQVF_WCT/9!U%M:$ :,9T_FA!YFI5IHG131,DB?\4;F-<TZ>UIU""O
MY#&0#SZ&#HU:=V1C7/R#ZC'UV^\ 6N V[G[?A'9!LX3A'&L/6$5:A7,A<99K
M#H8_,DE>=7R..WN3[$$NRE58X/9#&V0=GAC0[0_2 @UZ>"Q%(SFI3@@^9D\Z
MP(XVM\R3]MV@ZN09I,=1E<735H97.[E\;7$_I"#4/%^.F5LIQE3S&D.:_P B
M/<"#J"';=4";C.&GSU7/RP%V5IQ.@KV-[QMC?NW-V@[3KO/<(-7,<"X?F;IO
M97%07+;FM89I02[:WL._@@\3^GO";%"OCYL+4=3J%QKQ>6 &%_Q:$=?>\>J#
MU=X)Q2[6Q=6:@T0861LV,CC<^,0O80X;=KAK\/B@F[-:"U6EK3LWP3,='*PZ
MZ.:X:.'3V@H(-G .'LRD659C(VY"!_FPSAT@VO\ V@W=M_4@E,QBX<KB[6-G
MDEBAMQNBED@=Y<@:X:':[KIJ$&"CQZE2X]#@8I)_DX(&UF2>:]L^QHTU\UA:
MX.^D:(),#0:>Q!IC'RBU/8;<G_&:6L@<6&*,Z ;F-V@Z^[XN]J""Q%ZMQNA/
M7Y+RN#(6&2EYLVC!5?&QP&D98UW@=3]J"#H>HF'J9&U+)R=W(:KGN9#2Q^.=
M*827:M!FK->':-Z=>_=!O6N>Y._#\GA>/Y>&_;TBK7+M-T-6%TAT\Z5SB?=C
M!W::=>R#>XYAN087)C&0LK'BT-<EEESWNO2W7N#Y99=?=_$>YY*"RM\[=)YF
MWR]P\G;KNV[1KNU\=VO;P01M'_$?SSQ>%+Y+<[R3#YOG;?N;@_W=?;H@Q<DL
M\I@DQ_Y#2KW&.L-&2^8E,197/1SH] =SNOZD'SE?)XL'CG2LA-S(RZLQV-8?
MQ;,OA&P=_K=V'B@I.8I>J.<+H\CA*CL0^,'\HAO^5O?KJX690S<YOAM:0/:@
MM>(R')J^*LBS@(:DE2#6C2JVF2-D<T=(A[K!'UT&J#=Q>9S=K#5[EK#OJ9"5
MVD^.?+'NB&X@GS![KNVO1!IQ<BY8Z=C).+R1Q%P#YOG*Q#6Z]7$ Z]$&6KGN
M2R7V5Y^.2052[1UOYJN\-;K\6QIW%!FI9_)3\DOXF;#6*U*I&Q]?+O+#!8<[
MXF, .X%OTH,]3+9":[)!+BIJ\#-VRV]\3F/T.@T:QSG^]WZA!H0<LR4EQD#^
M-Y**-TFPV7"N8P-=-YVREVW[$&]F^0-Q7R.ZG8M_.V&5O[LPR>7NU_%>!V8/
M$H-VW<^6K23F*2;RP7>5"TOD=IX-;XE!!/YS&PG=@\QHWJ2*3B/U%!\//<>,
M7?R3L?DHX<<UKI8Y*DK)7AW^J81^)IXZ=D$E7Y%3GP4>:$4[:DL0F;&8G^>&
MGP,0!?N^C1!%O]2>+LT$CK;''7W74[0(T]H\M!)T>3XB[C)LI!(\4JX>Z:26
M*2(@1C5WNO:UW9!EPF>QF;Q=;*8V7SJ-QN^O+H6[AU\" 1V0;LTT4,,DTK@R
M*)I?(\]@UHU)_0@T,)R3"YMDLF+L_,L@<&2G8]FA(U'QM;K]B"@^K'+N*YCT
MNY-%2RL3FQ.90L2M#G;)G2M]W30:] >HZ=$$?^[WF>/4/3IM1^5K%U:U8?,2
M\1EK))7-B<YKCTW@=$'7V.#AN'4'L1XA!KY&'SZ-B'OYL4C/\YI"#E_[LKXA
MZ:_+MD+Y*V0N1S,)UV.#^C1]&G5!UE 0$! 0$! 0$! 0$'QSFM:7.(:UHU)/
M0 !!XAL5YV[X)&RLUTW,<'#7ZP@\Q7:<TCXH9XY)8_C8Q[7.;]8!U"##4@Q!
MLS6:<=?YEQTL30AGF$DZZ/<WKX>*##5H<=#):=6&J6ND\Z6!@8?Q 0=Y:/O:
MC75!XBH\;9EY+<3:XRCR=Y#AOW :..S7H[0=3IJ@^_E''7769(00&R]^]DX(
MT=(-1N !VE_7OW0>(:'%H9I*<<=5LTTXM/K$L+C8;H1(&$ZAPTUU 02=FS!6
MA=/8D$<3--SW= -3H/UE!\-NJ 29F -=L<=PZ./9IZ]T'UUJLUKW.E8UL9VR
M.+@ UW3H>O0]4'T3PF3RP]OF?L:C=^A!Z=(QI:'. +NC03H2?H0?#(P.#2X!
MSNS=>IT]@0>M4 D#OT0>?,;KIX^SQ0'2M U/P^T=4 2-/;KIWT05[D'-J>)S
M..PL56>_E,B6N;7@#0(H"\,=/(]Y:UK1^M!8T'PN 01'(^7<<XY5=:S-Z.I&
MT:ACCK([_)8-7']"#E-KE/J%ZF22TN*028/C3@6RY>R#'+(.WNGOM^AGVE!/
M<(],J/%,WBX1.V[,:5XW9Y!UFEGDAU(!UT:&MVZ(+S%Q3CD6._+F8JH*.[=\
MMY+/+UUW:[=/:@A_4?R:F#Q]@1C2ME,>Z,@:>7K99&7#^B[1!;MP]A0>)&2O
MV['F/1P)T .H'AU]J#V!]"#Z@(" @YKFO7#"8N5C7X^R8Q>LT+,LFD38W5M#
MO!(<'B37W0@V>-^M''LL:D%VE>Q5ZXYK(89J\KXW;W;6ELS&[=OM)TT0;M?U
M8XM?XWE<UB'NO.Q$;I;%+3RI>Y:WX_=T<6]"-4%RB>Y\3'.;L<YH+F$ZZ$CM
MK]"#T@(" @(" @BSQ3C#K4UMV(INMV'&2>PZ"-TCW$ $N<6DGL@WZU2I5C\J
MK#'!'KKLB:&-U[=F@(,J @$ ]#V0?-6CP04>?U*H97/6.-<3#<GF:KMMV9VK
M:=9G9TCY!_6;3[NUG<].B"9P'#JF,MS9*U,_(YNU_P!XR-CJX#_5PM^&*(?L
MM^U!8-/U(&@]B @("!H$#0>Q 0- @:#V(" @:! 0?"UK@00""-#K[$'QD<;&
MAK&AK1T#6@ #]"#T@(.>>M-##TO2OD9%:.M%.R,SO@B:';G3,;YFC0-SF@ZA
M!^<>.R\8LX2KA,SGW5,1):$=J!N/U(KLF=(R4V/8]YZ]]O4(/V72; VI"R @
MP-8T1:'4; T;>OU(,CP#H/;T0<D_=WA-2GRW&F/9\EG;3"XD:G7Z/#0 (.NH
M" @('B@(" @(" @(/,KF,C>]XU8T$N !<= .O0:DH*AA+,HXY7Q./JS5[\T,
M[72/@D@9#)M>6R/+F!OO/VC[4&2-T;AB!1HRP/QLA??'D.861LKO:^/7321S
MWN;H&DZ]T&KQYE_'WZN1GIM@CS1F=;;"R5T@?([S873,$;?+\MOX?4]W(-;!
M.Q4T.+CH47LS$-M\DDC8'P^7"9G^899"UK2UT1T#2>IT03..?ASS'([:VRQ-
M#!LD=7>W<YIF\W1Y:/ C4Z]4%=PU#9#C?E*SG5)LDZ0A\9!JV6ND<XACV@MC
M?'L/3H'#Z4$I0<V&'!T#C/-R-6=@O.FBD#XY"'!]IDH:6.#G!QUW==4$^2W*
M9(,VA]''/#G.[A]INA:!]$0.I_G?Y*")\JE&ZSC#6;\[/DF6FP&+4/C\]CS+
MJ&[2 S7WM>G9! YRI'Y7)IJ<+[$-BT8<A6V%Y$@CC\JPQI'A)N:XCPZ_=03<
M]OC-#E]R],8HK,-.-A(B]\OW2.=HX-U+MFT=/#1!XL3X*>>]8S,+VS6XH74&
MRL<Z1L3H&G;7T!(>)=VNWKKI]""-S4EZU/2E%7S,OQ^E':M3&412"9P:]S00
MT^8W:QP<T=-7!!NWK7$<AG!:R;(S!9QT3XI90X'4RO.@T^%[-/#J@P9?\NFP
M> 9F@UUOSX7.^8:?-^6#R';]!KH6:;M?'N@\\IC;'RW&'&.C;?;0G,57=M9:
MB;)&'5SUT<3%N+/80@I4/+<$VAB*%)L>3KFQ=_\ +!*8V?,RV=M8VB2=L3(G
M'WCTU06GTFQU2ZZUR>G-<JU+$LU>#"R3"2M"6.VR/B(/O-<]I+3[$$OZA\ E
MY'/B\IC7UX,YB9@ZO+;898#&3J0^,?$6N <SZ4'GD'/(N$XK&,Y-?@MY"=Y9
M:GB9Y7N@.<9&P-+W:#HWZT% L>I7.>:WY7<&H28ZC$PPSYF]*&PQ-!U+]O\
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M3%,W^@[N/I&H02/N:ZZ]?'J@TKV!PUYO][IQ3$=0YS 7#ZG?$/L*".'$FP-
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M4,'O%!LX/!1X\23V)'6\G8_[W?ETWOT[-:!T9&/NL'0?7U08>593R,>^C4E
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MTD$]J@(" @(" @U;YR $/R;HFGS&^<9MVGE^(;M^][$'R7\S.1KF(QBAL?\
M,M<#YF_ILV'MIWU01^8?S)E@G$04)J_3;\S)*Q^NG7X&N"#5^;]1 W_X?C'.
M\=+,P'ZXT'P7_4,?%B<>[_)MR#^&)!O"WR3\DL3OH0C+L8]U>DR;=$]S1[@,
MI:W3=]2#GG^S'E$ PV88:5S(XV8S.Q;X8XV%L_60.L?%(^/7W7.Z:H)OD/J?
MD.-.@;E^-VV_,$^5\I)'9&UI U=M'3N@B&?O"84EV[ 98!O<^2T_\9!H<@]:
MN%\@X_DL-<HY.M'>KR0N<:X<6[FG0@-<>H/9!K3^KW 7X['M@&0JW,)Y8QUG
MY1SMXC9Y;V.V_<E;T<T_04%D9^\'Z<E@<^>VQQ'5CJLNH^L(/I_>!].=.EBT
M3X 59"4&D_UPX0_)1W*^'REJ\8WP06&5#N,6K7O:TD_#KM)01',_66CEN+9?
M%_X=R\!NUGQ,FE@ C <--SCKT UZH+ORVWBX<3BJK&R'/S-;^000:?,B9K![
MPU^&,#I*7>[M[H-7AE2.QE+#^71MEYDV,>;'* ^NVOK[OR .H\K]L_%N^)!T
M !I&H[%!%Y["5\I5;$Y[H+$1\RG<C_K8)FCW9&'^$'H1T*"AU^4Y3E.0/%(K
M4=(P[VY;+UB0+;(R&OCQ[OVC_:D?U?@@Z/C\;1H4H:=2%L->!H9%$SL /]W=
M!@S>'@R=3R7ET<D9$E:S'H)(96_#(PGQ;^L((.'F+</6EJ\G(K9&JP%CHFN<
MRX"=K75AW<]SB 8^X/T=4&3$8>YE<C#G^00>78A#CBL83N;4:\_UC_!UAP[G
M[O8>*"QW*E:W4FJV8FS5YV&.:)XW-<UPT((/?5!3X+-KALT5#)RNFXS(YL>/
MR<GO.J.<0&5[3O\ 5Z](Y/#L[P*"2R>?M6K[L+@B)+S-/G;Q =#4:[]KP?*6
M_"P?6>B"2P>!HX>BVG5:XM+G2332'=++*\ZODE?]YSD$-D,?:X[?FS6(@=)C
M9W&3-8V/OKIJ;5=O^L'WV#XAU^+N%CH7JMZG%<JS-GK3M#XIF=6N:>Q05GTN
M>UW":LL>KS)-<D&O<EUN4]?K08\7Z@7K IS7L'+4I9&5]:E9CL0S@V&%X$3V
MC86%YB(:>HU[D(/&$]29,E:JQ28"]3@N220169'5G@21^8"U[(Y7/:"Z%[=Q
M&FH[H/=?U2XU:K8N9D=GSLK>.-AIEK/.CF:='.D&_:&#4'<">A&B"0K\Q\[D
M;\#^47X[$31))8>V#R1"YSV,EW"4NVO=&=/=U]H08H>=P6<D^I3Q5^S6ANG'
M6,E&R(UXYFG:XG\3S=K7]"[9IX]D&8<P)Y%^1?D]_P \#>;&E?R?)+_+\[7S
MMVS=_-W?0@U+GJ7QZH<PR>.VVQ@GM%^J("91&\Z,G8T'WHCKKN]B#S9]2<='
M-,*^,R5ZK7LBG/>K0-? V<O:PM!+VN=M<[1Q:T@(+<@^.>UK2YQ#0!J2>P'M
M*#4Q67QV5J_-X^=MFJ7.8V9FNQQ:=#M/B-?$(-Q 0$&IEY)H\9:?"SS)6PR.
M9&3M#B&GIN/9!P?]TP:1\GZ@DR53J.HZM>>_B@_0: @(" @(" @(" @(" @(
M" @(" @("#'T\Y!D0$'QQT!*"LYWU$XWA\;/?DL?,QP2-@V5_?<Z5WW6]@?I
M.N@\4$$,M9Y#%5Y+6XK'8KLB<()K[P9C%KK^% QLGO;QXC7V(,K.=<SE<!'Q
MJ1H)[O;8Z?\ 5!!S?UNSV:R5/$,R.,-'RIIG1N.\!Q+ -/?:W]2"_>FW,&0<
M;Q^)LUK,MFG$R)\L+!*-"?=.UAWAH![Z(.DCL@(-3*XV#)4+%*<?AV(W1N([
MC7L1](/4(/&%&0&.K#(Z?/MC:VP6GH7@:%P_RM-R#>0$! 0$!!AM1[XQ^'YI
M:0YK-=.H/1!F" >W1!BCGWRR1[2TQD#<1H#J =1^E!E0$!!#6)WMY3$QU@M@
M^2<37)T:7NF:UKOK[A!LQP7([\KW2NGK3Z%K'[0(-C0-&  %V_N=2@K.=]2,
M/QV,?G].6K8\N2:2*)GGAC&N+8R^1@V#S=-&CVH$'JGZ=24:-F;)5ZS<A&9:
MT<S=KM&.V/W#3[K_ '2@\R>H?IV;E1L=_'S0VY'P>8#'[LC6[@7$CX3VU]J#
M:L\Y]-:=@PV,KC8I  2-T9TU[>\T$((ZAR? 9OU"QL>"R->Y!6Q]TV(X"#M<
MZ2N&GH-/!!G]3ZUK_ _)[#YF[1CY!5;LT='TUD!=K[V\M'U(,'I7Q_--Q?YY
MRJ.*7D60V3></>?%#L CC!^%@#?NLZ>WJ@M.=X_5RE9@<]T-RN=]*\S^M@D\
M'-/L_:;V=XH(WBG)[]J6UALW#'3S^//OQ-=[MBOV;;B!^X_KT^Z>A01]W)6N
M9VI<7B)'P\;@<8LMEXSM-AP.CJM5WB/"20=NPZH)FQQC!7L+6H5X16@HD''2
MUQL?6?%T:^(Z:@C3K^UXH&"S=LVWX;+L$65KC<V8#;#:B\)H?I\'L^Z?HT02
M.7S%#%49+MV3RZ[.FH!<YSCT:QC1J7.<>@ 059O$YN4.&5Y'YM6>-PDPE.)Q
M:ZAH=6S%P[V#I[Q[ >[[4$O@LM=AL_DV;>S\T:TNKV&#:RW$TZ>8P>#V_P!H
MSP[CH@GR>FJ"F<KS0R]Z3AF*>V2]8B)RM@L$L-.J[H[S =6F:372-A^OP0:>
M!C=P*9F$G!DXM9>?R[*OZOKS/.I@N./<./5DKO\ )/@@OKW/\K6, OT]T'73
M[4'WJZ/KIJ1U0<\S=V[QC+3?X=C%JI;_ !<G2:TO9CWO/6[M9V8\.W/B[GXA
MXH-GT3KP1^G>/FA#2^V^S9FF;\,LDEB3633^=H"@^8CA'*J\&,I9#)U)L=AY
MG6ZT->"2-\LX+W1"9[WR>XTR$G:W7L@Q<8X=R[#V(91'B89G2RR9*[6\[SK+
M'OEF;"X/8!H))A[VNN@09,=PO+Q83'/MT:#\]7N0V;3XYYF1%M=Y,98?+<=P
M;H"- #H-3T02-6GR]G-Y\K+1J-QEFO'2<66WND;'!++(V;886@N<)=-N[I[4
M$5_@_DLW)/S&2GCZDC<BVR<M4L3QS25(Y-1'-6:P122.B_#+G.[(-UF(YL[U
M!.<?7H,Q@K_( "Q,93 )C*)-@B#?,.OPDZ#VH(3DO!>79.]R&Y4BK5[ER9K*
M-CSB1+2DACKSP3-V=.D7F-/71WZP^7.$\^J06</A++8*$V1??JY2*T^M-%'9
ME\R>*:$1O$NFKMIW#P0=1 T '\*#'8K0V87P3L$D,K2V2-W4.:>A!0(*\%>)
ML4#&Q1, :R-@#6M:.@  Z (-3+19*>NV/'VFTY?,89)G1^:?+:=7M:TD#<X=
M-2@W((HXHQ'&-K!V;KKW.OB@].#BTAIVN(Z.[Z'VH*KE<9;QF#CA%Z];DEFD
M?>L^[(7^;#)N\S7010M.G1@]WI]*#E'[ID,L=;D+WM<&RNJ/B+AIJUS)"@_0
M2 @(" @(" @(" @(" @(" @(" @("#'I^-J@R((C)YYU.^RE'6^8DD@?,P-D
M:USBU[8PT-/M?(!JX@?6@PR4<KD//%DOQPL01-!KRA\D<@)+]"1MZ>W;U0>,
M)P;C^'#G0P?,67G<^U:/G2'ZB[HW[ @GV,#0   !V &FB#Z@XK^\@[1O'P1J
M ZR[3ZA&@Z[B@V2A4L; U[X(R>@#NK0=$&[ITT0:[7V18F\QC1 T-,+P3N/3
MWMPTT&A09HWM>P/;V(U"#T@(*ER>?U";^:NPT==D$,$3\8[02S2RM.LL98XA
MHWM.C3X:?2@T*%WUBC:)+>-QEADFI\GSW12L#M- 2 YAV_K]J";@Y)E6YA]#
M(8:Q7KR63#1O1Z30NC#=6OE+"3'N<T]QTZ:H)V)DH'XKPYP)T(&G0GH@R("
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MU ^5H )]UKGZ GJ@[0@(" @(" @(" @(" @(" @(" @(" @\?VOV(/: @("
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M@EH<S<[KKV*",]"8!''RW0.!&:>PA_5P#:\0 )^U!U- 0$! 0$! 0$! 0$!
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M+6U]2X.8_0DR@^]]'9!=,??KWZT5NK(V6K,W?%(W71P)Z$:Z=$$=R3CL&7J
M"5]:] _SJ%Z+I)#+VU'M:1T<WL0@JV/Y%E.3Y%W&WNCIRTVG\YNUI-6V& [2
MVB3H=KCTD?W9\/=!?:M2O4A9!7C$<,;0UC&]@ @U<KBL?EJ4U"XQLT+]-S>S
MFN[A[7#JU[>[7#J$%?Q^=L\>G&'Y)8UA8TG'9R<M8RQ&T=8IG'0-L, U.O1X
MZCKJ$'QCI^9'=(U]7C+'ZMC<"V6^T=6N<#H65R=>G=X[Z!!8LA@\7D,<[&VX
M&OH.:&?+@;6AK?AV[=-NW3H1V00E#+6L#D(\-G)3+6F=LQ&7?VEU[5[![-F'
MW7=GCZ>B"7SN?QN%HFWD)1''N$<; TODDD=T;'%&.KWN/9H00.,X_D,[/^=<
MJBV;7%^+P6H=%5:-0R6;3H^P0>I[-[#VH,OI3&Z+T]P4;N[:H!^O<Y!;$!!I
M9G)PXO%V\C-_54X9)Y!XEL;2X@?H01?!,//C.-TX[(_OT[76KQ'C8LN,LI_2
M[1!84! 0$! 0? W:-!V]B".IY9UZW_<V-?CV[V.MDG1\C3H1%[0TM(<3]B"2
M08IWS-,?EM:X%P#]QTT;XD=#J?H043U8?<J<&NU('F2*6I:99DGD'F%ODDCP
M]X[B.R##Z+DOK<ILN:&&;/W&@#V0AD6O^\0=&0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0?-OO:H/J @(" @(.'>O\7G\DP$ TU?&6D.[:/F:WJ@[;6:UL+&LTV-
M: W;IIH/9IX(,B @(" 1J$%>L<:JX^W+E\+7;!D9'&2VQA+666GJYKQKMW'N
MUVG=!+XS(09&E';AU#)!J6.&CVN'1S'CP<T]"$'R;$XV:83S5(9)AVD=&QSO
MTD:H/M;%X^M.Z>"M%%,\;7RLC:UQ'?0EH'1!M("#0R^7JXVF^U9#RUI#8XXQ
MNDD>[X6,:.I<X] $&GC<7<M3MR>9T=9W;Z=+H656D::=.CI/VG?H03: @("
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M8]2YD;"=Q:S7L"XZH.FH" @(" @(" @(" @("#XX.+2&G:?;W0?0-$! 0$!
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MOJWE[,3'1QVJKGRQNZEA B&UQT:@[,@(" @(" >Q01N";I'==^W<G=_OM!_
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M40&>=CGN#0Y\#V@[G[ =3X;NFJ"L<9E:_P!=,UY9T863,.GCM9$#^L(.OH"
M@(" @((GC))Q\KB=2^U9)_Z=X_B02-NQ\M6DG\N2;RVEWE1-WR.T\&M\2@P8
MK)#(U38%:Q5T<6>5:C,,GN^.T^'L*"-Y%H_)X* ^-TS$?1#!(=?L+@@W<1/G
M)9;PR=2*M%'.64'1R>8Z6 =I'_LD^Q!(H" @(" @((;DW+L)QN"M-E9C$+D[
M*U=K6ESG22$#L.P&NI)03* @(" @YKZFPUI>?^GK)V-E8Z]9]QX#AJ(00>J"
MW9S!.FLPY7'/;7R]8;62Z>Y+%KJ8)M.[#X'[IZH(_2QR>>.&>5U+'4W:9#&
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MTT01&2R43<KF6S1N=!5HUV2;2 YWS#Y=0WV::!!8X&!C&L'PM: T'V#H$&1
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M+R#^W,[:-S^W@$$O^[4W3TLJ.Z:/LV7MT^EZ#JB @(" @(" @(" @(" @("
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M0?G!D==[^//+]N[E-UK@3U -B)W\2#]'H" @(" @U\E8-;'VK .AAADD!/\
M-:3_ !(-3C,+H,!CX7:;F5HMVG[18"?UE!)H![(*IC[/_P R9B#Y0V&27H8W
M2^Z6QZ5&N+R'?4&_:@M: @(" @(" @(" @(" @Y5Z@<@@PGJ/%>==AI3P<<M
M.KR6!K'YGS+"&EH]Y^_9IH$#C?+K_JA0DK14_P IQ<18,I+(]LLLF\![&5VZ
M:LW?ZP]A\/7J@Z1C\;1QM"*G1A9!5@;I'$SH ._Z=>I*"HLR@JMFY+@X)YL$
M^9[<I0,3HRX1G1URHQP!=_.'9XZCKW"X8RUC[-**?'.8^E*P20/B^!S'#4%N
MGM057F'+LJ^6'"\,?5N\ADF#;0E)DCJ0-_K)9MAZ:=@">I01U+B-[A-Z;.XP
M?F<%_63D=9D;63&0G<;-1K - /&+Q\.J"WG)29+%,LX&>"<3EHCL%VYC&N[O
MVC74M'W3X]T$DV%QA#)B)7%NV1Q&@<=-#[OTH.<\@SD?IO(QM:+YG#9$R?*8
MQKFM=4G/O%S2?AJ$GWSVB^KH@LO%^/VXWMSF<G9>Y!9CT?-'U@@B=U\FJ/!G
MM=W?W*"S=/8@KO*.-2WS!DL;(VIR"@'&A<(.P@]703@:;X9.SAX=QU00_P#M
M(:ZN,='0D?R\/^7DP(.KHY=.LKI.PKZ'<)/$=.Z";P/&Y:MJ3*Y.9M[.60&S
M6PW:V.,=1!78==D8_2>Y01_JS6JS< S'S$+9Q'$V2.-WA(U[2QP/@0[Q06N!
MTAC;YH#9-HW-!UT/CU09$'PM!.J#Z@CJ]&^^_9L7YF2UR6BE38W5D;6'<)'%
MPU=*7?8WP]J"100WRUW,27(,I49'A' PQTY?>EF+7]97EKMK6';[K>Y'Q:=D
M$QT: UK>@&@ \ $&I=JQ9"O-2L-D;7E :\M<6;VGJYNK3N /PN^A!M,CCBC;
M'&T-8P!K&-&@ '0 !!7,S)G\O>9BL4Y]#%%A=D,XPL,FG5OD50=VDA/Q2.;H
MWPU/8)O'4*F,HP4:K2VO78&1[G%YT;^TYQ+B?I*"*M\@?8RQP^*C%JS"0<C,
M';656'J-Q .Z4_=9^G0()FG#)!5CBEF-B1C0'S.#0YY'B0T!H^P(,&1R!KQ.
M\B(VK6@,=6-S0]VOTN.C1T/4H.'_ +Q^)A9A,1E,OMGR7GV((9(O,;&QCHGR
M1,V;M"=VW5Q0= ]"_P#^E?'3VUKN/L[RO07U 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 08K7S7DGY4L$VHT,FI;IJ-WP]>W9!E;KH->Z @("#X_X"@_.F&8VSE>
M&1:-/FYJ]8>TC7_Q&G_9H/T8@(" @(""(Y82>-Y-@.A?7?&/^<&W_C().O&V
M*)L8&@8UK1_1&G\2#(@^./3Z4%"QM=S_ %)N.'5L,L\Q;KVW5JL0<1]KD%^0
M$! 0$! 0$#4:Z>* @(" 4'S5!SG,8+$YWU?CK96I%=K5L"7B.9F]NZ2TYNHU
M\= @L?(,54H0,S- Q8^UCH]-W2.&2NS_ ,/+IH-O[!^Z>R#QBLC#R7Y'*T;\
MT-2ON%K&[0R03Z?U=D'WV[ ?@\>A060$-'3J@X7S/D^1J9K+X+A]N2+"2N8[
MD.49&Z2#%/E=^,Z)[.VX'5X'P]T'4N!\.P?%L)'2QA\[S?QK%YYW2V'OZF5S
M_'7P]B"1_,ZMR]:Q=9[S/#'^-/&WW(W/[-\PZM\S[VWV(*E'A+' ;!NXH/L\
M9G=YN9IZ%TT,I&C[L6WJX.[RLT^D()'/^H->O+C\?@(?SO,Y:,3T:\+]L3:[
MNUB:7J&1:^/CX(-KCW%#5,^0S#FY#.9!FR]8<W6)D9_\/ QVNV$=M/O=R@AQ
M8L\"G@IO:9N'6)A'!;>\[\:Y^ON2EVNZ NZ,/W>QZ:(+XR1A8"#J/:.J"M\G
MY-9KVH<-@XFW>0V0"V$_U5:)QT-BR1\+!]T=W'H/%!#R>FKZ369;%WI!RYDA
MFFR\YU^:W'WJ\[![ODN'1K6_!W'5!9./\C9EZTL;X32RU7W+V.E.KX93KIV^
M)CM-6O'1P00_J?Y_^SC+"R]C93"P2O9J&#\5FYWO=0 /:@MLMF)D(FZO8XM#
M3&"_7>0T:;0>G7N@^519,;7V &3.:#)&QVYC7:=0UQ#2?T(,DDL<8U>= 2!V
M)ZN.@[?2@](/$D\,3=TKVL;J!JXZ#4G0=_:4'@PO-ELOFN#&M<WRA\))(ZGZ
M1X(,DLT43'22O#&-!<Y[CH !W))[!!I7Z;[SJCXK+XZ\<@EDCBTTF;I[H+N^
MT'1W3N@WAT&I[^* "US=0=6GL1[$'QK8XQM: T>  T&I05[*V[^7DDQ>"N-@
M?7F$66O :R0,<W=M@!&PRGMJ?A[]]$$MB<1C\3394HQ>3"TEQZESG/<=7/>X
M]7/<3J7'J4&&WG*,66K8C>7W[;'2LA8"2V)@]Z1Y^ZW=HW7Q/1!BP?&X<;):
MLS3R7<C=?NLW9M XM!.R-K6^ZQC =  @Y%^];(W_  K@VZ]79!Q !ZZ-A=J@
MOOHG'L]*N,CQ^3:=?K<X_P :"\(" @(" @(" @(" @(" @(" @(" @(" @A\
M;+-1R<V)L/WPR!UG&R.[^67?B0DGN8W'4?S2/8@F$!!I9K+T\/BK.3NN+*M2
M,RS. U.UOL""-J\XXS<?CHZ]YCSEFO=1(!T?Y0U>W=V#FZ=6]T'(^"15[?,N
M*1M=[E<92UVUU/S$S6H.]H" @(&H0-1WUZ(*IS?DF!HX]L%R[&UT]BO'Y3#O
MDT$K7.]QNKOA:?!!M-Y<R9H..QEZ[NZM(A\EFGMW3&,:(,>4S7*JU&2VS&PQ
M,B;N>U\CIY=/$B.(>]M'70.0:>,.4S]-MZKR>-U27O\ E]>-NA]FZ4O<#]80
M8^)</IU>293.F]8N7C,^J73/W#8&1G1V@'4(+J@(" @(" @(*[F^(G)\DP^;
M%Z6N<47%U5O6.4.Z]1JW0^T]?!!8D! 0$$+RW*?EN MVA=AQSVAK([EEADBC
M?(\,:7M&FHU<@XYQ[U6P^/YW=NYO.C,N=0;3K/I4I(3YD<SG&,L/Q%Q'ND=P
M@M\WK+Q6VUC;>!S#A&1(QC\?*X->.QZ C4((^;U,X\<VW,XC%Y>"X_8S)@8^
M;98B;J V7IT>S[KOL*#!R?U=MY:@VGAL3FL=%/*&6,F:#GEL)!W!C'#XW=OH
M0;_'>:\+X]QZ#&TN.9BMCM-DF['O/F.(T>^70>^Y_P!XH-/"^KG%<%)+1AH9
MC\J8YSHFOI2'Y0'J(6^)8?N ]6]NR"5J>M_IU!&Z2.&_5B>XR.<:,S6ESSJY
MQT;XGN4#-^O'"*\$D=*TZ3(D-:V&Q#/%%&9.SYR6>ZW3K[7>""J\:YMZ><-S
M0E@SU3(U\T0,G.QI8^I,-7CRAIJ*Q<=/+^X>J"_Q>M7I<X$GD=5H'<N+F_PM
M0?;'JIZ47:TL%C/4)JTS3'-%*[5CF/Z%KFN&A!04IGJ5@L%,SC6&Y-5M8R^Y
MPQN3F>Z9V-;W=%(?[1@;TA/AV=T073CW(O3'#U7QT\]0?-.1-<MR6HW3SR$?
MUDKR[4G^#L@E7>H?!>@_Q#CP>_\ WF/_ $D%=S_)>$6;C<UAN18V'D-",[7&
MQ&&6(-"XUI]#JYATU:>[7=0@HW,/4/$<OX]9EL95F*9')7@AXZZ1HGFE,T9?
M)9\71-&[:WL1[SO8@Z[%R+B$);DVY>H(;P\FO*ZRWRG" D%L(+MGNDG=M\4$
M[7LP6(8YX)&2PRM#XY6.#FN:>H+2-004'WS(W2%@<"YNFX#N->H0>@]CM=K@
M=#H=#V(08'0U+#R'ELOE='1DAS6NZ.!+?VAX(,_8=$$98IV;UMHG=MQP;)%/
M1?&U[9]P #G/ZZ- U]WQ02443(HVQL :Q@#6M    Z  #V(-;*XV+)49*4TD
MC()M&S>4[:YS-?>9N[AKQ[KM.NB#/##%!!'# P,BB:&1QM&@:UHT  ]@""&Y
M#7S>1UQM&5U"N\#YK(-/XOE.UW-K?LR]/B<- "@EZM6&K R*/7:QH;N<=7.T
M &KG'JYQTZDH(G.Y;)MD&,P\#9<G.TN$TH/D01ZZ>;*1\77X6#JX_0@VL'B1
MCZ3(Y)Y+=GJ;%R;0R2/)U+CIT;U[-'0(/.<SL.,C8UK?F;\X<*6/8X"6=[1K
MHT'P'=Q\!U0<%_>-P]VQ6XO-:8QN=OV'P3ECI7P1:1@[86G7W>OO$#KH@[%Z
M40^5Z;\<8>A92C!T&@UTZ]"@MB @(" @(" @(" @(" @(" @(" @(" @(-#-
M8PWJK?*=Y=RL\3TYOV96=M?YKAJUP]A0>\3D69&C'9:PQ/)+)H"=71RL.U\9
M(_9<-/I[H-Q!%<IK8NSQ^]#EG.9C71DVG-UU#&D.Z: GP]B#C_"LKZ;Y3EUB
MQ#6L8ZW!+9FIUQ(759"&$/E;'I^&\Q_=0:?H;(VSS:0Q[G0T:4[*Q([,?."-
M3[2"@_0*#'/8@KQ^9-(V-FH;N>0T:N.@&I]I*#6R.6KX^)LDS)7EYVLCAC?*
M\GV;6 H(V;.YJ?1N/PDKFN[S6WLKL']'5S_U($%+EUIA^=O5J0/01U(C*0/^
M4F\?Z*#U)P^A8VF]9M7G-&GX\SPPCQUCC\MA^T(-'-<;P%2''_+XVK'Y60J.
M9I&UNCC*!NU'B@M8&B 02.AT04H\ CPN?L\EX\XLL2M=\QB20V";<=S]IZ;'
MG3W3V0;7 +T=J+-/V.@G.4L.FJRD":,EK-!(T$Z:Z=/:$%K0$! 0$! 0$! 0
M$! 01'*^.5>1\?OX6T]S(+\1A?(T N:"==S0[4:@H/RGP+T]IW?4>#!7KK_(
M;9OU_.JN+96R4="UVNAVAVH(0?H-GH[1CUV<ES[0=.U]WA_10?9?1W&2Q/BE
MS^<D9(YKG[K\A):.[?J*#Q:]#^(V98Y);>4=Y;/+8TWIB WP[G7Z>Z#9POI%
M@\+;=9QN3RL)?!)7+#<>]H\P@[VAX.CQMZ%!M0^G]N*$Q-Y1F-OFND83.PN
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M[)5GM>+%:U6!W!XTV>4_[IU00/[NS7?,Y^0[MA,.C-3H-7R>'Z$';4! 0$!
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MX>Q@ZF3(XYGZ;D:"\(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?+'Y3XK,[I8]"0=0TCH>G=!94! 0$! 0$'ELC'.<T.!<WX@#J1K[4'I 0$!
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M=OFYG&-U_P#S3#_$@N: @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MAK YSVM[@Z>\.R#J/")0[CE:$XS\HEJ U9Z(C,<;9(?<>8=?CC)&K'^(03J
M@(""I\]/]XXNSP?FZVI_R8Y7#^!!;$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M>'_S+B+?%V:CT_HUYC_$@MR @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$CKP?69#Y<U?RF R2_ZW?W;_ )(Z(,4-//,H"&3(MEN"3<ZV86@&/=KL\MI
M!V]-4&X66_-D(E C<T")FW7:_K[Q.O7ZD&NVKF ^H7706Q;OFP(FCS]1TTZG
MR]/H0>74LTZI:B_,=MB5Y-6R(6:Q,Z$-+#[K_K*#/\M<^8?)\V[RG0^6V$,;
MHV377S >^OT=D&O%B[[6TO-R5B1]0.$S@(VBP7#361H:>WAMT0?:S[%1T%!X
MLV_PW/=?<&EONG4->01[QUZ:!!%YGD4/^&[5B7'WPR=LU;Y?Y=SI1[KAN<UI
M.C#^T@Y'^ZF]@;R./3:\_*%HZD;0'CO]!0?H) 0$! 04SE_#\IR/D--TTSJV
M&I5; CDK3-98-FP/+<'-DBE;L\K5O?7WB@@CP3EN2I\1Q^;KU9:V"=(+TT5N
M5DCXS&88C'LB8=S&$'XAJ0@Q7?3O.NBQ.-.&QN2Q6%^;9$+%N6-UEMDC;)*&
MP.VR]-7G4ZNU/1!/7./<RS9P\>7DAIUZL\UJT:$[FRL>"]M5L9?$6O$;'#<3
MIJ>O@@E.!X3+X/"'%9!S'QUII!CW-E=,X52[6)DCG,C]Y@.WH$%C0$! 05'G
M!;^><.8>YRY('^34G06Y 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$%?]02T<)S1=\(JOUU^I!&>D,_G<%IC;M,4MB(_26S
M.Z_:@N: @(&H0$'S4ZH/J @(" @(" @(" @(" @(" @^%@)U_P#X(/$L0?"^
M/MO:6_1U0<)_=HKSU<MR^HX#9!-%'TZ#='),PZ?7H@[T@(" @(-'.YFKA<39
MREL.=7JMW/;&-7'4AH#0=.I)T0;R @(" @(" @I_-A_\S<*)[#)R_I-*?1!<
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M5SU&_P#H;-?^[/\ XD$)Z(VGV.$Z/_L;EF-O33H'[OM^)!?D!!A=;@;.('/
ME<TO#/':W34_K0>=]B5H+&B(A^A#_>U:#X:'[P[(,3\/2?D69![7.LQ-VQ.+
MG%K0>^C-=NOTZ(-T=D! 0$! 0$! 0$! 0$! 0$! 0$ ]D'%_02/9R3GC=H81
MD&M^T23(.T(" @(""I\_!N_D>!;U_-<E#Y[?;7IZVY?L_!:W[4%L0$! 0$!
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MAS^6\+C^[\]9D/\ 0I2_RH+>@(" @(" @(" @(" @(" @(" @(" @(" @("
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M;6:P[&OV!Q;IU0=7A]0N.2C5QM0$=Q-4LL/ZXT&3_'W%1\5]K/\ +CF;_"Q
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MS  -KNO5!9./7[MRBXWFL;<KS35IS'KL>Z%Y9YC0=2 \#=IX=D$F@(" @("
M@(" @(" @(" @(""L>H7F'#5!&='NR>/#=>W_>X]?U(+,WL@^H" @(" @("
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MQ8O#P>18J2:9\V!N%38='0#:1ODD^Z1TV^]]""0X$US.-0L=W;/; ZEW06I
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M1!>4! 0$! 0$! 0$&K<<X3U #H#(=1[?<<4&T.R @(" @(" @(" @(" @("
M@(" @(" @(" @((;E+]E" Z ZW*@T/TV&#5!,-\0@^H" @(" @(" @(" @("
M @("##'>I2N8V.Q&]TF[RPU[27;.CM-#UV^*#,@(" @(,$%ZE/--!!8CEFK$
M-L1,>USHRX:@/ .K21[4&"MCGMO27K,OG67 QPZ M9%"3KL:W4]20"YWCT\
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M(" @(" @((GDK]M&/IKNM56Z?7.Q!*CN4'U 0$! 0$! 0$! 0$! 0$! 0$!
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MX7J>O_3M03 \4'U 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0<PXGF,JSU.RE:W>L3T+TF0BJ597:PQ24I('#RF^&L<QU^I!T\'4
M:H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""
M(Y*/[E#_ .^5#_U[$$LWM_N]J#Z@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @((SDV>K<?P%_-VFN?6Q\+[$K&:;BU@U(;KXH-ZG8;9JQ
M6&ZALS&R-!TU < X=OK094''W225^0TLL- VMS&Y0DUZ:,OUVQZ_YP:@Z^W4
M-&O5!]0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 01/).M2#_WNK_Z]J"5'B@^H" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(""E^LH8[TSSD<G]5-%'%*!XLEGC8\?YKB@V/3C(69,#+C+;
M0VY@[<V+DTUT<RN1Y+^I)]Z%S"@MB#D^<IL=PSF5@>\^AGWY)GAHZJ^O*?\
M>M*#JL$C9862M.K7@.:?H/5![0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 01?(#I4A/?^]5M?^F:$$F/XT'U 0$! 0$! 0$!
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M$! T0$! T0?-K3W 0-C?8/T(/GE1ZZ[1K[= @]! 0$! 0$! 0$! 0$! 0$!
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MS,<'-FS5AS7#Q'DP@(+6@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @("" Y=AK>6JT:]<#2'(T[4Q<=/PJ\PD=I]/NH)YNNG7N@P7Z<-V
ME/3G:'P68WPRL(U!;(TM=^HH*'Z&4;5'ADU2VYS[4&3OQ222:[WB*8Q,<=?Y
MC&H.B(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @CLC
MG*-"]CZ=EVR;)RN@J#3HZ1D;I2-?#W6%!ZQ>:HY-UMM1^\T;+Z=GH1MFC +F
M]>_Q!!DRN2BQU-UN4%T;7,9H.Y=(\1M ^MS@@U\)F(,F+CH6.8VI:FJ/W:>\
M^$@.<W37H4$F@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(""D>H.';E\CB*3#Y=]@MV\9/V,5JNQCHI&GPZG0_04%$Q_/\Q3QUJWB17J
MNGR>3N3U+D;@ZTZ&=D+Z4.T@B8O<7 Z'ZM$$_F)<QF>,V;>=C\RE)FJ\$.-?
M"8S!6BO-A)+FNWO<\$.W'IXA!J8ZWDN*9>E#2#:W'K7(Y\0W%MCZ;9XBYL[Y
MWE[]WFM]WL-.B#KK?A"#Z@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @:H&J!J@:H&J!J@:H" @(" @(" @(" @(" @("
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M4N/L07A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$1RBC'=QS8
MGTI;^V5DC88)S6>'-U(>'A\?PGZ4%6&*F=C)\:>)VI:EJ1DTXFR;'%[F:;=T
MCI7/T&T>[KH@SWZ%ZY/<?8X@Z89)L8ODY%C0_P G3R]6-=ITT'4?:@S10Y(6
M;EH<7\JS=A;7L2'(-UDC8-K6ZM)VZ#Q&A0:4>%M1T+6/9P[2G= %J$934/ .
M[Q/B>^G?Q0;6&JY'$E[J'$O)?*T,?([(,D?L;V;ND+G!OT! Q]/(XV]+>I\6
M>RQ,-)GNR>\.[#4M>YS2=&CKH@]48LM2R=K*5^-3_.7?^\.=DV/8X:ZC1CWE
M@V^&@Z#H$$JW-\G)Z\><![?FX#_ @A'4KHQLM#_"MGY22R;CV?F3 ?.+Q)NW
M>9O W^]IKIJ@N\3W/8'.;L<0"6D@Z$CMJ.B#V@(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(![%!A'QH,@[C[4'EW@@]^(0#W0$'D=_L0?6H/+>X0
M>QXH/J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex1051006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1051006.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ -@#( P$1  (1 0,1 ?_$ ',   (!!0$!
M       )" ,$!08'"@(! 0                     0   & @(" @$# P,"
M!P    $" P0%!@<($1( $R$)%#$B%4%A%E$C%W$R@9%"4C,D&!$!
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MK-+W*_:<9Y=3,[A)_89]T,A*2N(K=$'5L6#G3J1=+.'+1JV?,';@1.8A0X
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M3,0Q!X\"8.-].]8L,H!'XKUUQ+3TBN$WYG450ZQ[%W11-T.+UZBYDT%T! #
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MG3S>,G%5M<M3LI9/D6"+?'9,@VNK04A$UIG79L$URDL*K&.<*CU%4_'40;/
MC7!15_QT(8$>C3W?P_\ '^KI^,3\/O\ @")>GXO7U]O_ $<=?CP,]X!X!X!X
5!X!X!X!X!X!X!X!X!X!X!X!X'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ex1051008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1051008.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ +P#( P$1  (1 0,1 ?_$ '4  0 !! ,! 0
M       ( 0(&"0,$!P4* 0$                     $   !@$# P($! 8"
M P     ! @,$!08' !$((1(3(@DQ05$4<8$C%6&A,D)2%L$7<M(S$0$
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M+1D\EFO[<LAX\78G@YK*^37J\2*7[K'M:A1VDM()2<:FN55=NOX54T?4)=A
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)#0- T#0-!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ex1051007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1051007.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (P#( P$1  (1 0,1 ?_$ '0   $$ P$! 0
M       "!@<( P0)!0$* 0$                     $   !@(" 0,!!P(&
M P     ! @,$!081!P ($B$Q$R)!43(4%1<),Q9A<:%2(Q@E)QD1 0
M              #_V@ , P$  A$#$0 _ /WA;&O]2U;2;!?[W/LZM4*PS(^G
MK"_^3\I$LCN4&GYI;XF[HXE*LX* ?0(9$,X#(@#J:.2KH_()RY*/B<?8H#@#
M?2)@((IX'Z1$ R'KP-DJA#_@.4WH4<E, A@V?$<@/L;'IP$J+H)!E59),,@7
M*BA2!Y". +DP@ "(^P?;P%&4(0 ,<Y"E'&#&, %'R$ +@1'&3"8 #[\\!? .
M < X#5LEXIE/6@6UKM]8J[FTRX0%90L,]%0JUBG3-G#T(6#3DG38TK+"S:JJ
M@W0 ZPIIF-XX*(\!S)J$4+DIRG]LB40'\10.7V_W$$!#[P'@*$Y"C@QB@.!-
M@1 !\2^YL>^ X&--P@L(@DLDJ)1P8$U"'$HXS@?$1P./LX&;VX'A3=HK5:1_
M,6.Q0< @!?,5YN6812/@(B'E\K]P@3QR AG/V<" IKMGHME^IMZYLNN;(GH]
M/Y INJ#_ +GW%TL<Z:*<>RA:6K+*JOC+JE#Q5%$A -E11,@"< T3;BV#=W+>
MI:]IY8B?42%2YV.TN6KJ%U21RB1:,AY9I".G"D_L.1;*%6_2&RWQ1P& 7;@/
MI*H#DU-"7*,L%G7F]I6#9\&1"-BFSB68U5%LPL[8TDM97+$];9LQ29D(9JV!
MFJ*PMU4CB)_(YL!83@' . < X!P#@4!_DC:1-RZIW'5,Y*-(%EN.[:PU.,B[
M68@8[:Q;"K;B;09-7Y#@]?C6HY\H1),BB@IIF.3ZBAP).4V+MV\,P2TM0J\R
M@5BE3B[UN=]+UN/=HMVY$ >P5$CXU:Z/VY?$HD.^+$E7P(DP&#"&;]J-^3;D
M'DYV5D*\95NF#F,UYJNEQ$:@IG/QQTA="W.>411#(%.JH(F <XSZ #$V!K6C
M:RK9IW=_:?=24+(R;.+(^M&UXVDM7<M,/D63")AFU*KU<D5'D@]<D3;-&8K+
M&,8I #&>!,U6ZU:=KKIE*H5EQ,RK!XRD&DQ;;!9+;-)O(THE8.32-CEY)?R0
M*/F4H@'B<<X >!,M@GXJL13V<G9*-A86,:KO928F7J$9$1;-NF*BSZ3DW9TF
M4<Q;E 3*++'*0A0]\XX&E6[?7K>BJ\K$S$SS!LX.R<O(B19R2#=\FDBN=HLJ
MR7722<))+$$Z9A!0H*$-CQ, \!S\ X%"OY =#OMN:786*OT.$VM>-*7B&V_4
M]=3S-JNTOS:'2EHJ]4 3NSBBFYMVO)Z2:,C@ *(R!6ZA# <I3%!@]8-SP+:_
M:WU?6;>M<]&[JTXXVWU@G+(Z<J6>(CJ9.M(O86F9%S(.#SDNZU^A)1:R O$_
MSD>1-=HX,<R(G,%KMK;RJM)=*U&/FV3K;<Q"OB4NDQL:K;K-(3)F2KI@L^JL
M(Z1FFT$T,0JZZSM:.9BCG+@O KQJWKMORXN).S[\[$[G9FD%':T;2:%::C0X
M1DTD'"3IH52/HM>5<L4HUN4S=N4TW).5"")UW*A_$"!%?9[K[J6F14-#13"[
M[,W=MVPQFJ]50FS-R[GL<!,SDR520F[-:ZW'W-FREJCKZI,WDQ*E,FDD+=@5
M YB&<)"<++T+HQU?JD+&).-/ZXMLVTCD&SZS62HQ\XXEWQ42$?2AXV;-*L&@
MOUR"H"1"B!""4OD;Q\Q",NX^Y8CJ!HV)@]$T_7[/=VZ;7':GZ\5!RPC:O7)+
M8=H9.UG5SMK6OM62R6O-25-N]LUE<?$($C(PZ.0463'@5QZT[6C):K7OI=U)
MM=HV[<M'S$)5^R/<FTD;KU -I7H'=BV[;(^VB91IL;=C:8%1<L9'IG:Q1EVI
M%%2I( 4P=)HXVI.I>CV+21L,51-3:LKHD>V.\6 C5I&LTCBLYDYZPR)S?/(S
M$DZ476.83J+.EC 0HC@H X4-[:D<S55K2.Q:,:S7:(C9ZJUD]JB&]CL$-,L_
MU"(DH:#=.&\D^0DF _,B4$RJJ$ 1*0<#P)&"8;?,W:J'10=.CN"MT%7"!3N
M;%*=4S<IE"*N0(10HG^,A_C$<&P.,AN-'B+LJP)+MUE&JYFKLJ"I%/R[DI$U
M3(+% PG16*DJ4PD.!3@!@$0P(<!:Z_P"D @405/X9,HF01-C)4TRG,4555,#
MXE#[N!F*8#E P" @(9 2CD!_R'@*X!P./7:J>9;@[^=:]/+,Y"TZ\ZE5*_\
M<[>D)6HY>POSVAXT+J;KU50A8P%Y!U..'=CG)L&HD_YFC,YA#QQP+@*=CYV5
M7<U_7G67L%:R-16;_KEBJ];U53@*Q3*DF)9+9,]#2BB*@IE^,R,:H4P#D/;
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M#%4VJ&*DJ"Y/!9ZHJL4I/(  .A81; HJB#9,3+'%50YB@8PJF  %4!-GQ4P
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MDU+\?@D!/B_!X"8GCZF' >(A@!$XCC[QS[\#(+=$WXDRC])2^OK@I!R4 ^[
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..P#@' . < X!P#@' _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ex1051009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1051009.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (P#( P$1  (1 0,1 ?_$ 'D   $#!0$!
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MQW!3!(BJ*=IVKUFR?<?4^HY0,*JR:3=V"V[<RA2B.@EA]\HHF*B29  JYDQ
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>>H?O#^N@SZ T& ?4?WC_ %T%-!F)_:'\?ZCH/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800913824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Mar. 14, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NANOPHASE TECHNOLOGIES Corp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NANX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity a Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity a Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity's Reporting Status Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,265,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingParValuePerShare', window );">Entity Common Stock, Par Value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,229,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The par value per share of security quoted in same currency as Trading currency. Example: "0.01".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document And Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804849024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,779<span></span>
</td>
<td class="nump">$ 1,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable, less allowance for doubtful accounts of $5 and $6 on December 31, 2016 and 2015, respectively</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">772<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">442<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,427<span></span>
</td>
<td class="nump">2,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Equipment and leasehold improvements, net</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, net</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4,842<span></span>
</td>
<td class="nump">4,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Current portion of capital lease obligations</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">669<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">521<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,297<span></span>
</td>
<td class="nump">878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Long-term portion of capital lease obligations</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Long-term deferred rent</a></td>
<td class="nump">466<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsNoncurrent', window );">Asset retirement obligations</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">754<span></span>
</td>
<td class="nump">835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingent liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.01 par value, 42,000,000 and 35,000,000 shares authorized; 31,229,996 and 28,585,496 shares issued and outstanding on December 31, 2016 and December 31, 2015, respectively</a></td>
<td class="nump">312<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">97,359<span></span>
</td>
<td class="nump">96,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(94,880)<span></span>
</td>
<td class="num">(93,597)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">2,791<span></span>
</td>
<td class="nump">2,861<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 4,842<span></span>
</td>
<td class="nump">$ 4,574<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capital lease obligation due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45023-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45023-112735<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800836768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade accounts receivable, less allowance for doubtful accounts</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ .01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">24,088<span></span>
</td>
<td class="nump">24,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ .01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">42,000,000<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">31,229,996<span></span>
</td>
<td class="nump">28,585,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">31,229,996<span></span>
</td>
<td class="nump">28,585,496<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804895776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product revenue</a></td>
<td class="nump">$ 10,720<span></span>
</td>
<td class="nump">$ 10,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSalesRevenueNet', window );">Other revenue</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total revenue</a></td>
<td class="nump">10,783<span></span>
</td>
<td class="nump">10,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">7,543<span></span>
</td>
<td class="nump">7,199<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="nump">3,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">1,554<span></span>
</td>
<td class="nump">1,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="nump">2,954<span></span>
</td>
<td class="nump">3,019<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,268)<span></span>
</td>
<td class="num">(1,178)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before provision for income taxes</a></td>
<td class="num">(1,283)<span></span>
</td>
<td class="num">(1,192)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,283)<span></span>
</td>
<td class="num">$ (1,192)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted</a></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of basic and diluted common shares outstanding</a></td>
<td class="nump">30,911,869<span></span>
</td>
<td class="nump">28,574,902<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after sales adjustments, returns, allowances, and discounts, of revenue classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800750496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning at Dec. 31, 2014</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 285<span></span>
</td>
<td class="nump">$ 95,966<span></span>
</td>
<td class="num">$ (92,405)<span></span>
</td>
<td class="nump">$ 3,846<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, beginning (shares) at Dec. 31, 2014</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,516,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercises (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,192)<span></span>
</td>
<td class="num">(1,192)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Dec. 31, 2015</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 286<span></span>
</td>
<td class="nump">96,172<span></span>
</td>
<td class="num">(93,597)<span></span>
</td>
<td class="nump">2,861<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, ending (shares) at Dec. 31, 2015</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,585,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercises (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,283)<span></span>
</td>
<td class="num">(1,283)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, ending at Dec. 31, 2016</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 97,359<span></span>
</td>
<td class="num">$ (94,880)<span></span>
</td>
<td class="nump">$ 2,791<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, ending (shares) at Dec. 31, 2016</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,229,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66904339&amp;loc=d3e4534-113899<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65896087&amp;loc=d3e11149-113907<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65896087&amp;loc=d3e11178-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801050112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,283)<span></span>
</td>
<td class="num">$ (1,192)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustment to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">610<span></span>
</td>
<td class="nump">735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of fixed asset</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities related to operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="nump">73<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(110)<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(194)<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">161<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">241<span></span>
</td>
<td class="num">(240)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
<td class="num">(241)<span></span>
</td>
<td class="num">(240)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisition of equipment and leasehold improvements</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(280)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Payment of accounts payable incurred for the purchase of equipment and leasehold improvements</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash used in investing activities</a></td>
<td class="num">(165)<span></span>
</td>
<td class="num">(288)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Principal payment on capital leases</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
<td class="nump">988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">910<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase/(Decrease) in cash and cash equivalents</a></td>
<td class="nump">504<span></span>
</td>
<td class="num">(587)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">1,275<span></span>
</td>
<td class="nump">1,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">1,779<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental non-cash investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable incurred for the purchase of equipment and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsIncurred', window );">Capital lease obligations incurred in the purchase of equipment</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68055307&amp;loc=d3e2420-110228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase during the period in capital lease obligations due to entering into new capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797183936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Business</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman Bold,serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"><td style="width: 0.5in; text-align: left">(1)</td><td style="text-align: justify">Description of Business</td>
</tr></table>

<p style="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nanophase Technologies Corporation
(&#8220;Nanophase&#8221;, &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221;, or &#8220;us&#8221;) is an advanced materials
and applications developer and commercial manufacturer with an integrated family of nanomaterial and related technologies. We produce
engineered nano and larger, sub-micron, materials for use in a variety of diverse markets: personal care including sunscreens,
architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics,
energy, and a variety of surface finishing technologies (polishing) applications, including optics. We have recently expanded our
offerings beyond active ingredients to include targeted full formulations of skin care products, marketed and sold by our wholly-owned
subsidiary, Sol&#233;sence &#8482; LLC. We target markets in which we believe practical solutions may be found using our products.
We work closely with current and potential customers in these target markets to identify their material and performance requirements
and market our materials to various end-use applications manufacturers. Recently developed technologies have made certain new products
possible and opened potential new markets. We recently developed new material solutions in the light energy-management area (particularly
solar control) that have been taken to potential customers, and for which we are experiencing early-stage, accelerating revenue
growth. We also developed a new solution for surface treatments (coatings) which we used to launch new products in personal care,
including those of our subsidiary, Sol&#233;sence &#8482; LLC, in the fall of 2016. Although our primary strategic focus has
been the North American market, we currently sell material to customers overseas and have been working to expand our reach within
foreign markets. The Company was incorporated in Illinois on November 25, 1989, and became a Delaware corporation during November
1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While product sales comprise
the majority of our revenue, we also recognize revenue from other sources from time to time. These activities are not expected
to drive the long-term growth of the business. For this reason, we classify such revenue as &#8220;other revenue&#8221; in our
Statements of Operations, as it does not represent revenue directly from our nanocrystalline materials.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6003-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=SL51803626-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6694344432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman Bold,serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"><td style="width: 0.5in; text-align: left">(2)</td><td style="text-align: justify">Summary of Significant Accounting Policies</td>
</tr></table>

<p style="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Use of Estimates and
Risks and Uncertainties</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial
statements requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying
notes. Actual results could differ from those estimates. Certain assumptions are also necessary to assess the impact of risks and
uncertainties on the financial statements, such as cash flow projections, availability of capital if needed to support the ongoing
operations of the business, and our expected compliance with contractual commitments. These risks and uncertainties are further
discussed in Note 12. Any changes in these assumptions or business plans could have a material impact on the financial statements.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Cash and Cash Equivalents</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash and cash equivalents primarily
consist of demand deposits, but also include certain lower risk investments with a stated maturity upon acquisition of 90 days
or less (e.g., money market funds or a certificate of deposit with a maturity of 90 days or less at the time of purchase).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"><b>Trade Accounts Receivable</b></p>

<p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Trade accounts receivable are
carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts
on a monthly basis. We determine the allowance for doubtful accounts by identifying troubled accounts and by using historical experience
applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts
receivable previously written off are recorded when received. Our typical credit terms are thirty days from shipment and invoicing.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Inventories</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Inventories are stated at the
lower of cost, maintained on a first in, first out basis, or market. We have recorded allowances to reduce inventory relating to
excess quantities of certain materials. Write-downs of inventories establish a new cost basis, which is not increased for future
increases in market value of inventories or changes in estimated excess quantities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Equipment and Leasehold
Improvements</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Equipment is stated at cost
and is being depreciated over its estimated useful life (3-20 years) using the straight-line method. Leasehold improvements are
stated at cost and are being amortized using the straight-line method over the shorter of the useful life of the asset or the term
of the lease (3-13 years). Depreciation expense for leased assets is included with depreciation expense for owned assets. From
time to time we have self-constructed assets. These assets are stated at cost plus the capitalization of labor and are depreciated
over an estimated useful life (7-10 years) using the straight-line method.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Long Lived Assets</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We review long-lived assets
for impairment whenever events or changes in circumstances indicate that the asset&#8217;s carrying amount may not be recoverable.
We conduct long-lived asset impairment analyses in accordance with ASC 360-10-15, <i>Impairment or Disposal of Long-Lived Assets</i>.
ASC 360-10-15 requires us to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent
of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash
flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is
measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis
or appraisals.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"><b>Asset Retirement Obligations</b></p>

<p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with our leased
facilities, we are required to remove certain leasehold improvements upon termination of our occupancy. We follow the provisions
of the FASB issued ASC 410-20, <i>Asset Retirement Obligations</i>, under which we recognize a liability for the fair value of
these asset retirement obligations. The fair value of that liability is measured based on an expected cash flow approach and accretion
expense is recognized each period to recognize increases to the fair value of the liability due to the passage of time. Increases
to the fair value of the liability, except for accretion, are added to the carrying value of the long-lived asset. Those increases
are then reported in amortization expense over the estimated useful life of the long-lived asset.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity in the asset retirement
obligation account for the years ended December 31, is as follows:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td><td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid">2016</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td><td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid">2015</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; text-align: left; text-indent: -9pt; padding-left: 9pt">Balance, beginning</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%">$</td>
    <td style="width: 8%; text-align: right">172</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%">$</td>
    <td style="width: 8%; text-align: right">166</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.15in">Accretion of liability due to passage of time</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">6</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">6</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2px; padding-left: 0.15in">Amortization of asset due to passage of time</td>
    <td>&#160;</td><td style="padding-bottom: 2px; border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 2px; text-align: left">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 2px; border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 2px; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -9pt; padding-left: 9pt">Balance, ending</td>
    <td>&#160;</td><td style="border-bottom: Black 2pt double">$</td>
    <td style="border-bottom: Black 2pt double; text-align: right">178</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td style="border-bottom: Black 2pt double">$</td>
    <td style="border-bottom: Black 2pt double; text-align: right">172</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>



<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Financial Instruments</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We follow ASC Topic 820, <i>Fair
Value Measurements and Disclosures</i>, which defines fair value, establishes a framework for measuring fair value, and expands
disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into
three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure
of fair value, whereas Level 3 generally requires significant management judgment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our financial instruments include
cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with the promissory note with no related
borrowings described in Note 3, and any borrowings on the working capital line of credit described in Note 3. The fair values of
all financial instruments were not materially different from their carrying values.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There were no financial assets
or liabilities adjusted to fair value on December 31, 2016 and 2015.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Product Revenue </font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Product revenue consists of
sales of product that are recognized when realized and earned. This occurs when persuasive evidence of an arrangement exists, title
transfers via shipment of products or when delivery has occurred, the price is fixed or determinable and collectability is reasonably
assured.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Other Revenue </font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other revenue may include revenue
from technology license fees and paid development projects. Technology license fees and paid development projects are recognized
when earned pursuant to the agreed upon contractual arrangement, when performance obligations are satisfied, the amount is fixed
or determinable, and collectability is reasonably assured.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Shipping and handling costs
are included in other revenue when products are shipped and invoiced to the customer. We include the related cost of shipping and
handling in cost of goods sold.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><b>Research and Development Expenses</b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;Research and development
expenses are recognized as expense when incurred.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Income Taxes </font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We account for income taxes
using the liability method. As such, deferred income taxes reflect the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets
and liabilities are calculated using the enacted tax rates and laws that are expected to be in effect when the anticipated reversal
of these differences is scheduled to occur. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,
it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When tax returns are filed,
it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are
subject to uncertainty about merits of the position taken or the amount of the position that would be ultimately sustained. The
benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence,
management believes it is more likely than not that the position will be sustained upon examination, including the resolution of
appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that
meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent
likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax
positions taken that exceeds the amount measured, as described above, is reflected as a liability for uncertain tax benefits in
the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities
upon examination.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not recorded a reserve
for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing
of such deductibility. We file tax returns in all appropriate jurisdictions, which includes a federal tax return and Illinois state
tax return. Open tax years for both jurisdictions are 2013 to 2015, which statutes expire in 2017 to 2019, respectively, under
most cases and subject to appropriate laws and regulations. When and if applicable, potential interest and penalty costs are accrued
as incurred, with expenses recognized in selling, general and administrative expenses in the statements of operations. As of December
31, 2016 and 2015, we had no liability for unrecognized tax benefits.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Earnings Per Share</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Options to purchase approximately
859,000 shares of common stock that were outstanding as of December 31, 2016 were not included in the computation of earnings per
share for the year ended December 31, 2016, as the impact of such shares would be both negligible and anti-dilutive. Options to
purchase approximately 210,000 shares of common stock that were outstanding as of December 31, 2015 were not included in the computation
of earnings per share for the year ended December 31, 2015, as the impact of such shares would be both negligible and anti-dilutive.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><b>New Accounting Pronouncements </b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During May 2014, the FASB issued Accounting Standards
Update (&#8220;ASU&#8221;) No. 2014-09 (&#8220;ASU 2014-09&#8221;), <i>Revenue from Contracts with Customers</i>, and several related
updates including ASU No. 2016-08 and ASU No. 2016-10, which supersedes nearly all existing revenue recognition guidance under
U.S. generally accepted accounting principles. The new standard requires a company to recognize revenue when it transfers goods
or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services.
Additionally, the guidance requires certain disclosures designed to help users of financial statements better understand the nature,
amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for annual
reporting periods beginning after December 15, 2017, including interim periods within that reporting period, which is our first
quarter of 2018. The new standard allows application either retrospectively to each prior reporting period presented or retrospectively
as a cumulative-effect adjustment as of the date of adoption. We are evaluating the effect that ASU 2014-09 will have on our financial
statements and related disclosures, but do not expect it to have a material impact on our financial position, results of operations,
or cash flows.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During February 2016, the FASB issued ASU No. 2016-02
(&#8220;ASU 2016-02&#8221;), <i>Leases (Topic 842)</i>. This standard requires the recognition of assets and liabilities arising
from lease transactions on the balance sheet and the disclosure of key information about leasing arrangements. Accordingly, a lessee
will recognize a lease asset for its right to use the underlying asset and a lease liability for the corresponding lease obligation.
Both the asset and liability will initially be measured at the present value of the future minimum lease payments over the lease
term. Subsequent measurement, including the presentation of expenses and cash flows, will depend on the classification of the lease
as either a finance or an operating lease. Initial costs directly attributable to negotiating and arranging the lease will be included
in the asset. For leases with a term of 12 months or less, a lessee can make an accounting policy election by class of underlying
asset to not recognize an asset and corresponding liability. Lessees will also be required to provide additional qualitative and
quantitative disclosures regarding the amount, timing and uncertainty of cash flows arising from leases. These disclosures are
intended to supplement the amounts recorded in the financial statements and provide additional information about the nature of
an organization&#8217;s leasing activities. The amendments in this standard are effective for fiscal years, and interim periods
within those fiscal years, beginning after December 15, 2018, with early adoption permitted. We are currently evaluating the impact
its adoption will have on the presentation of our financial statements and related disclosures.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During August 2014, the FASB issued ASU No. 2014-15,
<i>Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern</i> (&#8220;ASU 2014-15&#8221;).
ASU 2014-15 will explicitly require management to assess an entity&#8217;s ability to continue as a going concern, and to provide
related footnote disclosure in certain circumstances. The new standard is effective for all entities in the first annual period
ending after December 15, 2016, or January 1, 2017 for us. Earlier adoption was permitted. The adoption did not impact the presentation
of our financial statements, financial position, results of operations, cash flows and related disclosures.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During March 2016, the FASB issued ASU No. 2016-09,
<i>Improvements to Employee Share-Based Payment Accounting</i>, which amends ASC Topic 718, <i>Compensation - Stock Compensation</i>.
The objective of this update is part of the FASB&#8217;s Simplification Initiative as it applies to several aspects of the accounting
for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,
and classification on the statement of cash flows. The effective date of the update is for fiscal years beginning after December
15, 2016 and interim periods within that reporting period, or January 1, 2017 for us. Early adoption was permitted. The adoption
did not have a material impact on the presentation of our financial statements, financial position, results of operations, cash
flows and related disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797171856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note and Line of Credit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Note and Line of Credit</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Note and Line
of Credit</p>

<p style="font: bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">During
July 2014 we entered into a bank-issued letter of credit and related promissory note for up to $30 in borrowings to support our
obligations under our facility lease agreement. We then sold our certificates of deposit. No borrowings have been incurred under
this promissory note. Should any borrowings occur in the future, the interest rate would be the prime rate plus 1%, with the bank
having the right to &#8220;set off&#8221; or apply unpaid balances against our checking account if we fail to meet our obligations
under any borrowings under the note. It is our intention to renew this note annually, for as long as we need to pursuant to the
terms of our facility lease agreement. Because there were no amounts outstanding on the note at any time during 2016 or 2015, we
have recorded no related liability on our balance sheet. </font></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During March 2015, we entered
into a Business Loan Agreement (the &#8220;Line of Credit Agreement&#8221;) with Libertyville Bank and Trust Company, a Wintrust
Community Bank (&#8220;Libertyville&#8221;), our primary bank. This Line of Credit Agreement was subsequently amended on April
13, 2015. Under the Line of Credit Agreement, as amended, Libertyville will provide a maximum of $300, or 75% of our eligible accounts
receivable, whichever is less, of revolving credit, collateralized by a senior priority lien on our accounts receivable, inventory,
equipment, general intangibles and fixtures. Interest on any borrowings would be the prime rate at the time plus 1%. Availability
to draw on the line requires us to have at least $1 million in cash, including any amounts borrowed, at Libertyville on the date
of any advance. Advances may only occur at the beginning or end of a fiscal quarter and must be repaid in full within five days
of the advance. The Line of Credit Agreement was to expire on March 4, 2016, but during March 2016 was extended until March 4,
2017. During February 2017, this agreement was further extended to March 2018. No borrowing on this line was outstanding on December
31, 2016.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6694344432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Inventories</b></font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Inventories
consist of the following:</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif; margin-left: 5%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left">Raw materials</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">283</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">184</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">510</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">530</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">793</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">714</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Allowance for excess quantities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(21</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(52</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">772</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">662</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797191680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equipment and Leasehold Improvements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Equipment and Leasehold Improvements</a></td>
<td class="text"><p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>(5)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Equipment
and Leasehold Improvements</b></font></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Equipment
and leasehold improvements consist of the following:</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif; margin-left: 5%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Machinery and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,587</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,562</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Office equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">778</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office furniture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,814</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,789</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Construction in progress</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,250</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18,981</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18,389</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">1,395</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">1,861</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense was $605 and $726, for the years ended December 31, 2016 and 2015, respectively.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2921-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6788981024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">Lease Commitments</a></td>
<td class="text"><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>(6)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Lease
Commitments &#160;</b></font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">We
lease our operating facilities under operating leases. During October 2016 we entered into a Third Lease Amendment related to
our primary facility in Romeoville, Illinois, extending the term of the lease through December 31, 2024. The current monthly rent
on this lease amounts to $25.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">We
lease our Burr Ridge, Illinois, facility under an agreement extended during September 2010, which extended the term through September
2014 (we have since exercised our final tenant option to extend the term through September 2017). During March 2017, we entered
into a new Building Lease for this facility that will begin September 2017 and extend through September 2021, with our having
the option to further extend this lease by three additional one-year periods. The current monthly rent on this lease amounts to
$15. During 2016 we also renewed our lease for our offsite warehouse in Romeoville, Illinois, through August 2019. The current
monthly rent on this lease amounts to $5.&#160;<font style="font-family: Times New Roman, Times, Serif">&#160;</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">The
following is a schedule of future minimum lease payments including real estate taxes as required under the above operating leases,
as well as the remaining lease payments under capital leases as referenced below:</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-left: 1in; border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">Year ending December 31:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="text-align: right; font: 10pt Times New Roman, Times, Serif">Operating<br />
 Leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="text-align: right; font: 10pt Times New Roman, Times, Serif">Capital<br />
 Leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="width: 54%; text-align: justify; font: 10pt Times New Roman, Times, Serif">2017</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 11%; text-align: right; font: 10pt Times New Roman, Times, Serif">698</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="width: 11%; text-align: right; font: 10pt Times New Roman, Times, Serif">58</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">2018</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">700</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">45</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">2019</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">691</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">34</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">2020</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">589</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">18</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">2021</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">554</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">15</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">Thereafter</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,289</td><td style="padding-bottom: 1pt; text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Total minimum payments required:</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,521</td><td style="padding-bottom: 2pt; text-align: left; border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif">*</td><td style="padding-bottom: 2pt; border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">170</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">*</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif"><br />&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">*
After paying $60 to retire a capital lease during January 2017, the remaining payments under capital leases include principal
of $147 and interest of $23. Also, includes future payments of the Burr Ridge Building Lease executed March 2017 as described
above.&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Rent
expense, including real estate taxes, under these leases amounted to $597 and $588, for the years ended December 31, 2016 and
2015, respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">
On December 31, 2016 equipment under capital leases had a cost of $362 with accumulated depreciation of $62, compared to $316
and $29, respectively, on December 31, 2015. Principal and interest payments are due monthly under the capital lease
obligations through October 2020. We entered into one new capital lease during 2016 for $75 and a 5-year duration (through
August 2021), and recognized an impairment charge, reducing the value of two other pieces of capital equipment by $54 in
aggregate. We entered into three new capital leases during 2015 for $132 and 3 to 5 year durations (through August
2020).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6452660&amp;loc=d3e36991-112694<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 1,3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6851643&amp;loc=d3e12069-110248<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6788771088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>(7)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accrued
Expenses</b></font></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Accrued
expenses consist of the following:</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Accrued payroll and related expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">167</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">108</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer net volume rebate payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">201</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">153</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">168</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">521</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">276</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797219184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>(8)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income
Taxes</b></font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Our
net income tax provision, including both current and deferred, related to U.S. federal and state income taxes, is none.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">A
reconciliation of income tax expense to the amount computed by applying the Federal income tax rate to loss before provision for
income taxes as of December 31, 2016 and 2015 is as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">2016</td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">2015</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="width: 44%; text-align: left; font: 10pt Times New Roman, Times, Serif">Income tax credit at statutory rates</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif">(436</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">)</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif">(405</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">)</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">Nondeductible expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">2</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">3</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">State income tax, net of federal benefits</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(66</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(61</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">)</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">144</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(3</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">Increase in valuation allowance</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">356</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">466</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of our deferred income taxes consist of
the following:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">As of December 31,</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">Deferred tax assets:</td><td style="background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="width: 44%; text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Net operating loss carryforwards</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif">31,935</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif">31,590</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Inventory and other allowances</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">16</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">28</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Charitable contribution carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">5</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">6</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Excess (tax) book depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">805</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">709</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Excess (tax) book amortization</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">69</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">67</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Share-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">1,328</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">1,396</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Other accrued costs</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">219</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">225</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif">Total deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">34,377</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">34,021</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Less: Valuation allowance</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(34,377</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">)</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(34,021</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">Deferred income taxes</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><font style="font: 10pt Times New Roman, Times, Serif">The
valuation allowance increased approximately $0.4 million and $0.5 million for the years ended December 31, 2016 and 2015, respectively
(with no expiring net operating loss carryforwards and credits for either period; a portion of the charitable contribution carryforward
expired during 2016) due principally to the change in the net operating loss carryforward and uncertainty as to whether future
taxable income will be generated prior to the expiration of the carryforward period. Under the Internal Revenue Code, certain
ownership changes, including the prior issuance of preferred stock and our public offering of common stock, may subject us to
annual limitations on the utilization of our net operating loss carryforward. As of December 31, 2016, the amounts subject to
limitations has not yet been determined.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><font style="font: 10pt Times New Roman, Times, Serif">We
have net operating loss carryforwards for tax purposes of approximately $82 million on December 31, 2016, which expire between
2018 and 2036.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><font style="font: 10pt Times New Roman, Times, Serif">During
2011, the state of Illinois suspended the use of net operating loss carryforwards for a four year period beginning 2011, extending
the term of all net loss carryforwards by a corresponding four years.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797163520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Stock</a></td>
<td class="text"><p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>(9)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Capital
Stock</b></font></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2016 and 2015, we had 24,088 authorized but unissued shares of preferred stock. In addition, as of December 31,
2016, 1,196,000 authorized but unissued shares of common stock have been reserved for future issuance upon exercise of stock options.
During August 2016, our stockholders authorized an additional 7,000,000 shares of common stock, increasing our authorized shares
of common stock from 35,000,000 to 42,000,000 authorized shares. Our stockholders also authorized an additional 1,200,000 shares
of common stock that may be issued pursuant to our 2010 Equity Compensation Plan.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6639785056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Stock Grants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Options and Stock Grants</a></td>
<td class="text"><p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>(10)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stock
Options and Stock Grants</b></font></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">We
have entered into stock option agreements with certain officers, employees and directors. The stock options generally expire ten
years from the date of grant.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: italic 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: normal 10pt Times New Roman, Times, Serif"><u>Employee
Stock Options</u></font></p>

<p style="font: italic 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.1pt">We
follow </font><font style="font: 10pt Times New Roman, Times, Serif">FASB ASC Topic 718<font style="letter-spacing: -0.1pt">,
<i>Share-Based Payments</i>, in which compensation expense is recognized only for share-based payments expected to vest. We recognized
compensation expense related to stock options of </font>$207 and $181 for the years ended December 31, 2016 and 2015, respectively.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt; letter-spacing: -0.1pt">As
of December 31, 2016, there was approximately $183 of total unrecognized compensation cost related to nonvested share-based compensation
arrangements granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period
of 1.7 years.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt; letter-spacing: -0.1pt">The
following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for options granted
for all years presented:</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 9pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid"><font style="font-size: 10pt">Years Ended December
    31,</font></td><td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><font style="font-size: 10pt">2016</font></td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><font style="font-size: 10pt">&#160;</font></td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><font style="font-size: 10pt">2015</font></td><td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="2" style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="2" style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; text-align: left"><font style="font-size: 10pt">Weighted-average risk-free interest
    rates:</font></td><td style="width: 2%"><font style="font-size: 10pt">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="width: 12%; text-align: right"><font style="font-size: 10pt">1.5</font></td><td style="width: 1%; text-align: left"><font style="font-size: 10pt">%</font></td><td style="width: 2%"><font style="font-size: 10pt">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="width: 12%; text-align: right"><font style="font-size: 10pt">1.7</font></td><td style="width: 1%; text-align: left"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font-size: 10pt">Dividend yield:</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">0.00</font></td><td style="text-align: left"><font style="font-size: 10pt">%</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">0.00</font></td><td style="text-align: left"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font-size: 10pt">Weighted-average expected life of the option:</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">7 years</font></td><td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">7 years</font></td><td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font-size: 10pt">Weighted-average expected stock price volatility:</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">95</font></td><td style="text-align: left"><font style="font-size: 10pt">%</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">95</font></td><td style="text-align: left"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font-size: 10pt">Weighted-average fair value of the options
    granted:</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">$</font></td><td style="text-align: right"><font style="font-size: 10pt">0.36</font></td><td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">$</font></td><td style="text-align: right"><font style="font-size: 10pt">0.36</font></td><td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
</table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 10pt; letter-spacing: -0.1pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">We
use the Black&#8722;Scholes option pricing model to determine the fair value of stock based compensation. The Black&#8722;Scholes
model requires us to make several assumptions, including the estimated length of time employees will retain their vested stock
options before exercising them (&#8220;expected term&#8221;), the estimated volatility of our common stock price over the expected
term and estimated forfeitures. Expected price volatility of the fiscal 2016 and 2015 grants is based on the daily market rate
changes of our stock going back to January 1, 2008. The shares granted in fiscal 2016 and 2015 had a vesting period of three years
and a contractual life of 10 years. Forfeitures were estimated at 4% and 4% for the years ended December 31, 2016 and 2015, based
on our historical experience. The Black&#8722;Scholes model also requires a risk free interest rate, which is based on the U.S.
Treasury yield curve in effect at the time of the grant, and the dividend yield on our common stock, which is assumed to be zero
since we do not pay dividends and have no current plans to do so in the future. Changes in these assumptions can materially affect
the estimate of fair value of stock based compensation and consequently, the related expense recognized on the statement of operations.
We recognize stock based compensation expense on a straight-line basis.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">The
following table summarizes the option activity for our employees and directors during the year ended December 31, 2016:</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center"></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center"></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center; vertical-align: bottom">(rounded)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">Weighted Average Exercise Price per </td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">Weighted Average Remaining Contractual Term </td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">Aggregate Intrinsic </td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Options</td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">Shares</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">Share</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">(years)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">Value</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Outstanding on January 1, 2016</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">2,574,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.95</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">508,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(44,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(105,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3.08</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Outstanding on December 31, 2016</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,933,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.81</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.3</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">616</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Exercisable on December 31, 2016</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,053,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.96</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.3</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">378</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Shares available for grant</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,196,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">The
aggregate intrinsic value in the table above is based on our closing stock price of $0.72 on the last business day for the year
ended December 31, 2016.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">During
the years ended December 31, 2016 and 2015, the total intrinsic value of our stock options exercised was $19 and $10, respectively.
Cash received for option exercises was $18 and $26 during the years ended December 31, 2016 and 2015, respectively. We had approximately
44,000 options exercised during the year ended December 31, 2016, compared to 69,000 in 2015. Based on our election of the &#8220;with
and without&#8221; approach, no realized tax benefits from stock options were recognized for the years ended December 31, 2016
and 2015.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 10pt; letter-spacing: -0.1pt">Stock
Appreciation Rights</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">Prior
to 2011, we granted our Outside Directors stock appreciation rights (SARs) under our Amended and Restated 2006 Stock Appreciation
Rights Plan and subsequently under our 2010 Equity Plan. The change in fair value of the awards granted during prior years was
included in non-cash compensation expense for the years ended December 31, 2016 and 2015. The SARs granted vested immediately
and were payable upon the directors&#8217; removal or resignation from the position of director. These awards were accounted for
as liability awards, included in accrued expenses as of December 31, 2015, and adjusted to fair value each reporting period. The
fair value of the liability on December 31, 2016 and 2015 was zero. During November 2016, all vested SARs were terminated. Those
Outside Directors whose vested SARs were cancelled received immediately vested options in the same quantity, and at the same strike
price, as their cancelled SARs. The options granted are included in the above chart. We have no remaining SARs outstanding.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 10pt">Restricted
Stock</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 10pt">&#160;&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">As
of both December 31, 2016 and 2015, we did not have any unvested non-director restricted stock or performance shares outstanding.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65895303&amp;loc=d3e17540-113929<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797163520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Profit-Sharing Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Compensation and Retirement Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">401(k) Profit-Sharing Plan</a></td>
<td class="text"><p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">(11)&#160;&#160;&#160;&#160;&#160;&#160;&#160;401(k)
Profit-Sharing Plan</font></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">We
have a 401(k) profit-sharing plan covering substantially all employees who meet defined service requirements. We have made in
the past, and may make in the future, maximum contributions of 100% of the first 3% and 50% of the next 2% of the participant&#8217;s
salary. We made changes to our benefits program and, as part of those changes, discontinued these Company contributions effective
January 2014, which resulted in no contributions made during 2016 or 2015. During 2017, we implemented a new Company contribution
program, in which 10% of the employee&#8217;s contribution will be matched up to an 8% contribution (for a match of up to 0.8%
of a participant&#8217;s salary).</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450702-114947<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2410-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39675-114964<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6788825648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Customers and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Significant Customers and Contingencies</a></td>
<td class="text"><p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">(12)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Significant
Customers and Contingencies</font></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">Revenue
from three customers constituted approximately 69%, 5% and 4%, respectively, of our 2016 revenue. Amounts included in accounts
receivable on December 31, 2016 relating to these three customers were approximately none, $39 and $180, respectively. Revenue
from these three customers constituted approximately 63%, 4% and 7%, respectively, of our 2015 revenue. Amounts included in accounts
receivable on December 31, 2015 relating to these three customers were approximately none, $35 and $240, respectively. The loss
of one of these significant customers or the failure to attract new customers could have a material adverse effect on our business,
results of operations and financial condition.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt"></font></p>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">We
currently have exclusive supply agreements with BASF Corporation (&#8220;BASF&#8221;), our largest customer, that have contingencies
outlined which could potentially result in the license of technology and/or the sale of production equipment from the Company
to the customer intended to provide capacity sufficient to meet the customer&#8217;s production needs. This outcome may occur
if we fail to meet certain performance requirements, certain other obligations and/or certain financial condition covenants. The
financial condition covenants in one of our supply agreements with BASF &#8220;trigger&#8221; a technology transfer right (license
and equipment sale at BASF&#8217;s option) in the event (a) that earnings for the twelve month period ending with our most recently
published quarterly financial statements are less than zero and our cash, cash equivalents and certain investments are less than
$1 million, or (b) of an acceleration of any debt maturity having a principal amount of more than $10 million. Our supply agreements
with BASF also &#8220;trigger&#8221; a technology transfer right in the event of our insolvency, as further defined within the
agreements. In the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer
at either 115% of the equipment&#8217;s net book value or the greater of 30% of the original book value of such equipment, and
any associated upgrades to it, or 115% of the equipment&#8217;s net book value, depending on the equipment and related products.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">We
believe that we have sufficient cash and credit availability, (See Liquidity and Capital Resources in Management&#8217;s Discussion
and Analysis in Part II, Item 7 of this Form 10-K for a further discussion, as well as the description of our Line of Credit Agreement
described in Note 3<b>) </b>to operate our business during 2017. If a triggering event were to occur and BASF elected to proceed
with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products
sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to
replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer
pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity
would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar
consequences would occur if we were determined to have materially breached certain other provisions of the supply agreement with
BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities.
We believe that our employees are a critical component of our success and could be difficult to replace them quickly. Given the
occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event
and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including with respect
to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated investments.</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">Should
events arise that make it appropriate for us to seek additional financing, such additional financing may not be available on acceptable
terms or even at all, and any such financing could be dilutive to our stockholders. Such a financing could be necessitated by
such things as the loss of one or more significant customers or a significant decline in revenue from those customers, currently
unknown capital requirements, new regulatory requirements, the need to meet cash requirements under our BASF agreement to avoid
a triggering event, or other circumstances not currently anticipated by us. The failure to obtain sufficient capital may impair
or curtail our business plans and under such circumstances may raise doubt regarding our ability to continue as a going concern.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6327-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6442-108592<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6351-108592<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6624481568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segmentation and Geographical Distribution<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segmentation and Geographical Distribution</a></td>
<td class="text"><p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><font style="font-size: 10pt; text-transform: none"><b>(13)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business
Segmentation and Geographical Distribution</b></font></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">Revenue
from international sources approximated $1,039 and $1,393 for the years ended December 31, 2016 and 2015, respectively. <font style="letter-spacing: -0.1pt">As
part of our revenue from international sources, we recognized approximately $902 and $1,339 in product revenue from a number of
German companies, in the aggregate, for the years ended December 31, 2016 and 2015, respectively.</font></font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt"></font></p>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0.5in"><font style="font-size: 10pt; font-weight: normal; text-transform: none">Our
operations comprise a single business segment and all of our long-lived assets are located within the United States.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8981-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9038-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 33<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8971-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8595-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8380-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8984-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9031-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8538-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8864-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6641412416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><font style="font-size: 10pt; text-transform: none"><b>(14)&#160;&#160;&#160;&#160;&#160;&#160;
&#160;Subsequent Events</b></font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">As
discussed in Note 3, the Line of Credit Agreement with our primary bank (Libertyville) was to expire on March 4, 2017, but during
February 2017 this agreement was further extended to March 2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As discussed in Note
6, during March 2017 we entered into a new Building Lease for our Burr Ridge facility. The previous lease expires September 2017,
at which time this new lease will begin, and extend through September 2021. We have the option to further extend this lease by
up to three additional one year periods.&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">As
discussed in Note 6, during January 2017 we paid $60 to retire  a capital lease related to equipment that we sold to a third
party for $100, its remaining book value. No gain or loss was recognized during 2017 associated with the transaction.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807179344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates and Risks and Uncertainties</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Use of Estimates and
Risks and Uncertainties</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial
statements requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying
notes. Actual results could differ from those estimates. Certain assumptions are also necessary to assess the impact of risks and
uncertainties on the financial statements, such as cash flow projections, availability of capital if needed to support the ongoing
operations of the business, and our expected compliance with contractual commitments. These risks and uncertainties are further
discussed in Note 12. Any changes in these assumptions or business plans could have a material impact on the financial statements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Cash and Cash Equivalents</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash and cash equivalents primarily
consist of demand deposits, but also include certain lower risk investments with a stated maturity upon acquisition of 90 days
or less (e.g., money market funds or a certificate of deposit with a maturity of 90 days or less at the time of purchase).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade Accounts Receivable</a></td>
<td class="text"><p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"><b>Trade Accounts Receivable</b></p>

<p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Trade accounts receivable are
carried at original invoice amount less an estimate made for doubtful receivables based on a review of all outstanding amounts
on a monthly basis. We determine the allowance for doubtful accounts by identifying troubled accounts and by using historical experience
applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts
receivable previously written off are recorded when received. Our typical credit terms are thirty days from shipment and invoicing.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Inventories</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Inventories are stated at the
lower of cost, maintained on a first in, first out basis, or market. We have recorded allowances to reduce inventory relating to
excess quantities of certain materials. Write-downs of inventories establish a new cost basis, which is not increased for future
increases in market value of inventories or changes in estimated excess quantities.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Equipment and Leasehold Improvements</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Equipment and Leasehold
Improvements</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Equipment is stated at cost
and is being depreciated over its estimated useful life (3-20 years) using the straight-line method. Leasehold improvements are
stated at cost and are being amortized using the straight-line method over the shorter of the useful life of the asset or the term
of the lease (3-13 years). Depreciation expense for leased assets is included with depreciation expense for owned assets. From
time to time we have self-constructed assets. These assets are stated at cost plus the capitalization of labor and are depreciated
over an estimated useful life (7-10 years) using the straight-line method.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long Lived Assets</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Long Lived Assets</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We review long-lived assets
for impairment whenever events or changes in circumstances indicate that the asset&#8217;s carrying amount may not be recoverable.
We conduct long-lived asset impairment analyses in accordance with ASC 360-10-15, <i>Impairment or Disposal of Long-Lived Assets</i>.
ASC 360-10-15 requires us to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent
of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash
flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is
measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis
or appraisals.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsPolicy', window );">Asset Retirement Obligations</a></td>
<td class="text"><p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify"><b>Asset Retirement Obligations</b></p>

<p style="font: 10pt Times New Roman Bold,serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with our leased
facilities, we are required to remove certain leasehold improvements upon termination of our occupancy. We follow the provisions
of the FASB issued ASC 410-20, <i>Asset Retirement Obligations</i>, under which we recognize a liability for the fair value of
these asset retirement obligations. The fair value of that liability is measured based on an expected cash flow approach and accretion
expense is recognized each period to recognize increases to the fair value of the liability due to the passage of time. Increases
to the fair value of the liability, except for accretion, are added to the carrying value of the long-lived asset. Those increases
are then reported in amortization expense over the estimated useful life of the long-lived asset.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity in the asset retirement
obligation account for the years ended December 31, is as follows:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td><td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid">2016</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td><td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid">2015</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; text-align: left; text-indent: -9pt; padding-left: 9pt">Balance, beginning</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%">$</td>
    <td style="width: 8%; text-align: right">172</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%">$</td>
    <td style="width: 8%; text-align: right">166</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.15in">Accretion of liability due to passage of time</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">6</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">6</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2px; padding-left: 0.15in">Amortization of asset due to passage of time</td>
    <td>&#160;</td><td style="padding-bottom: 2px; border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 2px; text-align: left">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 2px; border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 2px; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -9pt; padding-left: 9pt">Balance, ending</td>
    <td>&#160;</td><td style="border-bottom: Black 2pt double">$</td>
    <td style="border-bottom: Black 2pt double; text-align: right">178</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td style="border-bottom: Black 2pt double">$</td>
    <td style="border-bottom: Black 2pt double; text-align: right">172</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Financial Instruments</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We follow ASC Topic 820, <i>Fair
Value Measurements and Disclosures</i>, which defines fair value, establishes a framework for measuring fair value, and expands
disclosures about fair value measurements. The fair value framework requires the categorization of assets and liabilities into
three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure
of fair value, whereas Level 3 generally requires significant management judgment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our financial instruments include
cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with the promissory note with no related
borrowings described in Note 3, and any borrowings on the working capital line of credit described in Note 3. The fair values of
all financial instruments were not materially different from their carrying values.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There were no financial assets
or liabilities adjusted to fair value on December 31, 2016 and 2015.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Product Revenue</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Product Revenue </font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Product revenue consists of
sales of product that are recognized when realized and earned. This occurs when persuasive evidence of an arrangement exists, title
transfers via shipment of products or when delivery has occurred, the price is fixed or determinable and collectability is reasonably
assured.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionSoftware', window );">Other Revenue</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Other Revenue </font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other revenue may include revenue
from technology license fees and paid development projects. Technology license fees and paid development projects are recognized
when earned pursuant to the agreed upon contractual arrangement, when performance obligations are satisfied, the amount is fixed
or determinable, and collectability is reasonably assured.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Shipping and handling costs
are included in other revenue when products are shipped and invoiced to the customer. We include the related cost of shipping and
handling in cost of goods sold.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><b>Research and Development Expenses</b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;Research and development
expenses are recognized as expense when incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Income Taxes </font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We account for income taxes
using the liability method. As such, deferred income taxes reflect the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Deferred tax assets
and liabilities are calculated using the enacted tax rates and laws that are expected to be in effect when the anticipated reversal
of these differences is scheduled to occur. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management,
it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When tax returns are filed,
it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are
subject to uncertainty about merits of the position taken or the amount of the position that would be ultimately sustained. The
benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence,
management believes it is more likely than not that the position will be sustained upon examination, including the resolution of
appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that
meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent
likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax
positions taken that exceeds the amount measured, as described above, is reflected as a liability for uncertain tax benefits in
the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities
upon examination.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not recorded a reserve
for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing
of such deductibility. We file tax returns in all appropriate jurisdictions, which includes a federal tax return and Illinois state
tax return. Open tax years for both jurisdictions are 2013 to 2015, which statutes expire in 2017 to 2019, respectively, under
most cases and subject to appropriate laws and regulations. When and if applicable, potential interest and penalty costs are accrued
as incurred, with expenses recognized in selling, general and administrative expenses in the statements of operations. As of December
31, 2016 and 2015, we had no liability for unrecognized tax benefits.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0"><font style="font-style: normal">Earnings Per Share</font></p>

<p style="font: italic bold 10pt Times New Roman Bold,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Options to purchase approximately
859,000 shares of common stock that were outstanding as of December 31, 2016 were not included in the computation of earnings per
share for the year ended December 31, 2016, as the impact of such shares would be both negligible and anti-dilutive. Options to
purchase approximately 210,000 shares of common stock that were outstanding as of December 31, 2015 were not included in the computation
of earnings per share for the year ended December 31, 2015, as the impact of such shares would be both negligible and anti-dilutive.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify"><b>New Accounting Pronouncements </b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During May 2014, the FASB issued Accounting Standards
Update (&#8220;ASU&#8221;) No. 2014-09 (&#8220;ASU 2014-09&#8221;), <i>Revenue from Contracts with Customers</i>, and several related
updates including ASU No. 2016-08 and ASU No. 2016-10, which supersedes nearly all existing revenue recognition guidance under
U.S. generally accepted accounting principles. The new standard requires a company to recognize revenue when it transfers goods
or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services.
Additionally, the guidance requires certain disclosures designed to help users of financial statements better understand the nature,
amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for annual
reporting periods beginning after December 15, 2017, including interim periods within that reporting period, which is our first
quarter of 2018. The new standard allows application either retrospectively to each prior reporting period presented or retrospectively
as a cumulative-effect adjustment as of the date of adoption. We are evaluating the effect that ASU 2014-09 will have on our financial
statements and related disclosures, but do not expect it to have a material impact on our financial position, results of operations,
or cash flows.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During February 2016, the FASB issued ASU No. 2016-02
(&#8220;ASU 2016-02&#8221;), <i>Leases (Topic 842)</i>. This standard requires the recognition of assets and liabilities arising
from lease transactions on the balance sheet and the disclosure of key information about leasing arrangements. Accordingly, a lessee
will recognize a lease asset for its right to use the underlying asset and a lease liability for the corresponding lease obligation.
Both the asset and liability will initially be measured at the present value of the future minimum lease payments over the lease
term. Subsequent measurement, including the presentation of expenses and cash flows, will depend on the classification of the lease
as either a finance or an operating lease. Initial costs directly attributable to negotiating and arranging the lease will be included
in the asset. For leases with a term of 12 months or less, a lessee can make an accounting policy election by class of underlying
asset to not recognize an asset and corresponding liability. Lessees will also be required to provide additional qualitative and
quantitative disclosures regarding the amount, timing and uncertainty of cash flows arising from leases. These disclosures are
intended to supplement the amounts recorded in the financial statements and provide additional information about the nature of
an organization&#8217;s leasing activities. The amendments in this standard are effective for fiscal years, and interim periods
within those fiscal years, beginning after December 15, 2018, with early adoption permitted. We are currently evaluating the impact
its adoption will have on the presentation of our financial statements and related disclosures.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During August 2014, the FASB issued ASU No. 2014-15,
<i>Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern</i> (&#8220;ASU 2014-15&#8221;).
ASU 2014-15 will explicitly require management to assess an entity&#8217;s ability to continue as a going concern, and to provide
related footnote disclosure in certain circumstances. The new standard is effective for all entities in the first annual period
ending after December 15, 2016, or January 1, 2017 for us. Earlier adoption was permitted. The adoption did not impact the presentation
of our financial statements, financial position, results of operations, cash flows and related disclosures.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-indent: 0.5in">During March 2016, the FASB issued ASU No. 2016-09,
<i>Improvements to Employee Share-Based Payment Accounting</i>, which amends ASC Topic 718, <i>Compensation - Stock Compensation</i>.
The objective of this update is part of the FASB&#8217;s Simplification Initiative as it applies to several aspects of the accounting
for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities,
and classification on the statement of cash flows. The effective date of the update is for fiscal years beginning after December
15, 2016 and interim periods within that reporting period, or January 1, 2017 for us. Early adoption was permitted. The adoption
did not have a material impact on the presentation of our financial statements, financial position, results of operations, cash
flows and related disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining amounts to accrue and charge against earnings so as to satisfy legal obligations associated with the retirement (through sale, abandonment, recycling, or disposal in some other manner) of a tangible long-lived asset that result from the acquisition, construction, or development and (or) the normal operation of a long-lived asset. This accounting policy disclosure excludes obligations arising 1) in connection with leased property, whether imposed by a lease agreement or by a party other than the lessor, that meet the definition of either minimum lease payments or contingent rentals; 2) solely from a plan to sell or otherwise dispose of a long-lived asset and 3) from certain environmental remediation liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4492-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4556-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Research and Development<br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition for software arrangements relating to the licensing, selling, leasing, or marketing of computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 605<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68047459&amp;loc=d3e131487-111767<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables.  If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65890831&amp;loc=d3e10133-111534<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5212-111524<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5093-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795501856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock', window );">Schedule of activity in asset retirement obligations</a></td>
<td class="text"><p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Activity in the asset retirement
obligation account for the years ended December 31, is as follows:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td><td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid">2016</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td><td colspan="2" style="padding-bottom: 2px; text-align: center; border-bottom: Black 1pt solid">2015</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; text-align: left; text-indent: -9pt; padding-left: 9pt">Balance, beginning</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%">$</td>
    <td style="width: 8%; text-align: right">172</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%">$</td>
    <td style="width: 8%; text-align: right">166</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.15in">Accretion of liability due to passage of time</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">6</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">6</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2px; padding-left: 0.15in">Amortization of asset due to passage of time</td>
    <td>&#160;</td><td style="padding-bottom: 2px; border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 2px; text-align: left">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 2px; border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 2px; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -9pt; padding-left: 9pt">Balance, ending</td>
    <td>&#160;</td><td style="border-bottom: Black 2pt double">$</td>
    <td style="border-bottom: Black 2pt double; text-align: right">178</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td style="border-bottom: Black 2pt double">$</td>
    <td style="border-bottom: Black 2pt double; text-align: right">172</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in carrying amount of a liability for asset retirement obligations, for changes such as new obligations, changes in estimates of existing obligations, spending on existing obligations, property dispositions, and foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13201-110859<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6788933632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory</a></td>
<td class="text"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Inventories
consist of the following:</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif; margin-left: 5%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left">Raw materials</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">283</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">184</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">510</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">530</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">793</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">714</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Allowance for excess quantities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(21</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(52</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">772</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">662</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6624247632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equipment and Leasehold Improvements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of components of equipment and leasehold improvements</a></td>
<td class="text"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Equipment
and leasehold improvements consist of the following:</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif; margin-left: 5%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Machinery and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,587</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,562</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Office equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">778</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office furniture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,814</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,789</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Construction in progress</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,250</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18,981</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18,389</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">1,395</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">1,861</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6788892576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock', window );">Schedule of future minimum lease payments</a></td>
<td class="text"><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">The
following is a schedule of future minimum lease payments including real estate taxes as required under the above operating leases,
as well as the remaining lease payments under capital leases as referenced below:</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-left: 1in; border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">Year ending December 31:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="text-align: right; font: 10pt Times New Roman, Times, Serif">Operating<br />
 Leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="text-align: right; font: 10pt Times New Roman, Times, Serif">Capital<br />
 Leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="width: 54%; text-align: justify; font: 10pt Times New Roman, Times, Serif">2017</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 11%; text-align: right; font: 10pt Times New Roman, Times, Serif">698</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="width: 11%; text-align: right; font: 10pt Times New Roman, Times, Serif">58</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">2018</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">700</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">45</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">2019</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">691</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">34</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">2020</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">589</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">18</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">2021</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">554</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">15</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">Thereafter</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,289</td><td style="padding-bottom: 1pt; text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Total minimum payments required:</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,521</td><td style="padding-bottom: 2pt; text-align: left; border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif">*</td><td style="padding-bottom: 2pt; border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">170</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">*</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif"><br />&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">*
After paying $60 to retire a capital lease during January 2017, the remaining payments under capital leases include principal
of $147 and interest of $23. Also, includes future payments of the Burr Ridge Building Lease executed March 2017 as described
above.&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating and capital leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797105712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses</a></td>
<td class="text"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Accrued
expenses consist of the following:</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Accrued payroll and related expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">167</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">108</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer net volume rebate payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">201</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">153</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">168</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">521</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">276</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797273920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of income tax expense by applying federal income tax rate to loss before provision for income taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">A
reconciliation of income tax expense to the amount computed by applying the Federal income tax rate to loss before provision for
income taxes as of December 31, 2016 and 2015 is as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">2016</td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">2015</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="width: 44%; text-align: left; font: 10pt Times New Roman, Times, Serif">Income tax credit at statutory rates</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif">(436</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">)</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif">(405</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">)</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">Nondeductible expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">2</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">3</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">State income tax, net of federal benefits</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(66</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(61</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">)</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">144</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(3</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">Increase in valuation allowance</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">356</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">466</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of significant components of deferred income taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. Significant components of our deferred income taxes consist of
the following:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.15in">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">As of December 31,</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">Deferred tax assets:</td><td style="background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; background-color: White; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="width: 44%; text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Net operating loss carryforwards</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif">31,935</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td><td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif">31,590</td><td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Inventory and other allowances</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">16</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">28</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Charitable contribution carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">5</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">6</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Excess (tax) book depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">805</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">709</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Excess (tax) book amortization</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">69</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">67</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Share-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">1,328</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">1,396</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Other accrued costs</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">219</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">225</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif">Total deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">34,377</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">34,021</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: right; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Less: Valuation allowance</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(34,377</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">)</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(34,021</td><td style="padding-bottom: 1pt; text-align: left; font: 10pt Times New Roman, Times, Serif">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">Deferred income taxes</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="padding-bottom: 2pt; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="padding-bottom: 2pt; text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6788941072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Stock Grants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used to calculate Black-Scholes Ooption Pricing Model for stock options granted</a></td>
<td class="text"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt; letter-spacing: -0.1pt">The
following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for options granted
for all years presented:</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 9pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1pt solid"><font style="font-size: 10pt">Years Ended December
    31,</font></td><td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><font style="font-size: 10pt">2016</font></td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><font style="font-size: 10pt">&#160;</font></td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><font style="font-size: 10pt">2015</font></td><td style="padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="2" style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td colspan="2" style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; text-align: left"><font style="font-size: 10pt">Weighted-average risk-free interest
    rates:</font></td><td style="width: 2%"><font style="font-size: 10pt">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="width: 12%; text-align: right"><font style="font-size: 10pt">1.5</font></td><td style="width: 1%; text-align: left"><font style="font-size: 10pt">%</font></td><td style="width: 2%"><font style="font-size: 10pt">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="width: 12%; text-align: right"><font style="font-size: 10pt">1.7</font></td><td style="width: 1%; text-align: left"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font-size: 10pt">Dividend yield:</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">0.00</font></td><td style="text-align: left"><font style="font-size: 10pt">%</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">0.00</font></td><td style="text-align: left"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font-size: 10pt">Weighted-average expected life of the option:</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">7 years</font></td><td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">7 years</font></td><td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font-size: 10pt">Weighted-average expected stock price volatility:</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">95</font></td><td style="text-align: left"><font style="font-size: 10pt">%</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 10pt">95</font></td><td style="text-align: left"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: right"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 12pt; text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font-size: 10pt">Weighted-average fair value of the options
    granted:</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">$</font></td><td style="text-align: right"><font style="font-size: 10pt">0.36</font></td><td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td><td><font style="font-size: 10pt">&#160;</font></td>
    <td style="text-align: left"><font style="font-size: 10pt">$</font></td><td style="text-align: right"><font style="font-size: 10pt">0.36</font></td><td style="text-align: left"><font style="font-size: 10pt">&#160;</font></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of option activity</a></td>
<td class="text"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">The
following table summarizes the option activity for our employees and directors during the year ended December 31, 2016:</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center"></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center"></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center; vertical-align: bottom">(rounded)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">Weighted Average Exercise Price per </td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">Weighted Average Remaining Contractual Term </td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">Aggregate Intrinsic </td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Options</td><td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">Shares</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">Share</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">(years)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">Value</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Outstanding on January 1, 2016</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">2,574,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.95</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">508,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(44,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(105,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3.08</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Outstanding on December 31, 2016</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,933,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.81</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.3</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">616</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Exercisable on December 31, 2016</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,053,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.96</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.3</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">378</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Shares available for grant</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,196,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807003952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_CashAndCashEquivalentsMaturityPeriodDescription', window );">Cash and cash equivalents description</a></td>
<td class="text">90 days or less<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountsReceivablesCreditPeriod', window );">Credit period after shipment and invoicing</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_IncomeTaxRecognitionThresholdPercentage', window );">Threshold percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">859,000<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax years for jurisdictions</a></td>
<td class="text">2013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_OpenTaxYearExpirationPeriod', window );">Income tax statutes expiration year</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax years for jurisdictions</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_OpenTaxYearExpirationPeriod', window );">Income tax statutes expiration year</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Equipment leasehold improvements and leased assets useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Equipment leasehold improvements and leased assets useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Equipment leasehold improvements and leased assets useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Equipment leasehold improvements and leased assets useful life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember', window );">Self-Constructed Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Equipment leasehold improvements and leased assets useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember', window );">Self-Constructed Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Equipment leasehold improvements and leased assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_AccountsReceivablesCreditPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of period for which credit is generally granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_AccountsReceivablesCreditPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_CashAndCashEquivalentsMaturityPeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents Maturity Period Description</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_CashAndCashEquivalentsMaturityPeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_IncomeTaxRecognitionThresholdPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Recognition Threshold Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_IncomeTaxRecognitionThresholdPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_OpenTaxYearExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Open Tax Year Expiration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_OpenTaxYearExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6641441920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationDisclosureAbstract', window );"><strong>Asset Retirement Obligation Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsNoncurrent', window );">Balance, beginning</a></td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion of liability due to passage of time</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsNoncurrent', window );">Balance, ending</a></td>
<td class="nump">$ 178<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807113840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note and Line of Credit (Detail Narratives) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Jul. 31, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Letter of credit and related promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Variable interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prime rate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Variable interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prime rate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable', window );">Borrowing capacity as percentage of accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Minimum amount of cash required on advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit facility, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  04,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit facility, expiration date</a></td>
<td class="text">Mar. 31,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility maximum borrowing capacity as percentage of accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6621147824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 283<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">510<span></span>
</td>
<td class="nump">530<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory gross, Total</a></td>
<td class="nump">793<span></span>
</td>
<td class="nump">714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Allowance for excess inventory quantities</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 772<span></span>
</td>
<td class="nump">$ 662<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6614705248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equipment and Leasehold Improvements (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 605<span></span>
</td>
<td class="nump">$ 726<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807105568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equipment and Leasehold Improvements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 20,376<span></span>
</td>
<td class="nump">$ 20,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(18,981)<span></span>
</td>
<td class="num">(18,389)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net, Total</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">14,587<span></span>
</td>
<td class="nump">14,562<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">790<span></span>
</td>
<td class="nump">778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office Furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">4,815<span></span>
</td>
<td class="nump">4,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807601504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease Commitments (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">$ 588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsGross', window );">Cost of equipment under capital lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">362<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_NumberOfCapitalLeases', window );">Number of capital leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract', window );">Capital lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquipmentOnLease', window );">Payments to acquire capital lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_PaymentToRetireCapitalLease', window );">Payment to retire capital lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges', window );">Change in value of capital equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract', window );">Capital lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract', window );">Capital lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal', window );">Capital leases, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments', window );">Capital leases, interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_PaymentToRetireCapitalLease', window );">Payment to retire capital lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=nanx_RomeovilleIllinoisMember', window );">Romeoville Illinois [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_OperatingLeaseNumberOfRenewals', window );">Operating lease number of renewals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Monthly rent on lease amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=nanx_OffsiteWarehouseMember', window );">Offsite Warehouse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Monthly rent on lease amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=nanx_BurrRidgeFacilityMember', window );">Burr Ridge Facility [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_OperatingLeaseNumberOfRenewals', window );">Operating lease number of renewals</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Monthly rent on lease amounts</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The principal amount of minimum lease payments for capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_CapitalLeasesFutureMinimumPaymentsDuePrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee leasing arrangements capital leases term of contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_LesseeLeasingArrangementsCapitalLeasesTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_NumberOfCapitalLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Capital Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_NumberOfCapitalLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_OperatingLeaseNumberOfRenewals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Number Of Renewals</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_OperatingLeaseNumberOfRenewals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_PaymentToRetireCapitalLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for retirement of the obligation for a capital lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_PaymentToRetireCapitalLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasedAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45014-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasedAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount necessary to reduce net minimum lease payments to present value for capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total charge for the use of long-lived depreciable assets subject to a lease meeting the criteria for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45014-112735<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=7661868&amp;loc=d3e34039-112682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseMinimumRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquipmentOnLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payments to acquire rented equipment which is recorded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquipmentOnLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTransfersAndChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=nanx_RomeovilleIllinoisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=nanx_RomeovilleIllinoisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=nanx_OffsiteWarehouseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=nanx_OffsiteWarehouseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=nanx_BurrRidgeFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=nanx_BurrRidgeFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807665024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lease Commitments (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2017</a></td>
<td class="nump">$ 698<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2018</a></td>
<td class="nump">700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2019</a></td>
<td class="nump">691<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2020</a></td>
<td class="nump">589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2021</a></td>
<td class="nump">554<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">1,289<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total minimum payments required</a></td>
<td class="nump">4,521<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsAbstract', window );"><strong>Capital leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent', window );">2017</a></td>
<td class="nump">58<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears', window );">2018</a></td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears', window );">2019</a></td>
<td class="nump">34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears', window );">2020</a></td>
<td class="nump">18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears', window );">2021</a></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue', window );">Total minimum payments required</a></td>
<td class="nump">$ 170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">After paying $60 to retire a capital lease during January 2017, the remaining payments under capital leases include principal of $147 and interest of $23.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797128816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_CustomerNetVolumeRebatePayable', window );">Customer net volume rebate payable</a></td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 521<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_CustomerNetVolumeRebatePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid for customer net volume rebates, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_CustomerNetVolumeRebatePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6641440816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2011</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_OperatingLossCarryforwardsExpirationYearStart', window );">Capital loss carryforwards expiration period start</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_OperatingLossCarryforwardsExpirationYearEnd', window );">Capital loss carryforwards expiration period end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards', window );">Period for suspension of net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_ExtensionOfTermOfNetLossCarryforwards', window );">Extension of the term of net loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_ExtensionOfTermOfNetLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extension Of Term Of Net Loss Carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_ExtensionOfTermOfNetLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_OperatingLossCarryforwardsExpirationYearEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards Expiration Year End</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_OperatingLossCarryforwardsExpirationYearEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_OperatingLossCarryforwardsExpirationYearStart">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards Expiration Year Start</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_OperatingLossCarryforwardsExpirationYearStart</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period For Suspension Of Net Operating Loss Carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_PeriodForSuspensionOfNetOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797054528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax credit at statutory rates</a></td>
<td class="num">$ (436)<span></span>
</td>
<td class="num">$ (405)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Nondeductible expenses</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal benefits</a></td>
<td class="num">(66)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">144<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 356<span></span>
</td>
<td class="nump">$ 466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6790798000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 31,935<span></span>
</td>
<td class="nump">$ 31,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory and other allowances</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards', window );">Charitable contribution carryforwards</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Excess (tax) book depreciation</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Excess (tax) book amortization</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">1,328<span></span>
</td>
<td class="nump">1,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Other accrued costs</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">34,377<span></span>
</td>
<td class="nump">34,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: Valuation allowance</a></td>
<td class="num">$ (34,377)<span></span>
</td>
<td class="num">$ (34,021)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6796202304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,088<span></span>
</td>
<td class="nump">24,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscribedButUnissued', window );">Authorized, unissued shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AddtionalSharesAuthorizedDuringPeriod', window );">Addtional shares authorized during period</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Addtional shares authorized 2010 Equity Compensation Plan during period</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_AddtionalSharesAuthorizedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance by stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_AddtionalSharesAuthorizedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscribedButUnissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscribedButUnissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under an established share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795642176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Stock Grants (Detail Narratives) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted</a></td>
<td class="nump">$ 183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which unrecognized compensation is expected to be recognized</a></td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions', window );">Forfeiture rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued pursuant to option exercises</a></td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">69,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of stock options exercised</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ .72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1', window );">Contractual life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated forfeitures percentage for options during a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRestrictions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The contractual life for stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6639802368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Stock Grants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted-average risk-free interest rates</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected life of the option</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted-average expected stock price volatility</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of the options granted</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average expected volatility rate of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807164368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Stock Grants (Details 1) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_StockOptionsAbstract', window );"><strong>Stock Options:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, beginning</a></td>
<td class="nump">2,574,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, Granted</a></td>
<td class="nump">508,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercises, Shares</a></td>
<td class="num">(44,000)<span></span>
</td>
<td class="num">(69,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Shares, Forfeited or expired</a></td>
<td class="num">(105,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, ending</a></td>
<td class="nump">2,933,000<span></span>
</td>
<td class="nump">2,574,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares, Exercisable</a></td>
<td class="nump">2,053,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant</a></td>
<td class="nump">1,196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Beginning Balance</a></td>
<td class="nump">$ 0.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Granted</a></td>
<td class="nump">.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercised</a></td>
<td class="nump">.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Forfeited or expired</a></td>
<td class="nump">3.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Ending Balance</a></td>
<td class="nump">.81<span></span>
</td>
<td class="nump">$ 0.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercisable</a></td>
<td class="nump">$ .96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Outstanding</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term Years, Exercisable</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="nump">$ 616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable</a></td>
<td class="nump">$ 378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_StockOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_StockOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_WeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_WeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6796330112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Profit-Sharing Plan (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution', window );">Defined contribution plan employer matching contribution percent for three percent of employee contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab', window );">Defined contribution plan employer matching contribution percent for first compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution', window );">Defined contribution plan employer matching contribution percent for two percent of employee contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab', window );">Defined contribution plan employer matching contribution percent for next compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_DefinedContributionPlanEmployerMatchingContributionAmount', window );">Contributions under profit sharing plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer's matching contribution</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Employee's contribution for matching</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Participant's salary for employer matching</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_DefinedContributionPlanEmployerMatchingContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_DefinedContributionPlanEmployerMatchingContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan Employer Matching Contribution Percent For First Compensation Slab</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_DefinedContributionPlanEmployerMatchingContributionPercentForFirstCompensationSlab</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan Employer Matching Contribution Percent For Next Compensation Slab</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_DefinedContributionPlanEmployerMatchingContributionPercentForNextCompensationSlab</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan Employer Matching Contribution Percent For Three Percent Of Employee Contribution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_DefinedContributionPlanEmployerMatchingContributionPercentForThreePercentOfEmployeeContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan Employer Matching Contribution Percent For Two Percent Of Employee Contribution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_DefinedContributionPlanEmployerMatchingContributionPercentForTwoPercentOfEmployeeContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807480080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Customers and Contingencies (Detail Narratives)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_MajorCustomersNumberOfCustomers', window );">Number of major customers</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="num">(1,283)<span></span>
</td>
<td class="num">(1,192)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersAxis=nanx_CustomersOneMember', window );">Customers One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersAxis=nanx_CustomersOneMember', window );">Customers One [Member] | Customer Concentration Risk [Member] | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue from top customers</a></td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersAxis=nanx_CustomersTwoMember', window );">Customers Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersAxis=nanx_CustomersTwoMember', window );">Customers Two [Member] | Customer Concentration Risk [Member] | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue from top customers</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersAxis=nanx_CustomersThreeMember', window );">Customers Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersAxis=nanx_CustomersThreeMember', window );">Customers Three [Member] | Customer Concentration Risk [Member] | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue from top customers</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember', window );">BASF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantSupplyCommitmentDescription', window );">Supply Agreement</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0; text-align: justify">We currently have
exclusive supply agreements with BASF Corporation (&#8220;BASF&#8221;), <br />
our largest customer, that have contingencies outlined
which could potentially result in the license of technology <br />
and/or the sale of production equipment from the Company to the customer
intended to provide capacity sufficient <br />
to meet the customer&#8217;s production needs.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades', window );">Equipment sale - net book value equipment and upgrades</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades', window );">Equipment sale - original book value of equipment and upgrades</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_EquipmentSaleNetBookValueEquipment', window );">Equipment sale - net book value equipment</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember', window );">BASF [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_PrincipalAmountDebtAcceleratedMaturity', window );">Accelerated debt maturity - principal amount debt</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember', window );">BASF [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents and investments</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_EquipmentSaleNetBookValueEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equipment's net book value to be sold to customer after a triggering event as stated in the supply agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_EquipmentSaleNetBookValueEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equipment's net book value, including upgrades; to be sold to customer after a triggering event as stated in the supply agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_EquipmentSaleNetBookValueEquipmentAndUpgrades</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equipment's original value, including upgrades; to be sold to customer after a triggering event as stated in the supply agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_MajorCustomersNumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of significant customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_MajorCustomersNumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_PrincipalAmountDebtAcceleratedMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total prinicipal amount of accelerated debt maturity, as defined in supply agreement financial convenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_PrincipalAmountDebtAcceleratedMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantSupplyCommitmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excluding long-term commitments, description of arrangements in which the entity must commit resources to supply goods or services to one or more customers, which may include identification of the goods or services to be furnished, identity of the buyer, pricing, effects on pricing (such as penalties) of failing to deliver minimum quantities required to be furnished, cancellation rights, and termination provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantSupplyCommitmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=nanx_CustomersOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=nanx_CustomersOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=nanx_CustomersTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=nanx_CustomersTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=nanx_CustomersThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=nanx_CustomersThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797094832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segmentation and Geographical Distribution (Detail Narratives)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-Domestic Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from international sources</a></td>
<td class="nump">$ 1,039<span></span>
</td>
<td class="nump">$ 1,393<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=us-gaap_EuropeanUnionMember', window );">Germany [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from international sources</a></td>
<td class="nump">$ 902<span></span>
</td>
<td class="nump">$ 1,339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=us-gaap_EuropeanUnionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=us-gaap_EuropeanUnionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795646000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2017</div></th>
<th class="th"><div>Jan. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_PaymentToRetireCapitalLease', window );">Payment to retire capital lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit facility, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  04,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_PaymentToRetireCapitalLease', window );">Payment to retire capital lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit facility, expiration date</a></td>
<td class="text">Mar. 31,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_PaymentToRetireCapitalLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for retirement of the obligation for a capital lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_PaymentToRetireCapitalLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M]8??5=CUQN[M/S:^",H6?MV%_ )02P,$%     @ \%-]2IE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MCT)H;IQ!=\:-LVG^QDG-C]H.%V8L^PZHGVC1#=U=,K:8ZW]02P,$%     @
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MQC_[V&<!][N/_</+LM2!P52$SIPPS!0A\&F(2P->'%+Z-+XJB6'FE  M6'=
M?!JO)A(OSB<@>>'B8#*8N[^ ES=(?)[4Y4F00)E+@XGF[@U>*L&OE85;*P>-
MLS=>:4!E4,Y42\#+)?CULG#KY:#)/^+!9/,\>.$$OW(6;N4<-'0:*+Z)O:O\
MD>P]#UX\@?H\A<M#D6^F!"CRTD7RE:3(:%K&[BY%D_ZC9>)@6S49;/FY4^:O
M?K(ZMH-WQ/0OSOK:M(FVKWEST_>8/RIQJ#L9/'&ENR/;P^PY5TR#QC<:\:C;
MVG'2L+TR0ZK'HN_M^HGBIZ%OC<;F>?4/4$L#!!0    ( /!3?4K#N,MP7P,
M #L.   8    >&PO=V]R:W-H965T<R]S:&5E=#4N>&ULA5=M;YLP$/XKB.\I
M-B_&KI)(2[)HDS:IVK3M,TV<!A5P!B3I_OW,2VFX.]HO 3O/G9_G\-W9\ZLI
MGZNCUK7SDF=%M7"/=7VZ][QJ=]1Y4MV9DR[L/P=3YDEMA^635YU*G>Q;HSSS
M?,:$ER=IX2[G[=Q#N9R;<YVEA7XHG>J<YTGY;Z4S<UVXW'V=^)$^'>MFPEO.
M3\F3_JGK7Z>'THZ\P<L^S751I:9P2GU8N)_X_9;'C4&+^)WJ:W7S[C12'HUY
M;@9?]PN7-8QTIG=UXR*QCXM>ZRQK/%D>?WNG[K!F8WC[_NI]VXJW8AZ32J]-
M]B?=U\>%*UUGKP_).:M_F.L7W0N*7*=7_TU?=&;A#1.[QLYD5?OK[,Y5;?+>
MBZ62)R_=,RW:Y[7[1[R:T09^;^ /!ER\:Q#T!L&;0?"N0=@;A(.!'[]K$/4&
MT9O!^QI$;R & ]5^CBY6;? W29TLYZ6Y.F6W?TY)LTWYO;"?=]=,ME^S_<_&
MO[*SEZ54<^_2^.DAJP[BWT 4&T/6!(2/(1L"XH\AGPE(,(9L"4@X0#RK=)#K
MDW+]UCZ\M8^ 7 R) (MU!Q$MI&@AO@1N-ABC(B4$D(Q1,^6'##C;8E@@0T$+
M#TCA 18.N*PP! GO(-%8.!=<!#27D.028BXQ6"A$@N%^"C$5&#7LQ)^(643R
MC#!/"7A&B(5000!W+85BC-%<!,E%8"X@3S<"K<(EB-I6X+C>8$8\8I)'C'A(
MN*=CQ&/&.4SV[4>H$1=)<I&("V>@,JTP!FUJ260ST+21B*T2/(8%#*-F*HC@
MYMYBF%UPXBLH4KDBE(-/O<(8I%Q1Z2RC4$VD"6=T#V$$'1";=0^:R,:^1S B
MS'#C4" I)PA/-#U.$(;!Z4&CZ C&)O.6TQV'$RTGAKI](G6A;-P#^)1JN@5P
MH@? >L9QA0_#"&;5EH1-1X9N YSH ["F<:+,,YA/G"CT-Z Q%[K4<USK45WC
MN(S/N"_1$>4CV)@/7>XYKO><A2##"1!*<8XK?L!]&&4,4K$M7#  &#93H91H
M=V"<'ZN) L?I/L-QH^'P6+0B0#@ N-'8 /A*H2+GW9R9FVO5]Z1\2HO*>32U
M/7VWA^2#,;6V7MF=]7>T-[EAD.E#W;S&]KWLKC/=H#:G_JKF#??%Y7]02P,$
M%     @ \%-]2F/_OIK1 P  G!$  !@   !X;"]W;W)K<VAE971S+W-H965T
M-BYX;6Q]F%N/HS@0A?\*XCT#+G-M)9$Z6:UVI!FI-:O=?:83)T$#. ND,_/O
MUUPZ0[N.]Z4#[N.J4]A\QE[?=?N]NRC5>S_JJNDV_J7OKT]!T!TNJBZZ3_JJ
M&O.?DV[KHC>W[3GHKJTJCF.GN@HH#).@+LK&WZ['MI=VN]:WOBH;]=)ZW:VN
MB_;G3E7ZOO&%_][PK3Q?^J$AV*ZOQ5G]J?J_KB^MN0L>48YEK9JNU(W7JM/&
M?Q9/>TE#AU'Q=ZGNW>+:&TIYU?K[<//YN/'#P9&JU*$?0A3FYTWM554-D8R/
M?^>@_B/GT'%Y_1[]][%X4\QKT:F]KOXIC_UEXV>^=U2GXE;UW_3]#S47%/O>
M7/T7]:8J(Q^<F!P'777C7^]PZWI=SU&,E;KX,?V6S?A[G^._=\,=:.Y CPXB
M^=\.<NX@?W6(QN(G9V.IOQ5]L5VW^NZUTVA=BV%2B"=I'N9A:!R?W?@_4VUG
M6M^V(DS6P=L0:-;L)@TM-0]%8*(_4A!*L2/6G3XFV'.%E#B#A$7(L;_\4$2*
M T0P0#0&B!8!,OLA3))DE#2C9"4HDU8E2"5RPEYBZ"4&Q60X0 (#)*P8$>96
M-9,F7OA,1&C5PC6IC+&1%!I)N1$[R2YE2>((Y\A@C@SD$%:.C.6@Q?28BN4:
MD3F&+8=&<CYLPA% A/A5#$$MTGX70S J5BU ,\Q"AQD'%P0P$]EF!$IDSR.@
MHLPQHP5$R+,@X":VW1!PDT>V&ZX2%#K<8-P(R=Q$S(SD:1)A>^&BE7!,?X')
M)3BZ(L;OB ] Q+QPT8HBUX/!Z!(Q&";F)D:)F!VH<MG!(!0)>"<=ZX+ "!.(
M89E=$8?8L#;8%0$59:Z*,.T$PIW-=L%9MI(V[Y#(]4YBX(F<>R$;[[/HXZ-)
M8ML,4#D109B>%/+!)M=W"F8> >:1]:VR(\"\W)KC>R3*'&LG8>010![9JP%Q
MF.7.YX9A1AQF@FS0$Z"9/;^!AA*'%<PRXBP39(.5.*=RMN0 T2IV+("$64:
M962SC#BEXM!><8!H%6<.#A%&&8&/.DIM-_R+S8CLEPVILL3QJ4(8BP2P: -O
M1QQX(DUSVPY0+4U_M(.Q2!EX]UW#C6E&@&;2IAEQ3ME?(7ND<2SI$I-, I))
M!\DD)ID$))/VKDMR2$G'K)2841(P2MJ,FD7+/1&;DT"S]#MY"19[VEJUYW'[
MWWD'?6OZ8?>X:'T<,3R/)PQ6^TX\[:>#@E]AIG.+KT5[+IO.>]6]V7&/^^*3
MUKTR'L-/YD%=5'%\W%3JU ^7J;ENI_."Z:;7U_DL)'@<R&S_ U!+ P04
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M/]AB2&A\.-[BV4YC-AG>]/,/8LLW+O\ 4$L#!!0    ( /!3?4I+W0YOL@$
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MCC=XMM.8388W_?R#V/*-B]]02P,$%     @ \%-]2AZPO,>T 0  T@,  !D
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MW_/PQ,DAQ=Y4P1E;$>]0O$/OI4RRZYQ= M$<<YQBTG7,$L&0?4F1;J4XIO_
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M^+*Q_XTQ'E#*Y@9'J,,/-AL2&A^.=WBVTYA-AC=]^D%L_L;E'U!+ P04
M" #P4WU*")DEN[,!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q]4]MNG# 0_17+'Q"S+$VB%2!E4U6IU$JK1&V?O3" %5^(;9;T[S,VA-*6
M]L7VC.><.3,>YZ.QSZX#\.152>T*VGG?'QAS50>*NRO3@\:;QEC%/9JV9:ZW
MP.L(4I*E27+-%!>:EGGTG6R9F\%+H>%DB1N4XO;G$:09"[JC[XY'T78^.%B9
M][R%)_#?^I-%BRTLM5"@G3":6&@*>K<['+,0'P.^"QC=ZDQ")6=CGH/QN2YH
M$@2!A,H'!H[;!>Y!RD"$,EYF3KJD#,#U^9W]4ZP=:SES!_=&_A"U[PIZ2TD-
M#1^D?S3C \SU?*!D+OX+7$!B>%"".2HC75Q)-3AOU,R"4A1_G7:AXSY.-S?9
M#-L&I#,@70"W,0^;$D7E'[GG96[-2.S4^YZ')]X=4NQ-%9RQ%?$.Q3OT7LK=
M=9*S2R":8XY33+J.62(8LB\ITJT4Q_0O>+H-WV\JW$?X_C>%_\B?;1)DD2#[
M;XE;,7^J9*N>*K!MG"9'*C/H.,DK[S*P=VE\DU_AT[1_Y;85VI&S\?BRL?^-
M,1Y02G*%(]3A!UL,"8T/QQL\VVG,)L.;?OY!;/G&Y1M02P,$%     @ \%-]
M2NI3+[ZT 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL?5-M
M;]L@$/XKB!]0$N)T561;:CI-J[1*4:>MGXE]?E&!<P''[;\?8,?S-FM?@#ON
M>>ZYXT@'-*^V 7#D74EM,]HXUQT8LT4#2M@;[$#[FPJ-$LZ;IF:V,R#*"%*2
M\<WFEBG1:IJGT7<R>8J]DZV&DR&V5TJ8CR-('#*ZI5?'<ULW+CA8GG:BAN_@
M?G0GXRTVLY2M FU;U,1 E='[[>&8A/@8\+.%P2[.)%1R1GP-QF.9T4T0!!(*
M%QB$WR[P %(&(B_C;>*D<\H 7)ZO[%]B[;Z6L[#P@/*E+5V3T3M*2JA$+]TS
M#E]AJF=/R53\-[B ].%!B<]1H+1Q)45O':J)Q4M1XGW<6QWW8;S97V'K #X!
M^ RXBP V)HK*/PLG\M3@0,S8^TZ$)]X>N.]-$9RQ%?'.B[?>>\FWM[N470+1
M%',<8_@R9HY@GGU.P==2'/D_<+X.WZTJW$7X[@^%R3I!LDJ01(+DOR6NQ>S_
M2L(6/55@ZCA-EA38ZSC)"^\\L/<\OLGO\'':GX2I6VW)&9U_V=C_"M&!E[*Y
M\2/4^ \V&Q(J%XZ?_-F,8S8:#KOI!['Y&^>_ %!+ P04    " #P4WU*]SR]
MDK0!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q]4]MNVS ,
M_15!'U ECI<&@6V@:3%LP 8$';8^*S9M"]7%D^2X^_M1LN-ZF[$72:1X#@\I
M*AN,?74M@"=O2FJ7T];[[LB8*UM0W-V9#C3>U,8J[M&T#7.=!5Y%D)(LV6SV
M3'&A:9%%W]D6F>F]%!K.EKA>*6Y_G4":(:=;>G,\BZ;UP<&*K.,-? /_O3M;
MM-C,4@D%V@FCB84ZIP_;XRD-\3'@AX#!+<XD5'(QYC48GZN<;H(@D%#ZP,!Q
MN\(C2!F(4,;/B9/.*0-P>;ZQ?XRU8RT7[N#1R!=1^3:G!THJJ'DO_;,9/L%4
MSP=*IN*_P!4DA@<EF*,TTL65E+WS1DTL*$7QMW$7.N[#>)/>8.N 9 (D,^ 0
M 6Q,%)4_<<^+S)J!V+'W'0]/O#TFV)LR.&,KXAV*=^B]%MO]/F/70#3%G,:8
M9!DS1S!DGU,D:RE.R3_P9!V^6U6XB_#='PKOUPG258(T$J3_+7$MYO!7$K;H
MJ0+;Q&ERI#2]CI.\\,X#^Y#$-WD/'Z?]*[>-T(Y<C,>7C?VOC?& 4C9W.$(M
M?K#9D%#[<+S'LQW';#2\Z:8?Q.9O7/P&4$L#!!0    ( /!3?4K3< 8!M0$
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M\1;/;AJSR0BVGW\06[YQ^0M02P,$%     @ \%-]2A7&VJ-N @  # D  !D
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MR@Q3/19#?QXFBO?CW0--%Z#R+U!+ P04    " #P4WU*]I 3M;8!  #2 P
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M^-F?S31FD^&PGW\06[YQ\1=02P,$%     @ \%-]2N$&K^.V 0  T@,  !D
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M/YMYS&;#X;#\(+9^X_(O4$L#!!0    ( /!3?4JV8J9:N $  -(#   9
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;&U3[8Z<(!1]%<(#+ YC9Z<3-=G9
MIFF3-IELT_8WHU<E"V(!Q^W;]X*NM5O_ /=RSKD?7++1V&?7 GCRHE7G<MIZ
MWY\8<V4+6K@[TT.'-[6Q6G@T;<-<;T%4D:05XTER8%K(CA99]%ULD9G!*]G!
MQ1(W:"WL[S,H,^9T1U\=3[)I?7"P(NM% ]_ ?^\O%BVVJ%120^>DZ8B%.J</
MN],Y#?@(^"%A=*LS"95<C7D.QN<JITE("!24/B@(W&[P"$H%(4SCUZQ)EY"!
MN#Z_JG^,M6,M5^'@T:B?LO)M3H^45%"+0?DG,WZ"N9YWE,S%?X$;*(2'3#!&
M:92+*RD'YXV>53 5+5ZF779Q'Z>;PWZF;1/X3. +X1CCL"E0S/R#\*+(K!F)
MG7K?B_#$NQ/'WI3!&5L1[S!YA]Y;P9/[C-V"T(PY3QB^PNP6!$/U)03?"G'F
M_]'Y-GV_F>$^TO?KZ.EA6R#=%$BC0/I/B<<W)6YAWK\)PE8]U6";.$V.E&;H
MXB2OO,O /O#X)G_AT[1_%;:1G2-7X_%E8_]K8SQ@*LD=CE"+'VPQ%-0^'._Q
M;*<QFPQO^OD'L>4;%W\ 4$L#!!0    ( /!3?4J9QPT1M@$  -(#   9
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M25&G=9^)?;91P7B X^[?#[#C>1E? G=^]]X[X))/2K^9#L"B=REZ4^#.VN%
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M=0=-$WB]_F#_8I/7R>RHA#5GOZN]*A?NS'7V<* GIE[XY2OT"<6NTV?_'<[
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M@)DB<E)$ICY>U(?)!P:QTR V!LF[&-B*,6HRH^E&31Y;0=::,$_<((D3)'&
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M7N1BJYK;@;ZONO&S6RAYZ$?KX#S?S_X"4$L#!!0    ( /!3?4J)Z;*=I@(
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M=STR)JGRWWU19UFH?NLVJ.A1ZL](??.^Z>@'DK5#0^7<NKKL'U!+ P04
M" #P4WU*@X7N]>\!  !&!0  &0   'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q]5-MNG# 4_!7$!\1@+INN "FAJEJIE5:IVCY[X;"@&$QM[Y+^?7TAE(";
M%WR;F3-C;&<3X\^B!9#>2T\'D?NME.,1(5&UT!-QQT88U$K#>$^D&O(+$B,'
M4AM23Q$.@A3UI!O\(C-S)UYD["II-\")>^+:]X3_>03*IMP/_=>)I^[22CV!
MBFPD%_@.\L=XXFJ$%I6ZZV$0'1L\#DWN/X3',M5X _C9P216?4\G.3/VK =?
MZMP/M"&@4$FM0%1S@Q(HU4+*QN]9TU]*:N*Z_ZK^R6176<Y$0,GHKZZ6;>[?
M^UX-#;E2^<2FSS#G27QO#O\5;D 57#M1-2I&A?EZU55(UL\JRDI/7FS;#::=
M[$J"9YJ;@&<"7@AA_"XAF@G1AH"L,Q/U(Y&DR#B;/&Y_UDCTF0B/D=K,2D^:
MO3-K*JU0L[<BPE&&;EIHQCQ:#%YA\%M$N4=$_T20,K"XP$X7V/"C%3],L%L@
M<@I$1B!^$R/>Q+"8U& &6R0];((X,,&]VTCL-!([C"0;(Q:3K(K@('0729Q%
M$D>1=%,DV14)D\V/+1V8]#]I4Z>1=&?DPW;7T]V.)CC<^-AC\"'=^$"K$ZU?
MF&^$7[I!>&<FU>4P1[AA3(+2"^Y4I%8]:LN 0B-U]Z#ZW%YM.Y!LG%\MM#R=
MQ5]02P,$%     @ \%-]2H8JOCDT @  L 8  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S@N>&UL?57K;ILP%'X5Q /4W$,B@M0DJC9IDZ).VWX[Y"2@VIC:
M3NC>?KY02HC;/]@^_B[G&',H>L9?1 T@O3=*6K'V:RF[%4*BJH%B\< Z:-7.
MB7&*I5KR,Q(=!WPT)$I0% 09HKAI_;(PL3TO"W:1I&EASSUQH13S?QL@K%_[
MH?\>>&[.M=0!5!8=/L,OD+^[/5<K-*H<&PJM:%CK<3BM_<=PM5MJO '\:: 7
MD[FG*SDP]J(7WX]K/] ) 8%*:@6LABML@1 MI-)X'33]T5(3I_-W]2=3NZKE
M@ 5L&?G;'&6]]G/?.\()7XA\9OTW&.I)?6\H_@=<@2BXSD1Y5(P(\_2JBY",
M#BHJ%8K?[-BT9NSM3IH/-#<A&@C12 BS+PGQ0(@_",F7A&0@)#,"LJ68L]EA
MB<N"L][C]NUV6%^B<)6HTZ]TT!RVV5/'(U3T6L;1HD!7+31@-A8333#AB$!*
M?;2(7!:;Z(X>W1IL[Q%Q? O9.2!1[LXB=A8:&X%X6D2:N@42IT!B!)*;#):S
MD[*8S&!:@TEFI=XC/DDB=2:1WB<1![,DTCN+7+6!P&V3.6TRATTXJ\1BTHE-
M%(2?O)*%TV7A<)E?C87#)<[<+KG3)7>XS&^7"Y.X399.DZ5#()V9N#!S$S3Y
M;BGPL^F)PJO8I97Z^D^B8]M]C/1W/XMO5#NVW?-#QO;RGYB?FU9X!R955S'?
M_HDQ"2K%X$$==*U^'^."P$GJZ4+-N6VB=B%9-_P?T/B3*O\#4$L#!!0    (
M /!3?4H7,3SY,@(  (,&   9    >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM
M;'U5VXZ;,!#]%<1[UN$:&@'2)E752JT4;;7MLT,F :V-J>V$[=_7%Y9EP>D+
MV,.9,V<.>,A[QE]$#2"]5TI:4?BUE-T6(5'50+%X8!VTZLF9<8JEVO(+$AT'
M?#))E*!PO4X1Q4WKE[F)'7B9LZLD30L'[HDKI9C_W0%A?>$'_EO@J;G44@=0
MF7?X C]!/G<'KG9H9#DU%%K1L-;C<"[\QV"[SS3> 'XUT(O)VM.='!E[T9MO
MI\)?:T% H)*: :O;#?9 B"92,OX,G/Y84B=.UV_L7TSOJI<C%K!GY'=SDG7A
M9[YW@C.^$OG$^J\P])/XWM#\=[@!47"M1-6H&!'FZE57(1D=6)04BE_MO6G-
MO;=/XFQ(<R>$0T(X)@3I?Q.B(2%Z3XA-\U:9:?4SEKC,.>L];E]6A_4W$6PC
M96:E@\8[\TQU*U3T5D91FJ.;)AHP.XL))YA@1"#%/I8(725VX2(]_%A@OT1$
MD;M"Y&PB,OG15&"2N EB)T%L".(/ C8S%RPF-9C68%;QW*J]"[2^(R5Q2DD<
M4K*9%(M))E7FCBX1=PQ-G2)2AXA/,Q'IHL0JG=OAPMSY=C9.(9NED'#^>6X6
M18(XG@E98E9W#,F<.C*'CKDAV>+=1\G<D"4FGIAFA:#)V:7 +V;,":]BUU;J
M4S*)CI/T,=1G?Q;?J0EK!^([C1W//S"_-*WPCDRJR6+._YDQ"4KB^D&Y5*L_
MPK@A<)9ZN5%K;N>BW4C6#2,?C?^=\A]02P,$%     @ \%-]2@UHYF%< @
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M],M[HE2 K,=[D*54LO^/$P(GH8:I'#/3!<U$T&YH\&C\RA1_ 5!+ P04
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M,SM"'8107,>(%KK[3GJJGA8-/RCS6NAW.8R6PT*)\S@V)]/LOOX+4$L#!!0
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MJ''!X6C<=&[GJF_3_<+(=KB"R'@/%O\ 4$L#!!0    ( /!3?4HA W@L(0,
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M2(Y2,.D-_-R P)N_[OJ:$*'UVU<7[R[>7U[IFS]>7=W>./ZB#W2<ZMO[;%W
M AN?^?QDW(6%85%$9?&R\3@L[HF_3?&/Z._K^"%,X/W&)(C_D0ZG4^2TA<ZC
M:02OWB51H).H*#0<:?88IM-( \?1LVQ]5\[7B?L@F^N#,<UT<*H!^+#H:'D'
M6& 8(3W#'00P>+&*IF7\$"4-G'B;/L#RLCR.BD"G40,A/N31*HQG.OH,#+^
M<\5AL_(>9II60-'88%;"X6Q_YPK@L[(B(0%*C.ZS9*;CY2K/'B)\TKZJ:UH
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MKQ_#8?,!(Z82.G<N/&(Y7EMLPR*IO]^UR\:'-V"9D,;H,<-]WNG<X8Z5-WP
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MXP-"R>'WYK^J'N+&I4QD02YT\)9HGT_)'0$"^#8#J:TG".,W@&B*TK#U3W#
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M@$!E7PP!BY*B3AN:MOXE>&&CT"C-21DF1Y(!7B7#C@2',0&-(Y>/V_C -W"
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M2,*9EZQ1$W\FSHI1>?11.)R R<P1$^@,7 F@XSX>&D:SE< 9$[LC#@B+8D7
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MH5:+J_+O8O]Z%LO3BTJ,VD7S2&>#7XS%IUH*>,E32$6(=2KTUN438D]?@;U
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MAG<9<*X+LR%]B&N4HZ[2O'O)\G]"FG=@AN3EY@%LT4B_ NPA.KS-D;M*]F:
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MK!T,&T&>EHPV2F0S?48J!VF/BE*7,2M+V(2CS\KZ*QXVPW.< !_VR:=6D>#
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M2:WJ1/WBO=T]K1F8^C95N\!(1ZXV@5E0LT(8N/ 8M&D@N;&AY Z-R?@?=E6
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MTZ0W@>C&D^V1Z/KK?QOLP(7&U/_2J+7>%K7>'4Q^NBFU1W2W ;^= =[&<6.
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MP    !,"   +              "  0    !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( /!3?4IF\PM@@@   +$    0              "  >D   !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ \%-]2B!?/,CO    *P(  !$
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M970R+GAM;%!+ 0(4 Q0    ( /!3?4J >6706 (  "P(   8
M  "  :</  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #P
M4WU*"5RNM_("  !("P  &               @ $U$@  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ \%-]2L.XRW!? P  .PX  !@
M         ( !714  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( /!3?4IC_[Z:T0,  )P1   8              "  ?(8  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #P4WU*_+&VI+ !  #2 P
M&               @ 'Y'   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ \%-]2H;HMARU 0  T@,  !@              ( !WQX  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( /!3?4I+W0YOL@$
M -(#   8              "  <H@  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " #P4WU*'K"\Q[0!  #2 P  &0              @ &R
M(@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( /!3?4HU
MGG_YM $  -(#   9              "  9TD  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ \%-]2OVT09:T 0  T@,  !D
M     ( !B"8  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /!3?4KJ4R^^M $  -(#   9              "
M 1TP  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ \%-]
M2O<\O9*T 0  T@,  !D              ( !"#(  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " #P4WU*TW & ;4!  #2 P  &0
M        @ 'S,P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( /!3?4I1>[1[M $  -(#   9              "  =\U  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ \%-]2A7&VJ-N @  # D
M !D              ( !RC<  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " #P4WU*]I 3M;8!  #2 P  &0              @ %O.@
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( /!3?4KA!J_C
MM@$  -(#   9              "  5P\  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ \%-]2K9BIEJX 0  T@,  !D
M ( !23X  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #P
M4WU*F<<-$;8!  #2 P  &0              @ $X0   >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( /!3?4J%%--EMP$  -(#   9
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M970S,"YX;6Q02P$"% ,4    " #P4WU*S*]G<64"  #!"   &0
M    @ &.30  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M /!3?4H)J"!E"P(  /,%   9              "  2I0  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ \%-]2ELJM1?: 0  8@0  !D
M             ( !;%(  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " #P4WU*^&"<KID"  !("@  &0              @ %]5   >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( /!3?4KTGISO=0,
M .L/   9              "  4U7  !X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ \%-]2HGILIVF @  X0D  !D              ( !
M^5H  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #P4WU*
M@X7N]>\!  !&!0  &0              @ '670  >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( /!3?4J&*KXY- (  + &   9
M      "  ?Q?  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ \%-]2A<Q//DR @  @P8  !D              ( !9V(  'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " #P4WU*#6CF85P"   I"
M&0              @ '09   >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( /!3?4KEWC$;, (  '$&   9              "  6-G  !X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ \%-]2@P (!Y[
M @  C0@  !D              ( !RFD  'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " #P4WU*9RNT:2@"  "(!@  &0
M@ %\;   >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( /!3
M?4II%.U)_0(  ,<+   9              "  =MN  !X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ \%-]2F)Y#+LP @  $P<  !D
M         ( !#W(  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M    " #P4WU*(0-X+"$#  "%#0  &0              @ %V=   >&PO=V]R
M:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( /!3?4JYL?CP!P(  )4%
M   9              "  <YW  !X;"]W;W)K<VAE971S+W-H965T-#<N>&UL
M4$L! A0#%     @ \%-]2@IQ0\A. @  7P<  !D              ( !#'H
M 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " #P4WU*F% 8
M&)$X  #&^P  %               @ &1?   >&PO<VAA<F5D4W1R:6YG<RYX
M;6Q02P$"% ,4    " #P4WU*G.W-,#$"  !]"0  #0              @ %4
MM0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( /!3?4K4Z_'\W0,  $4?   /
M              "  ;"W  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #P
M4WU*:]=\*\\!  !U'0  &@              @ &ZNP  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #P4WU*&7O2#L$!  !V'0  $P
M            @ '!O0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     .0 Y
+ ($/  "SOP     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>79</ContextCount>
  <ElementCount>243</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>28</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/BalanceSheets</Role>
      <ShortName>BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/StatementsOfOperations</Role>
      <ShortName>STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/StatementsOfStockholdersEquity</Role>
      <ShortName>STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/StatementsOfCashFlows</Role>
      <ShortName>STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Note and Line of Credit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/NoteAndLineOfCredit</Role>
      <ShortName>Note and Line of Credit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Equipment and Leasehold Improvements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/EquipmentAndLeaseholdImprovements</Role>
      <ShortName>Equipment and Leasehold Improvements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Lease Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/LeaseCommitments</Role>
      <ShortName>Lease Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Capital Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/CapitalStock</Role>
      <ShortName>Capital Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Stock Options and Stock Grants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/StockOptionsAndStockGrants</Role>
      <ShortName>Stock Options and Stock Grants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - 401(k) Profit-Sharing Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/KProfit-sharingPlan</Role>
      <ShortName>401(k) Profit-Sharing Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Significant Customers and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock</Role>
      <ShortName>Significant Customers and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Business Segmentation and Geographical Distribution</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock</Role>
      <ShortName>Business Segmentation and Geographical Distribution</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://nanophase.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nanophase.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Equipment and Leasehold Improvements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables</Role>
      <ShortName>Equipment and Leasehold Improvements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nanophase.com/role/EquipmentAndLeaseholdImprovements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Lease Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/LeaseCommitmentsTables</Role>
      <ShortName>Lease Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nanophase.com/role/LeaseCommitments</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nanophase.com/role/AccruedExpenses</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nanophase.com/role/IncomeTaxes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Stock Options and Stock Grants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/StockOptionsAndStockGrantsTables</Role>
      <ShortName>Stock Options and Stock Grants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nanophase.com/role/StockOptionsAndStockGrants</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Note and Line of Credit (Detail Narratives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/NoteAndLineOfCreditDetailNarratives</Role>
      <ShortName>Note and Line of Credit (Detail Narratives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/NoteAndLineOfCredit</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Equipment and Leasehold Improvements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetailsNarrative</Role>
      <ShortName>Equipment and Leasehold Improvements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Equipment and Leasehold Improvements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/EquipmentAndLeaseholdImprovementsDetails</Role>
      <ShortName>Equipment and Leasehold Improvements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/EquipmentAndLeaseholdImprovementsTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Lease Commitments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/LeaseCommitmentsDetailsNarrative</Role>
      <ShortName>Lease Commitments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/LeaseCommitmentsTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Lease Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/LeaseCommitmentsDetails</Role>
      <ShortName>Lease Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/LeaseCommitmentsTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/AccruedExpensesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/IncomeTaxesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/IncomeTaxesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Income Taxes (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/IncomeTaxesDetails1</Role>
      <ShortName>Income Taxes (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/IncomeTaxesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Capital Stock (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/CapitalStockDetailsNarrative</Role>
      <ShortName>Capital Stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/CapitalStock</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Stock Options and Stock Grants (Detail Narratives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/StockOptionsAndStockGrantsDetailNarratives</Role>
      <ShortName>Stock Options and Stock Grants (Detail Narratives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/StockOptionsAndStockGrantsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Stock Options and Stock Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/StockOptionsAndStockGrantsDetails</Role>
      <ShortName>Stock Options and Stock Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/StockOptionsAndStockGrantsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Stock Options and Stock Grants (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/StockOptionsAndStockGrantsDetails1</Role>
      <ShortName>Stock Options and Stock Grants (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/StockOptionsAndStockGrantsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - 401(k) Profit-Sharing Plan (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/KProfit-sharingPlanDetailsNarrative</Role>
      <ShortName>401(k) Profit-Sharing Plan (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/KProfit-sharingPlan</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Significant Customers and Contingencies (Detail Narratives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives</Role>
      <ShortName>Significant Customers and Contingencies (Detail Narratives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation</Role>
      <ShortName>Business Segmentation and Geographical Distribution (Detail Narratives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="nanx-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/SubsequentEvents</ParentRole>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>nanx-20161231.xml</File>
    <File>nanx-20161231.xsd</File>
    <File>nanx-20161231_cal.xml</File>
    <File>nanx-20161231_def.xml</File>
    <File>nanx-20161231_lab.xml</File>
    <File>nanx-20161231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001387131-17-001688-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001387131-17-001688-xbrl.zip
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MXG&5%HU^RF6?.=/6X)2/'QD/RX,3]UF:(G!J-YM$;Z4]:_8$NP!2L/S&8&=
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M7H1UB1I]H@ ?22KTS9EH:@$1,D7"R6/]HT7\;B2%:A$W*F4%VW'G*,B+"X\
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M7,$M<@)JHS"!JBMW^(A>]\( V"O#=U 3(RT,=$2JA$^6,KR28["#:VI"5EP
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MR@%==+JZIH_PA_'E"L4!7L@+&Y;K=1.7EE?KM^9^TF^!K,H."K4IFBE8U0#
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MIO?AP=K?EZCW5Q"X$'V]':[JG87AXO3@X.GIZ4T '^TGB+[C-PZ4JVX,(^2
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M^)Z*$ VJ3-))'CW0(K-;;6SRXA]57,(6Z#I+X<Z32Y18S3-+I-@DOC):K&+
M@RH'*8?H$J1D0XO*.MVRLFC.UB9\66LT3FI2GZ@R"=L%DXH.#88,P@VATY(2
M3HL#,7 :(TOM<%'0^?69-&+VG:0!$1J4Z"23W2"@PX2/DRB*P2<+DML@CJ[2
MLV =ET%BQ(J%QVOTWT7\7OS>Q( &3RY22C'TEH< TW&<DIH-!]+N:!G$*8V:
M[0(CQ'3$7L]=&07N'<)24J)!DU$\"49A6*VJ!"YFDG.ZC,.XQ(&?VSQ;T[Q\
MNV7BEB=I!)[:&KP[:Q34B=.O9^2L2M]1LK*AP9R[K+(;)3B/".<E01J1EAOA
MM<=6-O-NX)#*ZQZ@6L3>SE^?! V.U'*I5FUK<1(=55S@IGRB>3T+Q[_12#LJ
MC-@978I/;$U4L8N]D46@P>8TN:5X%DV6QV=96I1Y%<*L>U(4M,06X;JF04&?
MLB2Z6JWS[)F'5<PNG)'#[U5OJ^C]&]]:<C3(L\LHW_^N.4B7!1G(+BOFH)95
M3MG@N8Q?X9,98R8&GQ"S"]Y%F)X:#<"L(@[Q=;-D2P5*6CYDR!+B.4ZW:EJO
MDZI)W-[4J2)$@R*3=!H 8?7DV@DZSM*KE,WTCZRQS,;)S.)Y1]HJ_& W6DN/
M!EP.0BIVH5L6$J>D84*&M8]!^!2G-']S7B$8.?S>3;**WK^II"5'@S.[C/(M
MIIJC'[M AC+N$9[D.5S'!/$L030]N7=?WB"TY,@K:-$@RR*@TH4G'?J=!L,T
MN3K8M%S$)?USD+/50U48\G7H*+WE[#"+VN;M4)/-#@J[; J/"8A)2[WOO"UW
MV8IFSW&2T*N$46>QVO^QT'K#@TW<%A$Z0AR8L$@G7:]OR4E#CVSBN:\6!?U'
M!>=RGNWSCI;:;XH.H\C]'!U*TMFQY":?G.JEH2:<'-_VRT ?2[87)>V,2#+E
M>E$08D61.< ]Q! N<W110=@^2']*K3?Z5)1>]_'THO;V\F0R-,#1RR;?W\]7
M0?JV;Z?FM,KSNSAZI)=!&"=Q^:;W:;2DWEP:B["M1Z.AFQT%#L))>:(8->'D
MI*'?-R3.L[#B*=#8@C\M687PE 0#(X2-3A9%F0=AJ5+,C<\;6,:HT2+'A0D'
MC$9(.L14PTI.(#[#F4F'F_DW-?].IZB"AE\^9L]?132&V>D[^ #H^ZXS*;&O
M_B8$.N/799*K-**O_T'?!BU@H/.!+ZN8@"<MT>SXL4DF'2\1$*F)":<FC'P^
M=-S1QQ@@FI;PP(U6O2&97VRHA>Q#HT^#"!E*P33 V-#R]X;F@$5CTF!]IM"I
M_[,O&*B$:KJ_^QN*;E<(I)TW@&:.7CYAM4<@P642/"IT&/SNJY^58C4=W?L1
M14^K))*.03<T!(CF'-'M,U#P$)H!MP,ZWV-<*>9PL/>(4&#!))EV^ MBYCE&
M_'6Z.=#QD ?PN.#]VVJ1J?0:_.X+#4JQ&A3T?D31^RJ)AKU>TQ!!-$=?G[$E
M,%BKN B#Y"\TR/7&0$_J"P$V81LPZ.A0X,(BG)Q@@Y,304^ 85;C(-S2/],D
M^8\T>TGO:5!D*8VNBJ*2(EL.]'Y7#1:Q^\L'#3$*$+E(J%E0! 38CG\%/M(P
M$L$Y'Z!^SI(J+8/\C;\_.]RP,]#Y!9!&S#YP!D2( *.63 N4EIQP^AD#5L((
MWM%UEI<PJ?(W=_61%PVYY_"54>A!%$M)BP@Y1@'5 /I=05KR^I5D4A<S'Y(X
MD,_8W/F8Y?K YX#*+VZ4(O;ATB-!A!*57!KK4K\S7M/.!XC;:I'$X662!<-]
M%PV-7S HQ.M#H4. " BR5!H8"$+"*><#P75<@)6Z#7+^BGN3;5BKGI;>+S@L
M8O>!HB%&!!JSA+J-DT[:DR/"> EGGM%7V>1KX>(7-U59E$$*"WW]]&ID\NRW
M."@P\%X,'(CPY2"F$\@$,^EPSQG#%8$!$3:\9-^IW&(#K>]8KE;<83Q7(D2!
M))MTVKAN';^IP[N<97[40#3)#3,=RGD0(XFJQDM+AA M0]EL6.&QOITC90>9
M*&^6EW$:I&',1D!6Q(:S2^-89\E+Z:",,CVE@6]V[$T05G[<H&:%E/4M,VFX
M]W2.:8MD<SRSA06&0R*OZ>24 O;RQ_4HT(!(*9:TIWU_?_%PCPD*=:C)"1$2
MK7]@:,25\3$@1 83M72Z3:V \_R  S9G0?%TDD;P%]RK?0X2"OE\R[,@S]^8
MD\_7E1KE'7F]7LP?HT[OAKX+(QK8C9%6@B%CXO>H0_A -^PX 'D2AEG%I+FC
M(662+1+(7UX/'=T@-+)XM6H.PO>,FX$>#=@<A%0=\: DJ!E)WG(>D0320P1)
MDKTPYXJ299:3**L6Y;)*-@S,^_KGWW.0_O._$.9WG;,"X(("^?;#$0'@\-_8
MA]\?L<*+-0WAH;-DIQ'UZ1"^2N%65I:_L7;2M&F?Q"=$5<)U(=G]'0T$%4(-
M(=>0Q+0X(BE%DV.5KH,XNGA=T[2 W$\\Q5W/:]"H[,3I.?N\JRJ#9/0V-C0P
M<Y=5D:H>. D5K 6W3QEPD[#G]N& I0L 9X2:%53SP:?,RB"Y=ET1Z*9'* 0E
M,+09-_53F9D%119HS51GHD=DDZQ"ZI/W@A5*VD25<2=1):(YLF-D/[%.-AHE
M#:WW_+PZ<:4LO$-"-+@R22<EQN$3F;!3B( CI#?:X3GF+?V$A7&F,DY1F*:F
MZSA8P&UU>/@Z%:\'@56C>2&>F++$/-W9_3X$/$ZI_O/ ;KQH3,Y(@:5T;5<G
MIU?75P]7%_?DY-,YN7^X.?N/_WUS?7YQ=_\[<O%_?KIZ^ LZJ+H%Y$T,,\'1
M(32OI\8(N7%!^F3#B"92S_/B\Z2%-XLD?N2I%2R+.!N3W]B\BP+]H+R) PW(
MG,34 8V?%<]2"'F&HASAL9-L4Q(. #9QX-O@#4*Y;C'Y(?$<T7BUP*HX?)\2
M#<",XBG>FQ)!]+6@1@.>O**1;(_U*NOH/4/(+/8 16IB3$ R2JC $M"W84T<
M6'(&T=SH<8/-S'BQKA.=T=(/:W8\*!RPT4S3UIB3 Q\"-\H<B[(RH3%1KI)*
MJ\,L?3PN:;XZ((_JO'[?^(ZI=<;^CDLK&,TL/G'H(GP7@B9Z-.AS$%(/O*AY
MKGK7MSVW#)'>T3+.Q8G8$6;/C=5[>-51&2GX:N%#@\ 1PDK>&K R\#6\^ Q>
MQY6PXD]#.Y/_9D:8DA"M%V<%DG#DDM:PX7/ELM4J+OE&)AR#S%*X0DG3D FH
M<RM,''Z?CK**WG\Y2DN.QF39952\&R5H$"X31N\L8=E+&K=[= #[1:-WB+H,
MO^-'F\LW)-'[V[QV#KF,IE/U2DK/!_UTH@X.]@W)T"!'+YOBX%[MM!?BGO,_
M?_GU![(.<O(,7$?DF^^.OO[#'T@AKC\'5?F4Y? V,3];DV;-#S&DDA)?9ONY
M(KW=;%E? 3=>YY#(?,^+*B&'DV&7!@W>-(+)TQZ_4:]!VG??''W]]=?P/X?1
MM[]O_RF![X]P$/Z;;[X_^O[[^BC\'XY^_X??'WW'_FD$I/XP_?!;E"?K3Z*(
M7\0,DML@CJ[2.EBD6TKIJ+TN6LTB]]:I:E(T*#?+)ZU&6VH"1Z./X[0)Q^'
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M5$&>JYLEU[9S0-8-EE,+\XG6[13N@GA:26BPO97X0\@WA9% E$927AQL]DK
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MQ@Q;F0_AK4%7F9V?:,0*2;ATF[+:8JVW9^&9%X0*\<WHZS#@AYTLK)Q;HZ7
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MKMJ2U<$6,V_P[@,GWAPS ?90"$\2+CUY"I[AEQBL#?N6D>?M6Q(I QZ\49>
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MG4'8;] /6HCNI39L&-VODM[,JAVDW:^NV2?V=?,5^P.J8M_\/U!+ P04
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M!'5,LQ6";Q?Y^M##+-CI,WN4 IF+?Z_)DC)!4*\K@,'@O3D/=S'Y/>4?/7V
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M@EN%92E[.3O3Z@ 9A'\<2*UO&'$"Y<ALMW)VO-4!B3;^<$C^BI&E%Y2YP]S
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M->&N8APDY(:PA\ G.>/7Q*?S*!M%4U75_I==YYV#E6A?(.!0.:O)%?9OL.O
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M@;5[E )7C>]J=&UR%P;S#!; %E_;T?71 &B_#&0?A\F"CBZTNV:S45R']Z$
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M'%:/#D5E;!S*U+L!]N5X5"2U=K3=*E3.*__*^"E0Z$:MV9\#YAK3E7TJYAE
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MHC$*G!5_$?\CGI'CO_D_4$L! A0#%     @ \%-]2A"[B\(T>@   -8% !$
M             ( !     &YA;G@M,C Q-C$R,S$N>&UL4$L! A0#%     @
M\%-]2B'$W,1_#0  @X$  !$              ( !8WH  &YA;G@M,C Q-C$R
M,S$N>'-D4$L! A0#%     @ \%-]2G\%>MU^$0  ]^\  !4
M ( !$8@  &YA;G@M,C Q-C$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( /!3?4K!
MQZ/5F1H  +J7 0 5              "  <*9  !N86YX+3(P,38Q,C,Q7V1E
M9BYX;6Q02P$"% ,4    " #P4WU*UX-&BG!-   '7@0 %0
M@ &.M   ;F%N>"TR,#$V,3(S,5]L86(N>&UL4$L! A0#%     @ \%-]2D0%
MC>\+,P  F$P# !4              ( !,0(! &YA;G@M,C Q-C$R,S%?<')E
:+GAM;%!+!08     !@ & (H!  !O-0$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
